activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
,616604,[],CHEMBL766860,"Inhibition of Protein kinase B, Akt-1",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O,,,CHEMBL1136094,Bioorg. Med. Chem. Lett.,2003.0,"{'bei': '10.64', 'le': '0.19', 'lle': '0.58', 'sei': '5.31'}",CHEMBL307152,,CHEMBL307152,5.26,False,http://www.openphacts.org/units/Nanomolar,130093,=,1,True,=,,IC50,nM,,5480.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.48
,750633,[],CHEMBL766866,Inhibition of Protein kinase B (Akt-1),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1,,,CHEMBL1148336,J. Med. Chem.,2004.0,,CHEMBL115220,,CHEMBL115220,,False,http://www.openphacts.org/units/Nanomolar,215208,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,953939,[],CHEMBL766409,Inhibition of Protein kinase B alpha,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(O)c(C(=O)c2ccc(C(=O)O[C@@H]3CCCNCC3NC(=O)c3ccncc3)cc2)c1F.Cl.Cl,,,CHEMBL1149095,J. Med. Chem.,2004.0,"{'bei': '16.36', 'le': '0.31', 'lle': '5.43', 'sei': '6.54'}",CHEMBL3216643,,CHEMBL281464,8.30,False,http://www.openphacts.org/units/Nanomolar,44257,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,962852,[],CHEMBL766409,Inhibition of Protein kinase B alpha,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(O)c(C(=O)c2ccc(/C=C/[C@@H]3CCCNC[C@H]3NC(=O)c3ccncc3)cc2)c1F.Cl,,,CHEMBL1149095,J. Med. Chem.,2004.0,"{'bei': '13.88', 'le': '0.26', 'lle': '2.82', 'sei': '6.76'}",CHEMBL1204095,,CHEMBL283457,6.80,False,http://www.openphacts.org/units/Nanomolar,44261,=,1,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,160.0
,964153,[],CHEMBL766409,Inhibition of Protein kinase B alpha,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(O)c(C(=O)c2ccc(CO[C@@H]3CCCNCC3NC(=O)c3ccncc3)cc2)c1F.Cl.Cl,,,CHEMBL1149095,J. Med. Chem.,2004.0,"{'bei': '13.07', 'le': '0.24', 'lle': '3.22', 'sei': '5.88'}",CHEMBL1202525,,CHEMBL28982,6.45,False,http://www.openphacts.org/units/Nanomolar,44259,=,1,True,=,,IC50,nM,,355.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,355.0
,965573,[],CHEMBL766409,Inhibition of Protein kinase B alpha,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(O)c(C(=O)c2ccc(C(=O)N[C@@H]3CCCNCC3NC(=O)c3ccncc3)cc2)c1F.Cl.Cl,,,CHEMBL1149095,J. Med. Chem.,2004.0,"{'bei': '16.58', 'le': '0.31', 'lle': '5.95', 'sei': '6.48'}",CHEMBL1202518,,CHEMBL430530,8.40,False,http://www.openphacts.org/units/Nanomolar,44258,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,969291,[],CHEMBL766409,Inhibition of Protein kinase B alpha,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(O)c(C(=O)c2ccc(NC[C@@H]3CCCNCC3NC(=O)c3ccncc3)cc2)c1F.Cl,,,CHEMBL1149095,J. Med. Chem.,2004.0,"{'bei': '9.34', 'le': '0.17', 'lle': '1.22', 'sei': '4.09'}",CHEMBL1204097,,CHEMBL28873,4.60,False,http://www.openphacts.org/units/Nanomolar,44262,=,1,True,=,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,977961,[],CHEMBL766409,Inhibition of Protein kinase B alpha,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(O)c(C(=O)c2ccc(CN[C@@H]3CCCNC[C@H]3NC(=O)c3ccncc3)cc2)c1F.Cl,,,CHEMBL1149095,J. Med. Chem.,2004.0,"{'bei': '11.21', 'le': '0.21', 'lle': '2.71', 'sei': '4.91'}",CHEMBL1202519,,CHEMBL281973,5.52,False,http://www.openphacts.org/units/Nanomolar,44260,=,1,True,=,,IC50,nM,,3000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.0
,1006296,[],CHEMBL874644,Inhibition of PKBalpha (Akt1) ser/thr kinase.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccccn1)Nc1cccc2c1[C@H]1CCCN1C2=O,,,CHEMBL1134322,J. Med. Chem.,2001.0,,CHEMBL141247,,CHEMBL141247,,False,http://www.openphacts.org/units/Nanomolar,274991,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,1173967,[],CHEMBL768270,Inhibition of Protein kinase B alpha,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)C/C=C/c1nc(O)c2c(ccc3nc(Nc4c(Cl)cccc4Cl)n(C)c32)c1C,,,CHEMBL1136753,J. Med. Chem.,2003.0,,CHEMBL281957,,CHEMBL281957,,False,http://www.openphacts.org/units/Nanomolar,39786,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.0
,1421462,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc2ccccc2n1C1CCN(Cc2ccc(-c3nc4ccccc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.76', 'le': '0.23', 'lle': '-0.33', 'sei': '9.74'}",CHEMBL260397,,CHEMBL260397,6.53,True,http://www.openphacts.org/units/Nanomolar,365301,=,1,True,=,,IC50,nM,,295.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,295.0
,1421465,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '13.12', 'le': '0.24', 'lle': '0.92', 'sei': '7.58'}",CHEMBL258844,,CHEMBL258844,7.24,True,http://www.openphacts.org/units/Nanomolar,365306,=,1,True,=,,IC50,nM,,58.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,58.0
,1421468,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)c(-c2ccccc2)[nH]c1=O,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.45', 'le': '0.23', 'lle': '1.23', 'sei': '7.05'}",CHEMBL178397,,CHEMBL178397,6.12,True,http://www.openphacts.org/units/Nanomolar,365307,=,1,True,=,,IC50,nM,,760.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,760.0
,1421471,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Cc1nc(-c2ccccc2)c(-c2ccc(CN3CCC(n4c(O)nc5ccccc54)CC3)cc2)nc1O,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,,CHEMBL178468,,CHEMBL178468,,False,http://www.openphacts.org/units/Nanomolar,365311,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20000.0
,1421867,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc2ccccc2n1C1CCN(Cc2ccc(-c3nc4ccccc4cc3-c3ccccc3)cc2)CC1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.61', 'le': '0.23', 'lle': '-1.02', 'sei': '11.88'}",CHEMBL359864,,CHEMBL359864,6.44,False,http://www.openphacts.org/units/Nanomolar,365316,=,1,True,=,,IC50,nM,,365.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,365.0
,1421870,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc2ccccc2n1C1CCN(Cc2ccc(-c3cc4ccccc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '10.78', 'le': '0.19', 'lle': '-1.96', 'sei': '10.16'}",CHEMBL178349,,CHEMBL178349,5.50,False,http://www.openphacts.org/units/Nanomolar,365322,=,1,True,=,,IC50,nM,,3136.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3136.0
,1421873,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cnc(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)c(-c2ccccc2)c1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.60', 'le': '0.23', 'lle': '0.35', 'sei': '7.87'}",CHEMBL255212,,CHEMBL255212,6.12,False,http://www.openphacts.org/units/Nanomolar,365242,=,1,True,=,,IC50,nM,,762.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,762.0
,1421876,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cnc(-c2ccc(CNCc3ccc(-c4csnn4)cc3)cc2)c(-c2ccccc2)c1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.82', 'le': '0.24', 'lle': '-0.21', 'sei': '7.91'}",CHEMBL360333,,CHEMBL360333,5.89,False,http://www.openphacts.org/units/Nanomolar,365248,=,1,True,=,,IC50,nM,,1288.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1288.0
,1421879,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cnc(-c2ccc(CN3CCC(c4nc5cc(F)ccc5[nH]4)CC3)cc2)c(-c2ccccc2)c1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.43', 'le': '0.22', 'lle': '-0.62', 'sei': '8.84'}",CHEMBL368010,,CHEMBL368010,6.06,False,http://www.openphacts.org/units/Nanomolar,365253,=,1,True,=,,IC50,nM,,865.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,865.0
,1421885,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2[nH]c(C3CCN(Cc4ccc(-c5ncc(C#N)cc5-c5ccccc5)cc4)CC3)nc2c1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '11.46', 'le': '0.20', 'lle': '-1.31', 'sei': '8.08'}",CHEMBL181927,,CHEMBL181927,5.54,False,http://www.openphacts.org/units/Nanomolar,365264,=,1,True,=,,IC50,nM,,2874.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2874.0
,1421888,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cnc(-c2ccc(CN3CCC(c4nc5ccccc5[nH]4)CC3)cc2)c(-c2ccccc2)c1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.42', 'le': '0.22', 'lle': '-0.71', 'sei': '8.50'}",CHEMBL369094,,CHEMBL369094,5.83,False,http://www.openphacts.org/units/Nanomolar,365269,=,1,True,=,,IC50,nM,,1471.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1471.0
,1421993,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cnc(-c2ccc(CN3CCC(n4cnc5ccccc54)CC3)cc2)c(-c2ccccc2)c1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '11.41', 'le': '0.20', 'lle': '-1.11', 'sei': '9.28'}",CHEMBL361391,,CHEMBL361391,5.36,False,http://www.openphacts.org/units/Nanomolar,365275,=,1,True,=,,IC50,nM,,4397.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4397.0
,1421996,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccccc2n1C1CCN(Cc2ccc(-c3ncc(C#N)cc3-c3ccccc3)cc2)CC1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '10.61', 'le': '0.19', 'lle': '-1.65', 'sei': '8.89'}",CHEMBL425338,,CHEMBL425338,5.13,False,http://www.openphacts.org/units/Nanomolar,365279,=,1,True,=,,IC50,nM,,7407.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7407.0
,1421999,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3ncc(-c4nnn[nH]4)cc3-c3ccccc3)cc2)CC1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.42', 'le': '0.22', 'lle': '1.48', 'sei': '6.06'}",CHEMBL270847,,CHEMBL270847,6.56,False,http://www.openphacts.org/units/Nanomolar,365284,=,1,True,=,,IC50,nM,,273.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,273.0
,1422002,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc(-c3nn[nH]n3)cnc2-c2ccc(CNCc3ccc(-c4csnn4)cc3)cc2)cc1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '13.43', 'le': '0.25', 'lle': '1.35', 'sei': '6.42'}",CHEMBL425155,,CHEMBL425155,6.75,False,http://www.openphacts.org/units/Nanomolar,365290,=,1,True,=,,IC50,nM,,177.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,177.0
,1422005,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc2[nH]c(C3CCN(Cc4ccc(-c5ncc(-c6nn[nH]n6)cc5-c5ccccc5)cc4)CC3)nc2c1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.48', 'le': '0.23', 'lle': '0.63', 'sei': '6.67'}",CHEMBL181730,,CHEMBL181730,6.62,False,http://www.openphacts.org/units/Nanomolar,365296,=,1,True,=,,IC50,nM,,239.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,239.0
,1422008,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2[nH]c(C3CCN(Cc4ccc(-c5ncc(-c6nn[nH]n6)cc5-c5ccccc5)cc4)CC3)nc2c1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '11.62', 'le': '0.21', 'lle': '-0.04', 'sei': '6.16'}",CHEMBL367601,,CHEMBL367601,6.12,False,http://www.openphacts.org/units/Nanomolar,365302,=,1,True,=,,IC50,nM,,763.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,763.0
,1422400,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc(-c3nn[nH]n3)cnc2-c2ccc(CN3CCC(c4nc5ccccc5[nH]4)CC3)cc2)cc1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '10.69', 'le': '0.19', 'lle': '-0.37', 'sei': '5.52'}",CHEMBL178872,,CHEMBL178872,5.48,False,http://www.openphacts.org/units/Nanomolar,365308,=,1,True,=,,IC50,nM,,3323.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3323.0
,1422403,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc(-c3nn[nH]n3)cnc2-c2ccc(CN3CCC(n4cnc5ccccc54)CC3)cc2)cc1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '10.48', 'le': '0.19', 'lle': '-0.41', 'sei': '6.08'}",CHEMBL178445,,CHEMBL178445,5.37,False,http://www.openphacts.org/units/Nanomolar,365312,=,1,True,=,,IC50,nM,,4237.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4237.0
,1422409,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccccc2n1C1CCN(Cc2ccc(-c3ncc(-c4nn[nH]n4)cc3-c3ccccc3)cc2)CC1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '9.80', 'le': '0.18', 'lle': '-0.93', 'sei': '5.84'}",CHEMBL369532,,CHEMBL369532,5.16,False,http://www.openphacts.org/units/Nanomolar,365323,=,1,True,=,,IC50,nM,,6915.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6915.0
,1422412,[],CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nnnc1-c1cnc(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)c(-c2ccccc2)c1,,,CHEMBL1141976,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '10.60', 'le': '0.19', 'lle': '0.66', 'sei': '5.90'}",CHEMBL182101,,CHEMBL182101,5.75,False,http://www.openphacts.org/units/Nanomolar,365324,=,1,True,=,,IC50,nM,,1772.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1772.0
,1429965,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(N)c1ccc(-c2nc3ccccc3nc2-c2ccccc2)cc1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '16.11', 'le': '0.29', 'lle': '0.31', 'sei': '10.56'}",CHEMBL362455,,CHEMBL362455,5.47,True,http://www.openphacts.org/units/Nanomolar,368121,=,1,True,=,,IC50,nM,,3400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3400.0
,1429968,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc2ccccc2n1C1CCN(Cc2ccc(-c3nc4ccccc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.78', 'le': '0.23', 'lle': '-0.32', 'sei': '9.75'}",CHEMBL260397,,CHEMBL260397,6.54,True,http://www.openphacts.org/units/Nanomolar,368125,=,1,True,=,,IC50,nM,,290.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,290.0
,1429971,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cnc(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)c(-c2ccccc2)[nH]1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '11.56', 'le': '0.21', 'lle': '0.94', 'sei': '6.36'}",CHEMBL440560,,CHEMBL440560,5.52,True,http://www.openphacts.org/units/Nanomolar,368129,=,1,True,=,,IC50,nM,,3029.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3029.0
,1430075,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cnc(-c2ccccc2)c(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)[nH]1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.19', 'le': '0.22', 'lle': '1.24', 'sei': '6.71'}",CHEMBL577792,,CHEMBL577792,5.82,True,http://www.openphacts.org/units/Nanomolar,368045,=,1,True,=,,IC50,nM,,1500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1500.0
,1430079,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)c(-c2ccccc2)[nH]c1=O,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.45', 'le': '0.23', 'lle': '1.23', 'sei': '7.05'}",CHEMBL178397,,CHEMBL178397,6.12,True,http://www.openphacts.org/units/Nanomolar,368050,=,1,True,=,,IC50,nM,,760.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,760.0
,1430082,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(-c2ccccc2)c(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)[nH]c1=O,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.20', 'le': '0.22', 'lle': '1.11', 'sei': '6.91'}",CHEMBL572629,,CHEMBL572629,6.00,True,http://www.openphacts.org/units/Nanomolar,368055,=,1,True,=,,IC50,nM,,1003.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1003.0
,1430085,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc(-c2ccccc2)c(-c2ccc(CN3CCC(n4c(O)nc5ccccc54)CC3)cc2)nc1Cc1ccccc1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '8.40', 'le': '0.15', 'lle': '-2.23', 'sei': '5.46'}",CHEMBL180580,,CHEMBL180580,4.77,False,http://www.openphacts.org/units/Nanomolar,368056,=,1,True,=,,IC50,nM,,17000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17000.0
,1430088,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)c(-c2ccccc2)nc1Cc1ccccc1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,,CHEMBL3143722,,CHEMBL3143722,,False,http://www.openphacts.org/units/Nanomolar,368057,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
,1430091,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(-c2ccccc2)c(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)nc1Cc1ccc(O)cc1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '7.99', 'le': '0.14', 'lle': '-1.22', 'sei': '4.36'}",CHEMBL178133,,CHEMBL178133,4.66,True,http://www.openphacts.org/units/Nanomolar,368061,=,1,True,=,,IC50,nM,,21670.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21670.0
,1430094,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)c(-c2ccccc2)nc1Cc1ccc(O)cc1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,,CHEMBL3143723,,CHEMBL3143723,,False,http://www.openphacts.org/units/Nanomolar,368062,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
,1430097,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(C)c1nc(-c2ccc(CN3CCC(n4c(O)nc5ccccc54)CC3)cc2)c(-c2ccccc2)nc1O,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '8.94', 'le': '0.16', 'lle': '-2.15', 'sei': '5.46'}",CHEMBL428861,,CHEMBL428861,4.77,False,http://www.openphacts.org/units/Nanomolar,368063,=,1,True,=,,IC50,nM,,17000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17000.0
,1430522,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(C)c1nc(-c2ccccc2)c(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)[nH]c1=O,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,,CHEMBL3143721,,CHEMBL3143721,,False,http://www.openphacts.org/units/Nanomolar,368067,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
,1430525,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Cc1nc(-c2ccc(CN3CCC(n4c(O)nc5ccccc54)CC3)cc2)c(-c2ccccc2)nc1O,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,,CHEMBL362016,,CHEMBL362016,,False,http://www.openphacts.org/units/Nanomolar,368072,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
,1430528,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Cc1nc(-c2ccccc2)c(-c2ccc(CN3CCC(n4c(O)nc5ccccc54)CC3)cc2)nc1O,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '8.76', 'le': '0.16', 'lle': '-1.94', 'sei': '5.35'}",CHEMBL178468,,CHEMBL178468,4.67,False,http://www.openphacts.org/units/Nanomolar,368078,=,1,True,=,,IC50,nM,,21200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21200.0
,1430532,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1ccc2nc(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)c(-c3ccccc3)nc2c1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '11.91', 'le': '0.22', 'lle': '0.48', 'sei': '6.36'}",CHEMBL272292,,CHEMBL272292,6.62,True,http://www.openphacts.org/units/Nanomolar,368084,=,1,True,=,,IC50,nM,,240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,240.0
,1430535,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1ccc2nc(-c3ccccc3)c(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)nc2c1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.20', 'le': '0.22', 'lle': '0.64', 'sei': '6.51'}",CHEMBL273160,,CHEMBL273160,6.78,True,http://www.openphacts.org/units/Nanomolar,368085,=,1,True,=,,IC50,nM,,166.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,166.0
,1430639,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4ccc(-c5nn[nH]n5)cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.42', 'le': '0.22', 'lle': '1.58', 'sei': '5.94'}",CHEMBL271091,,CHEMBL271091,7.20,True,http://www.openphacts.org/units/Nanomolar,368086,=,1,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,63.0
,1430642,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc(-c5nn[nH]n5)ccc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '13.28', 'le': '0.24', 'lle': '2.08', 'sei': '6.35'}",CHEMBL408151,,CHEMBL408151,7.70,True,http://www.openphacts.org/units/Nanomolar,368087,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
,1430645,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nnc(-c2ccc3nc(-c4ccc(CN5CCC(n6c(O)nc7ccccc76)CC5)cc4)c(-c4ccccc4)nc3c2)n1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '10.04', 'le': '0.18', 'lle': '-0.09', 'sei': '5.39'}",CHEMBL181419,,CHEMBL181419,5.96,False,http://www.openphacts.org/units/Nanomolar,368092,=,1,True,=,,IC50,nM,,1089.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1089.0
,1430648,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nnc(-c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(n6c(O)nc7ccccc76)CC5)cc4)nc3c2)n1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.23', 'le': '0.22', 'lle': '1.21', 'sei': '6.56'}",CHEMBL180058,,CHEMBL180058,7.26,False,http://www.openphacts.org/units/Nanomolar,368093,=,1,True,=,,IC50,nM,,55.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,55.0
,1430651,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5cn[nH]c5cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '12.82', 'le': '0.23', 'lle': '0.75', 'sei': '7.40'}",CHEMBL180231,,CHEMBL180231,7.07,True,http://www.openphacts.org/units/Nanomolar,368094,=,1,True,=,,IC50,nM,,85.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,85.0
,1430654,[],CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1141888,Bioorg. Med. Chem. Lett.,2005.0,"{'bei': '13.12', 'le': '0.24', 'lle': '0.92', 'sei': '7.58'}",CHEMBL258844,,CHEMBL258844,7.24,True,http://www.openphacts.org/units/Nanomolar,368095,=,1,True,=,,IC50,nM,,58.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,58.0
,1462034,[],CHEMBL828500,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)OC(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1,,,CHEMBL1138659,J. Med. Chem.,2004.0,,CHEMBL363058,,CHEMBL363058,,False,http://www.openphacts.org/units/Nanomolar,378677,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1462150,[],CHEMBL828500,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCCCC1)CC2,,,CHEMBL1138659,J. Med. Chem.,2004.0,,CHEMBL362588,,CHEMBL362588,,False,http://www.openphacts.org/units/Nanomolar,378699,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1462172,[],CHEMBL828500,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2c3c(c1)c(C1=C(c4cnc5ccccn45)C(=O)NC1=O)cn3CCN(C(=O)N1CCCCC1)C2,,,CHEMBL1138659,J. Med. Chem.,2004.0,,CHEMBL186290,,CHEMBL186290,,False,http://www.openphacts.org/units/Nanomolar,378328,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1462285,[],CHEMBL828500,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2,,,CHEMBL1138659,J. Med. Chem.,2004.0,,CHEMBL178737,,CHEMBL178737,,False,http://www.openphacts.org/units/Nanomolar,378351,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1462301,[],CHEMBL828500,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1,,,CHEMBL1138659,J. Med. Chem.,2004.0,,CHEMBL362814,,CHEMBL362814,,False,http://www.openphacts.org/units/Nanomolar,378376,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1462427,[],CHEMBL828500,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2,,,CHEMBL1138659,J. Med. Chem.,2004.0,,CHEMBL362558,LY-2090314,CHEMBL362558,,False,http://www.openphacts.org/units/Nanomolar,378400,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1489880,[],CHEMBL828489,Inhibition of AKT kinase,B,,,BAO_0000190,BAO_0000357,single protein format,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,,,CHEMBL1140315,J. Med. Chem.,2005.0,,CHEMBL1788116,,CHEMBL191384,,False,http://www.openphacts.org/units/Nanomolar,385726,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,1498192,[],CHEMBL828149,Inhibition of protein kinase B alpha (Akt1) in fluorescent enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1=C(C#N)c2nc(N)c(C#N)c(C)c2/C1=C/c1ccc(-c2ccc(C(=O)O)c(Cl)c2)o1,,,CHEMBL1143561,J. Med. Chem.,2005.0,"{'bei': '12.61', 'le': '0.24', 'lle': '0.28', 'sei': '4.08'}",CHEMBL192519,,CHEMBL192519,5.58,False,http://www.openphacts.org/units/Nanomolar,387891,=,1,True,=,,IC50,nM,,2600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.6
,1498194,[],CHEMBL828149,Inhibition of protein kinase B alpha (Akt1) in fluorescent enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(/C=C/c1nc2ccccc2[nH]1)c1c(O)nc2ccc(Cl)cc2c1-c1ccccc1,,,CHEMBL1143561,J. Med. Chem.,2005.0,"{'bei': '12.55', 'le': '0.24', 'lle': '-0.68', 'sei': '6.78'}",CHEMBL190313,,CHEMBL190313,5.35,False,http://www.openphacts.org/units/Nanomolar,387917,=,1,True,=,,IC50,nM,,4500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.5
,1498199,[],CHEMBL828149,Inhibition of protein kinase B alpha (Akt1) in fluorescent enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc(-c2ccc(C=C3C(=O)c4ccccc4C3=O)o2)ccc1O,,,CHEMBL1143561,J. Med. Chem.,2005.0,"{'bei': '12.77', 'le': '0.23', 'lle': '0.79', 'sei': '4.39'}",CHEMBL175828,,CHEMBL175828,4.60,False,http://www.openphacts.org/units/Nanomolar,387970,=,1,True,=,,IC50,nM,,25100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.1
,1498201,[],CHEMBL828149,Inhibition of protein kinase B alpha (Akt1) in fluorescent enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,,,CHEMBL1143561,J. Med. Chem.,2005.0,"{'bei': '12.63', 'le': '0.29', 'lle': '2.06', 'sei': '7.93'}",CHEMBL104264,,CHEMBL104264,5.64,False,http://www.openphacts.org/units/Nanomolar,387971,=,1,True,=,,IC50,nM,,2300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.3
,1498299,[],CHEMBL828149,Inhibition of protein kinase B alpha (Akt1) in fluorescent enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1=C(C#N)c2nc(N)c(C#N)c(C)c2/C1=C/c1ccc(-c2ccc(C(=O)O)cc2)o1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1143561,J. Med. Chem.,2005.0,,CHEMBL365978,,CHEMBL365978,,True,http://www.openphacts.org/units/Nanomolar,387995,=,1,True,=,,IC50,nM,,126000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,126.0
,1498300,[],CHEMBL828149,Inhibition of protein kinase B alpha (Akt1) in fluorescent enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1=C(C#N)c2nc(N)c(C#N)c(C)c2/C1=C/c1ccc(-c2cccc(C(=O)O)c2)o1,,,CHEMBL1143561,J. Med. Chem.,2005.0,"{'bei': '10.33', 'le': '0.19', 'lle': '-0.43', 'sei': '3.08'}",CHEMBL193261,,CHEMBL193261,4.22,True,http://www.openphacts.org/units/Nanomolar,387651,=,1,True,=,,IC50,nM,,60200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,60.2
,1507333,[],CHEMBL829440,"Inhibition of Protein kinase B, alpha (Akt1)",B,,,BAO_0000190,BAO_0000357,single protein format,CC(CN(C)C)Oc1ccc(Cl)cc1NC(=O)Nc1cnc(C#N)cn1,,,CHEMBL1143624,J. Med. Chem.,2005.0,,CHEMBL425904,,CHEMBL425904,,False,http://www.openphacts.org/units/Nanomolar,390860,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
,1507350,[],CHEMBL829440,"Inhibition of Protein kinase B, alpha (Akt1)",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(COc2ccc(Cl)cc2NC(=O)Nc2cnc(C#N)cn2)COC1,,,CHEMBL1143624,J. Med. Chem.,2005.0,"{'bei': '13.47', 'le': '0.26', 'lle': '1.98', 'sei': '4.61'}",CHEMBL192161,,CHEMBL192161,5.04,False,http://www.openphacts.org/units/Nanomolar,390922,=,1,True,=,,IC50,nM,,9210.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9210.0
,1662509,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1cc2c(C)n[nH]c2s1,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL200586,,CHEMBL200586,,False,http://www.openphacts.org/units/Nanomolar,414718,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,1662594,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)Nc3ccccc3)c12,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.00', 'le': '0.31', 'lle': '2.37', 'sei': '4.47'}",CHEMBL199996,,CHEMBL199996,5.05,False,http://www.openphacts.org/units/Nanomolar,414739,=,1,True,=,,IC50,nM,,9000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,9.0
,1662595,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)c3ccc(Cl)cc3)c12,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL199658,,CHEMBL199658,,False,http://www.openphacts.org/units/Nanomolar,414738,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,1662596,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)c3cccc(Cl)c3)c12,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL199657,,CHEMBL199657,,False,http://www.openphacts.org/units/Nanomolar,414737,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,1662597,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)c3ccccc3Cl)c12,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL371695,,CHEMBL371695,,False,http://www.openphacts.org/units/Nanomolar,414736,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,1662598,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)c3cccs3)c12,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.57', 'le': '0.33', 'lle': '2.42', 'sei': '4.73'}",CHEMBL382070,,CHEMBL382070,4.77,False,http://www.openphacts.org/units/Nanomolar,414735,=,1,True,=,,IC50,nM,,17000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,17.0
,1662599,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)COc3ccccc3)c12,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL199759,,CHEMBL199759,,False,http://www.openphacts.org/units/Nanomolar,414734,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,1662600,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)C(=O)Nc1c(C(N)=O)sc2[nH]nc(C)c12,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL370199,,CHEMBL370199,,False,http://www.openphacts.org/units/Nanomolar,414733,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,1662601,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1c(C(N)=O)sc2[nH]nc(C)c12,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL199737,,CHEMBL199737,,False,http://www.openphacts.org/units/Nanomolar,414732,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1662602,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C(=O)c2cc3c(-c4ccccc4)[nH]nc3s2)CC1,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL371239,,CHEMBL371239,,False,http://www.openphacts.org/units/Nanomolar,414731,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1662603,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CNC(=O)c2cc3c(-c4ccccc4)[nH]nc3s2)cc1,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL199383,,CHEMBL199383,,False,http://www.openphacts.org/units/Nanomolar,414730,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1662604,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCCc1ccccc1)c1cc2c(-c3ccccc3)[nH]nc2s1,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL197923,,CHEMBL197923,,False,http://www.openphacts.org/units/Nanomolar,414729,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1662605,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1ccccc1)c1cc2c(-c3ccccc3)[nH]nc2s1,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.47', 'le': '0.27', 'lle': '0.60', 'sei': '8.35'}",CHEMBL200499,,CHEMBL200499,4.82,False,http://www.openphacts.org/units/Nanomolar,414728,=,1,True,=,,IC50,nM,,15000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,15.0
,1662606,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC1CCCCC1)c1cc2c(-c3ccccc3)[nH]nc2s1,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL199755,,CHEMBL199755,,False,http://www.openphacts.org/units/Nanomolar,414727,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1662607,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCN(C)C(=O)c1cc2c(-c3ccccc3)[nH]nc2s1,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL199528,,CHEMBL199528,,False,http://www.openphacts.org/units/Nanomolar,414726,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1662608,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2sc(C(=O)NCc3ccccc3)cc12,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL373001,,CHEMBL373001,,False,http://www.openphacts.org/units/Nanomolar,414725,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1662609,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2sc(C(=O)NC3CCCCC3)cc12,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL199951,,CHEMBL199951,,False,http://www.openphacts.org/units/Nanomolar,414724,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1662610,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCN(C)C(=O)c1cc2c(C)n[nH]c2s1,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL200657,,CHEMBL200657,,False,http://www.openphacts.org/units/Nanomolar,414723,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1662611,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCNC(=O)c1cc2c(C)n[nH]c2s1,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL371242,,CHEMBL371242,,False,http://www.openphacts.org/units/Nanomolar,414722,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1662612,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2sc(C(N)=O)cc12,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL198022,,CHEMBL198022,,False,http://www.openphacts.org/units/Nanomolar,414721,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,1662613,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1cc2c(CN3CCCCC3)n[nH]c2s1,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL200348,,CHEMBL200348,,False,http://www.openphacts.org/units/Nanomolar,414720,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,1662614,[],CHEMBL864555,Inhibitory activity against Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1cc2c(Nc3ccccc3)[nH]nc2s1,,,CHEMBL1148538,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.55', 'le': '0.34', 'lle': '1.65', 'sei': '7.16'}",CHEMBL200796,,CHEMBL200796,4.80,False,http://www.openphacts.org/units/Nanomolar,414719,=,1,True,=,,IC50,nM,,16000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,16.0
,1697120,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](N)COc1cnc(Cl)c(/C=C/c2ccncc2)c1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.21', 'le': '0.36', 'lle': '2.25', 'sei': '8.65'}",CHEMBL419932,,CHEMBL419932,5.28,True,http://www.openphacts.org/units/Nanomolar,443158,=,1,True,=,,IC50,nM,,5290.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5290.0
,1697121,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.91', 'le': '0.34', 'lle': '4.47', 'sei': '12.71'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.82,True,http://www.openphacts.org/units/Nanomolar,443210,=,1,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
,1697122,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccnc(-n3ccc4ccccc43)c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '11.28', 'le': '0.20', 'lle': '-0.54', 'sei': '6.70'}",CHEMBL206708,,CHEMBL206708,5.48,True,http://www.openphacts.org/units/Nanomolar,443209,=,1,True,=,,IC50,nM,,3340.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3340.0
,1697123,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccnc(NCc3ccccc3)c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.37', 'le': '0.26', 'lle': '1.14', 'sei': '7.69'}",CHEMBL381610,,CHEMBL381610,6.83,True,http://www.openphacts.org/units/Nanomolar,443208,=,1,True,=,,IC50,nM,,147.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,147.0
,1697124,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccnc(NC3CC3)c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.83', 'le': '0.31', 'lle': '2.51', 'sei': '8.06'}",CHEMBL203275,,CHEMBL203275,7.16,False,http://www.openphacts.org/units/Nanomolar,443207,=,1,True,=,,IC50,nM,,69.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,69.0
,1697125,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CCNc1cc(/C=C/c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)ccn1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.41', 'le': '0.30', 'lle': '2.28', 'sei': '7.64'}",CHEMBL382914,,CHEMBL382914,6.79,True,http://www.openphacts.org/units/Nanomolar,443206,=,1,True,=,,IC50,nM,,163.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,163.0
,1697126,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1cc(/C=C/c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)ccn1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.91', 'le': '0.31', 'lle': '2.63', 'sei': '7.60'}",CHEMBL202787,,CHEMBL202787,6.75,True,http://www.openphacts.org/units/Nanomolar,443205,=,1,True,=,,IC50,nM,,176.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,176.0
,1697127,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(/C=C/c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)ccn1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.94', 'le': '0.33', 'lle': '3.26', 'sei': '6.73'}",CHEMBL381075,,CHEMBL381075,6.92,True,http://www.openphacts.org/units/Nanomolar,443204,=,1,True,=,,IC50,nM,,121.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,121.0
,1697128,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccnc(SCc3ccccc3)c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '11.18', 'le': '0.21', 'lle': '-0.86', 'sei': '7.17'}",CHEMBL381260,,CHEMBL381260,5.51,False,http://www.openphacts.org/units/Nanomolar,443203,=,1,True,=,,IC50,nM,,3110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3110.0
,1697129,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccnc(Sc3ccccc3)c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '10.86', 'le': '0.20', 'lle': '-1.03', 'sei': '6.77'}",CHEMBL203483,,CHEMBL203483,5.20,False,http://www.openphacts.org/units/Nanomolar,443202,=,1,True,=,,IC50,nM,,6350.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6350.0
,1697130,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccnc(Oc3ccccc3)c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '11.22', 'le': '0.20', 'lle': '-0.68', 'sei': '6.03'}",CHEMBL378823,,CHEMBL378823,5.19,True,http://www.openphacts.org/units/Nanomolar,443201,=,1,True,=,,IC50,nM,,6450.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6450.0
,1697131,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(/C=C/c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)ccn1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '13.92', 'le': '0.25', 'lle': '1.48', 'sei': '6.48'}",CHEMBL377294,,CHEMBL377294,5.57,True,http://www.openphacts.org/units/Nanomolar,443200,=,1,True,=,,IC50,nM,,2670.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2670.0
,1697132,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1ccc(/C=C/c2ccncc2)cn1)Cc1ccccc1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '13.17', 'le': '0.24', 'lle': '0.77', 'sei': '7.15'}",CHEMBL203004,,CHEMBL203004,4.37,False,http://www.openphacts.org/units/Nanomolar,443199,=,1,True,=,,IC50,nM,,43010.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,43010.0
,1697134,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cccc(/C=C/c2ccncc2)n1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.51', 'le': '0.23', 'lle': '0.55', 'sei': '6.03'}",CHEMBL206654,,CHEMBL206654,4.63,False,http://www.openphacts.org/units/Nanomolar,443197,=,1,True,=,,IC50,nM,,23270.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23270.0
,1697138,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(C(CN)c2cncc(/C=C/c3ccncc3)c2)c2ccccc21,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.26', 'le': '0.31', 'lle': '1.89', 'sei': '10.79'}",CHEMBL202937,,CHEMBL202937,6.12,False,http://www.openphacts.org/units/Nanomolar,443193,=,1,True,=,,IC50,nM,,760.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,760.0
,1697139,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(c1ccccc1)c1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '21.72', 'le': '0.39', 'lle': '2.81', 'sei': '12.64'}",CHEMBL383254,,CHEMBL383254,6.55,False,http://www.openphacts.org/units/Nanomolar,443192,=,1,True,=,,IC50,nM,,284.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,284.0
,1697140,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Brc1ccc(/C=C/CNCCOc2cncc(/C=C/c3ccncc3)c2)cc1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '10.29', 'le': '0.22', 'lle': '-0.60', 'sei': '9.55'}",CHEMBL206328,,CHEMBL206328,4.49,True,http://www.openphacts.org/units/Nanomolar,443191,=,1,True,=,,IC50,nM,,32250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,32250.0
,1697141,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H](Cc1cccc2ccccc12)C(=O)Nc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.65', 'le': '0.28', 'lle': '1.87', 'sei': '7.63'}",CHEMBL383527,,CHEMBL383527,6.17,True,http://www.openphacts.org/units/Nanomolar,443190,=,1,True,=,,IC50,nM,,668.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,668.0
,1697142,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H](Cc1ccccc1)C(=O)Nc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.95', 'le': '0.29', 'lle': '2.33', 'sei': '6.79'}",CHEMBL205514,,CHEMBL205514,5.50,True,http://www.openphacts.org/units/Nanomolar,443189,=,1,True,=,,IC50,nM,,3200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3200.0
,1697144,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H](Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.10', 'le': '0.31', 'lle': '2.92', 'sei': '6.78'}",CHEMBL205415,,CHEMBL205415,6.56,True,http://www.openphacts.org/units/Nanomolar,443187,=,1,True,=,,IC50,nM,,278.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,278.0
,1697145,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '21.69', 'le': '0.39', 'lle': '3.90', 'sei': '10.06'}",CHEMBL203624,,CHEMBL203624,8.01,False,http://www.openphacts.org/units/Nanomolar,443186,=,1,True,=,,IC50,nM,,9.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.7
,1697146,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1cnc(Cl)c(/C=C/c2ccncc2)c1)CC1CNc2ccccc21,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.50', 'le': '0.33', 'lle': '2.46', 'sei': '9.36'}",CHEMBL381703,,CHEMBL381703,7.10,False,http://www.openphacts.org/units/Nanomolar,443185,=,1,True,=,,IC50,nM,,79.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,79.0
,1697147,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1cnc(Cl)c(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '19.12', 'le': '0.36', 'lle': '2.96', 'sei': '9.70'}",CHEMBL203384,,CHEMBL203384,7.72,False,http://www.openphacts.org/units/Nanomolar,443184,=,1,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.0
,1697148,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CCc1cnc(Cl)c(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.64', 'le': '0.32', 'lle': '1.42', 'sei': '9.92'}",CHEMBL203329,,CHEMBL203329,6.70,True,http://www.openphacts.org/units/Nanomolar,443183,=,1,True,=,,IC50,nM,,198.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,198.0
,1697149,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,C(=C/c1cncc(OCCCc2c[nH]c3ccccc23)c1)\c1ccncc1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL205836,,CHEMBL205836,,False,http://www.openphacts.org/units/Nanomolar,443182,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
,1697150,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,OC(COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.44', 'le': '0.23', 'lle': '0.51', 'sei': '6.50'}",CHEMBL380958,,CHEMBL380958,4.62,False,http://www.openphacts.org/units/Nanomolar,443181,=,1,True,=,,IC50,nM,,24010.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24010.0
,1697151,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.95', 'le': '0.27', 'lle': '1.28', 'sei': '11.03'}",CHEMBL202893,,CHEMBL202893,5.96,True,http://www.openphacts.org/units/Nanomolar,443180,=,1,True,=,,IC50,nM,,1100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1100.0
,1697152,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(C[C@H](N)COc2cncc(/C=C/c3ccncc3)c2)c2ccccc21,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.39', 'le': '0.30', 'lle': '2.21', 'sei': '9.55'}",CHEMBL204012,,CHEMBL204012,6.30,True,http://www.openphacts.org/units/Nanomolar,443179,=,1,True,=,,IC50,nM,,500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,500.0
,1697153,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cc(/C=C/c2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.21', 'le': '0.31', 'lle': '1.83', 'sei': '8.54'}",CHEMBL206198,,CHEMBL206198,6.56,False,http://www.openphacts.org/units/Nanomolar,443178,=,1,True,=,,IC50,nM,,273.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,273.0
,1697154,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cnc(Cl)c(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.86', 'le': '0.36', 'lle': '2.91', 'sei': '9.94'}",CHEMBL379914,,CHEMBL379914,7.64,False,http://www.openphacts.org/units/Nanomolar,443177,=,1,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
,1697155,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.39', 'le': '0.31', 'lle': '2.36', 'sei': '8.39'}",CHEMBL381808,,CHEMBL381808,6.44,False,http://www.openphacts.org/units/Nanomolar,443176,=,1,True,=,,IC50,nM,,360.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,360.0
,1697156,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '21.20', 'le': '0.38', 'lle': '3.77', 'sei': '10.22'}",CHEMBL383541,,CHEMBL383541,7.85,True,http://www.openphacts.org/units/Nanomolar,443175,=,1,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
,1697157,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1csc2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.67', 'le': '0.33', 'lle': '2.04', 'sei': '11.22'}",CHEMBL206183,,CHEMBL206183,6.85,False,http://www.openphacts.org/units/Nanomolar,443174,=,1,True,=,,IC50,nM,,142.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,142.0
,1697158,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1ccc2ccccc2c1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.92', 'le': '0.32', 'lle': '2.09', 'sei': '11.20'}",CHEMBL381328,,CHEMBL381328,6.84,False,http://www.openphacts.org/units/Nanomolar,443173,=,1,True,=,,IC50,nM,,146.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,146.0
,1697159,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1cccc2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.01', 'le': '0.31', 'lle': '1.74', 'sei': '10.63'}",CHEMBL205871,,CHEMBL205871,6.49,True,http://www.openphacts.org/units/Nanomolar,443172,=,1,True,=,,IC50,nM,,324.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,324.0
,1697160,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccc(C[C@H](N)COc2cncc(/C=C/c3ccncc3)c2)c1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.22', 'le': '0.33', 'lle': '3.02', 'sei': '7.66'}",CHEMBL205410,,CHEMBL205410,6.50,True,http://www.openphacts.org/units/Nanomolar,443171,=,1,True,=,,IC50,nM,,320.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,320.0
,1697161,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1cccc(O)c1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.44', 'le': '0.32', 'lle': '2.76', 'sei': '7.46'}",CHEMBL203685,,CHEMBL203685,6.06,False,http://www.openphacts.org/units/Nanomolar,443170,=,1,True,=,,IC50,nM,,875.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,875.0
,1697163,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H](COCc1ccccc1)COc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.92', 'le': '0.27', 'lle': '1.82', 'sei': '7.68'}",CHEMBL206236,,CHEMBL206236,5.39,True,http://www.openphacts.org/units/Nanomolar,443168,=,1,True,=,,IC50,nM,,4040.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4040.0
,1697164,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H](CCc1ccccc1)COc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.75', 'le': '0.27', 'lle': '1.11', 'sei': '8.35'}",CHEMBL381829,,CHEMBL381829,5.10,True,http://www.openphacts.org/units/Nanomolar,443167,=,1,True,=,,IC50,nM,,8020.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8020.0
,1697165,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)C(c1ccccc1)c1ccccc1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.69', 'le': '0.23', 'lle': '-0.02', 'sei': '8.47'}",CHEMBL203434,,CHEMBL203434,5.17,False,http://www.openphacts.org/units/Nanomolar,443166,=,1,True,=,,IC50,nM,,6760.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6760.0
,1697166,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1ccccc1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.59', 'le': '0.34', 'lle': '2.56', 'sei': '10.10'}",CHEMBL203673,,CHEMBL203673,6.16,True,http://www.openphacts.org/units/Nanomolar,443165,=,1,True,=,,IC50,nM,,690.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,690.0
,1697167,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,C(=C/c1cncc(OC[C@@H]2CCCN2)c1)\c1ccncc1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.43', 'le': '0.30', 'lle': '1.84', 'sei': '9.82'}",CHEMBL205645,,CHEMBL205645,4.62,False,http://www.openphacts.org/units/Nanomolar,443164,=,1,True,=,,IC50,nM,,23910.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23910.0
,1697168,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,C(=C/c1cncc(OC[C@@H]2CCN2)c1)\c1ccncc1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.57', 'le': '0.34', 'lle': '2.57', 'sei': '10.55'}",CHEMBL204213,,CHEMBL204213,4.96,False,http://www.openphacts.org/units/Nanomolar,443163,=,1,True,=,,IC50,nM,,10870.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10870.0
,1697170,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](N)COc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.63', 'le': '0.31', 'lle': '1.70', 'sei': '7.72'}",CHEMBL204059,,CHEMBL204059,4.71,True,http://www.openphacts.org/units/Nanomolar,443161,=,1,True,=,,IC50,nM,,19320.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19320.0
,1697171,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,NCCCOc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.93', 'le': '0.35', 'lle': '2.46', 'sei': '7.92'}",CHEMBL205820,,CHEMBL205820,4.83,False,http://www.openphacts.org/units/Nanomolar,443160,=,1,True,=,,IC50,nM,,14710.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14710.0
,1697172,[],CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,NCCOc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '21.94', 'le': '0.40', 'lle': '3.31', 'sei': '8.67'}",CHEMBL206382,,CHEMBL206382,5.29,False,http://www.openphacts.org/units/Nanomolar,443159,=,1,True,=,,IC50,nM,,5080.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5080.0
,1697196,[],CHEMBL869547,Antiproliferative activity against FL5.12-Akt1 cells by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL383541,,CHEMBL383541,5.52,True,http://www.openphacts.org/units/Nanomolar,443175,=,1,True,=,,IC50,nM,,3000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3000.0
,1697197,[],CHEMBL869547,Antiproliferative activity against FL5.12-Akt1 cells by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL1146058,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL388978,STAUROSPORINE,CHEMBL388978,6.54,True,http://www.openphacts.org/units/Nanomolar,443210,=,1,True,=,,IC50,nM,,290.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,290.0
,1704018,[],CHEMBL864436,Inhibitory activity against AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(N2Cc3cnc(Nc4ccc(F)cc4)nc3N([C@@H]3CC[C@@H](O)C3)C2=O)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1146929,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL606964,,CHEMBL606964,,False,http://www.openphacts.org/units/Nanomolar,455265,>,1,True,>,,IC50,nM,,125000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,125000.0
,1704885,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1ccccc1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.59', 'le': '0.34', 'lle': '2.56', 'sei': '10.10'}",CHEMBL203673,,CHEMBL203673,6.16,True,http://www.openphacts.org/units/Nanomolar,450016,=,1,True,=,,IC50,nM,,690.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,690.0
,1704886,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H](COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '19.23', 'le': '0.35', 'lle': '2.86', 'sei': '9.87'}",CHEMBL381187,,CHEMBL381187,7.58,False,http://www.openphacts.org/units/Nanomolar,450063,=,1,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.0
,1704887,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '22.53', 'le': '0.40', 'lle': '4.16', 'sei': '11.57'}",CHEMBL383264,,CHEMBL383264,8.89,False,http://www.openphacts.org/units/Nanomolar,450062,=,1,True,=,,IC50,nM,,1.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.3
,1704888,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc2nc(-c3ccncc3)ccc12)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.00', 'le': '0.31', 'lle': '2.60', 'sei': '7.49'}",CHEMBL207496,,CHEMBL207496,6.72,True,http://www.openphacts.org/units/Nanomolar,450061,=,1,True,=,,IC50,nM,,190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,190.0
,1704889,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1cncc(Nc2cccc3cnccc23)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.08', 'le': '0.29', 'lle': '1.73', 'sei': '7.17'}",CHEMBL205994,,CHEMBL205994,6.57,True,http://www.openphacts.org/units/Nanomolar,450060,=,1,True,=,,IC50,nM,,270.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,270.0
,1704890,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1cncc(Oc2cccc3cnccc23)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.31', 'le': '0.29', 'lle': '1.79', 'sei': '7.52'}",CHEMBL206732,,CHEMBL206732,6.68,True,http://www.openphacts.org/units/Nanomolar,450059,=,1,True,=,,IC50,nM,,210.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,210.0
,1704891,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cnc2ccc(-c3cccnc3)cc2c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '13.05', 'le': '0.23', 'lle': '0.42', 'sei': '6.70'}",CHEMBL205324,,CHEMBL205324,5.15,False,http://www.openphacts.org/units/Nanomolar,450058,=,1,True,=,,IC50,nM,,7090.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7090.0
,1704892,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cnc2ccc(-c3ccncc3)cc2c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.54', 'le': '0.30', 'lle': '1.79', 'sei': '8.49'}",CHEMBL206819,,CHEMBL206819,6.52,True,http://www.openphacts.org/units/Nanomolar,450057,=,1,True,=,,IC50,nM,,300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,300.0
,1704893,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2c(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.97', 'le': '0.23', 'lle': '1.23', 'sei': '5.29'}",CHEMBL205781,,CHEMBL205781,5.66,True,http://www.openphacts.org/units/Nanomolar,450056,=,1,True,=,,IC50,nM,,2170.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2170.0
,1704894,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '11.75', 'le': '0.22', 'lle': '0.19', 'sei': '5.46'}",CHEMBL439340,,CHEMBL439340,5.84,True,http://www.openphacts.org/units/Nanomolar,450055,=,1,True,=,,IC50,nM,,1450.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1450.0
,1704895,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cccc(Nc3nccs3)c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '11.79', 'le': '0.22', 'lle': '-0.17', 'sei': '5.86'}",CHEMBL380542,,CHEMBL380542,5.21,False,http://www.openphacts.org/units/Nanomolar,450054,=,1,True,=,,IC50,nM,,6230.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6230.0
,1704896,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cccc(Nc3ncccn3)c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.45', 'le': '0.22', 'lle': '0.73', 'sei': '5.34'}",CHEMBL202972,,CHEMBL202972,5.43,True,http://www.openphacts.org/units/Nanomolar,450053,=,1,True,=,,IC50,nM,,3670.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3670.0
,1704897,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc(Nc3ncccn3)cc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '11.10', 'le': '0.20', 'lle': '0.13', 'sei': '4.76'}",CHEMBL207031,,CHEMBL207031,4.84,False,http://www.openphacts.org/units/Nanomolar,450052,=,1,True,=,,IC50,nM,,14330.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14330.0
,1704898,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nccc(Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc2)n1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.33', 'le': '0.22', 'lle': '1.28', 'sei': '4.36'}",CHEMBL208406,,CHEMBL208406,5.57,False,http://www.openphacts.org/units/Nanomolar,450051,=,1,True,=,,IC50,nM,,2710.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2710.0
,1704899,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc(NC(=O)Nc3ccccc3)nc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.43', 'le': '0.23', 'lle': '0.73', 'sei': '5.05'}",CHEMBL378589,,CHEMBL378589,5.95,False,http://www.openphacts.org/units/Nanomolar,450050,=,1,True,=,,IC50,nM,,1120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1120.0
,1704900,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc(-c3nn[nH]n3)cc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '10.89', 'le': '0.20', 'lle': '1.12', 'sei': '3.78'}",CHEMBL206581,,CHEMBL206581,4.48,False,http://www.openphacts.org/units/Nanomolar,450049,=,1,True,=,,IC50,nM,,33160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,33160.0
,1704901,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)Nc1ccc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)cc1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '10.27', 'le': '0.20', 'lle': '0.93', 'sei': '4.07'}",CHEMBL383702,,CHEMBL383702,4.48,False,http://www.openphacts.org/units/Nanomolar,450048,=,1,True,=,,IC50,nM,,33010.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,33010.0
,1704902,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1cccc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)c1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.28', 'le': '0.22', 'lle': '0.78', 'sei': '5.29'}",CHEMBL205422,,CHEMBL205422,4.92,False,http://www.openphacts.org/units/Nanomolar,450046,=,1,True,=,,IC50,nM,,12030.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12030.0
,1704903,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1ccc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)cc1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.59', 'le': '0.30', 'lle': '2.50', 'sei': '7.14'}",CHEMBL381785,,CHEMBL381785,6.64,True,http://www.openphacts.org/units/Nanomolar,450045,=,1,True,=,,IC50,nM,,227.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,227.0
,1704904,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)Cc1cccc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)c1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.62', 'le': '0.27', 'lle': '2.65', 'sei': '5.47'}",CHEMBL206746,,CHEMBL206746,5.86,True,http://www.openphacts.org/units/Nanomolar,450044,=,1,True,=,,IC50,nM,,1390.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1390.0
,1704905,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)cc1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '13.02', 'le': '0.24', 'lle': '1.75', 'sei': '4.70'}",CHEMBL426126,,CHEMBL426126,5.03,False,http://www.openphacts.org/units/Nanomolar,450039,=,1,True,=,,IC50,nM,,9310.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9310.0
,1704906,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc(C(=O)O)cc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '11.63', 'le': '0.21', 'lle': '0.62', 'sei': '4.45'}",CHEMBL204892,,CHEMBL204892,4.50,True,http://www.openphacts.org/units/Nanomolar,450038,=,1,True,=,,IC50,nM,,31280.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31280.0
,1704907,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)cc1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.39', 'le': '0.26', 'lle': '1.40', 'sei': '5.74'}",CHEMBL206179,,CHEMBL206179,5.16,False,http://www.openphacts.org/units/Nanomolar,450037,=,1,True,=,,IC50,nM,,6940.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6940.0
,1704908,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.07', 'le': '0.29', 'lle': '1.49', 'sei': '9.08'}",CHEMBL382397,,CHEMBL382397,5.81,False,http://www.openphacts.org/units/Nanomolar,450035,=,1,True,=,,IC50,nM,,1560.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1560.0
,1704909,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)cc1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.57', 'le': '0.28', 'lle': '1.69', 'sei': '6.54'}",CHEMBL427388,,CHEMBL427388,5.74,False,http://www.openphacts.org/units/Nanomolar,450034,=,1,True,=,,IC50,nM,,1830.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1830.0
,1704910,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)cc(C#N)c(=O)n1C,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.20', 'le': '0.26', 'lle': '2.81', 'sei': '5.35'}",CHEMBL268054,,CHEMBL268054,5.87,False,http://www.openphacts.org/units/Nanomolar,450033,=,1,True,=,,IC50,nM,,1340.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1340.0
,1704911,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '19.12', 'le': '0.35', 'lle': '3.02', 'sei': '8.57'}",CHEMBL208199,,CHEMBL208199,6.58,False,http://www.openphacts.org/units/Nanomolar,450032,=,1,True,=,,IC50,nM,,260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,260.0
,1704912,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(Nc2cccnc2)c1)Cc1ccccc1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.09', 'le': '0.29', 'lle': '1.99', 'sei': '7.06'}",CHEMBL382379,,CHEMBL382379,5.16,True,http://www.openphacts.org/units/Nanomolar,450031,=,1,True,=,,IC50,nM,,6970.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6970.0
,1704913,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(Nc2ccncc2)c1)Cc1ccccc1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.75', 'le': '0.27', 'lle': '1.56', 'sei': '6.47'}",CHEMBL207699,,CHEMBL207699,4.72,False,http://www.openphacts.org/units/Nanomolar,450030,=,1,True,=,,IC50,nM,,18830.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18830.0
,1704914,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(Nc2cccnc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.76', 'le': '0.29', 'lle': '2.02', 'sei': '6.38'}",CHEMBL207671,,CHEMBL207671,5.67,True,http://www.openphacts.org/units/Nanomolar,450029,=,1,True,=,,IC50,nM,,2160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2160.0
,1704915,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(Nc2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.42', 'le': '0.28', 'lle': '1.89', 'sei': '6.24'}",CHEMBL383223,,CHEMBL383223,5.54,False,http://www.openphacts.org/units/Nanomolar,450028,=,1,True,=,,IC50,nM,,2860.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2860.0
,1704916,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2nc(-c3cccnc3)cs2)c1)Cc1ccccc1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.95', 'le': '0.25', 'lle': '0.81', 'sei': '6.80'}",CHEMBL207530,,CHEMBL207530,5.03,False,http://www.openphacts.org/units/Nanomolar,450027,=,1,True,=,,IC50,nM,,9350.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9350.0
,1704917,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2nc(-c3ccncc3)cs2)c1)Cc1ccccc1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.88', 'le': '0.24', 'lle': '0.79', 'sei': '6.77'}",CHEMBL377771,,CHEMBL377771,5.01,False,http://www.openphacts.org/units/Nanomolar,450026,=,1,True,=,,IC50,nM,,9870.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9870.0
,1704918,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(NC(=O)c2ccncc2)c1)Cc1ccccc1,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.90', 'le': '0.24', 'lle': '1.82', 'sei': '4.99'}",CHEMBL414861,,CHEMBL414861,4.50,False,http://www.openphacts.org/units/Nanomolar,450021,=,1,True,=,,IC50,nM,,31950.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31950.0
,1704919,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(C(=O)Nc2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.70', 'le': '0.27', 'lle': '2.53', 'sei': '5.38'}",CHEMBL208499,,CHEMBL208499,5.70,False,http://www.openphacts.org/units/Nanomolar,450020,=,1,True,=,,IC50,nM,,2020.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2020.0
,1704920,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(C#Cc2cccnc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.48', 'le': '0.22', 'lle': '1.29', 'sei': '5.99'}",CHEMBL205349,,CHEMBL205349,4.60,False,http://www.openphacts.org/units/Nanomolar,450019,=,1,True,=,,IC50,nM,,25200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25200.0
,1704921,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(C#Cc2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.12', 'le': '0.33', 'lle': '3.37', 'sei': '8.69'}",CHEMBL206208,,CHEMBL206208,6.68,False,http://www.openphacts.org/units/Nanomolar,450018,=,1,True,=,,IC50,nM,,210.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,210.0
,1704922,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '21.20', 'le': '0.38', 'lle': '3.77', 'sei': '10.22'}",CHEMBL383541,,CHEMBL383541,7.85,False,http://www.openphacts.org/units/Nanomolar,450017,=,1,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
,1704933,[],CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.91', 'le': '0.34', 'lle': '4.47', 'sei': '12.71'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.82,False,http://www.openphacts.org/units/Nanomolar,450064,=,1,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
,1704949,[],CHEMBL868852,Antiproliferative activity against Akt1 overexpressing murine FL5.12-Akt1 cell,F,,,BAO_0000190,BAO_0000019,assay format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL383541,,CHEMBL383541,5.52,False,http://www.openphacts.org/units/Nanomolar,450017,=,1,True,=,,IC50,nM,,3000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3000.0
,1704981,[],CHEMBL868852,Antiproliferative activity against Akt1 overexpressing murine FL5.12-Akt1 cell,F,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL388978,STAUROSPORINE,CHEMBL388978,6.54,False,http://www.openphacts.org/units/Nanomolar,450064,=,1,True,=,,IC50,nM,,290.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,290.0
,1704982,[],CHEMBL868852,Antiproliferative activity against Akt1 overexpressing murine FL5.12-Akt1 cell,F,,,BAO_0000190,BAO_0000019,assay format,N[C@H](COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1146102,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL383264,,CHEMBL383264,6.38,False,http://www.openphacts.org/units/Nanomolar,450062,=,1,True,=,,IC50,nM,,420.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,420.0
,1726410,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '22.05', 'le': '0.40', 'lle': '3.97', 'sei': '11.32'}",CHEMBL383264,,CHEMBL383264,8.70,True,http://www.openphacts.org/units/Nanomolar,485434,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,1726411,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1c(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)ccc2cnccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '19.11', 'le': '0.34', 'lle': '3.51', 'sei': '7.61'}",CHEMBL380196,,CHEMBL380196,7.82,True,http://www.openphacts.org/units/Nanomolar,485460,=,1,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
,1726412,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc2cc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)ccc2cn1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '20.68', 'le': '0.37', 'lle': '4.16', 'sei': '8.23'}",CHEMBL210390,,CHEMBL210390,8.47,True,http://www.openphacts.org/units/Nanomolar,485459,=,1,True,=,,IC50,nM,,3.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.4
,1726413,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3cnc(C#Cc4ccccc4)cc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.66', 'le': '0.26', 'lle': '1.12', 'sei': '9.44'}",CHEMBL378211,,CHEMBL378211,7.25,False,http://www.openphacts.org/units/Nanomolar,485458,=,1,True,=,,IC50,nM,,56.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,56.0
,1726414,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC#Cc1cc2cc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)ccc2cn1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.59', 'le': '0.28', 'lle': '1.64', 'sei': '8.78'}",CHEMBL378714,,CHEMBL378714,6.75,False,http://www.openphacts.org/units/Nanomolar,485457,=,1,True,=,,IC50,nM,,180.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,180.0
,1726415,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3cnc(-c4ccncc4)cc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.66', 'le': '0.26', 'lle': '1.12', 'sei': '7.71'}",CHEMBL209564,,CHEMBL209564,6.91,True,http://www.openphacts.org/units/Nanomolar,485456,=,1,True,=,,IC50,nM,,122.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,122.0
,1726416,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3cnc(-c4ccccc4)cc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '13.85', 'le': '0.25', 'lle': '0.13', 'sei': '8.48'}",CHEMBL210544,,CHEMBL210544,6.52,True,http://www.openphacts.org/units/Nanomolar,485455,=,1,True,=,,IC50,nM,,305.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,305.0
,1726417,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3cnc(-c4ccco4)cc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.73', 'le': '0.28', 'lle': '1.25', 'sei': '8.05'}",CHEMBL210333,,CHEMBL210333,7.24,False,http://www.openphacts.org/units/Nanomolar,485454,=,1,True,=,,IC50,nM,,57.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,57.0
,1726418,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1cc2cc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)ccc2cn1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.21', 'le': '0.33', 'lle': '2.29', 'sei': '9.97'}",CHEMBL377764,,CHEMBL377764,7.66,True,http://www.openphacts.org/units/Nanomolar,485453,=,1,True,=,,IC50,nM,,22.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22.0
,1726419,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2cc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)ccc2cn1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.19', 'le': '0.29', 'lle': '1.55', 'sei': '8.91'}",CHEMBL206924,,CHEMBL206924,6.84,False,http://www.openphacts.org/units/Nanomolar,485452,=,1,True,=,,IC50,nM,,144.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,144.0
,1726420,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cc2cc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)ccc2cn1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.77', 'le': '0.26', 'lle': '1.59', 'sei': '6.16'}",CHEMBL381273,,CHEMBL381273,6.19,False,http://www.openphacts.org/units/Nanomolar,485451,=,1,True,=,,IC50,nM,,640.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,640.0
,1726421,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3cnc(Cl)cc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.90', 'le': '0.28', 'lle': '1.01', 'sei': '8.32'}",CHEMBL210783,,CHEMBL210783,6.39,False,http://www.openphacts.org/units/Nanomolar,485450,=,1,True,=,,IC50,nM,,407.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,407.0
,1726422,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3cnc(F)cc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '20.50', 'le': '0.37', 'lle': '3.59', 'sei': '11.01'}",CHEMBL210246,,CHEMBL210246,8.46,True,http://www.openphacts.org/units/Nanomolar,485449,=,1,True,=,,IC50,nM,,3.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.5
,1726423,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nccc2cc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)ccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.60', 'le': '0.30', 'lle': '2.49', 'sei': '6.61'}",CHEMBL208962,,CHEMBL208962,6.80,False,http://www.openphacts.org/units/Nanomolar,485448,=,1,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,160.0
,1726424,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,COc1nccc2cc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)ccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '10.37', 'le': '0.19', 'lle': '-0.34', 'sei': '5.12'}",CHEMBL210337,,CHEMBL210337,4.40,False,http://www.openphacts.org/units/Nanomolar,485447,=,1,True,=,,IC50,nM,,39500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,39500.0
,1726425,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(Cl)nccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.24', 'le': '0.27', 'lle': '0.73', 'sei': '7.95'}",CHEMBL208014,,CHEMBL208014,6.11,False,http://www.openphacts.org/units/Nanomolar,485446,=,1,True,=,,IC50,nM,,778.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,778.0
,1726426,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(O)nccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.39', 'le': '0.26', 'lle': '1.48', 'sei': '6.09'}",CHEMBL207215,,CHEMBL207215,5.91,False,http://www.openphacts.org/units/Nanomolar,485445,=,1,True,=,,IC50,nM,,1240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1240.0
,1726427,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(F)nccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.11', 'le': '0.29', 'lle': '1.77', 'sei': '8.65'}",CHEMBL210093,,CHEMBL210093,6.64,False,http://www.openphacts.org/units/Nanomolar,485444,=,1,True,=,,IC50,nM,,227.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,227.0
,1726428,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N#C/C=C/c1c(OC[C@@H](N)Cc2c[nH]c3ccccc23)cncc1-c1ccc2cnccc2c1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '13.82', 'le': '0.25', 'lle': '0.90', 'sei': '6.12'}",CHEMBL210628,,CHEMBL210628,6.16,False,http://www.openphacts.org/units/Nanomolar,485443,=,1,True,=,,IC50,nM,,697.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,697.0
,1726429,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(OC[C@@H](N)Cc2c[nH]c3ccccc23)cncc1-c1ccc2cnccc2c1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.32', 'le': '0.31', 'lle': '2.04', 'sei': '9.21'}",CHEMBL378116,,CHEMBL378116,7.08,False,http://www.openphacts.org/units/Nanomolar,485442,=,1,True,=,,IC50,nM,,84.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,84.0
,1726430,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cc(-c2ccc3cnccc3c2)cnc1Cl)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.47', 'le': '0.35', 'lle': '2.54', 'sei': '10.31'}",CHEMBL210089,,CHEMBL210089,7.92,True,http://www.openphacts.org/units/Nanomolar,485441,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,1726431,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cnc(C#Cc2ccccc2)c(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '11.94', 'le': '0.21', 'lle': '-0.22', 'sei': '7.69'}",CHEMBL207545,,CHEMBL207545,5.91,False,http://www.openphacts.org/units/Nanomolar,485440,=,1,True,=,,IC50,nM,,1240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1240.0
,1726432,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,C#Cc1ncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1ccc2cnccc2c1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '21.74', 'le': '0.39', 'lle': '4.39', 'sei': '11.84'}",CHEMBL207544,,CHEMBL207544,9.10,False,http://www.openphacts.org/units/Nanomolar,485439,=,1,True,=,,IC50,nM,,0.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.8
,1726433,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cnc(-c2ccco2)c(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '19.16', 'le': '0.34', 'lle': '2.83', 'sei': '9.81'}",CHEMBL378843,,CHEMBL378843,8.82,True,http://www.openphacts.org/units/Nanomolar,485438,=,1,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
,1726434,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1ncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1ccc2cnccc2c1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '20.69', 'le': '0.37', 'lle': '3.33', 'sei': '11.32'}",CHEMBL209513,,CHEMBL209513,8.70,True,http://www.openphacts.org/units/Nanomolar,485437,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,1726435,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1ccc2cnccc2c1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '19.87', 'le': '0.36', 'lle': '3.74', 'sei': '8.29'}",CHEMBL379209,,CHEMBL379209,8.34,True,http://www.openphacts.org/units/Nanomolar,485436,=,1,True,=,,IC50,nM,,4.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.6
,1726436,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cnc(Cl)c(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '20.39', 'le': '0.39', 'lle': '3.36', 'sei': '11.38'}",CHEMBL378963,,CHEMBL378963,8.74,True,http://www.openphacts.org/units/Nanomolar,485435,=,1,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
,1726437,[],CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)cc2ccncc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.69', 'le': '0.26', 'lle': '0.96', 'sei': '7.81'}",CHEMBL208961,,CHEMBL208961,6.00,False,http://www.openphacts.org/units/Nanomolar,485461,=,1,True,=,,IC50,nM,,995.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,995.0
,1726483,[],CHEMBL861331,Inhibition of GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,N[C@H](COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL383264,,CHEMBL383264,5.82,True,http://www.openphacts.org/units/Nanomolar,485434,=,1,True,=,,IC50,nM,,1500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.5
,1726484,[],CHEMBL861331,Inhibition of GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,Nc1cc2cc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)ccc2cn1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210390,,CHEMBL210390,6.03,False,http://www.openphacts.org/units/Nanomolar,485459,=,1,True,=,,IC50,nM,,930.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.93
Not Determined,1726485,[],CHEMBL861331,Inhibition of GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,N[C@H](COc1cncc(-c2ccc3cnc(F)cc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210246,,CHEMBL210246,,False,,485449,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,1726486,[],CHEMBL861331,Inhibition of GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,C#Cc1ncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1ccc2cnccc2c1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL207544,,CHEMBL207544,,False,,485439,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,1726487,[],CHEMBL861331,Inhibition of GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,N[C@H](COc1cnc(Cl)c(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL378963,,CHEMBL378963,5.52,False,http://www.openphacts.org/units/Nanomolar,485435,=,1,True,=,,IC50,nM,,3000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.0
,1726488,[],CHEMBL861319,Antiproliferative activity against mouse FL5.12 cells overexpressing Akt1 by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL383264,,CHEMBL383264,6.38,True,http://www.openphacts.org/units/Nanomolar,485434,=,1,True,=,,IC50,nM,,420.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.42
,1726489,[],CHEMBL861319,Antiproliferative activity against mouse FL5.12 cells overexpressing Akt1 by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1cc2cc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)ccc2cn1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210390,,CHEMBL210390,6.70,False,http://www.openphacts.org/units/Nanomolar,485459,=,1,True,=,,IC50,nM,,200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.2
,1726490,[],CHEMBL861319,Antiproliferative activity against mouse FL5.12 cells overexpressing Akt1 by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](COc1cncc(-c2ccc3cnc(F)cc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210246,,CHEMBL210246,5.64,False,http://www.openphacts.org/units/Nanomolar,485449,=,1,True,=,,IC50,nM,,2300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.3
,1726491,[],CHEMBL861319,Antiproliferative activity against mouse FL5.12 cells overexpressing Akt1 by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C#Cc1ncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1ccc2cnccc2c1,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL207544,,CHEMBL207544,5.77,False,http://www.openphacts.org/units/Nanomolar,485439,=,1,True,=,,IC50,nM,,1700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.7
,1726492,[],CHEMBL861319,Antiproliferative activity against mouse FL5.12 cells overexpressing Akt1 by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](COc1cnc(Cl)c(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1147830,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL378963,,CHEMBL378963,5.24,False,http://www.openphacts.org/units/Nanomolar,485435,=,1,True,=,,IC50,nM,,5700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.7
,1733247,[],CHEMBL867323,Inhibition of GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(Cc1ccco1)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210954,,CHEMBL210954,5.60,False,http://www.openphacts.org/units/Nanomolar,508551,=,1,True,=,,IC50,nM,,2500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.5
,1733249,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Cc1ccco1)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.76', 'le': '0.34', 'lle': '3.69', 'sei': '9.20'}",CHEMBL210954,,CHEMBL210954,9.77,False,http://www.openphacts.org/units/Nanomolar,508551,=,1,True,=,,IC50,nM,,0.17,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.17
,1733251,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Cc1cccs1)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.85', 'le': '0.32', 'lle': '2.51', 'sei': '9.72'}",CHEMBL209826,,CHEMBL209826,9.05,False,http://www.openphacts.org/units/Nanomolar,508550,=,1,True,=,,IC50,nM,,0.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.9
,1733255,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(C)[nH]c(CC(C)(C)C2C(=O)Nc3ccc(-c4cncc(OC[C@@H](N)Cc5c[nH]c6ccccc56)c4)cc32)c1C,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.84', 'le': '0.23', 'lle': '0.40', 'sei': '6.80'}",CHEMBL380004,,CHEMBL380004,7.39,False,http://www.openphacts.org/units/Nanomolar,508549,=,1,True,=,,IC50,nM,,40.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,40.3
,1733266,[],CHEMBL867323,Inhibition of GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(Cc1ncc[nH]1)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210209,,CHEMBL210209,5.30,False,http://www.openphacts.org/units/Nanomolar,508548,=,1,True,=,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.0
,1733269,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Cc1ncc[nH]1)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.64', 'le': '0.29', 'lle': '2.93', 'sei': '6.69'}",CHEMBL210209,,CHEMBL210209,8.14,False,http://www.openphacts.org/units/Nanomolar,508548,=,1,True,=,,IC50,nM,,7.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.2
,1733271,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Cc1c[nH]c2ccccc12)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '11.96', 'le': '0.22', 'lle': '-0.14', 'sei': '6.26'}",CHEMBL210237,,CHEMBL210237,6.82,False,http://www.openphacts.org/units/Nanomolar,508547,=,1,True,=,,IC50,nM,,153.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,153.0
,1733273,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Cc1cc[nH]c1)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.17', 'le': '0.31', 'lle': '3.11', 'sei': '8.20'}",CHEMBL210940,,CHEMBL210940,8.92,False,http://www.openphacts.org/units/Nanomolar,508546,=,1,True,=,,IC50,nM,,1.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.2
,1733274,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CC(C)(C)C2C(=O)Nc3ccc(-c4cncc(OC[C@@H](N)Cc5c[nH]c6ccccc56)c4)cc32)o1,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.12', 'le': '0.31', 'lle': '2.77', 'sei': '8.62'}",CHEMBL426140,,CHEMBL426140,9.15,False,http://www.openphacts.org/units/Nanomolar,508552,=,1,True,=,,IC50,nM,,0.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.7
,1733276,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(CC(C)(C)C2C(=O)Nc3ccc(-c4cncc(OC[C@@H](N)Cc5c[nH]c6ccccc56)c4)cc32)oc1C,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.58', 'le': '0.27', 'lle': '1.31', 'sei': '7.54'}",CHEMBL211065,,CHEMBL211065,8.00,False,http://www.openphacts.org/units/Nanomolar,508553,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,1733278,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cccc1CC(C)(C)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.15', 'le': '0.28', 'lle': '2.27', 'sei': '8.25'}",CHEMBL379963,,CHEMBL379963,8.09,False,http://www.openphacts.org/units/Nanomolar,508545,=,1,True,=,,IC50,nM,,8.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.2
,1733280,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CC1CCCN1)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '11.80', 'le': '0.22', 'lle': '0.80', 'sei': '5.88'}",CHEMBL207139,,CHEMBL207139,6.18,False,http://www.openphacts.org/units/Nanomolar,508544,=,1,True,=,,IC50,nM,,660.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,660.0
,1733293,[],CHEMBL867323,Inhibition of GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(Cc1ccc[nH]1)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL377603,,CHEMBL377603,6.05,False,http://www.openphacts.org/units/Nanomolar,508543,=,1,True,=,,IC50,nM,,900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.9
,1733295,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Cc1ccc[nH]1)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.98', 'le': '0.31', 'lle': '3.01', 'sei': '8.11'}",CHEMBL377603,,CHEMBL377603,8.82,False,http://www.openphacts.org/units/Nanomolar,508543,=,1,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
,1733297,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Cc1ccccn1)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.02', 'le': '0.27', 'lle': '2.11', 'sei': '7.54'}",CHEMBL211774,,CHEMBL211774,7.99,False,http://www.openphacts.org/units/Nanomolar,508542,=,1,True,=,,IC50,nM,,10.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.3
,1733299,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Cc1cccnc1)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.02', 'le': '0.27', 'lle': '2.10', 'sei': '7.54'}",CHEMBL211690,,CHEMBL211690,7.98,False,http://www.openphacts.org/units/Nanomolar,508541,=,1,True,=,,IC50,nM,,10.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.4
,1733303,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Cc1ccc(Cl)cc1Cl)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '10.76', 'le': '0.21', 'lle': '-1.34', 'sei': '6.94'}",CHEMBL438431,,CHEMBL438431,6.45,False,http://www.openphacts.org/units/Nanomolar,508540,=,1,True,=,,IC50,nM,,352.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,352.0
,1733305,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Cc1ccccc1)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.51', 'le': '0.28', 'lle': '1.75', 'sei': '8.85'}",CHEMBL210034,,CHEMBL210034,8.23,False,http://www.openphacts.org/units/Nanomolar,508539,=,1,True,=,,IC50,nM,,5.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.9
,1733307,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CC1CC1)C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.15', 'le': '0.31', 'lle': '2.44', 'sei': '9.12'}",CHEMBL378827,,CHEMBL378827,8.48,False,http://www.openphacts.org/units/Nanomolar,508538,=,1,True,=,,IC50,nM,,3.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.3
,1733310,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2ccc(N[C@H](COc3cncc(-c4ccc5c(c4)C(F)(F)C(=O)N5)c3)Cc3c[nH]c4ccccc34)cc2C1(F)F,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.67', 'le': '0.27', 'lle': '2.40', 'sei': '8.16'}",CHEMBL212067,,CHEMBL212067,8.82,False,http://www.openphacts.org/units/Nanomolar,508537,=,1,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
,1733314,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)=C1C(=O)Nc2ccc(N[C@H](COc3cncc(-c4ccc5c(c4)C(=C(C)C)C(=O)N5)c3)Cc3c[nH]c4ccccc34)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '11.94', 'le': '0.22', 'lle': '-0.54', 'sei': '6.73'}",CHEMBL211932,,CHEMBL211932,7.28,False,http://www.openphacts.org/units/Nanomolar,508536,=,1,True,=,,IC50,nM,,52.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,52.7
,1733331,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '22.05', 'le': '0.40', 'lle': '3.97', 'sei': '11.32'}",CHEMBL383264,,CHEMBL383264,8.70,True,http://www.openphacts.org/units/Nanomolar,508517,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,1733339,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(C[C@@H](COc3cncc(-c4cc5cnccc5s4)c3)Nc3cc4cnccc4s3)c[nH]c2c1,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '11.83', 'le': '0.23', 'lle': '-1.24', 'sei': '8.34'}",CHEMBL211224,,CHEMBL211224,6.31,False,http://www.openphacts.org/units/Nanomolar,508519,=,1,True,=,,IC50,nM,,488.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,488.0
,1734720,[],CHEMBL865417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)(C)C)cc3)s2)cc1C(=O)N1CCN(C(C)=O)CC1,,,CHEMBL1138957,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL209148,,CHEMBL209148,,False,http://www.openphacts.org/units/Nanomolar,523262,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,1735153,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2ccc(N[C@H](COc3cncc(-c4ccc5c(c4)C(Cc4ccccc4)C(=O)N5)c3)Cc3c[nH]c4ccccc34)cc2C1Cc1ccccc1,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '8.44', 'le': '0.15', 'lle': '-2.90', 'sei': '5.54'}",CHEMBL209005,,CHEMBL209005,5.99,False,http://www.openphacts.org/units/Nanomolar,508535,=,1,True,=,,IC50,nM,,1020.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1020.0
,1735155,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CCC1C(=O)Nc2ccc(N[C@H](COc3cncc(-c4ccc5c(c4)C(CC)C(=O)N5)c3)Cc3c[nH]c4ccccc34)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.12', 'le': '0.22', 'lle': '-0.12', 'sei': '6.56'}",CHEMBL379576,,CHEMBL379576,7.10,False,http://www.openphacts.org/units/Nanomolar,508534,=,1,True,=,,IC50,nM,,80.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,80.0
,1735159,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC1C(=O)Nc2ccc(N[C@H](COc3cncc(-c4ccc5c(c4)C(C)C(=O)N5)c3)Cc3c[nH]c4ccccc34)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.06', 'le': '0.27', 'lle': '1.96', 'sei': '7.77'}",CHEMBL208761,,CHEMBL208761,8.40,False,http://www.openphacts.org/units/Nanomolar,508533,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,1735161,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)C(=O)Nc2ccc(N[C@H](COc3cncc(-c4ccc5c(c4)C(C)(C)C(=O)N5)c3)Cc3c[nH]c4ccccc34)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.99', 'le': '0.24', 'lle': '0.82', 'sei': '7.04'}",CHEMBL211011,,CHEMBL211011,7.61,False,http://www.openphacts.org/units/Nanomolar,508532,=,1,True,=,,IC50,nM,,24.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.6
,1735163,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=S1(=O)Nc2ccc(N[C@H](COc3cncc(-c4ccc5c(c4)NS(=O)(=O)N5)c3)Cc3c[nH]c4ccccc34)cc2N1,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '7.96', 'le': '0.16', 'lle': '0.31', 'sei': '2.89'}",CHEMBL378977,,CHEMBL378977,4.81,False,http://www.openphacts.org/units/Nanomolar,508531,=,1,True,=,,IC50,nM,,15600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15600.0
,1735165,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc2ccc(N[C@H](COc3cncc(-c4ccc5nc(O)sc5c4)c3)Cc3c[nH]c4ccccc34)cc2s1,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.79', 'le': '0.29', 'lle': '1.41', 'sei': '7.20'}",CHEMBL209503,,CHEMBL209503,8.37,False,http://www.openphacts.org/units/Nanomolar,508530,=,1,True,=,,IC50,nM,,4.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.3
,1735167,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc2ccc(N[C@H](COc3cncc(-c4ccc5nc(O)oc5c4)c3)Cc3c[nH]c4ccccc34)cc2o1,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.24', 'le': '0.28', 'lle': '2.10', 'sei': '5.71'}",CHEMBL209281,,CHEMBL209281,8.13,False,http://www.openphacts.org/units/Nanomolar,508529,=,1,True,=,,IC50,nM,,7.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.4
,1735169,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N#CCn1c(O)nc2cc(N[C@H](COc3cncc(-c4ccc5c(c4)nc(O)n5CC#N)c3)Cc3c[nH]c4ccccc34)ccc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '7.68', 'le': '0.14', 'lle': '-0.81', 'sei': '2.70'}",CHEMBL263512,,CHEMBL263512,4.68,False,http://www.openphacts.org/units/Nanomolar,508528,=,1,True,=,,IC50,nM,,20700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20700.0
,1735171,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N#CCn1c(O)nc2ccc(N[C@H](COc3cncc(-c4ccc5nc(O)n(CC#N)c5c4)c3)Cc3c[nH]c4ccccc34)cc21,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '10.49', 'le': '0.19', 'lle': '0.90', 'sei': '3.68'}",CHEMBL379342,,CHEMBL379342,6.39,False,http://www.openphacts.org/units/Nanomolar,508527,=,1,True,=,,IC50,nM,,405.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,405.0
,1735175,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc2cc(N[C@H](COc3cncc(-c4ccc5[nH]c(O)nc5c4)c3)Cc3c[nH]c4ccccc34)ccc2[nH]1,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.85', 'le': '0.23', 'lle': '1.33', 'sei': '4.62'}",CHEMBL209231,,CHEMBL209231,6.83,False,http://www.openphacts.org/units/Nanomolar,508526,=,1,True,=,,IC50,nM,,147.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,147.0
,1735181,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=Nc1c(O)[nH]c2ccc(N[C@H](COc3cncc(-c4ccc5[nH]c(O)c(N=O)c5c4)c3)Cc3c[nH]c4ccccc34)cc12,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '13.93', 'le': '0.25', 'lle': '0.69', 'sei': '4.53'}",CHEMBL376959,,CHEMBL376959,8.19,False,http://www.openphacts.org/units/Nanomolar,508525,=,1,True,=,,IC50,nM,,6.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.5
,1735183,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2ccc(N[C@H](COc3cncc(-c4ccc5c(c4)C(=O)C(=O)N5)c3)Cc3c[nH]c4ccccc34)cc2C1=O,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '12.10', 'le': '0.22', 'lle': '2.15', 'sei': '4.74'}",CHEMBL377687,,CHEMBL377687,6.75,False,http://www.openphacts.org/units/Nanomolar,508524,=,1,True,=,,IC50,nM,,179.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,179.0
,1735185,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Cc2ccc(N[C@H](COc3cncc(-c4ccc5c(n4)NC(=O)C5)c3)Cc3c[nH]c4ccccc34)nc2N1,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '13.18', 'le': '0.24', 'lle': '2.89', 'sei': '5.23'}",CHEMBL211434,,CHEMBL211434,7.00,False,http://www.openphacts.org/units/Nanomolar,508523,=,1,True,=,,IC50,nM,,99.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,99.0
,1735193,[],CHEMBL867323,Inhibition of GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,O=C1Cc2cc(N[C@H](COc3cncc(-c4ccc5c(c4)CC(=O)N5)c3)Cc3c[nH]c4ccccc34)ccc2N1,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL212566,,CHEMBL212566,5.71,False,http://www.openphacts.org/units/Nanomolar,508522,=,1,True,=,,IC50,nM,,1940.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.94
,1735195,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Cc2cc(N[C@H](COc3cncc(-c4ccc5c(c4)CC(=O)N5)c3)Cc3c[nH]c4ccccc34)ccc2N1,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.04', 'le': '0.29', 'lle': '3.17', 'sei': '7.86'}",CHEMBL212566,,CHEMBL212566,8.49,False,http://www.openphacts.org/units/Nanomolar,508522,=,1,True,=,,IC50,nM,,3.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.2
,1735198,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Cc2ccc(N[C@H](COc3cncc(-c4ccc5c(c4)NC(=O)C5)c3)Cc3c[nH]c4ccccc34)cc2N1,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '10.11', 'le': '0.18', 'lle': '0.04', 'sei': '4.95'}",CHEMBL438439,,CHEMBL438439,5.36,False,http://www.openphacts.org/units/Nanomolar,508521,=,1,True,=,,IC50,nM,,4400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4400.0
,1735204,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(C[C@@H](COc3cncc(-c4cc5ccncc5s4)c3)Nc3cc4ccncc4s3)c[nH]c2c1,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.49', 'le': '0.30', 'lle': '0.72', 'sei': '10.92'}",CHEMBL211281,,CHEMBL211281,8.27,False,http://www.openphacts.org/units/Nanomolar,508518,=,1,True,=,,IC50,nM,,5.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.4
,1735206,[],CHEMBL867323,Inhibition of GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,N[C@H](COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL383264,,CHEMBL383264,5.82,False,http://www.openphacts.org/units/Nanomolar,508517,=,1,True,=,,IC50,nM,,1500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.5
,1735217,[],CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(C[C@@H](COc3cncc(-c4ccc5nonc5c4)c3)Nc3ccc4nonc4c3)c[nH]c2c1,,,CHEMBL1138086,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.67', 'le': '0.27', 'lle': '1.99', 'sei': '5.78'}",CHEMBL207217,,CHEMBL207217,7.39,False,http://www.openphacts.org/units/Nanomolar,508520,=,1,True,=,,IC50,nM,,41.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,41.0
,1746711,[],CHEMBL853526,Inhibition of Akt by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,,,CHEMBL1138054,J. Med. Chem.,2006.0,,CHEMBL44,GENISTEIN,CHEMBL44,,False,http://www.openphacts.org/units/Nanomolar,503396,>,1,True,>,,IC50,nM,,70000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,70.0
,1751548,[],CHEMBL869145,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3Cl)cn12,,,CHEMBL1145312,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL215652,,CHEMBL215652,,False,http://www.openphacts.org/units/Nanomolar,528643,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,1751549,[],CHEMBL869145,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12,,,CHEMBL1145312,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL213423,,CHEMBL213423,,False,http://www.openphacts.org/units/Nanomolar,528646,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,1751550,[],CHEMBL869145,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CCNc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12,,,CHEMBL1145312,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL213451,,CHEMBL213451,,False,http://www.openphacts.org/units/Nanomolar,528667,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,1751551,[],CHEMBL869145,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3F)cn12,,,CHEMBL1145312,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL212382,,CHEMBL212382,,False,http://www.openphacts.org/units/Nanomolar,528687,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,1751552,[],CHEMBL869145,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12,,,CHEMBL1145312,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL212968,,CHEMBL212968,,False,http://www.openphacts.org/units/Nanomolar,528698,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,1751553,[],CHEMBL869145,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1nnc2ccc(-c3c[nH]nc3-c3cc(F)ccc3F)cn12,,,CHEMBL1145312,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL214198,,CHEMBL214198,,False,http://www.openphacts.org/units/Nanomolar,528700,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,1751651,[],CHEMBL869145,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1nnc2ccc(-c3ocnc3-c3ccccc3)cn12,,,CHEMBL1145312,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL379929,,CHEMBL379929,,False,http://www.openphacts.org/units/Nanomolar,528627,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,1755319,[],CHEMBL868045,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL1146851,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.06', 'le': '0.31', 'lle': '3.61', 'sei': '11.46'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,7.96,True,http://www.openphacts.org/units/Nanomolar,549438,=,1,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
,1755340,[],CHEMBL868045,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nccc(-c2ccc(C(=O)N[C@H](CN)Cc3ccc(Cl)cc3Cl)s2)n1,,,CHEMBL1146851,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.84', 'le': '0.40', 'lle': '4.37', 'sei': '8.85'}",CHEMBL213618,,CHEMBL213618,8.22,False,http://www.openphacts.org/units/Nanomolar,549433,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,1765523,[],CHEMBL871549,Inhibition of PKBalpha by HTRF kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CCN(C)CC4)ccc3C)ccc2n1,,,CHEMBL1149344,J. Med. Chem.,2006.0,,CHEMBL386661,,CHEMBL386661,,False,http://www.openphacts.org/units/Nanomolar,565637,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,1765531,[],CHEMBL871549,Inhibition of PKBalpha by HTRF kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1,,,CHEMBL1149344,J. Med. Chem.,2006.0,,CHEMBL215943,,CHEMBL215943,,False,http://www.openphacts.org/units/Nanomolar,565656,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,1769425,[],CHEMBL910939,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2,,,CHEMBL1149510,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL215803,,CHEMBL215803,,False,http://www.openphacts.org/units/Nanomolar,582040,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.0
,1782055,[],CHEMBL913517,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1,,,CHEMBL1137365,J. Med. Chem.,2006.0,,CHEMBL402548,DANUSERTIB,CHEMBL402548,,False,http://www.openphacts.org/units/Nanomolar,600232,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,1790439,[],CHEMBL912727,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC,,,CHEMBL1137241,J. Med. Chem.,2006.0,,CHEMBL201511,MALEIMIDE,CHEMBL201511,,False,http://www.openphacts.org/units/Nanomolar,614588,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,M,UO_0000065,,0.0001
,1800141,[],CHEMBL911091,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCN(C)CC5)c4)c(OC)cc23)c(Cl)cc1Cl,,,CHEMBL1138859,J. Med. Chem.,2006.0,,CHEMBL219557,,CHEMBL219557,,False,http://www.openphacts.org/units/Nanomolar,620683,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.0
,1811589,[],CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,O=C1C(Nc2ccccc2F)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1145295,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL220006,,CHEMBL220006,4.80,True,http://www.openphacts.org/units/Nanomolar,623692,=,1,True,=,,IC50,nM,,15800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,15.8
,1811590,[],CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,O=C1C(Sc2ccc(Cl)c(Cl)c2)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1145295,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL221064,,CHEMBL221064,4.91,False,http://www.openphacts.org/units/Nanomolar,623701,=,1,True,=,,IC50,nM,,12300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,12.3
,1811591,[],CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,O=C1C(Nc2cccc(Br)c2)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1145295,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL374701,,CHEMBL374701,4.86,True,http://www.openphacts.org/units/Nanomolar,623699,=,1,True,=,,IC50,nM,,13900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,13.9
,1811592,[],CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,O=C1C(Nc2ccc(C(F)(F)F)cc2)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1145295,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL222254,,CHEMBL222254,4.91,True,http://www.openphacts.org/units/Nanomolar,623698,=,1,True,=,,IC50,nM,,12400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,12.4
,1811593,[],CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,CCOc1ccc(NC2=C(Cl)C(=O)c3[nH]ncc3C2=O)cc1,,,CHEMBL1145295,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL375985,,CHEMBL375985,5.31,True,http://www.openphacts.org/units/Nanomolar,623697,=,1,True,=,,IC50,nM,,4900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.9
,1811594,[],CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,O=C1C(Nc2ccc(F)cc2F)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1145295,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL223314,,CHEMBL223314,4.80,False,http://www.openphacts.org/units/Nanomolar,623696,=,1,True,=,,IC50,nM,,16000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,16.0
,1811595,[],CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,O=C1C(Nc2cccc(F)c2)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1145295,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL375142,,CHEMBL375142,4.93,True,http://www.openphacts.org/units/Nanomolar,623693,=,1,True,=,,IC50,nM,,11800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,11.8
,1811596,[],CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,O=C1C(Nc2ccc(F)cc2)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1145295,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL223410,,CHEMBL223410,,False,http://www.openphacts.org/units/Nanomolar,623694,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,1811597,[],CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,Nc1ccc(N)c2[nH]ncc12,,,CHEMBL1145295,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL376871,,CHEMBL376871,,False,http://www.openphacts.org/units/Nanomolar,623702,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,1811598,[],CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(C)cc(SC2=C(Cl)C(=O)c3[nH]ncc3C2=O)c1,,,CHEMBL1145295,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL221222,,CHEMBL221222,,False,http://www.openphacts.org/units/Nanomolar,623700,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,1811599,[],CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,O=C1C(Nc2cc(F)cc(F)c2)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1145295,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL223464,,CHEMBL223464,,False,http://www.openphacts.org/units/Nanomolar,623695,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,1811640,[],CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,,,BAO_0000190,BAO_0000019,assay format,COC(=O)C1=C(C(=O)OC)C(=S)C2SC(=S)SC2C1=S,,,CHEMBL1145295,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL220290,,CHEMBL220290,4.60,False,http://www.openphacts.org/units/Nanomolar,623703,=,1,True,=,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,1815187,[],CHEMBL910143,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1,,,CHEMBL1141380,J. Med. Chem.,2007.0,"{'bei': '6.68', 'le': '0.13', 'lle': '-1.57', 'sei': '3.69'}",CHEMBL373882,,CHEMBL373882,4.00,False,http://www.openphacts.org/units/Nanomolar,624639,=,1,True,=,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
,1826443,[],CHEMBL919919,Inhibition of AKT using 5 to 10 ATP umol/L,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,,,CHEMBL1142982,J. Med. Chem.,2007.0,"{'bei': '11.46', 'le': '0.21', 'lle': '-0.60', 'sei': '4.49'}",CHEMBL223360,LINIFANIB,CHEMBL223360,4.30,False,http://www.openphacts.org/units/Nanomolar,628037,=,1,True,=,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
,1874451,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]ncc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '23.01', 'le': '0.42', 'lle': '4.76', 'sei': '9.53'}",CHEMBL374805,,CHEMBL374805,8.82,True,http://www.openphacts.org/units/Nanomolar,637031,=,1,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
,1874454,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cc3c(-c4ccccc4)n[nH]c3cn2)c1)Cc1ccccc1,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '19.17', 'le': '0.34', 'lle': '3.44', 'sei': '9.01'}",CHEMBL226383,,CHEMBL226383,8.08,False,http://www.openphacts.org/units/Nanomolar,637046,=,1,True,=,,IC50,nM,,8.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.3
,1874455,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cccc1-c1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '15.65', 'le': '0.28', 'lle': '2.67', 'sei': '7.02'}",CHEMBL375486,,CHEMBL375486,6.64,False,http://www.openphacts.org/units/Nanomolar,637045,=,1,True,=,,IC50,nM,,228.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,228.0
,1874456,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cc3c(-c4ccco4)n[nH]c3cn2)c1)Cc1ccccc1,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '19.96', 'le': '0.36', 'lle': '3.98', 'sei': '7.99'}",CHEMBL375485,,CHEMBL375485,8.21,True,http://www.openphacts.org/units/Nanomolar,637044,=,1,True,=,,IC50,nM,,6.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.1
,1874457,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '21.23', 'le': '0.38', 'lle': '4.28', 'sei': '8.79'}",CHEMBL226382,,CHEMBL226382,7.89,True,http://www.openphacts.org/units/Nanomolar,637043,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
,1874458,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2c[n+]([O-])c(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '18.60', 'le': '0.34', 'lle': '4.46', 'sei': '6.73'}",CHEMBL226381,,CHEMBL226381,6.98,False,http://www.openphacts.org/units/Nanomolar,637042,=,1,True,=,,IC50,nM,,104.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,104.0
,1874459,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cc3c(Cl)n[nH]c3cn2)c1)Cc1ccccc1,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '19.03', 'le': '0.37', 'lle': '3.61', 'sei': '8.06'}",CHEMBL226332,,CHEMBL226332,7.23,True,http://www.openphacts.org/units/Nanomolar,637041,=,1,True,=,,IC50,nM,,59.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,59.0
,1874460,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '21.15', 'le': '0.38', 'lle': '4.32', 'sei': '8.47'}",CHEMBL376570,,CHEMBL376570,7.60,False,http://www.openphacts.org/units/Nanomolar,637040,=,1,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
,1874461,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cc3cn[nH]c3cn2)c1)Cc1ccccc1,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '19.26', 'le': '0.35', 'lle': '3.68', 'sei': '7.41'}",CHEMBL226331,,CHEMBL226331,6.65,False,http://www.openphacts.org/units/Nanomolar,637039,=,1,True,=,,IC50,nM,,223.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,223.0
,1874462,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '23.76', 'le': '0.43', 'lle': '5.71', 'sei': '8.97'}",CHEMBL376569,,CHEMBL376569,9.47,True,http://www.openphacts.org/units/Nanomolar,637038,=,1,True,=,,IC50,nM,,0.34,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.34
,1874463,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cc3cn[nH]c3cn2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '23.99', 'le': '0.43', 'lle': '5.77', 'sei': '8.74'}",CHEMBL226330,,CHEMBL226330,9.22,False,http://www.openphacts.org/units/Nanomolar,637037,=,1,True,=,,IC50,nM,,0.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.6
,1874464,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc2[nH]nc(Cl)c2cc1-c1cncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)c1,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '18.82', 'le': '0.36', 'lle': '3.86', 'sei': '6.87'}",CHEMBL225789,,CHEMBL225789,8.15,True,http://www.openphacts.org/units/Nanomolar,637036,=,1,True,=,,IC50,nM,,7.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.1
,1874465,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc2[nH]ncc2cc1-c1cncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)c1,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '18.30', 'le': '0.33', 'lle': '3.65', 'sei': '6.15'}",CHEMBL388729,,CHEMBL388729,7.29,True,http://www.openphacts.org/units/Nanomolar,637035,=,1,True,=,,IC50,nM,,51.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,51.0
,1874466,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cc3cn[nH]c3cc2[N+](=O)[O-])c1)Cc1c[nH]c2ccccc12,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '14.05', 'le': '0.26', 'lle': '2.06', 'sei': '4.44'}",CHEMBL225788,,CHEMBL225788,6.02,True,http://www.openphacts.org/units/Nanomolar,637034,=,1,True,=,,IC50,nM,,953.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,953.0
,1874467,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]nc(C(F)(F)F)c3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '19.37', 'le': '0.36', 'lle': '3.67', 'sei': '9.44'}",CHEMBL374808,,CHEMBL374808,8.74,True,http://www.openphacts.org/units/Nanomolar,637033,=,1,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
,1874468,[],CHEMBL903964,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]nc(Cl)c3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1142911,Bioorg. Med. Chem.,2007.0,"{'bei': '21.54', 'le': '0.41', 'lle': '4.29', 'sei': '9.72'}",CHEMBL226148,,CHEMBL226148,9.00,True,http://www.openphacts.org/units/Nanomolar,637032,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,1891149,[],CHEMBL905889,Inhibition at AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1,,,CHEMBL1143787,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '15.01', 'le': '0.27', 'lle': '2.05', 'sei': '4.26'}",CHEMBL242237,,CHEMBL242237,4.82,False,http://www.openphacts.org/units/Nanomolar,640639,=,1,True,=,,IC50,nM,,15000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,15.0
,1900590,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '21.91', 'le': '0.40', 'lle': '3.97', 'sei': '10.22'}",CHEMBL379218,,CHEMBL379218,7.85,False,http://www.openphacts.org/units/Nanomolar,643040,=,1,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
,1900592,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(OCCN)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '17.55', 'le': '0.32', 'lle': '4.11', 'sei': '6.54'}",CHEMBL226798,,CHEMBL226798,7.33,False,http://www.openphacts.org/units/Nanomolar,643089,=,1,True,=,,IC50,nM,,47.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,47.0
,1900593,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(OCC5CCN(C)CC5)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '14.64', 'le': '0.27', 'lle': '2.51', 'sei': '7.96'}",CHEMBL226797,,CHEMBL226797,7.11,False,http://www.openphacts.org/units/Nanomolar,643088,=,1,True,=,,IC50,nM,,78.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,78.0
,1900594,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(OCC5CCCCC5)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '12.47', 'le': '0.23', 'lle': '0.03', 'sei': '6.82'}",CHEMBL226796,,CHEMBL226796,5.87,False,http://www.openphacts.org/units/Nanomolar,643087,=,1,True,=,,IC50,nM,,1360.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1360.0
,1900595,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(OCC5CCNCC5)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '17.32', 'le': '0.32', 'lle': '3.91', 'sei': '8.33'}",CHEMBL226745,,CHEMBL226745,8.17,False,http://www.openphacts.org/units/Nanomolar,643086,=,1,True,=,,IC50,nM,,6.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.8
,1900596,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(OCCC5CCNCC5)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '13.46', 'le': '0.25', 'lle': '1.89', 'sei': '6.67'}",CHEMBL388310,,CHEMBL388310,6.54,False,http://www.openphacts.org/units/Nanomolar,643085,=,1,True,=,,IC50,nM,,290.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,290.0
,1900597,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(OCCN5CCOCC5)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '12.56', 'le': '0.23', 'lle': '2.53', 'sei': '6.22'}",CHEMBL415220,,CHEMBL415220,6.12,False,http://www.openphacts.org/units/Nanomolar,643084,=,1,True,=,,IC50,nM,,751.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,751.0
,1900598,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc5c(c4)OC(F)(F)C(F)(F)O5)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '16.15', 'le': '0.31', 'lle': '3.05', 'sei': '8.28'}",CHEMBL226744,,CHEMBL226744,7.89,False,http://www.openphacts.org/units/Nanomolar,643083,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
,1900599,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc5c4OC(F)(F)O5)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '17.91', 'le': '0.34', 'lle': '3.65', 'sei': '8.24'}",CHEMBL227326,,CHEMBL227326,7.85,False,http://www.openphacts.org/units/Nanomolar,643082,=,1,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
,1900600,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc5c(c4)OCO5)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '18.33', 'le': '0.34', 'lle': '3.77', 'sei': '7.74'}",CHEMBL227325,,CHEMBL227325,7.38,False,http://www.openphacts.org/units/Nanomolar,643081,=,1,True,=,,IC50,nM,,42.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.0
,1900601,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(-c5ccccc5)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '15.88', 'le': '0.29', 'lle': '1.35', 'sei': '8.98'}",CHEMBL389468,,CHEMBL389468,6.90,False,http://www.openphacts.org/units/Nanomolar,643080,=,1,True,=,,IC50,nM,,126.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,126.0
,1900602,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(OC(F)(F)F)cc4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '17.39', 'le': '0.33', 'lle': '2.91', 'sei': '8.94'}",CHEMBL227324,,CHEMBL227324,7.69,False,http://www.openphacts.org/units/Nanomolar,643079,=,1,True,=,,IC50,nM,,20.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.3
,1900603,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(OC(F)(F)F)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '19.17', 'le': '0.36', 'lle': '3.70', 'sei': '9.86'}",CHEMBL227271,,CHEMBL227271,8.48,False,http://www.openphacts.org/units/Nanomolar,643078,=,1,True,=,,IC50,nM,,3.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.3
,1900604,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4OC(F)(F)F)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '17.66', 'le': '0.33', 'lle': '3.04', 'sei': '9.08'}",CHEMBL226529,,CHEMBL226529,7.82,False,http://www.openphacts.org/units/Nanomolar,643077,=,1,True,=,,IC50,nM,,15.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.3
,1900605,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(C(F)(F)F)cc4F)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '17.81', 'le': '0.34', 'lle': '2.88', 'sei': '10.31'}",CHEMBL227323,,CHEMBL227323,7.92,False,http://www.openphacts.org/units/Nanomolar,643076,=,1,True,=,,IC50,nM,,12.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.1
,1900606,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(C(F)(F)F)c(F)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '19.15', 'le': '0.36', 'lle': '3.47', 'sei': '11.08'}",CHEMBL375717,,CHEMBL375717,8.51,False,http://www.openphacts.org/units/Nanomolar,643075,=,1,True,=,,IC50,nM,,3.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.1
,1900607,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cc(C(F)(F)F)ccc4F)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '20.07', 'le': '0.38', 'lle': '3.88', 'sei': '11.61'}",CHEMBL227322,,CHEMBL227322,8.92,False,http://www.openphacts.org/units/Nanomolar,643074,=,1,True,=,,IC50,nM,,1.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.2
,1900608,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cc(F)cc(C(F)(F)F)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '17.72', 'le': '0.34', 'lle': '2.84', 'sei': '10.25'}",CHEMBL375716,,CHEMBL375716,7.88,False,http://www.openphacts.org/units/Nanomolar,643073,=,1,True,=,,IC50,nM,,13.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.3
,1900609,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(F)c(C(F)(F)F)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '19.68', 'le': '0.37', 'lle': '3.70', 'sei': '11.38'}",CHEMBL226627,,CHEMBL226627,8.74,False,http://www.openphacts.org/units/Nanomolar,643072,=,1,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
,1900610,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '14.65', 'le': '0.28', 'lle': '1.32', 'sei': '9.43'}",CHEMBL226626,,CHEMBL226626,7.24,False,http://www.openphacts.org/units/Nanomolar,643071,=,1,True,=,,IC50,nM,,57.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,57.0
,1900611,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '18.16', 'le': '0.34', 'lle': '2.84', 'sei': '10.08'}",CHEMBL389438,,CHEMBL389438,7.75,False,http://www.openphacts.org/units/Nanomolar,643070,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,1900612,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(C(F)(F)F)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '20.92', 'le': '0.39', 'lle': '4.02', 'sei': '11.61'}",CHEMBL226625,,CHEMBL226625,8.92,False,http://www.openphacts.org/units/Nanomolar,643069,=,1,True,=,,IC50,nM,,1.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.2
,1900613,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(F)cc1C[C@H](N)COc1cncc(-c2ccc3[nH]nc(C)c3c2)c1,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '19.96', 'le': '0.37', 'lle': '4.08', 'sei': '9.43'}",CHEMBL226577,,CHEMBL226577,8.11,False,http://www.openphacts.org/units/Nanomolar,643068,=,1,True,=,,IC50,nM,,7.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.7
,1900614,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C)c(C[C@H](N)COc2cncc(-c3ccc4[nH]nc(C)c4c3)c2)c(C)c1,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '18.50', 'le': '0.34', 'lle': '2.60', 'sei': '9.64'}",CHEMBL227051,,CHEMBL227051,7.41,False,http://www.openphacts.org/units/Nanomolar,643067,=,1,True,=,,IC50,nM,,39.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,39.0
,1900615,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C[C@H](N)COc2cncc(-c3ccc4[nH]nc(C)c4c3)c2)cc1F,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '22.08', 'le': '0.41', 'lle': '4.29', 'sei': '11.22'}",CHEMBL227050,,CHEMBL227050,8.62,False,http://www.openphacts.org/units/Nanomolar,643066,=,1,True,=,,IC50,nM,,2.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.4
,1900616,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)ccc1C[C@H](N)COc1cncc(-c2ccc3[nH]nc(C)c3c2)c1,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '21.06', 'le': '0.39', 'lle': '3.89', 'sei': '10.70'}",CHEMBL376394,,CHEMBL376394,8.22,False,http://www.openphacts.org/units/Nanomolar,643065,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,1900617,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C[C@H](N)COc2cncc(-c3ccc4[nH]nc(C)c4c3)c2)ccc1F,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '20.38', 'le': '0.37', 'lle': '3.63', 'sei': '10.36'}",CHEMBL427426,,CHEMBL427426,7.96,False,http://www.openphacts.org/units/Nanomolar,643064,=,1,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
,1900618,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C[C@H](N)COc2cncc(-c3ccc4[nH]nc(C)c4c3)c2)ccc1Br,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '19.06', 'le': '0.41', 'lle': '3.65', 'sei': '11.20'}",CHEMBL226996,,CHEMBL226996,8.60,False,http://www.openphacts.org/units/Nanomolar,643063,=,1,True,=,,IC50,nM,,2.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.5
,1900619,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)cc1C[C@H](N)COc1cncc(-c2ccc3[nH]nc(C)c3c2)c1,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '21.54', 'le': '0.40', 'lle': '4.08', 'sei': '10.95'}",CHEMBL227368,,CHEMBL227368,8.41,False,http://www.openphacts.org/units/Nanomolar,643062,=,1,True,=,,IC50,nM,,3.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.9
,1900620,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c(F)cc(F)cc4Br)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '15.44', 'le': '0.33', 'lle': '2.39', 'sei': '9.52'}",CHEMBL376792,,CHEMBL376792,7.31,False,http://www.openphacts.org/units/Nanomolar,643061,=,1,True,=,,IC50,nM,,49.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,49.0
,1900621,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(Br)c(F)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '19.52', 'le': '0.42', 'lle': '4.11', 'sei': '11.57'}",CHEMBL227367,,CHEMBL227367,8.89,False,http://www.openphacts.org/units/Nanomolar,643060,=,1,True,=,,IC50,nM,,1.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.3
,1900622,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(Br)cc4F)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '17.57', 'le': '0.38', 'lle': '3.22', 'sei': '10.41'}",CHEMBL227366,,CHEMBL227366,8.00,False,http://www.openphacts.org/units/Nanomolar,643059,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,1900623,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cc(Cl)cc(Cl)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '17.98', 'le': '0.36', 'lle': '2.49', 'sei': '10.00'}",CHEMBL376118,,CHEMBL376118,7.68,False,http://www.openphacts.org/units/Nanomolar,643058,=,1,True,=,,IC50,nM,,20.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.7
,1900624,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(Cl)c(Cl)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '20.46', 'le': '0.41', 'lle': '3.55', 'sei': '11.38'}",CHEMBL229968,,CHEMBL229968,8.74,False,http://www.openphacts.org/units/Nanomolar,643057,=,1,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
,1900625,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(Cl)c4Cl)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '19.31', 'le': '0.39', 'lle': '3.06', 'sei': '10.74'}",CHEMBL229918,,CHEMBL229918,8.25,False,http://www.openphacts.org/units/Nanomolar,643056,=,1,True,=,,IC50,nM,,5.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.6
,1900626,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(Cl)c(F)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '20.55', 'le': '0.40', 'lle': '3.77', 'sei': '10.99'}",CHEMBL229917,,CHEMBL229917,8.44,False,http://www.openphacts.org/units/Nanomolar,643055,=,1,True,=,,IC50,nM,,3.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.6
,1900627,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(F)c(Cl)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '20.71', 'le': '0.40', 'lle': '3.84', 'sei': '11.08'}",CHEMBL375919,,CHEMBL375919,8.51,False,http://www.openphacts.org/units/Nanomolar,643054,=,1,True,=,,IC50,nM,,3.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.1
,1900628,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(I)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '18.68', 'le': '0.44', 'lle': '4.56', 'sei': '11.78'}",CHEMBL229320,,CHEMBL229320,9.05,False,http://www.openphacts.org/units/Nanomolar,643053,=,1,True,=,,IC50,nM,,0.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.9
,1900629,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(Br)cc4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '18.98', 'le': '0.40', 'lle': '3.66', 'sei': '10.81'}",CHEMBL229855,,CHEMBL229855,8.30,False,http://www.openphacts.org/units/Nanomolar,643052,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,1900630,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(Br)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '19.84', 'le': '0.42', 'lle': '4.04', 'sei': '11.30'}",CHEMBL390372,,CHEMBL390372,8.68,False,http://www.openphacts.org/units/Nanomolar,643051,=,1,True,=,,IC50,nM,,2.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.1
,1900631,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4Br)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '17.47', 'le': '0.37', 'lle': '3.00', 'sei': '9.94'}",CHEMBL229854,,CHEMBL229854,7.64,False,http://www.openphacts.org/units/Nanomolar,643050,=,1,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
,1900632,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(Cl)cc4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '20.26', 'le': '0.39', 'lle': '3.42', 'sei': '10.36'}",CHEMBL229800,,CHEMBL229800,7.96,False,http://www.openphacts.org/units/Nanomolar,643049,=,1,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
,1900633,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(Cl)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '20.95', 'le': '0.40', 'lle': '3.69', 'sei': '10.71'}",CHEMBL229799,,CHEMBL229799,8.23,False,http://www.openphacts.org/units/Nanomolar,643048,=,1,True,=,,IC50,nM,,5.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.9
,1900634,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4Cl)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '19.19', 'le': '0.37', 'lle': '3.00', 'sei': '9.81'}",CHEMBL390371,,CHEMBL390371,7.54,False,http://www.openphacts.org/units/Nanomolar,643047,=,1,True,=,,IC50,nM,,29.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,29.0
,1900635,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c(F)cc(F)cc4F)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '18.21', 'le': '0.34', 'lle': '3.21', 'sei': '9.77'}",CHEMBL388809,,CHEMBL388809,7.51,False,http://www.openphacts.org/units/Nanomolar,643046,=,1,True,=,,IC50,nM,,31.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31.0
,1900636,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(F)c(F)c4F)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '19.21', 'le': '0.36', 'lle': '3.62', 'sei': '10.31'}",CHEMBL229798,,CHEMBL229798,7.92,False,http://www.openphacts.org/units/Nanomolar,643045,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,1900637,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c(F)cccc4F)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '18.21', 'le': '0.34', 'lle': '3.02', 'sei': '9.35'}",CHEMBL229748,,CHEMBL229748,7.18,False,http://www.openphacts.org/units/Nanomolar,643044,=,1,True,=,,IC50,nM,,65.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,65.5
,1900638,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(F)cc4F)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '19.47', 'le': '0.36', 'lle': '3.52', 'sei': '9.99'}",CHEMBL229315,,CHEMBL229315,7.68,False,http://www.openphacts.org/units/Nanomolar,643043,=,1,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.0
,1900639,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(F)c4F)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '20.46', 'le': '0.38', 'lle': '3.91', 'sei': '10.51'}",CHEMBL438483,,CHEMBL438483,8.07,False,http://www.openphacts.org/units/Nanomolar,643042,=,1,True,=,,IC50,nM,,8.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.5
,1900640,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4cccc(F)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '21.45', 'le': '0.39', 'lle': '4.06', 'sei': '10.51'}",CHEMBL229314,,CHEMBL229314,8.08,False,http://www.openphacts.org/units/Nanomolar,643041,=,1,True,=,,IC50,nM,,8.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.4
,1900690,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '24.64', 'le': '0.45', 'lle': '5.44', 'sei': '10.58'}",CHEMBL379300,A-443654,CHEMBL379300,9.80,True,http://www.openphacts.org/units/Nanomolar,643090,=,1,True,=,,IC50,nM,,0.16,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.16
,1900693,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)/C(=C\c2ccco2)C(=O)N3)c1)Cc1ccccc1,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '20.24', 'le': '0.37', 'lle': '4.07', 'sei': '9.80'}",CHEMBL226849,,CHEMBL226849,8.85,False,http://www.openphacts.org/units/Nanomolar,643093,=,1,True,=,,IC50,nM,,1.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.4
,1900694,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)/C(=C/c2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '17.86', 'le': '0.32', 'lle': '3.28', 'sei': '8.38'}",CHEMBL388311,,CHEMBL388311,7.80,False,http://www.openphacts.org/units/Nanomolar,643092,=,1,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
,1900695,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1ccccc1,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '15.52', 'le': '0.28', 'lle': '2.39', 'sei': '7.22'}",CHEMBL226848,,CHEMBL226848,5.58,False,http://www.openphacts.org/units/Nanomolar,643091,=,1,True,=,,IC50,nM,,2650.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2650.0
,1900698,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cc3cn[nH]c3cn2)c1)Cc1cccc(C(F)(F)F)c1,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '19.70', 'le': '0.37', 'lle': '4.15', 'sei': '9.08'}",CHEMBL226850,,CHEMBL226850,8.14,False,http://www.openphacts.org/units/Nanomolar,643094,=,1,True,=,,IC50,nM,,7.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.2
,1900711,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4cccc(F)c4F)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '20.99', 'le': '0.39', 'lle': '4.74', 'sei': '9.25'}",CHEMBL427422,,CHEMBL427422,8.30,False,http://www.openphacts.org/units/Nanomolar,643097,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,1900712,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4cccc(C(F)(F)F)c4)c3)cc12,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '21.58', 'le': '0.41', 'lle': '4.92', 'sei': '10.28'}",CHEMBL226898,,CHEMBL226898,9.22,False,http://www.openphacts.org/units/Nanomolar,643096,=,1,True,=,,IC50,nM,,0.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.6
,1900713,[],CHEMBL889241,Inhibition of human Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cc3c(Cl)n[nH]c3cn2)c1)Cc1cccc(C(F)(F)F)c1,,,CHEMBL1145373,J. Med. Chem.,2007.0,"{'bei': '19.06', 'le': '0.38', 'lle': '3.90', 'sei': '9.52'}",CHEMBL388312,,CHEMBL388312,8.54,False,http://www.openphacts.org/units/Nanomolar,643095,=,1,True,=,,IC50,nM,,2.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.9
,1916297,[],CHEMBL894158,Inhibition of recombinant Akt1 by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2ccc3c(c2)Nc2ccc(CC(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N,,,CHEMBL1148724,J. Med. Chem.,2007.0,"{'bei': '11.02', 'le': '0.20', 'lle': '0.79', 'sei': '5.13'}",CHEMBL395080,,CHEMBL395080,6.06,False,http://www.openphacts.org/units/Nanomolar,653783,=,1,True,=,,IC50,nM,,880.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.88
,1916355,[],CHEMBL894158,Inhibition of recombinant Akt1 by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2ccc3c(c2)Nc2ccc(C(C)(C)C(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N,,,CHEMBL1148724,J. Med. Chem.,2007.0,,CHEMBL389745,,CHEMBL389745,,False,http://www.openphacts.org/units/Nanomolar,653784,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,1969470,[],CHEMBL896554,Inhibition of cAKT,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2ccccc2/C1=C/c1ccc[nH]1,,,CHEMBL1149536,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '26.82', 'le': '0.48', 'lle': '3.13', 'sei': '12.56'}",CHEMBL86755,,CHEMBL86755,5.64,False,http://www.openphacts.org/units/Nanomolar,658108,=,1,True,=,,IC50,nM,,2300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.3
,1969472,[],CHEMBL896556,Inhibition of Akt phosphorylation in PC3 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1Nc2ccccc2/C1=C/c1ccc[nH]1,,,CHEMBL1149536,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '26.27', 'le': '0.47', 'lle': '3.01', 'sei': '12.30'}",CHEMBL86755,,CHEMBL86755,5.52,False,http://www.openphacts.org/units/Nanomolar,658108,=,1,True,=,,IC50,nM,,3000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.0
,1969512,[],CHEMBL896556,Inhibition of Akt phosphorylation in PC3 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1ccc[nH]1,,,CHEMBL1149536,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '24.80', 'le': '0.46', 'lle': '4.61', 'sei': '7.00'}",CHEMBL228654,,CHEMBL228654,7.00,False,http://www.openphacts.org/units/Nanomolar,658142,=,1,True,=,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100.0
,1986223,[],CHEMBL899824,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1,,,CHEMBL1137478,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL237570,,CHEMBL237570,,False,http://www.openphacts.org/units/Nanomolar,662702,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30000.0
,1989398,[],CHEMBL899084,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NCc1ccc(Nc2cc(-c3ccc(-c4ccc(O)cc4O)cc3)[nH]n2)cc1,,,CHEMBL1137531,J. Med. Chem.,2007.0,"{'bei': '11.03', 'le': '0.20', 'lle': '-0.83', 'sei': '4.90'}",CHEMBL398606,,CHEMBL398606,4.57,False,http://www.openphacts.org/units/Nanomolar,663624,=,1,True,=,,IC50,nM,,26890.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,26.89
,1998221,[],CHEMBL900103,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC,,,CHEMBL1138235,J. Med. Chem.,2007.0,,CHEMBL235157,,CHEMBL235157,,False,http://www.openphacts.org/units/Nanomolar,665471,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,2017698,[],CHEMBL885862,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Nc2c(C#N)cnc3cc(C#CCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,,,CHEMBL1139073,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL391738,,CHEMBL391738,,False,http://www.openphacts.org/units/Nanomolar,670164,>,1,True,>,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.0
,2021736,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)[C@@H](C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL437750,,CHEMBL437750,,False,http://www.openphacts.org/units/Nanomolar,671780,>,1,True,>,,IC50,nM,,500000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,500.0
,2021737,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](NC(=O)c1ccc(NC(=O)CCCCNC(=N)N)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL396530,,CHEMBL396530,,False,http://www.openphacts.org/units/Nanomolar,671805,=,1,True,=,,IC50,nM,,193000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,193.0
,2021738,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCCNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)c1ccc(NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)cc1)C(C)C,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL391793,,CHEMBL391793,,False,http://www.openphacts.org/units/Nanomolar,671804,=,1,True,=,,IC50,nM,,163000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,163.0
,2021739,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccccc2)C(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL245659,,CHEMBL245659,,False,http://www.openphacts.org/units/Nanomolar,671803,=,1,True,=,,IC50,nM,,119000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,119.0
,2021740,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)c2ccc(NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)cc2)C(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL394250,,CHEMBL394250,,False,http://www.openphacts.org/units/Nanomolar,671802,=,1,True,=,,IC50,nM,,104000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,104.0
,2021741,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCCc2cccc3ccccc23)C(C)C)cc1,,,CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '5.51', 'le': '0.10', 'lle': '0.66', 'sei': '1.95'}",CHEMBL246537,,CHEMBL246537,4.05,False,http://www.openphacts.org/units/Nanomolar,671801,=,1,True,=,,IC50,nM,,89000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,89.0
,2021742,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCCc2ccc3ccccc3c2)C(C)C)cc1,,,CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '5.84', 'le': '0.11', 'lle': '0.90', 'sei': '2.07'}",CHEMBL246327,,CHEMBL246327,4.29,False,http://www.openphacts.org/units/Nanomolar,671800,=,1,True,=,,IC50,nM,,51000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,51.0
,2021743,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccccc2)C(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL394041,,CHEMBL394041,,False,http://www.openphacts.org/units/Nanomolar,671799,>,1,True,>,,IC50,nM,,500000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,500.0
,2021744,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccccc2)C(C)C)cc1,,,CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '4.58', 'le': '0.09', 'lle': '3.30', 'sei': '1.43'}",CHEMBL396644,,CHEMBL396644,4.10,False,http://www.openphacts.org/units/Nanomolar,671798,=,1,True,=,,IC50,nM,,79000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,79.0
,2021745,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccccc2)C(C)C)cc1,,,CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '4.90', 'le': '0.09', 'lle': '3.59', 'sei': '1.53'}",CHEMBL396643,,CHEMBL396643,4.39,False,http://www.openphacts.org/units/Nanomolar,671797,=,1,True,=,,IC50,nM,,41000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,41.0
,2021746,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCCN2CCCCC2)C(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL246330,,CHEMBL246330,,False,http://www.openphacts.org/units/Nanomolar,671796,>,1,True,>,,IC50,nM,,500000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,500.0
,2021747,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCCCOc2cccc(NC(C)=O)c2)C(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL395678,,CHEMBL395678,,False,http://www.openphacts.org/units/Nanomolar,671795,=,1,True,=,,IC50,nM,,322000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,322.0
,2021748,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)c2ccc(NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(C)=O)cc2)C(C)C)cc1,,,CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '3.82', 'le': None, 'lle': None, 'sei': None}",CHEMBL397075,,CHEMBL397075,4.02,False,http://www.openphacts.org/units/Nanomolar,671794,=,1,True,=,,IC50,nM,,96000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,96.0
,2021749,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCCN2CCC(Cc3ccccc3)CC2)C(C)C)cc1,,,CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '3.69', 'le': None, 'lle': None, 'sei': None}",CHEMBL437188,,CHEMBL437188,4.03,False,http://www.openphacts.org/units/Nanomolar,671793,=,1,True,=,,IC50,nM,,94000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,94.0
,2021750,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCCc2cccc3ccccc23)C(C)C)cc1,,,CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '4.03', 'le': None, 'lle': None, 'sei': None}",CHEMBL269433,,CHEMBL269433,4.21,False,http://www.openphacts.org/units/Nanomolar,671792,=,1,True,=,,IC50,nM,,62000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,62.0
,2021751,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCCNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)c1ccc(NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(C)=O)cc1)C(C)C,,,CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '4.39', 'le': '0.08', 'lle': '3.85', 'sei': '1.23'}",CHEMBL396589,,CHEMBL396589,4.28,False,http://www.openphacts.org/units/Nanomolar,671791,=,1,True,=,,IC50,nM,,52000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,52.0
,2021752,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCCc2ccc3ccccc3c2)C(C)C)cc1,,,CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '4.25', 'le': None, 'lle': None, 'sei': None}",CHEMBL245965,,CHEMBL245965,4.44,False,http://www.openphacts.org/units/Nanomolar,671790,=,1,True,=,,IC50,nM,,36000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,36.0
,2021753,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccccc2)C(C)C)cc1,,,CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '4.64', 'le': '0.09', 'lle': '4.50', 'sei': '1.31'}",CHEMBL245565,,CHEMBL245565,4.55,False,http://www.openphacts.org/units/Nanomolar,671789,=,1,True,=,,IC50,nM,,28000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,28.0
,2021754,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1)C(C)C,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL246137,,CHEMBL246137,,False,http://www.openphacts.org/units/Nanomolar,671788,=,1,True,=,,IC50,nM,,438000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,438.0
,2021755,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1)C(C)C)[C@@H](C)O)[C@@H](C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL245933,,CHEMBL245933,,False,http://www.openphacts.org/units/Nanomolar,671787,=,1,True,=,,IC50,nM,,239000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,239.0
,2021756,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](O)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL231257,,CHEMBL231257,,False,http://www.openphacts.org/units/Nanomolar,671786,=,1,True,=,,IC50,nM,,229000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,229.0
,2021757,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)[C@@H](C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL437388,,CHEMBL437388,,False,http://www.openphacts.org/units/Nanomolar,671785,=,1,True,=,,IC50,nM,,241000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,241.0
,2021758,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)[C@@H](C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL245918,,CHEMBL245918,,False,http://www.openphacts.org/units/Nanomolar,671784,=,1,True,=,,IC50,nM,,409000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,409.0
,2021759,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL269244,,CHEMBL269244,,False,http://www.openphacts.org/units/Nanomolar,671783,=,1,True,=,,IC50,nM,,445000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,445.0
,2021760,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)[C@@H](C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL394715,,CHEMBL394715,,False,http://www.openphacts.org/units/Nanomolar,671782,>,1,True,>,,IC50,nM,,500000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,500.0
,2021761,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)[C@@H](C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL391820,,CHEMBL391820,,False,http://www.openphacts.org/units/Nanomolar,671781,>,1,True,>,,IC50,nM,,500000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,500.0
,2021762,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](NC(=O)c1ccc(NCCNC(=N)N)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL245587,,CHEMBL245587,,False,http://www.openphacts.org/units/Nanomolar,671806,=,1,True,=,,IC50,nM,,390000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,390.0
,2021763,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](NC(=O)c1ccc(CCNC(=N)N)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL248369,,CHEMBL248369,,False,http://www.openphacts.org/units/Nanomolar,671809,=,1,True,=,,IC50,nM,,120000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,120.0
,2021764,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](NC(=O)c1ccc(CNC(=N)N)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL245987,,CHEMBL245987,,False,http://www.openphacts.org/units/Nanomolar,671808,>,1,True,>,,IC50,nM,,500000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,500.0
,2021765,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](NC(=O)c1ccc(NC(=N)N)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1,,,CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '7.99', 'le': '0.15', 'lle': '1.32', 'sei': '2.76'}",CHEMBL393645,,CHEMBL393645,4.11,False,http://www.openphacts.org/units/Nanomolar,671807,=,1,True,=,,IC50,nM,,77000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,77.0
,2021766,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](NC(=O)c1ccc(N(CC(=O)NCc2ccccc2)C(=O)CCCCNC(=N)N)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1,,,CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '6.38', 'le': '0.12', 'lle': '1.06', 'sei': '2.44'}",CHEMBL395685,,CHEMBL395685,4.85,False,http://www.openphacts.org/units/Nanomolar,671810,=,1,True,=,,IC50,nM,,14000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,14.0
,2021767,[],CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](NC(=O)c1ccc(N(CC(=O)NC(C)(C)C)C(=O)CCCCNC(=N)N)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1,,,CHEMBL1139137,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '5.83', 'le': '0.11', 'lle': '0.85', 'sei': '2.13'}",CHEMBL391132,,CHEMBL391132,4.24,False,http://www.openphacts.org/units/Nanomolar,671811,=,1,True,=,,IC50,nM,,58000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,58.0
,2036737,[],CHEMBL922918,Inhibition of pAkt,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)Nc1ccc(CNc2c(C(=O)Nc3ccc4c(c3)OC(F)(F)C(F)(F)O4)cnn2C)cn1,,,CHEMBL1140657,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '14.50', 'le': '0.28', 'lle': '4.00', 'sei': '5.62'}",CHEMBL247619,,CHEMBL247619,7.39,False,http://www.openphacts.org/units/Nanomolar,676001,=,1,True,=,,IC50,nM,,41.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,41.0
,2036742,[],CHEMBL922918,Inhibition of pAkt,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)Nc1ccc(CNc2ncsc2C(=O)Nc2ccc3c(c2)OC(F)(F)O3)cn1,,,CHEMBL1140657,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '16.48', 'le': '0.33', 'lle': '4.14', 'sei': '6.02'}",CHEMBL247250,,CHEMBL247250,7.62,False,http://www.openphacts.org/units/Nanomolar,676004,=,1,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
,2036743,[],CHEMBL922918,Inhibition of pAkt,B,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)Nc1ccc(CNc2ncsc2C(=O)Nc2ccc3c(c2)OC(F)(F)O3)cn1,,,CHEMBL1140657,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '14.88', 'le': '0.29', 'lle': '3.22', 'sei': '5.61'}",CHEMBL247798,,CHEMBL247798,7.09,False,http://www.openphacts.org/units/Nanomolar,676003,=,1,True,=,,IC50,nM,,81.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,81.0
,2036744,[],CHEMBL922918,Inhibition of pAkt,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)Nc1ccc(CNc2c(C(=O)Nc3ccc(SC(F)(F)F)cc3)cnn2C)cn1,,,CHEMBL1140657,Bioorg. Med. Chem. Lett.,2007.0,"{'bei': '16.32', 'le': '0.32', 'lle': '3.78', 'sei': '6.93'}",CHEMBL247797,,CHEMBL247797,7.82,False,http://www.openphacts.org/units/Nanomolar,676002,=,1,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
,2080208,[],CHEMBL928479,Inhibition of PKB,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCOc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1,,,CHEMBL1141507,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL253292,,CHEMBL253292,,False,http://www.openphacts.org/units/Nanomolar,689561,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,2080221,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CNCCC(N)=O)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.47', 'le': '0.29', 'lle': '2.60', 'sei': '7.09'}",CHEMBL276130,,CHEMBL276130,6.65,False,http://www.openphacts.org/units/Nanomolar,689567,=,1,True,=,,IC50,nM,,226.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,226.0
,2080222,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CNCCC(=O)c4ccccc4N)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.47', 'le': '0.29', 'lle': '1.79', 'sei': '8.34'}",CHEMBL252456,,CHEMBL252456,7.82,False,http://www.openphacts.org/units/Nanomolar,689578,=,1,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
,2080223,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CNCCc4nnc(N)s4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.11', 'le': '0.29', 'lle': '2.49', 'sei': '7.16'}",CHEMBL252455,,CHEMBL252455,7.34,False,http://www.openphacts.org/units/Nanomolar,689577,=,1,True,=,,IC50,nM,,46.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,46.0
,2080224,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CNCCc4n[nH]c(-c5ccccc5)n4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.59', 'le': '0.25', 'lle': '1.00', 'sei': '7.80'}",CHEMBL252261,,CHEMBL252261,7.20,False,http://www.openphacts.org/units/Nanomolar,689576,=,1,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,63.0
,2080225,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CNCCc4n[nH]c(C)n4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.52', 'le': '0.27', 'lle': '1.95', 'sei': '7.36'}",CHEMBL403355,,CHEMBL403355,6.79,False,http://www.openphacts.org/units/Nanomolar,689575,=,1,True,=,,IC50,nM,,162.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,162.0
,2080226,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN(C)CCc4cn[nH]c4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.47', 'le': '0.23', 'lle': '0.34', 'sei': '8.24'}",CHEMBL252260,,CHEMBL252260,5.82,False,http://www.openphacts.org/units/Nanomolar,689574,=,1,True,=,,IC50,nM,,1521.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1521.0
,2080227,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CNCCCn4ccnc4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.71', 'le': '0.28', 'lle': '1.40', 'sei': '10.02'}",CHEMBL252259,,CHEMBL252259,6.86,False,http://www.openphacts.org/units/Nanomolar,689573,=,1,True,=,,IC50,nM,,137.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,137.0
,2080228,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CNCCc4cccnc4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.20', 'le': '0.28', 'lle': '1.24', 'sei': '11.08'}",CHEMBL403354,,CHEMBL403354,7.05,False,http://www.openphacts.org/units/Nanomolar,689572,=,1,True,=,,IC50,nM,,90.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,90.0
,2080229,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CNCCc4nccs4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.27', 'le': '0.28', 'lle': '0.83', 'sei': '10.54'}",CHEMBL252056,,CHEMBL252056,6.70,False,http://www.openphacts.org/units/Nanomolar,689571,=,1,True,=,,IC50,nM,,198.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,198.0
,2080230,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CNCCc4nc[nH]n4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.12', 'le': '0.28', 'lle': '2.33', 'sei': '7.43'}",CHEMBL252055,,CHEMBL252055,6.86,False,http://www.openphacts.org/units/Nanomolar,689570,=,1,True,=,,IC50,nM,,139.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,139.0
,2080231,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CNCCc4c[nH]cn4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.48', 'le': '0.29', 'lle': '1.86', 'sei': '8.82'}",CHEMBL252054,,CHEMBL252054,7.00,False,http://www.openphacts.org/units/Nanomolar,689569,=,1,True,=,,IC50,nM,,99.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,99.0
,2080232,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CNCCCN4CCN(C)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.26', 'le': '0.23', 'lle': '1.31', 'sei': '10.70'}",CHEMBL251860,,CHEMBL251860,6.12,False,http://www.openphacts.org/units/Nanomolar,689568,=,1,True,=,,IC50,nM,,765.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,765.0
,2080245,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.75', 'le': '0.27', 'lle': '1.78', 'sei': '8.74'}",CHEMBL254099,,CHEMBL254099,8.42,False,http://www.openphacts.org/units/Nanomolar,689587,=,1,True,=,,IC50,nM,,3.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.8
,2080246,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5cc(-c6ccncc6)[nH]n5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.65', 'le': '0.27', 'lle': '1.10', 'sei': '10.00'}",CHEMBL404554,,CHEMBL404554,8.35,False,http://www.openphacts.org/units/Nanomolar,689586,=,1,True,=,,IC50,nM,,4.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.5
,2080247,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nc(-c6cccnc6)no5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.58', 'le': '0.23', 'lle': '0.28', 'sei': '7.68'}",CHEMBL404553,,CHEMBL404553,7.19,False,http://www.openphacts.org/units/Nanomolar,689585,=,1,True,=,,IC50,nM,,64.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,64.0
,2080248,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(C(=O)Nc5ccncc5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.66', 'le': '0.27', 'lle': '1.68', 'sei': '9.55'}",CHEMBL252856,,CHEMBL252856,8.01,False,http://www.openphacts.org/units/Nanomolar,689584,=,1,True,=,,IC50,nM,,9.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.7
,2080249,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(N)s5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.35', 'le': '0.30', 'lle': '2.18', 'sei': '8.61'}",CHEMBL403356,,CHEMBL403356,8.07,False,http://www.openphacts.org/units/Nanomolar,689583,=,1,True,=,,IC50,nM,,8.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.5
,2080250,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(NC(=O)CNC(C)=O)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.10', 'le': '0.23', 'lle': '2.24', 'sei': '6.54'}",CHEMBL252654,,CHEMBL252654,6.54,False,http://www.openphacts.org/units/Nanomolar,689582,=,1,True,=,,IC50,nM,,286.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,286.0
,2080251,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(C(=O)NCCC(N)=O)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.02', 'le': '0.25', 'lle': '2.76', 'sei': '6.17'}",CHEMBL252653,,CHEMBL252653,7.04,False,http://www.openphacts.org/units/Nanomolar,689581,=,1,True,=,,IC50,nM,,91.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,91.0
,2080252,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)NC1CCN(Cc2ccc(-c3nc4nc(SC)ncc4cc3-c3ccccc3)cc2)CC1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.83', 'le': '0.26', 'lle': '1.73', 'sei': '8.54'}",CHEMBL252652,,CHEMBL252652,7.09,False,http://www.openphacts.org/units/Nanomolar,689580,=,1,True,=,,IC50,nM,,81.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,81.0
,2080253,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(C(N)=O)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '16.05', 'le': '0.30', 'lle': '2.76', 'sei': '8.87'}",CHEMBL252457,,CHEMBL252457,7.54,False,http://www.openphacts.org/units/Nanomolar,689579,=,1,True,=,,IC50,nM,,29.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,29.0
,2080263,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(C(N)=O)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.31', 'le': '0.25', 'lle': '1.47', 'sei': '7.36'}",CHEMBL252457,,CHEMBL252457,6.25,False,http://www.openphacts.org/units/Nanomolar,689579,=,1,True,=,,IC50,nM,,560.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,560.0
,2080264,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.85', 'le': '0.27', 'lle': '2.26', 'sei': '7.58'}",CHEMBL252857,,CHEMBL252857,8.22,False,http://www.openphacts.org/units/Nanomolar,689591,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,2080265,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.46', 'le': '0.26', 'lle': '3.19', 'sei': '5.89'}",CHEMBL404556,,CHEMBL404556,8.21,False,http://www.openphacts.org/units/Nanomolar,689590,=,1,True,=,,IC50,nM,,6.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.2
,2080266,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.86', 'le': '0.25', 'lle': '1.83', 'sei': '6.34'}",CHEMBL404555,,CHEMBL404555,7.62,False,http://www.openphacts.org/units/Nanomolar,689589,=,1,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
,2080267,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.75', 'le': '0.25', 'lle': '1.70', 'sei': '7.22'}",CHEMBL404347,,CHEMBL404347,7.63,False,http://www.openphacts.org/units/Nanomolar,689588,=,1,True,=,,IC50,nM,,23.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.6
,2080273,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.89', 'le': '0.25', 'lle': '1.73', 'sei': '7.10'}",CHEMBL252857,,CHEMBL252857,7.69,False,http://www.openphacts.org/units/Nanomolar,689591,=,1,True,=,,IC50,nM,,20.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.3
,2080274,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.36', 'le': '0.22', 'lle': '2.00', 'sei': '5.03'}",CHEMBL404556,,CHEMBL404556,7.02,False,http://www.openphacts.org/units/Nanomolar,689590,=,1,True,=,,IC50,nM,,96.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,96.4
,2080275,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.74', 'le': '0.23', 'lle': '1.21', 'sei': '5.83'}",CHEMBL404555,,CHEMBL404555,7.00,False,http://www.openphacts.org/units/Nanomolar,689589,=,1,True,=,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100.0
,2080276,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.29', 'le': '0.24', 'lle': '1.44', 'sei': '6.98'}",CHEMBL404347,,CHEMBL404347,7.37,False,http://www.openphacts.org/units/Nanomolar,689588,=,1,True,=,,IC50,nM,,42.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.6
,2080277,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.07', 'le': '0.26', 'lle': '1.39', 'sei': '8.33'}",CHEMBL254099,,CHEMBL254099,8.03,False,http://www.openphacts.org/units/Nanomolar,689587,=,1,True,=,,IC50,nM,,9.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.3
,2080278,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5cc(-c6ccncc6)[nH]n5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.41', 'le': '0.23', 'lle': '-0.18', 'sei': '8.47'}",CHEMBL404554,,CHEMBL404554,7.07,False,http://www.openphacts.org/units/Nanomolar,689586,=,1,True,=,,IC50,nM,,85.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,85.0
Not Determined,2080279,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nc(-c6cccnc6)no5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL404553,,CHEMBL404553,,False,,689585,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,2080280,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(C(=O)Nc5ccncc5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.58', 'le': '0.23', 'lle': '0.55', 'sei': '8.20'}",CHEMBL252856,,CHEMBL252856,6.88,False,http://www.openphacts.org/units/Nanomolar,689584,=,1,True,=,,IC50,nM,,133.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,133.0
,2080281,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(N)s5)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.51', 'le': '0.26', 'lle': '1.21', 'sei': '7.58'}",CHEMBL403356,,CHEMBL403356,7.10,False,http://www.openphacts.org/units/Nanomolar,689583,=,1,True,=,,IC50,nM,,79.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,79.0
Not Determined,2080282,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(NC(=O)CNC(C)=O)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL252654,,CHEMBL252654,,False,,689582,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,2080283,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(C(=O)NCCC(N)=O)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL252653,,CHEMBL252653,,False,,689581,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,2080284,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)NC1CCN(Cc2ccc(-c3nc4nc(SC)ncc4cc3-c3ccccc3)cc2)CC1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.90', 'le': '0.23', 'lle': '0.74', 'sei': '7.35'}",CHEMBL252652,,CHEMBL252652,6.10,False,http://www.openphacts.org/units/Nanomolar,689580,=,1,True,=,,IC50,nM,,795.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,795.0
,2080301,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc2nc(-c3ccc(CN4CCC(c5nc6ccc(F)cc6[nH]5)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.62', 'le': '0.26', 'lle': '1.40', 'sei': '8.02'}",CHEMBL253457,,CHEMBL253457,7.75,True,http://www.openphacts.org/units/Nanomolar,689592,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,2080303,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc2nc(-c3ccc(CN4CCC(n5ncc6c(N)ncnc65)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.86', 'le': '0.27', 'lle': '3.35', 'sei': '5.71'}",CHEMBL253458,,CHEMBL253458,7.85,True,http://www.openphacts.org/units/Nanomolar,689593,=,1,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
,2080304,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2nc(-c3ccc(CN4CCC(c5nc6ccc(F)cc6[nH]5)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.38', 'le': '0.22', 'lle': '0.22', 'sei': '6.79'}",CHEMBL253457,,CHEMBL253457,6.56,True,http://www.openphacts.org/units/Nanomolar,689592,=,1,True,=,,IC50,nM,,277.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,277.0
,2080306,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2nc(-c3ccc(CN4CCC(n5ncc6c(N)ncnc65)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.35', 'le': '0.22', 'lle': '2.03', 'sei': '4.75'}",CHEMBL253458,,CHEMBL253458,6.53,True,http://www.openphacts.org/units/Nanomolar,689593,=,1,True,=,,IC50,nM,,295.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,295.0
,2080309,[],CHEMBL928491,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(n5ncc6c(N)ncnc65)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.00', 'le': '0.28', 'lle': '2.76', 'sei': '7.53'}",CHEMBL253693,,CHEMBL253693,8.40,False,http://www.openphacts.org/units/Nanomolar,689594,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,2080311,[],CHEMBL928489,Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(n5ncc6c(N)ncnc65)CC4)cc3)nc2n1,,,CHEMBL1141509,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.90', 'le': '0.24', 'lle': '1.58', 'sei': '6.48'}",CHEMBL253693,,CHEMBL253693,7.22,False,http://www.openphacts.org/units/Nanomolar,689594,=,1,True,=,,IC50,nM,,60.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,60.0
,2092201,[],CHEMBL948032,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1ccc2nc(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)c(-c3ccccc3)nc2c1,,,CHEMBL1143241,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.91', 'le': '0.22', 'lle': '0.48', 'sei': '6.36'}",CHEMBL272292,,CHEMBL272292,6.62,True,http://www.openphacts.org/units/Nanomolar,701015,=,1,True,=,,IC50,nM,,240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,240.0
,2092204,[],CHEMBL948032,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCNC(=O)c1ccc2nc(-c3ccccc3)c(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)nc2c1,,,CHEMBL1143241,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.49', 'le': '0.19', 'lle': '0.34', 'sei': '6.92'}",CHEMBL258696,,CHEMBL258696,6.86,True,http://www.openphacts.org/units/Nanomolar,701020,=,1,True,=,,IC50,nM,,138.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,138.0
,2092205,[],CHEMBL948032,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCNC(=O)c1ccc2nc(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)c(-c3ccccc3)nc2c1,,,CHEMBL1143241,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '9.70', 'le': '0.18', 'lle': '-0.18', 'sei': '6.39'}",CHEMBL270444,,CHEMBL270444,6.34,False,http://www.openphacts.org/units/Nanomolar,701019,=,1,True,=,,IC50,nM,,458.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,458.0
,2092206,[],CHEMBL948032,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc(-c5nn[nH]n5)ccc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1143241,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.28', 'le': '0.24', 'lle': '2.08', 'sei': '6.35'}",CHEMBL408151,,CHEMBL408151,7.70,False,http://www.openphacts.org/units/Nanomolar,701018,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
,2092207,[],CHEMBL948032,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4ccc(-c5nn[nH]n5)cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1143241,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.42', 'le': '0.22', 'lle': '1.58', 'sei': '5.94'}",CHEMBL271091,,CHEMBL271091,7.20,False,http://www.openphacts.org/units/Nanomolar,701017,=,1,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,63.0
,2092208,[],CHEMBL948032,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1ccc2nc(-c3ccccc3)c(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)nc2c1,,,CHEMBL1143241,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.20', 'le': '0.22', 'lle': '0.64', 'sei': '6.51'}",CHEMBL273160,,CHEMBL273160,6.78,True,http://www.openphacts.org/units/Nanomolar,701016,=,1,True,=,,IC50,nM,,166.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,166.0
,2092219,[],CHEMBL948035,Inhibition of Akt1 by cell-based IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CCNC(=O)c1ccc2nc(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)c(-c3ccccc3)nc2c1,,,CHEMBL1143241,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '9.84', 'le': '0.18', 'lle': '-0.09', 'sei': '6.49'}",CHEMBL270444,,CHEMBL270444,6.43,False,http://www.openphacts.org/units/Nanomolar,701019,=,1,True,=,,IC50,nM,,368.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,368.0
,2092222,[],CHEMBL948035,Inhibition of Akt1 by cell-based IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CCNC(=O)c1ccc2nc(-c3ccccc3)c(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)nc2c1,,,CHEMBL1143241,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.09', 'le': '0.18', 'lle': '0.08', 'sei': '6.65'}",CHEMBL258696,,CHEMBL258696,6.60,False,http://www.openphacts.org/units/Nanomolar,701020,=,1,True,=,,IC50,nM,,253.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,253.0
,2092248,[],CHEMBL948032,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1143241,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.12', 'le': '0.24', 'lle': '0.92', 'sei': '7.58'}",CHEMBL258844,,CHEMBL258844,7.24,True,http://www.openphacts.org/units/Nanomolar,701021,=,1,True,=,,IC50,nM,,58.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,58.0
,2092251,[],CHEMBL948035,Inhibition of Akt1 by cell-based IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1143241,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.81', 'le': '0.21', 'lle': '0.20', 'sei': '6.82'}",CHEMBL258844,,CHEMBL258844,6.52,False,http://www.openphacts.org/units/Nanomolar,701021,=,1,True,=,,IC50,nM,,305.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,305.0
,2106296,[],CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N#CCc1ccc(-n2cnc3cnc4ccc(C#Cc5cccnc5)cc4c32)cc1,,,CHEMBL1142269,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '18.23', 'le': '0.32', 'lle': '2.60', 'sei': '10.43'}",CHEMBL272265,,CHEMBL272265,7.03,False,http://www.openphacts.org/units/Nanomolar,693105,=,1,True,=,,IC50,nM,,94.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,94.0
,2106297,[],CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(C#Cc4cccnc4)ccc3ncc21,,,CHEMBL1142269,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '16.87', 'le': '0.30', 'lle': '3.01', 'sei': '9.78'}",CHEMBL255592,,CHEMBL255592,7.48,False,http://www.openphacts.org/units/Nanomolar,693110,=,1,True,=,,IC50,nM,,33.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,33.0
,2106298,[],CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(C(C)C#N)cc1,,,CHEMBL1142269,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '17.77', 'le': '0.31', 'lle': '2.05', 'sei': '10.90'}",CHEMBL270638,,CHEMBL270638,7.35,False,http://www.openphacts.org/units/Nanomolar,693109,=,1,True,=,,IC50,nM,,45.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,45.0
,2106299,[],CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C#N)c1ccc(-n2cnc3cnc4ccc(C#Cc5cccnc5)cc4c32)cc1,,,CHEMBL1142269,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '17.17', 'le': '0.30', 'lle': '1.86', 'sei': '10.18'}",CHEMBL404024,,CHEMBL404024,6.86,False,http://www.openphacts.org/units/Nanomolar,693108,=,1,True,=,,IC50,nM,,139.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,139.0
,2106300,[],CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(CC#N)cc1,,,CHEMBL1142269,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '16.59', 'le': '0.29', 'lle': '1.86', 'sei': '10.18'}",CHEMBL270640,,CHEMBL270640,6.86,False,http://www.openphacts.org/units/Nanomolar,693107,=,1,True,=,,IC50,nM,,138.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,138.0
,2106301,[],CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(CC#N)cc1,,,CHEMBL1142269,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '17.81', 'le': '0.31', 'lle': '2.37', 'sei': '10.56'}",CHEMBL270639,,CHEMBL270639,7.11,False,http://www.openphacts.org/units/Nanomolar,693106,=,1,True,=,,IC50,nM,,77.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,77.0
,2110268,[],CHEMBL950970,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1OC(=O)/C(=C/N(CCO)C(C)(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,,,CHEMBL1143164,J. Med. Chem.,2008.0,,CHEMBL271190,,CHEMBL271190,,False,http://www.openphacts.org/units/Nanomolar,698866,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,2110279,[],CHEMBL950970,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1OC(=O)/C(=C/N(C)CCCN(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C,,,CHEMBL1143164,J. Med. Chem.,2008.0,,CHEMBL410643,,CHEMBL410643,,False,http://www.openphacts.org/units/Nanomolar,698873,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,2115743,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(N)c1ccc(-c2nc3ccccc3nc2-c2ccccc2)cc1,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '16.11', 'le': '0.29', 'lle': '0.31', 'sei': '10.56'}",CHEMBL362455,,CHEMBL362455,5.47,True,http://www.openphacts.org/units/Nanomolar,694592,=,1,True,=,,IC50,nM,,3400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3400.0
,2115744,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc2nc(-c3ccc(CN4CCC(n5ncc6c(N)ncnc65)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.86', 'le': '0.27', 'lle': '3.35', 'sei': '5.71'}",CHEMBL253458,,CHEMBL253458,7.85,False,http://www.openphacts.org/units/Nanomolar,694610,=,1,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
,2115745,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc2nc(-c3ccc(CN4CCC(c5cc(-c6ccncc6)[nH]n5)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.25', 'le': '0.26', 'lle': '1.57', 'sei': '7.01'}",CHEMBL255835,,CHEMBL255835,7.68,False,http://www.openphacts.org/units/Nanomolar,694609,=,1,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.0
,2115746,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc2nc(-c3ccc(CN4CCC(c5nc6ccc(F)cc6[nH]5)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.62', 'le': '0.26', 'lle': '1.40', 'sei': '8.02'}",CHEMBL253457,,CHEMBL253457,7.75,False,http://www.openphacts.org/units/Nanomolar,694608,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,2115747,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccccc2n1C1CCN(Cc2ccc(-c3nc4ncnc(N)c4cc3-c3ccccc3)cc2)CC1,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.62', 'le': '0.24', 'lle': '0.72', 'sei': '8.35'}",CHEMBL402579,,CHEMBL402579,7.16,False,http://www.openphacts.org/units/Nanomolar,694607,=,1,True,=,,IC50,nM,,69.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,69.0
,2115748,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc2nc(-c3ccc(CN4CCC(n5cnc6c(N)ncnc65)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.03', 'le': '0.24', 'lle': '2.39', 'sei': '5.01'}",CHEMBL255360,,CHEMBL255360,6.89,False,http://www.openphacts.org/units/Nanomolar,694606,=,1,True,=,,IC50,nM,,129.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,129.0
,2115749,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc2nc(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.44', 'le': '0.24', 'lle': '1.67', 'sei': '6.71'}",CHEMBL402199,,CHEMBL402199,7.09,False,http://www.openphacts.org/units/Nanomolar,694605,=,1,True,=,,IC50,nM,,81.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,81.0
,2115750,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nc(N)c2cc(-c3ccccc3)c(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)nc2n1,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.85', 'le': '0.23', 'lle': '1.97', 'sei': '5.29'}",CHEMBL401999,,CHEMBL401999,6.97,False,http://www.openphacts.org/units/Nanomolar,694604,=,1,True,=,,IC50,nM,,107.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,107.0
,2115751,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nc(O)nc2nc(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.16', 'le': '0.22', 'lle': '1.48', 'sei': '5.25'}",CHEMBL270815,,CHEMBL270815,6.61,False,http://www.openphacts.org/units/Nanomolar,694603,=,1,True,=,,IC50,nM,,244.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,244.0
,2115752,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nn(CCc2c[nH]cn2)c2nc(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.59', 'le': '0.23', 'lle': '1.89', 'sei': '6.07'}",CHEMBL255348,,CHEMBL255348,7.68,False,http://www.openphacts.org/units/Nanomolar,694602,=,1,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.0
,2115753,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nn(CCO)c2nc(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.30', 'le': '0.22', 'lle': '2.06', 'sei': '5.83'}",CHEMBL255559,,CHEMBL255559,6.88,False,http://www.openphacts.org/units/Nanomolar,694601,=,1,True,=,,IC50,nM,,131.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,131.0
,2115754,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(N)c2cc(-c3ccccc3)c(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)nc21,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.06', 'le': '0.24', 'lle': '1.56', 'sei': '7.08'}",CHEMBL401622,,CHEMBL401622,6.92,False,http://www.openphacts.org/units/Nanomolar,694600,=,1,True,=,,IC50,nM,,121.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,121.0
,2115755,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1n[nH]c2nc(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.70', 'le': '0.25', 'lle': '1.72', 'sei': '6.50'}",CHEMBL270157,,CHEMBL270157,7.07,False,http://www.openphacts.org/units/Nanomolar,694599,=,1,True,=,,IC50,nM,,86.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,86.0
,2115756,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1nc(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)c(-c2ccccc2)cc1C#N,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.19', 'le': '0.18', 'lle': '-0.52', 'sei': '6.05'}",CHEMBL402355,,CHEMBL402355,5.26,False,http://www.openphacts.org/units/Nanomolar,694598,=,1,True,=,,IC50,nM,,5548.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5548.0
,2115757,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1nc(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)c(-c2ccccc2)cc1C#N,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '9.60', 'le': '0.17', 'lle': '-0.76', 'sei': '6.27'}",CHEMBL257441,,CHEMBL257441,5.07,False,http://www.openphacts.org/units/Nanomolar,694597,=,1,True,=,,IC50,nM,,8457.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8457.0
,2115758,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nc(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)c(-c2ccccc2)cc1C#N,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.97', 'le': '0.20', 'lle': '-0.16', 'sei': '6.29'}",CHEMBL255772,,CHEMBL255772,5.65,False,http://www.openphacts.org/units/Nanomolar,694596,=,1,True,=,,IC50,nM,,2249.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2249.0
,2115759,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cc(-c2ccccc2)c(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)nc1N,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.60', 'le': '0.23', 'lle': '0.96', 'sei': '6.08'}",CHEMBL429576,,CHEMBL429576,6.30,False,http://www.openphacts.org/units/Nanomolar,694595,=,1,True,=,,IC50,nM,,495.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,495.0
,2115760,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cc(-c2ccccc2)c(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)nc1Cl,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.69', 'le': '0.24', 'lle': '0.18', 'sei': '8.49'}",CHEMBL270388,,CHEMBL270388,6.60,False,http://www.openphacts.org/units/Nanomolar,694594,=,1,True,=,,IC50,nM,,253.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,253.0
,2115761,[],CHEMBL951085,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.12', 'le': '0.24', 'lle': '0.92', 'sei': '7.58'}",CHEMBL258844,,CHEMBL258844,7.24,True,http://www.openphacts.org/units/Nanomolar,694593,=,1,True,=,,IC50,nM,,58.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,58.0
,2115783,[],CHEMBL951088,Inhibition of Akt1 phosphorylation in human C33a cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2nc(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.87', 'le': '0.20', 'lle': '0.32', 'sei': '5.43'}",CHEMBL402199,,CHEMBL402199,5.74,False,http://www.openphacts.org/units/Nanomolar,694605,=,1,True,=,,IC50,nM,,1834.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1834.0
,2115784,[],CHEMBL951088,Inhibition of Akt1 phosphorylation in human C33a cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2nc(-c3ccc(CN4CCC(n5ncc6c(N)ncnc65)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.35', 'le': '0.22', 'lle': '2.03', 'sei': '4.75'}",CHEMBL253458,,CHEMBL253458,6.53,False,http://www.openphacts.org/units/Nanomolar,694610,=,1,True,=,,IC50,nM,,295.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,295.0
,2115785,[],CHEMBL951088,Inhibition of Akt1 phosphorylation in human C33a cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2nc(-c3ccc(CN4CCC(c5cc(-c6ccncc6)[nH]n5)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.76', 'le': '0.21', 'lle': '0.22', 'sei': '5.78'}",CHEMBL255835,,CHEMBL255835,6.33,False,http://www.openphacts.org/units/Nanomolar,694609,=,1,True,=,,IC50,nM,,463.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,463.0
,2115786,[],CHEMBL951088,Inhibition of Akt1 phosphorylation in human C33a cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2nc(-c3ccc(CN4CCC(c5nc6ccc(F)cc6[nH]5)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.38', 'le': '0.22', 'lle': '0.22', 'sei': '6.79'}",CHEMBL253457,,CHEMBL253457,6.56,False,http://www.openphacts.org/units/Nanomolar,694608,=,1,True,=,,IC50,nM,,277.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,277.0
,2115787,[],CHEMBL951088,Inhibition of Akt1 phosphorylation in human C33a cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2ccccc2n1C1CCN(Cc2ccc(-c3nc4ncnc(N)c4cc3-c3ccccc3)cc2)CC1,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.66', 'le': '0.23', 'lle': '0.22', 'sei': '7.76'}",CHEMBL402579,,CHEMBL402579,6.66,False,http://www.openphacts.org/units/Nanomolar,694607,=,1,True,=,,IC50,nM,,221.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,221.0
Not Determined,2115788,[],CHEMBL951088,Inhibition of Akt1 phosphorylation in human C33a cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2nc(-c3ccc(CN4CCC(n5cnc6c(N)ncnc65)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1142344,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL255360,,CHEMBL255360,,False,,694606,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,2132669,[],CHEMBL938203,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nccn2c1c(-c1ccc3ccc(-c4ccccc4)nc3c1)nc2[C@H]1C[C@@H](CN2CCC2)C1,,,CHEMBL1143953,Bioorg. Med. Chem.,2008.0,,CHEMBL410659,,CHEMBL410659,,False,http://www.openphacts.org/units/Nanomolar,703189,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,2136981,[],CHEMBL939373,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1,,,CHEMBL1145498,Proc. Natl. Acad. Sci. U.S.A.,2007.0,,CHEMBL406375,,CHEMBL406375,,False,http://www.openphacts.org/units/Nanomolar,705181,>=,1,True,>=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,2158762,[],CHEMBL922525,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1,,,CHEMBL1144728,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL259922,,CHEMBL259922,,False,http://www.openphacts.org/units/Nanomolar,707289,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,2159780,[],CHEMBL928166,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc2c1N=C(c1ccccc1)CCN2,,,CHEMBL1144750,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '16.87', 'le': '0.31', 'lle': '2.04', 'sei': '5.30'}",CHEMBL262623,,CHEMBL262623,4.04,False,http://www.openphacts.org/units/Nanomolar,707673,=,1,True,=,,IC50,nM,,92000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,92.0
,2159806,[],CHEMBL928166,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(C2=Nc3c(N)ncnc3NCC2)c1,,,CHEMBL1144750,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL263902,,CHEMBL263902,,False,http://www.openphacts.org/units/Nanomolar,707674,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,2159807,[],CHEMBL928166,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nc(N)c2c(n1)NCCC(c1ccc(Cl)cc1)=N2,,,CHEMBL1144750,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL260620,,CHEMBL260620,,False,http://www.openphacts.org/units/Nanomolar,707680,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,2159808,[],CHEMBL928166,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nc(N)c2c(n1)NCCC(c1cccc(Cl)c1)=N2,,,CHEMBL1144750,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL259381,,CHEMBL259381,,False,http://www.openphacts.org/units/Nanomolar,707679,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,2159809,[],CHEMBL928166,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nc(N)c2c(n1)NCCC(c1ccccc1)=N2,,,CHEMBL1144750,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL259380,,CHEMBL259380,,False,http://www.openphacts.org/units/Nanomolar,707678,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,2159810,[],CHEMBL928166,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc2c1N=C(c1ccc(Cl)cc1)CCN2,,,CHEMBL1144750,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL407265,,CHEMBL407265,,False,http://www.openphacts.org/units/Nanomolar,707677,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,2159811,[],CHEMBL928166,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc2c1N=C(c1cccc(Cl)c1)CCN2,,,CHEMBL1144750,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL407532,,CHEMBL407532,,False,http://www.openphacts.org/units/Nanomolar,707676,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,2159812,[],CHEMBL928166,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C2=Nc3c(N)ncnc3NCC2)cc1,,,CHEMBL1144750,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL405233,,CHEMBL405233,,False,http://www.openphacts.org/units/Nanomolar,707675,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,2168118,[],CHEMBL927988,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(Nc2c(C#N)cnc3sc(-c4cccc(CN(C)C)c4)cc23)ccc2[nH]ccc12,,,CHEMBL1145639,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL402818,,CHEMBL402818,,False,http://www.openphacts.org/units/Nanomolar,711824,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,2169576,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2nnc[nH]2)c(Nc2ncnc3[nH]ccc23)c1,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '24.08', 'le': '0.43', 'lle': '4.19', 'sei': '7.02'}",CHEMBL261204,,CHEMBL261204,6.68,False,http://www.openphacts.org/units/Nanomolar,697043,=,1,True,=,,IC50,nM,,210.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,210.0
,2169577,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '26.09', 'le': '0.47', 'lle': '6.02', 'sei': '10.69'}",CHEMBL258837,,CHEMBL258837,8.62,False,http://www.openphacts.org/units/Nanomolar,697061,=,1,True,=,,IC50,nM,,2.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.4
,2169578,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(Cc2c[nH]c3ncnc(N4CC5(CCNCC5)c5ccccc54)c23)cc1,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.86', 'le': '0.27', 'lle': '1.56', 'sei': '10.34'}",CHEMBL411276,,CHEMBL411276,5.88,False,http://www.openphacts.org/units/Nanomolar,697060,=,1,True,=,,IC50,nM,,1330.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1330.0
,2169579,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '26.04', 'le': '0.47', 'lle': '5.28', 'sei': '14.64'}",CHEMBL259163,,CHEMBL259163,8.32,False,http://www.openphacts.org/units/Nanomolar,697059,=,1,True,=,,IC50,nM,,4.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.8
,2169580,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '24.24', 'le': '0.47', 'lle': '4.86', 'sei': '14.49'}",CHEMBL411515,,CHEMBL411515,8.24,False,http://www.openphacts.org/units/Nanomolar,697058,=,1,True,=,,IC50,nM,,5.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.8
,2169581,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC2(CC1)CN(c1ncnc3[nH]ccc13)c1ccc(F)cc12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.69', 'le': '0.27', 'lle': '2.96', 'sei': '6.69'}",CHEMBL410235,,CHEMBL410235,5.50,False,http://www.openphacts.org/units/Nanomolar,697057,=,1,True,=,,IC50,nM,,3190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3190.0
,2169582,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCC2(CC1)CN(c1ncnc3[nH]ccc13)c1ccc(F)cc12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.20', 'le': '0.28', 'lle': '2.42', 'sei': '8.53'}",CHEMBL411718,,CHEMBL411718,5.55,False,http://www.openphacts.org/units/Nanomolar,697056,=,1,True,=,,IC50,nM,,2790.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2790.0
,2169583,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC2(CC1)CN(c1ncnc3[nH]ccc13)c1ccccc12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '24.72', 'le': '0.45', 'lle': '4.83', 'sei': '16.43'}",CHEMBL258838,,CHEMBL258838,7.90,False,http://www.openphacts.org/units/Nanomolar,697055,=,1,True,=,,IC50,nM,,12.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.7
,2169584,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc2c(c1)C1(CCNCC1)CN2c1ncnc2[nH]ccc12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '26.31', 'le': '0.48', 'lle': '5.64', 'sei': '14.97'}",CHEMBL407718,,CHEMBL407718,8.51,False,http://www.openphacts.org/units/Nanomolar,697054,=,1,True,=,,IC50,nM,,3.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.1
,2169585,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc2c(c1)C1(CCNCC1)CN2c1ncnc2[nH]ccc12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '24.48', 'le': '0.47', 'lle': '4.94', 'sei': '14.64'}",CHEMBL449964,,CHEMBL449964,8.32,False,http://www.openphacts.org/units/Nanomolar,697053,=,1,True,=,,IC50,nM,,4.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.8
,2169586,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(c1)N(c1ncnc3[nH]ccc13)CC21CCNCC1,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '27.10', 'le': '0.49', 'lle': '5.55', 'sei': '14.56'}",CHEMBL259265,,CHEMBL259265,8.28,False,http://www.openphacts.org/units/Nanomolar,697052,=,1,True,=,,IC50,nM,,5.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.3
,2169587,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1c[nH]c2ncnc(N3CCc4[nH]cnc4C3)c12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '26.85', 'le': '0.53', 'lle': '5.48', 'sei': '10.04'}",CHEMBL259833,,CHEMBL259833,7.38,False,http://www.openphacts.org/units/Nanomolar,697051,=,1,True,=,,IC50,nM,,42.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.0
,2169588,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,c1nc(N2CCc3[nH]cnc3C2)c2cc[nH]c2n1,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '27.18', 'le': '0.50', 'lle': '5.29', 'sei': '8.89'}",CHEMBL407891,,CHEMBL407891,6.53,False,http://www.openphacts.org/units/Nanomolar,697050,=,1,True,=,,IC50,nM,,294.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,294.0
,2169589,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nnc(-c2ccc(Cl)cc2Nc2ncnc3[nH]ccc23)[nH]1,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL412114,,CHEMBL412114,,False,http://www.openphacts.org/units/Nanomolar,697049,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,2169590,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nnc(-c2cc(Cl)ccc2Nc2ncnc3[nH]ccc23)[nH]1,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.77', 'le': '0.40', 'lle': '3.32', 'sei': '7.11'}",CHEMBL259834,,CHEMBL259834,6.77,False,http://www.openphacts.org/units/Nanomolar,697048,=,1,True,=,,IC50,nM,,171.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,171.0
,2169591,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nnc(-c2ccccc2Nc2ncnc3[nH]ccc23)[nH]1,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '23.41', 'le': '0.42', 'lle': '4.02', 'sei': '7.17'}",CHEMBL428963,,CHEMBL428963,6.82,False,http://www.openphacts.org/units/Nanomolar,697047,=,1,True,=,,IC50,nM,,151.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,151.0
,2169592,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1c[nH]c2ncnc(Nc3ccccc3-c3nnc[nH]3)c12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.84', 'le': '0.40', 'lle': '3.36', 'sei': '6.83'}",CHEMBL260990,,CHEMBL260990,6.50,False,http://www.openphacts.org/units/Nanomolar,697046,=,1,True,=,,IC50,nM,,318.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,318.0
,2169593,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(Nc3ccccc3-c3nnc[nH]3)c12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '21.87', 'le': '0.40', 'lle': '3.57', 'sei': '6.69'}",CHEMBL409880,,CHEMBL409880,6.37,False,http://www.openphacts.org/units/Nanomolar,697045,=,1,True,=,,IC50,nM,,425.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,425.0
,2169594,[],CHEMBL936668,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1ccc2c(Nc3ccccc3-c3nnc[nH]3)ncnc21,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL261205,,CHEMBL261205,,False,http://www.openphacts.org/units/Nanomolar,697044,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,2169595,[],CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc2c(c1)N(c1ncnc3[nH]ccc13)CC21CCNCC1,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '22.98', 'le': '0.42', 'lle': '4.29', 'sei': '12.35'}",CHEMBL259265,,CHEMBL259265,7.02,False,http://www.openphacts.org/units/Nanomolar,697052,=,1,True,=,,IC50,nM,,96.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,96.0
,2169596,[],CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '22.10', 'le': '0.40', 'lle': '4.70', 'sei': '9.05'}",CHEMBL258837,,CHEMBL258837,7.30,False,http://www.openphacts.org/units/Nanomolar,697061,=,1,True,=,,IC50,nM,,50.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50.0
Not Determined,2169597,[],CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(Cc2c[nH]c3ncnc(N4CC5(CCNCC5)c5ccccc54)c23)cc1,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL411276,,CHEMBL411276,,False,,697060,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,2169598,[],CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '21.65', 'le': '0.39', 'lle': '3.87', 'sei': '12.16'}",CHEMBL259163,,CHEMBL259163,6.91,False,http://www.openphacts.org/units/Nanomolar,697059,=,1,True,=,,IC50,nM,,122.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,122.0
,2169599,[],CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Clc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '21.17', 'le': '0.41', 'lle': '3.81', 'sei': '12.66'}",CHEMBL411515,,CHEMBL411515,7.19,False,http://www.openphacts.org/units/Nanomolar,697058,=,1,True,=,,IC50,nM,,64.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,64.0
Not Determined,2169600,[],CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCC2(CC1)CN(c1ncnc3[nH]ccc13)c1ccc(F)cc12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL410235,,CHEMBL410235,,False,,697057,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,2169601,[],CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCC2(CC1)CN(c1ncnc3[nH]ccc13)c1ccccc12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '21.50', 'le': '0.39', 'lle': '3.80', 'sei': '14.29'}",CHEMBL258838,,CHEMBL258838,6.87,False,http://www.openphacts.org/units/Nanomolar,697055,=,1,True,=,,IC50,nM,,136.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,136.0
,2169602,[],CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc2c(c1)C1(CCNCC1)CN2c1ncnc2[nH]ccc12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '22.03', 'le': '0.41', 'lle': '4.25', 'sei': '12.54'}",CHEMBL407718,,CHEMBL407718,7.12,False,http://www.openphacts.org/units/Nanomolar,697054,=,1,True,=,,IC50,nM,,75.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,75.0
,2169603,[],CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Clc1ccc2c(c1)C1(CCNCC1)CN2c1ncnc2[nH]ccc12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '21.46', 'le': '0.41', 'lle': '3.91', 'sei': '12.83'}",CHEMBL449964,,CHEMBL449964,7.29,False,http://www.openphacts.org/units/Nanomolar,697053,=,1,True,=,,IC50,nM,,51.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,51.0
Not Determined,2169604,[],CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCC2(CC1)CN(c1ncnc3[nH]ccc13)c1ccc(F)cc12,,,CHEMBL1143084,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL411718,,CHEMBL411718,,False,,697056,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,2171146,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.12', 'le': '0.24', 'lle': '0.92', 'sei': '7.58'}",CHEMBL258844,,CHEMBL258844,7.24,True,http://www.openphacts.org/units/Nanomolar,697416,=,1,True,=,,IC50,nM,,58.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,58.0
,2171148,[],CHEMBL937419,Inhibition of Akt1 by cell-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.14', 'le': '0.22', 'lle': '0.38', 'sei': '7.02'}",CHEMBL258844,,CHEMBL258844,6.70,False,http://www.openphacts.org/units/Nanomolar,697416,=,1,True,=,,IC50,nM,,200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,200.0
,2171150,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1N=CC=C2N=C(c3ccc(CN4CCC(c5n[nH]c(-c6ccccn6)n5)CC4)cc3)C(c3ccccc3)=CC12,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.67', 'le': '0.28', 'lle': '3.22', 'sei': '8.50'}",CHEMBL262341,,CHEMBL262341,8.46,False,http://www.openphacts.org/units/Nanomolar,697429,=,1,True,=,,IC50,nM,,3.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.5
,2171151,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc3ncccc3nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.76', 'le': '0.28', 'lle': '1.73', 'sei': '9.88'}",CHEMBL259753,,CHEMBL259753,8.25,False,http://www.openphacts.org/units/Nanomolar,697428,=,1,True,=,,IC50,nM,,5.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.6
,2171152,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc3cnccc3nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.53', 'le': '0.28', 'lle': '1.61', 'sei': '9.74'}",CHEMBL259967,,CHEMBL259967,8.13,False,http://www.openphacts.org/units/Nanomolar,697427,=,1,True,=,,IC50,nM,,7.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.4
,2171153,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc3ccncc3nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.66', 'le': '0.26', 'lle': '1.16', 'sei': '9.20'}",CHEMBL259968,,CHEMBL259968,7.68,False,http://www.openphacts.org/units/Nanomolar,697426,=,1,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.0
,2171154,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc3cccnc3nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.03', 'le': '0.25', 'lle': '0.83', 'sei': '8.80'}",CHEMBL260670,,CHEMBL260670,7.35,False,http://www.openphacts.org/units/Nanomolar,697425,=,1,True,=,,IC50,nM,,45.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,45.0
,2171155,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc(C3CCN(Cc4ccc(-c5nc6ncccc6cc5-c5ccccc5)cc4)CC3)n[nH]2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.13', 'le': '0.22', 'lle': '-1.40', 'sei': '10.97'}",CHEMBL429703,,CHEMBL429703,6.33,False,http://www.openphacts.org/units/Nanomolar,697424,=,1,True,=,,IC50,nM,,470.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,470.0
,2171156,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1ccc(-c2cc(C3CCN(Cc4ccc(-c5nc6ncccc6cc5-c5ccccc5)cc4)CC3)n[nH]2)c[nH]1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.87', 'le': '0.25', 'lle': '1.05', 'sei': '8.25'}",CHEMBL260184,,CHEMBL260184,7.47,False,http://www.openphacts.org/units/Nanomolar,697423,=,1,True,=,,IC50,nM,,34.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,34.0
,2171157,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc3cccnc3nc2-c2ccc(CN3CCC(c4cc(-c5ccccn5)[nH]n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.08', 'le': '0.25', 'lle': '0.23', 'sei': '10.42'}",CHEMBL259982,,CHEMBL259982,7.36,False,http://www.openphacts.org/units/Nanomolar,697422,=,1,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,44.0
,2171158,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc3cccnc3nc2-c2ccc(CN3CCC(c4cc(-c5cccnc5)[nH]n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.63', 'le': '0.23', 'lle': '-0.53', 'sei': '9.35'}",CHEMBL407733,,CHEMBL407733,6.60,False,http://www.openphacts.org/units/Nanomolar,697421,=,1,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,250.0
,2171159,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc3cccnc3nc2-c2ccc(CN3CCC(c4cc(-c5ccncc5)[nH]n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.24', 'le': '0.24', 'lle': '-0.21', 'sei': '9.80'}",CHEMBL261540,,CHEMBL261540,6.92,False,http://www.openphacts.org/units/Nanomolar,697420,=,1,True,=,,IC50,nM,,120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,120.0
,2171160,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2nc3ccccc3nc2-c2ccc(CN3CCC(c4cc(-c5ccncc5)[nH]n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.63', 'le': '0.24', 'lle': '-0.01', 'sei': '10.09'}",CHEMBL261542,,CHEMBL261542,7.12,False,http://www.openphacts.org/units/Nanomolar,697419,=,1,True,=,,IC50,nM,,75.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,75.0
,2171161,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc2ccccc2n1C1CCN(Cc2ccc(-c3nc4ccccc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.76', 'le': '0.23', 'lle': '-0.33', 'sei': '9.74'}",CHEMBL260397,,CHEMBL260397,6.53,False,http://www.openphacts.org/units/Nanomolar,697418,=,1,True,=,,IC50,nM,,295.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,295.0
,2171162,[],CHEMBL937417,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCNC(=O)c1ccc2nc(-c3ccccc3)c(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)nc2c1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.49', 'le': '0.19', 'lle': '0.34', 'sei': '6.92'}",CHEMBL258696,,CHEMBL258696,6.86,False,http://www.openphacts.org/units/Nanomolar,697417,=,1,True,=,,IC50,nM,,138.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,138.0
,2171176,[],CHEMBL937419,Inhibition of Akt1 by cell-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1N=CC=C2N=C(c3ccc(CN4CCC(c5n[nH]c(-c6ccccn6)n5)CC4)cc3)C(c3ccccc3)=CC12,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.45', 'le': '0.26', 'lle': '2.56', 'sei': '7.84'}",CHEMBL262341,,CHEMBL262341,7.80,False,http://www.openphacts.org/units/Nanomolar,697429,=,1,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
,2171177,[],CHEMBL937419,Inhibition of Akt1 by cell-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc3ncccc3nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.37', 'le': '0.26', 'lle': '1.00', 'sei': '9.01'}",CHEMBL259753,,CHEMBL259753,7.52,False,http://www.openphacts.org/units/Nanomolar,697428,=,1,True,=,,IC50,nM,,30.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30.0
,2171178,[],CHEMBL937419,Inhibition of Akt1 by cell-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc3cnccc3nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.66', 'le': '0.26', 'lle': '1.16', 'sei': '9.20'}",CHEMBL259967,,CHEMBL259967,7.68,False,http://www.openphacts.org/units/Nanomolar,697427,=,1,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.0
,2171179,[],CHEMBL937419,Inhibition of Akt1 by cell-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc3ccncc3nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.34', 'le': '0.26', 'lle': '0.99', 'sei': '8.99'}",CHEMBL259968,,CHEMBL259968,7.51,False,http://www.openphacts.org/units/Nanomolar,697426,=,1,True,=,,IC50,nM,,31.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31.0
,2171180,[],CHEMBL937419,Inhibition of Akt1 by cell-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc3cccnc3nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.52', 'le': '0.24', 'lle': '0.56', 'sei': '8.48'}",CHEMBL260670,,CHEMBL260670,7.08,False,http://www.openphacts.org/units/Nanomolar,697425,=,1,True,=,,IC50,nM,,83.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,83.0
Not Determined,2171181,[],CHEMBL937419,Inhibition of Akt1 by cell-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc(C3CCN(Cc4ccc(-c5nc6ncccc6cc5-c5ccccc5)cc4)CC3)n[nH]2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL429703,,CHEMBL429703,,False,,697424,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,2171182,[],CHEMBL937419,Inhibition of Akt1 by cell-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1ccc(-c2cc(C3CCN(Cc4ccc(-c5nc6ncccc6cc5-c5ccccc5)cc4)CC3)n[nH]2)c[nH]1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.77', 'le': '0.23', 'lle': '0.46', 'sei': '7.60'}",CHEMBL260184,,CHEMBL260184,6.88,False,http://www.openphacts.org/units/Nanomolar,697423,=,1,True,=,,IC50,nM,,132.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,132.0
,2171183,[],CHEMBL937419,Inhibition of Akt1 by cell-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc3cccnc3nc2-c2ccc(CN3CCC(c4cc(-c5ccccn5)[nH]n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.06', 'le': '0.23', 'lle': '-0.30', 'sei': '9.67'}",CHEMBL259982,,CHEMBL259982,6.83,False,http://www.openphacts.org/units/Nanomolar,697422,=,1,True,=,,IC50,nM,,149.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,149.0
Not Determined,2171184,[],CHEMBL937419,Inhibition of Akt1 by cell-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc3cccnc3nc2-c2ccc(CN3CCC(c4cc(-c5cccnc5)[nH]n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL407733,,CHEMBL407733,,False,,697421,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,2171185,[],CHEMBL937419,Inhibition of Akt1 by cell-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc3cccnc3nc2-c2ccc(CN3CCC(c4cc(-c5ccncc5)[nH]n4)CC3)cc2)cc1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.31', 'le': '0.22', 'lle': '-0.70', 'sei': '9.11'}",CHEMBL261540,,CHEMBL261540,6.43,False,http://www.openphacts.org/units/Nanomolar,697420,=,1,True,=,,IC50,nM,,369.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,369.0
,2171186,[],CHEMBL937419,Inhibition of Akt1 by cell-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CCNC(=O)c1ccc2nc(-c3ccccc3)c(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)nc2c1,,,CHEMBL1143097,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '9.60', 'le': '0.17', 'lle': '-0.24', 'sei': '6.33'}",CHEMBL258696,,CHEMBL258696,6.28,False,http://www.openphacts.org/units/Nanomolar,697417,=,1,True,=,,IC50,nM,,527.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,527.0
,2250929,[],CHEMBL1022473,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1,,,CHEMBL1139384,J. Med. Chem.,2009.0,,CHEMBL524266,,CHEMBL524266,,False,http://www.openphacts.org/units/Nanomolar,776236,>,1,True,>,,IC50,nM,,4000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.0
,2360381,[],CHEMBL980865,Inhibition of Akt Ser 473 phosphorylation in PTEN-null human U87MG cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,,,CHEMBL1140078,J. Med. Chem.,2008.0,"{'bei': '14.28', 'le': '0.29', 'lle': '5.19', 'sei': '6.82'}",CHEMBL521851,PICTILISIB,CHEMBL521851,7.34,False,http://www.openphacts.org/units/Nanomolar,747281,=,1,True,=,,IC50,nM,,46.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.046
,2360382,[],CHEMBL980866,Inhibition of Akt Ser 473 phosphorylation in PTEN-null human PC3 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,,,CHEMBL1140078,J. Med. Chem.,2008.0,"{'bei': '14.47', 'le': '0.29', 'lle': '5.28', 'sei': '6.91'}",CHEMBL521851,PICTILISIB,CHEMBL521851,7.43,False,http://www.openphacts.org/units/Nanomolar,747281,=,1,True,=,,IC50,nM,,37.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.037
,2360383,[],CHEMBL980867,Inhibition of Akt Ser 473 phosphorylation in human MDA-MB-361 cells with PIK3CA E545-K mutation,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,,,CHEMBL1140078,J. Med. Chem.,2008.0,"{'bei': '14.70', 'le': '0.29', 'lle': '5.40', 'sei': '7.02'}",CHEMBL521851,PICTILISIB,CHEMBL521851,7.55,False,http://www.openphacts.org/units/Nanomolar,747281,=,1,True,=,,IC50,nM,,28.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.028
,2361194,[],CHEMBL970670,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,,,CHEMBL1140082,J. Med. Chem.,2008.0,,CHEMBL505896,,CHEMBL505896,,False,http://www.openphacts.org/units/Nanomolar,747816,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
,2361216,[],CHEMBL970670,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,,,CHEMBL1140082,J. Med. Chem.,2008.0,,CHEMBL453737,,CHEMBL453737,,False,http://www.openphacts.org/units/Nanomolar,747988,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
,2361239,[],CHEMBL970670,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1,,,CHEMBL1140082,J. Med. Chem.,2008.0,,CHEMBL447602,,CHEMBL447602,,False,http://www.openphacts.org/units/Nanomolar,748085,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
,2361597,[],CHEMBL980899,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C2CCN(CCCF)CC2)cc2[nH]c(-c3c(NCCn4cc(Cl)cn4)cc[nH]c3=O)nc12,,,CHEMBL1140084,J. Med. Chem.,2008.0,"{'bei': '8.43', 'le': '0.16', 'lle': '-0.41', 'sei': '4.56'}",CHEMBL459729,,CHEMBL459729,4.32,False,http://www.openphacts.org/units/Nanomolar,747727,=,1,True,=,,IC50,nM,,48390.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,48.39
,2362681,[],CHEMBL1034885,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2)cc1OC,,,CHEMBL1140097,J. Med. Chem.,2008.0,,CHEMBL492251,,CHEMBL492251,,False,http://www.openphacts.org/units/Nanomolar,747304,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,2367150,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(OC3CCNCC3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '21.56', 'le': '0.40', 'lle': '5.89', 'sei': '6.08'}",CHEMBL493911,,CHEMBL493911,7.10,True,http://www.openphacts.org/units/Nanomolar,746672,=,1,True,=,,IC50,nM,,79.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.079
,2367155,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCNC[C@H](O)CO)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '18.55', 'le': '0.35', 'lle': '8.60', 'sei': '4.80'}",CHEMBL522351,,CHEMBL522351,8.52,False,http://www.openphacts.org/units/Nanomolar,745854,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.003
,2367156,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCNCCc3ccc(OC)cc3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '15.98', 'le': '0.30', 'lle': '5.48', 'sei': '5.67'}",CHEMBL494060,,CHEMBL494060,8.30,False,http://www.openphacts.org/units/Nanomolar,745853,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.005
,2367157,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCNC3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '20.03', 'le': '0.38', 'lle': '6.94', 'sei': '6.21'}",CHEMBL521642,,CHEMBL521642,8.52,False,http://www.openphacts.org/units/Nanomolar,745852,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.003
,2367158,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '20.44', 'le': '0.38', 'lle': '7.12', 'sei': '6.34'}",CHEMBL494089,GSK-690693,CHEMBL494089,8.70,True,http://www.openphacts.org/units/Nanomolar,745757,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.002
,2367159,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '19.68', 'le': '0.37', 'lle': '6.76', 'sei': '5.90'}",CHEMBL1794066,GSK-619487A,CHEMBL522857,8.10,False,http://www.openphacts.org/units/Nanomolar,745756,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.008
,2367160,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNC3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '19.68', 'le': '0.37', 'lle': '6.91', 'sei': '5.90'}",CHEMBL494088,,CHEMBL494088,8.10,False,http://www.openphacts.org/units/Nanomolar,745755,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.008
,2367161,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC[C@@H](N)Cc3ccccc3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '17.92', 'le': '0.33', 'lle': '5.98', 'sei': '5.64'}",CHEMBL523859,,CHEMBL523859,8.52,False,http://www.openphacts.org/units/Nanomolar,745754,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.003
,2367162,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '23.42', 'le': '0.44', 'lle': '8.16', 'sei': '5.76'}",CHEMBL453510,,CHEMBL453510,8.70,False,http://www.openphacts.org/units/Nanomolar,745667,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.002
,2367163,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '18.80', 'le': '0.35', 'lle': '6.42', 'sei': '5.83'}",CHEMBL1794065,GSK-554170A,CHEMBL521658,8.00,False,http://www.openphacts.org/units/Nanomolar,745666,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.01
,2367164,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '20.14', 'le': '0.38', 'lle': '6.73', 'sei': '5.32'}",CHEMBL493269,,CHEMBL493269,8.05,False,http://www.openphacts.org/units/Nanomolar,745665,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.009
,2367165,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '17.12', 'le': '0.32', 'lle': '5.98', 'sei': '3.89'}",CHEMBL1794064,GSK-561866B,CHEMBL494280,6.10,False,http://www.openphacts.org/units/Nanomolar,745664,=,1,True,=,,IC50,nM,,794.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.794
,2367166,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CCCO)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '19.66', 'le': '0.37', 'lle': '6.76', 'sei': '4.83'}",CHEMBL493875,,CHEMBL493875,7.30,False,http://www.openphacts.org/units/Nanomolar,745548,=,1,True,=,,IC50,nM,,50.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.05
,2367167,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CCO)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '24.34', 'le': '0.46', 'lle': '8.55', 'sei': '5.76'}",CHEMBL523523,,CHEMBL523523,8.70,False,http://www.openphacts.org/units/Nanomolar,745547,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.002
,2367168,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '21.33', 'le': '0.40', 'lle': '7.29', 'sei': '5.44'}",CHEMBL493874,,CHEMBL493874,8.22,False,http://www.openphacts.org/units/Nanomolar,745546,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.006
,2367169,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC3CC3)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '19.33', 'le': '0.36', 'lle': '5.53', 'sei': '5.43'}",CHEMBL494882,,CHEMBL494882,7.10,False,http://www.openphacts.org/units/Nanomolar,745545,=,1,True,=,,IC50,nM,,79.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.079
,2367170,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(-c3cn[nH]c3)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '14.89', 'le': '0.28', 'lle': '4.30', 'sei': '3.45'}",CHEMBL450487,,CHEMBL450487,5.50,False,http://www.openphacts.org/units/Nanomolar,745544,=,1,True,=,,IC50,nM,,3160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.16
,2367171,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(-c3cc[nH]c3)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '20.34', 'le': '0.38', 'lle': '5.68', 'sei': '5.11'}",CHEMBL523057,,CHEMBL523057,7.50,False,http://www.openphacts.org/units/Nanomolar,745460,=,1,True,=,,IC50,nM,,32.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.032
,2367172,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(-c3ccoc3)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '19.23', 'le': '0.36', 'lle': '5.03', 'sei': '4.93'}",CHEMBL445180,,CHEMBL445180,7.10,False,http://www.openphacts.org/units/Nanomolar,745459,=,1,True,=,,IC50,nM,,79.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.079
,2367173,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(-c3ccc[nH]3)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '20.34', 'le': '0.38', 'lle': '5.68', 'sei': '5.11'}",CHEMBL493251,,CHEMBL493251,7.50,False,http://www.openphacts.org/units/Nanomolar,745458,=,1,True,=,,IC50,nM,,32.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.032
,2367174,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(-c3ccccc3)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '17.08', 'le': '0.32', 'lle': '4.00', 'sei': '4.95'}",CHEMBL493250,,CHEMBL493250,6.48,False,http://www.openphacts.org/units/Nanomolar,745457,=,1,True,=,,IC50,nM,,331.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.331
,2367175,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(CNC3CCNCC3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '19.56', 'le': '0.37', 'lle': '5.78', 'sei': '5.60'}",CHEMBL188434,,CHEMBL188434,6.70,False,http://www.openphacts.org/units/Nanomolar,745456,=,1,True,=,,IC50,nM,,200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.2
,2367176,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(C(=O)NC3CCNCC3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '17.54', 'le': '0.33', 'lle': '5.68', 'sei': '4.57'}",CHEMBL494662,,CHEMBL494662,6.25,False,http://www.openphacts.org/units/Nanomolar,745305,=,1,True,=,,IC50,nM,,562.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.562
,2367177,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(OCC3CCNCC3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '21.12', 'le': '0.40', 'lle': '5.79', 'sei': '6.20'}",CHEMBL521823,,CHEMBL521823,7.25,False,http://www.openphacts.org/units/Nanomolar,745215,=,1,True,=,,IC50,nM,,56.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.056
,2367178,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(C(=O)NC3CCCNC3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '17.40', 'le': '0.33', 'lle': '5.63', 'sei': '4.53'}",CHEMBL493067,,CHEMBL493067,6.20,False,http://www.openphacts.org/units/Nanomolar,745214,=,1,True,=,,IC50,nM,,631.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.631
,2367179,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '18.40', 'le': '0.34', 'lle': '6.17', 'sei': '4.92'}",CHEMBL493066,,CHEMBL493066,6.30,False,http://www.openphacts.org/units/Nanomolar,745213,=,1,True,=,,IC50,nM,,501.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.501
,2367180,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@@H](N)C3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '18.93', 'le': '0.35', 'lle': '6.22', 'sei': '4.56'}",CHEMBL523695,,CHEMBL523695,6.48,False,http://www.openphacts.org/units/Nanomolar,745212,=,1,True,=,,IC50,nM,,331.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.331
,2367181,[],CHEMBL1028090,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '20.89', 'le': '0.39', 'lle': '6.87', 'sei': '5.04'}",CHEMBL506153,GW876790X,CHEMBL506153,6.90,False,http://www.openphacts.org/units/Nanomolar,745211,=,1,True,=,,IC50,nM,,126.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.126
,2367232,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(-c3ccccc3)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,,CHEMBL493250,,CHEMBL493250,,False,http://www.openphacts.org/units/Nanomolar,745457,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
Not Determined,2367251,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F,,,CHEMBL1140130,J. Med. Chem.,2008.0,,CHEMBL1794064,GSK-561866B,CHEMBL494280,,False,,745664,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,2367252,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CCCO)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '14.02', 'le': '0.26', 'lle': '4.67', 'sei': '3.45'}",CHEMBL493875,,CHEMBL493875,5.21,False,http://www.openphacts.org/units/Nanomolar,745548,=,1,True,=,,IC50,nM,,6200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,6.2
,2367253,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CCO)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '16.64', 'le': '0.31', 'lle': '5.80', 'sei': '3.93'}",CHEMBL523523,,CHEMBL523523,5.95,False,http://www.openphacts.org/units/Nanomolar,745547,=,1,True,=,,IC50,nM,,1130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.13
,2367254,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '15.51', 'le': '0.29', 'lle': '5.05', 'sei': '3.96'}",CHEMBL493874,,CHEMBL493874,5.98,False,http://www.openphacts.org/units/Nanomolar,745546,=,1,True,=,,IC50,nM,,1050.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.05
,2367255,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CC3CC3)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '14.72', 'le': '0.27', 'lle': '3.84', 'sei': '4.13'}",CHEMBL494882,,CHEMBL494882,5.41,False,http://www.openphacts.org/units/Nanomolar,745545,=,1,True,=,,IC50,nM,,3900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.9
,2367256,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(-c3cn[nH]c3)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,,CHEMBL450487,,CHEMBL450487,,False,http://www.openphacts.org/units/Nanomolar,745544,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,2367257,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(-c3cc[nH]c3)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '15.09', 'le': '0.28', 'lle': '3.75', 'sei': '3.79'}",CHEMBL523057,,CHEMBL523057,5.56,False,http://www.openphacts.org/units/Nanomolar,745460,=,1,True,=,,IC50,nM,,2760.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.76
,2367258,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(-c3ccoc3)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,,CHEMBL445180,,CHEMBL445180,,False,http://www.openphacts.org/units/Nanomolar,745459,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,2367259,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(-c3ccc[nH]3)ncc(OCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '14.85', 'le': '0.28', 'lle': '3.66', 'sei': '3.73'}",CHEMBL493251,,CHEMBL493251,5.47,False,http://www.openphacts.org/units/Nanomolar,745458,=,1,True,=,,IC50,nM,,3380.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.38
,2367278,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '14.57', 'le': '0.27', 'lle': '4.50', 'sei': '3.85'}",CHEMBL493269,,CHEMBL493269,5.82,False,http://www.openphacts.org/units/Nanomolar,745665,=,1,True,=,,IC50,nM,,1510.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.51
,2367282,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCNC[C@H](O)CO)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,,CHEMBL522351,,CHEMBL522351,,False,http://www.openphacts.org/units/Nanomolar,745854,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,2367283,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCNCCc3ccc(OC)cc3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '13.19', 'le': '0.25', 'lle': '4.03', 'sei': '4.68'}",CHEMBL494060,,CHEMBL494060,6.85,False,http://www.openphacts.org/units/Nanomolar,745853,=,1,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.14
,2367284,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCNC3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '15.04', 'le': '0.28', 'lle': '4.82', 'sei': '4.67'}",CHEMBL521642,,CHEMBL521642,6.40,False,http://www.openphacts.org/units/Nanomolar,745852,=,1,True,=,,IC50,nM,,400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.4
,2367285,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '16.11', 'le': '0.30', 'lle': '5.27', 'sei': '5.00'}",CHEMBL494089,GSK-690693,CHEMBL494089,6.85,False,http://www.openphacts.org/units/Nanomolar,745757,=,1,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.14
,2367286,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '15.19', 'le': '0.28', 'lle': '4.91', 'sei': '4.56'}",CHEMBL1794066,GSK-619487A,CHEMBL522857,6.25,False,http://www.openphacts.org/units/Nanomolar,745756,=,1,True,=,,IC50,nM,,560.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.56
,2367287,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNC3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '14.57', 'le': '0.27', 'lle': '4.81', 'sei': '4.37'}",CHEMBL494088,,CHEMBL494088,6.00,False,http://www.openphacts.org/units/Nanomolar,745755,=,1,True,=,,IC50,nM,,1010.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.01
,2367288,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC[C@@H](N)Cc3ccccc3)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '14.72', 'le': '0.27', 'lle': '4.46', 'sei': '4.63'}",CHEMBL523859,,CHEMBL523859,7.00,False,http://www.openphacts.org/units/Nanomolar,745754,=,1,True,=,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.1
,2367289,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCN)c21,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '17.87', 'le': '0.34', 'lle': '6.10', 'sei': '4.39'}",CHEMBL453510,,CHEMBL453510,6.64,False,http://www.openphacts.org/units/Nanomolar,745667,=,1,True,=,,IC50,nM,,230.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.23
,2367290,[],CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F,,,CHEMBL1140130,J. Med. Chem.,2008.0,"{'bei': '13.34', 'le': '0.25', 'lle': '4.10', 'sei': '4.14'}",CHEMBL1794065,GSK-554170A,CHEMBL521658,5.68,False,http://www.openphacts.org/units/Nanomolar,745666,=,1,True,=,,IC50,nM,,2100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.1
,2401985,[],CHEMBL1016204,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccc(-c2ccoc2)c(O)c1,,,CHEMBL1153424,J. Med. Chem.,2009.0,"{'bei': '10.26', 'le': '0.24', 'lle': '1.33', 'sei': '5.45'}",CHEMBL504547,,CHEMBL504547,4.99,False,http://www.openphacts.org/units/Nanomolar,781677,=,1,True,=,,IC50,nM,,10200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.2
,2408688,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(NC(=O)c1ccc(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '22.68', 'le': '0.43', 'lle': '4.50', 'sei': '9.81'}",CHEMBL471034,,CHEMBL471034,8.22,False,http://www.openphacts.org/units/Nanomolar,810331,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,2408689,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(NC(=O)c1ccc(-c2c[nH]c3ncccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '21.51', 'le': '0.41', 'lle': '4.08', 'sei': '9.30'}",CHEMBL470192,,CHEMBL470192,7.80,False,http://www.openphacts.org/units/Nanomolar,810332,=,1,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
,2408690,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(NC(=O)c1cc(-c2ccnc3[nH]ccc23)cs1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '20.41', 'le': '0.39', 'lle': '3.68', 'sei': '8.83'}",CHEMBL512672,,CHEMBL512672,7.40,False,http://www.openphacts.org/units/Nanomolar,810333,=,1,True,=,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,40.0
,2408691,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(NC(=O)c1cc(-c2c[nH]c3ncccc23)cs1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '20.97', 'le': '0.40', 'lle': '3.88', 'sei': '9.07'}",CHEMBL512305,,CHEMBL512305,7.60,False,http://www.openphacts.org/units/Nanomolar,810412,=,1,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
,2408692,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(NCc1ccc(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '20.09', 'le': '0.38', 'lle': '2.92', 'sei': '10.49'}",CHEMBL469560,,CHEMBL469560,7.00,False,http://www.openphacts.org/units/Nanomolar,810413,=,1,True,=,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100.0
,2408693,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(CNc1ccc(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '18.95', 'le': '0.36', 'lle': '2.15', 'sei': '9.89'}",CHEMBL469561,,CHEMBL469561,6.60,False,http://www.openphacts.org/units/Nanomolar,810414,=,1,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,250.0
,2408694,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(C(=O)Nc1ccc(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '23.51', 'le': '0.45', 'lle': '4.55', 'sei': '10.17'}",CHEMBL512480,,CHEMBL512480,8.52,False,http://www.openphacts.org/units/Nanomolar,810415,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,2408695,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(C(=O)Nc1cc(Br)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '17.22', 'le': '0.38', 'lle': '2.87', 'sei': '9.07'}",CHEMBL472291,,CHEMBL472291,7.60,False,http://www.openphacts.org/units/Nanomolar,810416,=,1,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
,2408696,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '18.35', 'le': '0.41', 'lle': '3.62', 'sei': '9.66'}",CHEMBL512135,,CHEMBL512135,8.10,False,http://www.openphacts.org/units/Nanomolar,810492,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
,2408698,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C(=O)NC(CN)c2ccccc2)sc1-c1ccnc2[nH]ccc12,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '21.51', 'le': '0.41', 'lle': '4.07', 'sei': '9.66'}",CHEMBL469781,,CHEMBL469781,8.10,False,http://www.openphacts.org/units/Nanomolar,810493,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
,2408699,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(NC(=O)c1cc(C2CC2)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '20.43', 'le': '0.39', 'lle': '3.62', 'sei': '9.81'}",CHEMBL512858,,CHEMBL512858,8.22,False,http://www.openphacts.org/units/Nanomolar,810494,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,2408700,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(NC(=O)c1cc(-c2ccccc2)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '16.65', 'le': '0.31', 'lle': '1.91', 'sei': '8.71'}",CHEMBL470200,,CHEMBL470200,7.30,False,http://www.openphacts.org/units/Nanomolar,810495,=,1,True,=,,IC50,nM,,50.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50.0
,2408701,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(NC(=O)c1cc(-c2cccnc2)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '16.38', 'le': '0.31', 'lle': '2.42', 'sei': '7.45'}",CHEMBL469357,,CHEMBL469357,7.20,False,http://www.openphacts.org/units/Nanomolar,810570,=,1,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,63.0
,2408702,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(NC(=O)c1cc(-c2cn[nH]c2)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '16.80', 'le': '0.32', 'lle': '3.09', 'sei': '6.40'}",CHEMBL470202,,CHEMBL470202,7.20,False,http://www.openphacts.org/units/Nanomolar,810571,=,1,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,63.0
,2408703,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCCNC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '18.62', 'le': '0.44', 'lle': '4.06', 'sei': '8.12'}",CHEMBL470409,,CHEMBL470409,6.80,False,http://www.openphacts.org/units/Nanomolar,810572,=,1,True,=,,IC50,nM,,158.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,158.0
,2408704,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC(CNC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '16.76', 'le': '0.37', 'lle': '2.92', 'sei': '8.83'}",CHEMBL512148,,CHEMBL512148,7.40,False,http://www.openphacts.org/units/Nanomolar,810573,=,1,True,=,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,40.0
,2408705,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CNCC(NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '18.72', 'le': '0.42', 'lle': '3.78', 'sei': '12.21'}",CHEMBL470410,,CHEMBL470410,8.52,False,http://www.openphacts.org/units/Nanomolar,810574,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,2408706,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC(NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '16.40', 'le': '0.36', 'lle': '2.61', 'sei': '12.62'}",CHEMBL470620,,CHEMBL470620,7.70,False,http://www.openphacts.org/units/Nanomolar,810654,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
,2408707,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCCC(NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '17.78', 'le': '0.39', 'lle': '3.23', 'sei': '9.66'}",CHEMBL469802,,CHEMBL469802,8.10,False,http://www.openphacts.org/units/Nanomolar,810655,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
,2408708,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCCCC(NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '16.40', 'le': '0.36', 'lle': '2.44', 'sei': '9.19'}",CHEMBL513019,,CHEMBL513019,7.70,False,http://www.openphacts.org/units/Nanomolar,810656,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
,2408709,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCC(Cc1ccccc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '19.76', 'le': '0.44', 'lle': '4.65', 'sei': '10.74'}",CHEMBL469590,,CHEMBL469590,9.00,False,http://www.openphacts.org/units/Nanomolar,810657,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,2408711,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CNCC(Cc1ccccc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '18.53', 'le': '0.41', 'lle': '4.09', 'sei': '12.46'}",CHEMBL469591,,CHEMBL469591,8.70,False,http://www.openphacts.org/units/Nanomolar,810658,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,2408712,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCNCC(Cc1ccccc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '17.37', 'le': '0.38', 'lle': '3.40', 'sei': '12.03'}",CHEMBL471059,,CHEMBL471059,8.40,False,http://www.openphacts.org/units/Nanomolar,810772,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,2408713,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NCC(Cc1ccccc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '16.08', 'le': '0.35', 'lle': '2.61', 'sei': '11.46'}",CHEMBL470596,,CHEMBL470596,8.00,False,http://www.openphacts.org/units/Nanomolar,810773,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,2408714,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@@H](Cc1ccccc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '16.46', 'le': '0.37', 'lle': '3.14', 'sei': '8.94'}",CHEMBL513728,,CHEMBL513728,7.50,False,http://www.openphacts.org/units/Nanomolar,810774,=,1,True,=,,IC50,nM,,32.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,32.0
,2408715,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@H](Cc1ccccc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '19.76', 'le': '0.44', 'lle': '4.65', 'sei': '10.74'}",CHEMBL470597,,CHEMBL470597,9.00,False,http://www.openphacts.org/units/Nanomolar,810775,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,2408716,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@H](CC1CCCCC1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '19.50', 'le': '0.44', 'lle': '3.92', 'sei': '10.74'}",CHEMBL470598,,CHEMBL470598,9.00,False,http://www.openphacts.org/units/Nanomolar,810776,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,2408718,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C[C@@H](CN)NC(=O)c2cc(Br)c(-c3ccnc4[nH]ccc34)s2)cc1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '17.56', 'le': '0.39', 'lle': '4.16', 'sei': '9.16'}",CHEMBL524998,,CHEMBL524998,8.52,False,http://www.openphacts.org/units/Nanomolar,810876,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,2408719,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@H](Cc1ccccc1F)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '19.01', 'le': '0.42', 'lle': '4.51', 'sei': '10.74'}",CHEMBL498052,,CHEMBL498052,9.00,False,http://www.openphacts.org/units/Nanomolar,810877,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,2408720,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@H](Cc1cccc(F)c1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '19.01', 'le': '0.42', 'lle': '4.51', 'sei': '10.74'}",CHEMBL523586,,CHEMBL523586,9.00,False,http://www.openphacts.org/units/Nanomolar,810878,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,2408721,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@H](Cc1ccc(F)cc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '19.01', 'le': '0.42', 'lle': '4.51', 'sei': '10.74'}",CHEMBL496690,,CHEMBL496690,9.00,False,http://www.openphacts.org/units/Nanomolar,810879,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,2408722,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@H](Cc1ccccc1C(F)(F)F)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '16.28', 'le': '0.36', 'lle': '3.15', 'sei': '10.17'}",CHEMBL520788,,CHEMBL520788,8.52,False,http://www.openphacts.org/units/Nanomolar,809561,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,2408723,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@H](Cc1cccc(C(F)(F)F)c1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '17.20', 'le': '0.38', 'lle': '3.63', 'sei': '10.74'}",CHEMBL482536,,CHEMBL482536,9.00,False,http://www.openphacts.org/units/Nanomolar,809562,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,2408724,[],CHEMBL959242,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@H](Cc1ccc(C(F)(F)F)cc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,,,CHEMBL1153968,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '16.62', 'le': '0.37', 'lle': '3.33', 'sei': '10.38'}",CHEMBL482537,,CHEMBL482537,8.70,False,http://www.openphacts.org/units/Nanomolar,809563,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,2418069,[],CHEMBL1018807,Inhibition of AKT C296A mutant,B,P31749,C296A,BAO_0000190,BAO_0000019,assay format,C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '9.87', 'le': '0.19', 'lle': '3.21', 'sei': '3.68'}",CHEMBL2216825,LACTOQUINOMYCIN,CHEMBL2216825,4.52,False,http://www.openphacts.org/units/Nanomolar,753680,=,1,True,=,,IC50,nM,,30400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.4
,2418070,[],CHEMBL1018806,Inhibition of AKT C310A mutant,B,P31749,C310A,BAO_0000190,BAO_0000019,assay format,C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '9.65', 'le': '0.18', 'lle': '3.10', 'sei': '3.60'}",CHEMBL2216825,LACTOQUINOMYCIN,CHEMBL2216825,4.42,False,http://www.openphacts.org/units/Nanomolar,753680,=,1,True,=,,IC50,nM,,38500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,38.5
,2419112,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1ccccc1C2=O,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '19.58', 'le': '0.36', 'lle': '3.98', 'sei': '8.38'}",CHEMBL475840,,CHEMBL475840,5.84,False,http://www.openphacts.org/units/Nanomolar,753683,=,1,True,=,,IC50,nM,,1440.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.44
,2419113,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc([C@@H]2O[C@@H]3CC(=O)O[C@@H]3C3=C2C(=O)c2ccccc2C3=O)cc1,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '16.80', 'le': '0.31', 'lle': '3.67', 'sei': '6.34'}",CHEMBL514989,,CHEMBL514989,6.07,False,http://www.openphacts.org/units/Nanomolar,753682,=,1,True,=,,IC50,nM,,850.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.85
,2419114,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1ccccc1C2=O,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '20.55', 'le': '0.38', 'lle': '4.17', 'sei': '9.21'}",CHEMBL525077,,CHEMBL525077,6.42,False,http://www.openphacts.org/units/Nanomolar,753612,=,1,True,=,,IC50,nM,,383.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.383
,2419115,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C[C@H]2O[C@@H](c3cccc(O)c3)C3=C(C(=O)c4ccccc4C3=O)[C@H]2O1,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '17.82', 'le': '0.33', 'lle': '3.94', 'sei': '7.18'}",CHEMBL474000,,CHEMBL474000,6.46,False,http://www.openphacts.org/units/Nanomolar,753611,=,1,True,=,,IC50,nM,,350.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.35
,2419116,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C[C@H]2OC3(CCCC3)C3=C(C(=O)c4ccccc4C3=O)[C@H]2O1,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '20.13', 'le': '0.37', 'lle': '4.14', 'sei': '9.37'}",CHEMBL504537,,CHEMBL504537,6.53,False,http://www.openphacts.org/units/Nanomolar,753610,=,1,True,=,,IC50,nM,,295.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.295
,2419117,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1ccccc1C2=O,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '21.73', 'le': '0.40', 'lle': '4.54', 'sei': '9.74'}",CHEMBL475826,,CHEMBL475826,6.79,False,http://www.openphacts.org/units/Nanomolar,753609,=,1,True,=,,IC50,nM,,163.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.163
,2419118,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1ccccc1C2=O,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '24.01', 'le': '0.44', 'lle': '5.35', 'sei': '9.79'}",CHEMBL522996,,CHEMBL522996,6.82,True,http://www.openphacts.org/units/Nanomolar,754326,=,1,True,=,,IC50,nM,,150.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.15
,2419119,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C[C@H]2O[C@H](c3ccsc3)C3=C(C(=O)c4ccccc4C3=O)[C@H]2O1,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '19.62', 'le': '0.38', 'lle': '4.03', 'sei': '9.92'}",CHEMBL521638,,CHEMBL521638,6.91,False,http://www.openphacts.org/units/Nanomolar,754325,=,1,True,=,,IC50,nM,,122.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.122
,2419120,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C[C@H]2O[C@H](c3ccsc3)C3=C(C(=O)c4ccccc4C3=O)[C@H]2O1,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '19.88', 'le': '0.38', 'lle': '4.12', 'sei': '10.05'}",CHEMBL521638,,CHEMBL521638,7.00,False,http://www.openphacts.org/units/Nanomolar,754324,=,1,True,=,,IC50,nM,,99.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.099
,2419121,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C[C@H]2O[C@@H](c3ccc(O)cc3)C3=C(C(=O)c4ccccc4C3=O)[C@H]2O1,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '19.59', 'le': '0.36', 'lle': '4.58', 'sei': '7.89'}",CHEMBL493360,,CHEMBL493360,7.10,False,http://www.openphacts.org/units/Nanomolar,754323,=,1,True,=,,IC50,nM,,80.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.08
,2419122,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C[C@H]2O[C@H](COCc3ccccc3)C3=C(C(=O)c4ccccc4C3=O)[C@H]2O1,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '18.30', 'le': '0.34', 'lle': '4.48', 'sei': '9.05'}",CHEMBL493359,,CHEMBL493359,7.14,False,http://www.openphacts.org/units/Nanomolar,754322,=,1,True,=,,IC50,nM,,72.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.072
,2419123,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C[C@H]2O[C@H](c3cccs3)C3=C(C(=O)c4ccccc4C3=O)[C@H]2O1,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '20.56', 'le': '0.40', 'lle': '4.36', 'sei': '10.40'}",CHEMBL475401,,CHEMBL475401,7.24,False,http://www.openphacts.org/units/Nanomolar,754248,=,1,True,=,,IC50,nM,,57.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.057
,2419124,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C[C@H]2OCC3=C(C(=O)c4ccccc4C3=O)[C@H]2O1,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '27.22', 'le': '0.50', 'lle': '6.28', 'sei': '10.56'}",CHEMBL475400,,CHEMBL475400,7.36,True,http://www.openphacts.org/units/Nanomolar,754247,=,1,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.044
,2419125,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H]1O[C@H](CC(=O)O)CC2=C1C(=O)c1c(O)cccc1C2=O,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '19.29', 'le': '0.36', 'lle': '3.87', 'sei': '6.32'}",CHEMBL444165,DEOXYFRENOLICIN,CHEMBL444165,6.37,False,http://www.openphacts.org/units/Nanomolar,754246,=,1,True,=,,IC50,nM,,424.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.424
,2419126,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(OC)cccc1C2=O,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '18.41', 'le': '0.34', 'lle': '4.05', 'sei': '7.99'}",CHEMBL474391,,CHEMBL474391,6.30,False,http://www.openphacts.org/units/Nanomolar,754245,=,1,True,=,,IC50,nM,,497.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.497
,2419127,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(O)cccc1C2=O,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '20.42', 'le': '0.38', 'lle': '4.75', 'sei': '7.46'}",CHEMBL474390,FRENOLICIN B,CHEMBL474390,6.70,True,http://www.openphacts.org/units/Nanomolar,754244,=,1,True,=,,IC50,nM,,198.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.198
,2419128,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CC1OC2OC(=O)OC2C2=C1C(=O)c1c(O)cccc1C2=O,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '21.52', 'le': '0.40', 'lle': '5.15', 'sei': '6.56'}",CHEMBL1908343,KALAFUNGIN,CHEMBL1908343,6.50,False,http://www.openphacts.org/units/Nanomolar,753681,=,1,True,=,,IC50,nM,,313.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.313
,2419129,[],CHEMBL1018804,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O,,,CHEMBL1153413,J. Med. Chem.,2009.0,"{'bei': '14.92', 'le': '0.28', 'lle': '5.52', 'sei': '5.57'}",CHEMBL2216825,LACTOQUINOMYCIN,CHEMBL2216825,6.83,True,http://www.openphacts.org/units/Nanomolar,753680,=,1,True,=,,IC50,nM,,149.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.149
,2434917,[],CHEMBL954509,Inhibition of sulfhydryl-labeled human recombinant Akt1 expressed in baculovirus by affinity capillary electrophoresis assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1OC(=O)c2cc(O)c(O)c(O)c21,,,CHEMBL1148981,J. Nat. Prod.,2004.0,"{'bei': '23.99', 'le': '0.46', 'lle': '3.68', 'sei': '5.41'}",CHEMBL486813,,CHEMBL486813,4.71,False,http://www.openphacts.org/units/Nanomolar,715179,=,1,True,=,,IC50,nM,,19700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,19.7
,2434918,[],CHEMBL955241,Inhibition of sulfhydryl-labeled human recombinant Akt1 expressed in baculovirus assessed as phosphorylation of recombinant Bad protein by Western blotting,B,,,BAO_0000190,BAO_0000019,assay format,CC1OC(=O)c2cc(O)c(O)c(O)c21,,,CHEMBL1148981,J. Nat. Prod.,2004.0,"{'bei': '23.03', 'le': '0.44', 'lle': '3.49', 'sei': '5.19'}",CHEMBL486813,,CHEMBL486813,4.52,False,http://www.openphacts.org/units/Nanomolar,715179,=,1,True,=,,IC50,nM,,30400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.4
,2447591,[],CHEMBL947431,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2nc(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)c(-c3ccccc3)cc21,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.61', 'le': '0.28', 'lle': '3.20', 'sei': '8.48'}",CHEMBL446134,,CHEMBL446134,8.46,False,http://www.openphacts.org/units/Nanomolar,719312,=,1,True,=,,IC50,nM,,3.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.5
,2447596,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2nc(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)c(-c3ccccc3)cc21,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.39', 'le': '0.26', 'lle': '2.54', 'sei': '7.82'}",CHEMBL446134,,CHEMBL446134,7.80,False,http://www.openphacts.org/units/Nanomolar,719312,=,1,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
,2447597,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6nc(N7CCN(CCO)CC7)ccc6nc5-c5ccccc5)cc4)CC3)[nH]2)cn1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.39', 'le': '0.19', 'lle': '2.32', 'sei': '4.65'}",CHEMBL447558,,CHEMBL447558,6.94,False,http://www.openphacts.org/units/Nanomolar,719412,=,1,True,=,,IC50,nM,,115.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,115.0
,2447598,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccc(N)nc7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.22', 'le': '0.20', 'lle': '1.90', 'sei': '5.55'}",CHEMBL499961,,CHEMBL499961,7.16,False,http://www.openphacts.org/units/Nanomolar,719411,=,1,True,=,,IC50,nM,,70.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,70.0
,2447599,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ncccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.26', 'le': '0.19', 'lle': '1.98', 'sei': '5.87'}",CHEMBL506827,,CHEMBL506827,6.98,False,http://www.openphacts.org/units/Nanomolar,719410,=,1,True,=,,IC50,nM,,104.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,104.0
,2447600,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,OCCN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ncccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.93', 'le': '0.20', 'lle': '2.71', 'sei': '5.25'}",CHEMBL501612,,CHEMBL501612,7.14,False,http://www.openphacts.org/units/Nanomolar,719409,=,1,True,=,,IC50,nM,,72.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,72.0
,2447601,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ncccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.68', 'le': '0.21', 'lle': '2.21', 'sei': '6.29'}",CHEMBL508098,,CHEMBL508098,7.28,False,http://www.openphacts.org/units/Nanomolar,719408,=,1,True,=,,IC50,nM,,52.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,52.0
,2447602,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.77', 'le': '0.21', 'lle': '2.40', 'sei': '7.54'}",CHEMBL499554,,CHEMBL499554,8.00,False,http://www.openphacts.org/units/Nanomolar,719407,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,2447603,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,OCCN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.08', 'le': '0.22', 'lle': '2.86', 'sei': '6.41'}",CHEMBL449989,,CHEMBL449989,7.89,False,http://www.openphacts.org/units/Nanomolar,719406,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
,2447604,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc3nc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.44', 'le': '0.23', 'lle': '2.07', 'sei': '7.53'}",CHEMBL443620,,CHEMBL443620,7.75,False,http://www.openphacts.org/units/Nanomolar,719405,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,2447605,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7cc[n+]([O-])cc7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.75', 'le': '0.20', 'lle': '2.64', 'sei': '6.23'}",CHEMBL455071,,CHEMBL455071,7.48,False,http://www.openphacts.org/units/Nanomolar,719404,=,1,True,=,,IC50,nM,,33.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,33.0
,2447606,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,[O-][n+]1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6nc(N7CCN(CCO)CC7)ncc6cc5-c5ccccc5)cc4)CC3)[nH]2)cc1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.73', 'le': '0.20', 'lle': '2.90', 'sei': '5.23'}",CHEMBL449200,,CHEMBL449200,7.17,False,http://www.openphacts.org/units/Nanomolar,719403,=,1,True,=,,IC50,nM,,67.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,67.0
,2447607,[],CHEMBL947431,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)[nH]2)cn1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.96', 'le': '0.27', 'lle': '2.69', 'sei': '7.56'}",CHEMBL446966,,CHEMBL446966,8.52,False,http://www.openphacts.org/units/Nanomolar,719318,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,2447608,[],CHEMBL947431,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]ccc2nc(-c3ccc(CN4CCC(c5nnc(-c6cnccn6)[nH]5)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.53', 'le': '0.28', 'lle': '3.19', 'sei': '7.22'}",CHEMBL444136,,CHEMBL444136,8.40,False,http://www.openphacts.org/units/Nanomolar,719317,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,2447609,[],CHEMBL947431,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)[nH]2)cn1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.14', 'le': '0.27', 'lle': '3.00', 'sei': '6.49'}",CHEMBL502393,,CHEMBL502393,8.40,False,http://www.openphacts.org/units/Nanomolar,719316,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,2447610,[],CHEMBL947431,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)[nH]2)c[nH]1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '16.20', 'le': '0.29', 'lle': '3.89', 'sei': '7.29'}",CHEMBL488428,,CHEMBL488428,9.00,False,http://www.openphacts.org/units/Nanomolar,719315,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,2447611,[],CHEMBL947431,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]ccc2nc(-c3ccc(CN4CCC(c5nnc(-c6ncccn6)[nH]5)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.08', 'le': '0.27', 'lle': '2.94', 'sei': '7.01'}",CHEMBL447114,,CHEMBL447114,8.15,False,http://www.openphacts.org/units/Nanomolar,719314,=,1,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
,2447612,[],CHEMBL947431,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.35', 'le': '0.22', 'lle': '2.80', 'sei': '7.92'}",CHEMBL443661,,CHEMBL443661,8.40,True,http://www.openphacts.org/units/Nanomolar,719313,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,2447613,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7cc[n+]([O-])cc7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.05', 'le': '0.20', 'lle': '2.15', 'sei': '6.04'}",CHEMBL507204,,CHEMBL507204,7.06,False,http://www.openphacts.org/units/Nanomolar,719402,=,1,True,=,,IC50,nM,,88.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,88.0
,2447614,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccc(=O)[nH]c7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.29', 'le': '0.19', 'lle': '2.26', 'sei': '5.68'}",CHEMBL503652,,CHEMBL503652,7.16,False,http://www.openphacts.org/units/Nanomolar,719401,=,1,True,=,,IC50,nM,,69.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,69.0
,2447615,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6nc(N7CCN(CCO)CC7)ncc6cc5-c5ccccc5)cc4)CC3)[nH]2)c[nH]1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.31', 'le': '0.19', 'lle': '2.57', 'sei': '4.82'}",CHEMBL502113,,CHEMBL502113,6.90,False,http://www.openphacts.org/units/Nanomolar,719400,=,1,True,=,,IC50,nM,,127.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,127.0
,2447616,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccc(=O)[nH]c7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.19', 'le': '0.20', 'lle': '2.19', 'sei': '5.82'}",CHEMBL450266,,CHEMBL450266,7.15,False,http://www.openphacts.org/units/Nanomolar,719399,=,1,True,=,,IC50,nM,,71.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,71.0
,2447617,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccc(N)nc7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.69', 'le': '0.20', 'lle': '2.25', 'sei': '5.63'}",CHEMBL503270,,CHEMBL503270,7.43,False,http://www.openphacts.org/units/Nanomolar,719398,=,1,True,=,,IC50,nM,,37.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,37.0
,2447618,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6nc(N7CCN(CCO)CC7)ncc6cc5-c5ccccc5)cc4)CC3)[nH]2)cn1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.11', 'le': '0.20', 'lle': '2.80', 'sei': '4.98'}",CHEMBL503810,,CHEMBL503810,7.42,False,http://www.openphacts.org/units/Nanomolar,719397,=,1,True,=,,IC50,nM,,38.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,38.0
,2447619,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccc(N)nc7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.07', 'le': '0.22', 'lle': '2.45', 'sei': '5.97'}",CHEMBL445212,,CHEMBL445212,7.70,False,http://www.openphacts.org/units/Nanomolar,719396,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
,2447620,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ncccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.95', 'le': '0.20', 'lle': '2.46', 'sei': '6.27'}",CHEMBL505848,,CHEMBL505848,7.46,False,http://www.openphacts.org/units/Nanomolar,719395,=,1,True,=,,IC50,nM,,35.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,35.0
,2447621,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,OCCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ncccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.37', 'le': '0.21', 'lle': '3.00', 'sei': '5.47'}",CHEMBL455226,,CHEMBL455226,7.43,False,http://www.openphacts.org/units/Nanomolar,719394,=,1,True,=,,IC50,nM,,37.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,37.0
,2447622,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ncccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.19', 'le': '0.22', 'lle': '2.53', 'sei': '6.57'}",CHEMBL453288,,CHEMBL453288,7.60,False,http://www.openphacts.org/units/Nanomolar,719393,=,1,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
,2447623,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)[nH]2)cn1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.99', 'le': '0.23', 'lle': '1.57', 'sei': '6.57'}",CHEMBL446966,,CHEMBL446966,7.40,False,http://www.openphacts.org/units/Nanomolar,719318,=,1,True,=,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,40.0
,2447624,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]ccc2nc(-c3ccc(CN4CCC(c5nnc(-c6cnccn6)[nH]5)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.61', 'le': '0.25', 'lle': '2.15', 'sei': '6.32'}",CHEMBL444136,,CHEMBL444136,7.36,False,http://www.openphacts.org/units/Nanomolar,719317,=,1,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,44.0
,2447625,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)[nH]2)cn1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.68', 'le': '0.25', 'lle': '2.19', 'sei': '5.86'}",CHEMBL502393,,CHEMBL502393,7.58,False,http://www.openphacts.org/units/Nanomolar,719316,=,1,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.0
,2447626,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)[nH]2)c[nH]1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.97', 'le': '0.23', 'lle': '2.10', 'sei': '5.84'}",CHEMBL488428,,CHEMBL488428,7.21,False,http://www.openphacts.org/units/Nanomolar,719315,=,1,True,=,,IC50,nM,,62.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,62.0
,2447627,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]ccc2nc(-c3ccc(CN4CCC(c5nnc(-c6ncccn6)[nH]5)CC4)cc3)c(-c3ccccc3)cc12,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.13', 'le': '0.25', 'lle': '2.43', 'sei': '6.57'}",CHEMBL447114,,CHEMBL447114,7.64,False,http://www.openphacts.org/units/Nanomolar,719314,=,1,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
,2447628,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.77', 'le': '0.21', 'lle': '2.40', 'sei': '7.54'}",CHEMBL443661,,CHEMBL443661,8.00,True,http://www.openphacts.org/units/Nanomolar,719313,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,2447629,[],CHEMBL947433,Inhibition of Akt1 by cellular assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc3nc(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)c(-c4ccccc4)nc3n2)CC1,,,CHEMBL1157525,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '9.40', 'le': '0.17', 'lle': '0.18', 'sei': '5.69'}",CHEMBL452823,,CHEMBL452823,5.85,False,http://www.openphacts.org/units/Nanomolar,719311,=,1,True,=,,IC50,nM,,1408.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1408.0
,2460251,[],CHEMBL958718,Inhibition of protein kinase B,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]cc1-c1ccccc1,,,CHEMBL1157388,J. Med. Chem.,2008.0,"{'bei': '25.90', 'le': '0.47', 'lle': '1.71', 'sei': '14.28'}",CHEMBL228114,,CHEMBL228114,4.10,False,http://www.openphacts.org/units/Nanomolar,793043,=,1,True,=,,IC50,nM,,80000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,80.0
,2460252,[],CHEMBL958718,Inhibition of protein kinase B,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cn[nH]c2)cc1,,,CHEMBL1157388,J. Med. Chem.,2008.0,"{'bei': '26.84', 'le': '0.48', 'lle': '1.79', 'sei': '13.49'}",CHEMBL390066,,CHEMBL390066,3.87,False,http://www.openphacts.org/units/Nanomolar,793044,=,1,True,=,,IC50,nM,,135000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,135.0
,2461661,[],CHEMBL966174,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(O)cc2oc(=O)c3c(O)cc(O)cc3c12,,,CHEMBL1157406,J. Nat. Prod.,2008.0,,CHEMBL519982,ALTERNARIOL,CHEMBL519982,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,794454,>,1,True,>,,IC50,ug.mL-1,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-5g/ml,UO_0000274,,1.0
,2461686,[],CHEMBL966174,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C[C@H](O)[C@@H]2c3c(ccc(O)c31)-c1ccc(O)c3c1[C@@]2(O)CCC3=O,,,CHEMBL1157406,J. Nat. Prod.,2008.0,,CHEMBL521470,ALTERTOXIN I,CHEMBL521470,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,794543,>,1,True,>,,IC50,ug.mL-1,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-5g/ml,UO_0000274,,1.0
,2461687,[],CHEMBL966174,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(O)c(C(=O)O)c(C2=C(C)C[C@@H](O)C2=O)c1,,,CHEMBL1157406,J. Nat. Prod.,2008.0,,CHEMBL519395,ALTERNARIENONIC ACID,CHEMBL519395,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,793091,>,1,True,>,,IC50,ug.mL-1,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-5g/ml,UO_0000274,,1.0
,2461688,[],CHEMBL966174,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(O)c2c(c1)C1(OC2=O)C(C)=CC(=O)C1O,,,CHEMBL1157406,J. Nat. Prod.,2008.0,,CHEMBL408995,TALAROFLAVONE,CHEMBL408995,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,793090,>,1,True,>,,IC50,ug.mL-1,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-5g/ml,UO_0000274,,1.0
,2461689,[],CHEMBL966174,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(O)c2c(c1)-c1cc(O)c(O)cc1COC2=O,,,CHEMBL1157406,J. Nat. Prod.,2008.0,,CHEMBL507058,ALTERLACTONE,CHEMBL507058,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,794542,>,1,True,>,,IC50,ug.mL-1,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-5g/ml,UO_0000274,,1.0
,2461690,[],CHEMBL966174,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(O)c(O)cc1-c1cc(O)cc(O)c1C(=O)O,,,CHEMBL1157406,J. Nat. Prod.,2008.0,,CHEMBL483532,DESMETHYLALTENUSIN,CHEMBL483532,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,794541,>,1,True,>,,IC50,ug.mL-1,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-5g/ml,UO_0000274,,1.0
,2461691,[],CHEMBL966174,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(O)c(C(=O)O)c(-c2cc(O)c(O)cc2C)c1,,,CHEMBL1157406,J. Nat. Prod.,2008.0,,CHEMBL483531,ALTENUSIN,CHEMBL483531,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,794540,>,1,True,>,,IC50,ug.mL-1,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-5g/ml,UO_0000274,,1.0
,2461692,[],CHEMBL966174,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(O)cc2oc(=O)c3c(O)cc(OS(=O)(=O)O)cc3c12,,,CHEMBL1157406,J. Nat. Prod.,2008.0,,CHEMBL483525,,CHEMBL483525,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,794455,>,1,True,>,,IC50,ug.mL-1,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-5g/ml,UO_0000274,,1.0
,2461768,[],CHEMBL966174,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(O)c2c(=O)oc3cc(O)cc(C)c3c2c1,,,CHEMBL1157406,J. Nat. Prod.,2008.0,,CHEMBL483526,,CHEMBL483526,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,794456,=,1,True,=,,IC50,ug.mL-1,,7.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-6g/ml,UO_0000274,,7.9
,2461769,[],CHEMBL966174,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(O)c2c(=O)oc3c(O)c(O)cc(C)c3c2c1,,,CHEMBL1157406,J. Nat. Prod.,2008.0,,CHEMBL520144,,CHEMBL520144,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,794458,=,1,True,=,,IC50,ug.mL-1,,5.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-6g/ml,UO_0000274,,5.3
,2465573,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.85', 'le': '0.27', 'lle': '2.26', 'sei': '7.58'}",CHEMBL252857,,CHEMBL252857,8.22,True,http://www.openphacts.org/units/Nanomolar,720401,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,2465575,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.91', 'le': '0.25', 'lle': '1.74', 'sei': '7.10'}",CHEMBL252857,,CHEMBL252857,7.70,True,http://www.openphacts.org/units/Nanomolar,720401,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
,2465577,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2cc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3cn2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '9.86', 'le': '0.18', 'lle': '-0.15', 'sei': '6.81'}",CHEMBL448196,,CHEMBL448196,6.13,False,http://www.openphacts.org/units/Nanomolar,720325,=,1,True,=,,IC50,nM,,740.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,740.0
,2465578,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2nccc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc23)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '9.88', 'le': '0.18', 'lle': '-0.14', 'sei': '6.83'}",CHEMBL443633,,CHEMBL443633,6.14,False,http://www.openphacts.org/units/Nanomolar,720324,=,1,True,=,,IC50,nM,,720.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,720.0
,2465579,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2nccc3nc(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)c(-c4ccccc4)cc23)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.53', 'le': '0.19', 'lle': '0.27', 'sei': '7.28'}",CHEMBL506434,,CHEMBL506434,6.54,False,http://www.openphacts.org/units/Nanomolar,720323,=,1,True,=,,IC50,nM,,285.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,285.0
,2465580,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CC(N2CCN(c3ncc4cc(-c5ccccc5)c(-c5ccc(CN6CCC(c7nnc(-c8ccccn8)[nH]7)CC6)cc5)nc4n3)CC2)C1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.69', 'le': '0.21', 'lle': '2.57', 'sei': '7.47'}",CHEMBL448991,,CHEMBL448991,7.92,False,http://www.openphacts.org/units/Nanomolar,720322,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,2465581,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.35', 'le': '0.22', 'lle': '2.80', 'sei': '7.92'}",CHEMBL443661,,CHEMBL443661,8.40,False,http://www.openphacts.org/units/Nanomolar,720321,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,2465582,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,OCCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.32', 'le': '0.22', 'lle': '3.02', 'sei': '6.54'}",CHEMBL453995,,CHEMBL453995,8.05,False,http://www.openphacts.org/units/Nanomolar,720320,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
,2465583,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc3cnc(N4CCn5cnnc5C4)nc3nc2-c2ccc(CN3CCC(c4nnc(-c5ccccn5)[nH]4)CC3)cc2)cc1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.94', 'le': '0.22', 'lle': '2.19', 'sei': '5.92'}",CHEMBL447044,,CHEMBL447044,7.72,False,http://www.openphacts.org/units/Nanomolar,720319,=,1,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.0
,2465584,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC(=O)N1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.85', 'le': '0.22', 'lle': '3.09', 'sei': '6.68'}",CHEMBL447168,,CHEMBL447168,8.22,False,http://www.openphacts.org/units/Nanomolar,720318,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,2465585,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)N1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.39', 'le': '0.21', 'lle': '2.02', 'sei': '6.29'}",CHEMBL447348,,CHEMBL447348,7.75,False,http://www.openphacts.org/units/Nanomolar,720317,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,2465586,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.87', 'le': '0.22', 'lle': '3.15', 'sei': '5.95'}",CHEMBL502426,,CHEMBL502426,8.15,False,http://www.openphacts.org/units/Nanomolar,720316,=,1,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
,2465587,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.76', 'le': '0.23', 'lle': '2.71', 'sei': '6.92'}",CHEMBL453586,,CHEMBL453586,8.30,False,http://www.openphacts.org/units/Nanomolar,720315,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,2465588,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc3cnc(-n4ccnc4)nc3nc2-c2ccc(CN3CCC(c4nnc(-c5ccccn5)[nH]4)CC3)cc2)cc1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.05', 'le': '0.25', 'lle': '2.20', 'sei': '7.27'}",CHEMBL448926,,CHEMBL448926,8.30,False,http://www.openphacts.org/units/Nanomolar,720314,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,2465589,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.29', 'le': '0.22', 'lle': '1.55', 'sei': '7.78'}",CHEMBL454859,,CHEMBL454859,8.00,False,http://www.openphacts.org/units/Nanomolar,720313,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,2465590,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O[C@@H]1CN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CCN1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.17', 'le': '0.22', 'lle': '2.95', 'sei': '5.76'}",CHEMBL499683,,CHEMBL499683,7.60,False,http://www.openphacts.org/units/Nanomolar,720312,=,1,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
,2465591,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.63', 'le': '0.21', 'lle': '1.21', 'sei': '6.36'}",CHEMBL505758,,CHEMBL505758,7.10,False,http://www.openphacts.org/units/Nanomolar,720311,=,1,True,=,,IC50,nM,,79.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,79.0
,2465592,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)[C@H](C)CN1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.57', 'le': '0.21', 'lle': '1.26', 'sei': '6.60'}",CHEMBL454210,,CHEMBL454210,7.37,False,http://www.openphacts.org/units/Nanomolar,720310,=,1,True,=,,IC50,nM,,43.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,43.0
,2465593,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.92', 'le': '0.23', 'lle': '2.38', 'sei': '7.82'}",CHEMBL504251,,CHEMBL504251,8.05,False,http://www.openphacts.org/units/Nanomolar,720309,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
,2465594,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CCN1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.48', 'le': '0.23', 'lle': '2.05', 'sei': '6.96'}",CHEMBL508754,,CHEMBL508754,7.77,False,http://www.openphacts.org/units/Nanomolar,720308,=,1,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.0
,2465595,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CCN1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.00', 'le': '0.24', 'lle': '2.38', 'sei': '7.25'}",CHEMBL503980,,CHEMBL503980,8.10,False,http://www.openphacts.org/units/Nanomolar,720307,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
,2465596,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)C[C@@H](C)N1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.54', 'le': '0.21', 'lle': '1.24', 'sei': '6.58'}",CHEMBL450545,,CHEMBL450545,7.35,False,http://www.openphacts.org/units/Nanomolar,720306,=,1,True,=,,IC50,nM,,45.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,45.0
,2465597,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S1(=O)CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.28', 'le': '0.21', 'lle': '2.27', 'sei': '5.55'}",CHEMBL450772,,CHEMBL450772,7.42,False,http://www.openphacts.org/units/Nanomolar,720305,=,1,True,=,,IC50,nM,,38.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,38.0
,2465598,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)C[C@@H](C)O1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.84', 'le': '0.21', 'lle': '1.02', 'sei': '6.94'}",CHEMBL448826,,CHEMBL448826,7.55,False,http://www.openphacts.org/units/Nanomolar,720304,=,1,True,=,,IC50,nM,,28.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,28.0
,2465599,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,OC1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.07', 'le': '0.24', 'lle': '2.27', 'sei': '6.80'}",CHEMBL500993,,CHEMBL500993,8.15,False,http://www.openphacts.org/units/Nanomolar,720303,=,1,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
,2465600,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc3cnc(N4CCOCC4)nc3nc2-c2ccc(CN3CCC(c4nnc(-c5ccccn5)[nH]4)CC3)cc2)cc1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.61', 'le': '0.25', 'lle': '2.54', 'sei': '7.63'}",CHEMBL488654,,CHEMBL488654,8.30,False,http://www.openphacts.org/units/Nanomolar,720302,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,2465601,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc3cnc(N4CCCCC4)nc3nc2-c2ccc(CN3CCC(c4nnc(-c5ccccn5)[nH]4)CC3)cc2)cc1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.74', 'le': '0.23', 'lle': '0.83', 'sei': '7.78'}",CHEMBL442718,,CHEMBL442718,7.75,False,http://www.openphacts.org/units/Nanomolar,720301,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,2465602,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,FC1(F)CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)C1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.23', 'le': '0.22', 'lle': '0.94', 'sei': '7.73'}",CHEMBL451961,,CHEMBL451961,7.70,False,http://www.openphacts.org/units/Nanomolar,720300,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
,2465603,[],CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CNCCC(=O)c4ccccc4N)cc3)nc2n1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.47', 'le': '0.29', 'lle': '1.79', 'sei': '8.34'}",CHEMBL252456,,CHEMBL252456,7.82,True,http://www.openphacts.org/units/Nanomolar,720299,=,1,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
,2465631,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(c2cc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3cn2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '9.70', 'le': '0.18', 'lle': '-0.25', 'sei': '6.71'}",CHEMBL448196,,CHEMBL448196,6.03,False,http://www.openphacts.org/units/Nanomolar,720325,=,1,True,=,,IC50,nM,,924.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,924.0
,2465634,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CC(N2CCN(c3ncc4cc(-c5ccccc5)c(-c5ccc(CN6CCC(c7nnc(-c8ccccn8)[nH]7)CC6)cc5)nc4n3)CC2)C1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.13', 'le': '0.22', 'lle': '2.87', 'sei': '7.75'}",CHEMBL448991,,CHEMBL448991,8.22,False,http://www.openphacts.org/units/Nanomolar,720322,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,2465635,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.77', 'le': '0.21', 'lle': '2.40', 'sei': '7.54'}",CHEMBL443661,,CHEMBL443661,8.00,False,http://www.openphacts.org/units/Nanomolar,720321,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,2465636,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,OCCN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.90', 'le': '0.22', 'lle': '2.74', 'sei': '6.31'}",CHEMBL453995,,CHEMBL453995,7.77,False,http://www.openphacts.org/units/Nanomolar,720320,=,1,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.0
,2465637,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc3cnc(N4CCn5cnnc5C4)nc3nc2-c2ccc(CN3CCC(c4nnc(-c5ccccn5)[nH]4)CC3)cc2)cc1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.67', 'le': '0.19', 'lle': '1.37', 'sei': '5.30'}",CHEMBL447044,,CHEMBL447044,6.90,False,http://www.openphacts.org/units/Nanomolar,720319,=,1,True,=,,IC50,nM,,125.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,125.0
,2465638,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CC(=O)N1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.28', 'le': '0.22', 'lle': '3.39', 'sei': '6.92'}",CHEMBL447168,,CHEMBL447168,8.52,False,http://www.openphacts.org/units/Nanomolar,720318,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,2465639,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=O)N1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.60', 'le': '0.21', 'lle': '2.17', 'sei': '6.40'}",CHEMBL447348,,CHEMBL447348,7.89,False,http://www.openphacts.org/units/Nanomolar,720317,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
,2465640,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.21', 'le': '0.21', 'lle': '2.70', 'sei': '5.62'}",CHEMBL502426,,CHEMBL502426,7.70,False,http://www.openphacts.org/units/Nanomolar,720316,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
,2465641,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.02', 'le': '0.22', 'lle': '2.23', 'sei': '6.52'}",CHEMBL453586,,CHEMBL453586,7.82,False,http://www.openphacts.org/units/Nanomolar,720315,=,1,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
,2465642,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc3cnc(-n4ccnc4)nc3nc2-c2ccc(CN3CCC(c4nnc(-c5ccccn5)[nH]4)CC3)cc2)cc1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.62', 'le': '0.23', 'lle': '1.36', 'sei': '6.53'}",CHEMBL448926,,CHEMBL448926,7.46,False,http://www.openphacts.org/units/Nanomolar,720314,=,1,True,=,,IC50,nM,,35.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,35.0
,2465643,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.74', 'le': '0.21', 'lle': '1.19', 'sei': '7.43'}",CHEMBL454859,,CHEMBL454859,7.64,False,http://www.openphacts.org/units/Nanomolar,720313,=,1,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
,2465644,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O[C@@H]1CN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CCN1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.55', 'le': '0.21', 'lle': '2.56', 'sei': '5.47'}",CHEMBL499683,,CHEMBL499683,7.21,False,http://www.openphacts.org/units/Nanomolar,720312,=,1,True,=,,IC50,nM,,61.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,61.0
,2465645,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CCNc1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.94', 'le': '0.20', 'lle': '0.79', 'sei': '5.99'}",CHEMBL505758,,CHEMBL505758,6.68,False,http://www.openphacts.org/units/Nanomolar,720311,=,1,True,=,,IC50,nM,,208.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,208.0
,2465646,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1CN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)[C@H](C)CN1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '10.54', 'le': '0.19', 'lle': '0.60', 'sei': '6.01'}",CHEMBL454210,,CHEMBL454210,6.71,False,http://www.openphacts.org/units/Nanomolar,720310,=,1,True,=,,IC50,nM,,194.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,194.0
,2465647,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.95', 'le': '0.22', 'lle': '1.77', 'sei': '7.24'}",CHEMBL504251,,CHEMBL504251,7.44,False,http://www.openphacts.org/units/Nanomolar,720309,=,1,True,=,,IC50,nM,,36.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,36.0
,2465648,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1CN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CCN1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.44', 'le': '0.21', 'lle': '1.40', 'sei': '6.38'}",CHEMBL508754,,CHEMBL508754,7.12,False,http://www.openphacts.org/units/Nanomolar,720308,=,1,True,=,,IC50,nM,,75.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,75.0
,2465649,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CCN1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.95', 'le': '0.22', 'lle': '1.72', 'sei': '6.67'}",CHEMBL503980,,CHEMBL503980,7.44,False,http://www.openphacts.org/units/Nanomolar,720307,=,1,True,=,,IC50,nM,,36.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,36.0
,2465650,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1CN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)C[C@@H](C)N1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.52', 'le': '0.21', 'lle': '1.23', 'sei': '6.57'}",CHEMBL450545,,CHEMBL450545,7.34,False,http://www.openphacts.org/units/Nanomolar,720306,=,1,True,=,,IC50,nM,,46.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,46.0
,2465652,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1CN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)C[C@@H](C)O1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.57', 'le': '0.21', 'lle': '0.85', 'sei': '6.78'}",CHEMBL448826,,CHEMBL448826,7.38,False,http://www.openphacts.org/units/Nanomolar,720304,=,1,True,=,,IC50,nM,,42.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.0
,2465653,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,OC1CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)CC1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.46', 'le': '0.23', 'lle': '1.89', 'sei': '6.48'}",CHEMBL500993,,CHEMBL500993,7.77,False,http://www.openphacts.org/units/Nanomolar,720303,=,1,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.0
,2465654,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc3cnc(N4CCOCC4)nc3nc2-c2ccc(CN3CCC(c4nnc(-c5ccccn5)[nH]4)CC3)cc2)cc1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.66', 'le': '0.23', 'lle': '1.96', 'sei': '7.09'}",CHEMBL488654,,CHEMBL488654,7.72,False,http://www.openphacts.org/units/Nanomolar,720302,=,1,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.0
,2465655,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc3cnc(N4CCCCC4)nc3nc2-c2ccc(CN3CCC(c4nnc(-c5ccccn5)[nH]4)CC3)cc2)cc1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '12.25', 'le': '0.22', 'lle': '0.53', 'sei': '7.47'}",CHEMBL442718,,CHEMBL442718,7.44,False,http://www.openphacts.org/units/Nanomolar,720301,=,1,True,=,,IC50,nM,,36.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,36.0
,2465656,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCN(c2ncc3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6nnc(-c7ccccn7)[nH]6)CC5)cc4)nc3n2)C1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '11.31', 'le': '0.21', 'lle': '0.36', 'sei': '7.15'}",CHEMBL451961,,CHEMBL451961,7.12,False,http://www.openphacts.org/units/Nanomolar,720300,=,1,True,=,,IC50,nM,,75.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,75.0
,2465657,[],CHEMBL951579,Inhibition of Akt1 phosphorylation in human by C33a cells by IPKA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1ncc2cc(-c3ccccc3)c(-c3ccc(CNCCC(=O)c4ccccc4N)cc3)nc2n1,,,CHEMBL1157492,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '14.06', 'le': '0.26', 'lle': '1.08', 'sei': '7.58'}",CHEMBL252456,,CHEMBL252456,7.11,False,http://www.openphacts.org/units/Nanomolar,720299,=,1,True,=,,IC50,nM,,78.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,78.0
,2467260,[],CHEMBL991663,Inhibition of AKT in presence of 20 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1,,,CHEMBL1142456,Bioorg. Med. Chem.,2008.0,,CHEMBL489058,,CHEMBL489058,,False,http://www.openphacts.org/units/Nanomolar,801296,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,2469941,[],CHEMBL1030560,Inhibition of AKT1 after 55 mins,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc(-c2ccncc2)cs1)C1COc2ccccc2O1,,,CHEMBL1142492,J. Med. Chem.,2008.0,,CHEMBL510515,,CHEMBL510515,,False,http://www.openphacts.org/units/Nanomolar,801781,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,2469942,[],CHEMBL1030560,Inhibition of AKT1 after 55 mins,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2ccncc2)cc1)C1COc2ccccc2O1,,,CHEMBL1142492,J. Med. Chem.,2008.0,"{'bei': '15.62', 'le': '0.28', 'lle': '1.66', 'sei': '8.59'}",CHEMBL485213,,CHEMBL485213,5.19,False,http://www.openphacts.org/units/Nanomolar,801782,=,1,True,=,,IC50,nM,,6436.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,6.436
,2469943,[],CHEMBL1030560,Inhibition of AKT1 after 55 mins,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2c[nH]cn2)cc1)C1COc2ccccc2O1,,,CHEMBL1142492,J. Med. Chem.,2008.0,"{'bei': '18.21', 'le': '0.33', 'lle': '2.99', 'sei': '7.67'}",CHEMBL485214,,CHEMBL485214,5.85,False,http://www.openphacts.org/units/Nanomolar,801783,=,1,True,=,,IC50,nM,,1410.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.41
,2469944,[],CHEMBL1030560,Inhibition of AKT1 after 55 mins,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1,,,CHEMBL1142492,J. Med. Chem.,2008.0,"{'bei': '14.39', 'le': '0.27', 'lle': '2.19', 'sei': '5.91'}",CHEMBL485215,,CHEMBL485215,5.05,False,http://www.openphacts.org/units/Nanomolar,801784,=,1,True,=,,IC50,nM,,8819.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,8.819
,2469945,[],CHEMBL1030560,Inhibition of AKT1 after 55 mins,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1,,,CHEMBL1142492,J. Med. Chem.,2008.0,"{'bei': '12.55', 'le': '0.23', 'lle': '2.33', 'sei': '5.78'}",CHEMBL521179,SR-3677,CHEMBL521179,5.12,False,http://www.openphacts.org/units/Nanomolar,801785,=,1,True,=,,IC50,nM,,7491.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,7.491
,2504336,[],CHEMBL939833,Inhibition of Akt1 by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(n6cnc(-c7ccccn7)c6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '13.39', 'le': '0.24', 'lle': '1.45', 'sei': '7.51'}",CHEMBL508794,,CHEMBL508794,7.74,False,http://www.openphacts.org/units/Nanomolar,753356,=,1,True,=,,IC50,nM,,18.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.3
,2504337,[],CHEMBL939833,Inhibition of Akt1 by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,OCCNCc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '11.59', 'le': '0.21', 'lle': '2.13', 'sei': '5.55'}",CHEMBL442919,,CHEMBL442919,7.38,False,http://www.openphacts.org/units/Nanomolar,753355,=,1,True,=,,IC50,nM,,41.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,41.8
,2504338,[],CHEMBL939833,Inhibition of Akt1 by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(Cc2nnc3c4cc(-c5ccccc5)c(-c5ccc(CN6CCC(c7n[nH]c(-c8ccccn8)n7)CC6)cc5)nc4ccn23)CC1,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '10.66', 'le': '0.19', 'lle': '1.28', 'sei': '6.72'}",CHEMBL446779,,CHEMBL446779,7.20,False,http://www.openphacts.org/units/Nanomolar,753354,=,1,True,=,,IC50,nM,,62.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,62.5
,2504339,[],CHEMBL939833,Inhibition of Akt1 by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,ClCc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '11.35', 'le': '0.21', 'lle': '0.04', 'sei': '6.89'}",CHEMBL508861,,CHEMBL508861,6.95,False,http://www.openphacts.org/units/Nanomolar,753353,=,1,True,=,,IC50,nM,,113.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,113.5
,2504340,[],CHEMBL939833,Inhibition of Akt1 by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '13.17', 'le': '0.24', 'lle': '1.13', 'sei': '7.55'}",CHEMBL445464,,CHEMBL445464,7.61,False,http://www.openphacts.org/units/Nanomolar,753352,=,1,True,=,,IC50,nM,,24.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.6
,2504341,[],CHEMBL939833,Inhibition of Akt1 by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc3c(ccn4cnnc34)nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '14.73', 'le': '0.26', 'lle': '2.13', 'sei': '8.24'}",CHEMBL447328,,CHEMBL447328,8.30,False,http://www.openphacts.org/units/Nanomolar,753351,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,2504342,[],CHEMBL939833,Inhibition of Akt1 by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)Nc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '10.58', 'le': '0.19', 'lle': '0.92', 'sei': '4.22'}",CHEMBL509747,,CHEMBL509747,6.58,False,http://www.openphacts.org/units/Nanomolar,753350,=,1,True,=,,IC50,nM,,265.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,265.5
,2504343,[],CHEMBL939833,Inhibition of Akt1 by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Sc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '13.04', 'le': '0.24', 'lle': '1.31', 'sei': '7.71'}",CHEMBL502854,,CHEMBL502854,7.77,False,http://www.openphacts.org/units/Nanomolar,753349,=,1,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.0
,2504344,[],CHEMBL939833,Inhibition of Akt1 by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Oc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '13.06', 'le': '0.23', 'lle': '1.69', 'sei': '6.25'}",CHEMBL506077,,CHEMBL506077,7.57,False,http://www.openphacts.org/units/Nanomolar,753348,=,1,True,=,,IC50,nM,,27.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,27.0
,2504345,[],CHEMBL939833,Inhibition of Akt1 by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '13.38', 'le': '0.24', 'lle': '1.99', 'sei': '6.11'}",CHEMBL499555,,CHEMBL499555,7.74,False,http://www.openphacts.org/units/Nanomolar,753347,=,1,True,=,,IC50,nM,,18.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.1
,2504356,[],CHEMBL939831,Inhibition of human cloned Akt1 expressed in Drosophila S2 cells by HTRF assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(n6cnc(-c7ccccn7)c6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '14.68', 'le': '0.26', 'lle': '2.19', 'sei': '8.23'}",CHEMBL508794,,CHEMBL508794,8.48,False,http://www.openphacts.org/units/Nanomolar,753356,=,1,True,=,,IC50,nM,,3.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.3
,2504357,[],CHEMBL939831,Inhibition of human cloned Akt1 expressed in Drosophila S2 cells by HTRF assay,B,,,BAO_0000190,BAO_0000219,cell-based format,OCCNCc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '12.20', 'le': '0.22', 'lle': '2.52', 'sei': '5.84'}",CHEMBL442919,,CHEMBL442919,7.77,False,http://www.openphacts.org/units/Nanomolar,753355,=,1,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.0
,2504358,[],CHEMBL939831,Inhibition of human cloned Akt1 expressed in Drosophila S2 cells by HTRF assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(Cc2nnc3c4cc(-c5ccccc5)c(-c5ccc(CN6CCC(c7n[nH]c(-c8ccccn8)n7)CC6)cc5)nc4ccn23)CC1,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '11.84', 'le': '0.21', 'lle': '2.08', 'sei': '7.46'}",CHEMBL446779,,CHEMBL446779,8.00,False,http://www.openphacts.org/units/Nanomolar,753354,=,1,True,=,,IC50,nM,,9.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.9
,2504359,[],CHEMBL939831,Inhibition of human cloned Akt1 expressed in Drosophila S2 cells by HTRF assay,B,,,BAO_0000190,BAO_0000219,cell-based format,ClCc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '12.37', 'le': '0.23', 'lle': '0.66', 'sei': '7.51'}",CHEMBL508861,,CHEMBL508861,7.57,False,http://www.openphacts.org/units/Nanomolar,753353,=,1,True,=,,IC50,nM,,26.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.7
,2504360,[],CHEMBL939831,Inhibition of human cloned Akt1 expressed in Drosophila S2 cells by HTRF assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '14.43', 'le': '0.26', 'lle': '1.86', 'sei': '8.27'}",CHEMBL445464,,CHEMBL445464,8.34,False,http://www.openphacts.org/units/Nanomolar,753352,=,1,True,=,,IC50,nM,,4.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.6
,2504361,[],CHEMBL939831,Inhibition of human cloned Akt1 expressed in Drosophila S2 cells by HTRF assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cc3c(ccn4cnnc34)nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '14.90', 'le': '0.27', 'lle': '2.23', 'sei': '8.33'}",CHEMBL447328,,CHEMBL447328,8.40,True,http://www.openphacts.org/units/Nanomolar,753351,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,2504362,[],CHEMBL939831,Inhibition of human cloned Akt1 expressed in Drosophila S2 cells by HTRF assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)Nc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '12.98', 'le': '0.23', 'lle': '2.41', 'sei': '5.18'}",CHEMBL509747,,CHEMBL509747,8.07,False,http://www.openphacts.org/units/Nanomolar,753350,=,1,True,=,,IC50,nM,,8.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.5
,2504363,[],CHEMBL939831,Inhibition of human cloned Akt1 expressed in Drosophila S2 cells by HTRF assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Sc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '13.43', 'le': '0.25', 'lle': '1.54', 'sei': '7.94'}",CHEMBL502854,,CHEMBL502854,8.00,False,http://www.openphacts.org/units/Nanomolar,753349,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,2504364,[],CHEMBL939831,Inhibition of human cloned Akt1 expressed in Drosophila S2 cells by HTRF assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Oc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '14.81', 'le': '0.27', 'lle': '2.71', 'sei': '7.09'}",CHEMBL506077,,CHEMBL506077,8.59,False,http://www.openphacts.org/units/Nanomolar,753348,=,1,True,=,,IC50,nM,,2.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.6
,2504365,[],CHEMBL939831,Inhibition of human cloned Akt1 expressed in Drosophila S2 cells by HTRF assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CN5CCC(c6n[nH]c(-c7ccccn7)n6)CC5)cc4)nc3ccn12,,,CHEMBL1141029,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '14.78', 'le': '0.27', 'lle': '2.80', 'sei': '6.75'}",CHEMBL499555,,CHEMBL499555,8.55,False,http://www.openphacts.org/units/Nanomolar,753347,=,1,True,=,,IC50,nM,,2.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.8
,2505359,[],CHEMBL942700,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2C1,,,CHEMBL1141010,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL474425,,CHEMBL474425,,False,http://www.openphacts.org/units/Nanomolar,752561,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20000.0
,2505363,[],CHEMBL942700,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccc(F)cc2C1,,,CHEMBL1141010,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL481545,,CHEMBL481545,,False,http://www.openphacts.org/units/Nanomolar,752830,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20000.0
,2505364,[],CHEMBL942700,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(c1)CC(C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCN(C)C)CO2,,,CHEMBL1141010,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL482336,,CHEMBL482336,,False,http://www.openphacts.org/units/Nanomolar,752750,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20000.0
,2511563,[],CHEMBL972522,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL1138507,J. Med. Chem.,2009.0,"{'bei': '17.62', 'le': '0.32', 'lle': '3.87', 'sei': '11.84'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.22,True,http://www.openphacts.org/units/Nanomolar,735412,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.006
,2527202,[],CHEMBL984183,Inhibition of PKBalpha/Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O,,,CHEMBL1138470,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '8.41', 'le': '0.16', 'lle': '-0.87', 'sei': '4.26'}",CHEMBL451523,,CHEMBL451523,5.19,False,http://www.openphacts.org/units/Nanomolar,808617,=,1,True,=,,IC50,nM,,6400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,6.4
,2528124,[],CHEMBL985019,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,NCc1ccc(-c2cc3ccncc3cc2OC2CCNCC2)cc1,,,CHEMBL1138455,J. Med. Chem.,2009.0,,CHEMBL484967,,CHEMBL484967,,False,http://www.openphacts.org/units/Nanomolar,808835,<,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,5.0
,2528125,[],CHEMBL985019,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc3ccncc3cc2OC2CCNCC2)cc1,,,CHEMBL1138455,J. Med. Chem.,2009.0,,CHEMBL484968,,CHEMBL484968,,False,http://www.openphacts.org/units/Nanomolar,808836,<,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,5.0
,2528126,[],CHEMBL985019,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OC2CCNCC2)cc1,,,CHEMBL1138455,J. Med. Chem.,2009.0,"{'bei': '13.82', 'le': '0.27', 'lle': '2.62', 'sei': '5.62'}",CHEMBL519693,,CHEMBL519693,5.30,False,http://www.openphacts.org/units/Nanomolar,808832,=,1,True,=,,IC50,nM,,5011.87,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,5.3
,2582016,[],CHEMBL961569,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N)SCCCn1c(=O)c2n3ccc4cccc(c43)c3cc4ccccc4n3c=2c1=O,,,CHEMBL1151764,J. Med. Chem.,2008.0,"{'bei': '11.43', 'le': '0.22', 'lle': '1.85', 'sei': '5.16'}",CHEMBL489083,,CHEMBL489083,5.05,False,http://www.openphacts.org/units/Nanomolar,726267,=,1,True,=,,IC50,nM,,9000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,9.0
,2584890,[],CHEMBL956581,Inhibition of PKB,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccc(CN5CCOCC5)cc4)c3)cc12,,,CHEMBL1152141,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL461139,,CHEMBL461139,,False,http://www.openphacts.org/units/Nanomolar,724585,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,2584918,[],CHEMBL956581,Inhibition of PKB,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCOc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1,,,CHEMBL1152141,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL461140,,CHEMBL461140,,False,http://www.openphacts.org/units/Nanomolar,724586,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,2586392,[],CHEMBL1009214,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(c1)CC(c1nc3c(F)cc(-c4ccnc(N)n4)cc3[nH]1)CO2,,,CHEMBL1152196,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '13.54', 'le': '0.25', 'lle': '1.83', 'sei': '5.36'}",CHEMBL452598,,CHEMBL452598,5.30,False,http://www.openphacts.org/units/Nanomolar,725430,=,1,True,=,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5000.0
,2600117,[],CHEMBL1025728,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(cc1Nc1nc(Nc3cccc4c3C(=O)NC4)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2,,,CHEMBL1154545,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '16.78', 'le': '0.31', 'lle': '5.45', 'sei': '6.75'}",CHEMBL517163,,CHEMBL517163,8.60,False,http://www.openphacts.org/units/Nanomolar,777568,=,1,True,=,,IC50,nM,,2.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.5
,2609572,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccccc2)C(C)C)cc1C,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '4.32', 'le': '0.08', 'lle': '3.94', 'sei': '1.24'}",CHEMBL505490,,CHEMBL505490,4.30,False,http://www.openphacts.org/units/Nanomolar,805417,=,1,True,=,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,2609573,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccccc2)C(C)C)cc1-c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152730,Bioorg. Med. Chem.,2009.0,,CHEMBL486269,,CHEMBL486269,,False,http://www.openphacts.org/units/Nanomolar,805418,>,1,True,>,,IC50,nM,,500000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,500.0
,2609574,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccccc2)C(C)C)c(-c2ccccc2)c1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '4.54', 'le': None, 'lle': None, 'sei': None}",CHEMBL449564,,CHEMBL449564,4.80,False,http://www.openphacts.org/units/Nanomolar,805419,=,1,True,=,,IC50,nM,,16000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,16.0
,2609575,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccccc2)C(C)C)c(-c2cccc3ccccc23)c1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '3.71', 'le': None, 'lle': None, 'sei': None}",CHEMBL507059,,CHEMBL507059,4.11,False,http://www.openphacts.org/units/Nanomolar,805420,=,1,True,=,,IC50,nM,,78000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,78.0
,2609576,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccccc2)C(C)C)cc1-c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152730,Bioorg. Med. Chem.,2009.0,,CHEMBL444220,,CHEMBL444220,,False,http://www.openphacts.org/units/Nanomolar,805421,=,1,True,=,,IC50,nM,,288000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,288.0
,2609577,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccccc2)C(C)C)c(-c2ccccc2)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152730,Bioorg. Med. Chem.,2009.0,,CHEMBL505303,,CHEMBL505303,,False,http://www.openphacts.org/units/Nanomolar,805422,=,1,True,=,,IC50,nM,,173000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,173.0
,2609578,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N)NCCNc1ccc(C(=O)Nc2ccc(N(Cc3ccccc3)Cc3ccccc3)cc2)cc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '8.16', 'le': '0.15', 'lle': '-1.02', 'sei': '3.78'}",CHEMBL513216,,CHEMBL513216,4.02,False,http://www.openphacts.org/units/Nanomolar,805423,=,1,True,=,,IC50,nM,,96000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,96.0
,2609579,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N)NCCNc1ccc(C(=O)Nc2ccc(N(Cc3ccccc3)Cc3ccccc3)cc2)cc1-c1ccccc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '7.17', 'le': '0.13', 'lle': '-2.63', 'sei': '3.84'}",CHEMBL444649,,CHEMBL444649,4.08,False,http://www.openphacts.org/units/Nanomolar,805424,=,1,True,=,,IC50,nM,,84000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,84.0
,2609580,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CN(Cc2ccc(C)cc2)c2ccc(NC(=O)c3ccc(NCCNC(=N)N)c(-c4ccccc4)c3)cc2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152730,Bioorg. Med. Chem.,2009.0,,CHEMBL446065,,CHEMBL446065,,False,http://www.openphacts.org/units/Nanomolar,805425,=,1,True,=,,IC50,nM,,215000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,215.0
,2609581,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(CN(Cc2cccc(C)c2)c2ccc(NC(=O)c3ccc(NCCNC(=N)N)c(-c4ccccc4)c3)cc2)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152730,Bioorg. Med. Chem.,2009.0,,CHEMBL499846,,CHEMBL499846,,False,http://www.openphacts.org/units/Nanomolar,805426,=,1,True,=,,IC50,nM,,152000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,152.0
,2609582,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N)NCCNc1ccc(C(=O)Nc2ccc(N(Cc3ccc(-c4ccccc4)cc3)Cc3ccc(-c4ccccc4)cc3)cc2)cc1-c1ccccc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '5.65', 'le': '0.10', 'lle': '-5.96', 'sei': '3.84'}",CHEMBL510540,,CHEMBL510540,4.08,False,http://www.openphacts.org/units/Nanomolar,805427,=,1,True,=,,IC50,nM,,84000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,84.0
,2609583,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N)NCCNc1ccc(C(=O)Nc2ccc(N(Cc3ccc(F)cc3)Cc3ccc(F)cc3)cc2)cc1-c1ccccc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '7.04', 'le': '0.13', 'lle': '-2.73', 'sei': '4.01'}",CHEMBL448003,,CHEMBL448003,4.26,False,http://www.openphacts.org/units/Nanomolar,805428,=,1,True,=,,IC50,nM,,55000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,55.0
,2609584,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N)NCCNc1ccc(C(=O)Nc2ccc(N(Cc3cccc4ccccc34)Cc3cccc4ccccc34)cc2)cc1-c1ccccc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '6.53', 'le': '0.12', 'lle': '-4.64', 'sei': '4.11'}",CHEMBL453745,,CHEMBL453745,4.37,False,http://www.openphacts.org/units/Nanomolar,805429,=,1,True,=,,IC50,nM,,43000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,43.0
,2609585,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(CN(Cc2ccc(C(C)C)cc2)c2ccc(NC(=O)c3ccc(NCCNC(=N)N)c(-c4ccccc4)c3)cc2)cc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '6.97', 'le': '0.13', 'lle': '-4.40', 'sei': '4.28'}",CHEMBL450225,,CHEMBL450225,4.55,False,http://www.openphacts.org/units/Nanomolar,805430,=,1,True,=,,IC50,nM,,28000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,28.0
,2609586,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N)NCCNc1ccc(C(=O)Nc2ccc(N(Cc3ccc4ccccc4c3)Cc3ccc4ccccc4c3)cc2)cc1-c1ccccc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '6.93', 'le': '0.12', 'lle': '-4.37', 'sei': '4.36'}",CHEMBL446829,,CHEMBL446829,4.64,False,http://www.openphacts.org/units/Nanomolar,805431,=,1,True,=,,IC50,nM,,23000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,23.0
,2609587,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(CN(Cc2ccc(C#N)cc2)c2ccc(NC(=O)c3ccc(NCCNC(=N)N)c(-c4ccccc4)c3)cc2)cc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '7.63', 'le': '0.14', 'lle': '-1.73', 'sei': '3.07'}",CHEMBL449678,,CHEMBL449678,4.72,False,http://www.openphacts.org/units/Nanomolar,805432,=,1,True,=,,IC50,nM,,19000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,19.0
,2609588,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(CN(Cc2ccc(C(C)C)cc2)c2ccc(NC(=O)c3ccc(NCCNC(=N)N)c(-c4ccc5ccccc5c4)c3)cc2)cc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '6.29', 'le': '0.11', 'lle': '-5.69', 'sei': '4.16'}",CHEMBL447960,,CHEMBL447960,4.42,False,http://www.openphacts.org/units/Nanomolar,805433,=,1,True,=,,IC50,nM,,38000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,38.0
,2609589,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(CN(Cc2ccc(C#N)cc2)c2ccc(NC(=O)c3ccc(NCCNC(=N)N)c(-c4ccc5ccccc5c4)c3)cc2)cc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '7.13', 'le': '0.13', 'lle': '-2.83', 'sei': '3.10'}",CHEMBL509490,,CHEMBL509490,4.77,False,http://www.openphacts.org/units/Nanomolar,805434,=,1,True,=,,IC50,nM,,17000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,17.0
,2609590,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1ccc(-c2cc(C(=O)Nc3ccc(N(Cc4ccccc4)Cc4ccccc4)cc3)ccc2NCCNC(=N)N)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152730,Bioorg. Med. Chem.,2009.0,,CHEMBL457630,,CHEMBL457630,,False,http://www.openphacts.org/units/Nanomolar,805435,=,1,True,=,,IC50,nM,,253000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,253.0
,2609591,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccc(-c2cc(C(=O)Nc3ccc(N(Cc4ccccc4)Cc4ccccc4)cc3)ccc2NCCNC(=N)N)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152730,Bioorg. Med. Chem.,2009.0,,CHEMBL457309,,CHEMBL457309,,False,http://www.openphacts.org/units/Nanomolar,805436,=,1,True,=,,IC50,nM,,158000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,158.0
,2609592,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N)NCCNc1ccc(C(=O)Nc2ccc(N(Cc3ccccc3)Cc3ccccc3)cc2)cc1-c1ccc(-c2ccccc2)cc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '6.33', 'le': '0.11', 'lle': '-4.29', 'sei': '3.84'}",CHEMBL469523,,CHEMBL469523,4.08,False,http://www.openphacts.org/units/Nanomolar,805437,=,1,True,=,,IC50,nM,,83000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,83.0
,2609593,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(-c2cc(C(=O)Nc3ccc(N(Cc4ccccc4)Cc4ccccc4)cc3)ccc2NCCNC(=N)N)cc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '6.92', 'le': '0.12', 'lle': '-2.47', 'sei': '3.16'}",CHEMBL451291,,CHEMBL451291,4.11,False,http://www.openphacts.org/units/Nanomolar,805416,=,1,True,=,,IC50,nM,,78000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,78.0
,2609594,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(-c2cc(C(=O)Nc3ccc(N(Cc4ccccc4)Cc4ccccc4)cc3)ccc2NCCNC(=N)N)cc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '7.01', 'le': '0.13', 'lle': '-3.55', 'sei': '4.03'}",CHEMBL444400,,CHEMBL444400,4.28,False,http://www.openphacts.org/units/Nanomolar,805438,=,1,True,=,,IC50,nM,,52000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,52.0
,2609595,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N)NCCNc1ccc(C(=O)Nc2ccc(N(Cc3ccccc3)Cc3ccccc3)cc2)cc1-c1ccc2ccccc2c1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '7.04', 'le': '0.13', 'lle': '-3.50', 'sei': '4.10'}",CHEMBL444730,,CHEMBL444730,4.36,False,http://www.openphacts.org/units/Nanomolar,805439,=,1,True,=,,IC50,nM,,44000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,44.0
,2609596,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(CN(Cc2ccc(C(C)C)cc2)c2ccc(NC(=O)c3ccc(NC(=O)CNC(=N)N)c(-c4ccc5ccccc5c4)c3)cc2)cc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '6.65', 'le': '0.12', 'lle': '-4.86', 'sei': '3.87'}",CHEMBL438332,,CHEMBL438332,4.77,False,http://www.openphacts.org/units/Nanomolar,805440,=,1,True,=,,IC50,nM,,17000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,17.0
,2609597,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(CN(Cc2ccc(C#N)cc2)c2ccc(NC(=O)c3ccc(NC(=O)CNC(=N)N)c(-c4ccc5ccccc5c4)c3)cc2)cc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '7.21', 'le': '0.13', 'lle': '-2.21', 'sei': '2.88'}",CHEMBL445038,,CHEMBL445038,4.92,False,http://www.openphacts.org/units/Nanomolar,805441,=,1,True,=,,IC50,nM,,12000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,12.0
,2609598,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N)NCC(=O)Nc1ccc(-c2cc3cc(N(Cc4ccccc4)Cc4ccccc4)ccc3[nH]2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152730,Bioorg. Med. Chem.,2009.0,,CHEMBL471216,,CHEMBL471216,,False,http://www.openphacts.org/units/Nanomolar,805519,=,1,True,=,,IC50,nM,,126000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,126.0
,2609599,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(CN(Cc2ccc(C#N)cc2)c2ccc3[nH]c(-c4ccc(NC(=O)CNC(=N)N)cc4)cc3c2)cc1,,,CHEMBL1152730,Bioorg. Med. Chem.,2009.0,"{'bei': '8.13', 'le': '0.15', 'lle': '-0.72', 'sei': '2.85'}",CHEMBL448803,,CHEMBL448803,4.50,False,http://www.openphacts.org/units/Nanomolar,805520,=,1,True,=,,IC50,nM,,32000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,32.0
,2609600,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)Nc2ccc3c(=O)n(Cc4ccccc4)c(=O)n(Cc4ccccc4)c3c2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152730,Bioorg. Med. Chem.,2009.0,,CHEMBL501390,,CHEMBL501390,,False,http://www.openphacts.org/units/Nanomolar,805521,=,1,True,=,,IC50,nM,,112000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,112.0
,2609601,[],CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H](CCCNC(=N)N)C(=O)Nc1ccc(C(=O)Nc2ccc3c(c2)c(=O)n(Cc2ccccc2)c(=O)n3Cc2ccccc2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152730,Bioorg. Med. Chem.,2009.0,,CHEMBL471217,,CHEMBL471217,,False,http://www.openphacts.org/units/Nanomolar,805522,=,1,True,=,,IC50,nM,,232000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,232.0
,2613337,[],CHEMBL1015224,Inhibition of PKBa,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,,,CHEMBL1152817,Science,2003.0,,CHEMBL221959,TOFACITINIB,CHEMBL221959,,False,http://www.openphacts.org/units/Nanomolar,731836,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,2636768,[],CHEMBL978881,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(CCOc2cccc(-c3cncc(C#N)c3Nc3cccc4[nH]ccc34)c2)CC1,,,CHEMBL1138615,Bioorg. Med. Chem. Lett.,2009.0,,CHEMBL467321,,CHEMBL467321,,False,http://www.openphacts.org/units/Nanomolar,758887,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,2661408,[],CHEMBL1058614,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2,,,CHEMBL1151962,J. Med. Chem.,2009.0,,CHEMBL564829,MILCICLIB,CHEMBL564829,,False,http://www.openphacts.org/units/Nanomolar,817704,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,2661596,[],CHEMBL1060460,Inhibition of PKBalpha after 1 hr by mobility shift electrophoresis assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1,,,CHEMBL1151963,J. Med. Chem.,2009.0,,CHEMBL561708,,CHEMBL561708,,False,http://www.openphacts.org/units/Nanomolar,818332,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,2671907,[],CHEMBL1026218,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)cc1C2=O,,,CHEMBL1151842,J. Nat. Prod.,2009.0,,CHEMBL463054,MACROSPORIN,CHEMBL463054,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,819753,>,1,True,>,,IC50,ug.mL-1,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,ug ml-1,UO_0000274,,10.0
,2671908,[],CHEMBL1026218,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)c(O)c1C2=O,,,CHEMBL1151842,J. Nat. Prod.,2009.0,,CHEMBL556684,,CHEMBL556684,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,819755,>,1,True,>,,IC50,ug.mL-1,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,ug ml-1,UO_0000274,,10.0
,2672248,[],CHEMBL1026218,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(O)c2c(c1)C(=O)C1=C(C2=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O,,,CHEMBL1151842,J. Nat. Prod.,2009.0,,CHEMBL512054,ALTERSOLANOL A,CHEMBL512054,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,819660,=,1,True,=,,IC50,ug.mL-1,,6.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,ug ml-1,UO_0000274,,6.7
,2672309,[],CHEMBL1026218,Inhibition of recombinant AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(c(O)c1-c1c(OC)cc(O)c3c1C(=O)C1=C(C3=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O)C(=O)c1cc(O)c(C)cc1C2=O,,,CHEMBL1151842,J. Nat. Prod.,2009.0,,CHEMBL554993,ALTERPORRIOL G/H,CHEMBL554993,,False,http://www.openphacts.org/units/MicrogramPerMilliliter,819760,>,1,True,>,,IC50,ug.mL-1,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,ug ml-1,UO_0000274,,10.0
,2676431,[],CHEMBL1035535,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1cnn2c(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)ccnc12,,,CHEMBL1151868,Bioorg. Med. Chem. Lett.,2009.0,,CHEMBL565061,,CHEMBL565061,,False,http://www.openphacts.org/units/Nanomolar,818583,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,2705278,[],CHEMBL1061585,Inhibition of AKT1 by FRET based assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1COc2ccc(-c3cc(-c4ccccc4)cc(-c4ccc5oc(=O)[nH]c5c4)n3)cc2N1,,,CHEMBL1153468,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '12.83', 'le': '0.23', 'lle': '0.74', 'sei': '5.74'}",CHEMBL564972,,CHEMBL564972,5.58,False,http://www.openphacts.org/units/Nanomolar,828779,=,1,True,=,,IC50,nM,,2600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.6
,2705281,[],CHEMBL1061585,Inhibition of AKT1 by FRET based assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,,,CHEMBL1153468,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '12.98', 'le': '0.29', 'lle': '2.22', 'sei': '8.15'}",CHEMBL104264,,CHEMBL104264,5.80,False,http://www.openphacts.org/units/Nanomolar,828780,=,1,True,=,,IC50,nM,,1600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.6
,2915160,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](N)COc1cnc(Cl)c(/C=C/c2ccncc2)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.21', 'le': '0.36', 'lle': '2.25', 'sei': '8.65'}",CHEMBL419932,,CHEMBL419932,5.28,False,http://www.openphacts.org/units/Nanomolar,847795,=,1,True,=,,IC50,nM,,5290.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5290.0
,2915161,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,NCCOc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '20.03', 'le': '0.37', 'lle': '2.85', 'sei': '7.92'}",CHEMBL206382,,CHEMBL206382,4.83,False,http://www.openphacts.org/units/Nanomolar,847796,=,1,True,=,,IC50,nM,,14710.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14710.0
,2915162,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](N)COc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.63', 'le': '0.31', 'lle': '1.70', 'sei': '7.72'}",CHEMBL204059,,CHEMBL204059,4.71,False,http://www.openphacts.org/units/Nanomolar,847797,=,1,True,=,,IC50,nM,,19320.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19320.0
,2915163,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1ccccc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.59', 'le': '0.34', 'lle': '2.56', 'sei': '10.10'}",CHEMBL203673,,CHEMBL203673,6.16,False,http://www.openphacts.org/units/Nanomolar,847798,=,1,True,=,,IC50,nM,,690.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,690.0
,2915164,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)C(c1ccccc1)c1ccccc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.11', 'le': '0.29', 'lle': '1.37', 'sei': '10.76'}",CHEMBL203434,,CHEMBL203434,6.56,False,http://www.openphacts.org/units/Nanomolar,847773,=,1,True,=,,IC50,nM,,273.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,273.0
,2915165,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H](CCc1ccccc1)COc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '14.75', 'le': '0.27', 'lle': '1.11', 'sei': '8.35'}",CHEMBL381829,,CHEMBL381829,5.10,False,http://www.openphacts.org/units/Nanomolar,847777,=,1,True,=,,IC50,nM,,8020.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8020.0
,2915166,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H](COCc1ccccc1)COc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '14.92', 'le': '0.27', 'lle': '1.82', 'sei': '7.68'}",CHEMBL206236,,CHEMBL206236,5.39,False,http://www.openphacts.org/units/Nanomolar,847781,=,1,True,=,,IC50,nM,,4040.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4040.0
,2915167,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccc(C[C@H](N)COc2cncc(/C=C/c3ccncc3)c2)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.22', 'le': '0.33', 'lle': '3.02', 'sei': '7.66'}",CHEMBL205410,,CHEMBL205410,6.50,False,http://www.openphacts.org/units/Nanomolar,847789,=,1,True,=,,IC50,nM,,320.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,320.0
,2915168,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1cccc2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.01', 'le': '0.31', 'lle': '1.74', 'sei': '10.63'}",CHEMBL205871,,CHEMBL205871,6.49,False,http://www.openphacts.org/units/Nanomolar,847770,=,1,True,=,,IC50,nM,,324.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,324.0
,2915169,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.39', 'le': '0.31', 'lle': '2.36', 'sei': '8.39'}",CHEMBL383541,,CHEMBL383541,6.44,False,http://www.openphacts.org/units/Nanomolar,847775,=,1,True,=,,IC50,nM,,360.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,360.0
,2915170,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(C[C@H](N)COc2cncc(/C=C/c3ccncc3)c2)c2ccccc21,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.39', 'le': '0.30', 'lle': '2.21', 'sei': '9.55'}",CHEMBL204012,,CHEMBL204012,6.30,False,http://www.openphacts.org/units/Nanomolar,847778,=,1,True,=,,IC50,nM,,500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,500.0
,2915171,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,C(=C/c1cncc(OCC2CCN2)c1)\c1ccncc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.57', 'le': '0.34', 'lle': '2.57', 'sei': '10.55'}",CHEMBL577186,,CHEMBL577186,4.96,False,http://www.openphacts.org/units/Nanomolar,847786,=,1,True,=,,IC50,nM,,10870.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10870.0
,2915172,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Brc1ccc(/C=C/CNCCOc2cncc(/C=C/c3ccncc3)c2)cc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '10.29', 'le': '0.22', 'lle': '-0.60', 'sei': '9.55'}",CHEMBL206328,,CHEMBL206328,4.49,False,http://www.openphacts.org/units/Nanomolar,847793,=,1,True,=,,IC50,nM,,32250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,32250.0
,2915173,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '14.95', 'le': '0.27', 'lle': '1.28', 'sei': '11.03'}",CHEMBL202893,,CHEMBL202893,5.96,False,http://www.openphacts.org/units/Nanomolar,847799,=,1,True,=,,IC50,nM,,1100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1100.0
,2915174,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(C(CN)Oc2cncc(/C=C/c3ccncc3)c2)c2ccccc21,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.52', 'le': '0.30', 'lle': '1.90', 'sei': '9.28'}",CHEMBL574290,,CHEMBL574290,6.12,False,http://www.openphacts.org/units/Nanomolar,847771,=,1,True,=,,IC50,nM,,760.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,760.0
,2915175,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(/C=C/c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)ccn1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '13.92', 'le': '0.25', 'lle': '1.48', 'sei': '6.48'}",CHEMBL377294,,CHEMBL377294,5.57,False,http://www.openphacts.org/units/Nanomolar,847779,=,1,True,=,,IC50,nM,,2670.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2670.0
,2915176,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccnc(Oc3ccccc3)c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '11.22', 'le': '0.20', 'lle': '-0.68', 'sei': '6.03'}",CHEMBL378823,,CHEMBL378823,5.19,False,http://www.openphacts.org/units/Nanomolar,847780,=,1,True,=,,IC50,nM,,6450.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6450.0
,2915177,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(/C=C/c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)ccn1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.94', 'le': '0.33', 'lle': '3.26', 'sei': '6.73'}",CHEMBL381075,,CHEMBL381075,6.92,False,http://www.openphacts.org/units/Nanomolar,847784,=,1,True,=,,IC50,nM,,121.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,121.0
,2915178,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1cc(/C=C/c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)ccn1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.91', 'le': '0.31', 'lle': '2.63', 'sei': '7.60'}",CHEMBL202787,,CHEMBL202787,6.75,False,http://www.openphacts.org/units/Nanomolar,847787,=,1,True,=,,IC50,nM,,176.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,176.0
,2915179,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CCNc1cc(/C=C/c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)ccn1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.41', 'le': '0.30', 'lle': '2.28', 'sei': '7.64'}",CHEMBL382914,,CHEMBL382914,6.79,False,http://www.openphacts.org/units/Nanomolar,847772,=,1,True,=,,IC50,nM,,163.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,163.0
,2915180,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccnc(NCc3ccccc3)c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '14.37', 'le': '0.26', 'lle': '1.14', 'sei': '7.69'}",CHEMBL381610,,CHEMBL381610,6.83,False,http://www.openphacts.org/units/Nanomolar,847774,=,1,True,=,,IC50,nM,,147.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,147.0
,2915181,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(/C=C/c2ccnc(-n3ccc4ccccc43)c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '11.28', 'le': '0.20', 'lle': '-0.54', 'sei': '6.70'}",CHEMBL206708,,CHEMBL206708,5.48,False,http://www.openphacts.org/units/Nanomolar,847776,=,1,True,=,,IC50,nM,,3340.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3340.0
,2915182,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CCc1cnc(Cl)c(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.64', 'le': '0.32', 'lle': '1.42', 'sei': '9.92'}",CHEMBL203329,,CHEMBL203329,6.70,False,http://www.openphacts.org/units/Nanomolar,847788,=,1,True,=,,IC50,nM,,198.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,198.0
,2915183,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1cnc(Cl)c(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.58', 'le': '0.33', 'lle': '2.34', 'sei': '8.92'}",CHEMBL203384,,CHEMBL203384,7.10,False,http://www.openphacts.org/units/Nanomolar,847785,=,1,True,=,,IC50,nM,,79.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,79.0
,2915184,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H](Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.10', 'le': '0.31', 'lle': '2.92', 'sei': '6.78'}",CHEMBL205415,,CHEMBL205415,6.56,False,http://www.openphacts.org/units/Nanomolar,847782,=,1,True,=,,IC50,nM,,278.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,278.0
,2915185,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H](Cc1ccccc1)C(=O)Nc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '15.95', 'le': '0.29', 'lle': '2.33', 'sei': '6.79'}",CHEMBL205514,,CHEMBL205514,5.50,False,http://www.openphacts.org/units/Nanomolar,847783,=,1,True,=,,IC50,nM,,3200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3200.0
,2915186,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H](Cc1cccc2ccccc12)C(=O)Nc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '15.65', 'le': '0.28', 'lle': '1.87', 'sei': '7.63'}",CHEMBL383527,,CHEMBL383527,6.17,False,http://www.openphacts.org/units/Nanomolar,845678,=,1,True,=,,IC50,nM,,668.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,668.0
,2915187,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '22.05', 'le': '0.40', 'lle': '3.97', 'sei': '11.32'}",CHEMBL383264,,CHEMBL383264,8.70,False,http://www.openphacts.org/units/Nanomolar,845679,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,2915188,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cnc(Cl)c(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '20.39', 'le': '0.39', 'lle': '3.36', 'sei': '11.38'}",CHEMBL378963,,CHEMBL378963,8.74,False,http://www.openphacts.org/units/Nanomolar,845680,=,1,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
,2915189,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1ccc2cnccc2c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '19.87', 'le': '0.36', 'lle': '3.74', 'sei': '8.29'}",CHEMBL379209,,CHEMBL379209,8.34,False,http://www.openphacts.org/units/Nanomolar,845682,=,1,True,=,,IC50,nM,,4.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.6
,2915190,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1ncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1ccc2cnccc2c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '20.69', 'le': '0.37', 'lle': '3.33', 'sei': '11.32'}",CHEMBL209513,,CHEMBL209513,8.70,False,http://www.openphacts.org/units/Nanomolar,845684,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,2915191,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cnc(-c2ccco2)c(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '19.16', 'le': '0.34', 'lle': '2.83', 'sei': '9.81'}",CHEMBL378843,,CHEMBL378843,8.82,False,http://www.openphacts.org/units/Nanomolar,845653,=,1,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
,2915192,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1ccc2cnccc2c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.53', 'le': '0.39', 'lle': '3.81', 'sei': '11.84'}",CHEMBL572908,,CHEMBL572908,9.10,False,http://www.openphacts.org/units/Nanomolar,845661,=,1,True,=,,IC50,nM,,0.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.8
,2915193,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cc(-c2ccc3cnccc3c2)cnc1Cl)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.47', 'le': '0.35', 'lle': '2.54', 'sei': '10.31'}",CHEMBL210089,,CHEMBL210089,7.92,False,http://www.openphacts.org/units/Nanomolar,845662,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,2915194,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3cnc(F)cc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '20.50', 'le': '0.37', 'lle': '3.59', 'sei': '11.01'}",CHEMBL210246,,CHEMBL210246,8.46,False,http://www.openphacts.org/units/Nanomolar,845672,=,1,True,=,,IC50,nM,,3.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.5
,2915195,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1cc2cc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)ccc2cn1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.21', 'le': '0.33', 'lle': '2.29', 'sei': '9.97'}",CHEMBL377764,,CHEMBL377764,7.66,False,http://www.openphacts.org/units/Nanomolar,845673,=,1,True,=,,IC50,nM,,22.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22.0
,2915196,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3cnc(-c4ccccc4)cc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '13.85', 'le': '0.25', 'lle': '0.13', 'sei': '8.48'}",CHEMBL210544,,CHEMBL210544,6.52,False,http://www.openphacts.org/units/Nanomolar,845674,=,1,True,=,,IC50,nM,,305.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,305.0
,2915197,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3cnc(-c4ccncc4)cc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '14.66', 'le': '0.26', 'lle': '1.12', 'sei': '7.71'}",CHEMBL209564,,CHEMBL209564,6.91,False,http://www.openphacts.org/units/Nanomolar,845654,=,1,True,=,,IC50,nM,,122.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,122.0
,2915198,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc2cc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)ccc2cn1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '20.68', 'le': '0.37', 'lle': '4.16', 'sei': '8.23'}",CHEMBL210390,,CHEMBL210390,8.47,False,http://www.openphacts.org/units/Nanomolar,845667,=,1,True,=,,IC50,nM,,3.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.4
,2915199,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1c(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)ccc2cnccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '19.11', 'le': '0.34', 'lle': '3.51', 'sei': '7.61'}",CHEMBL380196,,CHEMBL380196,7.82,False,http://www.openphacts.org/units/Nanomolar,845675,=,1,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
,2915200,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3ccccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '15.13', 'le': '0.27', 'lle': '0.62', 'sei': '9.31'}",CHEMBL564795,,CHEMBL564795,5.95,False,http://www.openphacts.org/units/Nanomolar,845681,=,1,True,=,,IC50,nM,,1117.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1117.0
,2915201,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3ncccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.49', 'le': '0.30', 'lle': '1.78', 'sei': '8.47'}",CHEMBL573393,,CHEMBL573393,6.51,False,http://www.openphacts.org/units/Nanomolar,845683,=,1,True,=,,IC50,nM,,312.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,312.0
,2915202,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3nnccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.86', 'le': '0.30', 'lle': '2.55', 'sei': '7.43'}",CHEMBL573394,,CHEMBL573394,6.67,False,http://www.openphacts.org/units/Nanomolar,845685,=,1,True,=,,IC50,nM,,215.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,215.0
,2915203,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(O)nccc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '14.59', 'le': '0.26', 'lle': '1.56', 'sei': '6.17'}",CHEMBL207215,,CHEMBL207215,5.99,False,http://www.openphacts.org/units/Nanomolar,845686,=,1,True,=,,IC50,nM,,1022.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1022.0
,2915204,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nccc2cc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)ccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.42', 'le': '0.30', 'lle': '2.42', 'sei': '6.54'}",CHEMBL208962,,CHEMBL208962,6.73,False,http://www.openphacts.org/units/Nanomolar,845655,=,1,True,=,,IC50,nM,,188.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,188.0
,2915205,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cccc3cnccc23)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.43', 'le': '0.30', 'lle': '1.75', 'sei': '8.44'}",CHEMBL581848,,CHEMBL581848,6.48,False,http://www.openphacts.org/units/Nanomolar,845657,=,1,True,=,,IC50,nM,,331.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,331.0
,2915206,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '19.19', 'le': '0.35', 'lle': '3.04', 'sei': '8.61'}",CHEMBL208199,,CHEMBL208199,6.61,False,http://www.openphacts.org/units/Nanomolar,845658,=,1,True,=,,IC50,nM,,245.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,245.0
,2915207,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(C(=O)Nc2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '14.92', 'le': '0.27', 'lle': '2.62', 'sei': '5.46'}",CHEMBL208499,,CHEMBL208499,5.78,False,http://www.openphacts.org/units/Nanomolar,845663,=,1,True,=,,IC50,nM,,1659.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1659.0
,2915208,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc(CO)cc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '14.45', 'le': '0.26', 'lle': '1.73', 'sei': '6.41'}",CHEMBL576761,,CHEMBL576761,5.40,False,http://www.openphacts.org/units/Nanomolar,845665,=,1,True,=,,IC50,nM,,4022.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4022.0
,2915209,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]ncc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '23.01', 'le': '0.42', 'lle': '4.76', 'sei': '9.53'}",CHEMBL374805,,CHEMBL374805,8.82,False,http://www.openphacts.org/units/Nanomolar,845666,=,1,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
,2915210,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '24.64', 'le': '0.45', 'lle': '5.44', 'sei': '10.58'}",CHEMBL379300,A-443654,CHEMBL379300,9.80,False,http://www.openphacts.org/units/Nanomolar,845668,=,1,True,=,,IC50,nM,,0.16,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.16
,2915211,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]nc(Cl)c3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.54', 'le': '0.41', 'lle': '4.29', 'sei': '9.72'}",CHEMBL226148,,CHEMBL226148,9.00,False,http://www.openphacts.org/units/Nanomolar,845669,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,2915212,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]nc(C(F)(F)F)c3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '19.37', 'le': '0.36', 'lle': '3.67', 'sei': '9.44'}",CHEMBL374808,,CHEMBL374808,8.74,False,http://www.openphacts.org/units/Nanomolar,845671,=,1,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
,2915213,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.72', 'le': '0.39', 'lle': '4.32', 'sei': '9.65'}",CHEMBL574087,,CHEMBL574087,8.94,False,http://www.openphacts.org/units/Nanomolar,845676,=,1,True,=,,IC50,nM,,1.15,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.15
,2915214,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.43', 'le': '0.39', 'lle': '4.90', 'sei': '7.20'}",CHEMBL577795,,CHEMBL577795,8.54,False,http://www.openphacts.org/units/Nanomolar,845677,=,1,True,=,,IC50,nM,,2.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.9
,2915215,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.16', 'le': '0.33', 'lle': '3.62', 'sei': '8.08'}",CHEMBL572905,,CHEMBL572905,7.75,False,http://www.openphacts.org/units/Nanomolar,845652,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,2915216,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]nc(-c4ccccc4)c3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.30', 'le': '0.33', 'lle': '2.69', 'sei': '9.08'}",CHEMBL574764,,CHEMBL574764,8.41,False,http://www.openphacts.org/units/Nanomolar,845656,=,1,True,=,,IC50,nM,,3.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.9
,2915217,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]nc(-c4cccs4)c3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '19.09', 'le': '0.36', 'lle': '3.11', 'sei': '9.60'}",CHEMBL576733,,CHEMBL576733,8.89,False,http://www.openphacts.org/units/Nanomolar,845659,=,1,True,=,,IC50,nM,,1.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.3
,2915218,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]nc(C4CC4)c3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '20.27', 'le': '0.37', 'lle': '3.66', 'sei': '9.27'}",CHEMBL572907,,CHEMBL572907,8.59,False,http://www.openphacts.org/units/Nanomolar,845660,=,1,True,=,,IC50,nM,,2.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.6
,2915219,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]nc(-c4nccs4)c3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.17', 'le': '0.32', 'lle': '2.83', 'sei': '7.59'}",CHEMBL574995,,CHEMBL574995,8.01,False,http://www.openphacts.org/units/Nanomolar,845664,=,1,True,=,,IC50,nM,,9.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.8
,2915220,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]nc(-c4ccc[nH]4)c3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '19.89', 'le': '0.36', 'lle': '3.87', 'sei': '8.23'}",CHEMBL572670,,CHEMBL572670,8.92,False,http://www.openphacts.org/units/Nanomolar,845670,=,1,True,=,,IC50,nM,,1.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.2
,2915221,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]nc(N4CCOCC4)c3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.53', 'le': '0.30', 'lle': '3.85', 'sei': '7.37'}",CHEMBL578418,,CHEMBL578418,7.75,False,http://www.openphacts.org/units/Nanomolar,846163,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,2915222,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]nc(C=O)c3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '13.93', 'le': '0.25', 'lle': '1.86', 'sei': '5.23'}",CHEMBL574774,,CHEMBL574774,5.73,False,http://www.openphacts.org/units/Nanomolar,846137,=,1,True,=,,IC50,nM,,1848.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1848.0
,2915223,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cc3cn[nH]c3cc2[N+](=O)[O-])c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '14.05', 'le': '0.26', 'lle': '2.06', 'sei': '4.44'}",CHEMBL225788,,CHEMBL225788,6.02,False,http://www.openphacts.org/units/Nanomolar,846138,=,1,True,=,,IC50,nM,,953.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,953.0
,2915224,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc2[nH]ncc2cc1-c1cncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.30', 'le': '0.33', 'lle': '3.65', 'sei': '6.15'}",CHEMBL388729,,CHEMBL388729,7.29,False,http://www.openphacts.org/units/Nanomolar,846145,=,1,True,=,,IC50,nM,,51.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,51.0
,2915225,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc2[nH]nc(Cl)c2cc1-c1cncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.82', 'le': '0.36', 'lle': '3.86', 'sei': '6.87'}",CHEMBL225789,,CHEMBL225789,8.15,False,http://www.openphacts.org/units/Nanomolar,846146,=,1,True,=,,IC50,nM,,7.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.1
,2915226,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '23.76', 'le': '0.43', 'lle': '5.71', 'sei': '8.97'}",CHEMBL376569,,CHEMBL376569,9.47,False,http://www.openphacts.org/units/Nanomolar,846154,=,1,True,=,,IC50,nM,,0.34,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.34
,2915227,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cc3c(Cl)n[nH]c3cn2)c1)Cc1ccccc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '19.03', 'le': '0.37', 'lle': '3.61', 'sei': '8.06'}",CHEMBL226332,,CHEMBL226332,7.23,False,http://www.openphacts.org/units/Nanomolar,846157,=,1,True,=,,IC50,nM,,59.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,59.0
,2915228,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.23', 'le': '0.38', 'lle': '4.28', 'sei': '8.79'}",CHEMBL226382,,CHEMBL226382,7.89,False,http://www.openphacts.org/units/Nanomolar,846158,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
,2915229,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cc3c(-c4ccco4)n[nH]c3cn2)c1)Cc1ccccc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '19.96', 'le': '0.36', 'lle': '3.98', 'sei': '7.99'}",CHEMBL375485,,CHEMBL375485,8.21,False,http://www.openphacts.org/units/Nanomolar,846164,=,1,True,=,,IC50,nM,,6.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.1
,2915230,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.85', 'le': '0.40', 'lle': '4.57', 'sei': '8.75'}",CHEMBL376570,,CHEMBL376570,7.85,False,http://www.openphacts.org/units/Nanomolar,846141,=,1,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
,2915231,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4cccc(F)c4)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.40', 'le': '0.39', 'lle': '4.66', 'sei': '9.00'}",CHEMBL573592,,CHEMBL573592,8.08,False,http://www.openphacts.org/units/Nanomolar,846144,=,1,True,=,,IC50,nM,,8.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.4
,2915232,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C)c(C[C@H](N)COc2cncc(-c3cc4c(C)n[nH]c4cn3)c2)c(C)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.45', 'le': '0.34', 'lle': '3.21', 'sei': '8.26'}",CHEMBL572417,,CHEMBL572417,7.41,False,http://www.openphacts.org/units/Nanomolar,846147,=,1,True,=,,IC50,nM,,39.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,39.0
,2915233,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.12', 'le': '0.34', 'lle': '3.44', 'sei': '8.63'}",CHEMBL572418,,CHEMBL572418,7.75,False,http://www.openphacts.org/units/Nanomolar,846148,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,2915234,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4cccc5c4OC(F)(F)O5)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.87', 'le': '0.34', 'lle': '4.25', 'sei': '7.26'}",CHEMBL576135,,CHEMBL576135,7.85,False,http://www.openphacts.org/units/Nanomolar,846150,=,1,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
,2915235,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4cccc(OCCN5CCOCC5)c4)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '12.53', 'le': '0.23', 'lle': '3.13', 'sei': '5.50'}",CHEMBL575428,,CHEMBL575428,6.12,False,http://www.openphacts.org/units/Nanomolar,846160,=,1,True,=,,IC50,nM,,751.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,751.0
,2915236,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4cccc(OCC5CCNCC5)c4)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.28', 'le': '0.32', 'lle': '4.51', 'sei': '7.36'}",CHEMBL576372,,CHEMBL576372,8.17,False,http://www.openphacts.org/units/Nanomolar,846161,=,1,True,=,,IC50,nM,,6.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.8
,2915237,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4cccc(OCC5CCCCC5)c4)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '12.44', 'le': '0.23', 'lle': '0.63', 'sei': '5.93'}",CHEMBL574978,,CHEMBL574978,5.87,False,http://www.openphacts.org/units/Nanomolar,846139,=,1,True,=,,IC50,nM,,1360.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1360.0
,2915238,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4cccc(OCCN)c4)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.51', 'le': '0.32', 'lle': '4.72', 'sei': '5.86'}",CHEMBL574979,,CHEMBL574979,7.33,False,http://www.openphacts.org/units/Nanomolar,846142,=,1,True,=,,IC50,nM,,47.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,47.0
,2915239,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4c(F)cccc4F)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.17', 'le': '0.34', 'lle': '3.62', 'sei': '8.01'}",CHEMBL573355,,CHEMBL573355,7.18,False,http://www.openphacts.org/units/Nanomolar,846143,=,1,True,=,,IC50,nM,,65.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,65.5
,2915240,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4ccc(F)c(F)c4F)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '19.16', 'le': '0.36', 'lle': '4.23', 'sei': '8.83'}",CHEMBL574986,,CHEMBL574986,7.92,False,http://www.openphacts.org/units/Nanomolar,846151,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,2915241,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cncc(OC[C@@H](N)Cc4ccc(Br)cc4)c3)cc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.94', 'le': '0.40', 'lle': '4.26', 'sei': '9.25'}",CHEMBL573778,,CHEMBL573778,8.30,False,http://www.openphacts.org/units/Nanomolar,846152,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,2915242,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)cc1C[C@H](N)COc1cncc(-c2cc3c(C)n[nH]c3cn2)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.48', 'le': '0.40', 'lle': '4.69', 'sei': '9.37'}",CHEMBL573133,,CHEMBL573133,8.41,False,http://www.openphacts.org/units/Nanomolar,846155,=,1,True,=,,IC50,nM,,3.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.9
,2915243,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C[C@H](N)COc2cncc(-c3cc4c(C)n[nH]c4cn3)c2)ccc1F,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.97', 'le': '0.41', 'lle': '4.88', 'sei': '9.59'}",CHEMBL573359,,CHEMBL573359,8.60,False,http://www.openphacts.org/units/Nanomolar,846156,=,1,True,=,,IC50,nM,,2.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.5
,2915244,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)ccc1C[C@H](N)COc1cncc(-c2cc3c(C)n[nH]c3cn2)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.00', 'le': '0.39', 'lle': '4.50', 'sei': '9.16'}",CHEMBL575427,,CHEMBL575427,8.22,False,http://www.openphacts.org/units/Nanomolar,846159,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,2915245,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(CCc2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.93', 'le': '0.33', 'lle': '2.99', 'sei': '8.69'}",CHEMBL575646,,CHEMBL575646,6.68,False,http://www.openphacts.org/units/Nanomolar,846162,=,1,True,=,,IC50,nM,,210.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,210.0
,2915246,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(NC(=O)c2ccncc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '14.70', 'le': '0.27', 'lle': '2.53', 'sei': '5.38'}",CHEMBL576565,,CHEMBL576565,5.70,False,http://www.openphacts.org/units/Nanomolar,846140,=,1,True,=,,IC50,nM,,2020.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2020.0
,2915247,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(Nc2cccnc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '15.76', 'le': '0.29', 'lle': '2.02', 'sei': '6.38'}",CHEMBL207671,,CHEMBL207671,5.67,False,http://www.openphacts.org/units/Nanomolar,846149,=,1,True,=,,IC50,nM,,2160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2160.0
,2915248,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc(C(=O)O)cc2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '11.63', 'le': '0.21', 'lle': '0.62', 'sei': '4.45'}",CHEMBL204892,,CHEMBL204892,4.50,False,http://www.openphacts.org/units/Nanomolar,846153,=,1,True,=,,IC50,nM,,31280.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31280.0
,2915249,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)Cc1cccc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '14.62', 'le': '0.27', 'lle': '2.65', 'sei': '5.47'}",CHEMBL206746,,CHEMBL206746,5.86,False,http://www.openphacts.org/units/Nanomolar,847084,=,1,True,=,,IC50,nM,,1390.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1390.0
,2915250,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1ccc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)cc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.59', 'le': '0.30', 'lle': '2.50', 'sei': '7.14'}",CHEMBL381785,,CHEMBL381785,6.64,False,http://www.openphacts.org/units/Nanomolar,847085,=,1,True,=,,IC50,nM,,227.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,227.0
,2915251,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc(NC(=O)Nc3ccccc3)cn2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '12.43', 'le': '0.23', 'lle': '0.73', 'sei': '5.05'}",CHEMBL572859,,CHEMBL572859,5.95,False,http://www.openphacts.org/units/Nanomolar,847068,=,1,True,=,,IC50,nM,,1120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1120.0
,2915252,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '11.75', 'le': '0.22', 'lle': '0.19', 'sei': '5.46'}",CHEMBL439340,,CHEMBL439340,5.84,False,http://www.openphacts.org/units/Nanomolar,847081,=,1,True,=,,IC50,nM,,1450.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1450.0
,2915253,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2c(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '12.97', 'le': '0.23', 'lle': '1.23', 'sei': '5.29'}",CHEMBL205781,,CHEMBL205781,5.66,False,http://www.openphacts.org/units/Nanomolar,847083,=,1,True,=,,IC50,nM,,2170.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2170.0
,2915254,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cccc(Nc3ncccn3)c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '12.45', 'le': '0.22', 'lle': '0.73', 'sei': '5.34'}",CHEMBL202972,,CHEMBL202972,5.43,False,http://www.openphacts.org/units/Nanomolar,847091,=,1,True,=,,IC50,nM,,3670.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3670.0
,2915255,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(Nc2cccnc2)c1)Cc1ccccc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.09', 'le': '0.29', 'lle': '1.99', 'sei': '7.06'}",CHEMBL382379,,CHEMBL382379,5.16,False,http://www.openphacts.org/units/Nanomolar,847092,=,1,True,=,,IC50,nM,,6970.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6970.0
,2915256,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cnc2ccc(-c3ccncc3)cc2c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.54', 'le': '0.30', 'lle': '1.79', 'sei': '8.49'}",CHEMBL206819,,CHEMBL206819,6.52,False,http://www.openphacts.org/units/Nanomolar,847060,=,1,True,=,,IC50,nM,,300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,300.0
,2915257,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc2nc(-c3ccncc3)ccc12)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.00', 'le': '0.31', 'lle': '2.60', 'sei': '7.49'}",CHEMBL207496,,CHEMBL207496,6.72,False,http://www.openphacts.org/units/Nanomolar,847061,=,1,True,=,,IC50,nM,,190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,190.0
,2915258,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1cncc(Oc2cccc3cnccc23)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.31', 'le': '0.29', 'lle': '1.79', 'sei': '7.52'}",CHEMBL206732,,CHEMBL206732,6.68,False,http://www.openphacts.org/units/Nanomolar,847065,=,1,True,=,,IC50,nM,,210.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,210.0
,2915259,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1cncc(Nc2cccc3cnccc23)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.08', 'le': '0.29', 'lle': '1.73', 'sei': '7.17'}",CHEMBL205994,,CHEMBL205994,6.57,False,http://www.openphacts.org/units/Nanomolar,847069,=,1,True,=,,IC50,nM,,270.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,270.0
,2915581,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.85', 'le': '0.32', 'lle': '1.96', 'sei': '8.78'}",CHEMBL516429,,CHEMBL516429,6.75,False,http://www.openphacts.org/units/Nanomolar,847070,=,1,True,=,,IC50,nM,,179.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,179.0
,2915582,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2cnc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '20.35', 'le': '0.37', 'lle': '5.06', 'sei': '7.68'}",CHEMBL575385,,CHEMBL575385,8.13,False,http://www.openphacts.org/units/Nanomolar,847074,=,1,True,=,,IC50,nM,,7.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.4
,2915583,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)C(=O)C(=O)N3)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '20.05', 'le': '0.36', 'lle': '4.96', 'sei': '7.51'}",CHEMBL574268,,CHEMBL574268,8.27,False,http://www.openphacts.org/units/Nanomolar,847075,=,1,True,=,,IC50,nM,,5.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.4
,2915584,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '20.89', 'le': '0.38', 'lle': '4.76', 'sei': '7.61'}",CHEMBL575824,,CHEMBL575824,8.37,False,http://www.openphacts.org/units/Nanomolar,847082,=,1,True,=,,IC50,nM,,4.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.3
,2915585,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3[nH]c(=O)sc3c2)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.82', 'le': '0.32', 'lle': '2.92', 'sei': '7.24'}",CHEMBL577134,,CHEMBL577134,7.00,False,http://www.openphacts.org/units/Nanomolar,847088,=,1,True,=,,IC50,nM,,99.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,99.0
,2915586,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1ccccc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.69', 'le': '0.39', 'lle': '4.61', 'sei': '10.09'}",CHEMBL226848,,CHEMBL226848,7.80,False,http://www.openphacts.org/units/Nanomolar,847093,=,1,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
,2915587,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)C(Cc2ccco2)C(=O)N3)c1)Cc1ccccc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '20.14', 'le': '0.37', 'lle': '4.28', 'sei': '9.80'}",CHEMBL575811,,CHEMBL575811,8.85,False,http://www.openphacts.org/units/Nanomolar,847062,=,1,True,=,,IC50,nM,,1.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.4
,2915588,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)/C(=C/c2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.13', 'le': '0.38', 'lle': '4.70', 'sei': '9.91'}",CHEMBL388311,,CHEMBL388311,9.22,False,http://www.openphacts.org/units/Nanomolar,847063,=,1,True,=,,IC50,nM,,0.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.6
,2915589,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CC1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '20.36', 'le': '0.37', 'lle': '4.17', 'sei': '9.03'}",CHEMBL574262,,CHEMBL574262,8.40,False,http://www.openphacts.org/units/Nanomolar,847064,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,2915590,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CCC1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.06', 'le': '0.31', 'lle': '2.66', 'sei': '7.82'}",CHEMBL577375,,CHEMBL577375,7.28,False,http://www.openphacts.org/units/Nanomolar,847066,=,1,True,=,,IC50,nM,,52.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,52.7
,2915591,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.32', 'le': '0.39', 'lle': '4.82', 'sei': '9.13'}",CHEMBL579246,,CHEMBL579246,8.49,False,http://www.openphacts.org/units/Nanomolar,847071,=,1,True,=,,IC50,nM,,3.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.2
,2915592,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)=C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.18', 'le': '0.29', 'lle': '2.18', 'sei': '7.63'}",CHEMBL575384,,CHEMBL575384,7.10,False,http://www.openphacts.org/units/Nanomolar,847072,=,1,True,=,,IC50,nM,,80.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,80.0
,2915593,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)C(F)(F)C(=O)N3)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '20.31', 'le': '0.38', 'lle': '4.60', 'sei': '9.49'}",CHEMBL577377,,CHEMBL577377,8.82,False,http://www.openphacts.org/units/Nanomolar,847076,=,1,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
,2915594,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)C(C2CC2)C(=O)N3)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '19.34', 'le': '0.35', 'lle': '3.86', 'sei': '9.12'}",CHEMBL574269,,CHEMBL574269,8.48,False,http://www.openphacts.org/units/Nanomolar,847077,=,1,True,=,,IC50,nM,,3.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.3
,2915595,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)C(c2ccccc2)C(=O)N3)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.34', 'le': '0.31', 'lle': '2.97', 'sei': '8.85'}",CHEMBL577379,,CHEMBL577379,8.23,False,http://www.openphacts.org/units/Nanomolar,847086,=,1,True,=,,IC50,nM,,5.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.9
,2915596,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)C(c2cccnc2)C(=O)N3)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.79', 'le': '0.30', 'lle': '3.32', 'sei': '7.54'}",CHEMBL576386,,CHEMBL576386,7.98,False,http://www.openphacts.org/units/Nanomolar,847087,=,1,True,=,,IC50,nM,,10.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.4
,2915597,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)C(c2ccccn2)C(=O)N3)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.80', 'le': '0.30', 'lle': '3.33', 'sei': '7.54'}",CHEMBL573334,,CHEMBL573334,7.99,False,http://www.openphacts.org/units/Nanomolar,847089,=,1,True,=,,IC50,nM,,10.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.3
,2915598,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)C(c2ccc[nH]2)C(=O)N3)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '19.04', 'le': '0.34', 'lle': '4.23', 'sei': '8.11'}",CHEMBL576348,,CHEMBL576348,8.82,False,http://www.openphacts.org/units/Nanomolar,847090,=,1,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
,2915599,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cccc1C1C(=O)Nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc21,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.93', 'le': '0.31', 'lle': '3.49', 'sei': '8.25'}",CHEMBL583705,,CHEMBL583705,8.09,False,http://www.openphacts.org/units/Nanomolar,847067,=,1,True,=,,IC50,nM,,8.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.2
,2915600,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)C(c2c[nH]c4ccccc24)C(=O)N3)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '13.27', 'le': '0.24', 'lle': '1.08', 'sei': '6.26'}",CHEMBL573096,,CHEMBL573096,6.82,False,http://www.openphacts.org/units/Nanomolar,847079,=,1,True,=,,IC50,nM,,153.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,153.0
,2915601,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)C(c2ncc[nH]2)C(=O)N3)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '17.53', 'le': '0.32', 'lle': '4.15', 'sei': '6.69'}",CHEMBL579053,,CHEMBL579053,8.14,False,http://www.openphacts.org/units/Nanomolar,847073,=,1,True,=,,IC50,nM,,7.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.2
,2915602,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(C)[nH]c(C2C(=O)Nc3ccc(-c4cncc(OC[C@@H](N)Cc5c[nH]c6ccccc56)c4)cc32)c1C,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '14.23', 'le': '0.26', 'lle': '1.62', 'sei': '6.80'}",CHEMBL577567,,CHEMBL577567,7.39,False,http://www.openphacts.org/units/Nanomolar,847078,=,1,True,=,,IC50,nM,,40.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,40.3
,2915603,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)C(c2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '21.03', 'le': '0.38', 'lle': '4.91', 'sei': '9.20'}",CHEMBL573326,,CHEMBL573326,9.77,False,http://www.openphacts.org/units/Nanomolar,847080,=,1,True,=,,IC50,nM,,0.17,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.17
,2915604,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](COc1cncc(-c2ccc3c(c2)C(c2cccs2)C(=O)N3)c1)Cc1c[nH]c2ccccc12,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '18.82', 'le': '0.35', 'lle': '3.73', 'sei': '9.72'}",CHEMBL572884,,CHEMBL572884,9.05,False,http://www.openphacts.org/units/Nanomolar,847839,=,1,True,=,,IC50,nM,,0.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.9
,2915605,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C2C(=O)Nc3ccc(-c4cncc(OC[C@@H](N)Cc5c[nH]c6ccccc56)c4)cc32)o1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '19.13', 'le': '0.35', 'lle': '3.99', 'sei': '8.62'}",CHEMBL575631,,CHEMBL575631,9.15,False,http://www.openphacts.org/units/Nanomolar,847844,=,1,True,=,,IC50,nM,,0.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.7
,2915606,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C2C(=O)Nc3ccc(-c4cncc(OC[C@@H](N)Cc5c[nH]c6ccccc56)c4)cc32)oc1C,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.24', 'le': '0.30', 'lle': '2.53', 'sei': '7.54'}",CHEMBL577797,,CHEMBL577797,8.00,False,http://www.openphacts.org/units/Nanomolar,847848,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,2915607,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc2ccccc2n1C1CCN(Cc2ccc(-c3nc4ccccc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '12.78', 'le': '0.23', 'lle': '-0.32', 'sei': '9.75'}",CHEMBL260397,,CHEMBL260397,6.54,False,http://www.openphacts.org/units/Nanomolar,847805,=,1,True,=,,IC50,nM,,290.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,290.0
,2915608,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1ccc2nc(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)c(-c3ccccc3)nc2c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '11.91', 'le': '0.22', 'lle': '0.48', 'sei': '6.36'}",CHEMBL272292,,CHEMBL272292,6.62,False,http://www.openphacts.org/units/Nanomolar,847806,=,1,True,=,,IC50,nM,,240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,240.0
,2915609,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1ccc2nc(-c3ccccc3)c(-c3ccc(CN4CCC(n5c(=O)[nH]c6ccccc65)CC4)cc3)nc2c1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '12.20', 'le': '0.22', 'lle': '0.64', 'sei': '6.51'}",CHEMBL273160,,CHEMBL273160,6.78,False,http://www.openphacts.org/units/Nanomolar,847807,=,1,True,=,,IC50,nM,,166.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,166.0
,2915610,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4ccc(-n5cnnn5)cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '12.42', 'le': '0.22', 'lle': '1.78', 'sei': '6.52'}",CHEMBL574476,,CHEMBL574476,7.20,False,http://www.openphacts.org/units/Nanomolar,847808,=,1,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,63.0
,2915611,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc(-n5cnnn5)ccc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '13.28', 'le': '0.24', 'lle': '2.28', 'sei': '6.97'}",CHEMBL574289,,CHEMBL574289,7.70,False,http://www.openphacts.org/units/Nanomolar,847809,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
,2915612,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4ccc(Cn5cnnn5)cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '10.04', 'le': '0.18', 'lle': '0.48', 'sei': '5.40'}",CHEMBL583982,,CHEMBL583982,5.96,False,http://www.openphacts.org/units/Nanomolar,847810,=,1,True,=,,IC50,nM,,1089.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1089.0
,2915613,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5cn[nH]c5cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '12.82', 'le': '0.23', 'lle': '0.75', 'sei': '7.40'}",CHEMBL180231,,CHEMBL180231,7.07,False,http://www.openphacts.org/units/Nanomolar,847811,=,1,True,=,,IC50,nM,,85.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,85.0
,2915614,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cnc(-c2ccccc2)c(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)[nH]1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '12.19', 'le': '0.22', 'lle': '1.24', 'sei': '6.71'}",CHEMBL577792,,CHEMBL577792,5.82,False,http://www.openphacts.org/units/Nanomolar,847819,=,1,True,=,,IC50,nM,,1500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1500.0
,2915615,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(-c2ccccc2)c(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)[nH]c1=O,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '12.20', 'le': '0.22', 'lle': '1.11', 'sei': '6.91'}",CHEMBL572629,,CHEMBL572629,6.00,False,http://www.openphacts.org/units/Nanomolar,847823,=,1,True,=,,IC50,nM,,1003.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1003.0
,2915616,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1nc(-c2ccccc2)c(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)[nH]c1=O,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '8.99', 'le': '0.16', 'lle': '-1.04', 'sei': '5.39'}",CHEMBL575838,,CHEMBL575838,4.67,False,http://www.openphacts.org/units/Nanomolar,847845,=,1,True,=,,IC50,nM,,21200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21200.0
,2915617,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(N)c1ccc(-c2nc3ccccc3nc2-c2ccccc2)cc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.11', 'le': '0.29', 'lle': '0.31', 'sei': '10.56'}",CHEMBL362455,,CHEMBL362455,5.47,True,http://www.openphacts.org/units/Nanomolar,847849,=,1,True,=,,IC50,nM,,3400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3400.0
,2915618,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cnc(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)c(-c2ccccc2)[nH]1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '11.56', 'le': '0.21', 'lle': '0.94', 'sei': '6.36'}",CHEMBL440560,,CHEMBL440560,5.52,False,http://www.openphacts.org/units/Nanomolar,847850,=,1,True,=,,IC50,nM,,3029.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3029.0
,2915619,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)c(-c2ccccc2)[nH]c1=O,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '12.45', 'le': '0.23', 'lle': '1.23', 'sei': '7.05'}",CHEMBL178397,,CHEMBL178397,6.12,False,http://www.openphacts.org/units/Nanomolar,847813,=,1,True,=,,IC50,nM,,760.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,760.0
,2915620,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(-c2ccccc2)c(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)nc1Cc1ccc(O)cc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '7.99', 'le': '0.14', 'lle': '-1.22', 'sei': '4.36'}",CHEMBL178133,,CHEMBL178133,4.66,False,http://www.openphacts.org/units/Nanomolar,847814,=,1,True,=,,IC50,nM,,21670.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21670.0
,2915621,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C(Nc2ccccc2F)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.46', 'le': '0.33', 'lle': '2.31', 'sei': '6.41'}",CHEMBL220006,,CHEMBL220006,4.80,False,http://www.openphacts.org/units/Nanomolar,847816,=,1,True,=,,IC50,nM,,15800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15800.0
,2915622,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C(Nc2cccc(F)c2)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.90', 'le': '0.34', 'lle': '2.44', 'sei': '6.58'}",CHEMBL375142,,CHEMBL375142,4.93,False,http://www.openphacts.org/units/Nanomolar,847817,=,1,True,=,,IC50,nM,,11800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11800.0
,2915623,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C(Nc2cc(F)ccc2F)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '15.49', 'le': '0.31', 'lle': '2.17', 'sei': '6.41'}",CHEMBL584181,,CHEMBL584181,4.80,False,http://www.openphacts.org/units/Nanomolar,847820,=,1,True,=,,IC50,nM,,16000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16000.0
,2915624,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc(NC2=C(Cl)C(=O)c3[nH]ncc3C2=O)cc1,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '16.71', 'le': '0.33', 'lle': '2.56', 'sei': '6.32'}",CHEMBL375985,,CHEMBL375985,5.31,False,http://www.openphacts.org/units/Nanomolar,847827,=,1,True,=,,IC50,nM,,4900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4900.0
,2915625,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C(Nc2ccc(C(F)(F)F)cc2)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '14.36', 'le': '0.29', 'lle': '1.54', 'sei': '6.56'}",CHEMBL222254,,CHEMBL222254,4.91,False,http://www.openphacts.org/units/Nanomolar,847832,=,1,True,=,,IC50,nM,,12400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12400.0
,2915626,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C(Nc2cccc(Br)c2)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '13.78', 'le': '0.33', 'lle': '1.75', 'sei': '6.49'}",CHEMBL374701,,CHEMBL374701,4.86,False,http://www.openphacts.org/units/Nanomolar,847833,=,1,True,=,,IC50,nM,,13900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13900.0
,2915627,[],CHEMBL1049250,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C(Sc2cccc(Cl)c2Cl)=C(Cl)C(=O)c2[nH]ncc21,,,CHEMBL1154070,Eur. J. Med. Chem.,2009.0,"{'bei': '13.65', 'le': '0.32', 'lle': '0.57', 'sei': '7.82'}",CHEMBL572400,,CHEMBL572400,4.91,False,http://www.openphacts.org/units/Nanomolar,847836,=,1,True,=,,IC50,nM,,12300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12300.0
,2943698,[],CHEMBL1044077,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC,,,CHEMBL1154692,J. Med. Chem.,2009.0,,CHEMBL571040,,CHEMBL571040,,False,http://www.openphacts.org/units/Nanomolar,854053,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,microM,UO_0000065,,10.0
,2943710,[],CHEMBL1044077,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC,,,CHEMBL1154692,J. Med. Chem.,2009.0,,CHEMBL569880,,CHEMBL569880,,False,http://www.openphacts.org/units/Nanomolar,854054,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,microM,UO_0000065,,10.0
,2993556,[],CHEMBL1040931,Inhibition of human recombinant Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1,,,CHEMBL1156112,J. Med. Chem.,2009.0,,CHEMBL565612,SOTRASTAURIN,CHEMBL565612,,False,http://www.openphacts.org/units/Nanomolar,863023,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,3069169,[],CHEMBL1068578,Inhibition of pleckstrin homology domain of AKT by surface plasmon resonance spectroscopy,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nnc(NS(=O)(=O)c2ccc(NS(=O)(=O)c3ccc4ccccc4c3)cc2)s1,,,CHEMBL1152590,Bioorg. Med. Chem.,2009.0,"{'bei': '9.99', 'le': '0.21', 'lle': '1.00', 'sei': '3.90'}",CHEMBL595786,,CHEMBL595786,4.60,True,http://www.openphacts.org/units/Nanomolar,875167,=,1,True,=,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,3069175,[],CHEMBL1068579,Inhibition of Akt phosphorylation in human BxPC3 cells by Western blotting,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL1152590,Bioorg. Med. Chem.,2009.0,"{'bei': '18.33', 'le': '0.40', 'lle': '3.78', 'sei': '4.80'}",CHEMBL286737,,CHEMBL286737,4.70,True,http://www.openphacts.org/units/Nanomolar,875188,=,1,True,=,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,3069176,[],CHEMBL1068579,Inhibition of Akt phosphorylation in human BxPC3 cells by Western blotting,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL1152590,Bioorg. Med. Chem.,2009.0,,CHEMBL593946,,CHEMBL593946,,True,http://www.openphacts.org/units/Nanomolar,875189,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,3069177,[],CHEMBL1068579,Inhibition of Akt phosphorylation in human BxPC3 cells by Western blotting,B,,,BAO_0000190,BAO_0000219,cell-based format,COCCOCCOCC(=O)Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL1152590,Bioorg. Med. Chem.,2009.0,,CHEMBL611216,,CHEMBL611216,,True,http://www.openphacts.org/units/Nanomolar,875190,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,3069178,[],CHEMBL1068579,Inhibition of Akt phosphorylation in human BxPC3 cells by Western blotting,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL1152590,Bioorg. Med. Chem.,2009.0,"{'bei': '12.18', 'le': '0.25', 'lle': '0.58', 'sei': '4.95'}",CHEMBL595582,,CHEMBL595582,5.00,True,http://www.openphacts.org/units/Nanomolar,875216,=,1,True,=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3069179,[],CHEMBL1068579,Inhibition of Akt phosphorylation in human BxPC3 cells by Western blotting,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL1152590,Bioorg. Med. Chem.,2009.0,"{'bei': '12.70', 'le': '0.26', 'lle': '-0.60', 'sei': '7.23'}",CHEMBL595583,,CHEMBL595583,5.20,True,http://www.openphacts.org/units/Nanomolar,875217,=,1,True,=,,IC50,nM,,6300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,6.3
,3075697,[],CHEMBL1071956,Inhibition of AKT1 in human BT474 cells assessed as phosphorylation of GSK3,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ncccc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '12.98', 'le': '0.24', 'lle': '1.01', 'sei': '5.08'}",CHEMBL594310,,CHEMBL594310,6.03,False,http://www.openphacts.org/units/Nanomolar,873980,=,1,True,=,,IC50,nM,,930.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.93
,3075698,[],CHEMBL1071956,Inhibition of AKT1 in human BT474 cells assessed as phosphorylation of GSK3,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5c(F)cccc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.68', 'le': '0.25', 'lle': '0.83', 'sei': '6.23'}",CHEMBL594309,,CHEMBL594309,6.58,False,http://www.openphacts.org/units/Nanomolar,873979,=,1,True,=,,IC50,nM,,260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.26
,3075699,[],CHEMBL1071956,Inhibition of AKT1 in human BT474 cells assessed as phosphorylation of GSK3,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5cc(F)ccc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.83', 'le': '0.25', 'lle': '0.90', 'sei': '6.30'}",CHEMBL607374,,CHEMBL607374,6.66,False,http://www.openphacts.org/units/Nanomolar,873978,=,1,True,=,,IC50,nM,,220.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.22
,3075700,[],CHEMBL1071956,Inhibition of AKT1 in human BT474 cells assessed as phosphorylation of GSK3,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccc(F)cc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.38', 'le': '0.24', 'lle': '0.68', 'sei': '6.09'}",CHEMBL605528,,CHEMBL605528,6.44,False,http://www.openphacts.org/units/Nanomolar,874546,=,1,True,=,,IC50,nM,,360.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.36
,3075701,[],CHEMBL1071956,Inhibition of AKT1 in human BT474 cells assessed as phosphorylation of GSK3,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1occc1-c1ncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1ccc2[nH]nc(C)c2c1,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.82', 'le': '0.27', 'lle': '1.15', 'sei': '6.69'}",CHEMBL595939,,CHEMBL595939,7.08,False,http://www.openphacts.org/units/Nanomolar,874545,=,1,True,=,,IC50,nM,,84.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.084
,3075702,[],CHEMBL1071956,Inhibition of AKT1 in human BT474 cells assessed as phosphorylation of GSK3,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1[nH]nc2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.59', 'le': '0.25', 'lle': '0.68', 'sei': '5.96'}",CHEMBL593490,,CHEMBL593490,6.30,False,http://www.openphacts.org/units/Nanomolar,874544,=,1,True,=,,IC50,nM,,500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.5
,3075719,[],CHEMBL1071953,Inhibition of truncated AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3cc(F)ccc3O)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.07', 'le': '0.31', 'lle': '2.61', 'sei': '8.24'}",CHEMBL594517,,CHEMBL594517,8.00,False,http://www.openphacts.org/units/Nanomolar,874439,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.01
,3075720,[],CHEMBL1071953,Inhibition of truncated AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3ccco3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.38', 'le': '0.26', 'lle': '0.96', 'sei': '6.78'}",CHEMBL595708,,CHEMBL595708,6.10,False,http://www.openphacts.org/units/Nanomolar,874474,=,1,True,=,,IC50,nM,,790.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.79
,3075721,[],CHEMBL1071953,Inhibition of truncated AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3C#CC(C)(C)O)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '11.30', 'le': '0.21', 'lle': '0.98', 'sei': '5.13'}",CHEMBL594750,,CHEMBL594750,4.98,False,http://www.openphacts.org/units/Nanomolar,874510,=,1,True,=,,IC50,nM,,10500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.5
,3075722,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5cccnc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.22', 'le': '0.31', 'lle': '2.98', 'sei': '6.74'}",CHEMBL605838,,CHEMBL605838,8.00,False,http://www.openphacts.org/units/Nanomolar,874008,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.01
,3075723,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccncc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.98', 'le': '0.31', 'lle': '2.87', 'sei': '6.65'}",CHEMBL593142,,CHEMBL593142,7.89,False,http://www.openphacts.org/units/Nanomolar,873981,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.013
,3075724,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ncccc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.43', 'le': '0.32', 'lle': '3.08', 'sei': '6.82'}",CHEMBL594310,,CHEMBL594310,8.10,False,http://www.openphacts.org/units/Nanomolar,873980,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.008
,3075725,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5c(F)cccc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.69', 'le': '0.34', 'lle': '3.24', 'sei': '8.51'}",CHEMBL594309,,CHEMBL594309,9.00,False,http://www.openphacts.org/units/Nanomolar,873979,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3075726,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5cc(F)ccc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.89', 'le': '0.35', 'lle': '3.34', 'sei': '8.60'}",CHEMBL607374,,CHEMBL607374,9.10,False,http://www.openphacts.org/units/Nanomolar,873978,=,1,True,=,,IC50,nM,,0.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.0008
,3075727,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccc(F)cc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.69', 'le': '0.34', 'lle': '3.24', 'sei': '8.51'}",CHEMBL605528,,CHEMBL605528,9.00,False,http://www.openphacts.org/units/Nanomolar,874546,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3075728,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1occc1-c1ncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1ccc2[nH]nc(C)c2c1,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.05', 'le': '0.35', 'lle': '3.17', 'sei': '8.60'}",CHEMBL595939,,CHEMBL595939,9.10,False,http://www.openphacts.org/units/Nanomolar,874545,=,1,True,=,,IC50,nM,,0.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.0008
,3075729,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1[nH]nc2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.42', 'le': '0.35', 'lle': '3.38', 'sei': '8.51'}",CHEMBL593490,,CHEMBL593490,9.00,True,http://www.openphacts.org/units/Nanomolar,874544,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3075730,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3C#CCCO)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.40', 'le': '0.26', 'lle': '2.52', 'sei': '6.33'}",CHEMBL592898,,CHEMBL592898,6.14,False,http://www.openphacts.org/units/Nanomolar,874543,=,1,True,=,,IC50,nM,,720.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.72
,3075731,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3ccc[nH]3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.47', 'le': '0.33', 'lle': '2.94', 'sei': '8.45'}",CHEMBL594749,,CHEMBL594749,7.82,False,http://www.openphacts.org/units/Nanomolar,874509,=,1,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.015
,3075732,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3ccsc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.57', 'le': '0.31', 'lle': '1.69', 'sei': '9.50'}",CHEMBL604060,,CHEMBL604060,7.30,False,http://www.openphacts.org/units/Nanomolar,874508,=,1,True,=,,IC50,nM,,50.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.05
,3075733,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3cccs3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.12', 'le': '0.30', 'lle': '1.49', 'sei': '9.25'}",CHEMBL594748,,CHEMBL594748,7.10,False,http://www.openphacts.org/units/Nanomolar,874507,=,1,True,=,,IC50,nM,,79.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.079
,3075734,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.85', 'le': '0.34', 'lle': '2.86', 'sei': '8.89'}",CHEMBL595709,,CHEMBL595709,8.00,False,http://www.openphacts.org/units/Nanomolar,874475,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.01
,3075735,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.57', 'le': '0.33', 'lle': '2.61', 'sei': '8.78'}",CHEMBL605733,,CHEMBL605733,8.52,False,http://www.openphacts.org/units/Nanomolar,874473,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.003
,3075736,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3cc(F)cc(F)c3O)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.80', 'le': '0.27', 'lle': '1.67', 'sei': '7.42'}",CHEMBL596379,,CHEMBL596379,7.20,False,http://www.openphacts.org/units/Nanomolar,874472,=,1,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.063
,3075737,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1-c1ncc(OC[C@@H](N)Cc2ccccc2)cc1-c1ccc2[nH]nc(C)c2c1,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.07', 'le': '0.27', 'lle': '1.44', 'sei': '8.13'}",CHEMBL604684,,CHEMBL604684,7.00,False,http://www.openphacts.org/units/Nanomolar,874438,=,1,True,=,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.1
,3075738,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3ccc(O)cc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.99', 'le': '0.25', 'lle': '1.05', 'sei': '6.49'}",CHEMBL595685,,CHEMBL595685,6.30,False,http://www.openphacts.org/units/Nanomolar,874437,=,1,True,=,,IC50,nM,,500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.5
,3075739,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3cccc(O)c3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.76', 'le': '0.29', 'lle': '1.85', 'sei': '7.32'}",CHEMBL595684,,CHEMBL595684,7.10,False,http://www.openphacts.org/units/Nanomolar,874436,=,1,True,=,,IC50,nM,,79.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.079
,3075740,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3ccccc3O)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.37', 'le': '0.31', 'lle': '2.57', 'sei': '8.06'}",CHEMBL595476,,CHEMBL595476,7.82,False,http://www.openphacts.org/units/Nanomolar,874403,=,1,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.015
,3075741,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3ccccc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.80', 'le': '0.30', 'lle': '1.75', 'sei': '9.50'}",CHEMBL605732,,CHEMBL605732,7.30,False,http://www.openphacts.org/units/Nanomolar,874402,=,1,True,=,,IC50,nM,,50.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.05
,3075742,[],CHEMBL1071952,Inhibition of full length AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.26', 'le': '0.35', 'lle': '3.02', 'sei': '8.99'}",CHEMBL379218,,CHEMBL379218,6.90,False,http://www.openphacts.org/units/Nanomolar,874401,=,1,True,=,,IC50,nM,,125.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.125
,3075743,[],CHEMBL1071956,Inhibition of AKT1 in human BT474 cells assessed as phosphorylation of GSK3,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccncc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '11.12', 'le': '0.20', 'lle': '0.15', 'sei': '4.36'}",CHEMBL593142,,CHEMBL593142,5.17,False,http://www.openphacts.org/units/Nanomolar,873981,=,1,True,=,,IC50,nM,,6800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,6.8
,3075744,[],CHEMBL1071956,Inhibition of AKT1 in human BT474 cells assessed as phosphorylation of GSK3,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5cccnc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153241,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '11.55', 'le': '0.21', 'lle': '0.35', 'sei': '4.52'}",CHEMBL605838,,CHEMBL605838,5.37,False,http://www.openphacts.org/units/Nanomolar,874008,=,1,True,=,,IC50,nM,,4300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.3
,3076640,[],CHEMBL1072610,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1occc1-c1ncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1cnc2[nH]nc(C)c2n1,,,CHEMBL1153244,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.77', 'le': '0.34', 'lle': '4.28', 'sei': '6.84'}",CHEMBL596583,,CHEMBL596583,9.00,False,http://www.openphacts.org/units/Nanomolar,874514,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3076646,[],CHEMBL1072610,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1ccc2[nH]nc(C)c2c1,,,CHEMBL1153244,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.30', 'le': '0.31', 'lle': '3.01', 'sei': '6.47'}",CHEMBL593374,,CHEMBL593374,8.52,False,http://www.openphacts.org/units/Nanomolar,873982,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.003
,3076652,[],CHEMBL1072610,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1cnc2[nH]nc(C)c2c1,,,CHEMBL1153244,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.23', 'le': '0.33', 'lle': '4.09', 'sei': '6.22'}",CHEMBL593375,,CHEMBL593375,9.00,False,http://www.openphacts.org/units/Nanomolar,873983,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3076658,[],CHEMBL1072610,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1cnc2[nH]nc(C)c2n1,,,CHEMBL1153244,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.20', 'le': '0.33', 'lle': '4.70', 'sei': '5.71'}",CHEMBL595944,,CHEMBL595944,9.00,False,http://www.openphacts.org/units/Nanomolar,873984,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3076664,[],CHEMBL1072610,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1cc2c(C)n[nH]c2cn1,,,CHEMBL1153244,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.23', 'le': '0.33', 'lle': '4.09', 'sei': '6.22'}",CHEMBL595459,,CHEMBL595459,9.00,False,http://www.openphacts.org/units/Nanomolar,874012,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3076670,[],CHEMBL1072610,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ncc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c(C#N)nc3-c3ccoc3)nc12,,,CHEMBL1153244,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.31', 'le': '0.30', 'lle': '3.71', 'sei': '5.15'}",CHEMBL606467,,CHEMBL606467,8.00,False,http://www.openphacts.org/units/Nanomolar,874013,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.01
,3076676,[],CHEMBL1072610,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(-c2ccoc2)c(-c2cnc3[nH]nc(C)c3n2)cc1OC[C@@H](N)Cc1c[nH]c2ccccc12,,,CHEMBL1153244,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.77', 'le': '0.32', 'lle': '3.80', 'sei': '6.48'}",CHEMBL594523,,CHEMBL594523,8.52,False,http://www.openphacts.org/units/Nanomolar,874014,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.003
,3076682,[],CHEMBL1072610,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2ccccc2)cc1-c1cnc2[nH]nc(C)c2n1,,,CHEMBL1153244,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.05', 'le': '0.33', 'lle': '4.40', 'sei': '5.80'}",CHEMBL594755,,CHEMBL594755,8.22,False,http://www.openphacts.org/units/Nanomolar,874015,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.006
,3076688,[],CHEMBL1072610,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCNc1nc(-c2ccoc2)c(-c2cnc3[nH]nc(C)c3n2)cc1OC[C@@H](N)Cc1ccccc1,,,CHEMBL1153244,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.42', 'le': '0.25', 'lle': '1.94', 'sei': '4.93'}",CHEMBL593573,,CHEMBL593573,6.30,False,http://www.openphacts.org/units/Nanomolar,874058,=,1,True,=,,IC50,nM,,500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.5
,3076694,[],CHEMBL1072610,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c(Cl)[nH]c3ccccc23)cc1-c1cnc2[nH]nc(C)c2n1,,,CHEMBL1153244,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.01', 'le': '0.32', 'lle': '4.04', 'sei': '5.71'}",CHEMBL593813,,CHEMBL593813,9.00,False,http://www.openphacts.org/units/Nanomolar,874059,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3076700,[],CHEMBL1072610,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c(C#N)[nH]c3ccccc23)cc1-c1cnc2[nH]nc(C)c2n1,,,CHEMBL1153244,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.32', 'le': '0.32', 'lle': '4.82', 'sei': '4.96'}",CHEMBL605410,,CHEMBL605410,9.00,False,http://www.openphacts.org/units/Nanomolar,874060,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3076706,[],CHEMBL1072610,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c(C(N)=O)[nH]c3ccccc23)cc1-c1cnc2[nH]nc(C)c2n1,,,CHEMBL1153244,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.74', 'le': '0.31', 'lle': '5.60', 'sei': '4.49'}",CHEMBL594072,,CHEMBL594072,9.00,False,http://www.openphacts.org/units/Nanomolar,874093,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3084399,[],CHEMBL1072678,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21,,,CHEMBL1153138,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.10', 'le': '0.26', 'lle': '1.60', 'sei': '5.38'}",CHEMBL590109,,CHEMBL590109,6.00,False,http://www.openphacts.org/units/Nanomolar,871256,=,1,True,=,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.0
,3086979,[],CHEMBL1069941,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1[nH]nc2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153227,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.42', 'le': '0.35', 'lle': '3.38', 'sei': '8.51'}",CHEMBL593490,,CHEMBL593490,9.00,False,http://www.openphacts.org/units/Nanomolar,872837,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3086980,[],CHEMBL1069941,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ncc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153227,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.37', 'le': '0.35', 'lle': '3.98', 'sei': '7.59'}",CHEMBL596072,,CHEMBL596072,9.00,False,http://www.openphacts.org/units/Nanomolar,872887,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3086981,[],CHEMBL1069941,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)nc12,,,CHEMBL1153227,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.05', 'le': '0.31', 'lle': '2.90', 'sei': '6.68'}",CHEMBL596073,,CHEMBL596073,7.92,False,http://www.openphacts.org/units/Nanomolar,872888,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.012
,3086982,[],CHEMBL1069941,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ncc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)nc12,,,CHEMBL1153227,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.69', 'le': '0.34', 'lle': '4.29', 'sei': '6.61'}",CHEMBL596290,,CHEMBL596290,8.70,False,http://www.openphacts.org/units/Nanomolar,872889,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.002
,3086983,[],CHEMBL1069941,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)nc12,,,CHEMBL1153227,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.33', 'le': '0.35', 'lle': '4.59', 'sei': '6.84'}",CHEMBL603197,,CHEMBL603197,9.00,False,http://www.openphacts.org/units/Nanomolar,872890,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3086984,[],CHEMBL1069941,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2cnc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)cc12,,,CHEMBL1153227,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.37', 'le': '0.35', 'lle': '3.98', 'sei': '7.59'}",CHEMBL594933,,CHEMBL594933,9.00,False,http://www.openphacts.org/units/Nanomolar,872920,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.001
,3088558,[],CHEMBL1049483,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCOc1ccc2c(c1)CCn1nc(-c3ccc(Oc4ccccc4)cc3)c(C(N)=O)c1N2,,,CHEMBL1153155,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL591325,,CHEMBL591325,,False,http://www.openphacts.org/units/Nanomolar,872197,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,3088622,[],CHEMBL1049496,Inhibition of PKB,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)[nH]c(C(=O)c2c(F)cccc2F)c1N,,,CHEMBL1153156,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL589630,,CHEMBL589630,,False,http://www.openphacts.org/units/Nanomolar,871634,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,3089518,[],CHEMBL1067365,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](N)C2)ccc2[nH]ccc12,,,CHEMBL1153090,Bioorg. Med. Chem.,2009.0,"{'bei': '14.03', 'le': '0.26', 'lle': '1.31', 'sei': '5.99'}",CHEMBL606245,,CHEMBL606245,5.62,False,http://www.openphacts.org/units/Nanomolar,876940,=,1,True,=,,IC50,nM,,2400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2400.0
,3091559,[],CHEMBL1067153,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2nc3[nH]nc(C)c3c(OC)c2c1,,,CHEMBL1156890,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '20.32', 'le': '0.38', 'lle': '2.50', 'sei': '8.23'}",CHEMBL603097,,CHEMBL603097,4.94,False,http://www.openphacts.org/units/Nanomolar,886171,=,1,True,=,,IC50,nM,,11400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11400.0
,3099473,[],CHEMBL1070205,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCCNc1nnc(Sc2ncc([N+](=O)[O-])s2)s1,,,CHEMBL1159095,Bioorg. Med. Chem.,2010.0,,CHEMBL609039,,CHEMBL609039,,False,http://www.openphacts.org/units/Nanomolar,885611,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,3099474,[],CHEMBL1070205,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COCCNc1nnc(Sc2ncc([N+](=O)[O-])s2)s1,,,CHEMBL1159095,Bioorg. Med. Chem.,2010.0,,CHEMBL611079,,CHEMBL611079,,False,http://www.openphacts.org/units/Nanomolar,885613,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,3099475,[],CHEMBL1070205,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CCNc2nnc(Sc3ncc([N+](=O)[O-])s3)s2)cc1OC,,,CHEMBL1159095,Bioorg. Med. Chem.,2010.0,,CHEMBL599111,,CHEMBL599111,,False,http://www.openphacts.org/units/Nanomolar,885614,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,3099476,[],CHEMBL1070205,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCC(C)Nc1nnc(Sc2ncc([N+](=O)[O-])s2)s1,,,CHEMBL1159095,Bioorg. Med. Chem.,2010.0,,CHEMBL599518,,CHEMBL599518,,False,http://www.openphacts.org/units/Nanomolar,885704,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,3104134,[],CHEMBL1066414,Inhibition of recombinant AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Oc1ccc2ncccc2c1)c1c(Cl)ccc(F)c1Cl,,,CHEMBL1156877,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL600795,,CHEMBL600795,,False,http://www.openphacts.org/units/Nanomolar,885917,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,3104181,[],CHEMBL1066414,Inhibition of recombinant AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Oc1ccc2ncc(C3CC3C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl,,,CHEMBL1156877,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL602472,,CHEMBL602472,,False,http://www.openphacts.org/units/Nanomolar,886074,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,3104230,[],CHEMBL1066414,Inhibition of recombinant AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Oc1ccc2ncc(/C=C/C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl,,,CHEMBL1156877,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL602471,,CHEMBL602471,,False,http://www.openphacts.org/units/Nanomolar,886073,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,3117914,[],CHEMBL1072190,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1,,,CHEMBL1157561,J. Med. Chem.,2010.0,,CHEMBL599224,,CHEMBL599224,,False,http://www.openphacts.org/units/Nanomolar,887311,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3117967,[],CHEMBL1072190,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2,,,CHEMBL1157561,J. Med. Chem.,2010.0,,CHEMBL599428,,CHEMBL599428,,False,http://www.openphacts.org/units/Nanomolar,887313,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3118020,[],CHEMBL1072190,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2,,,CHEMBL1157561,J. Med. Chem.,2010.0,,CHEMBL597754,,CHEMBL597754,,False,http://www.openphacts.org/units/Nanomolar,887500,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3127183,[],CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,NC1(COCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL597793,,CHEMBL597793,9.23,False,http://www.openphacts.org/units/Nanomolar,879288,=,1,True,=,,IC50,nM,,0.59,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.59
,3127184,[],CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL263664,,CHEMBL263664,9.18,False,http://www.openphacts.org/units/Nanomolar,879007,=,1,True,=,,IC50,nM,,0.66,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.66
,3127186,[],CHEMBL1074386,Inhibition of PKB in human PC3M cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,NC1(Cc2ccc(Cl)cc2Cl)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL597414,,CHEMBL597414,8.72,False,http://www.openphacts.org/units/Nanomolar,879177,=,1,True,=,,IC50,nM,,1.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.9
,3127190,[],CHEMBL1074386,Inhibition of PKB in human PC3M cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL263664,,CHEMBL263664,8.52,False,http://www.openphacts.org/units/Nanomolar,879007,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,3127191,[],CHEMBL1074386,Inhibition of PKB in human PC3M cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,NC1(C(=O)NCc2ccc(Cl)cc2Cl)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL599849,,CHEMBL599849,8.42,False,http://www.openphacts.org/units/Nanomolar,879444,=,1,True,=,,IC50,nM,,3.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.8
,3127193,[],CHEMBL1074386,Inhibition of PKB in human PC3M cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(Cc1ccc(Cl)cc1)C(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL597803,,CHEMBL597803,8.38,False,http://www.openphacts.org/units/Nanomolar,879539,=,1,True,=,,IC50,nM,,4.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.2
,3127199,[],CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccc(CC2(N)CCN(c3ccnc4[nH]ncc34)CC2)cc1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL603675,,CHEMBL603675,8.19,False,http://www.openphacts.org/units/Nanomolar,879691,=,1,True,=,,IC50,nM,,6.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.5
,3127202,[],CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ccnc3[nH]ccc23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL599448,,CHEMBL599448,8.14,False,http://www.openphacts.org/units/Nanomolar,879614,=,1,True,=,,IC50,nM,,7.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.2
,3127221,[],CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]c(=O)[nH]c23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL598842,,CHEMBL598842,,False,http://www.openphacts.org/units/Nanomolar,879689,>,1,True,>,,IC50,nM,,50.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50.0
Not Determined,3127229,[],CHEMBL1074386,Inhibition of PKB in human PC3M cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,NC1(COCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL597793,,CHEMBL597793,,False,,879288,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,3127231,[],CHEMBL1074386,Inhibition of PKB in human PC3M cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ccnc3[nH]ccc23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL599448,,CHEMBL599448,,False,,879614,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,3127233,[],CHEMBL1074386,Inhibition of PKB in human PC3M cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]c(=O)[nH]c23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL598842,,CHEMBL598842,,False,,879689,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,3127235,[],CHEMBL1074386,Inhibition of PKB in human PC3M cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccc(CC2(N)CCN(c3ccnc4[nH]ncc34)CC2)cc1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL603675,,CHEMBL603675,,False,,879691,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,3127237,[],CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,NC1(Cc2ccc(Cl)cc2Cl)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL597414,,CHEMBL597414,,False,,879177,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,3127239,[],CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,NC1(C(=O)NCc2ccc(Cl)cc2Cl)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL599849,,CHEMBL599849,,False,,879444,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,3127240,[],CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(Cc1ccc(Cl)cc1)C(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1157584,J. Med. Chem.,2010.0,,CHEMBL597803,,CHEMBL597803,,False,,879539,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3128302,[],CHEMBL1074428,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,,,CHEMBL1157586,Bioorg. Med. Chem.,2010.0,,CHEMBL1230607,PHA-793887,CHEMBL1230607,,False,http://www.openphacts.org/units/Nanomolar,879181,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3128303,[],CHEMBL1074428,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C,,,CHEMBL1157586,Bioorg. Med. Chem.,2010.0,,CHEMBL604712,,CHEMBL604712,,False,http://www.openphacts.org/units/Nanomolar,878582,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3186211,[],CHEMBL1111477,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCNC3)c21,,,CHEMBL1155389,J. Med. Chem.,2010.0,"{'bei': '20.44', 'le': '0.38', 'lle': '7.12', 'sei': '6.34'}",CHEMBL521642,,CHEMBL521642,8.70,False,http://www.openphacts.org/units/Nanomolar,896186,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,3186221,[],CHEMBL1111477,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2cc3c(ccn4cnnc34)nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL1155389,J. Med. Chem.,2010.0,"{'bei': '14.90', 'le': '0.27', 'lle': '2.23', 'sei': '8.33'}",CHEMBL447328,,CHEMBL447328,8.40,False,http://www.openphacts.org/units/Nanomolar,896102,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,3186264,[],CHEMBL1111477,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL1155389,J. Med. Chem.,2010.0,"{'bei': '13.12', 'le': '0.24', 'lle': '0.92', 'sei': '7.58'}",CHEMBL258844,,CHEMBL258844,7.24,True,http://www.openphacts.org/units/Nanomolar,896100,=,1,True,=,,IC50,nM,,58.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,58.0
,3186266,[],CHEMBL1111477,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(OC3CCNCC3)c21,,,CHEMBL1155389,J. Med. Chem.,2010.0,"{'bei': '21.56', 'le': '0.40', 'lle': '5.89', 'sei': '6.08'}",CHEMBL493911,,CHEMBL493911,7.10,False,http://www.openphacts.org/units/Nanomolar,896185,=,1,True,=,,IC50,nM,,79.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,79.0
,3186277,[],CHEMBL1111477,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nnnc1-c1cnc(-c2ccc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2)c(-c2ccccc2)c1,,,CHEMBL1155389,J. Med. Chem.,2010.0,"{'bei': '12.10', 'le': '0.22', 'lle': '1.47', 'sei': '6.73'}",CHEMBL182101,,CHEMBL182101,6.56,False,http://www.openphacts.org/units/Nanomolar,896101,=,1,True,=,,IC50,nM,,273.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,273.0
,3186294,[],CHEMBL1111477,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL1155389,J. Med. Chem.,2010.0,"{'bei': '19.87', 'le': '0.36', 'lle': '3.86', 'sei': '9.09'}",CHEMBL1079175,MK-2206,CHEMBL1079175,8.10,False,http://www.openphacts.org/units/Nanomolar,896183,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
,3192021,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccccc4)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.53', 'le': '0.37', 'lle': '3.75', 'sei': '7.70'}",CHEMBL1087281,,CHEMBL1087281,7.12,False,http://www.openphacts.org/units/Nanomolar,892922,=,1,True,=,,IC50,nM,,76.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,76.0
,3192024,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3nnc(NC[C@H](N)Cc4ccccc4)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1088612,,CHEMBL1088612,,False,http://www.openphacts.org/units/Nanomolar,892923,>,1,True,>,,IC50,nM,,2200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2200.0
,3192027,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccccc4F)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.53', 'le': '0.34', 'lle': '3.19', 'sei': '7.25'}",CHEMBL1088613,,CHEMBL1088613,6.70,False,http://www.openphacts.org/units/Nanomolar,892924,=,1,True,=,,IC50,nM,,198.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,198.0
,3192030,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccccc4Cl)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.37', 'le': '0.37', 'lle': '3.30', 'sei': '7.92'}",CHEMBL1080891,,CHEMBL1080891,7.33,False,http://www.openphacts.org/units/Nanomolar,891760,=,1,True,=,,IC50,nM,,47.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,47.0
,3192033,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccccc4C(F)(F)F)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.59', 'le': '0.29', 'lle': '1.92', 'sei': '6.82'}",CHEMBL1080892,,CHEMBL1080892,6.31,False,http://www.openphacts.org/units/Nanomolar,891761,=,1,True,=,,IC50,nM,,491.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,491.0
,3192036,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4cccc(F)c4)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.40', 'le': '0.38', 'lle': '3.91', 'sei': '8.02'}",CHEMBL1076553,,CHEMBL1076553,7.42,False,http://www.openphacts.org/units/Nanomolar,891762,=,1,True,=,,IC50,nM,,38.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,38.0
,3192039,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4cccc(Cl)c4)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.36', 'le': '0.39', 'lle': '3.69', 'sei': '8.35'}",CHEMBL1080893,,CHEMBL1080893,7.72,False,http://www.openphacts.org/units/Nanomolar,891763,=,1,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.0
,3192042,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4cccc(C(F)(F)F)c4)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.99', 'le': '0.37', 'lle': '3.82', 'sei': '8.88'}",CHEMBL1080561,,CHEMBL1080561,8.21,False,http://www.openphacts.org/units/Nanomolar,891764,=,1,True,=,,IC50,nM,,6.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.1
,3193161,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccc(Cl)cc4)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '20.18', 'le': '0.41', 'lle': '4.02', 'sei': '8.70'}",CHEMBL1080740,,CHEMBL1080740,8.05,False,http://www.openphacts.org/units/Nanomolar,891837,=,1,True,=,,IC50,nM,,8.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.9
,3193164,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.10', 'le': '0.38', 'lle': '3.87', 'sei': '8.93'}",CHEMBL1080911,,CHEMBL1080911,8.26,False,http://www.openphacts.org/units/Nanomolar,891838,=,1,True,=,,IC50,nM,,5.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.5
,3193167,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccc(Cl)cc4Cl)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.87', 'le': '0.38', 'lle': '3.06', 'sei': '8.37'}",CHEMBL1080912,,CHEMBL1080912,7.75,False,http://www.openphacts.org/units/Nanomolar,891839,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,3193170,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccc(F)c(F)c4)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.61', 'le': '0.38', 'lle': '4.20', 'sei': '8.49'}",CHEMBL1080913,,CHEMBL1080913,7.85,False,http://www.openphacts.org/units/Nanomolar,891840,=,1,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
,3193173,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccccc4)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.99', 'le': '0.33', 'lle': '2.80', 'sei': '6.95'}",CHEMBL1081426,,CHEMBL1081426,6.43,False,http://www.openphacts.org/units/Nanomolar,891841,=,1,True,=,,IC50,nM,,370.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,370.0
,3193176,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1nnc(-c2ccc3[nH]nc(C4CC4)c3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.70', 'le': '0.29', 'lle': '1.78', 'sei': '7.29'}",CHEMBL1081437,,CHEMBL1081437,6.74,False,http://www.openphacts.org/units/Nanomolar,891910,=,1,True,=,,IC50,nM,,181.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,181.0
,3193179,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1nnc(-c2ccc3[nH]nc(-c4ccccc4)c3c2)s1)Cc1cccc(C(F)(F)F)c1,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '12.91', 'le': '0.25', 'lle': '0.63', 'sei': '6.90'}",CHEMBL1081438,,CHEMBL1081438,6.38,False,http://www.openphacts.org/units/Nanomolar,891911,=,1,True,=,,IC50,nM,,413.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,413.0
,3193182,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1cccc(C(F)(F)F)c1,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.17', 'le': '0.36', 'lle': '3.52', 'sei': '8.22'}",CHEMBL1076565,,CHEMBL1076565,7.60,False,http://www.openphacts.org/units/Nanomolar,891912,=,1,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
,3193185,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(F)cc1,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.46', 'le': '0.34', 'lle': '3.23', 'sei': '6.96'}",CHEMBL1081439,,CHEMBL1081439,6.43,False,http://www.openphacts.org/units/Nanomolar,891913,=,1,True,=,,IC50,nM,,368.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,368.0
,3193188,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(Cl)cc1,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.80', 'le': '0.40', 'lle': '3.90', 'sei': '8.24'}",CHEMBL1081451,,CHEMBL1081451,7.62,False,http://www.openphacts.org/units/Nanomolar,891998,=,1,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
,3193191,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.65', 'le': '0.39', 'lle': '4.14', 'sei': '8.89'}",CHEMBL1081628,,CHEMBL1081628,8.22,False,http://www.openphacts.org/units/Nanomolar,891999,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,3193194,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(Cl)cc1Cl,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.64', 'le': '0.37', 'lle': '3.03', 'sei': '8.00'}",CHEMBL1076581,,CHEMBL1076581,7.40,False,http://www.openphacts.org/units/Nanomolar,892000,=,1,True,=,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,40.0
,3193203,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2cc(-c3nnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)ccc2cn1,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.78', 'le': '0.29', 'lle': '1.49', 'sei': '8.54'}",CHEMBL1081629,,CHEMBL1081629,6.55,False,http://www.openphacts.org/units/Nanomolar,892002,=,1,True,=,,IC50,nM,,280.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,280.0
,3193207,[],CHEMBL1104223,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.91', 'le': '0.29', 'lle': '2.06', 'sei': '6.97'}",CHEMBL1080911,,CHEMBL1080911,6.45,False,http://www.openphacts.org/units/Nanomolar,891838,=,1,True,=,,IC50,nM,,357.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,357.0
,3193208,[],CHEMBL1104224,Inhibition of human AKT1 in human MDA-MB-468 cells assessed as phosphorylation-mediated nuclear translocation of GFP-tagged FKHRL1 by fluorescence microscopy,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc12,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.98', 'le': '0.29', 'lle': '2.09', 'sei': '7.00'}",CHEMBL1080911,,CHEMBL1080911,6.48,False,http://www.openphacts.org/units/Nanomolar,891838,=,1,True,=,,IC50,nM,,333.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,333.0
,3193212,[],CHEMBL1104223,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.18', 'le': '0.30', 'lle': '2.27', 'sei': '6.87'}",CHEMBL1081628,,CHEMBL1081628,6.35,False,http://www.openphacts.org/units/Nanomolar,891999,=,1,True,=,,IC50,nM,,444.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,444.0
,3193213,[],CHEMBL1104224,Inhibition of human AKT1 in human MDA-MB-468 cells assessed as phosphorylation-mediated nuclear translocation of GFP-tagged FKHRL1 by fluorescence microscopy,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.28', 'le': '0.32', 'lle': '2.73', 'sei': '7.36'}",CHEMBL1081628,,CHEMBL1081628,6.81,False,http://www.openphacts.org/units/Nanomolar,891999,=,1,True,=,,IC50,nM,,154.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,154.0
,3193217,[],CHEMBL1104223,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.38', 'le': '0.30', 'lle': '1.86', 'sei': '8.61'}",CHEMBL1080569,,CHEMBL1080569,6.61,False,http://www.openphacts.org/units/Nanomolar,892001,=,1,True,=,,IC50,nM,,247.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,247.0
,3193218,[],CHEMBL1104224,Inhibition of human AKT1 in human MDA-MB-468 cells assessed as phosphorylation-mediated nuclear translocation of GFP-tagged FKHRL1 by fluorescence microscopy,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.34', 'le': '0.28', 'lle': '1.41', 'sei': '8.03'}",CHEMBL1080569,,CHEMBL1080569,6.16,False,http://www.openphacts.org/units/Nanomolar,892001,=,1,True,=,,IC50,nM,,695.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,695.0
,3193232,[],CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154933,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.85', 'le': '0.39', 'lle': '3.77', 'sei': '11.11'}",CHEMBL1080569,,CHEMBL1080569,8.52,True,http://www.openphacts.org/units/Nanomolar,892001,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,3196136,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.78', 'le': '0.39', 'lle': '3.74', 'sei': '11.07'}",CHEMBL1080569,,CHEMBL1080569,8.49,False,http://www.openphacts.org/units/Nanomolar,891700,=,1,True,=,,IC50,nM,,3.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.2
,3196139,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.37', 'le': '0.30', 'lle': '1.85', 'sei': '8.61'}",CHEMBL1080569,,CHEMBL1080569,6.60,True,http://www.openphacts.org/units/Nanomolar,891700,=,1,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.25
,3196140,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1ncc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.39', 'le': '0.38', 'lle': '2.95', 'sei': '13.02'}",CHEMBL1081263,,CHEMBL1081263,8.31,False,http://www.openphacts.org/units/Nanomolar,891777,=,1,True,=,,IC50,nM,,4.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.9
,3196143,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1ncc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.86', 'le': '0.29', 'lle': '1.01', 'sei': '9.97'}",CHEMBL1081263,,CHEMBL1081263,6.37,False,http://www.openphacts.org/units/Nanomolar,891777,=,1,True,=,,IC50,nM,,430.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.43
,3196144,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1cnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.92', 'le': '0.29', 'lle': '1.03', 'sei': '10.02'}",CHEMBL1081425,,CHEMBL1081425,6.39,False,http://www.openphacts.org/units/Nanomolar,891778,=,1,True,=,,IC50,nM,,404.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,404.0
Not Determined,3196147,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1cnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1081425,,CHEMBL1081425,,False,,891778,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3196148,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1cc(-c2ccc3cnccc3c2)no1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.84', 'le': '0.35', 'lle': '2.88', 'sei': '10.09'}",CHEMBL1081104,,CHEMBL1081104,7.77,False,http://www.openphacts.org/units/Nanomolar,891779,=,1,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.0
Not Determined,3196151,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1cc(-c2ccc3cnccc3c2)no1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1081104,,CHEMBL1081104,,False,,891779,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3196152,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CCc1cc(-c2ccc3cnccc3c2)no1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.98', 'le': '0.34', 'lle': '1.99', 'sei': '11.39'}",CHEMBL1081105,,CHEMBL1081105,7.40,False,http://www.openphacts.org/units/Nanomolar,891780,=,1,True,=,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,40.0
,3196155,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CCc1cc(-c2ccc3cnccc3c2)no1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.17', 'le': '0.25', 'lle': '0.01', 'sei': '8.35'}",CHEMBL1081105,,CHEMBL1081105,5.42,False,http://www.openphacts.org/units/Nanomolar,891780,=,1,True,=,,IC50,nM,,3800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.8
,3196156,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CCc1nc(-c2ccc3cnccc3c2)no1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.05', 'le': '0.26', 'lle': '0.99', 'sei': '7.45'}",CHEMBL1081118,,CHEMBL1081118,5.80,False,http://www.openphacts.org/units/Nanomolar,891852,=,1,True,=,,IC50,nM,,1600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1600.0
Not Determined,3196159,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CCc1nc(-c2ccc3cnccc3c2)no1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1081118,,CHEMBL1081118,,False,,891852,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3196160,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)o1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.10', 'le': '0.32', 'lle': '2.78', 'sei': '7.87'}",CHEMBL1081119,,CHEMBL1081119,7.07,False,http://www.openphacts.org/units/Nanomolar,891853,=,1,True,=,,IC50,nM,,85.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,85.0
Not Determined,3196163,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)o1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1081119,,CHEMBL1081119,,False,,891853,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3196164,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc2cc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)ccc2cn1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.89', 'le': '0.35', 'lle': '3.00', 'sei': '8.83'}",CHEMBL1081295,,CHEMBL1081295,7.94,False,http://www.openphacts.org/units/Nanomolar,891854,=,1,True,=,,IC50,nM,,11.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.6
,3196167,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1cc2cc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)ccc2cn1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.64', 'le': '0.27', 'lle': '1.11', 'sei': '6.73'}",CHEMBL1081295,,CHEMBL1081295,6.05,False,http://www.openphacts.org/units/Nanomolar,891854,=,1,True,=,,IC50,nM,,890.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.89
,3196168,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1ncc(-c2ccc3cncnc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.36', 'le': '0.34', 'lle': '2.71', 'sei': '9.72'}",CHEMBL1081296,,CHEMBL1081296,7.46,False,http://www.openphacts.org/units/Nanomolar,891855,=,1,True,=,,IC50,nM,,35.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,35.0
,3196171,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1ncc(-c2ccc3cncnc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.71', 'le': '0.27', 'lle': '1.14', 'sei': '7.67'}",CHEMBL1081296,,CHEMBL1081296,5.89,False,http://www.openphacts.org/units/Nanomolar,891855,=,1,True,=,,IC50,nM,,1300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.3
,3196172,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1ncc(-c2ccc3nnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.95', 'le': '0.31', 'lle': '2.10', 'sei': '8.93'}",CHEMBL1081974,,CHEMBL1081974,6.85,False,http://www.openphacts.org/units/Nanomolar,891924,=,1,True,=,,IC50,nM,,141.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,141.0
Not Determined,3196175,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1ncc(-c2ccc3nnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1081974,,CHEMBL1081974,,False,,891924,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3196176,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1ncc(-c2ccc3cn[nH]c3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.88', 'le': '0.29', 'lle': '1.52', 'sei': '7.80'}",CHEMBL1079625,,CHEMBL1079625,6.21,False,http://www.openphacts.org/units/Nanomolar,891925,=,1,True,=,,IC50,nM,,613.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,613.0
Not Determined,3196179,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1ncc(-c2ccc3cn[nH]c3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1079625,,CHEMBL1079625,,False,,891925,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3196180,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1ncc2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc21,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.02', 'le': '0.28', 'lle': '1.35', 'sei': '8.80'}",CHEMBL1079626,,CHEMBL1079626,6.05,False,http://www.openphacts.org/units/Nanomolar,891926,=,1,True,=,,IC50,nM,,895.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,895.0
Not Determined,3196183,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ncc2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc21,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1079626,,CHEMBL1079626,,False,,891926,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3196184,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(N)c2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc21,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '12.58', 'le': '0.25', 'lle': '1.34', 'sei': '5.93'}",CHEMBL1079627,,CHEMBL1079627,5.62,False,http://www.openphacts.org/units/Nanomolar,891927,=,1,True,=,,IC50,nM,,2406.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2406.0
Not Determined,3196187,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1nc(N)c2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc21,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1079627,,CHEMBL1079627,,False,,891927,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3196188,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1noc2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc12,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.64', 'le': '0.29', 'lle': '1.81', 'sei': '6.16'}",CHEMBL1081660,,CHEMBL1081660,6.34,False,http://www.openphacts.org/units/Nanomolar,892013,=,1,True,=,,IC50,nM,,453.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,453.0
Not Determined,3196191,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1noc2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc12,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1081660,,CHEMBL1081660,,False,,892013,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3196192,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1ncc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.33', 'le': '0.38', 'lle': '3.38', 'sei': '10.14'}",CHEMBL1081829,,CHEMBL1081829,8.07,False,http://www.openphacts.org/units/Nanomolar,892014,=,1,True,=,,IC50,nM,,8.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.5
,3196195,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1ncc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.70', 'le': '0.29', 'lle': '1.45', 'sei': '7.71'}",CHEMBL1081829,,CHEMBL1081829,6.14,False,http://www.openphacts.org/units/Nanomolar,892014,=,1,True,=,,IC50,nM,,730.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.73
,3196196,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1ncc(-c2ccc3nnn(N)c3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.41', 'le': '0.32', 'lle': '3.84', 'sei': '6.61'}",CHEMBL1081830,,CHEMBL1081830,7.11,False,http://www.openphacts.org/units/Nanomolar,892015,=,1,True,=,,IC50,nM,,77.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,77.0
Not Determined,3196199,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1ncc(-c2ccc3nnn(N)c3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1081830,,CHEMBL1081830,,False,,892015,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3196200,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1ncc(-c2ccc3c(c2)CC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.89', 'le': '0.35', 'lle': '3.43', 'sei': '9.67'}",CHEMBL1081831,,CHEMBL1081831,7.74,False,http://www.openphacts.org/units/Nanomolar,892016,=,1,True,=,,IC50,nM,,18.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.3
,3196203,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1ncc(-c2ccc3c(c2)CC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.08', 'le': '0.30', 'lle': '2.21', 'sei': '8.15'}",CHEMBL1081831,,CHEMBL1081831,6.52,False,http://www.openphacts.org/units/Nanomolar,892016,=,1,True,=,,IC50,nM,,300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.3
,3196204,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1ncc(-c2ccc3[nH]c(=O)oc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.64', 'le': '0.37', 'lle': '3.85', 'sei': '8.35'}",CHEMBL1081852,,CHEMBL1081852,8.10,False,http://www.openphacts.org/units/Nanomolar,892097,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
,3196207,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1ncc(-c2ccc3[nH]c(=O)oc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.50', 'le': '0.29', 'lle': '2.05', 'sei': '6.50'}",CHEMBL1081852,,CHEMBL1081852,6.30,False,http://www.openphacts.org/units/Nanomolar,892097,=,1,True,=,,IC50,nM,,500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.5
,3196208,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1ncc(-c2ccc3[nH]c(=O)sc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.80', 'le': '0.34', 'lle': '2.86', 'sei': '9.03'}",CHEMBL1081853,,CHEMBL1081853,7.57,False,http://www.openphacts.org/units/Nanomolar,892098,=,1,True,=,,IC50,nM,,27.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,27.0
,3196211,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1ncc(-c2ccc3[nH]c(=O)sc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.40', 'le': '0.27', 'lle': '1.33', 'sei': '7.20'}",CHEMBL1081853,,CHEMBL1081853,6.04,False,http://www.openphacts.org/units/Nanomolar,892098,=,1,True,=,,IC50,nM,,920.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.92
,3196212,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(=O)[nH]c2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc21,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.46', 'le': '0.34', 'lle': '3.82', 'sei': '8.80'}",CHEMBL1082016,,CHEMBL1082016,7.81,False,http://www.openphacts.org/units/Nanomolar,892099,=,1,True,=,,IC50,nM,,15.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.4
,3196215,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(=O)[nH]c2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc21,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.86', 'le': '0.27', 'lle': '2.21', 'sei': '6.99'}",CHEMBL1082016,,CHEMBL1082016,6.20,False,http://www.openphacts.org/units/Nanomolar,892099,=,1,True,=,,IC50,nM,,630.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.63
,3196216,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1ncc(-c2ccc3c(c2)CCC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '12.27', 'le': '0.24', 'lle': '0.78', 'sei': '6.85'}",CHEMBL1082017,,CHEMBL1082017,5.48,False,http://www.openphacts.org/units/Nanomolar,892100,=,1,True,=,,IC50,nM,,3315.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3315.0
Not Determined,3196219,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1ncc(-c2ccc3c(c2)CCC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1082017,,CHEMBL1082017,,False,,892100,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3196220,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1ncc(-c2ccc3cn[nH]c(=O)c3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1082030,,CHEMBL1082030,,False,http://www.openphacts.org/units/Nanomolar,892177,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
Not Determined,3196223,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1ncc(-c2ccc3cn[nH]c(=O)c3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1082030,,CHEMBL1082030,,False,,892177,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3196224,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(-c2cnc(NC[C@@H](N)Cc3ccc(C(F)(F)F)cc3)s2)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1081028,,CHEMBL1081028,,False,http://www.openphacts.org/units/Nanomolar,892178,>,1,True,>,,IC50,nM,,3000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3000.0
Not Determined,3196227,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1ccc(-c2cnc(NC[C@@H](N)Cc3ccc(C(F)(F)F)cc3)s2)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1081028,,CHEMBL1081028,,False,,892178,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3196228,[],CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1ncc(-c2ccc3c(c2)CNC3=O)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.24', 'le': '0.32', 'lle': '2.97', 'sei': '8.77'}",CHEMBL1081029,,CHEMBL1081029,7.02,False,http://www.openphacts.org/units/Nanomolar,892179,=,1,True,=,,IC50,nM,,95.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,95.0
,3196231,[],CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1ncc(-c2ccc3c(c2)CNC3=O)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1154944,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '12.07', 'le': '0.24', 'lle': '1.17', 'sei': '6.52'}",CHEMBL1081029,,CHEMBL1081029,5.22,False,http://www.openphacts.org/units/Nanomolar,892179,=,1,True,=,,IC50,nM,,6000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,6.0
,3199573,[],CHEMBL1108601,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CC1=C(C#N)c2nc(N)c(C#N)c(C)c2/C1=C/c1ccc(-c2cccc(C(=O)O)c2)o1,,,CHEMBL1154821,Eur. J. Med. Chem.,2010.0,"{'bei': '10.33', 'le': '0.19', 'lle': '-0.43', 'sei': '3.08'}",CHEMBL193261,,CHEMBL193261,4.22,False,http://www.openphacts.org/units/Nanomolar,893290,=,1,True,=,,IC50,nM,,60200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,60.2
,3199574,[],CHEMBL1108601,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CC1=C(C#N)c2nc(N)c(C#N)c(C)c2/C1=C/c1ccc(-c2ccc(C(=O)O)cc2)o1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154821,Eur. J. Med. Chem.,2010.0,,CHEMBL365978,,CHEMBL365978,,False,http://www.openphacts.org/units/Nanomolar,893388,=,1,True,=,,IC50,nM,,126000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,126.0
,3210404,[],CHEMBL1109421,Inhibition of Akt after 1 hr,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1,,,CHEMBL1153704,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '8.54', 'le': '0.16', 'lle': '-1.77', 'sei': '4.47'}",CHEMBL1081198,,CHEMBL1081198,4.30,False,http://www.openphacts.org/units/Nanomolar,890197,=,1,True,=,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,3235772,[],CHEMBL1113529,Inhibition of PKB by radioactive kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CS)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1156226,Bioorg. Med. Chem.,2010.0,"{'bei': '6.96', 'le': '0.14', 'lle': '8.55', 'sei': '1.69'}",CHEMBL1090008,,CHEMBL1090008,6.40,False,http://www.openphacts.org/units/Nanomolar,904778,=,1,True,=,,IC50,nM,,400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.4
,3235773,[],CHEMBL1113529,Inhibition of PKB by radioactive kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1156226,Bioorg. Med. Chem.,2010.0,"{'bei': '5.74', 'le': None, 'lle': None, 'sei': None}",CHEMBL1089990,,CHEMBL1089990,6.08,False,http://www.openphacts.org/units/Nanomolar,904760,=,1,True,=,,IC50,nM,,840.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.84
,3235774,[],CHEMBL1113529,Inhibition of PKB by radioactive kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1156226,Bioorg. Med. Chem.,2010.0,"{'bei': '5.39', 'le': None, 'lle': None, 'sei': None}",CHEMBL1089991,,CHEMBL1089991,5.93,False,http://www.openphacts.org/units/Nanomolar,904761,=,1,True,=,,IC50,nM,,1170.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.17
,3235775,[],CHEMBL1113529,Inhibition of PKB by radioactive kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N(C)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1156226,Bioorg. Med. Chem.,2010.0,"{'bei': '6.40', 'le': '0.12', 'lle': '8.95', 'sei': '1.41'}",CHEMBL1090001,,CHEMBL1090001,5.69,False,http://www.openphacts.org/units/Nanomolar,904771,=,1,True,=,,IC50,nM,,2030.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.03
,3235776,[],CHEMBL1113529,Inhibition of PKB by radioactive kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1156226,Bioorg. Med. Chem.,2010.0,"{'bei': '6.59', 'le': '0.13', 'lle': '8.90', 'sei': '1.54'}",CHEMBL1090000,,CHEMBL1090000,6.04,False,http://www.openphacts.org/units/Nanomolar,904770,=,1,True,=,,IC50,nM,,920.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.92
,3235777,[],CHEMBL1113529,Inhibition of PKB by radioactive kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1156226,Bioorg. Med. Chem.,2010.0,"{'bei': '6.68', 'le': '0.13', 'lle': '9.15', 'sei': '1.49'}",CHEMBL1089661,,CHEMBL1089661,6.03,True,http://www.openphacts.org/units/Nanomolar,904742,=,1,True,=,,IC50,nM,,940.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.94
,3246478,[],CHEMBL1117089,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc(-c2ncnc3sc(-c4ccncc4)cc23)c1)c1cccc(C(F)(F)F)c1,,,CHEMBL1156181,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1090143,,CHEMBL1090143,,False,http://www.openphacts.org/units/Nanomolar,903154,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3260504,[],CHEMBL1109839,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc(-c2ccnc3cc(-c4ccncc4)nn23)c1)c1cccc(C(F)(F)F)c1,,,CHEMBL1156255,Bioorg. Med. Chem. Lett.,2009.0,,CHEMBL1089082,,CHEMBL1089082,,False,http://www.openphacts.org/units/Nanomolar,899536,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,3262023,[],CHEMBL1114557,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N[C@H]1CC[C@H](O)CC1)c1ccc2c(c1)Cc1c(-c3ccc(-c4ccc(O)cc4)cc3)n[nH]c1-2,,,CHEMBL1156260,J. Med. Chem.,2010.0,"{'bei': '11.50', 'le': '0.21', 'lle': '0.30', 'sei': '5.45'}",CHEMBL438485,,CHEMBL438485,5.35,False,http://www.openphacts.org/units/Nanomolar,900101,=,1,True,=,,IC50,nM,,4430.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.43
,3266047,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OCCN)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '16.34', 'le': '0.30', 'lle': '3.62', 'sei': '5.40'}",CHEMBL1095278,,CHEMBL1095278,6.40,False,http://www.openphacts.org/units/Nanomolar,905704,=,1,True,=,,IC50,nM,,402.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,402.0
,3266048,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@H](C)N)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '15.16', 'le': '0.28', 'lle': '2.98', 'sei': '5.19'}",CHEMBL1095279,,CHEMBL1095279,6.15,False,http://www.openphacts.org/units/Nanomolar,905705,=,1,True,=,,IC50,nM,,712.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,712.0
,3266049,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](C)N)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '15.84', 'le': '0.29', 'lle': '3.25', 'sei': '5.43'}",CHEMBL1097955,,CHEMBL1097955,6.42,False,http://www.openphacts.org/units/Nanomolar,905706,=,1,True,=,,IC50,nM,,377.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,377.0
,3266050,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](N)COc1cncc(-c2cc3c(cnc4cc(OC)c(OC)cc43)c(N)n2)c1,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '15.20', 'le': '0.28', 'lle': '2.81', 'sei': '5.38'}",CHEMBL1097956,,CHEMBL1097956,6.38,False,http://www.openphacts.org/units/Nanomolar,905707,=,1,True,=,,IC50,nM,,422.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,422.0
,3266051,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](N)COc1cncc(-c2cc3c(cnc4cc(OC)c(OC)cc43)c(N)n2)c1,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '15.49', 'le': '0.29', 'lle': '2.94', 'sei': '5.49'}",CHEMBL1094320,,CHEMBL1094320,6.50,False,http://www.openphacts.org/units/Nanomolar,905756,=,1,True,=,,IC50,nM,,318.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,318.0
,3266052,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)CC(C)C)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '13.50', 'le': '0.25', 'lle': '1.84', 'sei': '5.10'}",CHEMBL1094321,,CHEMBL1094321,6.04,False,http://www.openphacts.org/units/Nanomolar,905757,=,1,True,=,,IC50,nM,,905.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,905.0
,3266053,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@H](N)CC(C)C)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '13.08', 'le': '0.24', 'lle': '1.66', 'sei': '4.95'}",CHEMBL1094637,,CHEMBL1094637,5.86,False,http://www.openphacts.org/units/Nanomolar,905758,=,1,True,=,,IC50,nM,,1395.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1395.0
,3266054,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5ccccc5)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '13.67', 'le': '0.25', 'lle': '2.19', 'sei': '5.56'}",CHEMBL1097602,,CHEMBL1097602,6.58,False,http://www.openphacts.org/units/Nanomolar,905759,=,1,True,=,,IC50,nM,,261.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,261.0
,3266055,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@H](N)Cc5ccccc5)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '13.68', 'le': '0.25', 'lle': '2.20', 'sei': '5.56'}",CHEMBL1095294,,CHEMBL1095294,6.59,False,http://www.openphacts.org/units/Nanomolar,905805,=,1,True,=,,IC50,nM,,259.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,259.0
,3266056,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5ccc(F)cc5)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '13.49', 'le': '0.25', 'lle': '2.21', 'sei': '5.69'}",CHEMBL1095621,,CHEMBL1095621,6.74,False,http://www.openphacts.org/units/Nanomolar,905806,=,1,True,=,,IC50,nM,,183.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,183.0
,3266057,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@H](N)Cc5ccc(F)cc5)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '13.21', 'le': '0.24', 'lle': '2.07', 'sei': '5.57'}",CHEMBL1095622,,CHEMBL1095622,6.60,False,http://www.openphacts.org/units/Nanomolar,905807,=,1,True,=,,IC50,nM,,251.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,251.0
,3266058,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5cccc(C(F)(F)F)c5)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '12.16', 'le': '0.23', 'lle': '1.27', 'sei': '5.64'}",CHEMBL1098302,,CHEMBL1098302,6.68,False,http://www.openphacts.org/units/Nanomolar,905846,=,1,True,=,,IC50,nM,,209.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,209.0
,3266059,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@H](N)Cc5cccc(C(F)(F)F)c5)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '11.01', 'le': '0.21', 'lle': '0.64', 'sei': '5.11'}",CHEMBL1095285,,CHEMBL1095285,6.05,False,http://www.openphacts.org/units/Nanomolar,905847,=,1,True,=,,IC50,nM,,889.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,889.0
,3266060,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5c[nH]c6ccccc56)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '12.52', 'le': '0.23', 'lle': '1.65', 'sei': '4.86'}",CHEMBL1095612,,CHEMBL1095612,6.52,False,http://www.openphacts.org/units/Nanomolar,905848,=,1,True,=,,IC50,nM,,302.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,302.0
,3266061,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@H](N)Cc5c[nH]c6ccccc56)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '11.29', 'le': '0.21', 'lle': '1.01', 'sei': '4.38'}",CHEMBL1097604,,CHEMBL1097604,5.88,False,http://www.openphacts.org/units/Nanomolar,905891,=,1,True,=,,IC50,nM,,1324.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1324.0
,3266062,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5ccccc5Cl)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '11.82', 'le': '0.23', 'lle': '1.05', 'sei': '5.15'}",CHEMBL1095931,,CHEMBL1095931,6.10,False,http://www.openphacts.org/units/Nanomolar,905892,=,1,True,=,,IC50,nM,,793.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,793.0
,3266063,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5cccc(Cl)c5)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '13.78', 'le': '0.26', 'lle': '2.06', 'sei': '6.00'}",CHEMBL1096271,,CHEMBL1096271,7.11,False,http://www.openphacts.org/units/Nanomolar,905893,=,1,True,=,,IC50,nM,,78.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,78.0
,3266064,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5ccc(Cl)c(Cl)c5)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '11.56', 'le': '0.23', 'lle': '0.66', 'sei': '5.37'}",CHEMBL1097972,,CHEMBL1097972,6.36,False,http://www.openphacts.org/units/Nanomolar,905967,=,1,True,=,,IC50,nM,,433.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,433.0
,3266065,[],CHEMBL1103721,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5ccncc5)c4)cc3c2cc1OC,,,CHEMBL1157027,Eur. J. Med. Chem.,2010.0,"{'bei': '11.93', 'le': '0.22', 'lle': '1.97', 'sei': '4.38'}",CHEMBL1097973,,CHEMBL1097973,5.76,False,http://www.openphacts.org/units/Nanomolar,905968,=,1,True,=,,IC50,nM,,1750.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1750.0
,3269035,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CCCN)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '23.07', 'le': '0.43', 'lle': '7.42', 'sei': '6.01'}",CHEMBL1097974,,CHEMBL1097974,8.52,False,http://www.openphacts.org/units/Nanomolar,906033,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,3269036,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CNC)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '23.98', 'le': '0.45', 'lle': '7.59', 'sei': '6.66'}",CHEMBL1098316,,CHEMBL1098316,8.52,False,http://www.openphacts.org/units/Nanomolar,906034,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,3269037,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN(C)C)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '23.55', 'le': '0.44', 'lle': '7.43', 'sei': '7.30'}",CHEMBL1099290,,CHEMBL1099290,8.70,False,http://www.openphacts.org/units/Nanomolar,906092,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,3269038,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '20.79', 'le': '0.39', 'lle': '6.42', 'sei': '6.90'}",CHEMBL1096290,GSK-1000163A,CHEMBL1096290,8.22,False,http://www.openphacts.org/units/Nanomolar,906093,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,3269039,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCN)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '22.35', 'le': '0.42', 'lle': '7.76', 'sei': '5.49'}",CHEMBL1096291,,CHEMBL1096291,8.30,False,http://www.openphacts.org/units/Nanomolar,906094,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,3269040,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCCN)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '20.23', 'le': '0.38', 'lle': '6.87', 'sei': '5.16'}",CHEMBL1096292,,CHEMBL1096292,7.80,False,http://www.openphacts.org/units/Nanomolar,906095,=,1,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
,3269041,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCCCN)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '18.03', 'le': '0.34', 'lle': '5.88', 'sei': '4.76'}",CHEMBL1096636,,CHEMBL1096636,7.20,False,http://www.openphacts.org/units/Nanomolar,906096,=,1,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,63.0
,3269042,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '20.55', 'le': '0.39', 'lle': '7.12', 'sei': '5.78'}",CHEMBL1098943,,CHEMBL1098943,7.92,False,http://www.openphacts.org/units/Nanomolar,906148,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,3269043,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](C)N)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '21.01', 'le': '0.39', 'lle': '7.17', 'sei': '5.36'}",CHEMBL1098944,,CHEMBL1098944,8.10,False,http://www.openphacts.org/units/Nanomolar,906149,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
,3269044,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](C)N)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '20.46', 'le': '0.38', 'lle': '6.96', 'sei': '5.22'}",CHEMBL1099281,,CHEMBL1099281,7.89,False,http://www.openphacts.org/units/Nanomolar,906150,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
,3269045,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '19.05', 'le': '0.35', 'lle': '6.24', 'sei': '5.64'}",CHEMBL1096634,GSK-943949A,CHEMBL1096634,8.52,False,http://www.openphacts.org/units/Nanomolar,906151,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,3269046,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '18.55', 'le': '0.34', 'lle': '6.02', 'sei': '5.49'}",CHEMBL1096626,GSK-938890A,CHEMBL1096626,8.30,False,http://www.openphacts.org/units/Nanomolar,906216,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,3269047,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)Cc3ccccc3)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '19.98', 'le': '0.37', 'lle': '7.07', 'sei': '6.10'}",CHEMBL1098938,,CHEMBL1098938,9.22,False,http://www.openphacts.org/units/Nanomolar,906217,=,1,True,=,,IC50,nM,,0.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.6
,3269048,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)Cc3ccccc3)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '18.47', 'le': '0.34', 'lle': '6.37', 'sei': '5.64'}",CHEMBL1098939,,CHEMBL1098939,8.52,False,http://www.openphacts.org/units/Nanomolar,906218,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,3269049,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '20.11', 'le': '0.37', 'lle': '6.72', 'sei': '5.96'}",CHEMBL1099276,,CHEMBL1099276,9.00,False,http://www.openphacts.org/units/Nanomolar,906219,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,3269050,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@H](CN)c3ccccc3)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '19.05', 'le': '0.35', 'lle': '6.24', 'sei': '5.64'}",CHEMBL1099296,,CHEMBL1099296,8.52,False,http://www.openphacts.org/units/Nanomolar,905366,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,3269051,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CCN)c3ccccc3)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '18.85', 'le': '0.35', 'lle': '6.03', 'sei': '5.76'}",CHEMBL1099297,,CHEMBL1099297,8.70,False,http://www.openphacts.org/units/Nanomolar,905367,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,3269052,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@H](CCN)c3ccccc3)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '18.20', 'le': '0.34', 'lle': '5.73', 'sei': '5.56'}",CHEMBL1099298,,CHEMBL1099298,8.40,False,http://www.openphacts.org/units/Nanomolar,905368,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,3269522,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '24.08', 'le': '0.45', 'lle': '7.56', 'sei': '5.79'}",CHEMBL1098241,,CHEMBL1098241,8.22,False,http://www.openphacts.org/units/Nanomolar,906031,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,3269523,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '20.44', 'le': '0.38', 'lle': '7.12', 'sei': '6.34'}",CHEMBL494089,GSK-690693,CHEMBL494089,8.70,False,http://www.openphacts.org/units/Nanomolar,906030,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,3269524,[],CHEMBL1109952,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CCN)cc21,,,CHEMBL1157000,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '23.63', 'le': '0.44', 'lle': '7.69', 'sei': '5.92'}",CHEMBL1095624,,CHEMBL1095624,8.40,False,http://www.openphacts.org/units/Nanomolar,906032,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,3278001,[],CHEMBL1117424,Inhibition of AKT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,,,CHEMBL1157919,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1088240,,CHEMBL1088240,,False,http://www.openphacts.org/units/Nanomolar,911910,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3291445,[],CHEMBL1109159,Inhibition of AKT1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2,,,CHEMBL1157785,J. Med. Chem.,2010.0,,CHEMBL1094408,NMS-1286937,CHEMBL1094408,,False,http://www.openphacts.org/units/Nanomolar,908099,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3315905,[],CHEMBL1120251,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4ccc(N5CCN(C)CC5)cc4)cnn3c2N)cc1,,,CHEMBL1158604,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1085511,,CHEMBL1085511,,False,http://www.openphacts.org/units/Nanomolar,916944,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3368345,[],CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '16.84', 'le': '0.32', 'lle': '4.63', 'sei': '6.51'}",CHEMBL1170448,,CHEMBL1170448,6.51,False,http://www.openphacts.org/units/Nanomolar,923846,=,1,True,=,,IC50,nM,,310.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.31
,3368346,[],CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@]1(CNC(=O)c2ccc(F)cc2F)CCN(c2ncnc3[nH]cc(Cl)c23)C1,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '16.11', 'le': '0.32', 'lle': '4.32', 'sei': '6.56'}",CHEMBL1169623,,CHEMBL1169623,6.55,False,http://www.openphacts.org/units/Nanomolar,923847,=,1,True,=,,IC50,nM,,280.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.28
,3368347,[],CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '14.42', 'le': '0.27', 'lle': '4.28', 'sei': '4.63'}",CHEMBL1170447,,CHEMBL1170447,5.73,False,http://www.openphacts.org/units/Nanomolar,923845,=,1,True,=,,IC50,nM,,1860.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.86
,3368348,[],CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(Cl)cc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '15.13', 'le': '0.29', 'lle': '3.53', 'sei': '6.04'}",CHEMBL1170446,,CHEMBL1170446,6.04,False,http://www.openphacts.org/units/Nanomolar,923844,=,1,True,=,,IC50,nM,,920.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.92
,3368349,[],CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(Cl)cc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '14.84', 'le': '0.29', 'lle': '3.45', 'sei': '5.71'}",CHEMBL1170263,,CHEMBL1170263,5.71,False,http://www.openphacts.org/units/Nanomolar,923776,=,1,True,=,,IC50,nM,,1950.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.95
,3368350,[],CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@]1(CNC(=O)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]cc(Cl)c23)C1,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '15.93', 'le': '0.33', 'lle': '3.86', 'sei': '6.46'}",CHEMBL1170445,,CHEMBL1170445,6.46,False,http://www.openphacts.org/units/Nanomolar,923777,=,1,True,=,,IC50,nM,,350.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.35
,3368351,[],CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(Cl)cc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '13.13', 'le': '0.25', 'lle': '3.38', 'sei': '4.20'}",CHEMBL1170262,,CHEMBL1170262,5.20,False,http://www.openphacts.org/units/Nanomolar,923775,=,1,True,=,,IC50,nM,,6340.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,6.34
,3368352,[],CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '16.18', 'le': '0.30', 'lle': '4.19', 'sei': '6.19'}",CHEMBL1170261,,CHEMBL1170261,6.19,False,http://www.openphacts.org/units/Nanomolar,923774,=,1,True,=,,IC50,nM,,650.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.65
,3368353,[],CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@]1(CNC(=O)c2ccc(F)cc2)CCN(c2ncnc3[nH]cc(Cl)c23)C1,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '16.57', 'le': '0.33', 'lle': '4.35', 'sei': '6.45'}",CHEMBL1169610,,CHEMBL1169610,6.44,False,http://www.openphacts.org/units/Nanomolar,923773,=,1,True,=,,IC50,nM,,360.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.36
,3368354,[],CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '16.25', 'le': '0.31', 'lle': '4.37', 'sei': '6.51'}",CHEMBL1171647,,CHEMBL1171647,6.51,False,http://www.openphacts.org/units/Nanomolar,923848,=,1,True,=,,IC50,nM,,310.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.31
,3368355,[],CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '15.84', 'le': '0.30', 'lle': '4.10', 'sei': '5.84'}",CHEMBL1171994,,CHEMBL1171994,5.84,False,http://www.openphacts.org/units/Nanomolar,923702,=,1,True,=,,IC50,nM,,1460.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.46
,3368356,[],CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '13.81', 'le': '0.26', 'lle': '3.93', 'sei': '4.24'}",CHEMBL1171993,,CHEMBL1171993,5.24,False,http://www.openphacts.org/units/Nanomolar,923701,=,1,True,=,,IC50,nM,,5740.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.74
,3368756,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '23.23', 'le': '0.44', 'lle': '7.16', 'sei': '9.31'}",CHEMBL1171647,,CHEMBL1171647,9.30,False,http://www.openphacts.org/units/Nanomolar,923848,=,1,True,=,,IC50,nM,,0.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.5
,3368757,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@]1(CNC(=O)c2ccc(F)cc2F)CCN(c2ncnc3[nH]cc(Cl)c23)C1,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '22.02', 'le': '0.44', 'lle': '6.73', 'sei': '8.96'}",CHEMBL1169623,,CHEMBL1169623,8.96,False,http://www.openphacts.org/units/Nanomolar,923847,=,1,True,=,,IC50,nM,,1.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.1
,3368758,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '23.29', 'le': '0.44', 'lle': '7.12', 'sei': '9.01'}",CHEMBL1170448,,CHEMBL1170448,9.00,False,http://www.openphacts.org/units/Nanomolar,923846,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,3368759,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '20.42', 'le': '0.38', 'lle': '6.66', 'sei': '6.56'}",CHEMBL1170447,,CHEMBL1170447,8.11,False,http://www.openphacts.org/units/Nanomolar,923845,=,1,True,=,,IC50,nM,,7.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.7
,3368760,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(Cl)cc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '21.92', 'le': '0.43', 'lle': '6.23', 'sei': '8.75'}",CHEMBL1170446,,CHEMBL1170446,8.74,False,http://www.openphacts.org/units/Nanomolar,923844,=,1,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
,3368761,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@]1(CNC(=O)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]cc(Cl)c23)C1,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '20.93', 'le': '0.43', 'lle': '5.88', 'sei': '8.49'}",CHEMBL1170445,,CHEMBL1170445,8.48,False,http://www.openphacts.org/units/Nanomolar,923777,=,1,True,=,,IC50,nM,,3.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.3
,3368762,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(Cl)cc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '20.64', 'le': '0.40', 'lle': '5.68', 'sei': '7.95'}",CHEMBL1170263,,CHEMBL1170263,7.94,False,http://www.openphacts.org/units/Nanomolar,923776,=,1,True,=,,IC50,nM,,11.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.4
,3368763,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(Cl)cc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '19.60', 'le': '0.38', 'lle': '5.94', 'sei': '6.27'}",CHEMBL1170262,,CHEMBL1170262,7.76,False,http://www.openphacts.org/units/Nanomolar,923775,=,1,True,=,,IC50,nM,,17.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.5
,3368764,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '23.15', 'le': '0.43', 'lle': '6.85', 'sei': '8.86'}",CHEMBL1170261,,CHEMBL1170261,8.85,False,http://www.openphacts.org/units/Nanomolar,923774,=,1,True,=,,IC50,nM,,1.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.4
,3368765,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@]1(CNC(=O)c2ccc(F)cc2)CCN(c2ncnc3[nH]cc(Cl)c23)C1,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '22.08', 'le': '0.43', 'lle': '6.50', 'sei': '8.59'}",CHEMBL1169610,,CHEMBL1169610,8.59,False,http://www.openphacts.org/units/Nanomolar,923773,=,1,True,=,,IC50,nM,,2.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.6
,3368766,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '23.13', 'le': '0.43', 'lle': '6.78', 'sei': '8.53'}",CHEMBL1171994,,CHEMBL1171994,8.52,False,http://www.openphacts.org/units/Nanomolar,923702,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,3368767,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '21.37', 'le': '0.40', 'lle': '6.80', 'sei': '6.55'}",CHEMBL1171993,,CHEMBL1171993,8.11,False,http://www.openphacts.org/units/Nanomolar,923701,=,1,True,=,,IC50,nM,,7.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.8
,3368768,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCC(N)(CNC(=O)c4ccc(F)cc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '22.07', 'le': '0.41', 'lle': '6.39', 'sei': '8.14'}",CHEMBL1171673,,CHEMBL1171673,8.13,False,http://www.openphacts.org/units/Nanomolar,923700,=,1,True,=,,IC50,nM,,7.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.4
,3368769,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCC(N)(CNC(=O)c4cccc(F)c4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '20.14', 'le': '0.38', 'lle': '5.68', 'sei': '7.43'}",CHEMBL1171672,,CHEMBL1171672,7.42,False,http://www.openphacts.org/units/Nanomolar,923699,=,1,True,=,,IC50,nM,,38.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,38.0
,3368770,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC1(N)CCN(c2ncnc3[nH]cc(C)c23)C1,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '21.21', 'le': '0.40', 'lle': '5.81', 'sei': '6.12'}",CHEMBL1171841,,CHEMBL1171841,6.12,False,http://www.openphacts.org/units/Nanomolar,923618,=,1,True,=,,IC50,nM,,765.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,765.0
,3368771,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCC(N)(CNC(=O)c4ccccc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '20.57', 'le': '0.38', 'lle': '5.61', 'sei': '7.21'}",CHEMBL1171842,,CHEMBL1171842,7.21,False,http://www.openphacts.org/units/Nanomolar,923619,=,1,True,=,,IC50,nM,,62.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,62.0
,3368772,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCC(N)(CNC(=O)c4ccccc4F)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '19.97', 'le': '0.37', 'lle': '5.62', 'sei': '7.36'}",CHEMBL1171501,,CHEMBL1171501,7.36,False,http://www.openphacts.org/units/Nanomolar,923698,=,1,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,44.0
,3368773,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCC(N)(CNC=O)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '24.77', 'le': '0.46', 'lle': '6.88', 'sei': '6.80'}",CHEMBL1173384,"N-((3-AMINO-1-(5-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PYRROLIDIN-3-YL)METHYL)FORMAMIDE (RACEMIC)",CHEMBL1173384,6.80,False,http://www.openphacts.org/units/Nanomolar,924971,=,1,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,160.0
,3368774,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCC(N)(CNC=O)C3)c12,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL1177702,J. Med. Chem.,2010.0,,CHEMBL1173384,"N-((3-AMINO-1-(5-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PYRROLIDIN-3-YL)METHYL)FORMAMIDE (RACEMIC)",CHEMBL1173384,,False,,924972,=,1,False,=,,IC50,,,3500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,3500.0
,3368775,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCC(N)(CNC=O)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '26.43', 'le': '0.50', 'lle': '7.33', 'sei': '7.26'}",CHEMBL1173384,"N-((3-AMINO-1-(5-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PYRROLIDIN-3-YL)METHYL)FORMAMIDE (RACEMIC)",CHEMBL1173384,7.25,False,http://www.openphacts.org/units/Nanomolar,924973,=,1,True,=,,IC50,nM,,56.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,56.0
,3368776,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCC(N)(CNC(=O)Cl)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '23.44', 'le': '0.47', 'lle': '6.12', 'sei': '7.24'}",CHEMBL1171299,,CHEMBL1171299,7.24,False,http://www.openphacts.org/units/Nanomolar,923614,=,1,True,=,,IC50,nM,,58.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,58.0
,3368777,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCC(N)(CNC(=O)C(F)(F)F)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '21.08', 'le': '0.41', 'lle': '6.36', 'sei': '7.22'}",CHEMBL1171485,,CHEMBL1171485,7.21,False,http://www.openphacts.org/units/Nanomolar,923615,=,1,True,=,,IC50,nM,,61.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,61.0
,3368779,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCC(N)(CNC(=O)Oc4ccccc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '21.28', 'le': '0.39', 'lle': '5.84', 'sei': '7.14'}",CHEMBL1171840,,CHEMBL1171840,7.80,False,http://www.openphacts.org/units/Nanomolar,923617,=,1,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
,3368780,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CC[C@@H](NCc4ccccc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '18.28', 'le': '0.33', 'lle': '2.99', 'sei': '9.89'}",CHEMBL1173306,,CHEMBL1173306,5.62,False,http://www.openphacts.org/units/Nanomolar,924970,=,1,True,=,,IC50,nM,,2400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.4
,3368781,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCN[C@@H]1CCN(c2ncnc3[nH]cc(C)c23)C1,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '23.32', 'le': '0.43', 'lle': '4.27', 'sei': '10.07'}",CHEMBL1173305,,CHEMBL1173305,5.72,False,http://www.openphacts.org/units/Nanomolar,924969,=,1,True,=,,IC50,nM,,1900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.9
,3368782,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CC[C@@H](NC(=O)Nc4ccccc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '18.30', 'le': '0.34', 'lle': '3.48', 'sei': '7.16'}",CHEMBL1173304,,CHEMBL1173304,6.16,False,http://www.openphacts.org/units/Nanomolar,924968,=,1,True,=,,IC50,nM,,700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.7
,3368783,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CC[C@@H](NS(=O)(=O)c4ccccc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '17.41', 'le': '0.34', 'lle': '4.40', 'sei': '6.84'}",CHEMBL1173697,,CHEMBL1173697,6.22,False,http://www.openphacts.org/units/Nanomolar,924871,=,1,True,=,,IC50,nM,,600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.6
,3368784,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CC[C@@H](NS(C)(=O)=O)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '18.28', 'le': '0.37', 'lle': '5.01', 'sei': '5.93'}",CHEMBL1173696,,CHEMBL1173696,5.40,False,http://www.openphacts.org/units/Nanomolar,924870,=,1,True,=,,IC50,nM,,4000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.0
,3368785,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CC[C@@H](NC(=O)c4ccccc4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '19.15', 'le': '0.35', 'lle': '3.87', 'sei': '8.33'}",CHEMBL1170238,,CHEMBL1170238,6.16,False,http://www.openphacts.org/units/Nanomolar,924869,=,1,True,=,,IC50,nM,,700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.7
,3368786,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H]1CCN(c2ncnc3[nH]cc(C)c23)C1,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '19.28', 'le': '0.36', 'lle': '4.02', 'sei': '6.76'}",CHEMBL1173351,,CHEMBL1173351,5.00,False,http://www.openphacts.org/units/Nanomolar,924868,=,1,True,=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3368787,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1c[nH]c2ncnc(N3CCC4(CCNCC4)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '28.78', 'le': '0.57', 'lle': '6.21', 'sei': '14.77'}",CHEMBL1173350,,CHEMBL1173350,8.40,False,http://www.openphacts.org/units/Nanomolar,924867,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,3368788,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCCN(c2ncnc3[nH]cc(Cl)c23)C1,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '26.61', 'le': '0.54', 'lle': '5.16', 'sei': '9.46'}",CHEMBL1173349,,CHEMBL1173349,6.70,False,http://www.openphacts.org/units/Nanomolar,924866,=,1,True,=,,IC50,nM,,200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,200.0
,3368789,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CC[C@@H](N)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '31.04', 'le': '0.58', 'lle': '5.94', 'sei': '9.52'}",CHEMBL1173273,,CHEMBL1173273,6.75,False,http://www.openphacts.org/units/Nanomolar,924778,=,1,True,=,,IC50,nM,,180.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,180.0
,3368790,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCN(c2ncnc3[nH]cc(Cl)c23)C1,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '30.15', 'le': '0.61', 'lle': '6.02', 'sei': '10.12'}",CHEMBL1173272,,CHEMBL1173272,7.17,False,http://www.openphacts.org/units/Nanomolar,924777,=,1,True,=,,IC50,nM,,68.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,68.0
,3368791,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '26.33', 'le': '0.48', 'lle': '6.10', 'sei': '10.79'}",CHEMBL258837,,CHEMBL258837,8.70,False,http://www.openphacts.org/units/Nanomolar,924775,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,3368792,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2nnc[nH]2)c(Nc2ncnc3[nH]ccc23)c1,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '23.59', 'le': '0.43', 'lle': '4.05', 'sei': '6.87'}",CHEMBL261204,,CHEMBL261204,6.54,False,http://www.openphacts.org/units/Nanomolar,924774,=,1,True,=,,IC50,nM,,288.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,288.0
,3368793,[],CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CC[C@H](N)C3)c12,,,CHEMBL1177702,J. Med. Chem.,2010.0,"{'bei': '30.47', 'le': '0.57', 'lle': '5.82', 'sei': '9.35'}",CHEMBL2021603,,CHEMBL2021603,6.62,False,http://www.openphacts.org/units/Nanomolar,924776,=,1,True,=,,IC50,nM,,240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,240.0
,3419148,[],CHEMBL1228778,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[n+]1[O-],,,CHEMBL1221191,Nat. Chem. Biol.,2006.0,,CHEMBL476124,CYCLAPOLIN 9,CHEMBL476124,,False,http://www.openphacts.org/units/Nanomolar,935575,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,3419165,[],CHEMBL1228778,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1sc2c([N+](=O)[O-])cc(SC(F)(F)F)cc2[n+]1[O-],,,CHEMBL1221191,Nat. Chem. Biol.,2006.0,,CHEMBL1222044,CYCLAPOLIN 1,CHEMBL1222044,,False,http://www.openphacts.org/units/Nanomolar,935440,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,3420226,[],CHEMBL1226922,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3ccncc3)cc21,,,CHEMBL1221210,Nat. Chem. Biol.,2008.0,,CHEMBL225519,,CHEMBL225519,,False,http://www.openphacts.org/units/Nanomolar,935798,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,3439129,[],CHEMBL1247975,Inhibition of PKBalpha by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2C)n1,,,CHEMBL1240487,J. Med. Chem.,2010.0,,CHEMBL1242977,,CHEMBL1242977,,False,http://www.openphacts.org/units/Nanomolar,954412,>,1,True,>,,IC50,nM,,8000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8000.0
,3439195,[],CHEMBL1247975,Inhibition of PKBalpha by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Nc3ccccc3)cc2)n1,,,CHEMBL1240487,J. Med. Chem.,2010.0,,CHEMBL1243200,,CHEMBL1243200,,False,http://www.openphacts.org/units/Nanomolar,954703,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
,3439207,[],CHEMBL1247975,Inhibition of PKBalpha by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nccc(-c2cccnc2Oc2ccc(Nc3nnc(-c4ccc(F)cc4)c4ccccc34)cc2)n1,,,CHEMBL1240487,J. Med. Chem.,2010.0,,CHEMBL1243326,,CHEMBL1243326,,False,http://www.openphacts.org/units/Nanomolar,954870,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25000.0
,3446786,[],CHEMBL1249802,Inhibition of human PKBalpha expressed in SF9 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N,,,CHEMBL1240295,Biochem. J.,2000.0,"{'bei': '11.10', 'le': '0.22', 'lle': '1.10', 'sei': '2.78'}",CHEMBL34704,,CHEMBL34704,4.22,False,http://www.openphacts.org/units/Nanomolar,952494,=,1,True,=,,IC50,nM,,60000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,60.0
,3447277,[],CHEMBL1249802,Inhibition of human PKBalpha expressed in SF9 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,,,CHEMBL1240295,Biochem. J.,2000.0,"{'bei': '12.51', 'le': '0.28', 'lle': '2.01', 'sei': '7.86'}",CHEMBL104264,,CHEMBL104264,5.58,False,http://www.openphacts.org/units/Nanomolar,952356,=,1,True,=,,IC50,nM,,2600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.6
,3460948,[],CHEMBL1252348,Inhibition of PKB/Akt activation in human overnight starved MCF7 cells assessed as phosphorylated Akt at Ser473 level at 50 ug/ml after 1 hr followed by treated with 1 ug/mL of insulin for 15 mins by Western blotting,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1ccc(OC(C)=O)c(Cc2cc(CCCl)ccc2OC(C)=O)c1,,,CHEMBL1250440,Bioorg. Med. Chem.,2010.0,"{'bei': '12.28', 'le': '0.24', 'lle': '0.13', 'sei': '8.75'}",CHEMBL1254859,,CHEMBL1254859,4.60,False,http://www.openphacts.org/units/Nanomolar,957308,=,1,True,=,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,3462673,[],CHEMBL1252171,Inhibition of myristoylated wild type AKT1 expressed in HEK293T cells by in vitro immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,,,CHEMBL1250448,Nat. Chem. Biol.,2009.0,"{'bei': '21.64', 'le': '0.39', 'lle': '4.24', 'sei': '9.29'}",CHEMBL379300,A-443654,CHEMBL379300,8.60,False,http://www.openphacts.org/units/Nanomolar,956180,=,1,True,=,,IC50,nM,,2.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.5
,3462674,[],CHEMBL1252171,Inhibition of myristoylated wild type AKT1 expressed in HEK293T cells by in vitro immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCc1cc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)cc2c(C)n[nH]c12,,,CHEMBL1250448,Nat. Chem. Biol.,2009.0,,CHEMBL1254114,,CHEMBL1254114,,False,http://www.openphacts.org/units/Nanomolar,956289,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
,3462675,[],CHEMBL1252171,Inhibition of myristoylated wild type AKT1 expressed in HEK293T cells by in vitro immunoprecipitation kinase assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)n1nc(Cc2cccc(I)c2)c2c(N)ncnc21,,,CHEMBL1250448,Nat. Chem. Biol.,2009.0,,CHEMBL1254115,,CHEMBL1254115,,False,http://www.openphacts.org/units/Nanomolar,956290,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
Not Determined,3462676,[],CHEMBL1252172,Inhibition of myristoylated AKT1 M227G mutant expressed in HEK293T cells by in vitro immunoprecipitation kinase assay,B,P31749,M227G,BAO_0000190,BAO_0000219,cell-based format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,,,CHEMBL1250448,Nat. Chem. Biol.,2009.0,,CHEMBL379300,A-443654,CHEMBL379300,,False,,956180,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3462677,[],CHEMBL1252172,Inhibition of myristoylated AKT1 M227G mutant expressed in HEK293T cells by in vitro immunoprecipitation kinase assay,B,P31749,M227G,BAO_0000190,BAO_0000219,cell-based format,CCCc1cc(-c2cncc(OC[C@@H](N)Cc3c[nH]c4ccccc34)c2)cc2c(C)n[nH]c12,,,CHEMBL1250448,Nat. Chem. Biol.,2009.0,"{'bei': '19.46', 'le': '0.35', 'lle': '3.23', 'sei': '9.24'}",CHEMBL1254114,,CHEMBL1254114,8.55,False,http://www.openphacts.org/units/Nanomolar,956289,=,1,True,=,,IC50,nM,,2.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.8
,3462678,[],CHEMBL1252172,Inhibition of myristoylated AKT1 M227G mutant expressed in HEK293T cells by in vitro immunoprecipitation kinase assay,B,P31749,M227G,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)n1nc(Cc2cccc(I)c2)c2c(N)ncnc21,,,CHEMBL1250448,Nat. Chem. Biol.,2009.0,"{'bei': '18.55', 'le': '0.47', 'lle': '4.19', 'sei': '10.85'}",CHEMBL1254115,,CHEMBL1254115,7.55,False,http://www.openphacts.org/units/Nanomolar,956290,=,1,True,=,,IC50,nM,,28.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,28.0
,3463127,[],CHEMBL1252170,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL1250448,Nat. Chem. Biol.,2009.0,"{'bei': '11.97', 'le': '0.27', 'lle': '2.21', 'sei': '6.64'}",CHEMBL1254209,,CHEMBL1254209,4.66,False,http://www.openphacts.org/units/Nanomolar,956402,=,1,True,=,,IC50,nM,,22000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22000.0
,3502220,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccccc1)C(=O)N1CCN(c2ncnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.75', 'le': '0.31', 'lle': '4.20', 'sei': '8.03'}",CHEMBL1258329,,CHEMBL1258329,6.05,False,http://www.openphacts.org/units/Nanomolar,963296,=,1,True,=,,IC50,nM,,884.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,884.0
,3502221,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.45', 'le': '0.38', 'lle': '5.20', 'sei': '10.22'}",CHEMBL1258330,,CHEMBL1258330,7.70,False,http://www.openphacts.org/units/Nanomolar,963297,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
,3502222,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(C[C@@H](N)C(=O)N2CCN(c3ncnc4ccccc34)CC2)cc1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.94', 'le': '0.31', 'lle': '4.83', 'sei': '6.60'}",CHEMBL1258441,,CHEMBL1258441,6.55,False,http://www.openphacts.org/units/Nanomolar,963419,=,1,True,=,,IC50,nM,,284.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,284.0
,3502223,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(F)cc1)C(=O)N1CCN(c2ncnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.26', 'le': '0.34', 'lle': '4.94', 'sei': '9.19'}",CHEMBL1258442,,CHEMBL1258442,6.93,False,http://www.openphacts.org/units/Nanomolar,963420,=,1,True,=,,IC50,nM,,118.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,118.0
,3502224,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C[C@@H](N)C(=O)N2CCN(c3ncnc4ccccc34)CC2)cc1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.43', 'le': '0.32', 'lle': '4.96', 'sei': '8.07'}",CHEMBL1258550,,CHEMBL1258550,6.82,False,http://www.openphacts.org/units/Nanomolar,963546,=,1,True,=,,IC50,nM,,150.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,150.0
,3502225,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C[C@@H](N)C(=O)N2CCN(c3ncnc4ccccc34)CC2)cc1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.99', 'le': '0.35', 'lle': '4.97', 'sei': '9.46'}",CHEMBL1258551,,CHEMBL1258551,7.13,False,http://www.openphacts.org/units/Nanomolar,963547,=,1,True,=,,IC50,nM,,74.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,74.0
,3502226,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Br)cc1)C(=O)N1CCN(c2ncnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.08', 'le': '0.37', 'lle': '4.91', 'sei': '9.98'}",CHEMBL1258662,,CHEMBL1258662,7.52,False,http://www.openphacts.org/units/Nanomolar,963673,=,1,True,=,,IC50,nM,,30.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30.0
,3502227,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccccc1Cl)C(=O)N1CCN(c2ncnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.22', 'le': '0.27', 'lle': '3.13', 'sei': '7.47'}",CHEMBL1258663,,CHEMBL1258663,5.63,False,http://www.openphacts.org/units/Nanomolar,963674,=,1,True,=,,IC50,nM,,2346.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2346.0
,3502228,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1cccc(Cl)c1)C(=O)N1CCN(c2ncnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.73', 'le': '0.30', 'lle': '3.73', 'sei': '8.26'}",CHEMBL1258778,,CHEMBL1258778,6.22,False,http://www.openphacts.org/units/Nanomolar,963801,=,1,True,=,,IC50,nM,,595.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,595.0
,3502229,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1Cl)C(=O)N1CCN(c2ncnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.91', 'le': '0.32', 'lle': '3.69', 'sei': '9.09'}",CHEMBL1258779,,CHEMBL1258779,6.85,False,http://www.openphacts.org/units/Nanomolar,963802,=,1,True,=,,IC50,nM,,142.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,142.0
,3502230,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)c(Cl)c1)C(=O)N1CCN(c2ncnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.95', 'le': '0.34', 'lle': '4.13', 'sei': '9.68'}",CHEMBL1258898,,CHEMBL1258898,7.29,False,http://www.openphacts.org/units/Nanomolar,963928,=,1,True,=,,IC50,nM,,51.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,51.0
,3502231,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(F)c(F)c1)C(=O)N1CCN(c2ncnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.84', 'le': '0.33', 'lle': '4.96', 'sei': '9.41'}",CHEMBL1258899,,CHEMBL1258899,7.09,False,http://www.openphacts.org/units/Nanomolar,963929,=,1,True,=,,IC50,nM,,81.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,81.0
,3502232,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(C(F)(F)F)cc1)C(=O)N1CCN(c2ncnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.35', 'le': '0.31', 'lle': '4.15', 'sei': '9.32'}",CHEMBL1257163,,CHEMBL1257163,7.02,False,http://www.openphacts.org/units/Nanomolar,962017,=,1,True,=,,IC50,nM,,95.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,95.0
,3502233,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(-c2ccccc2)cc1)C(=O)N1CCN(c2ncnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '12.66', 'le': '0.23', 'lle': '2.02', 'sei': '7.35'}",CHEMBL1257164,,CHEMBL1257164,5.54,False,http://www.openphacts.org/units/Nanomolar,962018,=,1,True,=,,IC50,nM,,2883.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2883.0
,3502234,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1cc(F)cc(F)c1)C(=O)N1CCN(c2ncnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.50', 'le': '0.29', 'lle': '4.03', 'sei': '8.18'}",CHEMBL1257280,,CHEMBL1257280,6.16,False,http://www.openphacts.org/units/Nanomolar,962145,=,1,True,=,,IC50,nM,,690.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,690.0
,3502235,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C[C@@H](N)C(=O)N2CCN(c3ncnc4ccccc34)CC2)cc(OC)c1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.42', 'le': '0.27', 'lle': '4.21', 'sei': '6.48'}",CHEMBL1257281,,CHEMBL1257281,6.08,False,http://www.openphacts.org/units/Nanomolar,962146,=,1,True,=,,IC50,nM,,838.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,838.0
,3502237,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3cc(F)ccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.18', 'le': '0.35', 'lle': '4.88', 'sei': '9.98'}",CHEMBL1257401,,CHEMBL1257401,7.52,False,http://www.openphacts.org/units/Nanomolar,962278,=,1,True,=,,IC50,nM,,30.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30.0
,3502238,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c12,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.08', 'le': '0.33', 'lle': '4.19', 'sei': '9.29'}",CHEMBL1257510,,CHEMBL1257510,7.00,False,http://www.openphacts.org/units/Nanomolar,962403,=,1,True,=,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100.0
,3502239,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c2c1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.73', 'le': '0.34', 'lle': '4.46', 'sei': '9.65'}",CHEMBL1257511,,CHEMBL1257511,7.27,False,http://www.openphacts.org/units/Nanomolar,962404,=,1,True,=,,IC50,nM,,54.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,54.0
,3502240,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3ccc(-c4cn[nH]c4)cc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.36', 'le': '0.29', 'lle': '4.21', 'sei': '6.82'}",CHEMBL1257628,,CHEMBL1257628,7.10,False,http://www.openphacts.org/units/Nanomolar,962532,=,1,True,=,,IC50,nM,,80.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,80.0
,3502241,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c2c1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.93', 'le': '0.35', 'lle': '5.29', 'sei': '7.27'}",CHEMBL1257629,,CHEMBL1257629,7.37,False,http://www.openphacts.org/units/Nanomolar,962533,=,1,True,=,,IC50,nM,,43.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,43.0
,3502242,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ccc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c2c1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.49', 'le': '0.32', 'lle': '4.47', 'sei': '8.02'}",CHEMBL1257751,,CHEMBL1257751,7.01,False,http://www.openphacts.org/units/Nanomolar,962661,=,1,True,=,,IC50,nM,,98.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,98.0
,3502243,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c2c1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.29', 'le': '0.28', 'lle': '3.70', 'sei': '7.98'}",CHEMBL1257752,,CHEMBL1257752,6.27,False,http://www.openphacts.org/units/Nanomolar,962662,=,1,True,=,,IC50,nM,,536.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,536.0
,3502244,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1ccc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c2c1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.38', 'le': '0.26', 'lle': '3.60', 'sei': '5.80'}",CHEMBL1257873,,CHEMBL1257873,6.06,False,http://www.openphacts.org/units/Nanomolar,962791,=,1,True,=,,IC50,nM,,868.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,868.0
,3502245,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNS(=O)(=O)c1ccc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c2c1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.82', 'le': '0.28', 'lle': '5.35', 'sei': '5.56'}",CHEMBL2021429,,CHEMBL2021429,6.76,False,http://www.openphacts.org/units/Nanomolar,962792,=,1,True,=,,IC50,nM,,174.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,174.0
,3502246,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3ccc(-c4ccccc4)cc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '12.91', 'le': '0.24', 'lle': '1.92', 'sei': '8.09'}",CHEMBL1257985,,CHEMBL1257985,6.09,False,http://www.openphacts.org/units/Nanomolar,962921,=,1,True,=,,IC50,nM,,809.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,809.0
,3502247,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1ccc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c2c1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '12.91', 'le': '0.25', 'lle': '2.04', 'sei': '7.74'}",CHEMBL1257986,,CHEMBL1257986,5.84,False,http://www.openphacts.org/units/Nanomolar,962922,=,1,True,=,,IC50,nM,,1460.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1460.0
,3502248,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ccnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.58', 'le': '0.36', 'lle': '4.23', 'sei': '11.75'}",CHEMBL1258101,,CHEMBL1258101,7.34,False,http://www.openphacts.org/units/Nanomolar,963045,=,1,True,=,,IC50,nM,,46.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,46.0
,3502249,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2cnnc3ccccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '11.80', 'le': '0.23', 'lle': '2.17', 'sei': '6.20'}",CHEMBL1258102,,CHEMBL1258102,4.67,False,http://www.openphacts.org/units/Nanomolar,963046,=,1,True,=,,IC50,nM,,21233.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21233.0
,3502250,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ccnc3ccnn23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.24', 'le': '0.28', 'lle': '3.88', 'sei': '6.87'}",CHEMBL1258215,,CHEMBL1258215,5.48,False,http://www.openphacts.org/units/Nanomolar,963172,=,1,True,=,,IC50,nM,,3321.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3321.0
,3502251,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3cc[nH]c23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.04', 'le': '0.35', 'lle': '5.11', 'sei': '7.62'}",CHEMBL1258216,,CHEMBL1258216,6.94,False,http://www.openphacts.org/units/Nanomolar,963173,=,1,True,=,,IC50,nM,,114.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,114.0
,3502252,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ccnc3[nH]ccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '21.09', 'le': '0.41', 'lle': '5.67', 'sei': '10.35'}",CHEMBL1258331,,CHEMBL1258331,8.10,False,http://www.openphacts.org/units/Nanomolar,963298,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
,3502253,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2cnc3ccccn23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.26', 'le': '0.26', 'lle': '2.88', 'sei': '7.61'}",CHEMBL1258332,,CHEMBL1258332,5.09,False,http://www.openphacts.org/units/Nanomolar,963299,=,1,True,=,,IC50,nM,,8122.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8122.0
,3502254,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ccncn2)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.42', 'le': '0.26', 'lle': '3.29', 'sei': '6.16'}",CHEMBL1258443,,CHEMBL1258443,4.64,False,http://www.openphacts.org/units/Nanomolar,963421,=,1,True,=,,IC50,nM,,22920.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22920.0
,3502255,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ccnc3cc[nH]c23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.82', 'le': '0.29', 'lle': '3.26', 'sei': '7.27'}",CHEMBL1258444,,CHEMBL1258444,5.69,False,http://www.openphacts.org/units/Nanomolar,963422,=,1,True,=,,IC50,nM,,2048.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2048.0
,3502256,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '21.57', 'le': '0.42', 'lle': '6.47', 'sei': '9.11'}",CHEMBL1258552,,CHEMBL1258552,8.30,False,http://www.openphacts.org/units/Nanomolar,963548,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,3502257,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3[nH]ncc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.10', 'le': '0.35', 'lle': '5.76', 'sei': '6.71'}",CHEMBL1258553,,CHEMBL1258553,6.98,False,http://www.openphacts.org/units/Nanomolar,963549,=,1,True,=,,IC50,nM,,104.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,104.0
,3502258,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c12,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '22.56', 'le': '0.44', 'lle': '6.86', 'sei': '9.87'}",CHEMBL1258664,,CHEMBL1258664,9.00,False,http://www.openphacts.org/units/Nanomolar,963675,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,3502259,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c12,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '21.07', 'le': '0.41', 'lle': '6.31', 'sei': '9.54'}",CHEMBL1258665,,CHEMBL1258665,8.70,False,http://www.openphacts.org/units/Nanomolar,963676,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,3502260,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3[nH]cc(C4CC4)c23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '20.47', 'le': '0.40', 'lle': '5.99', 'sei': '9.54'}",CHEMBL1258780,,CHEMBL1258780,8.70,False,http://www.openphacts.org/units/Nanomolar,963803,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,3502261,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3[nH]cc(Cl)c23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '21.46', 'le': '0.44', 'lle': '6.52', 'sei': '9.87'}",CHEMBL1258781,,CHEMBL1258781,9.00,False,http://www.openphacts.org/units/Nanomolar,963804,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,3502262,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '20.81', 'le': '0.40', 'lle': '6.22', 'sei': '9.11'}",CHEMBL1236822,,CHEMBL1236822,8.30,False,http://www.openphacts.org/units/Nanomolar,963930,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,3502263,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](CN)Cc4ccc(Cl)cc4)CC3)c12,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '21.07', 'le': '0.41', 'lle': '6.31', 'sei': '9.54'}",CHEMBL1258900,,CHEMBL1258900,8.70,False,http://www.openphacts.org/units/Nanomolar,963931,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,3502264,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.76', 'le': '0.36', 'lle': '5.40', 'sei': '10.04'}",CHEMBL1257165,,CHEMBL1257165,7.75,False,http://www.openphacts.org/units/Nanomolar,962019,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,3502265,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.53', 'le': '0.32', 'lle': '4.38', 'sei': '10.32'}",CHEMBL1257166,,CHEMBL1257166,7.06,False,http://www.openphacts.org/units/Nanomolar,962020,=,1,True,=,,IC50,nM,,88.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,88.0
,3502266,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(F)cc4)CC3)c12,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '22.29', 'le': '0.42', 'lle': '6.90', 'sei': '9.35'}",CHEMBL1257282,,CHEMBL1257282,8.52,True,http://www.openphacts.org/units/Nanomolar,962147,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,3502267,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](N)C4Cc5ccccc5C4)CC3)c12,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.27', 'le': '0.35', 'lle': '5.86', 'sei': '8.25'}",CHEMBL1257283,,CHEMBL1257283,7.52,False,http://www.openphacts.org/units/Nanomolar,962148,=,1,True,=,,IC50,nM,,30.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30.0
,3502268,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@@H](C(=O)N1CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '22.60', 'le': '0.44', 'lle': '6.70', 'sei': '9.54'}",CHEMBL1257402,,CHEMBL1257402,8.70,False,http://www.openphacts.org/units/Nanomolar,962279,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,3502269,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.05', 'le': '0.35', 'lle': '5.12', 'sei': '7.90'}",CHEMBL1257403,,CHEMBL1257403,7.20,False,http://www.openphacts.org/units/Nanomolar,962280,=,1,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,63.0
,3502270,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@@H](C(=O)N1CCN(c2ncnc3[nH]cc(Cl)c23)CC1)c1ccc(Cl)c(Cl)c1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.17', 'le': '0.41', 'lle': '5.39', 'sei': '9.54'}",CHEMBL1257512,,CHEMBL1257512,8.70,False,http://www.openphacts.org/units/Nanomolar,962405,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,3502271,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(C[C@@H](CN)C(=O)N2CCN(c3ncnc4[nH]ccc34)CC2)cc1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.30', 'le': '0.28', 'lle': '3.67', 'sei': '6.82'}",CHEMBL1257513,,CHEMBL1257513,6.22,False,http://www.openphacts.org/units/Nanomolar,962406,=,1,True,=,,IC50,nM,,604.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,604.0
,3502601,[],CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2c(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)ncnc2c1,,,CHEMBL1255571,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.40', 'le': '0.26', 'lle': '2.68', 'sei': '7.29'}",CHEMBL1255592,,CHEMBL1255592,5.49,False,http://www.openphacts.org/units/Nanomolar,962277,=,1,True,=,,IC50,nM,,3203.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3203.0
,3504165,[],CHEMBL1260134,Inhibition of AKT in human BT20 cells assessed as inhibition of S473 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-c2nc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1,,,CHEMBL1255178,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '20.08', 'le': '0.38', 'lle': '6.30', 'sei': '6.39'}",CHEMBL1258910,,CHEMBL1258910,8.24,False,http://www.openphacts.org/units/Nanomolar,963942,=,1,True,=,,IC50,nM,,5.74,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.74
,3504169,[],CHEMBL1260134,Inhibition of AKT in human BT20 cells assessed as inhibition of S473 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc2c1nc(-c1cc[nH]n1)c(=O)n2C1CCOCC1,,,CHEMBL1255178,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '21.90', 'le': '0.41', 'lle': '6.35', 'sei': '5.75'}",CHEMBL1258911,,CHEMBL1258911,7.17,False,http://www.openphacts.org/units/Nanomolar,963943,=,1,True,=,,IC50,nM,,68.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,68.0
,3504173,[],CHEMBL1260134,Inhibition of AKT in human BT20 cells assessed as inhibition of S473 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2nc3c(C)nc(N)nc3n([C@H]3CC[C@H](O)CC3)c2=O)cn1,,,CHEMBL1255178,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '20.51', 'le': '0.38', 'lle': '6.22', 'sei': '6.08'}",CHEMBL1257177,,CHEMBL1257177,7.84,False,http://www.openphacts.org/units/Nanomolar,962031,=,1,True,=,,IC50,nM,,14.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.3
,3504176,[],CHEMBL1260134,Inhibition of AKT in human BT20 cells assessed as inhibition of S473 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-c2nc3c(C)nc(N)nc3n(C3CCOCC3)c2=O)cn1,,,CHEMBL1255178,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '21.57', 'le': '0.40', 'lle': '5.80', 'sei': '6.99'}",CHEMBL1257178,,CHEMBL1257178,7.60,False,http://www.openphacts.org/units/Nanomolar,962032,=,1,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
,3504180,[],CHEMBL1260134,Inhibition of AKT in human BT20 cells assessed as inhibition of S473 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-c2nc3c(C)nc(N)nc3n([C@H]3CC[C@H](O)CC3)c2=O)cn1,,,CHEMBL1255178,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '22.50', 'le': '0.42', 'lle': '6.32', 'sei': '6.88'}",CHEMBL1257295,,CHEMBL1257295,8.24,False,http://www.openphacts.org/units/Nanomolar,962161,=,1,True,=,,IC50,nM,,5.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.7
,3504206,[],CHEMBL1260179,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1,,,CHEMBL1255180,Bioorg. Med. Chem.,2010.0,,CHEMBL1258913,,CHEMBL1258913,,False,http://www.openphacts.org/units/Nanomolar,963945,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3521251,[],CHEMBL1272509,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc([C@@H](C)N3C[C@H](C)O[C@H](C)C3)ns2)n1,,,CHEMBL1268847,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1270399,,CHEMBL1270399,,False,http://www.openphacts.org/units/Nanomolar,965994,>,1,True,>,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,3523921,[],CHEMBL1273652,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1n[nH]c(Cl)c1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)cn2)n1,,,CHEMBL1269009,J. Med. Chem.,2010.0,,CHEMBL1272116,,CHEMBL1272116,,False,http://www.openphacts.org/units/Nanomolar,967985,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3523922,[],CHEMBL1273652,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1n[nH]c(C(F)(F)F)c1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)cn2)n1,,,CHEMBL1269009,J. Med. Chem.,2010.0,,CHEMBL1272171,,CHEMBL1272171,,False,http://www.openphacts.org/units/Nanomolar,968047,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,3526998,[],CHEMBL1275208,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1,,,CHEMBL1268909,J. Med. Chem.,2010.0,,CHEMBL1270230,,CHEMBL1270230,,False,http://www.openphacts.org/units/Nanomolar,965777,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
Not Determined,3527787,[],CHEMBL1274490,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(Nc1ccnc(NCCc2ccccc2)n1)c1ccc(Cl)cc1,,,CHEMBL1268914,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1270522,,CHEMBL1270522,,False,,966149,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,3527788,[],CHEMBL1274490,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(Nc1nc(NCCc2ccccc2)nc2c1CN(Cc1ccccc1)CC2)c1ccc2ccccc2c1,,,CHEMBL1268914,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '9.22', 'le': '0.17', 'lle': '-0.57', 'sei': '5.81'}",CHEMBL1271447,,CHEMBL1271447,5.07,False,http://www.openphacts.org/units/Nanomolar,967228,=,1,True,=,,IC50,nM,,8500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,8.5
,3527789,[],CHEMBL1274490,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(Cl)cccc1S(=O)(=O)Nc1nc(NCCc2ccccc2)nc2c1CN(Cc1ccccc1)CC2,,,CHEMBL1268914,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '8.25', 'le': '0.16', 'lle': '-0.93', 'sei': '5.19'}",CHEMBL1270331,,CHEMBL1270331,4.52,False,http://www.openphacts.org/units/Nanomolar,965903,=,1,True,=,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,5116047,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(F)cc4)CC3)c12,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '22.29', 'le': '0.42', 'lle': '6.90', 'sei': '9.35'}",CHEMBL1257282,,CHEMBL1257282,8.52,False,http://www.openphacts.org/units/Nanomolar,1316348,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,5116048,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2CSC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.96', 'le': '0.39', 'lle': '5.56', 'sei': '10.16'}",CHEMBL1632369,,CHEMBL1632369,7.66,False,http://www.openphacts.org/units/Nanomolar,1316349,=,1,True,=,,IC50,nM,,22.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22.0
,5116049,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2CS(=O)(=O)C3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.71', 'le': '0.34', 'lle': '6.50', 'sei': '6.65'}",CHEMBL1632370,,CHEMBL1632370,7.28,False,http://www.openphacts.org/units/Nanomolar,1316350,=,1,True,=,,IC50,nM,,52.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,52.0
,5116050,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CC1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '20.09', 'le': '0.41', 'lle': '5.74', 'sei': '11.15'}",CHEMBL1632371,,CHEMBL1632371,8.40,False,http://www.openphacts.org/units/Nanomolar,1316351,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,5116051,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCC1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.88', 'le': '0.38', 'lle': '5.10', 'sei': '10.82'}",CHEMBL1632372,,CHEMBL1632372,8.15,False,http://www.openphacts.org/units/Nanomolar,1316352,=,1,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
,5116052,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '21.53', 'le': '0.44', 'lle': '6.34', 'sei': '11.94'}",CHEMBL1632373,,CHEMBL1632373,9.00,False,http://www.openphacts.org/units/Nanomolar,1316353,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,5116053,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.75', 'le': '0.32', 'lle': '3.93', 'sei': '8.74'}",CHEMBL1632374,,CHEMBL1632374,6.58,False,http://www.openphacts.org/units/Nanomolar,1316354,=,1,True,=,,IC50,nM,,260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,260.0
,5116054,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)c(F)c4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.95', 'le': '0.41', 'lle': '5.90', 'sei': '11.54'}",CHEMBL1632375,,CHEMBL1632375,8.70,False,http://www.openphacts.org/units/Nanomolar,1316355,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,5116055,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(F)cc4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.82', 'le': '0.39', 'lle': '5.82', 'sei': '10.56'}",CHEMBL1632376,,CHEMBL1632376,7.96,False,http://www.openphacts.org/units/Nanomolar,1316356,=,1,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
,5116056,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(F)c(F)c4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '20.02', 'le': '0.40', 'lle': '6.12', 'sei': '11.15'}",CHEMBL1632377,,CHEMBL1632377,8.40,False,http://www.openphacts.org/units/Nanomolar,1316357,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,5116057,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4c[nH]c5ccccc45)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.12', 'le': '0.35', 'lle': '5.18', 'sei': '8.40'}",CHEMBL1235979,,CHEMBL1235979,7.66,False,http://www.openphacts.org/units/Nanomolar,1316358,=,1,True,=,,IC50,nM,,22.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22.0
,5116058,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1OCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '20.29', 'le': '0.40', 'lle': '6.21', 'sei': '9.64'}",CHEMBL1632378,,CHEMBL1632378,8.15,False,http://www.openphacts.org/units/Nanomolar,1316359,=,1,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
,5116059,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)C(Cc4ccc(Cl)cc4)C4(N)CC4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.11', 'le': '0.32', 'lle': '3.94', 'sei': '9.79'}",CHEMBL1632379,,CHEMBL1632379,7.38,False,http://www.openphacts.org/units/Nanomolar,1316360,=,1,True,=,,IC50,nM,,42.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.0
,5116060,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NCC(Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2[C@H](C)SC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.98', 'le': '0.36', 'lle': '4.58', 'sei': '13.89'}",CHEMBL1632380,,CHEMBL1632380,8.52,False,http://www.openphacts.org/units/Nanomolar,1316361,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,5116061,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)C(Cc4ccc(Cl)cc4)CN4CCCC4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.53', 'le': '0.35', 'lle': '4.48', 'sei': '16.21'}",CHEMBL1632381,,CHEMBL1632381,8.52,False,http://www.openphacts.org/units/Nanomolar,1316362,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,5116062,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CC(CNC(C)C)C(=O)N2CCN(c3ncnc4c3[C@H](C)SC4)CC2)cc1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.79', 'le': '0.36', 'lle': '4.92', 'sei': '13.89'}",CHEMBL1632382,,CHEMBL1632382,8.52,False,http://www.openphacts.org/units/Nanomolar,1316363,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,5116063,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NCC(Cc1ccc(Cl)c(F)c1)C(=O)N1CCN(c2ncnc3c2[C@H](C)SC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.68', 'le': '0.36', 'lle': '4.62', 'sei': '14.18'}",CHEMBL1632368,,CHEMBL1632368,8.70,False,http://www.openphacts.org/units/Nanomolar,1316347,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,5116064,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NCC(Cc1ccc(F)c(F)c1)C(=O)N1CCN(c2ncnc3c2[C@H](C)SC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.82', 'le': '0.33', 'lle': '4.43', 'sei': '13.04'}",CHEMBL1632383,,CHEMBL1632383,8.00,False,http://www.openphacts.org/units/Nanomolar,1316364,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,5116065,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2[C@H](C)SC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.98', 'le': '0.38', 'lle': '5.06', 'sei': '14.67'}",CHEMBL1632384,,CHEMBL1632384,9.00,False,http://www.openphacts.org/units/Nanomolar,1316365,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,5116066,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC[C@@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2[C@H](C)SC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.55', 'le': '0.29', 'lle': '2.96', 'sei': '11.24'}",CHEMBL1632385,,CHEMBL1632385,6.90,False,http://www.openphacts.org/units/Nanomolar,1316366,=,1,True,=,,IC50,nM,,127.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,127.0
,5116067,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)C(Cc4ccc(Cl)c(F)c4)CC4(N)CC4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.39', 'le': '0.35', 'lle': '4.55', 'sei': '11.31'}",CHEMBL1632386,,CHEMBL1632386,8.52,False,http://www.openphacts.org/units/Nanomolar,1316367,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,5116068,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)C(Cc4ccc(Cl)cc4)CC(C)(C)N)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.34', 'le': '0.35', 'lle': '4.15', 'sei': '10.91'}",CHEMBL1632387,,CHEMBL1632387,8.22,False,http://www.openphacts.org/units/Nanomolar,1316368,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,5116069,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)C(Cc4ccc(Cl)c(F)c4)CC(C)(C)N)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.57', 'le': '0.34', 'lle': '3.94', 'sei': '10.82'}",CHEMBL1632388,,CHEMBL1632388,8.15,False,http://www.openphacts.org/units/Nanomolar,1316369,=,1,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
,5116070,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CC(CNC(C)C)C(=O)N2CCN(c3ncnc4c3[C@H](C)OC4)CC2)cc1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.82', 'le': '0.33', 'lle': '4.92', 'sei': '11.04'}",CHEMBL1632389,,CHEMBL1632389,7.80,False,http://www.openphacts.org/units/Nanomolar,1316370,=,1,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
,5116071,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NCC(Cc1ccc(Cl)c(F)c1)C(=O)N1CCN(c2ncnc3c2[C@H](C)OC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.27', 'le': '0.34', 'lle': '4.85', 'sei': '11.65'}",CHEMBL1632390,,CHEMBL1632390,8.22,False,http://www.openphacts.org/units/Nanomolar,1316371,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,5116072,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2[C@H](C)OC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.61', 'le': '0.36', 'lle': '5.29', 'sei': '12.07'}",CHEMBL1632391,,CHEMBL1632391,8.52,False,http://www.openphacts.org/units/Nanomolar,1316372,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,5116073,[],CHEMBL1632819,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1OCc2ncnc(N3CCN(C(=O)C(Cc4ccc(Cl)c(F)c4)CC(C)(C)N)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.27', 'le': '0.32', 'lle': '4.24', 'sei': '9.16'}",CHEMBL1632392,,CHEMBL1632392,7.75,False,http://www.openphacts.org/units/Nanomolar,1316373,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,5116101,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(F)cc4)CC3)c12,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '17.77', 'le': '0.33', 'lle': '5.18', 'sei': '7.46'}",CHEMBL1257282,,CHEMBL1257282,6.80,False,http://www.openphacts.org/units/Nanomolar,1316348,=,1,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,160.0
,5116102,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2CSC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.41', 'le': '0.27', 'lle': '3.31', 'sei': '7.19'}",CHEMBL1632369,,CHEMBL1632369,5.42,False,http://www.openphacts.org/units/Nanomolar,1316349,=,1,True,=,,IC50,nM,,3846.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3846.0
,5116103,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2CS(=O)(=O)C3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '10.73', 'le': '0.22', 'lle': '3.90', 'sei': '4.27'}",CHEMBL1632370,,CHEMBL1632370,4.68,False,http://www.openphacts.org/units/Nanomolar,1316350,=,1,True,=,,IC50,nM,,21010.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21010.0
,5116104,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.57', 'le': '0.32', 'lle': '3.85', 'sei': '8.64'}",CHEMBL1632371,,CHEMBL1632371,6.51,False,http://www.openphacts.org/units/Nanomolar,1316351,=,1,True,=,,IC50,nM,,310.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,310.0
,5116105,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,CCC1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.71', 'le': '0.28', 'lle': '2.87', 'sei': '7.86'}",CHEMBL1632372,,CHEMBL1632372,5.92,False,http://www.openphacts.org/units/Nanomolar,1316352,=,1,True,=,,IC50,nM,,1201.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1201.0
,5116106,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '16.11', 'le': '0.33', 'lle': '4.08', 'sei': '8.94'}",CHEMBL1632373,,CHEMBL1632373,6.74,False,http://www.openphacts.org/units/Nanomolar,1316353,=,1,True,=,,IC50,nM,,184.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,184.0
,5116107,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '11.33', 'le': '0.23', 'lle': '2.07', 'sei': '6.28'}",CHEMBL1632374,,CHEMBL1632374,4.73,False,http://www.openphacts.org/units/Nanomolar,1316354,=,1,True,=,,IC50,nM,,18469.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18469.0
,5116108,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)c(F)c4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.49', 'le': '0.32', 'lle': '3.95', 'sei': '8.96'}",CHEMBL1632375,,CHEMBL1632375,6.75,False,http://www.openphacts.org/units/Nanomolar,1316355,=,1,True,=,,IC50,nM,,176.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,176.0
,5116109,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(F)cc4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.44', 'le': '0.28', 'lle': '3.66', 'sei': '7.69'}",CHEMBL1632376,,CHEMBL1632376,5.80,False,http://www.openphacts.org/units/Nanomolar,1316356,=,1,True,=,,IC50,nM,,1592.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1592.0
,5116110,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(F)c(F)c4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.83', 'le': '0.29', 'lle': '3.94', 'sei': '8.26'}",CHEMBL1632377,,CHEMBL1632377,6.22,False,http://www.openphacts.org/units/Nanomolar,1316357,=,1,True,=,,IC50,nM,,602.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,602.0
,5116111,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4c[nH]c5ccccc45)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '12.87', 'le': '0.25', 'lle': '2.96', 'sei': '5.97'}",CHEMBL1235979,,CHEMBL1235979,5.44,False,http://www.openphacts.org/units/Nanomolar,1316358,=,1,True,=,,IC50,nM,,3629.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3629.0
,5116112,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1OCc2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(Cl)cc4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.45', 'le': '0.30', 'lle': '4.27', 'sei': '7.34'}",CHEMBL1632378,,CHEMBL1632378,6.21,False,http://www.openphacts.org/units/Nanomolar,1316359,=,1,True,=,,IC50,nM,,615.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,615.0
,5116113,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)C(Cc4ccc(Cl)cc4)C4(N)CC4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '12.24', 'le': '0.25', 'lle': '2.17', 'sei': '7.44'}",CHEMBL1632379,,CHEMBL1632379,5.61,False,http://www.openphacts.org/units/Nanomolar,1316360,=,1,True,=,,IC50,nM,,2468.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2468.0
,5116114,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NCC(Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2[C@H](C)SC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.34', 'le': '0.29', 'lle': '2.86', 'sei': '11.08'}",CHEMBL1632380,,CHEMBL1632380,6.80,False,http://www.openphacts.org/units/Nanomolar,1316361,=,1,True,=,,IC50,nM,,159.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,159.0
,5116115,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)C(Cc4ccc(Cl)cc4)CN4CCCC4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.89', 'le': '0.28', 'lle': '2.71', 'sei': '12.84'}",CHEMBL1632381,,CHEMBL1632381,6.75,False,http://www.openphacts.org/units/Nanomolar,1316362,=,1,True,=,,IC50,nM,,178.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,178.0
,5116116,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(CC(CNC(C)C)C(=O)N2CCN(c3ncnc4c3[C@H](C)SC4)CC2)cc1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.69', 'le': '0.28', 'lle': '3.07', 'sei': '10.86'}",CHEMBL1632382,,CHEMBL1632382,6.67,False,http://www.openphacts.org/units/Nanomolar,1316363,=,1,True,=,,IC50,nM,,216.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,216.0
,5116117,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NCC(Cc1ccc(Cl)c(F)c1)C(=O)N1CCN(c2ncnc3c2[C@H](C)SC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.30', 'le': '0.29', 'lle': '2.96', 'sei': '11.47'}",CHEMBL1632368,,CHEMBL1632368,7.04,False,http://www.openphacts.org/units/Nanomolar,1316347,=,1,True,=,,IC50,nM,,92.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,92.0
,5116118,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NCC(Cc1ccc(F)c(F)c1)C(=O)N1CCN(c2ncnc3c2[C@H](C)SC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '12.87', 'le': '0.25', 'lle': '2.55', 'sei': '9.97'}",CHEMBL1632383,,CHEMBL1632383,6.12,False,http://www.openphacts.org/units/Nanomolar,1316364,=,1,True,=,,IC50,nM,,759.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,759.0
,5116119,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2[C@H](C)SC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '14.48', 'le': '0.29', 'lle': '2.92', 'sei': '11.19'}",CHEMBL1632384,,CHEMBL1632384,6.86,False,http://www.openphacts.org/units/Nanomolar,1316365,=,1,True,=,,IC50,nM,,137.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,137.0
Not Determined,5116120,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC[C@@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2[C@H](C)SC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1632385,,CHEMBL1632385,,False,,1316366,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,5116121,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)C(Cc4ccc(Cl)c(F)c4)CC4(N)CC4)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.47', 'le': '0.27', 'lle': '2.63', 'sei': '8.76'}",CHEMBL1632386,,CHEMBL1632386,6.60,False,http://www.openphacts.org/units/Nanomolar,1316367,=,1,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,250.0
,5116122,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)C(Cc4ccc(Cl)cc4)CC(C)(C)N)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.41', 'le': '0.27', 'lle': '2.29', 'sei': '8.44'}",CHEMBL1632387,,CHEMBL1632387,6.36,False,http://www.openphacts.org/units/Nanomolar,1316368,=,1,True,=,,IC50,nM,,438.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,438.0
,5116123,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1SCc2ncnc(N3CCN(C(=O)C(Cc4ccc(Cl)c(F)c4)CC(C)(C)N)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '12.66', 'le': '0.26', 'lle': '2.02', 'sei': '8.27'}",CHEMBL1632388,,CHEMBL1632388,6.23,False,http://www.openphacts.org/units/Nanomolar,1316369,=,1,True,=,,IC50,nM,,587.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,587.0
,5116124,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(CC(CNC(C)C)C(=O)N2CCN(c3ncnc4c3[C@H](C)OC4)CC2)cc1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.72', 'le': '0.26', 'lle': '3.12', 'sei': '8.50'}",CHEMBL1632389,,CHEMBL1632389,6.00,False,http://www.openphacts.org/units/Nanomolar,1316370,=,1,True,=,,IC50,nM,,995.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,995.0
,5116125,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NCC(Cc1ccc(Cl)c(F)c1)C(=O)N1CCN(c2ncnc3c2[C@H](C)OC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.66', 'le': '0.27', 'lle': '3.13', 'sei': '9.21'}",CHEMBL1632390,,CHEMBL1632390,6.50,False,http://www.openphacts.org/units/Nanomolar,1316371,=,1,True,=,,IC50,nM,,315.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,315.0
,5116126,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2[C@H](C)OC3)CC1,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '15.07', 'le': '0.29', 'lle': '3.67', 'sei': '9.78'}",CHEMBL1632391,,CHEMBL1632391,6.90,False,http://www.openphacts.org/units/Nanomolar,1316372,=,1,True,=,,IC50,nM,,125.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,125.0
,5116127,[],CHEMBL1632821,Inhibition of Akt in human LNCaP cell assessed as inhibition of PRAS40 phosphorylation,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1OCc2ncnc(N3CCN(C(=O)C(Cc4ccc(Cl)c(F)c4)CC(C)(C)N)CC3)c21,,,CHEMBL1629708,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.08', 'le': '0.26', 'lle': '2.73', 'sei': '7.36'}",CHEMBL1632392,,CHEMBL1632392,6.23,False,http://www.openphacts.org/units/Nanomolar,1316373,=,1,True,=,,IC50,nM,,592.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,592.0
,5143836,[],CHEMBL1656200,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO.Cl,,,CHEMBL1649074,J. Med. Chem.,2011.0,,CHEMBL1650533,,CHEMBL1232515,,False,http://www.openphacts.org/units/Nanomolar,1323214,>,1,True,>,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100.0
,5143853,[],CHEMBL1656200,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)C3)ns2)n1.Cl,,,CHEMBL1649074,J. Med. Chem.,2011.0,,CHEMBL1650545,,CHEMBL1739675,,False,http://www.openphacts.org/units/Nanomolar,1323226,>,1,True,>,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100.0
,5143870,[],CHEMBL1656200,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cl.[2H]C([2H])(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCC(F)(F)C1,,,CHEMBL1649074,J. Med. Chem.,2011.0,,CHEMBL1650551,,CHEMBL1739675,,False,http://www.openphacts.org/units/Nanomolar,1323232,>,1,True,>,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100.0
,5249833,[],CHEMBL1687351,Inhibition of AKT1 PH S473D mutant,B,P31749,S473D,BAO_0000190,BAO_0000019,assay format,COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1,,,CHEMBL1681781,Bioorg. Med. Chem.,2011.0,"{'bei': '14.53', 'le': '0.28', 'lle': '1.93', 'sei': '6.75'}",CHEMBL1684800,,CHEMBL1684800,8.33,False,http://www.openphacts.org/units/Nanomolar,1336208,=,1,True,=,,IC50,nM,,4.72,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.72
,5293786,[],CHEMBL1696296,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nccc(-c2ccc3c(N)n[nH]c3c2)n1,,,CHEMBL1687694,ACS Med. Chem. Lett.,2010.0,,CHEMBL1688215,,CHEMBL1688215,,False,http://www.openphacts.org/units/Nanomolar,1336848,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,5293874,[],CHEMBL1697109,Inhibition of Akt1 after 60 mins by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,,,CHEMBL1687697,ACS Med. Chem. Lett.,2010.0,"{'bei': '12.92', 'le': '0.27', 'lle': '0.37', 'sei': '4.57'}",CHEMBL1448,NICLOSAMIDE,CHEMBL1448,4.23,False,http://www.openphacts.org/units/Nanomolar,1336874,=,1,True,=,,IC50,nM,,59400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,59.4
,6159720,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CCN(c3ncnc4[nH]cc(C)c34)CC2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '12.34', 'le': '0.24', 'lle': '3.74', 'sei': '6.43'}",CHEMBL1760758,,CHEMBL1760758,7.39,False,http://www.openphacts.org/units/Nanomolar,1412864,=,1,True,=,,IC50,nM,,41.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.041
,6159721,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CCN(c3ncnc4[nH]cc(C)c34)C2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '14.88', 'le': '0.29', 'lle': '5.44', 'sei': '7.57'}",CHEMBL1760759,,CHEMBL1760759,8.70,False,http://www.openphacts.org/units/Nanomolar,1412865,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.002
,6159722,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCC2(CCN(c3ncnc4[nH]nc(C)c34)C2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.59', 'le': '0.27', 'lle': '5.50', 'sei': '6.08'}",CHEMBL1760760,,CHEMBL1760760,7.77,False,http://www.openphacts.org/units/Nanomolar,1412866,=,1,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.017
,6159723,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CCN(c3ncnc4[nH]nc(C)c34)C2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.11', 'le': '0.26', 'lle': '5.02', 'sei': '6.01'}",CHEMBL1760761,,CHEMBL1760761,7.68,False,http://www.openphacts.org/units/Nanomolar,1412867,=,1,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.021
,6159724,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CCN(c3ncnc4ccccc34)C2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '12.75', 'le': '0.25', 'lle': '3.79', 'sei': '7.49'}",CHEMBL1760762,,CHEMBL1760762,7.42,False,http://www.openphacts.org/units/Nanomolar,1412868,=,1,True,=,,IC50,nM,,38.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.038
,6159725,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CCN(c3ncncc3C3CC3)C2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.85', 'le': '0.27', 'lle': '4.57', 'sei': '7.99'}",CHEMBL1760763,,CHEMBL1760763,7.92,False,http://www.openphacts.org/units/Nanomolar,1412869,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.012
,6159726,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CCN(c3ncnc(N)c3C3CC3)C2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.50', 'le': '0.26', 'lle': '4.99', 'sei': '6.33'}",CHEMBL1760764,,CHEMBL1760764,7.92,False,http://www.openphacts.org/units/Nanomolar,1412870,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.012
,6159727,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(C)c1S(=O)(=O)N1CCC[C@H]1[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '14.50', 'le': '0.28', 'lle': '4.99', 'sei': '6.94'}",CHEMBL1760765,,CHEMBL1760765,8.05,False,http://www.openphacts.org/units/Nanomolar,1412871,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.009
,6159728,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(C)c1S(=O)(=O)N1CCC[C@H]1[C@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.90', 'le': '0.23', 'lle': '3.54', 'sei': '5.70'}",CHEMBL1760766,,CHEMBL1760766,6.60,False,http://www.openphacts.org/units/Nanomolar,1412872,=,1,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.25
,6159729,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(C)c1S(=O)(=O)N1CCC[C@@H]1[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.92', 'le': '0.27', 'lle': '4.66', 'sei': '6.66'}",CHEMBL1760767,,CHEMBL1760767,7.72,False,http://www.openphacts.org/units/Nanomolar,1412873,=,1,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.019
,6159730,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(C)c1S(=O)(=O)NC[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '16.32', 'le': '0.32', 'lle': '6.22', 'sei': '6.74'}",CHEMBL1760768,,CHEMBL1760768,8.40,False,http://www.openphacts.org/units/Nanomolar,1412874,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.004
,6159731,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1S(=O)(=O)NC[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '16.07', 'le': '0.31', 'lle': '6.17', 'sei': '6.45'}",CHEMBL1760769,,CHEMBL1760769,8.05,False,http://www.openphacts.org/units/Nanomolar,1412875,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.009
,6159732,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CC[C@@]3(CCCN(C[C@H](O)CNS(=O)(=O)c4ccccc4F)C3)C2)c1C1CC1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '14.05', 'le': '0.28', 'lle': '5.38', 'sei': '5.69'}",CHEMBL1760770,,CHEMBL1760770,7.09,False,http://www.openphacts.org/units/Nanomolar,1412876,=,1,True,=,,IC50,nM,,81.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.081
,6159733,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CC[C@@]3(CCCN(C[C@H](O)CNS(=O)(=O)c4ccccc4Cl)C3)C2)c1C1CC1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '15.44', 'le': '0.31', 'lle': '5.83', 'sei': '6.45'}",CHEMBL1760771,,CHEMBL1760771,8.05,False,http://www.openphacts.org/units/Nanomolar,1412877,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.009
,6159734,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CC[C@@]3(CCCN(C[C@H](O)CNS(=O)(=O)c4ccccc4Br)C3)C2)c1C1CC1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.74', 'le': '0.30', 'lle': '5.44', 'sei': '6.23'}",CHEMBL1760772,,CHEMBL1760772,7.77,False,http://www.openphacts.org/units/Nanomolar,1412878,=,1,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.017
,6159735,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)ccc1S(=O)(=O)NC[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '15.61', 'le': '0.31', 'lle': '6.08', 'sei': '6.49'}",CHEMBL1760773,,CHEMBL1760773,8.10,False,http://www.openphacts.org/units/Nanomolar,1412879,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.008
,6159736,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)NC[C@@H](O)CN2CCC[C@@]3(CCN(c4ncnc(N)c4C4CC4)C3)C2)c(C)c1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.20', 'le': '0.26', 'lle': '4.62', 'sei': '5.45'}",CHEMBL1760774,,CHEMBL1760774,6.80,False,http://www.openphacts.org/units/Nanomolar,1412880,=,1,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.16
,6159737,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccncc1S(=O)(=O)NC[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.88', 'le': '0.23', 'lle': '4.69', 'sei': '4.33'}",CHEMBL1760775,,CHEMBL1760775,5.96,False,http://www.openphacts.org/units/Nanomolar,1412881,=,1,True,=,,IC50,nM,,1100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.1
,6159738,[],CHEMBL1763788,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1noc(C)c1S(=O)(=O)NC[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '16.86', 'le': '0.33', 'lle': '7.35', 'sei': '5.66'}",CHEMBL1760776,,CHEMBL1760776,8.52,False,http://www.openphacts.org/units/Nanomolar,1412882,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.003
,6159777,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CCN(c3ncnc4[nH]cc(C)c34)CC2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '9.89', 'le': '0.19', 'lle': '2.27', 'sei': '5.15'}",CHEMBL1760758,,CHEMBL1760758,5.92,False,http://www.openphacts.org/units/Nanomolar,1412864,=,1,True,=,,IC50,nM,,1200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.2
,6159778,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CCN(c3ncnc4[nH]cc(C)c34)C2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.53', 'le': '0.22', 'lle': '3.48', 'sei': '5.87'}",CHEMBL1760759,,CHEMBL1760759,6.75,False,http://www.openphacts.org/units/Nanomolar,1412865,=,1,True,=,,IC50,nM,,180.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.18
,6159779,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCC2(CCN(c3ncnc4[nH]nc(C)c34)C2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '9.63', 'le': '0.19', 'lle': '3.24', 'sei': '4.31'}",CHEMBL1760760,,CHEMBL1760760,5.51,False,http://www.openphacts.org/units/Nanomolar,1412866,=,1,True,=,,IC50,nM,,3100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.1
,6159780,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CCN(c3ncnc4[nH]nc(C)c34)C2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.11', 'le': '0.22', 'lle': '3.85', 'sei': '5.09'}",CHEMBL1760761,,CHEMBL1760761,6.51,False,http://www.openphacts.org/units/Nanomolar,1412867,=,1,True,=,,IC50,nM,,310.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.31
,6159781,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CCN(c3ncnc4ccccc34)C2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '9.66', 'le': '0.19', 'lle': '1.99', 'sei': '5.67'}",CHEMBL1760762,,CHEMBL1760762,5.62,False,http://www.openphacts.org/units/Nanomolar,1412868,=,1,True,=,,IC50,nM,,2400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.4
,6159782,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CCN(c3ncncc3C3CC3)C2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.72', 'le': '0.21', 'lle': '2.78', 'sei': '6.19'}",CHEMBL1760763,,CHEMBL1760763,6.13,False,http://www.openphacts.org/units/Nanomolar,1412869,=,1,True,=,,IC50,nM,,740.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.74
,6159783,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CCN(c3ncnc(N)c3C3CC3)C2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.78', 'le': '0.21', 'lle': '3.40', 'sei': '5.06'}",CHEMBL1760764,,CHEMBL1760764,6.33,False,http://www.openphacts.org/units/Nanomolar,1412870,=,1,True,=,,IC50,nM,,470.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.47
,6159784,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(C)c1S(=O)(=O)N1CCC[C@H]1[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.11', 'le': '0.22', 'lle': '3.10', 'sei': '5.32'}",CHEMBL1760765,,CHEMBL1760765,6.16,False,http://www.openphacts.org/units/Nanomolar,1412871,=,1,True,=,,IC50,nM,,690.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.69
,6159785,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(C)c1S(=O)(=O)N1CCC[C@H]1[C@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '8.81', 'le': '0.17', 'lle': '1.83', 'sei': '4.22'}",CHEMBL1760766,,CHEMBL1760766,4.89,False,http://www.openphacts.org/units/Nanomolar,1412872,=,1,True,=,,IC50,nM,,13000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,13.0
,6159786,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(C)c1S(=O)(=O)N1CCC[C@@H]1[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.13', 'le': '0.20', 'lle': '2.56', 'sei': '4.85'}",CHEMBL1760767,,CHEMBL1760767,5.62,False,http://www.openphacts.org/units/Nanomolar,1412873,=,1,True,=,,IC50,nM,,2400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.4
,6159787,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(C)c1S(=O)(=O)NC[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.75', 'le': '0.23', 'lle': '3.87', 'sei': '4.85'}",CHEMBL1760768,,CHEMBL1760768,6.05,False,http://www.openphacts.org/units/Nanomolar,1412874,=,1,True,=,,IC50,nM,,900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.9
,6159788,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1S(=O)(=O)NC[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.83', 'le': '0.23', 'lle': '4.04', 'sei': '4.75'}",CHEMBL1760769,,CHEMBL1760769,5.92,False,http://www.openphacts.org/units/Nanomolar,1412875,=,1,True,=,,IC50,nM,,1200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.2
,6159789,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc(N2CC[C@@]3(CCCN(C[C@H](O)CNS(=O)(=O)c4ccccc4F)C3)C2)c1C1CC1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '9.62', 'le': '0.19', 'lle': '3.14', 'sei': '3.89'}",CHEMBL1760770,,CHEMBL1760770,4.85,False,http://www.openphacts.org/units/Nanomolar,1412876,=,1,True,=,,IC50,nM,,14000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,14.0
,6159790,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc(N2CC[C@@]3(CCCN(C[C@H](O)CNS(=O)(=O)c4ccccc4Cl)C3)C2)c1C1CC1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.98', 'le': '0.22', 'lle': '3.50', 'sei': '4.59'}",CHEMBL1760771,,CHEMBL1760771,5.72,False,http://www.openphacts.org/units/Nanomolar,1412877,=,1,True,=,,IC50,nM,,1900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.9
,6159791,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc(N2CC[C@@]3(CCCN(C[C@H](O)CNS(=O)(=O)c4ccccc4Br)C3)C2)c1C1CC1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.08', 'le': '0.22', 'lle': '3.37', 'sei': '4.57'}",CHEMBL1760772,,CHEMBL1760772,5.70,False,http://www.openphacts.org/units/Nanomolar,1412878,=,1,True,=,,IC50,nM,,2000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.0
,6159792,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(F)ccc1S(=O)(=O)NC[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.91', 'le': '0.21', 'lle': '3.64', 'sei': '4.54'}",CHEMBL1760773,,CHEMBL1760773,5.66,False,http://www.openphacts.org/units/Nanomolar,1412879,=,1,True,=,,IC50,nM,,2200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.2
,6159793,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(S(=O)(=O)NC[C@@H](O)CN2CCC[C@@]3(CCN(c4ncnc(N)c4C4CC4)C3)C2)c(C)c1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '9.22', 'le': '0.18', 'lle': '2.56', 'sei': '3.81'}",CHEMBL1760774,,CHEMBL1760774,4.75,False,http://www.openphacts.org/units/Nanomolar,1412880,=,1,True,=,,IC50,nM,,18000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,18.0
Not Determined,6159794,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccncc1S(=O)(=O)NC[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1760775,,CHEMBL1760775,,False,,1412881,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,6159795,[],CHEMBL1763791,Inhibition of AKT1-mediated PRAS40 phosphorylation in human LNCaP cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1noc(C)c1S(=O)(=O)NC[C@@H](O)CN1CCC[C@@]2(CCN(c3ncnc(N)c3C3CC3)C2)C1,,,CHEMBL1759869,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '12.48', 'le': '0.25', 'lle': '5.14', 'sei': '4.19'}",CHEMBL1760776,,CHEMBL1760776,6.31,False,http://www.openphacts.org/units/Nanomolar,1412882,=,1,True,=,,IC50,nM,,490.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.49
,6161763,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3c(ccc4[nH]ncc34)O2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '14.45', 'le': '0.28', 'lle': '4.62', 'sei': '7.45'}",CHEMBL1761090,,CHEMBL1761090,8.05,False,http://www.openphacts.org/units/Nanomolar,1413237,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.009
,6161764,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3cc4c(cc3O2)CNC4=O)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.99', 'le': '0.27', 'lle': '5.21', 'sei': '7.38'}",CHEMBL1761089,,CHEMBL1761089,8.00,False,http://www.openphacts.org/units/Nanomolar,1413236,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.01
,6161765,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3cc(C(N)=O)ccc3O2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.55', 'le': '0.27', 'lle': '4.94', 'sei': '6.20'}",CHEMBL1761088,,CHEMBL1761088,7.58,False,http://www.openphacts.org/units/Nanomolar,1413235,=,1,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.026
,6161767,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3cc4c(cc3O2)CNC4=O)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.04', 'le': '0.25', 'lle': '4.67', 'sei': '6.88'}",CHEMBL1761089,,CHEMBL1761089,7.46,False,http://www.openphacts.org/units/Nanomolar,1413236,=,1,True,=,,IC50,nM,,35.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.035
,6161768,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.89', 'le': '0.27', 'lle': '4.14', 'sei': '7.43'}",CHEMBL1761085,,CHEMBL1761085,7.40,False,http://www.openphacts.org/units/Nanomolar,1413232,=,1,True,=,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.04
,6161769,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3c(ccc4[nH]ncc34)O2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.21', 'le': '0.26', 'lle': '3.93', 'sei': '6.81'}",CHEMBL1761090,,CHEMBL1761090,7.36,False,http://www.openphacts.org/units/Nanomolar,1413237,=,1,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.044
,6161771,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.66', 'le': '0.27', 'lle': '4.91', 'sei': '5.70'}",CHEMBL1761084,,CHEMBL1761084,7.16,False,http://www.openphacts.org/units/Nanomolar,1413231,=,1,True,=,,IC50,nM,,70.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.07
,6161772,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3cc(C#N)ccc3O2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '12.50', 'le': '0.24', 'lle': '3.35', 'sei': '6.57'}",CHEMBL1761087,,CHEMBL1761087,6.77,False,http://www.openphacts.org/units/Nanomolar,1413234,=,1,True,=,,IC50,nM,,170.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.17
,6161773,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3cc(F)ccc3O2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '12.61', 'le': '0.25', 'lle': '3.05', 'sei': '8.50'}",CHEMBL1761086,,CHEMBL1761086,6.75,False,http://www.openphacts.org/units/Nanomolar,1413233,=,1,True,=,,IC50,nM,,180.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.18
,6161774,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1noc(C)c1S(=O)(=O)N(CCOC(C)C)C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.82', 'le': '0.23', 'lle': '4.25', 'sei': '4.57'}",CHEMBL1761072,,CHEMBL1761072,6.52,False,http://www.openphacts.org/units/Nanomolar,1413219,=,1,True,=,,IC50,nM,,300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.3
,6161775,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.93', 'le': '0.23', 'lle': '3.62', 'sei': '5.59'}",CHEMBL1761083,,CHEMBL1761083,6.52,False,http://www.openphacts.org/units/Nanomolar,1413230,=,1,True,=,,IC50,nM,,300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.3
,6161776,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.83', 'le': '0.23', 'lle': '3.71', 'sei': '5.40'}",CHEMBL1761082,,CHEMBL1761082,6.30,False,http://www.openphacts.org/units/Nanomolar,1413229,=,1,True,=,,IC50,nM,,500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.5
,6161777,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.16', 'le': '0.22', 'lle': '4.11', 'sei': '4.21'}",CHEMBL1761071,,CHEMBL1761071,6.00,False,http://www.openphacts.org/units/Nanomolar,1413218,=,1,True,=,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.0
,6161778,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccccc1Cl,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.85', 'le': '0.22', 'lle': '3.07', 'sei': '5.15'}",CHEMBL1761077,,CHEMBL1761077,6.00,False,http://www.openphacts.org/units/Nanomolar,1413224,=,1,True,=,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.0
,6161779,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.12', 'le': '0.22', 'lle': '2.92', 'sei': '4.47'}",CHEMBL1761073,,CHEMBL1761073,5.96,False,http://www.openphacts.org/units/Nanomolar,1413220,=,1,True,=,,IC50,nM,,1100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.1
,6161780,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccccc1C(F)(F)F,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.03', 'le': '0.20', 'lle': '2.59', 'sei': '5.05'}",CHEMBL1761081,,CHEMBL1761081,5.89,False,http://www.openphacts.org/units/Nanomolar,1413228,=,1,True,=,,IC50,nM,,1300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.3
,6161781,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.84', 'le': '0.22', 'lle': '4.18', 'sei': '3.98'}",CHEMBL1761069,,CHEMBL1761069,5.68,False,http://www.openphacts.org/units/Nanomolar,1413215,=,1,True,=,,IC50,nM,,2100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.1
,6161782,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3cc(C(N)=O)ccc3O2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.05', 'le': '0.20', 'lle': '2.98', 'sei': '4.60'}",CHEMBL1761088,,CHEMBL1761088,5.63,False,http://www.openphacts.org/units/Nanomolar,1413235,=,1,True,=,,IC50,nM,,2360.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.36
,6161783,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3cc(C#N)ccc3O2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.32', 'le': '0.20', 'lle': '2.17', 'sei': '5.42'}",CHEMBL1761087,,CHEMBL1761087,5.59,False,http://www.openphacts.org/units/Nanomolar,1413234,=,1,True,=,,IC50,nM,,2580.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.58
,6161784,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.48', 'le': '0.21', 'lle': '2.33', 'sei': '5.61'}",CHEMBL1761085,,CHEMBL1761085,5.58,False,http://www.openphacts.org/units/Nanomolar,1413232,=,1,True,=,,IC50,nM,,2600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.6
,6161786,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COCCN(CC(O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.44', 'le': '0.21', 'lle': '3.97', 'sei': '3.83'}",CHEMBL1761067,,CHEMBL1761067,5.47,False,http://www.openphacts.org/units/Nanomolar,1413212,=,1,True,=,,IC50,nM,,3400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.4
,6161787,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1noc(C)c1S(=O)(=O)N(Cc1ccccc1)CC(O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '9.73', 'le': '0.19', 'lle': '2.36', 'sei': '4.05'}",CHEMBL1761068,,CHEMBL1761068,5.41,False,http://www.openphacts.org/units/Nanomolar,1413213,=,1,True,=,,IC50,nM,,3900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.9
,6161788,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1noc(C)c1S(=O)(=O)N(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)C1CCCCC1,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '9.86', 'le': '0.19', 'lle': '2.22', 'sei': '4.05'}",CHEMBL1761074,,CHEMBL1761074,5.40,False,http://www.openphacts.org/units/Nanomolar,1413221,=,1,True,=,,IC50,nM,,4000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.0
,6161789,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3cc(F)ccc3O2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '10.02', 'le': '0.20', 'lle': '1.67', 'sei': '6.76'}",CHEMBL1761086,,CHEMBL1761086,5.36,False,http://www.openphacts.org/units/Nanomolar,1413233,=,1,True,=,,IC50,nM,,4380.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.38
,6161790,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccccc1C#N,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '9.85', 'le': '0.19', 'lle': '3.21', 'sei': '3.82'}",CHEMBL1761080,,CHEMBL1761080,5.36,False,http://www.openphacts.org/units/Nanomolar,1413227,=,1,True,=,,IC50,nM,,4400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.4
,6161792,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccccc1F,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '9.70', 'le': '0.19', 'lle': '2.79', 'sei': '4.47'}",CHEMBL1761079,,CHEMBL1761079,5.21,False,http://www.openphacts.org/units/Nanomolar,1413226,=,1,True,=,,IC50,nM,,6200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,6.2
,6161793,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CCc3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '9.92', 'le': '0.20', 'lle': '2.95', 'sei': '4.14'}",CHEMBL1761084,,CHEMBL1761084,5.19,False,http://www.openphacts.org/units/Nanomolar,1413231,=,1,True,=,,IC50,nM,,6400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,6.4
,6161794,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '9.91', 'le': '0.20', 'lle': '3.69', 'sei': '3.64'}",CHEMBL1761069,,CHEMBL1761069,5.19,False,http://www.openphacts.org/units/Nanomolar,1413214,=,1,True,=,,IC50,nM,,6500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,6.5
,6161796,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)cccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '8.69', 'le': '0.17', 'lle': '1.85', 'sei': '4.07'}",CHEMBL1761083,,CHEMBL1761083,4.75,False,http://www.openphacts.org/units/Nanomolar,1413230,=,1,True,=,,IC50,nM,,17800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,17.8
,6161797,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1noc(C)c1S(=O)(=O)N(CCOC(C)C)C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '8.58', 'le': '0.17', 'lle': '2.46', 'sei': '3.32'}",CHEMBL1761072,,CHEMBL1761072,4.73,False,http://www.openphacts.org/units/Nanomolar,1413219,=,1,True,=,,IC50,nM,,18600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,18.6
,6161798,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COCCN(C[C@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '8.87', 'le': '0.18', 'lle': '3.14', 'sei': '3.25'}",CHEMBL1761070,,CHEMBL1761070,4.64,False,http://www.openphacts.org/units/Nanomolar,1413217,=,1,True,=,,IC50,nM,,22800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,22.8
,6161799,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '8.40', 'le': '0.17', 'lle': '2.90', 'sei': '3.08'}",CHEMBL1761069,,CHEMBL1761069,4.40,False,http://www.openphacts.org/units/Nanomolar,1413216,=,1,True,=,,IC50,nM,,40000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,40.0
,6161805,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1cccc(Cl)c1,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761075,,CHEMBL1761075,,False,http://www.openphacts.org/units/Nanomolar,1413222,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,6161806,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccccc1OC,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761078,,CHEMBL1761078,,False,http://www.openphacts.org/units/Nanomolar,1413225,>,1,True,>,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,6161807,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761069,,CHEMBL1761069,,False,http://www.openphacts.org/units/Nanomolar,1413214,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161808,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761069,,CHEMBL1761069,,False,http://www.openphacts.org/units/Nanomolar,1413215,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161809,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761069,,CHEMBL1761069,,False,http://www.openphacts.org/units/Nanomolar,1413216,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161810,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COCCN(C[C@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761070,,CHEMBL1761070,,False,http://www.openphacts.org/units/Nanomolar,1413217,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161811,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761071,,CHEMBL1761071,,False,http://www.openphacts.org/units/Nanomolar,1413218,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161812,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1c(C)noc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761073,,CHEMBL1761073,,False,http://www.openphacts.org/units/Nanomolar,1413220,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161813,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1noc(C)c1S(=O)(=O)N(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)C1CCCCC1,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761074,,CHEMBL1761074,,False,http://www.openphacts.org/units/Nanomolar,1413221,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161814,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1cccc(Cl)c1,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761075,,CHEMBL1761075,,False,http://www.openphacts.org/units/Nanomolar,1413222,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161815,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccc(Cl)cc1,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761076,,CHEMBL1761076,,False,http://www.openphacts.org/units/Nanomolar,1413223,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161816,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccccc1Cl,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761077,,CHEMBL1761077,,False,http://www.openphacts.org/units/Nanomolar,1413224,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161817,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccccc1OC,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761078,,CHEMBL1761078,,False,http://www.openphacts.org/units/Nanomolar,1413225,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161818,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccccc1F,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761079,,CHEMBL1761079,,False,http://www.openphacts.org/units/Nanomolar,1413226,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161819,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccccc1C#N,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761080,,CHEMBL1761080,,False,http://www.openphacts.org/units/Nanomolar,1413227,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161820,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccccc1C(F)(F)F,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761081,,CHEMBL1761081,,False,http://www.openphacts.org/units/Nanomolar,1413228,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161821,[],CHEMBL1764866,Inhibition of AKT1 in human LNCaP cells assessed as PRAS40 phosphorylation at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccccc1C,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1761082,,CHEMBL1761082,,False,http://www.openphacts.org/units/Nanomolar,1413229,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6161824,[],CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCN(C[C@@H](O)CN1CCCC2(CC(=O)c3cc(O)ccc3O2)C1)S(=O)(=O)c1ccc(Cl)cc1,,,CHEMBL1759945,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '8.50', 'le': '0.17', 'lle': '1.77', 'sei': '4.03'}",CHEMBL1761076,,CHEMBL1761076,4.70,False,http://www.openphacts.org/units/Nanomolar,1413223,=,1,True,=,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,6169211,[],CHEMBL1769079,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1,,,CHEMBL1765070,J. Med. Chem.,2011.0,,CHEMBL1765740,,CHEMBL1765740,,False,http://www.openphacts.org/units/Nanomolar,1416438,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,6189339,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3ccnc(NCc4ccccc4)n3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,,CHEMBL1773588,,CHEMBL1773588,,False,http://www.openphacts.org/units/Nanomolar,1421270,>,1,True,>,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5000.0
,6189340,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3ccnc(NC(C)(C)c4ccccc4)n3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '13.76', 'le': '0.26', 'lle': '0.49', 'sei': '6.96'}",CHEMBL1773572,,CHEMBL1773572,5.55,False,http://www.openphacts.org/units/Nanomolar,1421253,=,1,True,=,,IC50,nM,,2800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2800.0
Not Determined,6189341,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)Nc2nccc(-c3ccc4nc(NC(C)=O)sc4c3)n2)cc1,,,CHEMBL1773016,J. Med. Chem.,2011.0,,CHEMBL1773573,,CHEMBL1773573,,False,,1421254,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,6189342,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)Nc2nccc(-c3ccc4nc(NC(C)=O)sc4c3)n2)cc1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '12.30', 'le': '0.25', 'lle': '2.08', 'sei': '4.55'}",CHEMBL1773574,,CHEMBL1773574,5.60,False,http://www.openphacts.org/units/Nanomolar,1421255,=,1,True,=,,IC50,nM,,2500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2500.0
,6189343,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)N(C)c2nccc(-c3ccc4nc(NC(C)=O)sc4c3)n2)cc1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '13.79', 'le': '0.28', 'lle': '2.92', 'sei': '5.66'}",CHEMBL1773575,,CHEMBL1773575,6.47,False,http://www.openphacts.org/units/Nanomolar,1421256,=,1,True,=,,IC50,nM,,336.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,336.0
,6189344,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(c1nccc(-c2ccc3nc(NC(C)=O)sc3c2)n1)S(=O)(=O)c1ccc(OC)cc1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '13.47', 'le': '0.27', 'lle': '2.58', 'sei': '5.70'}",CHEMBL1773576,,CHEMBL1773576,6.52,False,http://www.openphacts.org/units/Nanomolar,1421257,=,1,True,=,,IC50,nM,,305.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,305.0
,6189345,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3ccnc(NS(=O)(=O)c4ccccc4F)n3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '12.17', 'le': '0.25', 'lle': '1.75', 'sei': '4.74'}",CHEMBL1773577,,CHEMBL1773577,5.40,False,http://www.openphacts.org/units/Nanomolar,1421258,=,1,True,=,,IC50,nM,,4010.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4010.0
,6189346,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3ccnc(N(C)S(=O)(=O)c4ccccc4F)n3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '13.49', 'le': '0.27', 'lle': '2.49', 'sei': '5.87'}",CHEMBL1773578,,CHEMBL1773578,6.17,False,http://www.openphacts.org/units/Nanomolar,1421259,=,1,True,=,,IC50,nM,,676.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,676.0
,6189347,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3ccnc(NS(=O)(=O)c4cccc(F)c4)n3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,,CHEMBL1773579,,CHEMBL1773579,,False,http://www.openphacts.org/units/Nanomolar,1421260,>,1,True,>,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5000.0
,6189348,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3ccnc(NS(=O)(=O)c4ccc(F)cc4)n3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,,CHEMBL1773580,,CHEMBL1773580,,False,http://www.openphacts.org/units/Nanomolar,1421261,>,1,True,>,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5000.0
,6189349,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3ccnc(NS(=O)(=O)c4ccc(C)cc4)n3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '13.42', 'le': '0.27', 'lle': '2.08', 'sei': '5.18'}",CHEMBL1773581,,CHEMBL1773581,5.90,False,http://www.openphacts.org/units/Nanomolar,1421262,=,1,True,=,,IC50,nM,,1260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1260.0
,6189350,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3ccnc(N(C)S(=O)(=O)c4ccc(C)cc4)n3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '14.28', 'le': '0.29', 'lle': '2.63', 'sei': '6.16'}",CHEMBL1773582,,CHEMBL1773582,6.48,False,http://www.openphacts.org/units/Nanomolar,1421263,=,1,True,=,,IC50,nM,,334.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,334.0
,6189351,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)Nc2cc(-c3ccc4nc(NC(C)=O)sc4c3)ccn2)cc1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '16.46', 'le': '0.33', 'lle': '3.35', 'sei': '6.78'}",CHEMBL1773558,,CHEMBL1773558,7.48,False,http://www.openphacts.org/units/Nanomolar,1421238,=,1,True,=,,IC50,nM,,33.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,33.0
,6189352,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)Nc2cncc(-c3ccc4nc(NC(C)=O)sc4c3)c2)cc1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '15.37', 'le': '0.31', 'lle': '2.86', 'sei': '6.34'}",CHEMBL1773599,,CHEMBL1773599,6.99,False,http://www.openphacts.org/units/Nanomolar,1421281,=,1,True,=,,IC50,nM,,103.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,103.0
,6189353,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)Nc2cncc(-c3ccc4nc(NC(C)=O)sc4c3)n2)cc1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '13.46', 'le': '0.27', 'lle': '2.61', 'sei': '4.98'}",CHEMBL1773600,,CHEMBL1773600,6.13,False,http://www.openphacts.org/units/Nanomolar,1421282,=,1,True,=,,IC50,nM,,739.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,739.0
,6189354,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)Nc2cccc(-c3ccc4nc(NC(C)=O)sc4c3)c2)cc1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '13.09', 'le': '0.26', 'lle': '1.21', 'sei': '6.09'}",CHEMBL1773601,,CHEMBL1773601,5.94,False,http://www.openphacts.org/units/Nanomolar,1421283,=,1,True,=,,IC50,nM,,1160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1160.0
,6189368,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)Nc2cc(-c3ccc4nc(NC(C)=O)sc4c3)cnc2C#N)cc1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '12.76', 'le': '0.25', 'lle': '2.12', 'sei': '4.57'}",CHEMBL1773602,,CHEMBL1773602,6.12,False,http://www.openphacts.org/units/Nanomolar,1421284,=,1,True,=,,IC50,nM,,757.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,757.0
,6189369,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)Nc2cc(-c3ccc4nc(NC(C)=O)sc4c3)cnc2C)cc1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '16.53', 'le': '0.33', 'lle': '3.31', 'sei': '7.02'}",CHEMBL1773603,,CHEMBL1773603,7.75,False,http://www.openphacts.org/units/Nanomolar,1421285,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,6189370,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)Nc2cc(-c3ccc4nc(NC(C)=O)sc4c3)cnc2Cl)cc1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '16.98', 'le': '0.35', 'lle': '3.52', 'sei': '7.53'}",CHEMBL1773604,,CHEMBL1773604,8.30,False,http://www.openphacts.org/units/Nanomolar,1421286,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,6189400,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccccc4)c3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '18.09', 'le': '0.38', 'lle': '3.53', 'sei': '8.21'}",CHEMBL1773605,,CHEMBL1773605,8.30,False,http://www.openphacts.org/units/Nanomolar,1421287,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,6189401,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccccc4C(F)(F)F)c3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '15.37', 'le': '0.33', 'lle': '2.31', 'sei': '8.01'}",CHEMBL1773606,,CHEMBL1773606,8.10,False,http://www.openphacts.org/units/Nanomolar,1421288,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
,6189402,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4cccc(C(F)(F)F)c4)c3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '15.03', 'le': '0.32', 'lle': '2.13', 'sei': '7.84'}",CHEMBL1773728,,CHEMBL1773728,7.92,False,http://www.openphacts.org/units/Nanomolar,1421441,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,6189403,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(C(F)(F)F)cc4)c3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '14.65', 'le': '0.31', 'lle': '1.93', 'sei': '7.64'}",CHEMBL1773729,,CHEMBL1773729,7.72,False,http://www.openphacts.org/units/Nanomolar,1421442,=,1,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.0
,6189404,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccccc4Cl)c3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '16.84', 'le': '0.37', 'lle': '2.89', 'sei': '8.22'}",CHEMBL1773730,,CHEMBL1773730,8.31,False,http://www.openphacts.org/units/Nanomolar,1421443,=,1,True,=,,IC50,nM,,4.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.9
,6189405,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4cccc(Cl)c4)c3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '16.05', 'le': '0.35', 'lle': '2.50', 'sei': '7.84'}",CHEMBL1773731,,CHEMBL1773731,7.92,False,http://www.openphacts.org/units/Nanomolar,1421444,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,6189406,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(Cl)cc4)c3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '16.34', 'le': '0.36', 'lle': '2.64', 'sei': '7.98'}",CHEMBL1773732,,CHEMBL1773732,8.06,False,http://www.openphacts.org/units/Nanomolar,1421445,=,1,True,=,,IC50,nM,,8.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.7
,6189407,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4cccc(C(C)(C)C)c4)c3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '15.31', 'le': '0.32', 'lle': '1.82', 'sei': '7.80'}",CHEMBL1773733,,CHEMBL1773733,7.89,False,http://www.openphacts.org/units/Nanomolar,1421446,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
,6189408,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(C(C)(C)C)cc4)c3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '15.83', 'le': '0.33', 'lle': '2.08', 'sei': '8.07'}",CHEMBL1773734,,CHEMBL1773734,8.15,False,http://www.openphacts.org/units/Nanomolar,1421447,=,1,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
,6189409,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccccc4F)c3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '16.87', 'le': '0.35', 'lle': '3.14', 'sei': '7.96'}",CHEMBL1773735,,CHEMBL1773735,8.05,False,http://www.openphacts.org/units/Nanomolar,1421448,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
,6189410,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4cccc(F)c4)c3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '16.53', 'le': '0.35', 'lle': '2.98', 'sei': '7.80'}",CHEMBL1773736,,CHEMBL1773736,7.89,False,http://www.openphacts.org/units/Nanomolar,1421449,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
,6189411,[],CHEMBL1775878,Inhibition of AKT phosphorylation at S473 in human U-87MG cells at 5 mM after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,,,CHEMBL1773016,J. Med. Chem.,2011.0,"{'bei': '17.19', 'le': '0.36', 'lle': '3.29', 'sei': '8.12'}",CHEMBL1615189,,CHEMBL1615189,8.20,False,http://www.openphacts.org/units/Nanomolar,1421450,=,1,True,=,,IC50,nM,,6.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.3
,6198101,[],CHEMBL1776512,Inhibition of AKT1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1,,,CHEMBL1773059,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1738758,ONVANSERTIB,CHEMBL1738758,,False,http://www.openphacts.org/units/Nanomolar,1422263,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,6201879,[],CHEMBL1781778,Inhibition of AKT1 assessed as FI-H1-peptide phosphorylation by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21,,,CHEMBL1777813,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1779202,,CHEMBL1779202,,True,http://www.openphacts.org/units/Nanomolar,1425158,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,6268156,[],CHEMBL1805343,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1,,,CHEMBL1799927,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1270795,,CHEMBL1270795,,False,http://www.openphacts.org/units/Nanomolar,1440209,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
Not Determined,6284135,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800145,,CHEMBL1800145,,False,,1438945,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284136,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800147,,CHEMBL1800147,,False,,1438947,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284137,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800148,,CHEMBL1800148,,False,,1438948,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284138,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800149,,CHEMBL1800149,,False,,1438949,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284139,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800252,,CHEMBL1800252,,False,,1439083,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284140,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800253,,CHEMBL1800253,,False,,1439084,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284141,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800254,,CHEMBL1800254,,False,,1439085,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284142,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800255,,CHEMBL1800255,,False,,1439086,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284143,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800256,,CHEMBL1800256,,False,,1439087,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284144,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800257,,CHEMBL1800257,,False,,1439088,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284145,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800258,,CHEMBL1800258,,False,,1439089,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284146,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800261,,CHEMBL1800261,,False,,1439092,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284147,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800263,,CHEMBL1800263,,False,,1439094,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284148,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800264,,CHEMBL1800264,,False,,1439095,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284149,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCCCCCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800391,,CHEMBL1800391,,False,,1439320,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284150,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCCCCCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800392,,CHEMBL1800392,,False,,1439321,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284151,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCCCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCCCCCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800393,,CHEMBL1800393,,False,,1439322,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284152,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCCCCCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCCCCCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800394,,CHEMBL1800394,,False,,1439323,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284153,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCNC(=O)NCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800395,,CHEMBL1800395,,False,,1439324,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284154,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCCNC(=O)NCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800396,,CHEMBL1800396,,False,,1439325,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284155,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCCCNC(=O)NCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800397,,CHEMBL1800397,,False,,1439326,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284156,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCCCCCNC(=O)NCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800398,,CHEMBL1800398,,False,,1439327,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284157,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCCCNC(=O)NCCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800401,,CHEMBL1800401,,False,,1439330,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284158,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCCNC(=O)NCCCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800565,,CHEMBL1800565,,False,,1439511,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284159,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCCCNC(=O)NCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800570,,CHEMBL1800570,,False,,1439516,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284160,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCCCCCNC(=O)NCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800571,,CHEMBL1800571,,False,,1439517,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284161,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNCCCCNC(=O)NCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800700,,CHEMBL1800700,,False,,1439671,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Determined,6284162,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNCCCCCCNC(=O)NCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,,CHEMBL1800701,,CHEMBL1800701,,False,,1439672,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,6284163,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.68', 'le': '0.13', 'lle': '9.15', 'sei': '1.49'}",CHEMBL1089661,,CHEMBL1089661,6.03,False,http://www.openphacts.org/units/Nanomolar,1438944,=,1,True,=,,IC50,nM,,940.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.94
,6284164,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.28', 'le': '0.12', 'lle': '7.67', 'sei': '1.46'}",CHEMBL1800146,,CHEMBL1800146,6.02,False,http://www.openphacts.org/units/Nanomolar,1438946,=,1,True,=,,IC50,nM,,950.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.95
,6284165,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.81', 'le': '0.13', 'lle': '10.73', 'sei': '1.38'}",CHEMBL1800260,,CHEMBL1800260,6.07,False,http://www.openphacts.org/units/Nanomolar,1439091,=,1,True,=,,IC50,nM,,860.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.86
,6284166,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.07', 'le': '0.12', 'lle': '9.16', 'sei': '1.29'}",CHEMBL1800262,,CHEMBL1800262,5.67,False,http://www.openphacts.org/units/Nanomolar,1439093,=,1,True,=,,IC50,nM,,2150.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.15
,6284167,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.37', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800265,,CHEMBL1800265,6.50,False,http://www.openphacts.org/units/Nanomolar,1439096,=,1,True,=,,IC50,nM,,320.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.32
,6284168,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCCCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.44', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800266,,CHEMBL1800266,6.66,False,http://www.openphacts.org/units/Nanomolar,1439097,=,1,True,=,,IC50,nM,,220.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.22
,6284169,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCCCCCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.12', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800267,,CHEMBL1800267,6.50,False,http://www.openphacts.org/units/Nanomolar,1439098,=,1,True,=,,IC50,nM,,320.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.32
,6284170,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.48', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800259,,CHEMBL1800259,6.60,False,http://www.openphacts.org/units/Nanomolar,1439090,=,1,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.25
,6284171,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.66', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800268,,CHEMBL1800268,6.89,False,http://www.openphacts.org/units/Nanomolar,1439099,=,1,True,=,,IC50,nM,,130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.13
,6284172,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCCCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.52', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800269,,CHEMBL1800269,6.82,False,http://www.openphacts.org/units/Nanomolar,1439100,=,1,True,=,,IC50,nM,,150.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.15
,6284173,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCCCCCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.47', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800386,,CHEMBL1800386,6.96,False,http://www.openphacts.org/units/Nanomolar,1439315,=,1,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.11
,6284174,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCCCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.54', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800387,,CHEMBL1800387,6.75,False,http://www.openphacts.org/units/Nanomolar,1439316,=,1,True,=,,IC50,nM,,176.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.176
,6284175,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCCCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.58', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800388,,CHEMBL1800388,6.89,False,http://www.openphacts.org/units/Nanomolar,1439317,=,1,True,=,,IC50,nM,,128.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.128
,6284176,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCCCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCCCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.49', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800389,,CHEMBL1800389,6.89,False,http://www.openphacts.org/units/Nanomolar,1439318,=,1,True,=,,IC50,nM,,130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.13
,6284177,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(CCCCCCN)C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(=O)N(CCCCN)CC(N)=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.24', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800390,,CHEMBL1800390,6.80,False,http://www.openphacts.org/units/Nanomolar,1439319,=,1,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.16
,6284178,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCNC(=O)NCCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '5.77', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800399,,CHEMBL1800399,6.04,False,http://www.openphacts.org/units/Nanomolar,1439328,=,1,True,=,,IC50,nM,,920.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.92
,6284179,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCCNC(=O)NCCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '5.88', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800400,,CHEMBL1800400,6.23,False,http://www.openphacts.org/units/Nanomolar,1439329,=,1,True,=,,IC50,nM,,590.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.59
,6284180,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCCCCCNC(=O)NCCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.17', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800402,,CHEMBL1800402,6.80,False,http://www.openphacts.org/units/Nanomolar,1439331,=,1,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.16
,6284181,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCNC(=O)NCCCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.18', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800403,,CHEMBL1800403,6.55,False,http://www.openphacts.org/units/Nanomolar,1439332,=,1,True,=,,IC50,nM,,282.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.282
,6284182,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCCCNC(=O)NCCCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.23', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800566,,CHEMBL1800566,6.77,False,http://www.openphacts.org/units/Nanomolar,1439512,=,1,True,=,,IC50,nM,,170.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.17
,6284183,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCCCCCNC(=O)NCCCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '5.87', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800567,,CHEMBL1800567,6.55,False,http://www.openphacts.org/units/Nanomolar,1439513,=,1,True,=,,IC50,nM,,280.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.28
,6284184,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCNC(=O)NCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '6.01', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800568,,CHEMBL1800568,6.54,False,http://www.openphacts.org/units/Nanomolar,1439514,=,1,True,=,,IC50,nM,,290.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.29
,6284185,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN(C(=O)[C@@H](N)CCCNC(=N)N)CCCNC(=O)NCCCCCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '5.90', 'le': None, 'lle': None, 'sei': None}",CHEMBL1800569,,CHEMBL1800569,6.50,False,http://www.openphacts.org/units/Nanomolar,1439515,=,1,True,=,,IC50,nM,,320.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.32
,6284186,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNCCNC(=O)NCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '7.32', 'le': '0.14', 'lle': '10.38', 'sei': '1.73'}",CHEMBL1800698,,CHEMBL1800698,6.41,False,http://www.openphacts.org/units/Nanomolar,1439669,=,1,True,=,,IC50,nM,,390.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.39
,6284187,[],CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNCCCNC(=O)NCCN(CC(N)=O)C(=O)[C@H](CCC(C)C)NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,,,CHEMBL1799953,J. Med. Chem.,2011.0,"{'bei': '7.45', 'le': '0.14', 'lle': '10.20', 'sei': '1.79'}",CHEMBL1800699,,CHEMBL1800699,6.62,False,http://www.openphacts.org/units/Nanomolar,1439670,=,1,True,=,,IC50,nM,,240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.24
,6299675,[],CHEMBL1811572,Inhibition of Akt,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12,,,CHEMBL1806462,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1807446,,CHEMBL1807446,,False,http://www.openphacts.org/units/Nanomolar,1443786,>,1,True,>,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,25.0
,6307601,[],CHEMBL1816862,Inhibition of recombinant AKT1 assessed as 33Pi incorporation after 60 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12,,,CHEMBL1811781,Bioorg. Med. Chem.,2011.0,,CHEMBL466154,NORLICHEXANTHONE,CHEMBL466154,,False,http://www.openphacts.org/units/Nanomolar,1448676,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,6307602,[],CHEMBL1816862,Inhibition of recombinant AKT1 assessed as 33Pi incorporation after 60 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(O)c(O)cc2oc3cc(O)cc(O)c3c(=O)c12,,,CHEMBL1811781,Bioorg. Med. Chem.,2011.0,,CHEMBL454440,ANOMALIN A,CHEMBL454440,,False,http://www.openphacts.org/units/Nanomolar,1448677,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,6325392,[],CHEMBL1820096,Inhibition of AKT1 expressed in Escherichia coli or baculovirus-infected insect cells by scintillation proximity assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1cnc2[nH]ccc2c1,,,CHEMBL1817560,J. Med. Chem.,2011.0,,CHEMBL389685,,CHEMBL389685,,False,http://www.openphacts.org/units/Nanomolar,1449882,>,1,True,>,,IC50,nM,,400000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,400.0
,6325425,[],CHEMBL1820096,Inhibition of AKT1 expressed in Escherichia coli or baculovirus-infected insect cells by scintillation proximity assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc2[nH]ncc2c1,,,CHEMBL1817560,J. Med. Chem.,2011.0,,CHEMBL86795,INDAZOLE,CHEMBL86795,,False,http://www.openphacts.org/units/Nanomolar,1449883,>,1,True,>,,IC50,nM,,400000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,400.0
,6326126,[],CHEMBL1820096,Inhibition of AKT1 expressed in Escherichia coli or baculovirus-infected insect cells by scintillation proximity assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NCC(NC(=O)c1ccc(-c2ccnc3[nH]ccc23)s1)c1ccccc1,,,CHEMBL1817560,J. Med. Chem.,2011.0,"{'bei': '18.54', 'le': '0.35', 'lle': '3.00', 'sei': '8.02'}",CHEMBL471034,,CHEMBL471034,6.72,False,http://www.openphacts.org/units/Nanomolar,1449902,=,1,True,=,,IC50,nM,,190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,190.0
,6326132,[],CHEMBL1820096,Inhibition of AKT1 expressed in Escherichia coli or baculovirus-infected insect cells by scintillation proximity assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1cnc2[nH]ccc2c1,,,CHEMBL1817560,J. Med. Chem.,2011.0,,CHEMBL389685,,CHEMBL389685,,False,http://www.openphacts.org/units/Nanomolar,1449882,<,1,True,>,,IC50,nM,,398107.17,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,3.4
,6326135,[],CHEMBL1820096,Inhibition of AKT1 expressed in Escherichia coli or baculovirus-infected insect cells by scintillation proximity assay,B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc2[nH]ncc2c1,,,CHEMBL1817560,J. Med. Chem.,2011.0,,CHEMBL86795,INDAZOLE,CHEMBL86795,,False,http://www.openphacts.org/units/Nanomolar,1449883,<,1,True,>,,IC50,nM,,398107.17,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,3.4
,6339239,[],CHEMBL1828185,Inhibition of AKT1 activity by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,,,CHEMBL1821705,J. Med. Chem.,2011.0,,CHEMBL1823221,,CHEMBL1823221,,False,http://www.openphacts.org/units/Nanomolar,1454357,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,6339240,[],CHEMBL1828185,Inhibition of AKT1 activity by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21,,,CHEMBL1821705,J. Med. Chem.,2011.0,,CHEMBL1779202,,CHEMBL1779202,,False,http://www.openphacts.org/units/Nanomolar,1454353,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,6339841,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,,,CHEMBL1821651,J. Med. Chem.,2011.0,"{'bei': '17.19', 'le': '0.36', 'lle': '3.29', 'sei': '8.12'}",CHEMBL1615189,,CHEMBL1615189,8.20,True,http://www.openphacts.org/units/Nanomolar,1452525,=,1,True,=,,IC50,nM,,6.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.3
,6339842,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,,,CHEMBL1821651,J. Med. Chem.,2011.0,"{'bei': '16.92', 'le': '0.36', 'lle': '2.83', 'sei': '7.51'}",CHEMBL1822052,,CHEMBL1822052,7.36,False,http://www.openphacts.org/units/Nanomolar,1452526,=,1,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,44.0
,6339843,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(Nc1cc(-c2ccc3ncsc3c2)cnc1Cl)c1ccc(F)cc1,,,CHEMBL1821651,J. Med. Chem.,2011.0,"{'bei': '14.56', 'le': '0.31', 'lle': '1.16', 'sei': '8.50'}",CHEMBL1822053,,CHEMBL1822053,6.11,False,http://www.openphacts.org/units/Nanomolar,1452527,=,1,True,=,,IC50,nM,,769.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,769.0
,6339844,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,,,CHEMBL1821651,J. Med. Chem.,2011.0,"{'bei': '17.11', 'le': '0.35', 'lle': '4.55', 'sei': '6.66'}",CHEMBL1822054,,CHEMBL1822054,7.89,False,http://www.openphacts.org/units/Nanomolar,1452528,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
,6339845,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,,,CHEMBL1821651,J. Med. Chem.,2011.0,"{'bei': '15.24', 'le': '0.31', 'lle': '3.41', 'sei': '5.54'}",CHEMBL1822055,,CHEMBL1822055,6.38,False,http://www.openphacts.org/units/Nanomolar,1452529,=,1,True,=,,IC50,nM,,415.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,415.0
,6339846,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(Nc1cc(-c2ccc3nccn3n2)cnc1Cl)c1ccc(F)cc1,,,CHEMBL1821651,J. Med. Chem.,2011.0,"{'bei': '18.08', 'le': '0.37', 'lle': '3.92', 'sei': '8.18'}",CHEMBL1822056,,CHEMBL1822056,7.30,False,http://www.openphacts.org/units/Nanomolar,1452530,=,1,True,=,,IC50,nM,,50.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50.0
,6339847,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cn2cc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,,,CHEMBL1821651,J. Med. Chem.,2011.0,"{'bei': '15.06', 'le': '0.31', 'lle': '2.98', 'sei': '6.57'}",CHEMBL1822057,,CHEMBL1822057,6.93,False,http://www.openphacts.org/units/Nanomolar,1452531,=,1,True,=,,IC50,nM,,118.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,118.0
,6339848,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1cn2cc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,,,CHEMBL1821651,J. Med. Chem.,2011.0,,CHEMBL1822058,,CHEMBL1822058,,False,http://www.openphacts.org/units/Nanomolar,1452532,>,1,True,>,,IC50,nM,,12000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12000.0
,6339849,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(Nc1cc(-c2ccc3nccn3c2)cnc1Cl)c1ccc(F)cc1,,,CHEMBL1821651,J. Med. Chem.,2011.0,"{'bei': '15.49', 'le': '0.32', 'lle': '2.25', 'sei': '8.17'}",CHEMBL1822059,,CHEMBL1822059,6.24,False,http://www.openphacts.org/units/Nanomolar,1452533,=,1,True,=,,IC50,nM,,574.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,574.0
,6339850,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2[nH]1,,,CHEMBL1821651,J. Med. Chem.,2011.0,"{'bei': '14.08', 'le': '0.29', 'lle': '2.29', 'sei': '5.54'}",CHEMBL1822060,,CHEMBL1822060,6.47,False,http://www.openphacts.org/units/Nanomolar,1452534,=,1,True,=,,IC50,nM,,335.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,335.0
,6339851,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2[nH]1,,,CHEMBL1821651,J. Med. Chem.,2011.0,,CHEMBL1822208,,CHEMBL1822208,,False,http://www.openphacts.org/units/Nanomolar,1452748,>,1,True,>,,IC50,nM,,12000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12000.0
,6339852,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(Nc1cc(-c2ccc3nc[nH]c3c2)cnc1Cl)c1ccc(F)cc1,,,CHEMBL1821651,J. Med. Chem.,2011.0,,CHEMBL1822209,,CHEMBL1822209,,False,http://www.openphacts.org/units/Nanomolar,1452749,>,1,True,>,,IC50,nM,,12000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12000.0
,6339853,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2o1,,,CHEMBL1821651,J. Med. Chem.,2011.0,"{'bei': '12.93', 'le': '0.26', 'lle': '1.52', 'sei': '5.22'}",CHEMBL1822210,,CHEMBL1822210,5.96,False,http://www.openphacts.org/units/Nanomolar,1452750,=,1,True,=,,IC50,nM,,1100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1100.0
,6339854,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2o1,,,CHEMBL1821651,J. Med. Chem.,2011.0,"{'bei': '16.70', 'le': '0.34', 'lle': '2.93', 'sei': '6.30'}",CHEMBL1822211,,CHEMBL1822211,7.00,False,http://www.openphacts.org/units/Nanomolar,1452751,=,1,True,=,,IC50,nM,,101.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,101.0
,6339855,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(Nc1cc(-c2ccc3ncoc3c2)cnc1Cl)c1ccc(F)cc1,,,CHEMBL1821651,J. Med. Chem.,2011.0,,CHEMBL1822212,,CHEMBL1822212,,False,http://www.openphacts.org/units/Nanomolar,1452752,>,1,True,>,,IC50,nM,,12000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12000.0
,6339856,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(Nc1cc(-c2ccc3nncn3c2)cnc1Cl)c1ccc(F)cc1,,,CHEMBL1821651,J. Med. Chem.,2011.0,,CHEMBL1822213,,CHEMBL1822213,,False,http://www.openphacts.org/units/Nanomolar,1452753,>,1,True,>,,IC50,nM,,12000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12000.0
,6339857,[],CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(Nc1cc(-c2ccc3sncc3c2)cnc1Cl)c1ccc(F)cc1,,,CHEMBL1821651,J. Med. Chem.,2011.0,,CHEMBL1822214,,CHEMBL1822214,,False,http://www.openphacts.org/units/Nanomolar,1452754,>,1,True,>,,IC50,nM,,12000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12000.0
,6340469,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '19.85', 'le': '0.39', 'lle': '3.77', 'sei': '11.11'}",CHEMBL1080569,,CHEMBL1080569,8.52,False,http://www.openphacts.org/units/Nanomolar,1454889,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.003
,6340470,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNc1nnc(-c2ccc3c(c2)CC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '17.76', 'le': '0.35', 'lle': '4.00', 'sei': '8.28'}",CHEMBL1823630,,CHEMBL1823630,7.70,False,http://www.openphacts.org/units/Nanomolar,1454890,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.02
,6340471,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H](CNC(=O)c1ccc2cnccc2c1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '14.65', 'le': '0.28', 'lle': '1.92', 'sei': '8.04'}",CHEMBL1823631,,CHEMBL1823631,5.47,False,http://www.openphacts.org/units/Nanomolar,1454891,=,1,True,=,,IC50,nM,,3380.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.38
,6340472,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccccc1)C1CCNCC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '17.57', 'le': '0.32', 'lle': '2.36', 'sei': '11.24'}",CHEMBL1823632,,CHEMBL1823632,6.07,False,http://www.openphacts.org/units/Nanomolar,1454892,=,1,True,=,,IC50,nM,,850.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.85
,6340473,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc2ccccc2c1)C1CCNCC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '16.18', 'le': '0.29', 'lle': '1.54', 'sei': '11.84'}",CHEMBL1823633,,CHEMBL1823633,6.40,False,http://www.openphacts.org/units/Nanomolar,1454893,=,1,True,=,,IC50,nM,,400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.4
,6340474,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1nccs1)C1CCNCC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '16.47', 'le': '0.32', 'lle': '2.64', 'sei': '8.67'}",CHEMBL1823634,,CHEMBL1823634,5.80,False,http://www.openphacts.org/units/Nanomolar,1454894,=,1,True,=,,IC50,nM,,1570.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.57
,6340475,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(NC(=O)c2ccc3cnccc3c2)C2CCNCC2)cc1F,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '14.79', 'le': '0.27', 'lle': '1.97', 'sei': '9.20'}",CHEMBL1823635,,CHEMBL1823635,5.82,False,http://www.openphacts.org/units/Nanomolar,1454895,=,1,True,=,,IC50,nM,,1510.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.51
,6340476,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc(F)c(F)c1)C1CCNCC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '14.61', 'le': '0.27', 'lle': '1.59', 'sei': '10.31'}",CHEMBL1823636,,CHEMBL1823636,5.57,False,http://www.openphacts.org/units/Nanomolar,1454896,=,1,True,=,,IC50,nM,,2680.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.68
,6340477,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc(Cl)c(-c2ccccc2)c1)C1CCNCC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '14.69', 'le': '0.28', 'lle': '0.67', 'sei': '12.40'}",CHEMBL1823637,,CHEMBL1823637,6.70,False,http://www.openphacts.org/units/Nanomolar,1454897,=,1,True,=,,IC50,nM,,200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.2
,6340478,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cc(C(NC(=O)c2ccc3cnccc3c2)C2CCNCC2)ccc1Cl,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '17.53', 'le': '0.33', 'lle': '2.87', 'sei': '9.12'}",CHEMBL1823638,,CHEMBL1823638,7.10,False,http://www.openphacts.org/units/Nanomolar,1454898,=,1,True,=,,IC50,nM,,80.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.08
,6340479,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1cccc(Cl)c1)C1CCNCC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '18.83', 'le': '0.36', 'lle': '2.79', 'sei': '13.24'}",CHEMBL1823639,,CHEMBL1823639,7.16,False,http://www.openphacts.org/units/Nanomolar,1454899,=,1,True,=,,IC50,nM,,70.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.07
,6340480,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc(Cl)cc1)C1CCNCC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '17.69', 'le': '0.34', 'lle': '2.36', 'sei': '12.44'}",CHEMBL1823640,,CHEMBL1823640,6.72,False,http://www.openphacts.org/units/Nanomolar,1454900,=,1,True,=,,IC50,nM,,190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.19
,6340481,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc(Cl)c(F)c1)C1CCNCC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '18.59', 'le': '0.36', 'lle': '2.90', 'sei': '13.69'}",CHEMBL1823641,,CHEMBL1823641,7.40,False,http://www.openphacts.org/units/Nanomolar,1454901,=,1,True,=,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.04
,6340482,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1cccc(Cl)c1Cl)C1CCNCC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '16.70', 'le': '0.34', 'lle': '1.91', 'sei': '12.81'}",CHEMBL1823642,,CHEMBL1823642,6.92,False,http://www.openphacts.org/units/Nanomolar,1454902,=,1,True,=,,IC50,nM,,120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.12
,6340483,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCNCC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '17.85', 'le': '0.36', 'lle': '2.39', 'sei': '13.69'}",CHEMBL1823643,,CHEMBL1823643,7.40,False,http://www.openphacts.org/units/Nanomolar,1454903,=,1,True,=,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.04
,6340484,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1cnc(Cl)c(Cl)c1)C1CCNCC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '16.50', 'le': '0.33', 'lle': '2.44', 'sei': '10.24'}",CHEMBL1823644,,CHEMBL1823644,6.85,False,http://www.openphacts.org/units/Nanomolar,1454904,=,1,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.14
,6340485,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Cc2cc(C(=O)NC(c3ccc(Cl)c(Cl)c3)C3CCNCC3)ccc2N1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '15.43', 'le': '0.31', 'lle': '2.50', 'sei': '9.19'}",CHEMBL1823645,,CHEMBL1823645,6.46,False,http://www.openphacts.org/units/Nanomolar,1454905,=,1,True,=,,IC50,nM,,350.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.35
,6340486,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCNCC1)c1ccc2[nH]c(=O)oc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '15.08', 'le': '0.31', 'lle': '2.44', 'sei': '7.27'}",CHEMBL1823646,,CHEMBL1823646,6.34,False,http://www.openphacts.org/units/Nanomolar,1454906,=,1,True,=,,IC50,nM,,460.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.46
,6340487,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCNCC1)c1ccc2[nH]ncc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '16.37', 'le': '0.33', 'lle': '2.26', 'sei': '9.46'}",CHEMBL1823647,,CHEMBL1823647,6.60,False,http://www.openphacts.org/units/Nanomolar,1454907,=,1,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.25
,6340488,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCNCC1)c1ccc2cnncc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '15.61', 'le': '0.32', 'lle': '2.07', 'sei': '9.69'}",CHEMBL1823648,,CHEMBL1823648,6.48,False,http://www.openphacts.org/units/Nanomolar,1454908,=,1,True,=,,IC50,nM,,330.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.33
,6340489,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2cnccc2cc1C(=O)NC(c1ccc(Cl)c(Cl)c1)C1CCNCC1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '16.67', 'le': '0.34', 'lle': '2.39', 'sei': '11.71'}",CHEMBL1823649,,CHEMBL1823649,7.41,False,http://www.openphacts.org/units/Nanomolar,1454909,=,1,True,=,,IC50,nM,,39.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.039
,6340490,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cc3cnccc3cc2C(=O)NC(c2ccc(Cl)c(Cl)c2)C2CCNCC2)cc1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '9.92', 'le': '0.20', 'lle': '-1.53', 'sei': '8.16'}",CHEMBL1823650,,CHEMBL1823650,5.16,False,http://www.openphacts.org/units/Nanomolar,1454910,=,1,True,=,,IC50,nM,,6850.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,6.85
,6340491,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCNCC1)c1ccc2cnc(F)cc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '17.81', 'le': '0.36', 'lle': '2.55', 'sei': '14.25'}",CHEMBL1823651,,CHEMBL1823651,7.70,False,http://www.openphacts.org/units/Nanomolar,1454911,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.02
,6340492,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCNCC1)c1ccc2cnc(Cl)cc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '15.27', 'le': '0.32', 'lle': '1.18', 'sei': '12.69'}",CHEMBL1823652,,CHEMBL1823652,6.85,False,http://www.openphacts.org/units/Nanomolar,1454912,=,1,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.14
,6340493,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCCNC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '18.58', 'le': '0.38', 'lle': '2.69', 'sei': '14.25'}",CHEMBL1823653,,CHEMBL1823653,7.70,False,http://www.openphacts.org/units/Nanomolar,1454913,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.02
,6340494,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCNC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '18.79', 'le': '0.38', 'lle': '2.90', 'sei': '13.93'}",CHEMBL1823654,,CHEMBL1823654,7.52,False,http://www.openphacts.org/units/Nanomolar,1454914,=,1,True,=,,IC50,nM,,30.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.03
,6340495,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N[C@@H](c1ccc(Cl)c(Cl)c1)C1CNC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '21.11', 'le': '0.43', 'lle': '3.92', 'sei': '15.10'}",CHEMBL1823655,,CHEMBL1823655,8.15,False,http://www.openphacts.org/units/Nanomolar,1454915,=,1,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.007
,6340496,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N[C@H](c1ccc(Cl)c(Cl)c1)C1CNC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '18.01', 'le': '0.37', 'lle': '2.73', 'sei': '12.88'}",CHEMBL1823656,,CHEMBL1823656,6.96,False,http://www.openphacts.org/units/Nanomolar,1454916,=,1,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.11
,6340497,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCCCC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '12.67', 'le': '0.26', 'lle': '-1.35', 'sei': '12.47'}",CHEMBL1823657,,CHEMBL1823657,5.24,False,http://www.openphacts.org/units/Nanomolar,1454917,=,1,True,=,,IC50,nM,,5800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.8
,6340498,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1cncnc1)c1ccc(Cl)c(Cl)c1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.97', 'le': '0.24', 'lle': '0.05', 'sei': '7.23'}",CHEMBL1823658,,CHEMBL1823658,4.90,False,http://www.openphacts.org/units/Nanomolar,1454918,=,1,True,=,,IC50,nM,,12650.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,12.65
,6340499,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(c1ccncc1)c1ccc(Cl)c(Cl)c1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '11.49', 'le': '0.23', 'lle': '-0.77', 'sei': '8.55'}",CHEMBL1823659,,CHEMBL1823659,4.69,False,http://www.openphacts.org/units/Nanomolar,1454919,=,1,True,=,,IC50,nM,,20440.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.44
,6340500,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CN1CCC([C@@H](NC(=O)c2ccc3cnccc3c2)c2ccc(Cl)c(Cl)c2)CC1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '12.05', 'le': '0.24', 'lle': '-0.71', 'sei': '12.54'}",CHEMBL1823660,,CHEMBL1823660,5.67,False,http://www.openphacts.org/units/Nanomolar,1454920,=,1,True,=,,IC50,nM,,2140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.14
,6340501,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N[C@@H](c1ccc(Cl)c(Cl)c1)C1CCN(Cc2ccccc2)CC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '13.12', 'le': '0.26', 'lle': '-0.30', 'sei': '14.64'}",CHEMBL1823661,,CHEMBL1823661,6.62,False,http://www.openphacts.org/units/Nanomolar,1454921,=,1,True,=,,IC50,nM,,240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.24
,6340502,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N[C@@H](c1ccc(Cl)c(Cl)c1)C1CCN(Cc2ccc(C(F)(F)F)cc2)CC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '9.85', 'le': '0.20', 'lle': '-2.30', 'sei': '12.47'}",CHEMBL1823662,,CHEMBL1823662,5.64,False,http://www.openphacts.org/units/Nanomolar,1454922,=,1,True,=,,IC50,nM,,2300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.3
,6340503,[],CHEMBL1825378,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CC([C@@H](NC(=O)c2ccc3cnccc3c2)c2ccc(Cl)c(Cl)c2)C1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '20.37', 'le': '0.41', 'lle': '3.58', 'sei': '18.03'}",CHEMBL1823663,,CHEMBL1823663,8.15,False,http://www.openphacts.org/units/Nanomolar,1454923,=,1,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.007
,6340567,[],CHEMBL1825376,Inhibition of AKT1-mediated PRAS40 phosphorylation in human U87MG cells after 1 hr in presence of 5% FBS by ELISA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '15.37', 'le': '0.30', 'lle': '1.85', 'sei': '8.61'}",CHEMBL1080569,,CHEMBL1080569,6.60,False,http://www.openphacts.org/units/Nanomolar,1454889,=,1,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.25
,6340568,[],CHEMBL1825376,Inhibition of AKT1-mediated PRAS40 phosphorylation in human U87MG cells after 1 hr in presence of 5% FBS by ELISA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@H](CNc1nnc(-c2ccc3c(c2)CC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '15.05', 'le': '0.30', 'lle': '2.82', 'sei': '7.02'}",CHEMBL1823630,,CHEMBL1823630,6.52,False,http://www.openphacts.org/units/Nanomolar,1454890,=,1,True,=,,IC50,nM,,300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.3
,6340569,[],CHEMBL1825376,Inhibition of AKT1-mediated PRAS40 phosphorylation in human U87MG cells after 1 hr in presence of 5% FBS by ELISA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCNCC1)c1ccc2cnc(F)cc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '14.82', 'le': '0.30', 'lle': '1.26', 'sei': '11.86'}",CHEMBL1823651,,CHEMBL1823651,6.41,False,http://www.openphacts.org/units/Nanomolar,1454911,=,1,True,=,,IC50,nM,,390.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.39
,6340570,[],CHEMBL1825376,Inhibition of AKT1-mediated PRAS40 phosphorylation in human U87MG cells after 1 hr in presence of 5% FBS by ELISA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(N[C@@H](c1ccc(Cl)c(Cl)c1)C1CNC1)c1ccc2cnccc2c1,,,CHEMBL1821694,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '17.14', 'le': '0.35', 'lle': '2.39', 'sei': '12.25'}",CHEMBL1823655,,CHEMBL1823655,6.62,False,http://www.openphacts.org/units/Nanomolar,1454915,=,1,True,=,,IC50,nM,,240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.24
,6386325,[],CHEMBL1839916,Inhibition of recombinant PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O,,,CHEMBL1833940,J. Med. Chem.,2011.0,,CHEMBL1834657,INFIGRATINIB PHOSPHATE,CHEMBL1852688,,False,http://www.openphacts.org/units/Nanomolar,1460724,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,7937319,[],CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)=CCc1cc(C(=O)/C=C/c2cccc(O)c2)c(O)cc1O,,,CHEMBL1914446,Eur. J. Med. Chem.,2011.0,"{'bei': '12.53', 'le': '0.23', 'lle': '-0.14', 'sei': '5.23'}",CHEMBL1915456,,CHEMBL1915456,4.07,False,http://www.openphacts.org/units/Nanomolar,1557649,=,1,True,=,,IC50,nM,,85900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,85.9
,7937320,[],CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)=CCc1c(O)cc(O)c(C(=O)/C=C/c2ccc(O)cc2)c1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1914446,Eur. J. Med. Chem.,2011.0,,CHEMBL466143,DEMETHYLXANTHOHUMOL,CHEMBL466143,,False,http://www.openphacts.org/units/Nanomolar,1557650,=,1,True,=,,IC50,nM,,143900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,143.9
Not Active,7937321,[],CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)=CCc1cc2c(=O)cc(-c3ccc(O)cc3O)oc2cc1O,,,CHEMBL1914446,Eur. J. Med. Chem.,2011.0,,CHEMBL1915457,,CHEMBL1915457,,False,,1557651,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,7937322,[],CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)cc(=O)c2c1O,,,CHEMBL1914446,Eur. J. Med. Chem.,2011.0,"{'bei': '12.03', 'le': '0.22', 'lle': '0.47', 'sei': '3.84'}",CHEMBL1915458,,CHEMBL1915458,4.26,False,http://www.openphacts.org/units/Nanomolar,1557652,=,1,True,=,,IC50,nM,,54480.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,54.48
,7937323,[],CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)c(O)c3)cc(=O)c2c1O,,,CHEMBL1914446,Eur. J. Med. Chem.,2011.0,"{'bei': '14.87', 'le': '0.28', 'lle': '1.48', 'sei': '4.74'}",CHEMBL1915459,,CHEMBL1915459,5.27,False,http://www.openphacts.org/units/Nanomolar,1557653,=,1,True,=,,IC50,nM,,5400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.4
,7937324,[],CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)=CCc1c(O)cc(O)c2c(=O)cc(-c3ccc(O)c(O)c3)oc12,,,CHEMBL1914446,Eur. J. Med. Chem.,2011.0,"{'bei': '15.26', 'le': '0.28', 'lle': '1.62', 'sei': '4.87'}",CHEMBL1783943,,CHEMBL1783943,5.41,False,http://www.openphacts.org/units/Nanomolar,1557654,=,1,True,=,,IC50,nM,,3900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.9
,7937325,[],CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1cccc(-n2nnc(SCC(=O)NCc3cccs3)n2)c1,,,CHEMBL1914446,Eur. J. Med. Chem.,2011.0,,CHEMBL1915460,,CHEMBL1915460,,False,http://www.openphacts.org/units/Nanomolar,1557655,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
Not Active,7937326,[],CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]c(NC(=O)C(C)C)nc43)C[C@H]2O)cc1,,,CHEMBL1914446,Eur. J. Med. Chem.,2011.0,,CHEMBL1915461,,CHEMBL1915461,,False,,1557656,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
Not Active,7937327,[],CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(CSc2nnc(O)n2C2Cc3ccccc3C2)c2ccc(O)cc2o1,,,CHEMBL1914446,Eur. J. Med. Chem.,2011.0,,CHEMBL387393,,CHEMBL387393,,False,,1557657,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,7937328,[],CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,,,CHEMBL1914446,Eur. J. Med. Chem.,2011.0,"{'bei': '12.87', 'le': '0.29', 'lle': '2.16', 'sei': '8.08'}",CHEMBL104264,,CHEMBL104264,5.75,False,http://www.openphacts.org/units/Nanomolar,1557658,=,1,True,=,,IC50,nM,,1800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.8
,7939951,[],CHEMBL1919620,Inhibition of human PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl,,,CHEMBL1914450,J. Med. Chem.,2011.0,,CHEMBL1916359,,CHEMBL1916359,,False,http://www.openphacts.org/units/Nanomolar,1558774,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,7943721,[],CHEMBL1921564,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL1914457,Bioorg. Med. Chem.,2011.0,"{'bei': '17.80', 'le': '0.32', 'lle': '3.96', 'sei': '11.96'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.30,False,http://www.openphacts.org/units/Nanomolar,1560631,=,1,True,=,,IC50,nM,,4.95,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.95
,7951318,[],CHEMBL1926219,Inhibition of recombinant human AKT1 using GSK3 (amino acids 14 to 27) as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(O)cc1CC[C@@H]1[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C,,,CHEMBL1921742,Bioorg. Med. Chem.,2011.0,,CHEMBL1922224,,CHEMBL1922224,,False,http://www.openphacts.org/units/Nanomolar,1561178,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,7951319,[],CHEMBL1926219,Inhibition of recombinant human AKT1 using GSK3 (amino acids 14 to 27) as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C,,,CHEMBL1921742,Bioorg. Med. Chem.,2011.0,,CHEMBL518060,CALICOFEROL A,CHEMBL518060,,False,http://www.openphacts.org/units/Nanomolar,1561179,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,7951320,[],CHEMBL1926219,Inhibition of recombinant human AKT1 using GSK3 (amino acids 14 to 27) as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)C(=O)CC[C@@]21C)C(C)C,,,CHEMBL1921742,Bioorg. Med. Chem.,2011.0,,CHEMBL1922225,,CHEMBL1922225,,False,http://www.openphacts.org/units/Nanomolar,1561180,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,7951321,[],CHEMBL1926219,Inhibition of recombinant human AKT1 using GSK3 (amino acids 14 to 27) as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C,,,CHEMBL1921742,Bioorg. Med. Chem.,2011.0,,CHEMBL456936,CALICOFEROL E,CHEMBL456936,,False,http://www.openphacts.org/units/Nanomolar,1561181,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,7951322,[],CHEMBL1926219,Inhibition of recombinant human AKT1 using GSK3 (amino acids 14 to 27) as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(O)cc1CC[C@H]1[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O,,,CHEMBL1921742,Bioorg. Med. Chem.,2011.0,,CHEMBL517956,ASTROGORGIADIOL,CHEMBL517956,,False,http://www.openphacts.org/units/Nanomolar,1561182,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,7951323,[],CHEMBL1926219,Inhibition of recombinant human AKT1 using GSK3 (amino acids 14 to 27) as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1C[C@H](O)[C@@H]2[C@H](C)CCCC(C)C,,,CHEMBL1921742,Bioorg. Med. Chem.,2011.0,,CHEMBL456294,CALICOFEROL I,CHEMBL456294,,False,http://www.openphacts.org/units/Nanomolar,1561183,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,7951324,[],CHEMBL1926219,Inhibition of recombinant human AKT1 using GSK3 (amino acids 14 to 27) as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)[C@H](O)CC[C@@]21C)C(C)C,,,CHEMBL1921742,Bioorg. Med. Chem.,2011.0,,CHEMBL515982,CALICOFEROL C,CHEMBL515982,,False,http://www.openphacts.org/units/Nanomolar,1561184,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,7951325,[],CHEMBL1926219,Inhibition of recombinant human AKT1 using GSK3 (amino acids 14 to 27) as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(O)cc1CC[C@H]1[C@@H]2C[C@H](O)[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O,,,CHEMBL1921742,Bioorg. Med. Chem.,2011.0,,CHEMBL464351,CALICOFEROL B,CHEMBL464351,,False,http://www.openphacts.org/units/Nanomolar,1561185,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,7954614,[],CHEMBL1924333,Inhibition of His-tagged ATP-binding domain of AKT1 assessed as GRPRTSSFAEG crosstide phosphorylation using [33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](NC(=O)[C@@H]1CC[C@H]2[C@H](NC(=O)CCCCNC(=N)N)COC(=O)N12)C(=O)NC(Cc1ccccc1)C(=O)NCc1ccccc1,,,CHEMBL1921701,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '6.49', 'le': '0.12', 'lle': '3.11', 'sei': '2.11'}",CHEMBL1922692,,CHEMBL1922692,4.40,False,http://www.openphacts.org/units/Nanomolar,1561716,=,1,True,=,,IC50,nM,,40200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,40.2
,7954615,[],CHEMBL1924333,Inhibition of His-tagged ATP-binding domain of AKT1 assessed as GRPRTSSFAEG crosstide phosphorylation using [33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](NC(=O)[C@@H]1CC[C@H]2[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)c3ccccc3)COC(=O)N12)C(=O)NC(Cc1ccccc1)C(=O)NCc1ccccc1,,,CHEMBL1921701,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '6.02', 'le': '0.11', 'lle': '3.09', 'sei': '2.02'}",CHEMBL1922693,,CHEMBL1922693,4.79,False,http://www.openphacts.org/units/Nanomolar,1561717,=,1,True,=,,IC50,nM,,16300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,16.3
,7954616,[],CHEMBL1924333,Inhibition of His-tagged ATP-binding domain of AKT1 assessed as GRPRTSSFAEG crosstide phosphorylation using [33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](NC(=O)[C@@H]1CC[C@H]2[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)Cc3ccccc3)COC(=O)N12)C(=O)NC(Cc1ccccc1)C(=O)NCc1ccccc1,,,CHEMBL1921701,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '5.96', 'le': '0.11', 'lle': '3.19', 'sei': '2.04'}",CHEMBL1922694,,CHEMBL1922694,4.82,False,http://www.openphacts.org/units/Nanomolar,1561718,=,1,True,=,,IC50,nM,,15000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,15.0
,7954617,[],CHEMBL1924333,Inhibition of His-tagged ATP-binding domain of AKT1 assessed as GRPRTSSFAEG crosstide phosphorylation using [33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](NC(=O)[C@@H]1CC[C@H]2[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc3ccccc3)COC(=O)N12)C(=O)NC(Cc1ccccc1)C(=O)NCc1ccccc1,,,CHEMBL1921701,Bioorg. Med. Chem. Lett.,2011.0,"{'bei': '6.67', 'le': '0.13', 'lle': '3.31', 'sei': '2.24'}",CHEMBL1922695,,CHEMBL1922695,5.51,False,http://www.openphacts.org/units/Nanomolar,1561719,=,1,True,=,,IC50,nM,,3100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.1
,7959663,[],CHEMBL1932322,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O,,,CHEMBL1926590,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1929238,,CHEMBL1929238,,False,http://www.openphacts.org/units/Nanomolar,1566418,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,7959664,[],CHEMBL1932322,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,,,CHEMBL1926590,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL103667,DORAMAPIMOD,CHEMBL103667,,False,http://www.openphacts.org/units/Nanomolar,1566420,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,7984056,[],CHEMBL1936504,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1,,,CHEMBL1933058,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL1933576,,CHEMBL1933576,,False,http://www.openphacts.org/units/Nanomolar,1567399,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,7984057,[],CHEMBL1936504,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1,,,CHEMBL1933058,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL1933582,,CHEMBL1933582,,False,http://www.openphacts.org/units/Nanomolar,1567406,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,7987180,[],CHEMBL1935935,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1,,,CHEMBL1933021,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL1933552,,CHEMBL1933552,,False,http://www.openphacts.org/units/Nanomolar,1567374,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,8004557,[],CHEMBL1944084,Inhibition of AKT-1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](n3[se]c4ccccc4c3=O)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O,,,CHEMBL1938284,Eur. J. Med. Chem.,2012.0,"{'bei': '7.45', 'le': None, 'lle': None, 'sei': None}",CHEMBL1940993,,CHEMBL1940993,6.08,False,http://www.openphacts.org/units/Nanomolar,1573305,=,1,True,=,,IC50,nM,,830.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.83
,8005221,[],CHEMBL1944084,Inhibition of AKT-1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)OC[C@H]1O[C@@H](NC(=O)CCCn2[se]c3ccccc3c2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,,,CHEMBL1938284,Eur. J. Med. Chem.,2012.0,"{'bei': '9.94', 'le': None, 'lle': None, 'sei': None}",CHEMBL1940997,,CHEMBL1940997,6.10,False,http://www.openphacts.org/units/Nanomolar,1573309,=,1,True,=,,IC50,nM,,800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.8
,8005264,[],CHEMBL1944084,Inhibition of AKT-1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCCn1[se]c2ccccc2c1=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,,,CHEMBL1938284,Eur. J. Med. Chem.,2012.0,"{'bei': '13.60', 'le': None, 'lle': None, 'sei': None}",CHEMBL1940999,,CHEMBL1940999,6.06,False,http://www.openphacts.org/units/Nanomolar,1573311,=,1,True,=,,IC50,nM,,880.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.88
,8013071,[],CHEMBL1947858,Inhibition of PKBalpha using ATP as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O,,,CHEMBL1944596,J. Med. Chem.,2012.0,,CHEMBL1945559,,CHEMBL1945559,,False,http://www.openphacts.org/units/Nanomolar,1574680,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,8046162,[],CHEMBL1960376,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1,,,CHEMBL1955730,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL1957085,,CHEMBL1957085,,False,http://www.openphacts.org/units/Nanomolar,1581576,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,8047307,[],CHEMBL1960791,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21,,,CHEMBL1955726,J. Pharmacol. Exp. Ther.,2007.0,"{'bei': '10.55', 'le': '0.20', 'lle': '2.18', 'sei': '3.87'}",CHEMBL220241,GSK-269962A,CHEMBL220241,6.02,False,http://www.openphacts.org/units/Nanomolar,1580283,=,1,True,=,,IC50,nM,,955.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,955.0
,8047308,[],CHEMBL1960791,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21,,,CHEMBL1955726,J. Pharmacol. Exp. Ther.,2007.0,"{'bei': '18.96', 'le': '0.35', 'lle': '6.23', 'sei': '4.57'}",CHEMBL1956071,,CHEMBL1956071,6.49,False,http://www.openphacts.org/units/Nanomolar,1580284,=,1,True,=,,IC50,nM,,324.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,324.0
,8060097,[],CHEMBL1961273,Inhibition of human recombinant AKT1 expressed in Sf9 cells using GSK3(14-27) as substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)n1c2c(c3c1-c1ccccc1C3=O)C(=O)CCC2,,,CHEMBL1955824,Bioorg. Med. Chem.,2012.0,,CHEMBL1957190,,CHEMBL1957190,,False,http://www.openphacts.org/units/Nanomolar,1581693,>,1,True,>,,IC50,nM,,35000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,35.0
,8060098,[],CHEMBL1961273,Inhibition of human recombinant AKT1 expressed in Sf9 cells using GSK3(14-27) as substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,,,CHEMBL1955824,Bioorg. Med. Chem.,2012.0,"{'bei': '18.12', 'le': '0.34', 'lle': '4.17', 'sei': '3.87'}",CHEMBL6246,ELLAGIC ACID,CHEMBL6246,5.48,False,http://www.openphacts.org/units/Nanomolar,1581711,=,1,True,=,,IC50,nM,,3340.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.34
,10840582,[],CHEMBL2014740,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1n[nH]c2ncnc(N3CCN(c4cc(Cl)cc(NCCN(C)C)c4C)CC3)c12,,,CHEMBL2010702,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '14.52', 'le': '0.28', 'lle': '3.25', 'sei': '8.44'}",CHEMBL2012701,,CHEMBL2012701,6.43,True,http://www.openphacts.org/units/Nanomolar,1633348,=,1,True,=,,IC50,nM,,371.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,371.0
,10840583,[],CHEMBL2014740,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(NCCN(C)C)cc(Cl)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2010702,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '14.73', 'le': '0.33', 'lle': '3.90', 'sei': '9.55'}",CHEMBL2012702,,CHEMBL2012702,7.28,True,http://www.openphacts.org/units/Nanomolar,1633349,=,1,True,=,,IC50,nM,,53.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,53.0
,10840584,[],CHEMBL2014740,Inhibition of Akt1,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(NCCN(C)C)cc(Cl)cc1N1CCN(c2ncnc3[nH]nc(C(F)(F)F)c23)CC1,,,CHEMBL2010702,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '14.77', 'le': '0.30', 'lle': '3.50', 'sei': '9.36'}",CHEMBL2012703,,CHEMBL2012703,7.13,False,http://www.openphacts.org/units/Nanomolar,1633350,=,1,True,=,,IC50,nM,,74.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,74.0
,10849699,[],CHEMBL2019658,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,,,CHEMBL2016462,ACS Med. Chem. Lett.,2011.0,,CHEMBL2017214,,CHEMBL2017214,,False,http://www.openphacts.org/units/Nanomolar,1634757,>,1,True,>,,IC50,nM,,40000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,40.0
,10850637,[],CHEMBL2019915,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1,,,CHEMBL2016522,ACS Med. Chem. Lett.,2011.0,,CHEMBL1938680,,CHEMBL1938680,,False,http://www.openphacts.org/units/Nanomolar,1635001,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30000.0
,10858119,[],CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1n[nH]c2ncnc(N3CCN(c4cc(Cl)cc(NCCN(C)C)c4C)CC3)c12,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '14.52', 'le': '0.28', 'lle': '3.25', 'sei': '8.44'}",CHEMBL2012701,,CHEMBL2012701,6.43,False,http://www.openphacts.org/units/Nanomolar,1634253,=,1,True,=,,IC50,nM,,371.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,371.0
,10858120,[],CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1n[nH]c2ncnc(N3CCN(c4cc(Cl)cc(NCCN5CCCC5)c4C)CC3)c12,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '13.56', 'le': '0.26', 'lle': '2.65', 'sei': '8.35'}",CHEMBL2012699,,CHEMBL2012699,6.36,False,http://www.openphacts.org/units/Nanomolar,1634254,=,1,True,=,,IC50,nM,,434.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,434.0
,10858121,[],CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(NCCN(C)C)cc(Cl)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '14.73', 'le': '0.33', 'lle': '3.90', 'sei': '9.55'}",CHEMBL2012702,,CHEMBL2012702,7.28,False,http://www.openphacts.org/units/Nanomolar,1634255,=,1,True,=,,IC50,nM,,53.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,53.0
,10858122,[],CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(NCCN2CCCC2)cc(Cl)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '14.19', 'le': '0.31', 'lle': '3.47', 'sei': '9.68'}",CHEMBL2016771,,CHEMBL2016771,7.38,False,http://www.openphacts.org/units/Nanomolar,1634256,=,1,True,=,,IC50,nM,,42.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.0
,10858135,[],CHEMBL2020675,Inhibition of AKT1-mediated GSK3beta phosphorylation in human PC3 cells after 3 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1n[nH]c2ncnc(N3CCN(c4cc(Cl)cc(NCCN(C)C)c4C)CC3)c12,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '11.39', 'le': '0.22', 'lle': '1.86', 'sei': '6.62'}",CHEMBL2012701,,CHEMBL2012701,5.04,False,http://www.openphacts.org/units/Nanomolar,1634253,=,1,True,=,,IC50,nM,,9026.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9026.0
,10858136,[],CHEMBL2020675,Inhibition of AKT1-mediated GSK3beta phosphorylation in human PC3 cells after 3 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1n[nH]c2ncnc(N3CCN(c4cc(Cl)cc(NCCN5CCCC5)c4C)CC3)c12,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '11.61', 'le': '0.23', 'lle': '1.74', 'sei': '7.14'}",CHEMBL2012699,,CHEMBL2012699,5.45,False,http://www.openphacts.org/units/Nanomolar,1634254,=,1,True,=,,IC50,nM,,3589.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3589.0
,10858137,[],CHEMBL2020675,Inhibition of AKT1-mediated GSK3beta phosphorylation in human PC3 cells after 3 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(NCCN(C)C)cc(Cl)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '10.87', 'le': '0.24', 'lle': '1.99', 'sei': '7.04'}",CHEMBL2012702,,CHEMBL2012702,5.37,False,http://www.openphacts.org/units/Nanomolar,1634255,=,1,True,=,,IC50,nM,,4285.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4285.0
,10858138,[],CHEMBL2020675,Inhibition of AKT1-mediated GSK3beta phosphorylation in human PC3 cells after 3 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(NCCN2CCCC2)cc(Cl)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '11.34', 'le': '0.25', 'lle': '1.99', 'sei': '7.74'}",CHEMBL2016771,,CHEMBL2016771,5.90,False,http://www.openphacts.org/units/Nanomolar,1634256,=,1,True,=,,IC50,nM,,1271.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1271.0
,10858148,[],CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cc(NCCN2CCCC2)c(C)c(N2CCN(c3ncnc4[nH]nc(Br)c34)CC2)c1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '13.70', 'le': '0.29', 'lle': '3.59', 'sei': '8.49'}",CHEMBL2016885,,CHEMBL2016885,7.25,False,http://www.openphacts.org/units/Nanomolar,1634389,=,1,True,=,,IC50,nM,,56.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,56.0
,10858149,[],CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(NCCN2CCCC2)cc(OCC(C)C)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '14.43', 'le': '0.31', 'lle': '3.76', 'sei': '9.42'}",CHEMBL2016886,,CHEMBL2016886,8.05,False,http://www.openphacts.org/units/Nanomolar,1634390,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
,10858150,[],CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(NCCN2CCCC2)cc(C(=O)Nc2ccccc2)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '13.04', 'le': '0.27', 'lle': '3.38', 'sei': '7.49'}",CHEMBL2016887,,CHEMBL2016887,7.89,False,http://www.openphacts.org/units/Nanomolar,1634391,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
,10858151,[],CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(NCCN2CCCC2)cc(COCC(F)(F)F)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '13.55', 'le': '0.29', 'lle': '3.76', 'sei': '9.48'}",CHEMBL2016888,,CHEMBL2016888,8.10,False,http://www.openphacts.org/units/Nanomolar,1634392,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
,10858152,[],CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(NCCN2CCCC2)cc(CCC(C)(C)C)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '14.32', 'le': '0.30', 'lle': '2.91', 'sei': '10.70'}",CHEMBL2016889,,CHEMBL2016889,8.15,False,http://www.openphacts.org/units/Nanomolar,1634393,=,1,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
,10858153,[],CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1noc(-c2cc(NCCN3CCCC3)c(C)c(N3CCN(c4ncnc5[nH]nc(Br)c45)CC3)c2)n1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '14.49', 'le': '0.30', 'lle': '4.60', 'sei': '7.14'}",CHEMBL2016890,,CHEMBL2016890,8.22,False,http://www.openphacts.org/units/Nanomolar,1634394,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,10858154,[],CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1cc(NCCN2CCCC2)c(C)c(N2CCN(c3ncnc4[nH]nc(Br)c34)CC2)c1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '15.27', 'le': '0.32', 'lle': '5.26', 'sei': '8.10'}",CHEMBL2016891,,CHEMBL2016891,8.30,False,http://www.openphacts.org/units/Nanomolar,1634395,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,10858155,[],CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC(=O)c1cc(NCCN2CCCC2)c(C)c(N2CCN(c3ncnc4[nH]nc(Br)c34)CC2)c1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '15.33', 'le': '0.32', 'lle': '4.45', 'sei': '8.90'}",CHEMBL2016892,,CHEMBL2016892,8.30,False,http://www.openphacts.org/units/Nanomolar,1634396,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,10858156,[],CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(NCCN2CCCC2)cc(C(=O)CCC(F)(F)F)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '14.77', 'le': '0.32', 'lle': '4.22', 'sei': '9.65'}",CHEMBL2016893,,CHEMBL2016893,9.00,False,http://www.openphacts.org/units/Nanomolar,1634397,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,10858782,[],CHEMBL2020675,Inhibition of AKT1-mediated GSK3beta phosphorylation in human PC3 cells after 3 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOc1cc(NCCN2CCCC2)c(C)c(N2CCN(c3ncnc4[nH]nc(Br)c34)CC2)c1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '9.52', 'le': '0.20', 'lle': '1.38', 'sei': '5.90'}",CHEMBL2016885,,CHEMBL2016885,5.04,False,http://www.openphacts.org/units/Nanomolar,1634389,=,1,True,=,,IC50,nM,,9067.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9067.0
,10858783,[],CHEMBL2020675,Inhibition of AKT1-mediated GSK3beta phosphorylation in human PC3 cells after 3 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(NCCN2CCCC2)cc(OCC(C)C)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '11.04', 'le': '0.23', 'lle': '1.86', 'sei': '7.20'}",CHEMBL2016886,,CHEMBL2016886,6.16,False,http://www.openphacts.org/units/Nanomolar,1634390,=,1,True,=,,IC50,nM,,700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,700.0
,10858784,[],CHEMBL2020675,Inhibition of AKT1-mediated GSK3beta phosphorylation in human PC3 cells after 3 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(NCCN2CCCC2)cc(C(=O)Nc2ccccc2)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '8.45', 'le': '0.17', 'lle': '0.60', 'sei': '4.85'}",CHEMBL2016887,,CHEMBL2016887,5.11,False,http://www.openphacts.org/units/Nanomolar,1634391,=,1,True,=,,IC50,nM,,7811.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7811.0
,10858785,[],CHEMBL2020675,Inhibition of AKT1-mediated GSK3beta phosphorylation in human PC3 cells after 3 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(NCCN2CCCC2)cc(COCC(F)(F)F)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '10.27', 'le': '0.22', 'lle': '1.80', 'sei': '7.18'}",CHEMBL2016888,,CHEMBL2016888,6.14,False,http://www.openphacts.org/units/Nanomolar,1634392,=,1,True,=,,IC50,nM,,730.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,730.0
,10858786,[],CHEMBL2020675,Inhibition of AKT1-mediated GSK3beta phosphorylation in human PC3 cells after 3 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(NCCN2CCCC2)cc(CCC(C)(C)C)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '10.01', 'le': '0.21', 'lle': '0.46', 'sei': '7.48'}",CHEMBL2016889,,CHEMBL2016889,5.70,False,http://www.openphacts.org/units/Nanomolar,1634393,=,1,True,=,,IC50,nM,,1982.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1982.0
,10858787,[],CHEMBL2020675,Inhibition of AKT1-mediated GSK3beta phosphorylation in human PC3 cells after 3 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1noc(-c2cc(NCCN3CCCC3)c(C)c(N3CCN(c4ncnc5[nH]nc(Br)c45)CC3)c2)n1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '10.88', 'le': '0.23', 'lle': '2.56', 'sei': '5.37'}",CHEMBL2016890,,CHEMBL2016890,6.18,False,http://www.openphacts.org/units/Nanomolar,1634394,=,1,True,=,,IC50,nM,,665.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,665.0
,10858788,[],CHEMBL2020675,Inhibition of AKT1-mediated GSK3beta phosphorylation in human PC3 cells after 3 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cc(NCCN2CCCC2)c(C)c(N2CCN(c3ncnc4[nH]nc(Br)c34)CC2)c1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '10.55', 'le': '0.22', 'lle': '2.69', 'sei': '5.59'}",CHEMBL2016891,,CHEMBL2016891,5.73,False,http://www.openphacts.org/units/Nanomolar,1634395,=,1,True,=,,IC50,nM,,1843.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1843.0
,10858789,[],CHEMBL2020675,Inhibition of AKT1-mediated GSK3beta phosphorylation in human PC3 cells after 3 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCC(=O)c1cc(NCCN2CCCC2)c(C)c(N2CCN(c3ncnc4[nH]nc(Br)c34)CC2)c1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '11.10', 'le': '0.23', 'lle': '2.16', 'sei': '6.44'}",CHEMBL2016892,,CHEMBL2016892,6.01,False,http://www.openphacts.org/units/Nanomolar,1634396,=,1,True,=,,IC50,nM,,976.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,976.0
,10858790,[],CHEMBL2020675,Inhibition of AKT1-mediated GSK3beta phosphorylation in human PC3 cells after 3 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(NCCN2CCCC2)cc(C(=O)CCC(F)(F)F)cc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL2016487,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '11.01', 'le': '0.24', 'lle': '1.93', 'sei': '7.20'}",CHEMBL2016893,,CHEMBL2016893,6.71,False,http://www.openphacts.org/units/Nanomolar,1634397,=,1,True,=,,IC50,nM,,194.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,194.0
,10889045,[],CHEMBL2032470,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1,,,CHEMBL2029218,J. Med. Chem.,2012.0,"{'bei': '9.27', 'le': '0.17', 'lle': '0.29', 'sei': '4.15'}",CHEMBL460472,,CHEMBL460472,5.00,False,http://www.openphacts.org/units/Nanomolar,1644201,=,1,True,=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,10889072,[],CHEMBL2032470,Inhibition of PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC,,,CHEMBL2029218,J. Med. Chem.,2012.0,"{'bei': '9.46', 'le': '0.18', 'lle': '-0.23', 'sei': '5.18'}",CHEMBL2031893,,CHEMBL2031893,5.00,False,http://www.openphacts.org/units/Nanomolar,1644002,=,1,True,=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,10909517,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc(-c2ccc(C3(N)CCC3)cc2)c(-c2ccccc2)c1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '17.42', 'le': '0.31', 'lle': '2.13', 'sei': '7.30'}",CHEMBL2035040,,CHEMBL2035040,5.98,False,http://www.openphacts.org/units/Nanomolar,1644737,=,1,True,=,,IC50,nM,,1042.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.042
,10909518,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4ccccc4)nc4ccccc4c3=O)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '11.92', 'le': '0.21', 'lle': '-0.01', 'sei': '7.19'}",CHEMBL2035039,,CHEMBL2035039,4.38,False,http://www.openphacts.org/units/Nanomolar,1644736,=,1,True,=,,IC50,nM,,41722.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,41.722
,10909519,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccccc4c(=O)n3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '14.02', 'le': '0.25', 'lle': '0.76', 'sei': '8.46'}",CHEMBL2035038,,CHEMBL2035038,5.15,False,http://www.openphacts.org/units/Nanomolar,1644735,=,1,True,=,,IC50,nM,,7024.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,7.024
,10909520,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cnc2c(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)ccc21,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '15.71', 'le': '0.28', 'lle': '0.30', 'sei': '12.67'}",CHEMBL2035037,,CHEMBL2035037,5.55,False,http://www.openphacts.org/units/Nanomolar,1644734,=,1,True,=,,IC50,nM,,2799.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.799
,10909521,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3c(-c4ccccc4)ccc4ncnn34)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '16.66', 'le': '0.30', 'lle': '1.27', 'sei': '10.09'}",CHEMBL2035036,,CHEMBL2035036,5.67,False,http://www.openphacts.org/units/Nanomolar,1644733,=,1,True,=,,IC50,nM,,2135.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.135
,10909522,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3c(-c4ccccc4)ccn4ncnc34)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '16.37', 'le': '0.29', 'lle': '1.17', 'sei': '9.92'}",CHEMBL2035035,,CHEMBL2035035,5.57,False,http://www.openphacts.org/units/Nanomolar,1644732,=,1,True,=,,IC50,nM,,2668.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.668
,10909523,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3c(-c4ccccc4)ncc4nccn34)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '15.47', 'le': '0.28', 'lle': '0.87', 'sei': '9.37'}",CHEMBL2035034,,CHEMBL2035034,5.27,False,http://www.openphacts.org/units/Nanomolar,1644731,=,1,True,=,,IC50,nM,,5404.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.404
,10909524,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3c(-c4ccccc4)ccn4ccnc34)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '16.92', 'le': '0.30', 'lle': '0.73', 'sei': '13.26'}",CHEMBL2035033,,CHEMBL2035033,5.74,False,http://www.openphacts.org/units/Nanomolar,1644730,=,1,True,=,,IC50,nM,,1807.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.807
,10909525,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3c(-c4ccccc4)ccc4ccnn34)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '16.40', 'le': '0.29', 'lle': '0.56', 'sei': '12.85'}",CHEMBL2035032,,CHEMBL2035032,5.57,False,http://www.openphacts.org/units/Nanomolar,1644729,=,1,True,=,,IC50,nM,,2716.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.716
,10909526,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3ncc4cccnc4c3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '18.02', 'le': '0.32', 'lle': '1.03', 'sei': '12.22'}",CHEMBL2035031,,CHEMBL2035031,6.33,False,http://www.openphacts.org/units/Nanomolar,1644728,=,1,True,=,,IC50,nM,,465.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.465
,10909527,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3ncc4ccncc4c3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '19.10', 'le': '0.34', 'lle': '1.41', 'sei': '12.96'}",CHEMBL2035030,,CHEMBL2035030,6.71,False,http://www.openphacts.org/units/Nanomolar,1644727,=,1,True,=,,IC50,nM,,193.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.193
,10909528,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3ncc4cnccc4c3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '19.72', 'le': '0.35', 'lle': '1.63', 'sei': '13.38'}",CHEMBL2035029,,CHEMBL2035029,6.93,False,http://www.openphacts.org/units/Nanomolar,1644726,=,1,True,=,,IC50,nM,,117.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.117
,10909529,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3ncc4ncccc4c3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '19.14', 'le': '0.34', 'lle': '1.43', 'sei': '12.98'}",CHEMBL2035028,,CHEMBL2035028,6.73,False,http://www.openphacts.org/units/Nanomolar,1644725,=,1,True,=,,IC50,nM,,188.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.188
,10909530,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3ncc4ccccc4c3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '18.61', 'le': '0.33', 'lle': '0.61', 'sei': '16.76'}",CHEMBL2035027,,CHEMBL2035027,6.52,False,http://www.openphacts.org/units/Nanomolar,1644724,=,1,True,=,,IC50,nM,,301.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.301
,10909531,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cnc2cnc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)c21,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '13.70', 'le': '0.25', 'lle': '-0.07', 'sei': '8.90'}",CHEMBL2035026,,CHEMBL2035026,5.05,False,http://www.openphacts.org/units/Nanomolar,1644723,=,1,True,=,,IC50,nM,,8976.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,8.976
,10909532,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3ncc4nccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '17.33', 'le': '0.31', 'lle': '1.50', 'sei': '10.49'}",CHEMBL2035025,,CHEMBL2035025,5.90,False,http://www.openphacts.org/units/Nanomolar,1644722,=,1,True,=,,IC50,nM,,1262.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.262
,10909533,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3ncc4cccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '17.98', 'le': '0.32', 'lle': '1.09', 'sei': '14.09'}",CHEMBL2035024,,CHEMBL2035024,6.10,False,http://www.openphacts.org/units/Nanomolar,1644721,=,1,True,=,,IC50,nM,,787.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.787
,10909534,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nn4ccc(=O)nc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '13.74', 'le': '0.25', 'lle': '1.30', 'sei': '6.91'}",CHEMBL2035023,,CHEMBL2035023,5.06,False,http://www.openphacts.org/units/Nanomolar,1644720,=,1,True,=,,IC50,nM,,8665.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,8.665
,10909535,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '16.89', 'le': '0.30', 'lle': '2.35', 'sei': '7.47'}",CHEMBL2035022,,CHEMBL2035022,6.46,False,http://www.openphacts.org/units/Nanomolar,1644719,=,1,True,=,,IC50,nM,,348.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.348
,10909536,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '18.89', 'le': '0.34', 'lle': '1.40', 'sei': '14.80'}",CHEMBL2035021,,CHEMBL2035021,6.41,False,http://www.openphacts.org/units/Nanomolar,1644718,=,1,True,=,,IC50,nM,,387.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.387
,10909537,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nn4ccccc4c3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '19.74', 'le': '0.35', 'lle': '1.69', 'sei': '15.47'}",CHEMBL2035020,,CHEMBL2035020,6.70,False,http://www.openphacts.org/units/Nanomolar,1644717,=,1,True,=,,IC50,nM,,199.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.199
,10909538,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nn4ccnc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '18.44', 'le': '0.33', 'lle': '1.88', 'sei': '11.17'}",CHEMBL2035019,,CHEMBL2035019,6.28,False,http://www.openphacts.org/units/Nanomolar,1644716,=,1,True,=,,IC50,nM,,528.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.528
,10909539,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nn4cccc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '17.77', 'le': '0.32', 'lle': '1.02', 'sei': '13.93'}",CHEMBL2035018,,CHEMBL2035018,6.03,False,http://www.openphacts.org/units/Nanomolar,1644715,=,1,True,=,,IC50,nM,,926.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.926
,10909540,[],CHEMBL2039955,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccccc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL2034885,J. Med. Chem.,2012.0,"{'bei': '18.87', 'le': '0.33', 'lle': '0.70', 'sei': '17.00'}",CHEMBL2035017,,CHEMBL2035017,6.61,False,http://www.openphacts.org/units/Nanomolar,1644714,=,1,True,=,,IC50,nM,,243.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.243
,10912549,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(=O)c2ccc(-c3nc4ccccc4n3C)nc2n(C)c1=O,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,,CHEMBL2036871,,CHEMBL2036871,,False,http://www.openphacts.org/units/Nanomolar,1646916,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,10912565,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Nc2ncc3c(n2)-c2ccccc2NC(=O)C3)cc1O,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,,CHEMBL603463,,CHEMBL603463,,False,http://www.openphacts.org/units/Nanomolar,1646765,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,10913459,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(-c2ccnc(Nc3ccccc3)n2)nc2ccccc21,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,,CHEMBL2036725,,CHEMBL2036725,,False,http://www.openphacts.org/units/Nanomolar,1646766,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,10913475,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,,CHEMBL2036726,,CHEMBL2036726,,False,http://www.openphacts.org/units/Nanomolar,1646767,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,10913491,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(-c2ccnc(Nc3ccc(Cl)cc3)n2)nc2ccccc21,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,"{'bei': '13.06', 'le': '0.25', 'lle': '-0.04', 'sei': '7.89'}",CHEMBL2036727,,CHEMBL2036727,4.39,False,http://www.openphacts.org/units/Nanomolar,1646768,=,1,True,=,,IC50,nM,,41000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,41.0
,10913507,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)nc2ccccc21,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,,CHEMBL2036728,,CHEMBL2036728,,False,http://www.openphacts.org/units/Nanomolar,1646769,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,10913523,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,,CHEMBL2036867,,CHEMBL2036867,,False,http://www.openphacts.org/units/Nanomolar,1646912,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,10913539,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,"{'bei': '12.45', 'le': '0.23', 'lle': '0.34', 'sei': '6.36'}",CHEMBL2036868,,CHEMBL2036868,4.12,False,http://www.openphacts.org/units/Nanomolar,1646913,=,1,True,=,,IC50,nM,,75000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,75.0
,10913555,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(-c2ccnc(Nc3ccc(O)cc3)n2)nc2ccccc21,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,,CHEMBL2036869,,CHEMBL2036869,,False,http://www.openphacts.org/units/Nanomolar,1646914,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,10913560,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(-c2ccnc(Nc3cccc(O)c3)n2)nc2ccccc21,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,,CHEMBL2036870,,CHEMBL2036870,,False,http://www.openphacts.org/units/Nanomolar,1646915,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,10913565,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(-c2ccnc(Nc3ccc(O)c(Cl)c3)n2)nc2ccccc21,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,,CHEMBL2036865,,CHEMBL2036865,,False,http://www.openphacts.org/units/Nanomolar,1646910,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,10913570,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1O,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,,CHEMBL2036866,,CHEMBL2036866,,False,http://www.openphacts.org/units/Nanomolar,1646911,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,10913585,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,,CHEMBL1200485,SORAFENIB TOSYLATE,CHEMBL1336,,False,http://www.openphacts.org/units/Nanomolar,1646917,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,10913600,[],CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,,,CHEMBL2034932,Eur. J. Med. Chem.,2012.0,,CHEMBL535,SUNITINIB,CHEMBL535,,False,http://www.openphacts.org/units/Nanomolar,1646918,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,10974725,[],CHEMBL2067501,Inhibition of AKT1 by AKT1/PKBalpha KinEASE FP fluorescein green assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C=C(C(=O)/C=C/c2cccc(OC)c2OC)C(=O)/C=C/c2cccc(OC)c2OC)ccc1O,,,CHEMBL2062524,Eur. J. Med. Chem.,2012.0,"{'bei': '11.48', 'le': '0.21', 'lle': '0.71', 'sei': '6.06'}",CHEMBL2063990,,CHEMBL2063990,6.09,False,http://www.openphacts.org/units/Nanomolar,1659996,=,1,True,=,,IC50,nM,,810.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.81
,10974726,[],CHEMBL2067501,Inhibition of AKT1 by AKT1/PKBalpha KinEASE FP fluorescein green assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(OC)c(/C=C/C(=O)C(=Cc2cc(Br)c(O)c(OC)c2)C(=O)/C=C/c2cc(OC)ccc2OC)c1,,,CHEMBL2062524,Eur. J. Med. Chem.,2012.0,"{'bei': '8.69', 'le': '0.18', 'lle': '-0.85', 'sei': '5.27'}",CHEMBL2064002,,CHEMBL2064002,5.30,False,http://www.openphacts.org/units/Nanomolar,1660009,=,1,True,=,,IC50,nM,,5020.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.02
,10974727,[],CHEMBL2067501,Inhibition of AKT1 by AKT1/PKBalpha KinEASE FP fluorescein green assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(/C=C/C(=O)C(=Cc2ccc(OC)c(O)c2)C(=O)/C=C/c2ccc(OC)cc2OC)c(OC)c1,,,CHEMBL2062524,Eur. J. Med. Chem.,2012.0,"{'bei': '10.89', 'le': '0.20', 'lle': '0.40', 'sei': '5.75'}",CHEMBL2064009,,CHEMBL2064009,5.78,False,http://www.openphacts.org/units/Nanomolar,1660016,=,1,True,=,,IC50,nM,,1660.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.66
,10980292,[],CHEMBL2065136,Inhibition of AKT1 by FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12,,,CHEMBL2062359,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL2063926,,CHEMBL2063926,,False,http://www.openphacts.org/units/Nanomolar,1659922,<,1,True,<,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12060756,[],CHEMBL2156891,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N,,,CHEMBL2150966,J. Med. Chem.,2012.0,,CHEMBL2152252,,CHEMBL2152252,,False,http://www.openphacts.org/units/Nanomolar,1730877,>,1,True,>,,IC50,nM,,3600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3600.0
,12060757,[],CHEMBL2156891,Inhibition of AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3C)c2)cnc1N,,,CHEMBL2150966,J. Med. Chem.,2012.0,,CHEMBL2152253,,CHEMBL2152253,,False,http://www.openphacts.org/units/Nanomolar,1730878,>,1,True,>,,IC50,nM,,3600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3600.0
,12143266,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccc(-n2c(-c3cccnc3)nc3cccnc32)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177844,,CHEMBL2177844,,False,http://www.openphacts.org/units/Nanomolar,1750643,=,1,True,=,,IC50,nM,,185000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,185.0
,12143276,[],CHEMBL2183039,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells by indirect affinity mass spectrometry assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1Cn1c(-c2ccncc2)nc2cc(Br)cnc21,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.23', 'le': '0.29', 'lle': '0.92', 'sei': '9.90'}",CHEMBL2177843,,CHEMBL2177843,5.23,False,http://www.openphacts.org/units/Nanomolar,1750642,=,1,True,=,,IC50,nM,,5900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.9
,12143279,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1Cn1c(-c2cccnc2N)nc2cccnc21,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.78', 'le': '0.23', 'lle': '1.11', 'sei': '5.37'}",CHEMBL2177841,,CHEMBL2177841,4.24,False,http://www.openphacts.org/units/Nanomolar,1750640,=,1,True,=,,IC50,nM,,58000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,58.0
,12143293,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1cccc(CNC(=O)c2ccccc2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.62', 'le': '0.21', 'lle': '0.90', 'sei': '4.95'}",CHEMBL2177823,,CHEMBL2177823,4.89,False,http://www.openphacts.org/units/Nanomolar,1750621,=,1,True,=,,IC50,nM,,13000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,13.0
,12143308,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(C3CCCC3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '10.29', 'le': '0.19', 'lle': '-0.62', 'sei': '5.09'}",CHEMBL2177826,,CHEMBL2177826,5.03,False,http://www.openphacts.org/units/Nanomolar,1750624,=,1,True,=,,IC50,nM,,9400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,9.4
,12143311,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NCc1ccc(-n2c(-c3cccnc3)nc3cccnc32)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '16.78', 'le': '0.30', 'lle': '2.12', 'sei': '7.26'}",CHEMBL2177848,,CHEMBL2177848,5.06,False,http://www.openphacts.org/units/Nanomolar,1750647,=,1,True,=,,IC50,nM,,8800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,8.8
,12143321,[],CHEMBL2183039,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells by indirect affinity mass spectrometry assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N=P([O-])(OP(=O)([O-])[O-])OP(=O)([O-])OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O.[Li+].[Li+].[Li+].[Li+],,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '10.33', 'le': '0.23', 'lle': '6.44', 'sei': '1.83'}",CHEMBL2177838,ADENYLYL IMIDODIPHOSPHATE TETRALITHIUM SALT,CHEMBL2220361,5.23,False,http://www.openphacts.org/units/Nanomolar,1750636,=,1,True,=,,IC50,nM,,5900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.9
,12143324,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.49', 'le': '0.22', 'lle': '1.26', 'sei': '5.32'}",CHEMBL2177819,,CHEMBL2177819,5.25,False,http://www.openphacts.org/units/Nanomolar,1750617,=,1,True,=,,IC50,nM,,5600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.6
,12143330,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '10.81', 'le': '0.19', 'lle': '0.32', 'sei': '4.82'}",CHEMBL2177832,,CHEMBL2177832,5.38,False,http://www.openphacts.org/units/Nanomolar,1750630,=,1,True,=,,IC50,nM,,4200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.2
,12143332,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccc(-n2c(-c3cccnc3N)nc3cccnc32)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '15.75', 'le': '0.28', 'lle': '1.05', 'sei': '7.77'}",CHEMBL2177840,,CHEMBL2177840,5.41,False,http://www.openphacts.org/units/Nanomolar,1750639,=,1,True,=,,IC50,nM,,3900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.9
,12143333,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(C3CCCC3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.12', 'le': '0.20', 'lle': '-0.22', 'sei': '5.50'}",CHEMBL2177826,,CHEMBL2177826,5.43,False,http://www.openphacts.org/units/Nanomolar,1750624,=,1,True,=,,IC50,nM,,3700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.7
,12143338,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.04', 'le': '0.20', 'lle': '0.43', 'sei': '4.92'}",CHEMBL2177832,,CHEMBL2177832,5.50,False,http://www.openphacts.org/units/Nanomolar,1750630,=,1,True,=,,IC50,nM,,3200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.2
,12143339,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(Br)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.03', 'le': '0.23', 'lle': '0.75', 'sei': '5.58'}",CHEMBL2177825,,CHEMBL2177825,5.51,False,http://www.openphacts.org/units/Nanomolar,1750623,=,1,True,=,,IC50,nM,,3100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.1
,12143342,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.26', 'le': '0.20', 'lle': '0.29', 'sei': '5.02'}",CHEMBL2177829,,CHEMBL2177829,5.60,False,http://www.openphacts.org/units/Nanomolar,1750627,=,1,True,=,,IC50,nM,,2500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.5
,12143343,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(Br)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.22', 'le': '0.23', 'lle': '0.84', 'sei': '5.67'}",CHEMBL2177825,,CHEMBL2177825,5.60,False,http://www.openphacts.org/units/Nanomolar,1750623,=,1,True,=,,IC50,nM,,2500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.5
,12143344,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.32', 'le': '0.24', 'lle': '1.35', 'sei': '5.67'}",CHEMBL2177818,,CHEMBL2177818,5.60,False,http://www.openphacts.org/units/Nanomolar,1750616,=,1,True,=,,IC50,nM,,2500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.5
,12143348,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.01', 'le': '0.20', 'lle': '0.48', 'sei': '5.09'}",CHEMBL2177837,,CHEMBL2177837,5.68,False,http://www.openphacts.org/units/Nanomolar,1750635,=,1,True,=,,IC50,nM,,2100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.1
,12143349,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(C3CCCC3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.62', 'le': '0.21', 'lle': '0.03', 'sei': '5.75'}",CHEMBL2177826,,CHEMBL2177826,5.68,False,http://www.openphacts.org/units/Nanomolar,1750624,=,1,True,=,,IC50,nM,,2100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.1
,12143354,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3ccccc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.57', 'le': '0.21', 'lle': '0.08', 'sei': '5.82'}",CHEMBL2177830,,CHEMBL2177830,5.75,False,http://www.openphacts.org/units/Nanomolar,1750628,=,1,True,=,,IC50,nM,,1800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.8
,12143360,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.70', 'le': '0.21', 'lle': '0.76', 'sei': '5.22'}",CHEMBL2177831,,CHEMBL2177831,5.82,False,http://www.openphacts.org/units/Nanomolar,1750629,=,1,True,=,,IC50,nM,,1500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.5
,12143361,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '10.19', 'le': '0.18', 'lle': '-0.19', 'sei': '4.56'}",CHEMBL2177828,,CHEMBL2177828,5.82,False,http://www.openphacts.org/units/Nanomolar,1750626,=,1,True,=,,IC50,nM,,1500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.5
,12143362,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.77', 'le': '0.21', 'lle': '0.79', 'sei': '5.24'}",CHEMBL2177832,,CHEMBL2177832,5.85,False,http://www.openphacts.org/units/Nanomolar,1750630,=,1,True,=,,IC50,nM,,1400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.4
,12143363,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1ccc(-n2c(-c3cccnc3N)nc3cccnc32)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '17.09', 'le': '0.31', 'lle': '2.87', 'sei': '5.96'}",CHEMBL2177815,,CHEMBL2177815,5.89,False,http://www.openphacts.org/units/Nanomolar,1750613,=,1,True,=,,IC50,nM,,1300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.3
,12143365,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.42', 'le': '0.21', 'lle': '0.69', 'sei': '5.27'}",CHEMBL2177837,,CHEMBL2177837,5.89,False,http://www.openphacts.org/units/Nanomolar,1750635,=,1,True,=,,IC50,nM,,1300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.3
,12143366,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.00', 'le': '0.25', 'lle': '1.64', 'sei': '5.96'}",CHEMBL2177818,,CHEMBL2177818,5.89,False,http://www.openphacts.org/units/Nanomolar,1750616,=,1,True,=,,IC50,nM,,1300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.3
,12143372,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3ccccc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.00', 'le': '0.21', 'lle': '0.30', 'sei': '6.04'}",CHEMBL2177830,,CHEMBL2177830,5.96,False,http://www.openphacts.org/units/Nanomolar,1750628,=,1,True,=,,IC50,nM,,1100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.1
,12143374,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3ccccc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.10', 'le': '0.22', 'lle': '0.35', 'sei': '6.09'}",CHEMBL2177830,,CHEMBL2177830,6.01,False,http://www.openphacts.org/units/Nanomolar,1750628,=,1,True,=,,IC50,nM,,980.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.98
,12143375,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.10', 'le': '0.22', 'lle': '0.96', 'sei': '5.40'}",CHEMBL2177831,,CHEMBL2177831,6.02,False,http://www.openphacts.org/units/Nanomolar,1750629,=,1,True,=,,IC50,nM,,950.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.95
,12143376,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NCc1ccc(-n2c(-c3cccnc3N)nc3cccnc32)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '19.06', 'le': '0.34', 'lle': '3.51', 'sei': '6.31'}",CHEMBL2177847,,CHEMBL2177847,6.03,False,http://www.openphacts.org/units/Nanomolar,1750646,=,1,True,=,,IC50,nM,,930.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.93
,12143377,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '10.91', 'le': '0.20', 'lle': '0.42', 'sei': '4.73'}",CHEMBL2177834,,CHEMBL2177834,6.04,False,http://www.openphacts.org/units/Nanomolar,1750632,=,1,True,=,,IC50,nM,,910.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.91
,12143379,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '10.97', 'le': '0.20', 'lle': '0.46', 'sei': '4.75'}",CHEMBL2177834,,CHEMBL2177834,6.08,False,http://www.openphacts.org/units/Nanomolar,1750632,=,1,True,=,,IC50,nM,,840.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.84
,12143380,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.81', 'le': '0.21', 'lle': '0.89', 'sei': '5.45'}",CHEMBL2177833,,CHEMBL2177833,6.09,False,http://www.openphacts.org/units/Nanomolar,1750631,=,1,True,=,,IC50,nM,,820.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.82
,12143381,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)NCc1ccc(-n2c(-c3cccnc3N)nc3cccnc32)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '17.00', 'le': '0.31', 'lle': '3.39', 'sei': '6.17'}",CHEMBL2177822,,CHEMBL2177822,6.09,False,http://www.openphacts.org/units/Nanomolar,1750620,=,1,True,=,,IC50,nM,,810.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.81
,12143383,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(-n2c(-c3cccnc3N)nc3cccnc32)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '20.28', 'le': '0.36', 'lle': '3.48', 'sei': '6.41'}",CHEMBL2177816,,CHEMBL2177816,6.13,False,http://www.openphacts.org/units/Nanomolar,1750614,=,1,True,=,,IC50,nM,,740.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.74
,12143384,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.32', 'le': '0.22', 'lle': '1.07', 'sei': '5.49'}",CHEMBL2177832,,CHEMBL2177832,6.13,False,http://www.openphacts.org/units/Nanomolar,1750630,=,1,True,=,,IC50,nM,,740.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.74
,12143386,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.95', 'le': '0.22', 'lle': '0.96', 'sei': '5.52'}",CHEMBL2177837,,CHEMBL2177837,6.16,False,http://www.openphacts.org/units/Nanomolar,1750635,=,1,True,=,,IC50,nM,,690.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.69
,12143387,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3ccccc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.42', 'le': '0.22', 'lle': '0.51', 'sei': '6.25'}",CHEMBL2177830,,CHEMBL2177830,6.17,False,http://www.openphacts.org/units/Nanomolar,1750628,=,1,True,=,,IC50,nM,,680.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.68
,12143390,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)Cc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.22', 'le': '0.26', 'lle': '2.26', 'sei': '6.26'}",CHEMBL2177821,,CHEMBL2177821,6.18,False,http://www.openphacts.org/units/Nanomolar,1750619,=,1,True,=,,IC50,nM,,660.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.66
,12143392,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.10', 'le': '0.22', 'lle': '1.04', 'sei': '5.59'}",CHEMBL2177833,,CHEMBL2177833,6.24,False,http://www.openphacts.org/units/Nanomolar,1750631,=,1,True,=,,IC50,nM,,580.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.58
,12143393,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.70', 'le': '0.23', 'lle': '1.01', 'sei': '5.66'}",CHEMBL2177829,,CHEMBL2177829,6.32,False,http://www.openphacts.org/units/Nanomolar,1750627,=,1,True,=,,IC50,nM,,480.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.48
,12143394,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.86', 'le': '0.23', 'lle': '0.73', 'sei': '6.47'}",CHEMBL2177835,,CHEMBL2177835,6.39,False,http://www.openphacts.org/units/Nanomolar,1750633,=,1,True,=,,IC50,nM,,410.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.41
,12143395,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '15.19', 'le': '0.27', 'lle': '2.40', 'sei': '6.47'}",CHEMBL2177819,,CHEMBL2177819,6.39,False,http://www.openphacts.org/units/Nanomolar,1750617,=,1,True,=,,IC50,nM,,410.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.41
,12143397,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '15.30', 'le': '0.27', 'lle': '2.44', 'sei': '6.52'}",CHEMBL2177819,,CHEMBL2177819,6.43,False,http://www.openphacts.org/units/Nanomolar,1750617,=,1,True,=,,IC50,nM,,370.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.37
,12143398,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.55', 'le': '0.23', 'lle': '1.27', 'sei': '5.80'}",CHEMBL2177837,,CHEMBL2177837,6.47,False,http://www.openphacts.org/units/Nanomolar,1750635,=,1,True,=,,IC50,nM,,340.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.34
,12143399,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3ccccc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.05', 'le': '0.23', 'lle': '0.82', 'sei': '6.57'}",CHEMBL2177830,,CHEMBL2177830,6.48,False,http://www.openphacts.org/units/Nanomolar,1750628,=,1,True,=,,IC50,nM,,330.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.33
,12143400,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.76', 'le': '0.21', 'lle': '0.64', 'sei': '5.09'}",CHEMBL2177827,,CHEMBL2177827,6.51,False,http://www.openphacts.org/units/Nanomolar,1750625,=,1,True,=,,IC50,nM,,310.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.31
,12143401,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(C3CCCC3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.44', 'le': '0.24', 'lle': '0.92', 'sei': '6.65'}",CHEMBL2177826,,CHEMBL2177826,6.57,False,http://www.openphacts.org/units/Nanomolar,1750624,=,1,True,=,,IC50,nM,,270.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.27
,12143402,[],CHEMBL2183039,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells by indirect affinity mass spectrometry assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL379218,,CHEMBL379218,,False,http://www.openphacts.org/units/Nanomolar,1750637,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,12143403,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNCc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '16.20', 'le': '0.29', 'lle': '2.24', 'sei': '8.06'}",CHEMBL2177824,,CHEMBL2177824,6.58,False,http://www.openphacts.org/units/Nanomolar,1750622,=,1,True,=,,IC50,nM,,260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.26
,12143404,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.52', 'le': '0.21', 'lle': '0.58', 'sei': '5.15'}",CHEMBL2177828,,CHEMBL2177828,6.58,False,http://www.openphacts.org/units/Nanomolar,1750626,=,1,True,=,,IC50,nM,,260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.26
,12143405,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)C2CCCCC2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '15.48', 'le': '0.28', 'lle': '2.34', 'sei': '6.69'}",CHEMBL2177820,,CHEMBL2177820,6.60,False,http://www.openphacts.org/units/Nanomolar,1750618,=,1,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.25
,12143406,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.55', 'le': '0.21', 'lle': '0.84', 'sei': '5.17'}",CHEMBL2177836,,CHEMBL2177836,6.60,False,http://www.openphacts.org/units/Nanomolar,1750634,=,1,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.25
,12143407,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.65', 'le': '0.21', 'lle': '0.90', 'sei': '5.21'}",CHEMBL2177836,,CHEMBL2177836,6.66,False,http://www.openphacts.org/units/Nanomolar,1750634,=,1,True,=,,IC50,nM,,220.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.22
,12143408,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(C3CCCC3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.67', 'le': '0.25', 'lle': '1.03', 'sei': '6.76'}",CHEMBL2177826,,CHEMBL2177826,6.68,False,http://www.openphacts.org/units/Nanomolar,1750624,=,1,True,=,,IC50,nM,,210.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.21
,12143409,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '15.88', 'le': '0.29', 'lle': '2.43', 'sei': '6.76'}",CHEMBL2177818,,CHEMBL2177818,6.68,False,http://www.openphacts.org/units/Nanomolar,1750616,=,1,True,=,,IC50,nM,,210.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.21
,12143410,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.99', 'le': '0.23', 'lle': '1.50', 'sei': '6.00'}",CHEMBL2177833,,CHEMBL2177833,6.70,False,http://www.openphacts.org/units/Nanomolar,1750631,=,1,True,=,,IC50,nM,,200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.2
,12143411,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.04', 'le': '0.24', 'lle': '1.52', 'sei': '6.02'}",CHEMBL2177837,,CHEMBL2177837,6.72,False,http://www.openphacts.org/units/Nanomolar,1750635,=,1,True,=,,IC50,nM,,190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.19
,12143412,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.58', 'le': '0.24', 'lle': '1.08', 'sei': '6.83'}",CHEMBL2177835,,CHEMBL2177835,6.75,False,http://www.openphacts.org/units/Nanomolar,1750633,=,1,True,=,,IC50,nM,,180.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.18
,12143413,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.23', 'le': '0.22', 'lle': '1.15', 'sei': '5.30'}",CHEMBL2177834,,CHEMBL2177834,6.77,False,http://www.openphacts.org/units/Nanomolar,1750632,=,1,True,=,,IC50,nM,,170.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.17
,12143414,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(Br)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.56', 'le': '0.28', 'lle': '2.01', 'sei': '6.86'}",CHEMBL2177825,,CHEMBL2177825,6.77,False,http://www.openphacts.org/units/Nanomolar,1750623,=,1,True,=,,IC50,nM,,170.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.17
,12143415,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3ccccc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.69', 'le': '0.24', 'lle': '1.14', 'sei': '6.88'}",CHEMBL2177830,,CHEMBL2177830,6.80,False,http://www.openphacts.org/units/Nanomolar,1750628,=,1,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.16
,12143416,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.99', 'le': '0.22', 'lle': '0.84', 'sei': '5.36'}",CHEMBL2177828,,CHEMBL2177828,6.85,False,http://www.openphacts.org/units/Nanomolar,1750626,=,1,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.14
,12143417,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.38', 'le': '0.22', 'lle': '1.23', 'sei': '5.36'}",CHEMBL2177834,,CHEMBL2177834,6.85,False,http://www.openphacts.org/units/Nanomolar,1750632,=,1,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.14
,12143419,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.44', 'le': '0.22', 'lle': '1.27', 'sei': '5.39'}",CHEMBL2177834,,CHEMBL2177834,6.89,False,http://www.openphacts.org/units/Nanomolar,1750632,=,1,True,=,,IC50,nM,,130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.13
,12143420,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.11', 'le': '0.22', 'lle': '0.91', 'sei': '5.41'}",CHEMBL2177828,,CHEMBL2177828,6.92,False,http://www.openphacts.org/units/Nanomolar,1750626,=,1,True,=,,IC50,nM,,120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.12
,12143421,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(C3CCCC3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.24', 'le': '0.26', 'lle': '1.31', 'sei': '7.05'}",CHEMBL2177826,,CHEMBL2177826,6.96,False,http://www.openphacts.org/units/Nanomolar,1750624,=,1,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.11
,12143422,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.57', 'le': '0.23', 'lle': '1.34', 'sei': '5.44'}",CHEMBL2177834,,CHEMBL2177834,6.96,False,http://www.openphacts.org/units/Nanomolar,1750632,=,1,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.11
,12143423,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.07', 'le': '0.25', 'lle': '1.94', 'sei': '6.27'}",CHEMBL2177831,,CHEMBL2177831,7.00,False,http://www.openphacts.org/units/Nanomolar,1750629,=,1,True,=,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.1
,12143424,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.62', 'le': '0.25', 'lle': '1.82', 'sei': '6.29'}",CHEMBL2177837,,CHEMBL2177837,7.02,False,http://www.openphacts.org/units/Nanomolar,1750635,=,1,True,=,,IC50,nM,,95.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.095
,12143425,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.15', 'le': '0.25', 'lle': '1.98', 'sei': '6.31'}",CHEMBL2177831,,CHEMBL2177831,7.04,False,http://www.openphacts.org/units/Nanomolar,1750629,=,1,True,=,,IC50,nM,,91.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.091
,12143426,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.33', 'le': '0.22', 'lle': '1.04', 'sei': '5.51'}",CHEMBL2177828,,CHEMBL2177828,7.05,False,http://www.openphacts.org/units/Nanomolar,1750626,=,1,True,=,,IC50,nM,,90.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.09
,12143427,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.26', 'le': '0.26', 'lle': '2.04', 'sei': '6.36'}",CHEMBL2177831,,CHEMBL2177831,7.10,False,http://www.openphacts.org/units/Nanomolar,1750629,=,1,True,=,,IC50,nM,,80.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.08
,12143428,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.39', 'le': '0.26', 'lle': '1.85', 'sei': '6.42'}",CHEMBL2177829,,CHEMBL2177829,7.16,False,http://www.openphacts.org/units/Nanomolar,1750627,=,1,True,=,,IC50,nM,,69.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.069
,12143429,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.43', 'le': '0.26', 'lle': '1.51', 'sei': '7.26'}",CHEMBL2177835,,CHEMBL2177835,7.17,False,http://www.openphacts.org/units/Nanomolar,1750633,=,1,True,=,,IC50,nM,,68.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.068
,12143430,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.42', 'le': '0.26', 'lle': '2.11', 'sei': '6.43'}",CHEMBL2177832,,CHEMBL2177832,7.17,False,http://www.openphacts.org/units/Nanomolar,1750630,=,1,True,=,,IC50,nM,,67.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.067
,12143431,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.44', 'le': '0.26', 'lle': '1.88', 'sei': '6.44'}",CHEMBL2177829,,CHEMBL2177829,7.19,False,http://www.openphacts.org/units/Nanomolar,1750627,=,1,True,=,,IC50,nM,,65.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.065
,12143432,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.49', 'le': '0.26', 'lle': '2.15', 'sei': '6.46'}",CHEMBL2177831,,CHEMBL2177831,7.21,False,http://www.openphacts.org/units/Nanomolar,1750629,=,1,True,=,,IC50,nM,,62.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.062
,12143433,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.59', 'le': '0.26', 'lle': '1.95', 'sei': '6.50'}",CHEMBL2177829,,CHEMBL2177829,7.26,False,http://www.openphacts.org/units/Nanomolar,1750627,=,1,True,=,,IC50,nM,,55.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.055
,12143434,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.13', 'le': '0.24', 'lle': '1.40', 'sei': '5.69'}",CHEMBL2177827,,CHEMBL2177827,7.27,False,http://www.openphacts.org/units/Nanomolar,1750625,=,1,True,=,,IC50,nM,,54.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.054
,12143435,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.10', 'le': '0.25', 'lle': '2.07', 'sei': '6.51'}",CHEMBL2177833,,CHEMBL2177833,7.27,False,http://www.openphacts.org/units/Nanomolar,1750631,=,1,True,=,,IC50,nM,,54.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.054
,12143436,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.66', 'le': '0.26', 'lle': '1.98', 'sei': '6.53'}",CHEMBL2177829,,CHEMBL2177829,7.29,False,http://www.openphacts.org/units/Nanomolar,1750627,=,1,True,=,,IC50,nM,,51.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.051
,12143437,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.67', 'le': '0.26', 'lle': '1.99', 'sei': '6.54'}",CHEMBL2177829,,CHEMBL2177829,7.30,False,http://www.openphacts.org/units/Nanomolar,1750627,=,1,True,=,,IC50,nM,,50.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.05
,12143438,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.18', 'le': '0.26', 'lle': '2.11', 'sei': '6.55'}",CHEMBL2177833,,CHEMBL2177833,7.31,False,http://www.openphacts.org/units/Nanomolar,1750631,=,1,True,=,,IC50,nM,,49.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.049
,12143439,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.20', 'le': '0.24', 'lle': '1.44', 'sei': '5.72'}",CHEMBL2177827,,CHEMBL2177827,7.31,False,http://www.openphacts.org/units/Nanomolar,1750625,=,1,True,=,,IC50,nM,,49.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.049
,12143440,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.21', 'le': '0.26', 'lle': '2.13', 'sei': '6.57'}",CHEMBL2177837,,CHEMBL2177837,7.33,False,http://www.openphacts.org/units/Nanomolar,1750635,=,1,True,=,,IC50,nM,,47.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.047
,12143441,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.24', 'le': '0.24', 'lle': '1.46', 'sei': '5.73'}",CHEMBL2177827,,CHEMBL2177827,7.33,False,http://www.openphacts.org/units/Nanomolar,1750625,=,1,True,=,,IC50,nM,,47.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.047
,12143442,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.23', 'le': '0.26', 'lle': '2.14', 'sei': '6.57'}",CHEMBL2177833,,CHEMBL2177833,7.34,False,http://www.openphacts.org/units/Nanomolar,1750631,=,1,True,=,,IC50,nM,,46.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.046
,12143443,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.25', 'le': '0.24', 'lle': '1.47', 'sei': '5.74'}",CHEMBL2177827,,CHEMBL2177827,7.34,False,http://www.openphacts.org/units/Nanomolar,1750625,=,1,True,=,,IC50,nM,,46.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.046
,12143444,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.85', 'le': '0.23', 'lle': '1.59', 'sei': '5.75'}",CHEMBL2177836,,CHEMBL2177836,7.35,False,http://www.openphacts.org/units/Nanomolar,1750634,=,1,True,=,,IC50,nM,,45.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.045
,12143445,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '12.87', 'le': '0.23', 'lle': '1.60', 'sei': '5.76'}",CHEMBL2177836,,CHEMBL2177836,7.36,False,http://www.openphacts.org/units/Nanomolar,1750634,=,1,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.044
,12143446,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '15.01', 'le': '0.27', 'lle': '2.41', 'sei': '6.69'}",CHEMBL2177832,,CHEMBL2177832,7.47,False,http://www.openphacts.org/units/Nanomolar,1750630,=,1,True,=,,IC50,nM,,34.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.034
,12143447,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3ccccc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '15.07', 'le': '0.27', 'lle': '1.82', 'sei': '7.58'}",CHEMBL2177830,,CHEMBL2177830,7.48,False,http://www.openphacts.org/units/Nanomolar,1750628,=,1,True,=,,IC50,nM,,33.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.033
,12143448,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.11', 'le': '0.24', 'lle': '1.73', 'sei': '5.86'}",CHEMBL2177836,,CHEMBL2177836,7.50,False,http://www.openphacts.org/units/Nanomolar,1750634,=,1,True,=,,IC50,nM,,32.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.032
,12143450,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '15.18', 'le': '0.27', 'lle': '2.49', 'sei': '6.77'}",CHEMBL2177832,,CHEMBL2177832,7.55,False,http://www.openphacts.org/units/Nanomolar,1750630,=,1,True,=,,IC50,nM,,28.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.028
,12143451,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '17.96', 'le': '0.32', 'lle': '3.30', 'sei': '7.65'}",CHEMBL2177818,,CHEMBL2177818,7.55,False,http://www.openphacts.org/units/Nanomolar,1750616,=,1,True,=,,IC50,nM,,28.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.028
,12143453,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(Br)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '15.16', 'le': '0.31', 'lle': '2.81', 'sei': '7.67'}",CHEMBL2177825,,CHEMBL2177825,7.57,False,http://www.openphacts.org/units/Nanomolar,1750623,=,1,True,=,,IC50,nM,,27.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.027
,12143454,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.24', 'le': '0.24', 'lle': '1.81', 'sei': '5.92'}",CHEMBL2177836,,CHEMBL2177836,7.57,False,http://www.openphacts.org/units/Nanomolar,1750634,=,1,True,=,,IC50,nM,,27.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.027
,12143455,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '15.34', 'le': '0.27', 'lle': '1.96', 'sei': '7.72'}",CHEMBL2177835,,CHEMBL2177835,7.62,False,http://www.openphacts.org/units/Nanomolar,1750633,=,1,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.024
,12143456,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '18.17', 'le': '0.33', 'lle': '3.65', 'sei': '7.74'}",CHEMBL2177819,,CHEMBL2177819,7.64,False,http://www.openphacts.org/units/Nanomolar,1750617,=,1,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.023
,12145185,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.59', 'le': '0.25', 'lle': '1.76', 'sei': '6.08'}",CHEMBL2177828,,CHEMBL2177828,7.77,False,http://www.openphacts.org/units/Nanomolar,1750626,=,1,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.017
,12145186,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.08', 'le': '0.25', 'lle': '1.93', 'sei': '6.10'}",CHEMBL2177827,,CHEMBL2177827,7.80,False,http://www.openphacts.org/units/Nanomolar,1750625,=,1,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.016
,12145187,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.13', 'le': '0.25', 'lle': '2.20', 'sei': '6.12'}",CHEMBL2177834,,CHEMBL2177834,7.82,False,http://www.openphacts.org/units/Nanomolar,1750632,=,1,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.015
,12145188,[],CHEMBL2186215,Inhibition of Akt 1 in human A2780 cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '13.69', 'le': '0.25', 'lle': '1.81', 'sei': '6.12'}",CHEMBL2177828,,CHEMBL2177828,7.82,False,http://www.openphacts.org/units/Nanomolar,1750626,=,1,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.015
,12145189,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(NC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '19.32', 'le': '0.35', 'lle': '3.53', 'sei': '7.96'}",CHEMBL2177817,,CHEMBL2177817,7.85,False,http://www.openphacts.org/units/Nanomolar,1750615,=,1,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.014
,12145190,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '16.27', 'le': '0.29', 'lle': '3.04', 'sei': '7.25'}",CHEMBL2177831,,CHEMBL2177831,8.10,False,http://www.openphacts.org/units/Nanomolar,1750629,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.008
,12145191,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(-c3cccnc3)cnc2n1-c1ccc(CNC(=O)c2cccc(F)c2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '16.07', 'le': '0.29', 'lle': '3.08', 'sei': '7.42'}",CHEMBL2177833,,CHEMBL2177833,8.28,False,http://www.openphacts.org/units/Nanomolar,1750631,=,1,True,=,,IC50,nM,,5.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.0052
,12145192,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5cccc(F)c5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '14.52', 'le': '0.26', 'lle': '2.54', 'sei': '6.49'}",CHEMBL2177836,,CHEMBL2177836,8.30,False,http://www.openphacts.org/units/Nanomolar,1750634,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.005
,12145230,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177835,,CHEMBL2177835,,False,http://www.openphacts.org/units/Nanomolar,1750633,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12145231,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5ccccc5)cc4)c3n2)c1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177827,,CHEMBL2177827,,False,http://www.openphacts.org/units/Nanomolar,1750625,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12145232,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(C3CCCC3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177826,,CHEMBL2177826,,False,http://www.openphacts.org/units/Nanomolar,1750624,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12145233,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(Br)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177825,,CHEMBL2177825,,False,http://www.openphacts.org/units/Nanomolar,1750623,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12145234,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177819,,CHEMBL2177819,,False,http://www.openphacts.org/units/Nanomolar,1750617,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12145235,[],CHEMBL2186218,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177818,,CHEMBL2177818,,False,http://www.openphacts.org/units/Nanomolar,1750616,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12145236,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177819,,CHEMBL2177819,,False,http://www.openphacts.org/units/Nanomolar,1750617,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12145237,[],CHEMBL2186217,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation PRAS40 at T246 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177818,,CHEMBL2177818,,False,http://www.openphacts.org/units/Nanomolar,1750616,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12145238,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177835,,CHEMBL2177835,,False,http://www.openphacts.org/units/Nanomolar,1750633,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12145239,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(Br)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177825,,CHEMBL2177825,,False,http://www.openphacts.org/units/Nanomolar,1750623,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12145240,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177819,,CHEMBL2177819,,False,http://www.openphacts.org/units/Nanomolar,1750617,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12145241,[],CHEMBL2186216,Inhibition of Akt 1 in human AN3CA cells assessed as phosphorylation of Akt at T308 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177818,,CHEMBL2177818,,False,http://www.openphacts.org/units/Nanomolar,1750616,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12145242,[],CHEMBL2186214,Inhibition of Akt1 in human AN3CA cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177835,,CHEMBL2177835,,False,http://www.openphacts.org/units/Nanomolar,1750633,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12145243,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1cccc(-n2c(-c3cccnc3N)nc3cccnc32)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177846,,CHEMBL2177846,,False,http://www.openphacts.org/units/Nanomolar,1750645,>,1,True,>,,IC50,nM,,300000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,300.0
,12145244,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccc(-n2c(-c3cccnc3N)nc3cc(Br)cnc32)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177845,,CHEMBL2177845,,False,http://www.openphacts.org/units/Nanomolar,1750644,>,1,True,>,,IC50,nM,,300000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,300.0
,12145245,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1Cn1c(-c2ccncc2)nc2cc(Br)cnc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177843,,CHEMBL2177843,,False,http://www.openphacts.org/units/Nanomolar,1750642,>,1,True,>,,IC50,nM,,300000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,300.0
,12145246,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1Cn1c(-c2cccnc2N)nc2cc(Br)cnc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177842,,CHEMBL2177842,,False,http://www.openphacts.org/units/Nanomolar,1750641,>,1,True,>,,IC50,nM,,300000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,300.0
,12145247,[],CHEMBL2186223,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells using biotin-GRPRTSSFAEG as substrate after 20 mins by Alpha-screen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccc(-n2c(-c3ccncc3)nc3cccnc32)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177839,,CHEMBL2177839,,False,http://www.openphacts.org/units/Nanomolar,1750638,>,1,True,>,,IC50,nM,,300000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,300.0
,12145318,[],CHEMBL2183039,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells by indirect affinity mass spectrometry assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '11.54', 'le': '0.21', 'lle': '0.60', 'sei': '4.92'}",CHEMBL2177818,,CHEMBL2177818,4.85,False,http://www.openphacts.org/units/Nanomolar,1750616,=,1,True,=,,IC50,nM,,14000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,14.0
,12145319,[],CHEMBL2183039,Inhibition of Akt1 (1 to 480) expressed in Sf9 cells by indirect affinity mass spectrometry assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(C3CCCC3)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,"{'bei': '10.07', 'le': '0.18', 'lle': '-0.73', 'sei': '4.98'}",CHEMBL2177826,,CHEMBL2177826,4.92,False,http://www.openphacts.org/units/Nanomolar,1750624,=,1,True,=,,IC50,nM,,12000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,12.0
,12145323,[],CHEMBL2186213,Inhibition of Akt1 in human A2780 cells assessed as phosphorylation of Akt at S473 after 2 hrs by Western Blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncccc1-c1nc2cc(Br)cnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1,,,CHEMBL2176970,J. Med. Chem.,2012.0,,CHEMBL2177825,,CHEMBL2177825,,False,http://www.openphacts.org/units/Nanomolar,1750623,<,1,True,<,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.012
,12149897,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNC4CCOCC4)c4ccc(Cl)c(F)c4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '15.29', 'le': '0.30', 'lle': '4.91', 'sei': '8.72'}",CHEMBL2177362,,CHEMBL2177362,7.92,False,http://www.openphacts.org/units/Nanomolar,1750056,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,12149898,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNCC4CC4)c4ccc(C(F)(F)F)c(F)c4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '16.34', 'le': '0.31', 'lle': '4.91', 'sei': '10.45'}",CHEMBL2177361,,CHEMBL2177361,8.52,False,http://www.openphacts.org/units/Nanomolar,1750055,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,12149899,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNC(C)(C)CO)c4ccc(C(F)(F)F)c(F)c4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '15.24', 'le': '0.30', 'lle': '5.25', 'sei': '8.07'}",CHEMBL2178598,,CHEMBL2178598,8.22,False,http://www.openphacts.org/units/Nanomolar,1751529,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,12149900,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNC(C)(C)C)c4ccc(C(F)(F)F)c(F)c4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '16.28', 'le': '0.31', 'lle': '4.52', 'sei': '10.45'}",CHEMBL2178597,,CHEMBL2178597,8.52,False,http://www.openphacts.org/units/Nanomolar,1751528,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,12149901,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)c(F)c1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '17.91', 'le': '0.35', 'lle': '5.28', 'sei': '10.45'}",CHEMBL2177372,,CHEMBL2177372,8.52,False,http://www.openphacts.org/units/Nanomolar,1750066,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,12149902,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CN)c4ccc(C(F)(F)F)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '17.62', 'le': '0.34', 'lle': '5.49', 'sei': '8.29'}",CHEMBL2177371,,CHEMBL2177371,7.92,False,http://www.openphacts.org/units/Nanomolar,1750065,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,12149903,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@@H](c4ccc(Cl)cc4)[C@@H]4COCCN4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '16.78', 'le': '0.33', 'lle': '5.83', 'sei': '8.72'}",CHEMBL2177370,,CHEMBL2177370,7.92,False,http://www.openphacts.org/units/Nanomolar,1750064,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,12149904,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@@H](c4ccc(Cl)cc4)[C@@H]4CCCCN4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '17.12', 'le': '0.33', 'lle': '4.80', 'sei': '9.86'}",CHEMBL2177369,,CHEMBL2177369,8.05,False,http://www.openphacts.org/units/Nanomolar,1750063,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
,12149905,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNCC4CCOCC4)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '16.58', 'le': '0.32', 'lle': '5.40', 'sei': '9.38'}",CHEMBL2177368,,CHEMBL2177368,8.52,False,http://www.openphacts.org/units/Nanomolar,1750062,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,12149906,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,CO[C@H]1CC[C@H](NC[C@@H](C(=O)N2CCN(c3ncnc4c3[C@H](C)C[C@H]4O)CC2)c2ccc(Cl)cc2)CC1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '15.72', 'le': '0.31', 'lle': '4.65', 'sei': '9.14'}",CHEMBL2177367,,CHEMBL2177367,8.30,False,http://www.openphacts.org/units/Nanomolar,1750061,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,12149907,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNC4CCOCC4)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '16.60', 'le': '0.32', 'lle': '5.43', 'sei': '9.14'}",CHEMBL2177366,,CHEMBL2177366,8.30,False,http://www.openphacts.org/units/Nanomolar,1750060,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,12149908,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@@H](c4ccc(Cl)cc4)[C@@H]4CCCN4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '18.69', 'le': '0.36', 'lle': '5.66', 'sei': '10.45'}",CHEMBL2177379,,CHEMBL2177379,8.52,False,http://www.openphacts.org/units/Nanomolar,1750073,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,12149909,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)N(C)C[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '16.41', 'le': '0.32', 'lle': '4.30', 'sei': '10.64'}",CHEMBL2177365,,CHEMBL2177365,7.75,False,http://www.openphacts.org/units/Nanomolar,1750059,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,12149910,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNC4CCCCC4)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '16.15', 'le': '0.31', 'lle': '4.02', 'sei': '9.86'}",CHEMBL2177364,,CHEMBL2177364,8.05,False,http://www.openphacts.org/units/Nanomolar,1750058,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
,12149911,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CN4CCC(F)CC4)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '16.38', 'le': '0.32', 'lle': '4.68', 'sei': '11.29'}",CHEMBL2177363,,CHEMBL2177363,8.22,False,http://www.openphacts.org/units/Nanomolar,1750057,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,12149912,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNC(C)(C)CO)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '17.82', 'le': '0.35', 'lle': '6.24', 'sei': '8.54'}",CHEMBL2177378,,CHEMBL2177378,8.70,False,http://www.openphacts.org/units/Nanomolar,1750072,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,12149913,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,COCCNC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '17.08', 'le': '0.34', 'lle': '5.76', 'sei': '8.92'}",CHEMBL2177377,,CHEMBL2177377,8.10,False,http://www.openphacts.org/units/Nanomolar,1750071,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
,12149914,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNCC(F)(F)F)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '12.14', 'le': '0.24', 'lle': '2.79', 'sei': '7.41'}",CHEMBL2177376,,CHEMBL2177376,6.04,False,http://www.openphacts.org/units/Nanomolar,1750070,=,1,True,=,,IC50,nM,,902.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,902.0
,12150579,[],CHEMBL2188514,Inhibition of human recombinant PKBalpha by radiometric kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1,,,CHEMBL2177100,J. Med. Chem.,2012.0,,CHEMBL2178352,,CHEMBL2178352,,False,http://www.openphacts.org/units/Nanomolar,1751227,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12151660,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNCCF)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '17.15', 'le': '0.34', 'lle': '5.26', 'sei': '9.71'}",CHEMBL2177375,,CHEMBL2177375,7.92,False,http://www.openphacts.org/units/Nanomolar,1750069,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,12151661,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNCC4CC4)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '17.66', 'le': '0.34', 'lle': '5.20', 'sei': '10.17'}",CHEMBL2177374,,CHEMBL2177374,8.30,False,http://www.openphacts.org/units/Nanomolar,1750068,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,12151662,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CN)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '18.32', 'le': '0.36', 'lle': '5.56', 'sei': '7.97'}",CHEMBL2177373,,CHEMBL2177373,7.62,False,http://www.openphacts.org/units/Nanomolar,1750067,=,1,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
,12151663,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNC4CCOCC4)c4ccc(Cl)c(F)c4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.24', 'le': '0.26', 'lle': '3.85', 'sei': '7.55'}",CHEMBL2177362,,CHEMBL2177362,6.86,False,http://www.openphacts.org/units/Nanomolar,1750056,=,1,True,=,,IC50,nM,,139.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,139.0
,12151664,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNCC4CC4)c4ccc(C(F)(F)F)c(F)c4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.78', 'le': '0.27', 'lle': '3.58', 'sei': '8.81'}",CHEMBL2177361,,CHEMBL2177361,7.19,False,http://www.openphacts.org/units/Nanomolar,1750055,=,1,True,=,,IC50,nM,,65.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,65.0
,12151665,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNC(C)(C)CO)c4ccc(C(F)(F)F)c(F)c4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.58', 'le': '0.26', 'lle': '4.36', 'sei': '7.20'}",CHEMBL2178598,,CHEMBL2178598,7.33,False,http://www.openphacts.org/units/Nanomolar,1751529,=,1,True,=,,IC50,nM,,47.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,47.0
,12151666,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNC(C)(C)C)c4ccc(C(F)(F)F)c(F)c4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.44', 'le': '0.26', 'lle': '3.04', 'sei': '8.62'}",CHEMBL2178597,,CHEMBL2178597,7.04,False,http://www.openphacts.org/units/Nanomolar,1751528,=,1,True,=,,IC50,nM,,92.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,92.0
,12151667,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)c(F)c1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.93', 'le': '0.27', 'lle': '3.39', 'sei': '8.13'}",CHEMBL2177372,,CHEMBL2177372,6.63,False,http://www.openphacts.org/units/Nanomolar,1750066,=,1,True,=,,IC50,nM,,234.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,234.0
,12151668,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CN)c4ccc(C(F)(F)F)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.84', 'le': '0.27', 'lle': '3.79', 'sei': '6.51'}",CHEMBL2177371,,CHEMBL2177371,6.22,False,http://www.openphacts.org/units/Nanomolar,1750065,=,1,True,=,,IC50,nM,,603.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,603.0
,12151669,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@@H](c4ccc(Cl)cc4)[C@@H]4COCCN4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '12.86', 'le': '0.25', 'lle': '3.98', 'sei': '6.68'}",CHEMBL2177370,,CHEMBL2177370,6.07,False,http://www.openphacts.org/units/Nanomolar,1750064,=,1,True,=,,IC50,nM,,855.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,855.0
,12151670,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@@H](c4ccc(Cl)cc4)[C@@H]4CCCCN4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.35', 'le': '0.26', 'lle': '3.03', 'sei': '7.69'}",CHEMBL2177369,,CHEMBL2177369,6.28,False,http://www.openphacts.org/units/Nanomolar,1750063,=,1,True,=,,IC50,nM,,530.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,530.0
,12151671,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNCC4CCOCC4)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.60', 'le': '0.27', 'lle': '3.87', 'sei': '7.70'}",CHEMBL2177368,,CHEMBL2177368,6.99,False,http://www.openphacts.org/units/Nanomolar,1750062,=,1,True,=,,IC50,nM,,102.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,102.0
,12151672,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CO[C@H]1CC[C@H](NC[C@@H](C(=O)N2CCN(c3ncnc4c3[C@H](C)C[C@H]4O)CC2)c2ccc(Cl)cc2)CC1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.03', 'le': '0.25', 'lle': '3.23', 'sei': '7.57'}",CHEMBL2177367,,CHEMBL2177367,6.88,False,http://www.openphacts.org/units/Nanomolar,1750061,=,1,True,=,,IC50,nM,,132.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,132.0
,12151673,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNC4CCOCC4)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.47', 'le': '0.26', 'lle': '3.87', 'sei': '7.42'}",CHEMBL2177366,,CHEMBL2177366,6.74,False,http://www.openphacts.org/units/Nanomolar,1750060,=,1,True,=,,IC50,nM,,184.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,184.0
,12151674,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@@H](c4ccc(Cl)cc4)[C@@H]4CCCN4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '14.51', 'le': '0.28', 'lle': '3.76', 'sei': '8.11'}",CHEMBL2177379,,CHEMBL2177379,6.62,False,http://www.openphacts.org/units/Nanomolar,1750073,=,1,True,=,,IC50,nM,,241.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,241.0
,12151675,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)N(C)C[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '14.53', 'le': '0.28', 'lle': '3.42', 'sei': '9.42'}",CHEMBL2177365,,CHEMBL2177365,6.86,False,http://www.openphacts.org/units/Nanomolar,1750059,=,1,True,=,,IC50,nM,,139.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,139.0
,12151676,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNC4CCCCC4)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '12.92', 'le': '0.25', 'lle': '2.41', 'sei': '7.89'}",CHEMBL2177364,,CHEMBL2177364,6.43,False,http://www.openphacts.org/units/Nanomolar,1750058,=,1,True,=,,IC50,nM,,367.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,367.0
,12151677,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CN4CCC(F)CC4)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.36', 'le': '0.26', 'lle': '3.17', 'sei': '9.21'}",CHEMBL2177363,,CHEMBL2177363,6.71,False,http://www.openphacts.org/units/Nanomolar,1750057,=,1,True,=,,IC50,nM,,196.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,196.0
,12151678,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNC(C)(C)CO)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '14.60', 'le': '0.29', 'lle': '4.66', 'sei': '7.00'}",CHEMBL2177378,,CHEMBL2177378,7.12,False,http://www.openphacts.org/units/Nanomolar,1750072,=,1,True,=,,IC50,nM,,75.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,75.0
,12151679,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,COCCNC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.53', 'le': '0.27', 'lle': '4.08', 'sei': '7.06'}",CHEMBL2177377,,CHEMBL2177377,6.42,False,http://www.openphacts.org/units/Nanomolar,1750071,=,1,True,=,,IC50,nM,,384.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,384.0
Not Determined,12151680,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNCC(F)(F)F)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,,CHEMBL2177376,,CHEMBL2177376,,False,,1750070,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,12151681,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNCCF)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '12.74', 'le': '0.25', 'lle': '3.23', 'sei': '7.22'}",CHEMBL2177375,,CHEMBL2177375,5.89,False,http://www.openphacts.org/units/Nanomolar,1750069,=,1,True,=,,IC50,nM,,1296.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1296.0
,12151682,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CNCC4CC4)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '14.36', 'le': '0.28', 'lle': '3.65', 'sei': '8.27'}",CHEMBL2177374,,CHEMBL2177374,6.75,False,http://www.openphacts.org/units/Nanomolar,1750068,=,1,True,=,,IC50,nM,,179.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,179.0
,12151683,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@@H](O)c2ncnc(N3CCN(C(=O)[C@H](CN)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '14.03', 'le': '0.27', 'lle': '3.78', 'sei': '6.11'}",CHEMBL2177373,,CHEMBL2177373,5.84,False,http://www.openphacts.org/units/Nanomolar,1750067,=,1,True,=,,IC50,nM,,1454.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1454.0
,12151736,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)CC3(F)F)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '12.41', 'le': '0.25', 'lle': '1.77', 'sei': '9.67'}",CHEMBL2177383,,CHEMBL2177383,5.93,False,http://www.openphacts.org/units/Nanomolar,1750077,=,1,True,=,,IC50,nM,,1169.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1169.0
,12151737,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@@H]3F)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '17.22', 'le': '0.34', 'lle': '3.84', 'sei': '12.91'}",CHEMBL2177382,,CHEMBL2177382,7.92,False,http://www.openphacts.org/units/Nanomolar,1750076,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,12151738,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3F)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '18.26', 'le': '0.36', 'lle': '4.32', 'sei': '13.69'}",CHEMBL2177381,,CHEMBL2177381,8.40,False,http://www.openphacts.org/units/Nanomolar,1750075,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,12151739,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@@H]3O)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '15.65', 'le': '0.31', 'lle': '4.07', 'sei': '8.78'}",CHEMBL2177380,,CHEMBL2177380,7.17,False,http://www.openphacts.org/units/Nanomolar,1750074,=,1,True,=,,IC50,nM,,68.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,68.0
,12151740,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '18.12', 'le': '0.35', 'lle': '5.20', 'sei': '10.17'}",CHEMBL2177390,IPATASERTIB,CHEMBL2177390,8.30,False,http://www.openphacts.org/units/Nanomolar,1750085,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,12151741,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](CO)CC3)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '15.48', 'le': '0.30', 'lle': '4.51', 'sei': '8.69'}",CHEMBL2177389,,CHEMBL2177389,7.09,False,http://www.openphacts.org/units/Nanomolar,1750084,=,1,True,=,,IC50,nM,,81.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,81.0
,12151742,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](CF)CC3)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '18.53', 'le': '0.36', 'lle': '4.96', 'sei': '13.89'}",CHEMBL2177388,,CHEMBL2177388,8.52,False,http://www.openphacts.org/units/Nanomolar,1750083,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,12151743,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,C=C[C@@H]1CCc2ncnc(N3CCN(C(=O)[C@H](CNC(C)C)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '19.16', 'le': '0.37', 'lle': '4.92', 'sei': '14.18'}",CHEMBL2177387,,CHEMBL2177387,8.70,False,http://www.openphacts.org/units/Nanomolar,1750082,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,12151744,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2C(C)(C)CC3)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,,CHEMBL2177386,,CHEMBL2177386,,False,http://www.openphacts.org/units/Nanomolar,1750081,>,1,True,>,,IC50,nM,,2000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2000.0
,12151745,[],CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)CC3)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '18.60', 'le': '0.36', 'lle': '4.61', 'sei': '13.40'}",CHEMBL2177385,,CHEMBL2177385,8.22,False,http://www.openphacts.org/units/Nanomolar,1750080,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,12151785,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)CC3(F)F)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '10.60', 'le': '0.21', 'lle': '0.91', 'sei': '8.26'}",CHEMBL2177383,,CHEMBL2177383,5.07,False,http://www.openphacts.org/units/Nanomolar,1750077,=,1,True,=,,IC50,nM,,8548.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8548.0
,12151786,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@@H]3F)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.14', 'le': '0.26', 'lle': '1.97', 'sei': '9.85'}",CHEMBL2177382,,CHEMBL2177382,6.04,False,http://www.openphacts.org/units/Nanomolar,1750076,=,1,True,=,,IC50,nM,,901.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,901.0
,12151787,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3F)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '14.82', 'le': '0.29', 'lle': '2.74', 'sei': '11.11'}",CHEMBL2177381,,CHEMBL2177381,6.82,False,http://www.openphacts.org/units/Nanomolar,1750075,=,1,True,=,,IC50,nM,,152.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,152.0
,12151788,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@@H]3O)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.39', 'le': '0.26', 'lle': '3.03', 'sei': '7.51'}",CHEMBL2177380,,CHEMBL2177380,6.13,False,http://www.openphacts.org/units/Nanomolar,1750074,=,1,True,=,,IC50,nM,,740.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,740.0
,12151789,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '14.86', 'le': '0.29', 'lle': '3.70', 'sei': '8.34'}",CHEMBL2177390,IPATASERTIB,CHEMBL2177390,6.80,False,http://www.openphacts.org/units/Nanomolar,1750085,=,1,True,=,,IC50,nM,,157.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,157.0
,12151790,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](CO)CC3)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '13.26', 'le': '0.26', 'lle': '3.49', 'sei': '7.44'}",CHEMBL2177389,,CHEMBL2177389,6.07,False,http://www.openphacts.org/units/Nanomolar,1750084,=,1,True,=,,IC50,nM,,846.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,846.0
,12151791,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](CF)CC3)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '15.02', 'le': '0.29', 'lle': '3.35', 'sei': '11.26'}",CHEMBL2177388,,CHEMBL2177388,6.91,False,http://www.openphacts.org/units/Nanomolar,1750083,=,1,True,=,,IC50,nM,,123.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,123.0
,12151792,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,C=C[C@@H]1CCc2ncnc(N3CCN(C(=O)[C@H](CNC(C)C)c4ccc(Cl)cc4)CC3)c21,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '14.88', 'le': '0.29', 'lle': '2.97', 'sei': '11.01'}",CHEMBL2177387,,CHEMBL2177387,6.75,False,http://www.openphacts.org/units/Nanomolar,1750082,=,1,True,=,,IC50,nM,,176.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,176.0
Not Determined,12151793,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2C(C)(C)CC3)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,,CHEMBL2177386,,CHEMBL2177386,,False,,1750081,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,12151794,[],CHEMBL2188026,Inhibition of Akt1 in human LNCAP cells assessed as phosphorylation of PRAS40 at Thr246 after 1.5 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)CC3)CC1)c1ccc(Cl)cc1,,,CHEMBL2177010,J. Med. Chem.,2012.0,"{'bei': '14.80', 'le': '0.29', 'lle': '2.93', 'sei': '10.66'}",CHEMBL2177385,,CHEMBL2177385,6.54,False,http://www.openphacts.org/units/Nanomolar,1750080,=,1,True,=,,IC50,nM,,287.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,287.0
,12205213,[],CHEMBL2217254,Inhibition of human AKT1 using biotinylated GSKalpha peptide (SGRARTSSFA) as a substrate after 1 hr,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(O)cccc1C2=O,,,CHEMBL2216750,J. Med. Chem.,2012.0,"{'bei': '19.81', 'le': '0.37', 'lle': '4.55', 'sei': '7.24'}",CHEMBL474390,FRENOLICIN B,CHEMBL474390,6.50,False,http://www.openphacts.org/units/Nanomolar,1762537,=,1,True,=,,IC50,nM,,313.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,313.0
,12205214,[],CHEMBL2217254,Inhibition of human AKT1 using biotinylated GSKalpha peptide (SGRARTSSFA) as a substrate after 1 hr,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O,,,CHEMBL2216750,J. Med. Chem.,2012.0,"{'bei': '14.92', 'le': '0.28', 'lle': '5.52', 'sei': '5.57'}",CHEMBL2216825,LACTOQUINOMYCIN,CHEMBL2216825,6.83,True,http://www.openphacts.org/units/Nanomolar,1762538,=,1,True,=,,IC50,nM,,149.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,149.0
,12629565,[],CHEMBL2319139,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1,,,CHEMBL2311468,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2312304,,CHEMBL2312304,,False,http://www.openphacts.org/units/Nanomolar,1841874,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,12629566,[],CHEMBL2319139,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1,,,CHEMBL2311468,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2312303,,CHEMBL2312303,,False,http://www.openphacts.org/units/Nanomolar,1841873,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,12629567,[],CHEMBL2319139,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1,,,CHEMBL2311468,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2312301,,CHEMBL2312301,,False,http://www.openphacts.org/units/Nanomolar,1841871,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,12629568,[],CHEMBL2319139,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CCNc2ncc(C(=O)NCCCN3CCCC3=O)c(NC3CCCC3)n2)cc1OC,,,CHEMBL2311468,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2312290,,CHEMBL2312290,,False,http://www.openphacts.org/units/Nanomolar,1841860,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,12631757,[],CHEMBL2317787,Inhibition of AKT1 (unknown origin) in presence of ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)on1,,,CHEMBL2311250,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '11.94', 'le': '0.24', 'lle': '-0.27', 'sei': '6.96'}",CHEMBL2312654,,CHEMBL2312654,5.51,False,http://www.openphacts.org/units/Nanomolar,1842315,=,1,True,=,,IC50,nM,,3100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.1
,12631758,[],CHEMBL2317787,Inhibition of AKT1 (unknown origin) in presence of ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]2COC[C@H]2O)CC1,,,CHEMBL2311250,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '9.40', 'le': '0.19', 'lle': '2.00', 'sei': '4.05'}",CHEMBL2312652,,CHEMBL2312652,4.52,False,http://www.openphacts.org/units/Nanomolar,1842313,=,1,True,=,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,12631759,[],CHEMBL2317787,Inhibition of AKT1 (unknown origin) in presence of ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)CC1,,,CHEMBL2311250,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '8.69', 'le': '0.18', 'lle': '-0.12', 'sei': '5.29'}",CHEMBL2312649,,CHEMBL2312649,4.52,False,http://www.openphacts.org/units/Nanomolar,1842309,=,1,True,=,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,12631760,[],CHEMBL2317787,Inhibition of AKT1 (unknown origin) in presence of ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC2CCCC2)CC1,,,CHEMBL2311250,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '9.91', 'le': '0.20', 'lle': '0.16', 'sei': '5.76'}",CHEMBL2312646,,CHEMBL2312646,4.73,False,http://www.openphacts.org/units/Nanomolar,1842306,=,1,True,=,,IC50,nM,,18580.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,18.58
,12631761,[],CHEMBL2317787,Inhibition of AKT1 (unknown origin) in presence of ATP,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1CNc1ncc(C(=O)NC2CCN(C)CC2)c(NC2CCCC2)n1,,,CHEMBL2311250,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '10.31', 'le': '0.19', 'lle': '1.24', 'sei': '4.95'}",CHEMBL2312645,,CHEMBL2312645,4.52,False,http://www.openphacts.org/units/Nanomolar,1842305,=,1,True,=,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,12656675,[],CHEMBL2328964,Inhibition of IGF-1 induced Akt phosphorylation in PTEN-deficient human MDA-MB-468 cells pretreated for 2 hrs before IGF1 induction measured after 15 mins by Western blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1,,,CHEMBL2321664,ACS Med. Chem. Lett.,2013.0,,CHEMBL2322664,,CHEMBL2322664,,False,http://www.openphacts.org/units/Nanomolar,1848472,<,1,True,<,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,12662154,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '19.87', 'le': '0.39', 'lle': '6.37', 'sei': '7.09'}",CHEMBL2325741,CAPIVASERTIB,CHEMBL2325741,8.52,False,http://www.openphacts.org/units/Nanomolar,1852090,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,12662155,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COCCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '18.06', 'le': '0.35', 'lle': '5.20', 'sei': '7.33'}",CHEMBL2325740,,CHEMBL2325740,8.00,False,http://www.openphacts.org/units/Nanomolar,1852089,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,12662156,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)NC(CCCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '18.56', 'le': '0.36', 'lle': '5.68', 'sei': '6.84'}",CHEMBL2325739,,CHEMBL2325739,8.22,False,http://www.openphacts.org/units/Nanomolar,1852088,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,12662157,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)NC(CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '19.58', 'le': '0.38', 'lle': '6.25', 'sei': '6.99'}",CHEMBL2325738,,CHEMBL2325738,8.40,False,http://www.openphacts.org/units/Nanomolar,1852087,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,12662158,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)NC(CO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '19.66', 'le': '0.38', 'lle': '6.39', 'sei': '6.79'}",CHEMBL2325737,,CHEMBL2325737,8.15,False,http://www.openphacts.org/units/Nanomolar,1852086,=,1,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
,12662159,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)NCCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '16.12', 'le': '0.33', 'lle': '6.44', 'sei': '5.58'}",CHEMBL2325736,,CHEMBL2325736,8.15,False,http://www.openphacts.org/units/Nanomolar,1852085,=,1,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
,12662160,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)NCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '15.84', 'le': '0.32', 'lle': '6.48', 'sei': '5.34'}",CHEMBL2325735,,CHEMBL2325735,7.80,False,http://www.openphacts.org/units/Nanomolar,1852084,=,1,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
,12662161,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)NC(CCS(N)(=O)=O)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '16.71', 'le': '0.34', 'lle': '6.77', 'sei': '5.14'}",CHEMBL2325734,,CHEMBL2325734,8.22,False,http://www.openphacts.org/units/Nanomolar,1852083,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
,12662162,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)NC(CS(N)(=O)=O)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '16.57', 'le': '0.34', 'lle': '6.87', 'sei': '4.95'}",CHEMBL2325733,,CHEMBL2325733,7.92,False,http://www.openphacts.org/units/Nanomolar,1852082,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,12662163,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '16.47', 'le': '0.32', 'lle': '5.61', 'sei': '5.82'}",CHEMBL2325732,,CHEMBL2325732,7.51,False,http://www.openphacts.org/units/Nanomolar,1852081,=,1,True,=,,IC50,nM,,31.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31.0
,12662164,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '15.70', 'le': '0.31', 'lle': '5.14', 'sei': '6.14'}",CHEMBL2325731,,CHEMBL2325731,7.38,False,http://www.openphacts.org/units/Nanomolar,1852080,=,1,True,=,,IC50,nM,,42.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.0
,12662165,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)C(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '17.58', 'le': '0.34', 'lle': '6.27', 'sei': '5.26'}",CHEMBL2325730,,CHEMBL2325730,7.52,False,http://www.openphacts.org/units/Nanomolar,1852079,=,1,True,=,,IC50,nM,,30.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30.0
,12662166,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)N[C@@H](CCN2CCCCC2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '16.93', 'le': '0.33', 'lle': '4.76', 'sei': '8.14'}",CHEMBL2325729,,CHEMBL2325729,8.40,False,http://www.openphacts.org/units/Nanomolar,1852078,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,12662167,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)N[C@@H](CCN2CCCC2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '17.42', 'le': '0.34', 'lle': '5.15', 'sei': '8.14'}",CHEMBL2325728,,CHEMBL2325728,8.40,False,http://www.openphacts.org/units/Nanomolar,1852077,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,12662168,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC[C@H](NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '18.69', 'le': '0.36', 'lle': '5.80', 'sei': '8.26'}",CHEMBL2325727,,CHEMBL2325727,8.52,False,http://www.openphacts.org/units/Nanomolar,1852076,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,12662169,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)NC(CCCN2CCCCC2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '16.27', 'le': '0.31', 'lle': '4.27', 'sei': '8.05'}",CHEMBL2325996,,CHEMBL2325996,8.30,False,http://www.openphacts.org/units/Nanomolar,1852399,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,12662170,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)NC(CCCN2CCOCC2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '16.21', 'le': '0.31', 'lle': '5.42', 'sei': '7.39'}",CHEMBL2325995,,CHEMBL2325995,8.30,False,http://www.openphacts.org/units/Nanomolar,1852398,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,12662171,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)NC(CCCN2CCCC2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '16.93', 'le': '0.33', 'lle': '4.76', 'sei': '8.14'}",CHEMBL2325994,,CHEMBL2325994,8.40,False,http://www.openphacts.org/units/Nanomolar,1852397,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,12662172,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '18.13', 'le': '0.35', 'lle': '5.41', 'sei': '8.26'}",CHEMBL2325993,,CHEMBL2325993,8.52,False,http://www.openphacts.org/units/Nanomolar,1852396,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,12662173,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '19.08', 'le': '0.37', 'lle': '5.98', 'sei': '8.43'}",CHEMBL2325992,,CHEMBL2325992,8.70,False,http://www.openphacts.org/units/Nanomolar,1852395,=,1,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
,12662174,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(C)NC(=O)C2(N)CCN(c3ncnc4[nH]ccc34)CC2)cc1OC,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '13.95', 'le': '0.26', 'lle': '3.77', 'sei': '5.00'}",CHEMBL2325991,,CHEMBL2325991,5.92,False,http://www.openphacts.org/units/Nanomolar,1852394,=,1,True,=,,IC50,nM,,1192.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1192.0
,12662175,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(S(C)(=O)=O)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '15.22', 'le': '0.30', 'lle': '5.20', 'sei': '5.03'}",CHEMBL2325990,,CHEMBL2325990,6.74,False,http://www.openphacts.org/units/Nanomolar,1852393,=,1,True,=,,IC50,nM,,183.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,183.0
,12662176,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccccn1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '15.22', 'le': '0.28', 'lle': '4.03', 'sei': '4.93'}",CHEMBL2325989,,CHEMBL2325989,5.56,False,http://www.openphacts.org/units/Nanomolar,1852392,=,1,True,=,,IC50,nM,,2753.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2753.0
,12662177,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1cccnc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '16.09', 'le': '0.30', 'lle': '4.35', 'sei': '5.21'}",CHEMBL2325988,,CHEMBL2325988,5.88,False,http://www.openphacts.org/units/Nanomolar,1852391,=,1,True,=,,IC50,nM,,1313.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1313.0
,12662178,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(F)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '21.04', 'le': '0.39', 'lle': '5.78', 'sei': '8.05'}",CHEMBL2325987,,CHEMBL2325987,8.05,False,http://www.openphacts.org/units/Nanomolar,1852390,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
,12662179,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccccc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '18.73', 'le': '0.35', 'lle': '4.70', 'sei': '6.83'}",CHEMBL2325986,,CHEMBL2325986,6.83,False,http://www.openphacts.org/units/Nanomolar,1852389,=,1,True,=,,IC50,nM,,149.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,149.0
,12662180,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)NC(Cc2ccccc2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '15.81', 'le': '0.30', 'lle': '3.50', 'sei': '7.51'}",CHEMBL2325985,,CHEMBL2325985,7.51,False,http://www.openphacts.org/units/Nanomolar,1852388,=,1,True,=,,IC50,nM,,31.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31.0
,12662181,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)NC(c2ccccc2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '16.03', 'le': '0.31', 'lle': '3.58', 'sei': '7.39'}",CHEMBL2325984,,CHEMBL2325984,7.39,False,http://www.openphacts.org/units/Nanomolar,1852387,=,1,True,=,,IC50,nM,,41.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,41.0
,12662182,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)NC(c2ccc(Cl)cc2)C2CC2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '19.53', 'le': '0.38', 'lle': '5.12', 'sei': '8.31'}",CHEMBL2325983,,CHEMBL2325983,8.30,False,http://www.openphacts.org/units/Nanomolar,1852386,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
,12662183,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '19.75', 'le': '0.38', 'lle': '4.97', 'sei': '8.16'}",CHEMBL2325982,,CHEMBL2325982,8.15,False,http://www.openphacts.org/units/Nanomolar,1852385,=,1,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
,12662184,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '20.30', 'le': '0.39', 'lle': '5.31', 'sei': '8.10'}",CHEMBL2325997,,CHEMBL2325997,8.10,False,http://www.openphacts.org/units/Nanomolar,1852401,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
,12662185,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '16.44', 'le': '0.32', 'lle': '3.77', 'sei': '6.56'}",CHEMBL2325742,,CHEMBL2325742,6.56,False,http://www.openphacts.org/units/Nanomolar,1852091,=,1,True,=,,IC50,nM,,276.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,276.0
,12662186,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '20.49', 'le': '0.40', 'lle': '5.66', 'sei': '7.89'}",CHEMBL598194,,CHEMBL598194,7.89,False,http://www.openphacts.org/units/Nanomolar,1852400,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
,12662187,[],CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)C1(N)CCN(c2ncnc3[nH]ccc23)CC1)c1ccc(Cl)cc1,,,CHEMBL2321772,J. Med. Chem.,2013.0,"{'bei': '21.05', 'le': '0.41', 'lle': '5.61', 'sei': '8.40'}",CHEMBL2325743,,CHEMBL2325743,8.40,False,http://www.openphacts.org/units/Nanomolar,1852092,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,12671317,[],CHEMBL2344170,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(-c2cc(C/C(=N/O)C(=O)NCCc3ccc(O)c(Br)c3)cc(Br)c2O)c1)=N\O,,,CHEMBL2331160,J. Nat. Prod.,2013.0,"{'bei': '6.07', 'le': '0.16', 'lle': '-0.97', 'sei': '2.80'}",CHEMBL505637,BASTADIN 3,CHEMBL505637,5.72,False,http://www.openphacts.org/units/Nanomolar,1867104,=,1,True,=,,IC50,nM,,1900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.9
,12693298,[],CHEMBL2341972,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F,,,CHEMBL2331117,J. Med. Chem.,2013.0,,CHEMBL2333365,,CHEMBL2333365,,False,http://www.openphacts.org/units/Nanomolar,1867358,>,1,True,>,,IC50,nM,,3500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3500.0
,12700061,[],CHEMBL2344124,Inhibition of recombinant AKT1 (unknown origin) by FRET-based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C/C(=C\c2ccccn2)C(=O)[C@@H](Cc2ccccn2)C1,,,CHEMBL2331439,J. Med. Chem.,2013.0,,CHEMBL2338335,,CHEMBL2338335,,False,http://www.openphacts.org/units/Nanomolar,1873723,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,12700073,[],CHEMBL2344124,Inhibition of recombinant AKT1 (unknown origin) by FRET-based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C/C(=C\c2ccccn2)C(=O)[C@H](Cc2ccccn2)C1,,,CHEMBL2331439,J. Med. Chem.,2013.0,,CHEMBL2338334,,CHEMBL2338334,,False,http://www.openphacts.org/units/Nanomolar,1873722,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,12700085,[],CHEMBL2344124,Inhibition of recombinant AKT1 (unknown origin) by FRET-based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1/C(=C/c2ccccn2)CSC/C1=C\c1ccccn1,,,CHEMBL2331439,J. Med. Chem.,2013.0,"{'bei': '18.49', 'le': '0.35', 'lle': '2.18', 'sei': '12.70'}",CHEMBL2036343,,CHEMBL2036343,5.44,False,http://www.openphacts.org/units/Nanomolar,1873724,=,1,True,=,,IC50,nM,,3600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.6
,12700097,[],CHEMBL2344124,Inhibition of recombinant AKT1 (unknown origin) by FRET-based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C/C(=C\c2ccccn2)C(=O)/C(=C/c2ccccn2)C1,,,CHEMBL2331439,J. Med. Chem.,2013.0,"{'bei': '19.17', 'le': '0.35', 'lle': '3.13', 'sei': '12.12'}",CHEMBL2338333,,CHEMBL2338333,5.58,False,http://www.openphacts.org/units/Nanomolar,1873721,=,1,True,=,,IC50,nM,,2600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.6
,12700110,[],CHEMBL2344124,Inhibition of recombinant AKT1 (unknown origin) by FRET-based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1,,,CHEMBL2331439,J. Med. Chem.,2013.0,"{'bei': '27.76', 'le': '0.50', 'lle': '5.58', 'sei': '14.03'}",CHEMBL574646,,CHEMBL574646,7.70,False,http://www.openphacts.org/units/Nanomolar,1873720,=,1,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.02
,12700172,[],CHEMBL2344124,Inhibition of recombinant AKT1 (unknown origin) by FRET-based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1/C(=C/c2ccccc2F)CNC/C1=C\c1ccccc1F,,,CHEMBL2331439,J. Med. Chem.,2013.0,"{'bei': '19.62', 'le': '0.36', 'lle': '2.51', 'sei': '20.99'}",CHEMBL379849,,CHEMBL379849,6.11,False,http://www.openphacts.org/units/Nanomolar,1873719,=,1,True,=,,IC50,nM,,780.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.78
,12705261,[],CHEMBL2345797,Inhibition of Akt1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1c2ccc(NCc3ccc(C(C)(C)C)cc3)cc2-c2c(cnn2C)S1(=O)=O,,,CHEMBL2331389,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2333444,,CHEMBL2333444,,False,http://www.openphacts.org/units/Nanomolar,1867447,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12705262,[],CHEMBL2345797,Inhibition of Akt1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2ccc3c(c2)-c2c(cnn2C)S(=O)(=O)N3C)cc1,,,CHEMBL2331389,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2333435,,CHEMBL2333435,,False,http://www.openphacts.org/units/Nanomolar,1867438,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12705263,[],CHEMBL2345797,Inhibition of Akt1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1,,,CHEMBL2331389,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2333445,,CHEMBL2333445,,False,http://www.openphacts.org/units/Nanomolar,1867448,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,12713906,[],CHEMBL2349705,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,,,CHEMBL2346609,Bioorg. Med. Chem.,2013.0,"{'bei': '10.42', 'le': '0.21', 'lle': '-1.03', 'sei': '7.08'}",CHEMBL28509,EDELFOSINE,CHEMBL28509,5.46,False,http://www.openphacts.org/units/Nanomolar,1877221,=,1,True,=,,IC50,nM,,3500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.5
,12713907,[],CHEMBL2349705,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1,,,CHEMBL2346609,Bioorg. Med. Chem.,2013.0,"{'bei': '11.43', 'le': '0.23', 'lle': '-1.71', 'sei': '9.00'}",CHEMBL372764,PERIFOSINE,CHEMBL372764,5.28,False,http://www.openphacts.org/units/Nanomolar,1877220,=,1,True,=,,IC50,nM,,5300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.3
,12713908,[],CHEMBL2349705,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,,,CHEMBL2346609,Bioorg. Med. Chem.,2013.0,"{'bei': '12.31', 'le': '0.25', 'lle': '-0.66', 'sei': '8.56'}",CHEMBL125,MILTEFOSINE,CHEMBL125,5.02,False,http://www.openphacts.org/units/Nanomolar,1877219,=,1,True,=,,IC50,nM,,9600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,9.6
,12713909,[],CHEMBL2349705,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCCCCCCCCCCC[C@@]1(C(=O)OCC)CCC[C@@H]1OP(=O)([O-])OCC[N+](C)(C)C,,,CHEMBL2346609,Bioorg. Med. Chem.,2013.0,"{'bei': '7.47', 'le': '0.15', 'lle': '-4.79', 'sei': '5.56'}",CHEMBL2349083,,CHEMBL2349083,4.72,False,http://www.openphacts.org/units/Nanomolar,1877218,=,1,True,=,,IC50,nM,,19100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,19.1
,12713910,[],CHEMBL2349705,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCCCCCCCCC[C@@]1(C(=O)OCC)CCC[C@@H]1OP(=O)([O-])OCC[N+](C)(C)C,,,CHEMBL2346609,Bioorg. Med. Chem.,2013.0,"{'bei': '8.55', 'le': '0.17', 'lle': '-3.57', 'sei': '6.08'}",CHEMBL2349082,,CHEMBL2349082,5.16,False,http://www.openphacts.org/units/Nanomolar,1877217,=,1,True,=,,IC50,nM,,6900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,6.9
,12713911,[],CHEMBL2349705,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCCCCCCC[C@@]1(C(=O)OCC)CCC[C@@H]1OP(=O)([O-])OCC[N+](C)(C)C,,,CHEMBL2346609,Bioorg. Med. Chem.,2013.0,"{'bei': '9.59', 'le': '0.19', 'lle': '-2.43', 'sei': '6.51'}",CHEMBL2349081,,CHEMBL2349081,5.52,False,http://www.openphacts.org/units/Nanomolar,1877216,=,1,True,=,,IC50,nM,,3000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.0
,12713912,[],CHEMBL2349705,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCCCCC[C@@]1(C(=O)OCC)CCC[C@@H]1OP(=O)([O-])OCC[N+](C)(C)C,,,CHEMBL2346609,Bioorg. Med. Chem.,2013.0,"{'bei': '9.68', 'le': '0.20', 'lle': '-1.87', 'sei': '6.24'}",CHEMBL2349080,,CHEMBL2349080,5.30,False,http://www.openphacts.org/units/Nanomolar,1877215,=,1,True,=,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.0
,12713913,[],CHEMBL2349705,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCC[C@@]1(C(=O)OCC)CCC[C@@H]1OP(=O)([O-])OCC[N+](C)(C)C,,,CHEMBL2346609,Bioorg. Med. Chem.,2013.0,"{'bei': '10.30', 'le': '0.21', 'lle': '-0.79', 'sei': '6.13'}",CHEMBL2349079,,CHEMBL2349079,5.21,False,http://www.openphacts.org/units/Nanomolar,1877214,=,1,True,=,,IC50,nM,,6200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,6.2
,12713914,[],CHEMBL2349705,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCCCCCCCCCCC[C@@]1(C(=O)OCC)CCC[C@H]1OP(=O)([O-])OCC[N+](C)(C)C,,,CHEMBL2346609,Bioorg. Med. Chem.,2013.0,"{'bei': '8.32', 'le': '0.17', 'lle': '-4.25', 'sei': '6.20'}",CHEMBL2349078,,CHEMBL2349078,5.26,False,http://www.openphacts.org/units/Nanomolar,1877213,=,1,True,=,,IC50,nM,,5500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.5
,12713915,[],CHEMBL2349705,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCCCCCCCCC[C@@]1(C(=O)OCC)CCC[C@H]1OP(=O)([O-])OCC[N+](C)(C)C,,,CHEMBL2346609,Bioorg. Med. Chem.,2013.0,"{'bei': '8.54', 'le': '0.17', 'lle': '-3.58', 'sei': '6.07'}",CHEMBL2349077,,CHEMBL2349077,5.16,False,http://www.openphacts.org/units/Nanomolar,1877212,=,1,True,=,,IC50,nM,,7000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,7.0
,12713916,[],CHEMBL2349705,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCCCCCCC[C@@]1(C(=O)OCC)CCC[C@H]1OP(=O)([O-])OCC[N+](C)(C)C,,,CHEMBL2346609,Bioorg. Med. Chem.,2013.0,"{'bei': '8.62', 'le': '0.17', 'lle': '-2.99', 'sei': '5.85'}",CHEMBL2349076,,CHEMBL2349076,4.96,False,http://www.openphacts.org/units/Nanomolar,1877211,=,1,True,=,,IC50,nM,,10900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.9
,12713917,[],CHEMBL2349705,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCCCCC[C@@]1(C(=O)OCC)CCC[C@H]1OP(=O)([O-])OCC[N+](C)(C)C,,,CHEMBL2346609,Bioorg. Med. Chem.,2013.0,"{'bei': '10.40', 'le': '0.21', 'lle': '-1.47', 'sei': '6.71'}",CHEMBL2349075,,CHEMBL2349075,5.70,False,http://www.openphacts.org/units/Nanomolar,1877210,=,1,True,=,,IC50,nM,,2000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.0
,12713918,[],CHEMBL2349705,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCC[C@@]1(C(=O)OCC)CCC[C@H]1OP(=O)([O-])OCC[N+](C)(C)C,,,CHEMBL2346609,Bioorg. Med. Chem.,2013.0,"{'bei': '10.89', 'le': '0.22', 'lle': '-0.49', 'sei': '6.49'}",CHEMBL2349074,,CHEMBL2349074,5.51,False,http://www.openphacts.org/units/Nanomolar,1877209,=,1,True,=,,IC50,nM,,3100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.1
,12716044,[],CHEMBL2350816,Inhibition of PKBalpha (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nc(C)c(-c2nc(Nc3cccc(N4CCCNCC4)c3)ncc2C#N)s1,,,CHEMBL2346630,J. Med. Chem.,2013.0,,CHEMBL2312185,,CHEMBL2312185,,False,http://www.openphacts.org/units/Nanomolar,1876713,>,1,True,>,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5000.0
,12718779,[],CHEMBL2353277,Inhibition of AKT1 (unknown origin) after 10 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-],,,CHEMBL2346519,Bioorg. Med. Chem.,2013.0,"{'bei': '23.95', 'le': '0.43', 'lle': '4.48', 'sei': '7.89'}",CHEMBL2347053,,CHEMBL2347053,7.96,False,http://www.openphacts.org/units/Nanomolar,1874786,=,1,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
,13295617,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '18.53', 'le': '0.35', 'lle': '5.64', 'sei': '6.29'}",CHEMBL1234354,PF-04691502,CHEMBL1234354,7.89,False,http://www.openphacts.org/units/Nanomolar,1890253,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
,13295618,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc2c1cc(-c1cnc3ccccc3c1)c(=O)n2[C@H]1CC[C@H](OCC(N)=O)CC1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '15.80', 'le': '0.29', 'lle': '4.37', 'sei': '5.21'}",CHEMBL2375953,,CHEMBL2375953,7.25,False,http://www.openphacts.org/units/Nanomolar,1890254,=,1,True,=,,IC50,nM,,56.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,56.8
,13295619,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc2c1cc(-c1cnn(C)c1)c(=O)n2[C@H]1CC[C@H](OCC(N)=O)CC1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '15.61', 'le': '0.29', 'lle': '5.35', 'sei': '4.46'}",CHEMBL2375954,,CHEMBL2375954,6.42,False,http://www.openphacts.org/units/Nanomolar,1890255,=,1,True,=,,IC50,nM,,376.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,376.0
,13295620,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc2c1cc(-c1cn[nH]c1)c(=O)n2[C@H]1CC[C@H](OCC(N)=O)CC1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '16.59', 'le': '0.31', 'lle': '5.53', 'sei': '4.26'}",CHEMBL2375955,,CHEMBL2375955,6.59,False,http://www.openphacts.org/units/Nanomolar,1890256,=,1,True,=,,IC50,nM,,256.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,256.0
,13295621,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ncc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCC(N)=O)CC3)c2=O)cn1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '16.58', 'le': '0.31', 'lle': '6.15', 'sei': '4.52'}",CHEMBL2375956,,CHEMBL2375956,7.29,False,http://www.openphacts.org/units/Nanomolar,1890257,=,1,True,=,,IC50,nM,,51.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,51.9
,13295622,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ncc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCC(N)=O)CC3)c2=O)cc1F,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '18.04', 'le': '0.34', 'lle': '6.36', 'sei': '5.56'}",CHEMBL2375957,,CHEMBL2375957,8.23,False,http://www.openphacts.org/units/Nanomolar,1890258,=,1,True,=,,IC50,nM,,5.82,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.82
,13295623,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCC(N)=O)CC3)c2=O)cn1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '17.59', 'le': '0.33', 'lle': '5.97', 'sei': '5.20'}",CHEMBL2375958,,CHEMBL2375958,7.71,False,http://www.openphacts.org/units/Nanomolar,1890259,=,1,True,=,,IC50,nM,,19.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.3
,13295624,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc2c1cc(-c1cnc3ccccc3c1)c(=O)n2[C@H]1CC[C@@H](OCC(N)=O)CC1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '15.13', 'le': '0.28', 'lle': '4.06', 'sei': '4.99'}",CHEMBL2375959,,CHEMBL2375959,6.94,False,http://www.openphacts.org/units/Nanomolar,1890260,=,1,True,=,,IC50,nM,,116.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,116.0
,13295625,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc2c1cc(-c1cnn(C)c1)c(=O)n2[C@H]1CC[C@@H](OCC(N)=O)CC1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '14.59', 'le': '0.27', 'lle': '4.94', 'sei': '4.17'}",CHEMBL2375960,,CHEMBL2375960,6.00,False,http://www.openphacts.org/units/Nanomolar,1890261,=,1,True,=,,IC50,nM,,988.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,988.0
,13295626,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc2c1cc(-c1cn[nH]c1)c(=O)n2[C@H]1CC[C@@H](OCC(N)=O)CC1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '17.18', 'le': '0.32', 'lle': '5.77', 'sei': '4.41'}",CHEMBL2375962,,CHEMBL2375962,6.83,False,http://www.openphacts.org/units/Nanomolar,1890263,=,1,True,=,,IC50,nM,,148.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,148.0
,13295627,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ncc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@@H](OCC(N)=O)CC3)c2=O)cn1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '16.11', 'le': '0.30', 'lle': '5.95', 'sei': '4.39'}",CHEMBL2375961,,CHEMBL2375961,7.08,False,http://www.openphacts.org/units/Nanomolar,1890262,=,1,True,=,,IC50,nM,,82.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,82.9
,13295628,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ncc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@@H](OCC(N)=O)CC3)c2=O)cc1F,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '17.71', 'le': '0.33', 'lle': '6.21', 'sei': '5.45'}",CHEMBL2375963,,CHEMBL2375963,8.09,False,http://www.openphacts.org/units/Nanomolar,1890264,=,1,True,=,,IC50,nM,,8.22,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.22
,13295629,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@@H](OCC(N)=O)CC3)c2=O)cn1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '17.41', 'le': '0.33', 'lle': '5.89', 'sei': '5.15'}",CHEMBL2375964,,CHEMBL2375964,7.63,False,http://www.openphacts.org/units/Nanomolar,1890265,=,1,True,=,,IC50,nM,,23.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.3
,13295630,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc2c1cc(-c1cnc3ccccc3c1)c(=O)n2[C@H]1CC[C@H](OCO)CC1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '17.67', 'le': '0.33', 'lle': '4.27', 'sei': '6.56'}",CHEMBL2375965,,CHEMBL2375965,7.62,False,http://www.openphacts.org/units/Nanomolar,1890266,=,1,True,=,,IC50,nM,,23.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.8
,13295631,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc2c1cc(-c1cnn(C)c1)c(=O)n2[C@H]1CC[C@H](OCO)CC1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '17.01', 'le': '0.32', 'lle': '5.01', 'sei': '5.40'}",CHEMBL2375966,,CHEMBL2375966,6.54,False,http://www.openphacts.org/units/Nanomolar,1890267,=,1,True,=,,IC50,nM,,288.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,288.0
,13295632,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc2c1cc(-c1cn[nH]c1)c(=O)n2[C@H]1CC[C@H](OCO)CC1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '20.48', 'le': '0.38', 'lle': '6.07', 'sei': '5.75'}",CHEMBL2375967,,CHEMBL2375967,7.59,False,http://www.openphacts.org/units/Nanomolar,1890268,=,1,True,=,,IC50,nM,,25.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.9
,13295633,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ncc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCO)CC3)c2=O)cn1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '18.57', 'le': '0.35', 'lle': '6.06', 'sei': '5.54'}",CHEMBL2375365,,CHEMBL2375365,7.66,False,http://www.openphacts.org/units/Nanomolar,1890269,=,1,True,=,,IC50,nM,,22.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22.0
,13295634,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ncc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCO)CC3)c2=O)cc1F,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '19.28', 'le': '0.36', 'lle': '5.94', 'sei': '6.60'}",CHEMBL2375968,,CHEMBL2375968,8.28,False,http://www.openphacts.org/units/Nanomolar,1890270,=,1,True,=,,IC50,nM,,5.24,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.24
,13295635,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc2c1cc(-c1cnc3ccccc3c1)c(=O)n2[C@H]1CC[C@@H](OCO)CC1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '16.18', 'le': '0.30', 'lle': '3.63', 'sei': '6.01'}",CHEMBL2375969,,CHEMBL2375969,6.98,False,http://www.openphacts.org/units/Nanomolar,1890271,=,1,True,=,,IC50,nM,,104.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,104.0
,13295636,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc2c1cc(-c1cnn(C)c1)c(=O)n2[C@H]1CC[C@@H](OCO)CC1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '16.93', 'le': '0.32', 'lle': '4.98', 'sei': '5.38'}",CHEMBL2375970,,CHEMBL2375970,6.51,False,http://www.openphacts.org/units/Nanomolar,1890272,=,1,True,=,,IC50,nM,,310.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,310.0
,13295637,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc2c1cc(-c1cn[nH]c1)c(=O)n2[C@H]1CC[C@@H](OCO)CC1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '21.46', 'le': '0.40', 'lle': '6.43', 'sei': '6.03'}",CHEMBL2376092,,CHEMBL2376092,7.95,False,http://www.openphacts.org/units/Nanomolar,1890413,=,1,True,=,,IC50,nM,,11.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.2
,13295638,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ncc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@@H](OCO)CC3)c2=O)cn1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '18.26', 'le': '0.34', 'lle': '5.93', 'sei': '5.45'}",CHEMBL2376093,,CHEMBL2376093,7.53,False,http://www.openphacts.org/units/Nanomolar,1890414,=,1,True,=,,IC50,nM,,29.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,29.4
Not Determined,13295639,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ncc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@@H](OCO)CC3)c2=O)cc1F,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2376094,,CHEMBL2376094,,False,,1890415,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,13295640,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@@H](OCO)CC3)c2=O)cn1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '18.63', 'le': '0.35', 'lle': '5.47', 'sei': '6.11'}",CHEMBL2376095,,CHEMBL2376095,7.67,False,http://www.openphacts.org/units/Nanomolar,1890416,=,1,True,=,,IC50,nM,,21.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.6
,13295641,[],CHEMBL2379605,Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCC(=O)O)CC3)c2=O)cn1,,,CHEMBL2375270,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '12.93', 'le': '0.24', 'lle': '3.34', 'sei': '3.99'}",CHEMBL2376096,,CHEMBL2376096,5.68,False,http://www.openphacts.org/units/Nanomolar,1890417,=,1,True,=,,IC50,nM,,2070.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2070.0
,13296927,[],CHEMBL2383903,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc(N[C@H]2CC[C@H](N)CC2)c2nc(-c3ccc(Cl)cc3)cn12,,,CHEMBL2380230,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2381601,,CHEMBL2381601,,False,http://www.openphacts.org/units/Nanomolar,1894218,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,13311870,[],CHEMBL2382842,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(c1)C(=O)N(c1nc(C(=O)Nc3cnccc3N3CCNCC3)cs1)C2,,,CHEMBL2380296,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '11.81', 'le': '0.23', 'lle': '2.95', 'sei': '5.34'}",CHEMBL2381116,,CHEMBL2381116,5.32,False,http://www.openphacts.org/units/Nanomolar,1893648,=,1,True,=,,IC50,nM,,4800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4800.0
,13321299,[],CHEMBL2388368,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccc1-c1cccnc1,,,CHEMBL2384992,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '8.55', 'le': '0.16', 'lle': '-2.02', 'sei': '7.78'}",CHEMBL2385543,,CHEMBL2385543,4.80,False,http://www.openphacts.org/units/Nanomolar,1895722,=,1,True,=,,IC50,nM,,16000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,16.0
,13421003,[],CHEMBL2424130,Inhibition of AKT1 (unknown origin) by microfluidic mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1,,,CHEMBL2417369,Bioorg. Med. Chem.,2013.0,"{'bei': '21.28', 'le': '0.40', 'lle': '4.48', 'sei': '8.31'}",CHEMBL2420911,,CHEMBL2420911,5.80,False,http://www.openphacts.org/units/Nanomolar,1917195,=,1,True,=,,IC50,nM,,1600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.6
,13421004,[],CHEMBL2424130,Inhibition of AKT1 (unknown origin) by microfluidic mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1,,,CHEMBL2417369,Bioorg. Med. Chem.,2013.0,"{'bei': '17.82', 'le': '0.33', 'lle': '3.38', 'sei': '6.96'}",CHEMBL2420909,,CHEMBL2420909,4.85,False,http://www.openphacts.org/units/Nanomolar,1917193,=,1,True,=,,IC50,nM,,14000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,14.0
,13472920,[],CHEMBL2438112,Inhibition of AKT (unknown origin) after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=[N+]([O-])c1ccc(S(=O)(=O)Nc2ccc(O)c(Sc3ncn[nH]3)c2)cc1,,,CHEMBL2434840,Eur. J. Med. Chem.,2013.0,"{'bei': '15.00', 'le': '0.31', 'lle': '3.53', 'sei': '3.90'}",CHEMBL2436727,,CHEMBL2436727,5.90,False,http://www.openphacts.org/units/Nanomolar,1925290,=,1,True,=,,IC50,nM,,1260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.26
,13507659,[],CHEMBL2444020,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1,,,CHEMBL2439976,Bioorg. Med. Chem.,2013.0,,CHEMBL2443026,,CHEMBL2443026,,False,http://www.openphacts.org/units/Nanomolar,1929780,>,1,True,>,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,13507660,[],CHEMBL2444020,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1,,,CHEMBL2439976,Bioorg. Med. Chem.,2013.0,,CHEMBL2443139,,CHEMBL2443139,,False,http://www.openphacts.org/units/Nanomolar,1929917,>,1,True,>,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,13507661,[],CHEMBL2444020,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1,,,CHEMBL2439976,Bioorg. Med. Chem.,2013.0,,CHEMBL2443138,,CHEMBL2443138,,False,http://www.openphacts.org/units/Nanomolar,1929916,>,1,True,>,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,13507662,[],CHEMBL2444020,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1,,,CHEMBL2439976,Bioorg. Med. Chem.,2013.0,,CHEMBL2443044,,CHEMBL2443044,,False,http://www.openphacts.org/units/Nanomolar,1929798,>,1,True,>,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
,13870250,[],CHEMBL3100278,Inhibition of AKT1 (unknown origin) by high-throughput screen assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(O)cccc1C2=O,,,CHEMBL3098129,Bioorg. Med. Chem. Lett.,2014.0,"{'bei': '20.42', 'le': '0.38', 'lle': '4.75', 'sei': '7.46'}",CHEMBL474390,FRENOLICIN B,CHEMBL474390,6.70,False,http://www.openphacts.org/units/Nanomolar,1956825,=,1,True,=,,IC50,nM,,198.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,198.0
,13870251,[],CHEMBL3100278,Inhibition of AKT1 (unknown origin) by high-throughput screen assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O,,,CHEMBL3098129,Bioorg. Med. Chem. Lett.,2014.0,"{'bei': '14.92', 'le': '0.28', 'lle': '5.52', 'sei': '5.57'}",CHEMBL2216825,LACTOQUINOMYCIN,CHEMBL2216825,6.83,False,http://www.openphacts.org/units/Nanomolar,1956824,=,1,True,=,,IC50,nM,,149.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,149.0
,13870252,[],CHEMBL3100278,Inhibition of AKT1 (unknown origin) by high-throughput screen assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1ccccc1C2=O,,,CHEMBL3098129,Bioorg. Med. Chem. Lett.,2014.0,"{'bei': '24.01', 'le': '0.44', 'lle': '5.35', 'sei': '9.79'}",CHEMBL522996,,CHEMBL522996,6.82,False,http://www.openphacts.org/units/Nanomolar,1956817,=,1,True,=,,IC50,nM,,150.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,150.0
,13870260,[],CHEMBL3100280,Inhibition of recombinant AKT1 (unknown origin) using serine/threonine 06 peptide as substrate after 1 hr by FRET based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C[C@H]2OCC3=C(C(=O)c4ccccc4C3=O)[C@H]2O1,,,CHEMBL3098129,Bioorg. Med. Chem. Lett.,2014.0,"{'bei': '27.22', 'le': '0.50', 'lle': '6.28', 'sei': '10.56'}",CHEMBL475400,,CHEMBL475400,7.36,False,http://www.openphacts.org/units/Nanomolar,1956823,=,1,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.044
,13870261,[],CHEMBL3100280,Inhibition of recombinant AKT1 (unknown origin) using serine/threonine 06 peptide as substrate after 1 hr by FRET based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C=CC(=O)c2ccccc21,,,CHEMBL3098129,Bioorg. Med. Chem. Lett.,2014.0,"{'bei': '31.36', 'le': '0.56', 'lle': '3.34', 'sei': '14.53'}",CHEMBL55934,NAPHTHOQUINONE,CHEMBL55934,4.96,False,http://www.openphacts.org/units/Nanomolar,1956822,=,1,True,=,,IC50,nM,,10980.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.98
,13870262,[],CHEMBL3100280,Inhibition of recombinant AKT1 (unknown origin) using serine/threonine 06 peptide as substrate after 1 hr by FRET based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,C=CC(=O)c1ccccc1,,,CHEMBL3098129,Bioorg. Med. Chem. Lett.,2014.0,"{'bei': '37.16', 'le': '0.67', 'lle': '2.85', 'sei': '28.77'}",CHEMBL3099615,,CHEMBL3099615,4.91,False,http://www.openphacts.org/units/Nanomolar,1956821,=,1,True,=,,IC50,nM,,12270.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,12.27
,13870263,[],CHEMBL3100280,Inhibition of recombinant AKT1 (unknown origin) using serine/threonine 06 peptide as substrate after 1 hr by FRET based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)CC/C=C/C(=O)c1ccccc1,,,CHEMBL3098129,Bioorg. Med. Chem. Lett.,2014.0,"{'bei': '22.29', 'le': '0.42', 'lle': '2.48', 'sei': '11.22'}",CHEMBL3099614,,CHEMBL3099614,4.86,False,http://www.openphacts.org/units/Nanomolar,1956820,=,1,True,=,,IC50,nM,,13670.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,13.67
,13870264,[],CHEMBL3100280,Inhibition of recombinant AKT1 (unknown origin) using serine/threonine 06 peptide as substrate after 1 hr by FRET based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC/C=C/C(=O)c1ccccc1,,,CHEMBL3098129,Bioorg. Med. Chem. Lett.,2014.0,"{'bei': '24.41', 'le': '0.45', 'lle': '2.23', 'sei': '16.35'}",CHEMBL3099613,,CHEMBL3099613,4.30,False,http://www.openphacts.org/units/Nanomolar,1956819,=,1,True,=,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,13870265,[],CHEMBL3100280,Inhibition of recombinant AKT1 (unknown origin) using serine/threonine 06 peptide as substrate after 1 hr by FRET based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C[C@@H](O)[C@@H](C2=CC(=O)c3ccccc3C2=O)O1,,,CHEMBL3098129,Bioorg. Med. Chem. Lett.,2014.0,"{'bei': '21.42', 'le': '0.40', 'lle': '4.86', 'sei': '6.86'}",CHEMBL3099612,,CHEMBL3099612,5.53,False,http://www.openphacts.org/units/Nanomolar,1956818,=,1,True,=,,IC50,nM,,2940.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.94
,13870266,[],CHEMBL3100280,Inhibition of recombinant AKT1 (unknown origin) using serine/threonine 06 peptide as substrate after 1 hr by FRET based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1ccccc1C2=O,,,CHEMBL3098129,Bioorg. Med. Chem. Lett.,2014.0,"{'bei': '23.05', 'le': '0.43', 'lle': '5.08', 'sei': '9.41'}",CHEMBL522996,,CHEMBL522996,6.55,False,http://www.openphacts.org/units/Nanomolar,1956817,=,1,True,=,,IC50,nM,,280.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.28
,13870267,[],CHEMBL3100280,Inhibition of recombinant AKT1 (unknown origin) using serine/threonine 06 peptide as substrate after 1 hr by FRET based Z'-LYTE assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL3098129,Bioorg. Med. Chem. Lett.,2014.0,"{'bei': '17.06', 'le': '0.31', 'lle': '3.61', 'sei': '11.46'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,7.96,False,http://www.openphacts.org/units/Nanomolar,1956816,=,1,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.011
,13878449,[],CHEMBL3108329,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,,,CHEMBL3102702,J. Nat. Prod.,2014.0,"{'bei': '17.43', 'le': '0.33', 'lle': '3.28', 'sei': '4.01'}",CHEMBL50,QUERCETIN,CHEMBL50,5.27,False,http://www.openphacts.org/units/Nanomolar,1959932,=,1,True,=,,IC50,nM,,5390.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.39
,13878450,[],CHEMBL3108329,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL3102702,J. Nat. Prod.,2014.0,"{'bei': '16.12', 'le': '0.29', 'lle': '3.17', 'sei': '10.83'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,7.52,False,http://www.openphacts.org/units/Nanomolar,1959931,=,1,True,=,,IC50,nM,,30.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.03
,13878451,[],CHEMBL3108329,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(O)c(O)c(O)c(C=O)c1-c1cc2c(C=O)c(C)c(O)c(O)c2o1,,,CHEMBL3102702,J. Nat. Prod.,2014.0,"{'bei': '15.04', 'le': '0.28', 'lle': '2.52', 'sei': '3.63'}",CHEMBL3104855,,CHEMBL3104855,5.39,False,http://www.openphacts.org/units/Nanomolar,1959930,=,1,True,=,,IC50,nM,,4070.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.07
,13878452,[],CHEMBL3108329,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(O)c(O)c(O)c2c1COC2=O,,,CHEMBL3102702,J. Nat. Prod.,2014.0,"{'bei': '23.63', 'le': '0.45', 'lle': '3.85', 'sei': '5.33'}",CHEMBL3104854,,CHEMBL3104854,4.63,False,http://www.openphacts.org/units/Nanomolar,1959929,=,1,True,=,,IC50,nM,,23200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,23.2
,13878453,[],CHEMBL3108329,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COCc1c(C)c(O)c(O)c(O)c1C=O,,,CHEMBL3102702,J. Nat. Prod.,2014.0,,CHEMBL3104853,,CHEMBL3104853,,False,http://www.openphacts.org/units/Nanomolar,1959928,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,13878454,[],CHEMBL3108329,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COC1OC(=O)c2c(O)c(O)c(O)c(C)c21,,,CHEMBL3102702,J. Nat. Prod.,2014.0,,CHEMBL3104852,,CHEMBL3104852,,False,http://www.openphacts.org/units/Nanomolar,1959927,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,13878455,[],CHEMBL3108329,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(O)c(O)c2c(c1C=O)[C@@H]1O[C@H](O2)c2c(C)c(O)c(O)c(O)c2C1=O,,,CHEMBL3102702,J. Nat. Prod.,2014.0,"{'bei': '15.14', 'le': '0.29', 'lle': '3.68', 'sei': '3.69'}",CHEMBL3104851,,CHEMBL3104851,5.67,False,http://www.openphacts.org/units/Nanomolar,1959926,=,1,True,=,,IC50,nM,,2150.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.15
,13897478,[],CHEMBL3111649,Inhibition of recombinant AKT1 (unknown origin) using GSK3 (14 to 27) as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1cc(O)c(O)c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1,,,CHEMBL3108666,J. Nat. Prod.,2014.0,"{'bei': '11.58', 'le': '0.22', 'lle': '-0.91', 'sei': '6.46'}",CHEMBL3109404,,CHEMBL3109404,4.32,False,http://www.openphacts.org/units/Nanomolar,1962025,=,1,True,=,,IC50,nM,,48400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,48.4
,13897479,[],CHEMBL3111649,Inhibition of recombinant AKT1 (unknown origin) using GSK3 (14 to 27) as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2nc(C)oc2c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1O,,,CHEMBL3108666,J. Nat. Prod.,2014.0,,CHEMBL3109402,,CHEMBL3109402,,False,http://www.openphacts.org/units/Nanomolar,1962023,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,13897480,[],CHEMBL3111649,Inhibition of recombinant AKT1 (unknown origin) using GSK3 (14 to 27) as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCC(C)C)C1=O,,,CHEMBL3108666,J. Nat. Prod.,2014.0,"{'bei': '10.00', 'le': '0.19', 'lle': '-1.52', 'sei': '6.23'}",CHEMBL3109401,,CHEMBL3109401,4.13,False,http://www.openphacts.org/units/Nanomolar,1962022,=,1,True,=,,IC50,nM,,73200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,73.2
,13906549,[],CHEMBL3117479,Inhibition of AKT1 (unknown origin) after 30 mins,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c3ccccc23)cc1OC,,,CHEMBL3112530,Bioorg. Med. Chem.,2014.0,"{'bei': '11.31', 'le': '0.22', 'lle': '1.58', 'sei': '4.14'}",CHEMBL3113284,,CHEMBL3113284,5.76,False,http://www.openphacts.org/units/Nanomolar,1963934,=,1,True,=,,IC50,nM,,1730.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.73
,13906552,[],CHEMBL3117479,Inhibition of AKT1 (unknown origin) after 30 mins,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL3112530,Bioorg. Med. Chem.,2014.0,"{'bei': '14.76', 'le': '0.27', 'lle': '2.54', 'sei': '9.92'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,6.89,False,http://www.openphacts.org/units/Nanomolar,1963942,=,1,True,=,,IC50,nM,,130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.13
,13919660,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,NCCNC(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '18.62', 'le': '0.36', 'lle': '2.72', 'sei': '9.12'}",CHEMBL3113150,,CHEMBL3113150,6.09,False,http://www.openphacts.org/units/Nanomolar,1963785,=,1,True,=,,IC50,nM,,820.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.82
,13919661,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,OCCNC(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '18.87', 'le': '0.37', 'lle': '2.79', 'sei': '10.15'}",CHEMBL3113149,,CHEMBL3113149,6.19,False,http://www.openphacts.org/units/Nanomolar,1963784,=,1,True,=,,IC50,nM,,650.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.65
,13919662,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(C(NCc2ccccc2)c2ccc(-c3cn[nH]c3)cc2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '15.73', 'le': '0.30', 'lle': '0.27', 'sei': '14.44'}",CHEMBL3113148,,CHEMBL3113148,5.88,False,http://www.openphacts.org/units/Nanomolar,1963783,=,1,True,=,,IC50,nM,,1320.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.32
,13919663,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(C(NC2CCCCC2)c2ccc(-c3cn[nH]c3)cc2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '16.28', 'le': '0.31', 'lle': '0.22', 'sei': '14.64'}",CHEMBL3113146,,CHEMBL3113146,5.96,False,http://www.openphacts.org/units/Nanomolar,1963781,=,1,True,=,,IC50,nM,,1100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.1
,13919664,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(C(NC2CC2)c2ccc(-c3cn[nH]c3)cc2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '19.51', 'le': '0.38', 'lle': '1.75', 'sei': '15.52'}",CHEMBL3113145,,CHEMBL3113145,6.32,False,http://www.openphacts.org/units/Nanomolar,1963780,=,1,True,=,,IC50,nM,,480.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.48
,13919665,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)NC(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '21.83', 'le': '0.42', 'lle': '2.21', 'sei': '18.23'}",CHEMBL3112595,,CHEMBL3112595,7.42,False,http://www.openphacts.org/units/Nanomolar,1963779,=,1,True,=,,IC50,nM,,38.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.038
,13919666,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CNC(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '17.79', 'le': '0.34', 'lle': '0.98', 'sei': '14.85'}",CHEMBL3113144,,CHEMBL3113144,6.05,False,http://www.openphacts.org/units/Nanomolar,1963778,=,1,True,=,,IC50,nM,,900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.9
,13919667,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '19.74', 'le': '0.38', 'lle': '1.61', 'sei': '15.80'}",CHEMBL3113143,,CHEMBL3113143,6.43,False,http://www.openphacts.org/units/Nanomolar,1963777,=,1,True,=,,IC50,nM,,370.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.37
,13919668,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(C(NCc2ccccc2)c2ccc(-c3ncnc4[nH]cnc34)cc2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '14.39', 'le': '0.27', 'lle': '0.58', 'sei': '9.22'}",CHEMBL3113142,,CHEMBL3113142,6.13,False,http://www.openphacts.org/units/Nanomolar,1963776,=,1,True,=,,IC50,nM,,740.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.74
,13919669,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(C(NC2CCCCC2)c2ccc(-c3ncnc4[nH]cnc34)cc2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '14.82', 'le': '0.28', 'lle': '0.50', 'sei': '9.32'}",CHEMBL3113141,,CHEMBL3113141,6.19,False,http://www.openphacts.org/units/Nanomolar,1963775,=,1,True,=,,IC50,nM,,640.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.64
,13919670,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CNC(c1ccc(Cl)cc1)c1ccc(-c2ncnc3[nH]cnc23)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '15.64', 'le': '0.30', 'lle': '1.12', 'sei': '9.22'}",CHEMBL3113140,,CHEMBL3113140,6.13,False,http://www.openphacts.org/units/Nanomolar,1963774,=,1,True,=,,IC50,nM,,740.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.74
,13919671,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(C(NCc2ccccc2)c2ccc(-c3ccncc3)cc2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '15.34', 'le': '0.29', 'lle': '-0.38', 'sei': '23.69'}",CHEMBL3113139,,CHEMBL3113139,5.90,False,http://www.openphacts.org/units/Nanomolar,1963773,=,1,True,=,,IC50,nM,,1250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.25
,13919672,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(C(NC2CCCCC2)c2ccc(-c3ccncc3)cc2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '15.65', 'le': '0.30', 'lle': '-0.51', 'sei': '23.67'}",CHEMBL3113137,,CHEMBL3113137,5.90,False,http://www.openphacts.org/units/Nanomolar,1963771,=,1,True,=,,IC50,nM,,1260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.26
,13919673,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)NC(c1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '19.29', 'le': '0.37', 'lle': '0.89', 'sei': '27.17'}",CHEMBL3113136,,CHEMBL3113136,6.77,False,http://www.openphacts.org/units/Nanomolar,1963770,=,1,True,=,,IC50,nM,,170.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.17
,13919674,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CNC(c1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '16.66', 'le': '0.32', 'lle': '0.10', 'sei': '23.45'}",CHEMBL3113135,,CHEMBL3113135,5.84,False,http://www.openphacts.org/units/Nanomolar,1963769,=,1,True,=,,IC50,nM,,1430.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.43
,13919675,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(c1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '19.76', 'le': '0.38', 'lle': '1.17', 'sei': '26.72'}",CHEMBL3113134,,CHEMBL3113134,6.66,False,http://www.openphacts.org/units/Nanomolar,1963768,=,1,True,=,,IC50,nM,,220.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.22
,13919676,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(C(NC2CC2)c2ccc(-c3ncnc4[nH]cnc34)cc2)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '16.84', 'le': '0.32', 'lle': '1.82', 'sei': '9.52'}",CHEMBL3113130,,CHEMBL3113130,6.33,False,http://www.openphacts.org/units/Nanomolar,1963764,=,1,True,=,,IC50,nM,,470.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.47
,13919677,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(c1ccc(Cl)cc1)c1ccc(-c2ncnc3[nH]cnc23)cc1,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '17.98', 'le': '0.34', 'lle': '2.04', 'sei': '10.22'}",CHEMBL3113129,,CHEMBL3113129,6.80,False,http://www.openphacts.org/units/Nanomolar,1963763,=,1,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.16
,13919678,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '12.91', 'le': '0.29', 'lle': '2.18', 'sei': '8.11'}",CHEMBL104264,,CHEMBL104264,5.76,False,http://www.openphacts.org/units/Nanomolar,1963762,=,1,True,=,,IC50,nM,,1720.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.72
,13919679,[],CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL3112393,Eur. J. Med. Chem.,2014.0,"{'bei': '15.86', 'le': '0.29', 'lle': '3.05', 'sei': '10.65'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,7.40,False,http://www.openphacts.org/units/Nanomolar,1963786,=,1,True,=,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.04
,13933027,[],CHEMBL3124141,Inhibition of Akt/mTOR in human 786-O cells assessed as inhibition of nuclear export of transcription factor FOXO1a,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)Cc1c(O)ccc2oc(Cc3ccccc3)cc12,,,CHEMBL3120078,Eur. J. Med. Chem.,2014.0,"{'bei': '16.70', 'le': '0.31', 'lle': '0.91', 'sei': '12.84'}",CHEMBL526034,,CHEMBL526034,4.70,False,http://www.openphacts.org/units/Nanomolar,1967846,=,1,True,=,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,20.0
,13950553,[],CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCN(C(=O)C(N)Cc3ccccc3)CC2)c1Br,,,CHEMBL3124803,Eur. J. Med. Chem.,2014.0,"{'bei': '15.69', 'le': '0.35', 'lle': '5.32', 'sei': '6.27'}",CHEMBL3127380,,CHEMBL3127380,6.36,False,http://www.openphacts.org/units/Nanomolar,1973425,=,1,True,=,,IC50,nM,,436.52,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,6.36
,13950554,[],CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCN(C(=O)C(N)Cc3ccc(Cl)cc3)CC2)c1Br,,,CHEMBL3124803,Eur. J. Med. Chem.,2014.0,"{'bei': '18.44', 'le': '0.43', 'lle': '6.42', 'sei': '8.00'}",CHEMBL3127379,,CHEMBL3127379,8.11,False,http://www.openphacts.org/units/Nanomolar,1973424,=,1,True,=,,IC50,nM,,7.762,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.11
,13950555,[],CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCN(C(=O)C(N)Cc3ccc(Cl)cc3)CC2)c1Cl,,,CHEMBL3124803,Eur. J. Med. Chem.,2014.0,"{'bei': '19.66', 'le': '0.41', 'lle': '6.19', 'sei': '7.67'}",CHEMBL3127378,,CHEMBL3127378,7.77,False,http://www.openphacts.org/units/Nanomolar,1973423,=,1,True,=,,IC50,nM,,16.98,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,7.77
,13950556,[],CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCN(C(=O)[C@@H](N)Cc3ccccc3)CC2)c1Cl,,,CHEMBL3124803,Eur. J. Med. Chem.,2014.0,"{'bei': '15.91', 'le': '0.31', 'lle': '4.81', 'sei': '5.66'}",CHEMBL3127377,,CHEMBL3127377,5.74,False,http://www.openphacts.org/units/Nanomolar,1973422,=,1,True,=,,IC50,nM,,1819.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,5.74
,13950557,[],CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,NCC1(c2ccc(Cl)c(Cl)c2)CCN(c2cc(N)ncn2)CC1,,,CHEMBL3124803,Eur. J. Med. Chem.,2014.0,"{'bei': '15.22', 'le': '0.32', 'lle': '2.50', 'sei': '6.61'}",CHEMBL3127376,,CHEMBL3127376,5.36,False,http://www.openphacts.org/units/Nanomolar,1973421,=,1,True,=,,IC50,nM,,4365.16,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,5.36
,13950558,[],CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1cc(N2CCC(CN)(c3ccc(Cl)c(Cl)c3)CC2)ncn1,,,CHEMBL3124803,Eur. J. Med. Chem.,2014.0,"{'bei': '15.56', 'le': '0.32', 'lle': '2.38', 'sei': '8.50'}",CHEMBL3124965,,CHEMBL3124965,5.70,False,http://www.openphacts.org/units/Nanomolar,1973420,=,1,True,=,,IC50,nM,,1995.26,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,5.7
,13950573,[],CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,,,CHEMBL3124803,Eur. J. Med. Chem.,2014.0,"{'bei': '12.67', 'le': '0.29', 'lle': '2.08', 'sei': '7.96'}",CHEMBL104264,,CHEMBL104264,5.66,False,http://www.openphacts.org/units/Nanomolar,1973426,=,1,True,=,,IC50,nM,,2200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.2
,13950574,[],CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCN(C(=O)C(N)Cc3ccccc3)CC2)c1Br,,,CHEMBL3124803,Eur. J. Med. Chem.,2014.0,"{'bei': '15.70', 'le': '0.35', 'lle': '5.32', 'sei': '6.28'}",CHEMBL3127380,,CHEMBL3127380,6.37,False,http://www.openphacts.org/units/Nanomolar,1973425,=,1,True,=,,IC50,nM,,432.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.432
,13950575,[],CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCN(C(=O)C(N)Cc3ccc(Cl)cc3)CC2)c1Br,,,CHEMBL3124803,Eur. J. Med. Chem.,2014.0,"{'bei': '18.45', 'le': '0.43', 'lle': '6.42', 'sei': '8.00'}",CHEMBL3127379,,CHEMBL3127379,8.11,False,http://www.openphacts.org/units/Nanomolar,1973424,=,1,True,=,,IC50,nM,,7.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.0077
,13950576,[],CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCN(C(=O)C(N)Cc3ccc(Cl)cc3)CC2)c1Cl,,,CHEMBL3124803,Eur. J. Med. Chem.,2014.0,"{'bei': '19.66', 'le': '0.41', 'lle': '6.19', 'sei': '7.66'}",CHEMBL3127378,,CHEMBL3127378,7.77,False,http://www.openphacts.org/units/Nanomolar,1973423,=,1,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.017
,13950577,[],CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCN(C(=O)[C@@H](N)Cc3ccccc3)CC2)c1Cl,,,CHEMBL3124803,Eur. J. Med. Chem.,2014.0,"{'bei': '15.90', 'le': '0.31', 'lle': '4.81', 'sei': '5.66'}",CHEMBL3127377,,CHEMBL3127377,5.74,False,http://www.openphacts.org/units/Nanomolar,1973422,=,1,True,=,,IC50,nM,,1830.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.83
,13950578,[],CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,NCC1(c2ccc(Cl)c(Cl)c2)CCN(c2cc(N)ncn2)CC1,,,CHEMBL3124803,Eur. J. Med. Chem.,2014.0,"{'bei': '15.23', 'le': '0.32', 'lle': '2.50', 'sei': '6.62'}",CHEMBL3127376,,CHEMBL3127376,5.37,False,http://www.openphacts.org/units/Nanomolar,1973421,=,1,True,=,,IC50,nM,,4320.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.32
,13950579,[],CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1cc(N2CCC(CN)(c3ccc(Cl)c(Cl)c3)CC2)ncn1,,,CHEMBL3124803,Eur. J. Med. Chem.,2014.0,"{'bei': '15.66', 'le': '0.33', 'lle': '2.42', 'sei': '8.55'}",CHEMBL3124965,,CHEMBL3124965,5.74,False,http://www.openphacts.org/units/Nanomolar,1973420,=,1,True,=,,IC50,nM,,1830.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.83
,14545812,[],CHEMBL3224479,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)O.O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1,,,CHEMBL3217586,MedChemComm,2012.0,"{'bei': '26.55', 'le': '0.51', 'lle': '5.44', 'sei': '9.94'}",CHEMBL3218297,,CHEMBL3218011,8.67,False,http://www.openphacts.org/units/Nanomolar,2072671,=,1,True,=,,IC50,nM,,2.16,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.16
,14593771,[],CHEMBL3241187,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1,,,CHEMBL3232836,Bioorg. Med. Chem. Lett.,2014.0,,CHEMBL3133821,,CHEMBL3133821,,False,http://www.openphacts.org/units/Nanomolar,2087586,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,14751163,[],CHEMBL3301291,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21,,,CHEMBL3297733,Bioorg. Med. Chem.,2013.0,,CHEMBL3298400,,CHEMBL3298400,,False,http://www.openphacts.org/units/Nanomolar,2120532,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,14751164,[],CHEMBL3301291,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1,,,CHEMBL3297733,Bioorg. Med. Chem.,2013.0,,CHEMBL3297762,,CHEMBL3297762,,False,http://www.openphacts.org/units/Nanomolar,2119750,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,14992854,[],CHEMBL3372235,Inhibition of recombinant AKT1 (unknown origin) after 60 mins by z'-lyte kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21,,,CHEMBL3351909,Eur. J. Med. Chem.,2015.0,"{'bei': '17.36', 'le': '0.32', 'lle': '1.70', 'sei': '6.61'}",CHEMBL3361128,,CHEMBL3361128,4.41,False,http://www.openphacts.org/units/Nanomolar,2273281,=,1,True,=,,IC50,nM,,38600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,38.6
,15019134,[],CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,"{'bei': '22.65', 'le': '0.43', 'lle': '3.36', 'sei': '11.26'}",CHEMBL3298512,,CHEMBL3298512,6.24,False,http://www.openphacts.org/units/Nanomolar,2263043,=,1,True,=,,IC50,nM,,580.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.58
,15019135,[],CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCI,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,,CHEMBL3298513,,CHEMBL3298513,,False,http://www.openphacts.org/units/Nanomolar,2263044,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,15019136,[],CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCBr,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,,CHEMBL3298514,,CHEMBL3298514,,False,http://www.openphacts.org/units/Nanomolar,2263045,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,15019137,[],CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCl,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,,CHEMBL3298515,,CHEMBL3298515,,False,http://www.openphacts.org/units/Nanomolar,2263046,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,15019138,[],CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCN1C(=O)C=CC1=O,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,"{'bei': '13.81', 'le': '0.26', 'lle': '4.19', 'sei': '5.10'}",CHEMBL3298516,,CHEMBL3298516,5.35,False,http://www.openphacts.org/units/Nanomolar,2263047,=,1,True,=,,IC50,nM,,4480.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.48
,15019139,[],CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)CCl,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,,CHEMBL3298610,,CHEMBL3298610,,False,http://www.openphacts.org/units/Nanomolar,2263048,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,15019140,[],CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)CBr,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,"{'bei': '13.43', 'le': '0.31', 'lle': '1.76', 'sei': '7.86'}",CHEMBL3298611,,CHEMBL3298611,4.61,False,http://www.openphacts.org/units/Nanomolar,2263049,=,1,True,=,,IC50,nM,,24660.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,24.66
,15019141,[],CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)CI,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,"{'bei': '12.28', 'le': '0.33', 'lle': '1.90', 'sei': '8.17'}",CHEMBL3298792,,CHEMBL3298792,4.79,False,http://www.openphacts.org/units/Nanomolar,2263050,=,1,True,=,,IC50,nM,,16130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,16.13
,15019142,[],CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,C=CC(=O)N(Cc1ccccc1)NC(=O)OC(C)(C)C,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,,CHEMBL3298928,,CHEMBL3298928,,False,http://www.openphacts.org/units/Nanomolar,2263051,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,15019143,[],CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)CN1C(=O)C=CC1=O,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,"{'bei': '14.83', 'le': '0.28', 'lle': '3.95', 'sei': '5.55'}",CHEMBL3298929,,CHEMBL3298929,5.33,False,http://www.openphacts.org/units/Nanomolar,2263052,=,1,True,=,,IC50,nM,,4680.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,4.68
,15019144,[],CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CCC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,,CHEMBL3358446,,CHEMBL3358446,,False,http://www.openphacts.org/units/Nanomolar,2263053,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,15019145,[],CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,"{'bei': '21.67', 'le': '0.41', 'lle': '7.64', 'sei': '6.72'}",CHEMBL494089,GSK-690693,CHEMBL494089,9.22,False,http://www.openphacts.org/units/Nanomolar,2263055,=,1,True,=,,IC50,nM,,0.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.0006
,15019146,[],CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,"{'bei': '19.63', 'le': '0.35', 'lle': '3.76', 'sei': '8.98'}",CHEMBL1079175,MK-2206,CHEMBL1079175,8.00,False,http://www.openphacts.org/units/Nanomolar,2263056,=,1,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.01
,15019212,[],CHEMBL3364360,Inhibition of AKT1 (unknown origin) after 30 mins by scintillation counting analysis in presence of 100 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCCCC(=O)O,,,CHEMBL3297689,ACS Med. Chem. Lett.,2014.0,"{'bei': '7.53', 'le': '0.15', 'lle': '9.36', 'sei': '1.79'}",CHEMBL3299032,,CHEMBL3299032,6.70,False,http://www.openphacts.org/units/Nanomolar,2263057,=,1,True,=,,IC50,nM,,200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.2
,15036713,[],CHEMBL3381058,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1,,,CHEMBL3352169,Bioorg. Med. Chem.,2014.0,,CHEMBL3309990,,CHEMBL3309990,,False,http://www.openphacts.org/units/Nanomolar,2269657,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,15036714,[],CHEMBL3381058,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21,,,CHEMBL3352169,Bioorg. Med. Chem.,2014.0,,CHEMBL3309995,,CHEMBL3309995,,False,http://www.openphacts.org/units/Nanomolar,2269662,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,15036715,[],CHEMBL3381058,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21,,,CHEMBL3352169,Bioorg. Med. Chem.,2014.0,,CHEMBL3309997,,CHEMBL3309997,,False,http://www.openphacts.org/units/Nanomolar,2269664,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,15036716,[],CHEMBL3381058,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1,,,CHEMBL3352169,Bioorg. Med. Chem.,2014.0,,CHEMBL3309998,,CHEMBL3309998,,False,http://www.openphacts.org/units/Nanomolar,2269665,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,15036717,[],CHEMBL3381058,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1,,,CHEMBL3352169,Bioorg. Med. Chem.,2014.0,,CHEMBL3310151,,CHEMBL3310151,,False,http://www.openphacts.org/units/Nanomolar,2269674,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,15053965,[],CHEMBL3369600,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3)o2)cc1,,,CHEMBL3351352,Bioorg. Med. Chem. Lett.,2014.0,,CHEMBL3314140,,CHEMBL3314140,,False,http://www.openphacts.org/units/Nanomolar,2273692,>,1,True,>,,IC50,nM,,15000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,15.0
,15055294,[],CHEMBL3380460,Inhibition of human recombinant AKT1 using GSK3/14-27 substrate,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)cc(OC)c1OC,,,CHEMBL3351621,J. Med. Chem.,2015.0,,CHEMBL3358966,,CHEMBL3358966,,False,http://www.openphacts.org/units/Nanomolar,2265579,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,100.0
,15080990,[],CHEMBL3384751,Inhibition of Akt1 PH domain (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(N)c1ccc(-c2nc3ccccc3nc2-c2ccccc2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3352585,J. Med. Chem.,2014.0,,CHEMBL362455,,CHEMBL362455,,False,http://www.openphacts.org/units/Nanomolar,2274681,>,1,True,>,,IC50,nM,,250000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,250.0
,15080991,[],CHEMBL3384750,Inhibition of Akt1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(N)c1ccc(-c2nc3ccccc3nc2-c2ccccc2)cc1,,,CHEMBL3352585,J. Med. Chem.,2014.0,"{'bei': '16.11', 'le': '0.29', 'lle': '0.31', 'sei': '10.56'}",CHEMBL362455,,CHEMBL362455,5.47,False,http://www.openphacts.org/units/Nanomolar,2274681,=,1,True,=,,IC50,nM,,3400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.4
,15107867,[],CHEMBL3385203,Inhibition of wild type AKT1 (unknown origin) incubated for 5 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN(C)C,,,CHEMBL3351667,J. Med. Chem.,2014.0,,CHEMBL3357634,,CHEMBL3357634,,False,http://www.openphacts.org/units/Nanomolar,2260495,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,15116483,[],CHEMBL3376471,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1ccc(N2CCN(C(=O)CN3CC[C@@H](C(=O)Nc4ccc(O)c(Cl)c4)C3)CC2)cc1,,,CHEMBL3351461,J. Med. Chem.,2014.0,,CHEMBL3356117,,CHEMBL3356117,,False,http://www.openphacts.org/units/Nanomolar,2254072,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,30.0
,15160284,[],CHEMBL3398960,Inhibition of recombinant N-terminal His-tagged AKT1 (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 6 peptide substrate by Z'-LYTE kinase assay,B,,,BAO_0000190,BAO_0000019,assay format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL3397021,Bioorg. Med. Chem.,2015.0,"{'bei': '16.62', 'le': '0.30', 'lle': '3.40', 'sei': '11.17'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,7.75,True,http://www.openphacts.org/units/Nanomolar,2280167,=,1,True,=,,IC50,nM,,17.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.6
,15253201,[],CHEMBL3430009,Inhibition of human PKBalpha,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21,,,CHEMBL3425429,J. Med. Chem.,2015.0,,CHEMBL3426225,,CHEMBL3426225,,False,http://www.openphacts.org/units/Nanomolar,2297067,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,15649112,[],CHEMBL3595097,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1,,,CHEMBL3593212,Bioorg. Med. Chem.,2015.0,,CHEMBL3593777,,CHEMBL3593777,,False,http://www.openphacts.org/units/Nanomolar,2488153,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
,15685870,[],CHEMBL3607946,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2,,,CHEMBL3603755,J. Med. Chem.,2015.0,,CHEMBL3606021,,CHEMBL3606021,,False,http://www.openphacts.org/units/Nanomolar,2496286,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,15710558,[],CHEMBL3615480,Inhibition of AKT1 (unknown origin) by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12,,,CHEMBL3611979,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3356433,,CHEMBL3356433,,False,http://www.openphacts.org/units/Nanomolar,2500141,<,1,True,<,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,15710559,[],CHEMBL3615480,Inhibition of AKT1 (unknown origin) by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]c(C)c(C)c34)CC2)c1,,,CHEMBL3611979,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3613623,,CHEMBL3613623,,False,http://www.openphacts.org/units/Nanomolar,2500167,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
,15710560,[],CHEMBL3615480,Inhibition of AKT1 (unknown origin) by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1[nH]c2ncnc(N3CCC(CN(C)C)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c2c1C,,,CHEMBL3611979,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3613624,,CHEMBL3613624,,False,http://www.openphacts.org/units/Nanomolar,2500168,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
,15723421,[],CHEMBL3620015,Inhibition of AKT1 (unknown origin) after 40 mins by scintillation counting analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL3616395,Eur. J. Med. Chem.,2015.0,"{'bei': '17.87', 'le': '0.33', 'lle': '3.99', 'sei': '12.00'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.34,False,http://www.openphacts.org/units/Nanomolar,2501318,=,1,True,=,,IC50,nM,,4.62,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.62
,15753959,[],CHEMBL3630466,Inhibition of human Akt1 by kinase inhibition assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL3627617,Eur. J. Med. Chem.,2015.0,"{'bei': '16.98', 'le': '0.31', 'lle': '3.57', 'sei': '11.41'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,7.92,True,http://www.openphacts.org/units/Nanomolar,2507853,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-8M,UO_0000065,,1.2
234067,16258426,[],CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 μM recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C)cc(C(=O)NC(=S)Nc2c(O)cc(C(F)(F)F)cc2C(F)(F)F)c1,,,CHEMBL3638437,,2014.0,"{'bei': '10.73', 'le': '0.22', 'lle': '-0.49', 'sei': '7.63'}",CHEMBL3693947,,CHEMBL3693947,4.68,False,http://www.openphacts.org/units/Nanomolar,2570601,=,37,True,=,,IC50,nM,,20800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20800.0
256507,16259826,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccc(-c5ccn[nH]5)cc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.58', 'le': '0.34', 'lle': '3.78', 'sei': '8.92'}",CHEMBL3701762,,CHEMBL3701762,9.10,False,http://www.openphacts.org/units/Nanomolar,2579091,=,37,True,=,,IC50,nM,,0.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.8
256519,16260143,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccc(C(=O)NCCO)cc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '16.88', 'le': '0.31', 'lle': '4.97', 'sei': '7.03'}",CHEMBL3701774,,CHEMBL3701774,8.62,False,http://www.openphacts.org/units/Nanomolar,2579103,=,37,True,=,,IC50,nM,,2.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.4
256461,16262098,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cccc(F)c3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.88', 'le': '0.35', 'lle': '3.27', 'sei': '11.37'}",CHEMBL3701718,,CHEMBL3701718,8.34,False,http://www.openphacts.org/units/Nanomolar,2579045,=,37,True,=,,IC50,nM,,4.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.6
256512,16262803,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccc(C(N)=O)cc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.85', 'le': '0.34', 'lle': '4.77', 'sei': '7.56'}",CHEMBL3701767,,CHEMBL3701767,8.80,False,http://www.openphacts.org/units/Nanomolar,2579096,=,37,True,=,,IC50,nM,,1.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.6
256497,16265639,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ncccc3-4)cc2)CC(O)(C2CC2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '19.65', 'le': '0.36', 'lle': '4.13', 'sei': '10.27'}",CHEMBL3701752,,CHEMBL3701752,8.85,False,http://www.openphacts.org/units/Nanomolar,2579081,=,37,True,=,,IC50,nM,,1.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.4
256522,16266041,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(O)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccc(C(=O)O)cc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '17.72', 'le': '0.32', 'lle': '3.64', 'sei': '7.92'}",CHEMBL3701777,,CHEMBL3701777,8.30,False,http://www.openphacts.org/units/Nanomolar,2579106,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
256460,16267045,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cccc(F)c3-4)cc2)CC(O)(C2CC2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.03', 'le': '0.33', 'lle': '2.97', 'sei': '11.50'}",CHEMBL3701717,,CHEMBL3701717,8.43,False,http://www.openphacts.org/units/Nanomolar,2579044,=,37,True,=,,IC50,nM,,3.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.7
256516,16267522,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=O)c1ccc2c(c1)OCn1c-2nc(-c2ccc(C3(N)CC(C)(O)C3)cc2)c1-c1ccccc1,,,CHEMBL3639231,,2014.0,"{'bei': '15.82', 'le': '0.29', 'lle': '3.19', 'sei': '8.36'}",CHEMBL3701771,,CHEMBL3701771,7.82,False,http://www.openphacts.org/units/Nanomolar,2579100,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
234064,16268415,[],CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 μM recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C)cc(C(=O)NC(=S)Nc2cc([N+](=O)[O-])ccc2O)c1,,,CHEMBL3638437,,2014.0,"{'bei': '13.22', 'le': '0.26', 'lle': '1.53', 'sei': '4.37'}",CHEMBL3596524,,CHEMBL3596524,4.57,False,http://www.openphacts.org/units/Nanomolar,2570598,=,37,True,=,,IC50,nM,,27100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,27100.0
219800,16268760,[],CHEMBL3705350,Kinase Assay: Activated Akt isoforms and pleckstrin homology domain deletion constructs were assayed utilizing a GSK-derived biotinylated peptide substrate. The extend of peptide was determined by Homogeneous Time Resolved Fluorescence (HTRF) using a lanthanide chelate (Lance)-coupled monoclonal antibody specific for the phosphopeptide in combination with a streptavidin-linked allophycocyanin (SA-APC) fluorophore which will bind to the biotin moiety on the peptide.,B,,,BAO_0000190,BAO_0000357,single protein format,N=C(c1ccccc1)n1c(=N)ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)cc21,,,CHEMBL3638765,,2013.0,"{'bei': '18.40', 'le': '0.33', 'lle': '2.58', 'sei': '9.44'}",CHEMBL3679633,,CHEMBL3679633,8.64,False,http://www.openphacts.org/units/Nanomolar,2555467,=,37,True,=,,IC50,nM,,2.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.3
256467,16268844,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccc(F)cc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.56', 'le': '0.34', 'lle': '3.12', 'sei': '11.18'}",CHEMBL3701724,,CHEMBL3701724,8.19,False,http://www.openphacts.org/units/Nanomolar,2579051,=,37,True,=,,IC50,nM,,6.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.4
219802,16269298,[],CHEMBL3705350,Kinase Assay: Activated Akt isoforms and pleckstrin homology domain deletion constructs were assayed utilizing a GSK-derived biotinylated peptide substrate. The extend of peptide was determined by Homogeneous Time Resolved Fluorescence (HTRF) using a lanthanide chelate (Lance)-coupled monoclonal antibody specific for the phosphopeptide in combination with a streptavidin-linked allophycocyanin (SA-APC) fluorophore which will bind to the biotin moiety on the peptide.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=N)n1c(=N)ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)cc21,,,CHEMBL3638765,,2013.0,"{'bei': '19.84', 'le': '0.36', 'lle': '3.06', 'sei': '8.83'}",CHEMBL3679630,,CHEMBL3679630,8.09,False,http://www.openphacts.org/units/Nanomolar,2555464,=,37,True,=,,IC50,nM,,8.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.2
256514,16270429,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)c1ccc2c(c1)-c1nc(-c3ccc(C4(N)CC(C)(O)C4)cc3)c(-c3ccccc3)n1CO2,,,CHEMBL3639231,,2014.0,"{'bei': '17.68', 'le': '0.32', 'lle': '4.06', 'sei': '8.54'}",CHEMBL3701769,,CHEMBL3701769,8.74,False,http://www.openphacts.org/units/Nanomolar,2579098,=,37,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
256482,16270536,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCOc1cccc2c1-c1nc(-c3ccc(C4(N)CC(O)(C5CC5)C4)cc3)c(-c3ccccc3)n1CO2,,,CHEMBL3639231,,2014.0,"{'bei': '15.30', 'le': '0.28', 'lle': '1.83', 'sei': '9.15'}",CHEMBL3701738,,CHEMBL3701738,7.55,False,http://www.openphacts.org/units/Nanomolar,2579066,=,37,True,=,,IC50,nM,,28.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,28.0
256481,16273574,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cccc(Cl)c3-4)cc2)CC(O)(C2CC2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '16.71', 'le': '0.32', 'lle': '2.11', 'sei': '11.03'}",CHEMBL3701737,,CHEMBL3701737,8.09,False,http://www.openphacts.org/units/Nanomolar,2579065,=,37,True,=,,IC50,nM,,8.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.2
256501,16275675,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3nccnc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '19.26', 'le': '0.35', 'lle': '4.47', 'sei': '8.27'}",CHEMBL3701756,,CHEMBL3701756,8.19,False,http://www.openphacts.org/units/Nanomolar,2579085,=,37,True,=,,IC50,nM,,6.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.4
256523,16275757,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(O)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cc(C(=O)O)ccc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.16', 'le': '0.33', 'lle': '3.85', 'sei': '8.12'}",CHEMBL3701778,,CHEMBL3701778,8.51,False,http://www.openphacts.org/units/Nanomolar,2579107,=,37,True,=,,IC50,nM,,3.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.1
256477,16277635,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1)OCn1c-2nc(-c2ccc(C3(N)CC(O)(C4CC4)C3)cc2)c1-c1ccccc1,,,CHEMBL3639231,,2014.0,"{'bei': '17.58', 'le': '0.32', 'lle': '3.10', 'sei': '10.22'}",CHEMBL3701734,,CHEMBL3701734,8.43,False,http://www.openphacts.org/units/Nanomolar,2579061,=,37,True,=,,IC50,nM,,3.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.7
256480,16278551,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1)OCn1c-2nc(-c2ccc(C3(N)CC(C)(O)C3)cc2)c1-c1ccccc1,,,CHEMBL3639231,,2014.0,"{'bei': '18.13', 'le': '0.33', 'lle': '3.28', 'sei': '9.96'}",CHEMBL3701736,,CHEMBL3701736,8.22,False,http://www.openphacts.org/units/Nanomolar,2579064,=,37,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
256471,16279397,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccccc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '19.54', 'le': '0.35', 'lle': '3.35', 'sei': '11.29'}",CHEMBL3701728,,CHEMBL3701728,8.28,False,http://www.openphacts.org/units/Nanomolar,2579055,=,37,True,=,,IC50,nM,,5.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.3
256478,16279485,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc2c1-c1nc(-c3ccc(C4(N)CC(O)(C5CC5)C4)cc3)c(-c3ccccc3)n1CO2,,,CHEMBL3639231,,2014.0,"{'bei': '16.26', 'le': '0.30', 'lle': '2.47', 'sei': '9.45'}",CHEMBL3701732,,CHEMBL3701732,7.80,False,http://www.openphacts.org/units/Nanomolar,2579062,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
256508,16280013,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccc(-c5cn[nH]c5)cc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.15', 'le': '0.33', 'lle': '3.57', 'sei': '8.71'}",CHEMBL3701763,,CHEMBL3701763,8.89,False,http://www.openphacts.org/units/Nanomolar,2579092,=,37,True,=,,IC50,nM,,1.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.3
256520,16280218,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCONC(=O)c1ccc2c(c1)-c1nc(-c3ccc(C4(N)CC(C)(O)C4)cc3)c(-c3ccccc3)n1CO2,,,CHEMBL3639231,,2014.0,"{'bei': '17.13', 'le': '0.31', 'lle': '4.13', 'sei': '7.83'}",CHEMBL3701775,,CHEMBL3701775,8.74,False,http://www.openphacts.org/units/Nanomolar,2579104,=,37,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
256511,16281589,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CNC(=O)c1ccc2c(c1)-c1nc(-c3ccc(C4(N)CC(C)(O)C4)cc3)c(-c3ccccc3)n1CO2,,,CHEMBL3639231,,2014.0,"{'bei': '18.36', 'le': '0.33', 'lle': '4.53', 'sei': '8.62'}",CHEMBL3701766,,CHEMBL3701766,8.82,False,http://www.openphacts.org/units/Nanomolar,2579095,=,37,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
256492,16283497,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccncc3-4)cc2)CCC1,,,CHEMBL3639231,,2014.0,"{'bei': '19.91', 'le': '0.36', 'lle': '2.88', 'sei': '11.91'}",CHEMBL3701748,,CHEMBL3701748,7.85,False,http://www.openphacts.org/units/Nanomolar,2579076,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
256509,16285541,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cnc2c(c1)OCn1c-2nc(-c2ccc(C3(N)CC(C)(O)C3)cc2)c1-c1ccccc1,,,CHEMBL3639231,,2014.0,"{'bei': '18.15', 'le': '0.33', 'lle': '3.32', 'sei': '9.23'}",CHEMBL3701764,,CHEMBL3701764,7.96,False,http://www.openphacts.org/units/Nanomolar,2579093,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
256506,16287453,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccc(C#N)cc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.63', 'le': '0.34', 'lle': '3.56', 'sei': '8.61'}",CHEMBL3701761,,CHEMBL3701761,8.36,False,http://www.openphacts.org/units/Nanomolar,2579090,=,37,True,=,,IC50,nM,,4.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.4
256486,16288423,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cccnc3-4)cc2)CC(O)(C2CC2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '17.66', 'le': '0.32', 'lle': '3.24', 'sei': '9.23'}",CHEMBL3701742,,CHEMBL3701742,7.96,False,http://www.openphacts.org/units/Nanomolar,2579070,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
256515,16288912,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CNC(=O)c1ccc2c(c1)OCn1c-2nc(-c2ccc(C3(N)CC(C)(O)C3)cc2)c1-c1ccccc1,,,CHEMBL3639231,,2014.0,"{'bei': '18.20', 'le': '0.33', 'lle': '4.45', 'sei': '8.54'}",CHEMBL3701770,,CHEMBL3701770,8.74,False,http://www.openphacts.org/units/Nanomolar,2579099,=,37,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
256505,16294889,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cc(C#N)ccc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.30', 'le': '0.33', 'lle': '3.41', 'sei': '8.45'}",CHEMBL3701760,,CHEMBL3701760,8.21,False,http://www.openphacts.org/units/Nanomolar,2579089,=,37,True,=,,IC50,nM,,6.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.2
234066,16294896,[],CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 μM recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C)cc(C(=O)NC(=S)Nc2cc(C(F)(F)F)ccc2O)c1,,,CHEMBL3638437,,2014.0,"{'bei': '12.61', 'le': '0.25', 'lle': '0.50', 'sei': '7.57'}",CHEMBL3693946,,CHEMBL3693946,4.65,False,http://www.openphacts.org/units/Nanomolar,2570600,=,37,True,=,,IC50,nM,,22600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22600.0
256521,16297843,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cc(C(N)=O)ccc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '19.05', 'le': '0.35', 'lle': '4.86', 'sei': '7.63'}",CHEMBL3701776,,CHEMBL3701776,8.89,False,http://www.openphacts.org/units/Nanomolar,2579105,=,37,True,=,,IC50,nM,,1.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.3
256463,16300558,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccsc3)COc3cccc(F)c3-4)cc2)CC(O)(C2CC2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '17.21', 'le': '0.33', 'lle': '2.63', 'sei': '11.12'}",CHEMBL3701720,,CHEMBL3701720,8.15,False,http://www.openphacts.org/units/Nanomolar,2579047,=,37,True,=,,IC50,nM,,7.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.1
256490,16301470,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccncc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '19.10', 'le': '0.35', 'lle': '3.66', 'sei': '9.72'}",CHEMBL3701746,,CHEMBL3701746,8.38,False,http://www.openphacts.org/units/Nanomolar,2579074,=,37,True,=,,IC50,nM,,4.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.2
256464,16301914,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccncc3)COc3cccc(F)c3-4)cc2)CC(O)(C2CC2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '16.34', 'le': '0.30', 'lle': '2.80', 'sei': '8.88'}",CHEMBL3701721,,CHEMBL3701721,7.66,False,http://www.openphacts.org/units/Nanomolar,2579048,=,37,True,=,,IC50,nM,,22.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22.0
256462,16303293,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cccc(F)c3-4)cc2)CCC1,,,CHEMBL3639231,,2014.0,"{'bei': '18.95', 'le': '0.34', 'lle': '2.09', 'sei': '14.69'}",CHEMBL3701719,,CHEMBL3701719,7.80,False,http://www.openphacts.org/units/Nanomolar,2579046,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
256465,16303795,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccsc3)COc3cccc(F)c3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '17.90', 'le': '0.34', 'lle': '2.88', 'sei': '10.93'}",CHEMBL3701722,,CHEMBL3701722,8.01,False,http://www.openphacts.org/units/Nanomolar,2579049,=,37,True,=,,IC50,nM,,9.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.8
234065,16306425,[],CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 μM recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C)cc(C(=O)NC(=S)Nc2c(O)cc(C)c(Cl)c2C)c1,,,CHEMBL3638437,,2014.0,"{'bei': '13.11', 'le': '0.27', 'lle': '0.35', 'sei': '7.75'}",CHEMBL3693945,,CHEMBL3693945,4.76,False,http://www.openphacts.org/units/Nanomolar,2570599,=,37,True,=,,IC50,nM,,17500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17500.0
17442,16307705,[],CHEMBL3705350,Kinase Assay: Activated Akt isoforms and pleckstrin homology domain deletion constructs were assayed utilizing a GSK-derived biotinylated peptide substrate. The extend of peptide was determined by Homogeneous Time Resolved Fluorescence (HTRF) using a lanthanide chelate (Lance)-coupled monoclonal antibody specific for the phosphopeptide in combination with a streptavidin-linked allophycocyanin (SA-APC) fluorophore which will bind to the biotin moiety on the peptide.,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@]1(c2ccc(-c3nc4ccc5nnc(C(F)F)n5c4cc3-c3ccccc3)cc2)C[C@](O)(C2CC2)C1,,,CHEMBL3638765,,2013.0,"{'bei': '19.03', 'le': '0.35', 'lle': '3.83', 'sei': '10.60'}",CHEMBL3679636,,CHEMBL3679636,9.47,False,http://www.openphacts.org/units/Nanomolar,2555470,=,37,True,=,,IC50,nM,,0.34,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.34
256518,16308026,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCONC(=O)c1ccc2c(c1)OCn1c-2nc(-c2ccc(C3(N)CC(C)(O)C3)cc2)c1-c1ccccc1,,,CHEMBL3639231,,2014.0,"{'bei': '17.00', 'le': '0.31', 'lle': '4.07', 'sei': '7.77'}",CHEMBL3701773,,CHEMBL3701773,8.68,False,http://www.openphacts.org/units/Nanomolar,2579102,=,37,True,=,,IC50,nM,,2.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.1
256472,16308087,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccccc3-4)cc2)CCC1,,,CHEMBL3639231,,2014.0,"{'bei': '20.04', 'le': '0.36', 'lle': '2.32', 'sei': '14.86'}",CHEMBL3701729,,CHEMBL3701729,7.89,False,http://www.openphacts.org/units/Nanomolar,2579056,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
256468,16308698,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cc(F)ccc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.28', 'le': '0.33', 'lle': '3.00', 'sei': '11.01'}",CHEMBL3701725,,CHEMBL3701725,8.07,False,http://www.openphacts.org/units/Nanomolar,2579052,=,37,True,=,,IC50,nM,,8.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.5
256502,16309362,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3nccnc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.42', 'le': '0.34', 'lle': '3.99', 'sei': '8.17'}",CHEMBL3701757,,CHEMBL3701757,8.10,False,http://www.openphacts.org/units/Nanomolar,2579086,=,37,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
256487,16311206,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cccnc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.75', 'le': '0.34', 'lle': '3.63', 'sei': '9.23'}",CHEMBL3701743,,CHEMBL3701743,7.96,False,http://www.openphacts.org/units/Nanomolar,2579071,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
256504,16313022,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cc(CO)ccc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '17.78', 'le': '0.32', 'lle': '3.64', 'sei': '8.62'}",CHEMBL3701759,,CHEMBL3701759,8.07,False,http://www.openphacts.org/units/Nanomolar,2579088,=,37,True,=,,IC50,nM,,8.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.6
256499,16313609,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ncccc3-4)cc2)CCC1,,,CHEMBL3639231,,2014.0,"{'bei': '21.32', 'le': '0.38', 'lle': '3.44', 'sei': '12.75'}",CHEMBL3701754,,CHEMBL3701754,8.41,False,http://www.openphacts.org/units/Nanomolar,2579083,=,37,True,=,,IC50,nM,,3.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.9
17441,16313735,[],CHEMBL3705350,Kinase Assay: Activated Akt isoforms and pleckstrin homology domain deletion constructs were assayed utilizing a GSK-derived biotinylated peptide substrate. The extend of peptide was determined by Homogeneous Time Resolved Fluorescence (HTRF) using a lanthanide chelate (Lance)-coupled monoclonal antibody specific for the phosphopeptide in combination with a streptavidin-linked allophycocyanin (SA-APC) fluorophore which will bind to the biotin moiety on the peptide.,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@]1(c2ccc(-c3nc4ccc5nnc(C6NCNN6)n5c4cc3-c3ccccc3)cc2)C[C@](O)(C2CC2)C1,,,CHEMBL3638765,,2013.0,"{'bei': '17.65', 'le': '0.32', 'lle': '5.80', 'sei': '7.30'}",CHEMBL3679635,,CHEMBL3679635,9.15,False,http://www.openphacts.org/units/Nanomolar,2555469,=,37,True,=,,IC50,nM,,0.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.7
256517,16316246,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cc(C(=O)NCCO)ccc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '16.66', 'le': '0.31', 'lle': '4.86', 'sei': '6.94'}",CHEMBL3701772,,CHEMBL3701772,8.51,False,http://www.openphacts.org/units/Nanomolar,2579101,=,37,True,=,,IC50,nM,,3.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.1
234069,16316648,[],CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 μM recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C)cc(C(=O)NC(=S)Nc2cc(-c3ccccc3)ccc2O)c1,,,CHEMBL3638437,,2014.0,"{'bei': '12.94', 'le': '0.25', 'lle': '0.07', 'sei': '7.94'}",CHEMBL3693949,,CHEMBL3693949,4.87,False,http://www.openphacts.org/units/Nanomolar,2570603,=,37,True,=,,IC50,nM,,13400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13400.0
256491,16317082,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccncc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '19.27', 'le': '0.35', 'lle': '3.85', 'sei': '9.49'}",CHEMBL3701747,,CHEMBL3701747,8.18,False,http://www.openphacts.org/units/Nanomolar,2579075,=,37,True,=,,IC50,nM,,6.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.6
256483,16318121,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCOc1cccc2c1-c1nc(-c3ccc(C4(N)CC(C)(O)C4)cc3)c(-c3ccccc3)n1CO2,,,CHEMBL3639231,,2014.0,"{'bei': '16.09', 'le': '0.29', 'lle': '2.19', 'sei': '9.12'}",CHEMBL3701739,,CHEMBL3701739,7.52,False,http://www.openphacts.org/units/Nanomolar,2579067,=,37,True,=,,IC50,nM,,30.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30.0
256475,16320160,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc2c1-c1nc(-c3ccc(C4(N)CC(O)(C5CC5)C4)cc3)c(-c3ccccc3)n1CO2,,,CHEMBL3639231,,2014.0,"{'bei': '17.35', 'le': '0.32', 'lle': '2.99', 'sei': '10.08'}",CHEMBL3701732,,CHEMBL3701732,8.32,False,http://www.openphacts.org/units/Nanomolar,2579059,=,37,True,=,,IC50,nM,,4.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.8
256484,16324058,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(OC)c2c(c1)OCn1c-2nc(-c2ccc(C3(N)CC(O)(C4CC4)C3)cc2)c1-c1ccccc1,,,CHEMBL3639231,,2014.0,"{'bei': '15.54', 'le': '0.28', 'lle': '2.58', 'sei': '8.63'}",CHEMBL3701740,,CHEMBL3701740,7.92,False,http://www.openphacts.org/units/Nanomolar,2579068,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
256473,16324115,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccsc3)COc3ccccc3-4)cc2)CCC1,,,CHEMBL3639231,,2014.0,"{'bei': '18.94', 'le': '0.36', 'lle': '1.94', 'sei': '14.26'}",CHEMBL3701730,,CHEMBL3701730,7.57,False,http://www.openphacts.org/units/Nanomolar,2579057,=,37,True,=,,IC50,nM,,27.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,27.0
256470,16325514,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccccc3-4)cc2)CC(O)(C2CC2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.71', 'le': '0.34', 'lle': '3.09', 'sei': '11.47'}",CHEMBL3701727,,CHEMBL3701727,8.41,False,http://www.openphacts.org/units/Nanomolar,2579054,=,37,True,=,,IC50,nM,,3.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.9
256513,16325900,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=O)c1ccc2c(c1)-c1nc(-c3ccc(C4(N)CC(C)(O)C4)cc3)c(-c3ccccc3)n1CO2,,,CHEMBL3639231,,2014.0,"{'bei': '16.90', 'le': '0.31', 'lle': '3.73', 'sei': '8.93'}",CHEMBL3701768,,CHEMBL3701768,8.36,False,http://www.openphacts.org/units/Nanomolar,2579097,=,37,True,=,,IC50,nM,,4.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.4
256476,16327742,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1)-c1nc(-c3ccc(C4(N)CC(O)(C5CC5)C4)cc3)c(-c3ccccc3)n1CO2,,,CHEMBL3639231,,2014.0,"{'bei': '18.23', 'le': '0.33', 'lle': '3.41', 'sei': '10.60'}",CHEMBL3701733,,CHEMBL3701733,8.74,False,http://www.openphacts.org/units/Nanomolar,2579060,=,37,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
256503,16333209,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccc(CO)cc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '19.09', 'le': '0.35', 'lle': '4.23', 'sei': '9.26'}",CHEMBL3701758,,CHEMBL3701758,8.66,False,http://www.openphacts.org/units/Nanomolar,2579087,=,37,True,=,,IC50,nM,,2.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.2
256495,16335421,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cnccc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '20.49', 'le': '0.37', 'lle': '4.37', 'sei': '10.09'}",CHEMBL3701750,,CHEMBL3701750,8.70,False,http://www.openphacts.org/units/Nanomolar,2579079,=,37,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
256510,16338302,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(n1)-c1nc(-c3ccc(C4(N)CC(C)(O)C4)cc3)c(-c3ccccc3)n1CO2,,,CHEMBL3639231,,2014.0,"{'bei': '18.17', 'le': '0.33', 'lle': '3.92', 'sei': '8.66'}",CHEMBL3701765,,CHEMBL3701765,8.26,False,http://www.openphacts.org/units/Nanomolar,2579094,=,37,True,=,,IC50,nM,,5.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.5
256494,16338450,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cnccc3-4)cc2)CC(O)(C2CC2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '19.52', 'le': '0.35', 'lle': '4.08', 'sei': '10.21'}",CHEMBL3701749,,CHEMBL3701749,8.80,False,http://www.openphacts.org/units/Nanomolar,2579078,=,37,True,=,,IC50,nM,,1.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.6
256488,16338934,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cccnc3-4)cc2)CCC1,,,CHEMBL3639231,,2014.0,"{'bei': '18.90', 'le': '0.34', 'lle': '2.49', 'sei': '11.30'}",CHEMBL3701744,,CHEMBL3701744,7.46,False,http://www.openphacts.org/units/Nanomolar,2579072,=,37,True,=,,IC50,nM,,35.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,35.0
256466,16339646,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccncc3)COc3cccc(F)c3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '17.18', 'le': '0.31', 'lle': '3.13', 'sei': '8.82'}",CHEMBL3701723,,CHEMBL3701723,7.60,False,http://www.openphacts.org/units/Nanomolar,2579050,=,37,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
256489,16340981,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cccnc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '17.06', 'le': '0.31', 'lle': '2.76', 'sei': '8.68'}",CHEMBL3701745,,CHEMBL3701745,7.48,False,http://www.openphacts.org/units/Nanomolar,2579073,=,37,True,=,,IC50,nM,,33.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,33.0
256479,16342057,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1)-c1nc(-c3ccc(C4(N)CC(C)(O)C4)cc3)c(-c3ccccc3)n1CO2,,,CHEMBL3639231,,2014.0,"{'bei': '18.82', 'le': '0.34', 'lle': '3.60', 'sei': '10.34'}",CHEMBL3701735,,CHEMBL3701735,8.54,False,http://www.openphacts.org/units/Nanomolar,2579063,=,37,True,=,,IC50,nM,,2.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.9
256485,16343794,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc2c(c1)OCn1c-2nc(-c2ccc(C3(N)CC(O)(C4CC4)C3)cc2)c1-c1ccccc1,,,CHEMBL3639231,,2014.0,"{'bei': '16.36', 'le': '0.30', 'lle': '1.96', 'sei': '10.35'}",CHEMBL3701741,,CHEMBL3701741,7.58,False,http://www.openphacts.org/units/Nanomolar,2579069,=,37,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.0
219801,16344251,[],CHEMBL3705350,Kinase Assay: Activated Akt isoforms and pleckstrin homology domain deletion constructs were assayed utilizing a GSK-derived biotinylated peptide substrate. The extend of peptide was determined by Homogeneous Time Resolved Fluorescence (HTRF) using a lanthanide chelate (Lance)-coupled monoclonal antibody specific for the phosphopeptide in combination with a streptavidin-linked allophycocyanin (SA-APC) fluorophore which will bind to the biotin moiety on the peptide.,B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N)n1c(=N)ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)cc21,,,CHEMBL3638765,,2013.0,"{'bei': '20.11', 'le': '0.36', 'lle': '4.28', 'sei': '6.99'}",CHEMBL3679629,,CHEMBL3679629,8.21,False,http://www.openphacts.org/units/Nanomolar,2555463,=,37,True,=,,IC50,nM,,6.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.1
219799,16344381,[],CHEMBL3705350,Kinase Assay: Activated Akt isoforms and pleckstrin homology domain deletion constructs were assayed utilizing a GSK-derived biotinylated peptide substrate. The extend of peptide was determined by Homogeneous Time Resolved Fluorescence (HTRF) using a lanthanide chelate (Lance)-coupled monoclonal antibody specific for the phosphopeptide in combination with a streptavidin-linked allophycocyanin (SA-APC) fluorophore which will bind to the biotin moiety on the peptide.,B,,,BAO_0000190,BAO_0000357,single protein format,N=c1ccc2nc(-c3ccc(C4(NC(=O)Cc5cccnc5)CCC4)cc3)c(-c3ccccc3)cc2n1C(N)=O,,,CHEMBL3638765,,2013.0,"{'bei': '14.02', 'le': '0.25', 'lle': '2.50', 'sei': '5.85'}",CHEMBL3679634,,CHEMBL3679634,7.41,False,http://www.openphacts.org/units/Nanomolar,2555468,=,37,True,=,,IC50,nM,,39.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,39.0
256469,16345644,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3c(F)cccc3-4)cc2)CC(O)(C2CC2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.48', 'le': '0.34', 'lle': '3.18', 'sei': '11.78'}",CHEMBL3701726,,CHEMBL3701726,8.64,False,http://www.openphacts.org/units/Nanomolar,2579053,=,37,True,=,,IC50,nM,,2.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.3
234068,16345716,[],CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 μM recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C)cc(C(=O)NC(=S)Nc2c(O)cc(C)c(Br)c2C)c1,,,CHEMBL3638437,,2014.0,"{'bei': '11.64', 'le': '0.27', 'lle': '0.22', 'sei': '7.73'}",CHEMBL3693948,,CHEMBL3693948,4.74,False,http://www.openphacts.org/units/Nanomolar,2570602,=,37,True,=,,IC50,nM,,18100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18100.0
256500,16347838,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3nccnc3-4)cc2)CC(O)(C2CC2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.31', 'le': '0.33', 'lle': '4.16', 'sei': '8.34'}",CHEMBL3701755,,CHEMBL3701755,8.27,False,http://www.openphacts.org/units/Nanomolar,2579084,=,37,True,=,,IC50,nM,,5.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.4
256493,16349150,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccncc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '18.06', 'le': '0.33', 'lle': '3.20', 'sei': '9.19'}",CHEMBL3701746,,CHEMBL3701746,7.92,False,http://www.openphacts.org/units/Nanomolar,2579077,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
256474,16349244,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccncc3)COc3ccccc3-4)cc2)CCC1,,,CHEMBL3639231,,2014.0,"{'bei': '18.49', 'le': '0.33', 'lle': '2.32', 'sei': '11.06'}",CHEMBL3701731,,CHEMBL3701731,7.29,False,http://www.openphacts.org/units/Nanomolar,2579058,=,37,True,=,,IC50,nM,,51.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,51.0
256496,16349596,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cnccc3-4)cc2)CCC1,,,CHEMBL3639231,,2014.0,"{'bei': '20.94', 'le': '0.38', 'lle': '3.29', 'sei': '12.52'}",CHEMBL3701751,,CHEMBL3701751,8.26,False,http://www.openphacts.org/units/Nanomolar,2579080,=,37,True,=,,IC50,nM,,5.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.5
234063,16352115,[],CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 μM recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC(=S)Nc1cc([N+](=O)[O-])cc(Cl)c1O)c1ccccc1,,,CHEMBL3638437,,2014.0,"{'bei': '12.82', 'le': '0.27', 'lle': '1.43', 'sei': '4.31'}",CHEMBL3596523,,CHEMBL3596523,4.51,False,http://www.openphacts.org/units/Nanomolar,2570597,=,37,True,=,,IC50,nM,,31000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31000.0
219804,16353205,[],CHEMBL3705350,Kinase Assay: Activated Akt isoforms and pleckstrin homology domain deletion constructs were assayed utilizing a GSK-derived biotinylated peptide substrate. The extend of peptide was determined by Homogeneous Time Resolved Fluorescence (HTRF) using a lanthanide chelate (Lance)-coupled monoclonal antibody specific for the phosphopeptide in combination with a streptavidin-linked allophycocyanin (SA-APC) fluorophore which will bind to the biotin moiety on the peptide.,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]1(O)C[C@@](N)(c2ccc(-c3nc4ccc5nnc(C(F)F)n5c4cc3-c3ccccc3)cc2)C1,,,CHEMBL3638765,,2013.0,"{'bei': '19.98', 'le': '0.37', 'lle': '4.17', 'sei': '10.55'}",CHEMBL3679632,,CHEMBL3679632,9.42,False,http://www.openphacts.org/units/Nanomolar,2555466,=,37,True,=,,IC50,nM,,0.38,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.38
219803,16353825,[],CHEMBL3705350,Kinase Assay: Activated Akt isoforms and pleckstrin homology domain deletion constructs were assayed utilizing a GSK-derived biotinylated peptide substrate. The extend of peptide was determined by Homogeneous Time Resolved Fluorescence (HTRF) using a lanthanide chelate (Lance)-coupled monoclonal antibody specific for the phosphopeptide in combination with a streptavidin-linked allophycocyanin (SA-APC) fluorophore which will bind to the biotin moiety on the peptide.,B,,,BAO_0000190,BAO_0000357,single protein format,N=C(c1ccccc1)n1c(=N)ccc2nc(-c3ccc(C4(N)CC(F)(F)C4)cc3)c(-c3ccccc3)cc21,,,CHEMBL3638765,,2013.0,"{'bei': '15.82', 'le': '0.29', 'lle': '1.69', 'sei': '8.74'}",CHEMBL3679631,,CHEMBL3679631,8.00,False,http://www.openphacts.org/units/Nanomolar,2555465,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
256498,16355204,[],CHEMBL3705737,"Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at Ã¢ 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ncccc3-4)cc2)C1,,,CHEMBL3639231,,2014.0,"{'bei': '20.86', 'le': '0.38', 'lle': '4.52', 'sei': '10.27'}",CHEMBL3701753,,CHEMBL3701753,8.85,False,http://www.openphacts.org/units/Nanomolar,2579082,=,37,True,=,,IC50,nM,,1.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.4
,16413402,[],CHEMBL3743742,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1,,,CHEMBL3739276,J. Med. Chem.,2015.0,,CHEMBL3741589,,CHEMBL3741589,,False,http://www.openphacts.org/units/Nanomolar,2738383,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,16421938,[],CHEMBL3750421,Inhibition of PKBalpha (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,,,CHEMBL3745712,J. Med. Chem.,2015.0,,CHEMBL3651966,,CHEMBL3651966,,False,http://www.openphacts.org/units/Nanomolar,2742405,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,16431723,[],CHEMBL3749731,Inhibition of human AKT1 using [KGSGSGRPRTSSFAEG] as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21,,,CHEMBL3745707,Bioorg. Med. Chem.,2016.0,,CHEMBL3745885,,CHEMBL3745885,,False,http://www.openphacts.org/units/Nanomolar,2741358,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,16456950,[],CHEMBL3760810,Inhibition of recombinant human AKT for 60 mins by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2ncc(OCC3CCNCC3)cc2-c2ccc(C#N)cc2)cc1,,,CHEMBL3758149,J. Med. Chem.,2016.0,"{'bei': '10.58', 'le': '0.19', 'lle': '-0.91', 'sei': '7.00'}",CHEMBL3759201,,CHEMBL3759201,4.06,False,http://www.openphacts.org/units/Nanomolar,2748415,=,1,True,=,,IC50,nM,,87600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,87.6
,16467131,[],CHEMBL3767267,"Antagonist activity at human AKT1-PH domain (1 to 121 residues) assessed as reduction of AKT1-PH interaction with PC/PE/PS/PI(3,4,5)P3 after 30 mins by competitive SPR analysis",B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N/C(=N/O)c1nonc1N)c1ccccc1Br,,,CHEMBL3763051,MedChemComm,2015.0,"{'bei': '14.72', 'le': '0.34', 'lle': '3.62', 'sei': '3.59'}",CHEMBL3764688,,CHEMBL3764688,4.79,False,http://www.openphacts.org/units/Nanomolar,2756549,=,1,True,=,,IC50,nM,,16350.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,16.35
,16467132,[],CHEMBL3767267,"Antagonist activity at human AKT1-PH domain (1 to 121 residues) assessed as reduction of AKT1-PH interaction with PC/PE/PS/PI(3,4,5)P3 after 30 mins by competitive SPR analysis",B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N/C(=N/O)c1nonc1N)N1CCCN=C1N,,,CHEMBL3763051,MedChemComm,2015.0,"{'bei': '20.55', 'le': '0.39', 'lle': '7.16', 'sei': '3.14'}",CHEMBL3764684,,CHEMBL3764684,5.49,False,http://www.openphacts.org/units/Nanomolar,2756548,=,1,True,=,,IC50,nM,,3230.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.23
,16467133,[],CHEMBL3767267,"Antagonist activity at human AKT1-PH domain (1 to 121 residues) assessed as reduction of AKT1-PH interaction with PC/PE/PS/PI(3,4,5)P3 after 30 mins by competitive SPR analysis",B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N/C(=N/O)c1nonc1N)c1ccccc1N,,,CHEMBL3763051,MedChemComm,2015.0,"{'bei': '19.39', 'le': '0.36', 'lle': '5.08', 'sei': '3.18'}",CHEMBL3763907,,CHEMBL3763907,5.07,False,http://www.openphacts.org/units/Nanomolar,2756547,=,1,True,=,,IC50,nM,,8610.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,8.61
,16467134,[],CHEMBL3767267,"Antagonist activity at human AKT1-PH domain (1 to 121 residues) assessed as reduction of AKT1-PH interaction with PC/PE/PS/PI(3,4,5)P3 after 30 mins by competitive SPR analysis",B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N/C(=N/O)c1nonc1N)c1ccccc1,,,CHEMBL3763051,MedChemComm,2015.0,"{'bei': '20.89', 'le': '0.39', 'lle': '4.74', 'sei': '3.86'}",CHEMBL3764457,,CHEMBL3764457,5.14,False,http://www.openphacts.org/units/Nanomolar,2756546,=,1,True,=,,IC50,nM,,7190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,7.19
,16467135,[],CHEMBL3767267,"Antagonist activity at human AKT1-PH domain (1 to 121 residues) assessed as reduction of AKT1-PH interaction with PC/PE/PS/PI(3,4,5)P3 after 30 mins by competitive SPR analysis",B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N)NC(=N)N/C(=N/O)c1nonc1N,,,CHEMBL3763051,MedChemComm,2015.0,"{'bei': '25.23', 'le': '0.49', 'lle': '7.93', 'sei': '2.94'}",CHEMBL3764886,,CHEMBL3764886,5.73,False,http://www.openphacts.org/units/Nanomolar,2756545,=,1,True,=,,IC50,nM,,1850.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.85
,16518661,[],CHEMBL3782579,Inhibition of Akt1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL3779812,Eur. J. Med. Chem.,2016.0,"{'bei': '13.12', 'le': '0.24', 'lle': '0.92', 'sei': '7.58'}",CHEMBL258844,,CHEMBL258844,7.24,False,http://www.openphacts.org/units/Nanomolar,2765910,=,1,True,=,,IC50,nM,,58.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,58.0
,16540736,[],CHEMBL3789974,Inhibition of AKT1 (unknown origin) in presence of [gamma33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,,,CHEMBL3785066,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL1614712,,CHEMBL1614712,,False,http://www.openphacts.org/units/Nanomolar,2767460,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,16540737,[],CHEMBL3789974,Inhibition of AKT1 (unknown origin) in presence of [gamma33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,,,CHEMBL3785066,Bioorg. Med. Chem. Lett.,2016.0,"{'bei': '14.75', 'le': '0.27', 'lle': '2.11', 'sei': '6.43'}",CHEMBL3787112,,CHEMBL3787112,5.16,False,http://www.openphacts.org/units/Nanomolar,2767463,=,1,True,=,,IC50,nM,,7000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,7.0
,16540738,[],CHEMBL3789974,Inhibition of AKT1 (unknown origin) in presence of [gamma33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1,,,CHEMBL3785066,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3785951,,CHEMBL3785951,,False,http://www.openphacts.org/units/Nanomolar,2767477,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,16587020,[],CHEMBL3807432,Inhibition of AKT1 (unknown origin) in presence of gamma33-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,,,CHEMBL3804811,J. Med. Chem.,2016.0,,CHEMBL1983268,ENTRECTINIB,CHEMBL1983268,,False,http://www.openphacts.org/units/Nanomolar,2777067,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,16589677,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '18.04', 'le': '0.38', 'lle': '4.18', 'sei': '9.00'}",CHEMBL3137336,UPROSERTIB,CHEMBL3137336,7.75,False,http://www.openphacts.org/units/Nanomolar,2776825,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.018
,16589678,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '17.41', 'le': '0.34', 'lle': '5.32', 'sei': '6.22'}",CHEMBL2325741,CAPIVASERTIB,CHEMBL2325741,7.47,False,http://www.openphacts.org/units/Nanomolar,2776824,=,1,True,=,,IC50,nM,,34.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.034
,16589679,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Br)c1-c1ccc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)cc1,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '11.52', 'le': '0.27', 'lle': '0.68', 'sei': '9.93'}",CHEMBL3805037,,CHEMBL3805037,5.85,False,http://www.openphacts.org/units/Nanomolar,2776823,=,1,True,=,,IC50,nM,,1400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.4
,16589680,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1ccc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)cc1,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '12.33', 'le': '0.26', 'lle': '0.66', 'sei': '9.70'}",CHEMBL3805006,,CHEMBL3805006,5.72,False,http://www.openphacts.org/units/Nanomolar,2776822,=,1,True,=,,IC50,nM,,1910.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.91
,16589681,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1c(Cl)c(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)n(C)c1Cl,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '11.33', 'le': '0.26', 'lle': '0.37', 'sei': '9.50'}",CHEMBL3805319,,CHEMBL3805319,6.07,False,http://www.openphacts.org/units/Nanomolar,2776821,=,1,True,=,,IC50,nM,,850.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.85
,16589682,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(Br)cnn2C)cc1C(=O)NC1(c2ccc(Cl)c(Cl)c2)CCNCC1,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '11.54', 'le': '0.27', 'lle': '1.40', 'sei': '9.24'}",CHEMBL3805443,,CHEMBL3805443,5.90,False,http://www.openphacts.org/units/Nanomolar,2776819,=,1,True,=,,IC50,nM,,1260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.26
,16589683,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1oc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)cc1Br,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '10.94', 'le': '0.27', 'lle': '0.42', 'sei': '8.09'}",CHEMBL3805457,,CHEMBL3805457,5.83,False,http://www.openphacts.org/units/Nanomolar,2776817,=,1,True,=,,IC50,nM,,1480.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.48
,16589684,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)oc1Cl,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '14.78', 'le': '0.33', 'lle': '1.91', 'sei': '10.01'}",CHEMBL3805228,,CHEMBL3805228,7.21,True,http://www.openphacts.org/units/Nanomolar,2776665,=,1,True,=,,IC50,nM,,61.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.061
,16589685,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)NC2(c3ccc(F)cc3)CCNCC2)oc1Cl,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '14.66', 'le': '0.30', 'lle': '2.28', 'sei': '8.89'}",CHEMBL3805691,,CHEMBL3805691,6.41,False,http://www.openphacts.org/units/Nanomolar,2776664,=,1,True,=,,IC50,nM,,390.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.39
,16589686,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Br)c1-c1coc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)c1,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '12.76', 'le': '0.30', 'lle': '1.60', 'sei': '8.82'}",CHEMBL3805855,,CHEMBL3805855,6.36,False,http://www.openphacts.org/units/Nanomolar,2776663,=,1,True,=,,IC50,nM,,440.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.44
,16589687,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Br)c1-c1coc(C(=O)NC2(c3ccc(F)cc3)CCNCC2)c1,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '12.73', 'le': '0.28', 'lle': '2.10', 'sei': '7.90'}",CHEMBL3805617,,CHEMBL3805617,5.70,False,http://www.openphacts.org/units/Nanomolar,2776662,=,1,True,=,,IC50,nM,,2020.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.02
,16589688,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1coc(C(=O)NC2(c3ccc(F)cc3)CCNCC2)c1,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '14.98', 'le': '0.29', 'lle': '2.56', 'sei': '8.37'}",CHEMBL3806229,,CHEMBL3806229,6.04,False,http://www.openphacts.org/units/Nanomolar,2776661,=,1,True,=,,IC50,nM,,920.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.92
,16589689,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1nccc1-c1csc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)c1,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '16.42', 'le': '0.35', 'lle': '2.69', 'sei': '12.13'}",CHEMBL3805163,,CHEMBL3805163,7.15,False,http://www.openphacts.org/units/Nanomolar,2776660,=,1,True,=,,IC50,nM,,71.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.071
,16589690,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Br)c1-c1csc(C(=O)NC2(c3ccc(F)cc3)CCNCC2)c1,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '13.91', 'le': '0.31', 'lle': '2.38', 'sei': '10.93'}",CHEMBL3805232,,CHEMBL3805232,6.44,False,http://www.openphacts.org/units/Nanomolar,2776659,=,1,True,=,,IC50,nM,,360.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.36
,16589691,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1csc(C(=O)NC2(c3ccc(F)cc3)CCNCC2)c1,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '15.50', 'le': '0.32', 'lle': '2.54', 'sei': '11.02'}",CHEMBL3806131,,CHEMBL3806131,6.50,False,http://www.openphacts.org/units/Nanomolar,2776658,=,1,True,=,,IC50,nM,,320.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.32
,16589692,[],CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1nccc1-c1csc(C(=O)NC2(c3ccc(F)cc3)CCNCC2)c1,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '15.70', 'le': '0.31', 'lle': '2.74', 'sei': '10.24'}",CHEMBL3805292,,CHEMBL3805292,6.04,False,http://www.openphacts.org/units/Nanomolar,2776657,=,1,True,=,,IC50,nM,,920.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.92
,16589701,[],CHEMBL3807613,Inhibition of Akt1 (unknown origin) after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL3804794,Eur. J. Med. Chem.,2016.0,"{'bei': '16.62', 'le': '0.30', 'lle': '3.40', 'sei': '11.17'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,7.75,False,http://www.openphacts.org/units/Nanomolar,2776826,=,1,True,=,,IC50,nM,,17.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.6
,16621475,[],CHEMBL3820468,Inhibition of AKT1 (unknown origin) incubated for 1 hr by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21,,,CHEMBL3817824,Bioorg. Med. Chem.,2016.0,,CHEMBL3818247,,CHEMBL3818247,,False,http://www.openphacts.org/units/Nanomolar,2784915,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30000.0
,16622190,[],CHEMBL3820468,Inhibition of AKT1 (unknown origin) incubated for 1 hr by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL3817824,Bioorg. Med. Chem.,2016.0,"{'bei': '17.25', 'le': '0.31', 'lle': '3.70', 'sei': '11.58'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.05,False,http://www.openphacts.org/units/Nanomolar,2783100,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
,16625063,[],CHEMBL3821461,Inhibition of human Akt1 PH domain using AKTide-2T as substrate by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCCCCCCCCCCCCCC(=O)OCC(CO)O[C@@H]1O[C@H](CS(=O)(=O)O)[C@@H](O)[C@H](O)[C@H]1O,,,CHEMBL3817785,Bioorg. Med. Chem.,2016.0,"{'bei': '7.70', 'le': '0.16', 'lle': '1.64', 'sei': '2.50'}",CHEMBL3818018,,CHEMBL3818018,4.50,False,http://www.openphacts.org/units/Nanomolar,2784501,=,1,True,=,,IC50,nM,,31330.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,31.33
,16625064,[],CHEMBL3821461,Inhibition of human Akt1 PH domain using AKTide-2T as substrate by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1,,,CHEMBL3817785,Bioorg. Med. Chem.,2016.0,"{'bei': '9.45', 'le': '0.19', 'lle': '-2.63', 'sei': '7.45'}",CHEMBL372764,PERIFOSINE,CHEMBL372764,4.36,False,http://www.openphacts.org/units/Nanomolar,2784509,=,1,True,=,,IC50,nM,,43350.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,43.35
,16837422,[],CHEMBL3876093,Inhibition of human recombinant full length His-tagged AKT1alpha expressed in baculovirus expression system,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21,,,CHEMBL3875183,Bioorg Med Chem Lett,2017.0,"{'bei': '12.94', 'le': '0.24', 'lle': '0.76', 'sei': '6.38'}",CHEMBL3884319,,CHEMBL3884319,5.00,False,http://www.openphacts.org/units/Nanomolar,2815468,=,1,True,=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,16881148,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccccc2C(F)(F)F)sc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3892820,,CHEMBL3892820,,False,http://www.openphacts.org/units/Nanomolar,2825378,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881149,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ncc(Br)c1-c1cc(C(=O)N[C@H](CN)Cc2ccccc2C(F)(F)F)sc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3890070,,CHEMBL3890070,,False,http://www.openphacts.org/units/Nanomolar,2825379,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881150,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cnn(C)c1-c1cc(C(=O)N[C@H](CN)Cc2ccccc2C(F)(F)F)sc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3952025,,CHEMBL3952025,,False,http://www.openphacts.org/units/Nanomolar,2825380,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881151,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1nccc1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3942525,,CHEMBL3942525,,False,http://www.openphacts.org/units/Nanomolar,2825381,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881152,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1sc(C(=O)N[C@H](CN)Cc2cccc(F)c2)cc1-c1c(Cl)cnn1C,,,CHEMBL3880416,,2011.0,,CHEMBL3907254,,CHEMBL3907254,,False,http://www.openphacts.org/units/Nanomolar,2825382,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881153,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccccc2C(F)(F)F)oc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3904492,,CHEMBL3904492,,False,http://www.openphacts.org/units/Nanomolar,2825383,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881154,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cnn(C)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)oc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3968297,,CHEMBL3968297,,False,http://www.openphacts.org/units/Nanomolar,2825384,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881155,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1sc(C(=O)N[C@H](CN)Cc2cccc(F)c2)cc1-c1c(Cl)cnn1C,,,CHEMBL3880416,,2011.0,,CHEMBL3965875,,CHEMBL3965875,,False,http://www.openphacts.org/units/Nanomolar,2825385,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,8.8,8.6
,16881156,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ncc(Br)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3926382,,CHEMBL3926382,,False,http://www.openphacts.org/units/Nanomolar,2825386,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881157,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ncc(Br)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(C(F)(F)F)c2)sc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3923631,,CHEMBL3923631,,False,http://www.openphacts.org/units/Nanomolar,2825387,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881158,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ncc(Br)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)cc2)sc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3905729,,CHEMBL3905729,,False,http://www.openphacts.org/units/Nanomolar,2825388,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881159,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1sc(C(=O)N[C@H](CN)Cc2cccc(F)c2)cc1-c1c(Cl)cnn1C,,,CHEMBL3880416,,2011.0,,CHEMBL3963487,,CHEMBL3963487,,False,http://www.openphacts.org/units/Nanomolar,2825389,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881160,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)sc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3953883,,CHEMBL3953883,,False,http://www.openphacts.org/units/Nanomolar,2825390,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,8.8,8.6
,16881161,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1nccc1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3929383,,CHEMBL3929383,,False,http://www.openphacts.org/units/Nanomolar,2825391,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881162,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)cc2)sc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3932335,,CHEMBL3932335,,False,http://www.openphacts.org/units/Nanomolar,2825392,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881163,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cnn(C)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3935057,,CHEMBL3935057,,False,http://www.openphacts.org/units/Nanomolar,2825393,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881164,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)sc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3971992,,CHEMBL3971992,,False,http://www.openphacts.org/units/Nanomolar,2825394,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881165,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl,,,CHEMBL3880416,,2011.0,,CHEMBL3903718,,CHEMBL3903718,,False,http://www.openphacts.org/units/Nanomolar,2825395,>=,38,True,<=,,IC50,nM,,2.512,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.6
,16881166,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl,,,CHEMBL3880416,,2011.0,"{'bei': '21.06', 'le': '0.46', 'lle': '5.11', 'sei': '12.34'}",CHEMBL2219422,AFURESERTIB,CHEMBL2219422,9.00,False,http://www.openphacts.org/units/Nanomolar,2825396,=,38,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,9.0
,16881167,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)oc1Cl,,,CHEMBL3880416,,2011.0,"{'bei': '21.88', 'le': '0.46', 'lle': '5.57', 'sei': '10.46'}",CHEMBL3953878,,CHEMBL3953878,9.00,False,http://www.openphacts.org/units/Nanomolar,2825397,=,38,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,9.0
,16881168,[],CHEMBL3880964,Inhibition of full length human AKT1 expressed in Sf9 cells assessed as reduction in substrate phosphorylation using biotin-ahx-ARKRERAYSFGHHA-amide substrate and [gamma-33P]ATP incubated for 40 mins by top count microplate scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl,,,CHEMBL3880416,,2011.0,"{'bei': '20.27', 'le': '0.42', 'lle': '5.14', 'sei': '10.11'}",CHEMBL3137336,UPROSERTIB,CHEMBL3137336,8.70,False,http://www.openphacts.org/units/Nanomolar,2825398,=,38,True,=,,IC50,nM,,1.995,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,8.7
220746,17609745,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '17.83', 'le': '0.32', 'lle': '1.50', 'sei': '9.98'}",CHEMBL3679710,,CHEMBL3679710,5.55,False,http://www.openphacts.org/units/Nanomolar,2555624,=,37,True,=,,IC50,nM,,2800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2800.0
220747,17609746,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1coc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)c1,,,CHEMBL3638978,,2013.0,"{'bei': '17.26', 'le': '0.31', 'lle': '1.55', 'sei': '7.56'}",CHEMBL3679711,,CHEMBL3679711,5.20,False,http://www.openphacts.org/units/Nanomolar,2555625,=,37,True,=,,IC50,nM,,6300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6300.0
220748,17609747,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)ccn1,,,CHEMBL3638978,,2013.0,"{'bei': '14.93', 'le': '0.27', 'lle': '1.86', 'sei': '5.17'}",CHEMBL3679712,,CHEMBL3679712,4.89,False,http://www.openphacts.org/units/Nanomolar,2555626,=,37,True,=,,IC50,nM,,13000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13000.0
220749,17609748,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1c[nH]c(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)c1,,,CHEMBL3638978,,2013.0,"{'bei': '16.99', 'le': '0.30', 'lle': '1.72', 'sei': '7.14'}",CHEMBL3679713,,CHEMBL3679713,5.10,False,http://www.openphacts.org/units/Nanomolar,2555627,=,37,True,=,,IC50,nM,,7900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7900.0
220750,17609749,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cn1,,,CHEMBL3638978,,2013.0,"{'bei': '17.34', 'le': '0.31', 'lle': '2.65', 'sei': '6.01'}",CHEMBL3679714,,CHEMBL3679714,5.68,False,http://www.openphacts.org/units/Nanomolar,2555628,=,37,True,=,,IC50,nM,,2100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2100.0
220751,17609750,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.02', 'le': '0.27', 'lle': '0.53', 'sei': '8.78'}",CHEMBL3679715,,CHEMBL3679715,4.89,False,http://www.openphacts.org/units/Nanomolar,2555629,=,37,True,=,,IC50,nM,,13000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13000.0
220752,17609751,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.50', 'le': '0.26', 'lle': '-0.02', 'sei': '9.58'}",CHEMBL3679716,,CHEMBL3679716,5.33,False,http://www.openphacts.org/units/Nanomolar,2555630,=,37,True,=,,IC50,nM,,4700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4700.0
220753,17609752,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)c1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '11.92', 'le': '0.22', 'lle': '-0.55', 'sei': '8.13'}",CHEMBL3679717,,CHEMBL3679717,4.52,False,http://www.openphacts.org/units/Nanomolar,2555631,=,37,True,=,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30000.0
220754,17609753,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.31', 'le': '0.29', 'lle': '0.58', 'sei': '9.51'}",CHEMBL3679718,,CHEMBL3679718,5.29,False,http://www.openphacts.org/units/Nanomolar,2555632,=,37,True,=,,IC50,nM,,5100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5100.0
220755,17609754,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(c1)Nc1ncccc1-n1c(-c3ccc4ccccc4c3)nnc1-2,,,CHEMBL3638978,,2013.0,"{'bei': '12.56', 'le': '0.22', 'lle': '-0.67', 'sei': '8.16'}",CHEMBL3679719,,CHEMBL3679719,4.54,False,http://www.openphacts.org/units/Nanomolar,2555633,=,37,True,=,,IC50,nM,,29000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,29000.0
220756,17609755,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '18.80', 'le': '0.34', 'lle': '2.50', 'sei': '7.52'}",CHEMBL3679720,,CHEMBL3679720,6.14,False,http://www.openphacts.org/units/Nanomolar,2555634,=,37,True,=,,IC50,nM,,730.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,730.0
220757,17609756,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '16.35', 'le': '0.29', 'lle': '1.68', 'sei': '9.85'}",CHEMBL3679721,,CHEMBL3679721,5.80,False,http://www.openphacts.org/units/Nanomolar,2555635,=,37,True,=,,IC50,nM,,1600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1600.0
220758,17609757,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1Cl,,,CHEMBL3638978,,2013.0,"{'bei': '13.92', 'le': '0.28', 'lle': '-0.07', 'sei': '9.51'}",CHEMBL3679722,,CHEMBL3679722,5.29,False,http://www.openphacts.org/units/Nanomolar,2555636,=,37,True,=,,IC50,nM,,5100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5100.0
220759,17609758,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CN1c2ccccc2-c2nnc(-c3ccc4ccccc4c3)n2-c2ccccc21,,,CHEMBL3638978,,2013.0,"{'bei': '11.15', 'le': '0.20', 'lle': '-1.67', 'sei': '12.29'}",CHEMBL3679723,,CHEMBL3679723,4.17,False,http://www.openphacts.org/units/Nanomolar,2555637,=,37,True,=,,IC50,nM,,67000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,67000.0
220760,17609759,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.08', 'le': '0.25', 'lle': '0.45', 'sei': '8.34'}",CHEMBL3679724,,CHEMBL3679724,4.64,False,http://www.openphacts.org/units/Nanomolar,2555638,=,37,True,=,,IC50,nM,,23000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23000.0
220761,17609760,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1nnc2n1-c1cccnc1Nc1ccccc1-2,,,CHEMBL3638978,,2013.0,"{'bei': '13.11', 'le': '0.24', 'lle': '0.22', 'sei': '8.18'}",CHEMBL3679725,,CHEMBL3679725,4.55,False,http://www.openphacts.org/units/Nanomolar,2555639,=,37,True,=,,IC50,nM,,28000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,28000.0
220762,17609761,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)c(F)c1,,,CHEMBL3638978,,2013.0,"{'bei': '14.81', 'le': '0.27', 'lle': '0.81', 'sei': '9.24'}",CHEMBL3679726,,CHEMBL3679726,5.14,False,http://www.openphacts.org/units/Nanomolar,2555640,=,37,True,=,,IC50,nM,,7200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7200.0
220763,17609762,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)c1,,,CHEMBL3638978,,2013.0,"{'bei': '15.60', 'le': '0.28', 'lle': '1.45', 'sei': '6.24'}",CHEMBL3679727,,CHEMBL3679727,5.09,False,http://www.openphacts.org/units/Nanomolar,2555641,=,37,True,=,,IC50,nM,,8100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8100.0
220764,17609763,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '17.28', 'le': '0.31', 'lle': '1.90', 'sei': '7.46'}",CHEMBL3679728,,CHEMBL3679728,5.66,False,http://www.openphacts.org/units/Nanomolar,2555642,=,37,True,=,,IC50,nM,,2200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2200.0
220765,17609764,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2nnc3n2-c2ccccc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '18.43', 'le': '0.33', 'lle': '1.06', 'sei': '13.39'}",CHEMBL3679729,,CHEMBL3679729,5.72,False,http://www.openphacts.org/units/Nanomolar,2555643,=,37,True,=,,IC50,nM,,1900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1900.0
220766,17609765,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(-c2nnc3n2-c2ccccc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.44', 'le': '0.28', 'lle': '0.74', 'sei': '11.87'}",CHEMBL3679730,,CHEMBL3679730,5.46,False,http://www.openphacts.org/units/Nanomolar,2555644,=,37,True,=,,IC50,nM,,3500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3500.0
220767,17609766,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2nnc3n2-c2ccccc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '17.66', 'le': '0.31', 'lle': '1.50', 'sei': '8.35'}",CHEMBL3679731,,CHEMBL3679731,5.75,False,http://www.openphacts.org/units/Nanomolar,2555645,=,37,True,=,,IC50,nM,,1800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1800.0
220768,17609767,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,OCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '17.58', 'le': '0.32', 'lle': '2.45', 'sei': '7.91'}",CHEMBL3684334,,CHEMBL3684334,6.00,False,http://www.openphacts.org/units/Nanomolar,2560538,=,37,True,=,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
220769,17609768,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '13.10', 'le': '0.24', 'lle': '1.55', 'sei': '7.33'}",CHEMBL3684335,,CHEMBL3684335,7.08,False,http://www.openphacts.org/units/Nanomolar,2560539,=,37,True,=,,IC50,nM,,83.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,83.0
220770,17609769,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.12', 'le': '0.27', 'lle': '1.75', 'sei': '6.82'}",CHEMBL3684336,,CHEMBL3684336,5.58,False,http://www.openphacts.org/units/Nanomolar,2560540,=,37,True,=,,IC50,nM,,2600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2600.0
220771,17609770,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.99', 'le': '0.20', 'lle': '0.93', 'sei': '5.36'}",CHEMBL3684337,,CHEMBL3684337,6.10,False,http://www.openphacts.org/units/Nanomolar,2560541,=,37,True,=,,IC50,nM,,800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,800.0
220772,17609771,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(C(=O)Nc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '14.76', 'le': '0.27', 'lle': '1.49', 'sei': '7.23'}",CHEMBL3684338,,CHEMBL3684338,6.80,False,http://www.openphacts.org/units/Nanomolar,2560542,=,37,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,160.0
220773,17609772,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccc2ccccc2c1,,,CHEMBL3638978,,2013.0,"{'bei': '12.83', 'le': '0.23', 'lle': '-0.29', 'sei': '7.28'}",CHEMBL3684339,,CHEMBL3684339,6.17,False,http://www.openphacts.org/units/Nanomolar,2560543,=,37,True,=,,IC50,nM,,680.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,680.0
220774,17609773,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,,,CHEMBL3638978,,2013.0,"{'bei': '9.89', 'le': '0.19', 'lle': '-1.74', 'sei': '6.61'}",CHEMBL3684340,,CHEMBL3684340,5.60,False,http://www.openphacts.org/units/Nanomolar,2560544,=,37,True,=,,IC50,nM,,2500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2500.0
220775,17609774,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C(=O)Nc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.75', 'le': '0.28', 'lle': '1.39', 'sei': '8.26'}",CHEMBL3684341,,CHEMBL3684341,7.00,False,http://www.openphacts.org/units/Nanomolar,2560545,=,37,True,=,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100.0
220776,17609775,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)Nc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.76', 'le': '0.27', 'lle': '1.49', 'sei': '7.23'}",CHEMBL3684342,,CHEMBL3684342,6.80,False,http://www.openphacts.org/units/Nanomolar,2560546,=,37,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,160.0
220777,17609776,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(=O)Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.48', 'le': '0.28', 'lle': '1.35', 'sei': '7.24'}",CHEMBL3684343,,CHEMBL3684343,6.14,False,http://www.openphacts.org/units/Nanomolar,2560547,=,37,True,=,,IC50,nM,,730.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,730.0
220778,17609777,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC(=O)Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.99', 'le': '0.27', 'lle': '1.11', 'sei': '7.26'}",CHEMBL3684344,,CHEMBL3684344,6.16,False,http://www.openphacts.org/units/Nanomolar,2560548,=,37,True,=,,IC50,nM,,700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,700.0
220779,17609778,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1cccc2ccccc12,,,CHEMBL3638978,,2013.0,"{'bei': '12.89', 'le': '0.23', 'lle': '-0.27', 'sei': '7.31'}",CHEMBL3684345,,CHEMBL3684345,6.19,False,http://www.openphacts.org/units/Nanomolar,2560549,=,37,True,=,,IC50,nM,,640.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,640.0
220780,17609779,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Cc1cccc2ccccc12)Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.18', 'le': '0.22', 'lle': '-0.37', 'sei': '7.11'}",CHEMBL3684346,,CHEMBL3684346,6.02,False,http://www.openphacts.org/units/Nanomolar,2560550,=,37,True,=,,IC50,nM,,950.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,950.0
220781,17609780,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)CC(=O)Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.24', 'le': '0.28', 'lle': '1.04', 'sei': '7.63'}",CHEMBL3684347,,CHEMBL3684347,6.47,False,http://www.openphacts.org/units/Nanomolar,2560551,=,37,True,=,,IC50,nM,,340.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,340.0
220782,17609781,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccc(F)c(F)c1,,,CHEMBL3638978,,2013.0,"{'bei': '14.63', 'le': '0.27', 'lle': '1.24', 'sei': '8.05'}",CHEMBL3684348,,CHEMBL3684348,6.82,False,http://www.openphacts.org/units/Nanomolar,2560552,=,37,True,=,,IC50,nM,,150.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,150.0
220783,17609782,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]c1ccc(C(=O)Nc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.05', 'le': '0.27', 'lle': '0.99', 'sei': '7.69'}",CHEMBL3684349,,CHEMBL3684349,6.85,False,http://www.openphacts.org/units/Nanomolar,2560553,=,37,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,140.0
220784,17609783,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CCC(=O)Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.02', 'le': '0.27', 'lle': '1.34', 'sei': '6.78'}",CHEMBL3684350,,CHEMBL3684350,5.75,False,http://www.openphacts.org/units/Nanomolar,2560554,=,37,True,=,,IC50,nM,,1800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1800.0
220785,17609784,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1cccnc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.26', 'le': '0.27', 'lle': '1.89', 'sei': '6.75'}",CHEMBL3684351,,CHEMBL3684351,6.58,False,http://www.openphacts.org/units/Nanomolar,2560555,=,37,True,=,,IC50,nM,,260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,260.0
220786,17609785,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1C(=O)Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '13.65', 'le': '0.25', 'lle': '0.97', 'sei': '6.69'}",CHEMBL3684352,,CHEMBL3684352,6.28,False,http://www.openphacts.org/units/Nanomolar,2560556,=,37,True,=,,IC50,nM,,520.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,520.0
220787,17609786,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1cc2ccccc2s1,,,CHEMBL3638978,,2013.0,"{'bei': '13.24', 'le': '0.24', 'lle': '-0.08', 'sei': '7.60'}",CHEMBL3684353,,CHEMBL3684353,6.44,False,http://www.openphacts.org/units/Nanomolar,2560557,=,37,True,=,,IC50,nM,,360.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,360.0
220788,17609787,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)C(=O)Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.53', 'le': '0.28', 'lle': '1.34', 'sei': '7.53'}",CHEMBL3684354,,CHEMBL3684354,6.38,False,http://www.openphacts.org/units/Nanomolar,2560558,=,37,True,=,,IC50,nM,,420.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,420.0
220789,17609788,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1ccc(C(=O)Nc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '13.64', 'le': '0.25', 'lle': '0.04', 'sei': '7.83'}",CHEMBL3684355,,CHEMBL3684355,6.64,False,http://www.openphacts.org/units/Nanomolar,2560559,=,37,True,=,,IC50,nM,,230.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,230.0
220790,17609789,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(C(=O)Nc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.08', 'le': '0.22', 'lle': '0.35', 'sei': '6.50'}",CHEMBL3684356,,CHEMBL3684356,5.72,False,http://www.openphacts.org/units/Nanomolar,2560560,=,37,True,=,,IC50,nM,,1900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1900.0
220791,17609790,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccc(F)c(C(F)(F)F)c1,,,CHEMBL3638978,,2013.0,"{'bei': '10.22', 'le': '0.19', 'lle': '-1.18', 'sei': '6.23'}",CHEMBL3684357,,CHEMBL3684357,5.28,False,http://www.openphacts.org/units/Nanomolar,2560561,=,37,True,=,,IC50,nM,,5300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5300.0
220792,17609791,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccc2c(c1)OCO2,,,CHEMBL3638978,,2013.0,"{'bei': '15.33', 'le': '0.28', 'lle': '2.25', 'sei': '7.05'}",CHEMBL3684358,,CHEMBL3684358,7.28,False,http://www.openphacts.org/units/Nanomolar,2560562,=,37,True,=,,IC50,nM,,53.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,53.0
220793,17609792,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C(=O)Nc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)no1,,,CHEMBL3638978,,2013.0,"{'bei': '15.89', 'le': '0.29', 'lle': '2.32', 'sei': '6.25'}",CHEMBL3639832,,CHEMBL3639832,6.92,False,http://www.openphacts.org/units/Nanomolar,2560563,=,37,True,=,,IC50,nM,,120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,120.0
220794,17609793,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Cc1ccccc1)Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.89', 'le': '0.27', 'lle': '1.39', 'sei': '7.81'}",CHEMBL3684359,,CHEMBL3684359,6.62,False,http://www.openphacts.org/units/Nanomolar,2560564,=,37,True,=,,IC50,nM,,240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,240.0
220795,17609794,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccco1,,,CHEMBL3638978,,2013.0,"{'bei': '16.38', 'le': '0.29', 'lle': '1.99', 'sei': '7.04'}",CHEMBL3684360,,CHEMBL3684360,6.89,False,http://www.openphacts.org/units/Nanomolar,2560565,=,37,True,=,,IC50,nM,,130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,130.0
220796,17609795,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccccc1F,,,CHEMBL3638978,,2013.0,"{'bei': '15.52', 'le': '0.28', 'lle': '1.52', 'sei': '8.21'}",CHEMBL3684361,,CHEMBL3684361,6.96,False,http://www.openphacts.org/units/Nanomolar,2560566,=,37,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,110.0
220797,17609796,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccc(C(F)(F)F)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.41', 'le': '0.23', 'lle': '-0.13', 'sei': '7.30'}",CHEMBL3684362,,CHEMBL3684362,6.19,False,http://www.openphacts.org/units/Nanomolar,2560567,=,37,True,=,,IC50,nM,,650.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,650.0
220798,17609797,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COCC(=O)Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.62', 'le': '0.27', 'lle': '2.18', 'sei': '6.20'}",CHEMBL3684363,,CHEMBL3684363,5.82,False,http://www.openphacts.org/units/Nanomolar,2560568,=,37,True,=,,IC50,nM,,1500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1500.0
220799,17609798,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCc1ccccc1)Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.53', 'le': '0.22', 'lle': '0.12', 'sei': '6.78'}",CHEMBL3684364,,CHEMBL3684364,5.75,False,http://www.openphacts.org/units/Nanomolar,2560569,=,37,True,=,,IC50,nM,,1800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1800.0
220800,17609799,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1cnc2ccccc2n1,,,CHEMBL3638978,,2013.0,"{'bei': '14.08', 'le': '0.25', 'lle': '1.55', 'sei': '6.15'}",CHEMBL3684365,,CHEMBL3684365,6.80,False,http://www.openphacts.org/units/Nanomolar,2560570,=,37,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,160.0
220801,17609800,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccc(F)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.52', 'le': '0.28', 'lle': '1.52', 'sei': '8.21'}",CHEMBL3684366,,CHEMBL3684366,6.96,False,http://www.openphacts.org/units/Nanomolar,2560571,=,37,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,110.0
220802,17609801,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)C1CCC1,,,CHEMBL3638978,,2013.0,"{'bei': '15.07', 'le': '0.27', 'lle': '1.36', 'sei': '7.26'}",CHEMBL3684367,,CHEMBL3684367,6.16,False,http://www.openphacts.org/units/Nanomolar,2560572,=,37,True,=,,IC50,nM,,700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,700.0
220803,17609802,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccncc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.96', 'le': '0.27', 'lle': '1.76', 'sei': '6.61'}",CHEMBL3684368,,CHEMBL3684368,6.46,False,http://www.openphacts.org/units/Nanomolar,2560573,=,37,True,=,,IC50,nM,,350.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,350.0
220804,17609803,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccccc1,,,CHEMBL3638978,,2013.0,"{'bei': '16.62', 'le': '0.30', 'lle': '1.84', 'sei': '8.44'}",CHEMBL3684369,,CHEMBL3684369,7.16,False,http://www.openphacts.org/units/Nanomolar,2560574,=,37,True,=,,IC50,nM,,70.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,70.0
220805,17609804,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]c1cccc(C(=O)Nc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '15.63', 'le': '0.28', 'lle': '1.26', 'sei': '7.99'}",CHEMBL3684370,,CHEMBL3684370,7.12,False,http://www.openphacts.org/units/Nanomolar,2560575,=,37,True,=,,IC50,nM,,76.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,76.0
220806,17609805,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccc(-c2ccccc2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.06', 'le': '0.21', 'lle': '-0.86', 'sei': '7.21'}",CHEMBL3684371,,CHEMBL3684371,6.11,False,http://www.openphacts.org/units/Nanomolar,2560576,=,37,True,=,,IC50,nM,,780.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,780.0
220807,17609806,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '18.10', 'le': '0.32', 'lle': '2.65', 'sei': '7.55'}",CHEMBL3684372,,CHEMBL3684372,6.16,False,http://www.openphacts.org/units/Nanomolar,2560577,=,37,True,=,,IC50,nM,,690.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,690.0
220808,17609807,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nnc6n5-c5cccnc5Nc5ccccc5-6)cc4)CC3)[nH]2)nc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.80', 'le': '0.23', 'lle': '1.47', 'sei': '6.24'}",CHEMBL3684373,,CHEMBL3684373,7.08,False,http://www.openphacts.org/units/Nanomolar,2560578,=,37,True,=,,IC50,nM,,84.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,84.0
220809,17609808,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)OCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.04', 'le': '0.29', 'lle': '2.78', 'sei': '6.37'}",CHEMBL3684374,,CHEMBL3684374,6.31,False,http://www.openphacts.org/units/Nanomolar,2560579,=,37,True,=,,IC50,nM,,490.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,490.0
220810,17609809,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(c1)Nc1ncccc1-n1c(-c3ccc(CN4CCCC4)cc3)nnc1-2,,,CHEMBL3638978,,2013.0,"{'bei': '13.60', 'le': '0.24', 'lle': '0.72', 'sei': '9.12'}",CHEMBL3684375,,CHEMBL3684375,5.37,False,http://www.openphacts.org/units/Nanomolar,2560580,=,37,True,=,,IC50,nM,,4300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4300.0
220811,17609810,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(CNCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '13.29', 'le': '0.24', 'lle': '0.38', 'sei': '8.46'}",CHEMBL3684376,,CHEMBL3684376,5.72,False,http://www.openphacts.org/units/Nanomolar,2560581,=,37,True,=,,IC50,nM,,1900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1900.0
220812,17609811,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1N1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.03', 'le': '0.20', 'lle': '0.04', 'sei': '8.94'}",CHEMBL3684377,,CHEMBL3684377,5.55,False,http://www.openphacts.org/units/Nanomolar,2560582,=,37,True,=,,IC50,nM,,2800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2800.0
220813,17609812,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CCNCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '13.05', 'le': '0.24', 'lle': '0.17', 'sei': '7.92'}",CHEMBL3684378,,CHEMBL3684378,5.36,False,http://www.openphacts.org/units/Nanomolar,2560583,=,37,True,=,,IC50,nM,,4400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4400.0
220814,17609813,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(c1)Nc1ncccc1-n1c(-c3ccc(CNC4CCC4)cc3)nnc1-2,,,CHEMBL3638978,,2013.0,"{'bei': '13.55', 'le': '0.24', 'lle': '0.65', 'sei': '7.90'}",CHEMBL3684379,,CHEMBL3684379,5.35,False,http://www.openphacts.org/units/Nanomolar,2560584,=,37,True,=,,IC50,nM,,4500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4500.0
220815,17609814,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(Cc1ccncc1)Cc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.35', 'le': '0.22', 'lle': '0.21', 'sei': '7.91'}",CHEMBL3684380,,CHEMBL3684380,5.68,False,http://www.openphacts.org/units/Nanomolar,2560585,=,37,True,=,,IC50,nM,,2100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2100.0
220816,17609815,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CNCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '13.10', 'le': '0.24', 'lle': '0.39', 'sei': '7.68'}",CHEMBL3684381,,CHEMBL3684381,5.19,False,http://www.openphacts.org/units/Nanomolar,2560586,=,37,True,=,,IC50,nM,,6400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6400.0
220817,17609816,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)CN1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.31', 'le': '0.19', 'lle': '1.84', 'sei': '6.18'}",CHEMBL3684382,,CHEMBL3684382,5.10,False,http://www.openphacts.org/units/Nanomolar,2560587,=,37,True,=,,IC50,nM,,8000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8000.0
220818,17609817,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COCCNCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '13.39', 'le': '0.24', 'lle': '1.55', 'sei': '6.94'}",CHEMBL3684383,,CHEMBL3684383,5.34,False,http://www.openphacts.org/units/Nanomolar,2560588,=,37,True,=,,IC50,nM,,4600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4600.0
220819,17609818,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(c1)Nc1ncccc1-n1c(-c3ccc(CN4CCN(Cc5ccncc5)CC4)cc3)nnc1-2,,,CHEMBL3638978,,2013.0,"{'bei': '10.56', 'le': '0.19', 'lle': '0.51', 'sei': '7.05'}",CHEMBL3684384,,CHEMBL3684384,5.28,False,http://www.openphacts.org/units/Nanomolar,2560589,=,37,True,=,,IC50,nM,,5200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5200.0
220820,17609819,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCc1ccccn1)Cc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.97', 'le': '0.23', 'lle': '0.84', 'sei': '8.30'}",CHEMBL3684385,,CHEMBL3684385,5.96,False,http://www.openphacts.org/units/Nanomolar,2560590,=,37,True,=,,IC50,nM,,1100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1100.0
220821,17609820,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,OCC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.59', 'le': '0.21', 'lle': '0.82', 'sei': '6.42'}",CHEMBL3684386,,CHEMBL3684386,5.08,False,http://www.openphacts.org/units/Nanomolar,2560591,=,37,True,=,,IC50,nM,,8300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8300.0
220822,17609821,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COCCN(C)Cc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.92', 'le': '0.23', 'lle': '1.20', 'sei': '7.82'}",CHEMBL3684387,,CHEMBL3684387,5.33,False,http://www.openphacts.org/units/Nanomolar,2560592,=,37,True,=,,IC50,nM,,4700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4700.0
220823,17609822,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1CCCN1CCCNCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '11.51', 'le': '0.21', 'lle': '1.20', 'sei': '6.09'}",CHEMBL3684388,,CHEMBL3684388,5.36,False,http://www.openphacts.org/units/Nanomolar,2560593,=,37,True,=,,IC50,nM,,4400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4400.0
220824,17609823,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCc1ccccc1)Cc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '13.32', 'le': '0.24', 'lle': '0.38', 'sei': '10.38'}",CHEMBL3684389,,CHEMBL3684389,6.11,False,http://www.openphacts.org/units/Nanomolar,2560594,=,37,True,=,,IC50,nM,,780.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,780.0
220825,17609824,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,OC1(c2ccccc2)CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.43', 'le': '0.21', 'lle': '0.18', 'sei': '7.23'}",CHEMBL3684390,,CHEMBL3684390,5.72,False,http://www.openphacts.org/units/Nanomolar,2560595,=,37,True,=,,IC50,nM,,1900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1900.0
220826,17609825,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)C(=O)C1CCCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)C1,,,CHEMBL3638978,,2013.0,"{'bei': '10.48', 'le': '0.19', 'lle': '0.19', 'sei': '6.72'}",CHEMBL3684391,,CHEMBL3684391,5.32,False,http://www.openphacts.org/units/Nanomolar,2560596,=,37,True,=,,IC50,nM,,4800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4800.0
220827,17609826,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(CN2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '10.56', 'le': '0.19', 'lle': '-0.09', 'sei': '8.49'}",CHEMBL3684392,,CHEMBL3684392,5.28,False,http://www.openphacts.org/units/Nanomolar,2560597,=,37,True,=,,IC50,nM,,5300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5300.0
220828,17609827,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,OC1CCCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)C1,,,CHEMBL3638978,,2013.0,"{'bei': '12.35', 'le': '0.22', 'lle': '1.23', 'sei': '6.63'}",CHEMBL3684393,,CHEMBL3684393,5.24,False,http://www.openphacts.org/units/Nanomolar,2560598,=,37,True,=,,IC50,nM,,5700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5700.0
220829,17609828,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(c1)Nc1ncccc1-n1c(-c3ccc(CN4CCOCC4)cc3)nnc1-2,,,CHEMBL3638978,,2013.0,"{'bei': '14.12', 'le': '0.26', 'lle': '1.91', 'sei': '8.51'}",CHEMBL3684394,,CHEMBL3684394,5.80,False,http://www.openphacts.org/units/Nanomolar,2560599,=,37,True,=,,IC50,nM,,1600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1600.0
220830,17609829,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CN(C)Cc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.54', 'le': '0.23', 'lle': '0.01', 'sei': '8.75'}",CHEMBL3684395,,CHEMBL3684395,5.15,False,http://www.openphacts.org/units/Nanomolar,2560600,=,37,True,=,,IC50,nM,,7100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7100.0
220831,17609830,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)C1,,,CHEMBL3638978,,2013.0,"{'bei': '12.11', 'le': '0.22', 'lle': '1.71', 'sei': '6.22'}",CHEMBL3684396,,CHEMBL3684396,5.47,False,http://www.openphacts.org/units/Nanomolar,2560601,=,37,True,=,,IC50,nM,,3400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3400.0
220832,17609831,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CCCNCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '13.69', 'le': '0.25', 'lle': '0.69', 'sei': '7.74'}",CHEMBL3684397,,CHEMBL3684397,5.24,False,http://www.openphacts.org/units/Nanomolar,2560602,=,37,True,=,,IC50,nM,,5800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5800.0
220833,17609832,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(N(C)Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.65', 'le': '0.21', 'lle': '0.68', 'sei': '8.47'}",CHEMBL3684398,,CHEMBL3684398,5.26,False,http://www.openphacts.org/units/Nanomolar,2560603,=,37,True,=,,IC50,nM,,5500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5500.0
220834,17609833,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)N1CCC(NCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.38', 'le': '0.21', 'lle': '0.88', 'sei': '5.80'}",CHEMBL3684399,,CHEMBL3684399,5.64,False,http://www.openphacts.org/units/Nanomolar,2560604,=,37,True,=,,IC50,nM,,2300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2300.0
220835,17609834,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN(C)Cc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.13', 'le': '0.26', 'lle': '0.70', 'sei': '9.52'}",CHEMBL3684400,,CHEMBL3684400,5.60,False,http://www.openphacts.org/units/Nanomolar,2560605,=,37,True,=,,IC50,nM,,2500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2500.0
220836,17609835,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CN2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '10.81', 'le': '0.19', 'lle': '-0.13', 'sei': '8.94'}",CHEMBL3684401,,CHEMBL3684401,5.55,False,http://www.openphacts.org/units/Nanomolar,2560606,=,37,True,=,,IC50,nM,,2800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2800.0
220837,17609836,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccco1)N1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.62', 'le': '0.21', 'lle': '1.25', 'sei': '6.34'}",CHEMBL3684402,,CHEMBL3684402,5.85,False,http://www.openphacts.org/units/Nanomolar,2560607,=,37,True,=,,IC50,nM,,1400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1400.0
220838,17609837,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(c1)Nc1ncccc1-n1c(-c3ccc(CNCC4CC4)cc3)nnc1-2,,,CHEMBL3638978,,2013.0,"{'bei': '13.12', 'le': '0.24', 'lle': '0.62', 'sei': '7.65'}",CHEMBL3684403,,CHEMBL3684403,5.17,False,http://www.openphacts.org/units/Nanomolar,2560608,=,37,True,=,,IC50,nM,,6700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6700.0
220839,17609838,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(CCN2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '10.19', 'le': '0.18', 'lle': '-0.17', 'sei': '8.43'}",CHEMBL3684404,,CHEMBL3684404,5.24,False,http://www.openphacts.org/units/Nanomolar,2560609,=,37,True,=,,IC50,nM,,5800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5800.0
220840,17609839,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccc(F)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.10', 'le': '0.25', 'lle': '1.40', 'sei': '7.70'}",CHEMBL3684405,,CHEMBL3684405,6.52,False,http://www.openphacts.org/units/Nanomolar,2560610,=,37,True,=,,IC50,nM,,300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,300.0
220841,17609840,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1cccnc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.04', 'le': '0.27', 'lle': '2.32', 'sei': '6.86'}",CHEMBL3684406,,CHEMBL3684406,6.70,False,http://www.openphacts.org/units/Nanomolar,2560611,=,37,True,=,,IC50,nM,,200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,200.0
220842,17609841,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccco1,,,CHEMBL3638978,,2013.0,"{'bei': '13.71', 'le': '0.25', 'lle': '1.38', 'sei': '6.09'}",CHEMBL3684407,,CHEMBL3684407,5.96,False,http://www.openphacts.org/units/Nanomolar,2560612,=,37,True,=,,IC50,nM,,1100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1100.0
220843,17609842,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(C(=O)NCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.27', 'le': '0.26', 'lle': '1.91', 'sei': '7.91'}",CHEMBL3684408,,CHEMBL3684408,6.96,False,http://www.openphacts.org/units/Nanomolar,2560613,=,37,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,110.0
220844,17609843,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccccc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.07', 'le': '0.27', 'lle': '1.72', 'sei': '7.91'}",CHEMBL3684409,,CHEMBL3684409,6.70,False,http://www.openphacts.org/units/Nanomolar,2560614,=,37,True,=,,IC50,nM,,200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,200.0
220845,17609844,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)C1CCC1,,,CHEMBL3638978,,2013.0,"{'bei': '13.60', 'le': '0.25', 'lle': '1.27', 'sei': '6.78'}",CHEMBL3684410,,CHEMBL3684410,5.75,False,http://www.openphacts.org/units/Nanomolar,2560615,=,37,True,=,,IC50,nM,,1800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1800.0
220846,17609845,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccccc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.26', 'le': '0.27', 'lle': '2.32', 'sei': '6.73'}",CHEMBL3684411,,CHEMBL3684411,6.85,False,http://www.openphacts.org/units/Nanomolar,2560616,=,37,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,140.0
220847,17609846,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(S(=O)(=O)NCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '11.94', 'le': '0.23', 'lle': '1.56', 'sei': '5.49'}",CHEMBL3684412,,CHEMBL3684412,6.10,False,http://www.openphacts.org/units/Nanomolar,2560617,=,37,True,=,,IC50,nM,,800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,800.0
220848,17609847,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cnc(S(=O)(=O)NCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '13.66', 'le': '0.26', 'lle': '3.35', 'sei': '5.53'}",CHEMBL3684413,,CHEMBL3684413,6.62,False,http://www.openphacts.org/units/Nanomolar,2560618,=,37,True,=,,IC50,nM,,240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,240.0
220849,17609848,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1ccc(S(=O)(=O)NCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)n1,,,CHEMBL3638978,,2013.0,"{'bei': '14.28', 'le': '0.27', 'lle': '3.65', 'sei': '5.79'}",CHEMBL3684414,,CHEMBL3684414,6.92,False,http://www.openphacts.org/units/Nanomolar,2560619,=,37,True,=,,IC50,nM,,120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,120.0
220850,17609849,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1cccnc1,,,CHEMBL3638978,,2013.0,"{'bei': '13.83', 'le': '0.26', 'lle': '2.73', 'sei': '5.80'}",CHEMBL3684415,,CHEMBL3684415,6.66,False,http://www.openphacts.org/units/Nanomolar,2560620,=,37,True,=,,IC50,nM,,220.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,220.0
220851,17609850,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(Nc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccccc1,,,CHEMBL3638978,,2013.0,"{'bei': '11.10', 'le': '0.21', 'lle': '0.33', 'sei': '5.09'}",CHEMBL3684416,,CHEMBL3684416,5.18,False,http://www.openphacts.org/units/Nanomolar,2560621,=,37,True,=,,IC50,nM,,6600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6600.0
220852,17609851,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)Nc1ccccc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.05', 'le': '0.22', 'lle': '0.16', 'sei': '5.72'}",CHEMBL3684417,,CHEMBL3684417,5.54,False,http://www.openphacts.org/units/Nanomolar,2560622,=,37,True,=,,IC50,nM,,2900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2900.0
220853,17609852,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NCCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccccc1,,,CHEMBL3638978,,2013.0,"{'bei': '10.59', 'le': '0.20', 'lle': '0.67', 'sei': '5.14'}",CHEMBL3684418,,CHEMBL3684418,5.24,False,http://www.openphacts.org/units/Nanomolar,2560623,=,37,True,=,,IC50,nM,,5800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5800.0
220854,17609853,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(S(=O)(=O)NCCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '9.61', 'le': '0.18', 'lle': '0.46', 'sei': '4.54'}",CHEMBL3684419,,CHEMBL3684419,5.04,False,http://www.openphacts.org/units/Nanomolar,2560624,=,37,True,=,,IC50,nM,,9100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9100.0
220855,17609854,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)Nc1ccccc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.62', 'le': '0.26', 'lle': '1.50', 'sei': '7.15'}",CHEMBL3684420,,CHEMBL3684420,6.92,False,http://www.openphacts.org/units/Nanomolar,2560625,=,37,True,=,,IC50,nM,,120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,120.0
220856,17609855,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccccc1,,,CHEMBL3638978,,2013.0,"{'bei': '13.52', 'le': '0.24', 'lle': '1.17', 'sei': '7.32'}",CHEMBL3684421,,CHEMBL3684421,6.20,False,http://www.openphacts.org/units/Nanomolar,2560626,=,37,True,=,,IC50,nM,,630.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,630.0
220857,17609856,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccccc1F,,,CHEMBL3638978,,2013.0,"{'bei': '13.58', 'le': '0.26', 'lle': '2.10', 'sei': '6.65'}",CHEMBL3684422,,CHEMBL3684422,6.77,False,http://www.openphacts.org/units/Nanomolar,2560627,=,37,True,=,,IC50,nM,,170.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,170.0
220858,17609857,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1cccc(F)c1,,,CHEMBL3638978,,2013.0,"{'bei': '12.83', 'le': '0.24', 'lle': '1.73', 'sei': '6.28'}",CHEMBL3684423,,CHEMBL3684423,6.40,False,http://www.openphacts.org/units/Nanomolar,2560628,=,37,True,=,,IC50,nM,,400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,400.0
220859,17609858,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(S(=O)(=O)NCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '13.42', 'le': '0.25', 'lle': '2.31', 'sei': '6.17'}",CHEMBL3684424,,CHEMBL3684424,6.85,False,http://www.openphacts.org/units/Nanomolar,2560629,=,37,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,140.0
220860,17609859,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(S(=O)(=O)NCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '14.07', 'le': '0.26', 'lle': '2.12', 'sei': '6.84'}",CHEMBL3684425,,CHEMBL3684425,6.96,False,http://www.openphacts.org/units/Nanomolar,2560630,=,37,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,110.0
220861,17609860,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1cccc(Cl)c1,,,CHEMBL3638978,,2013.0,"{'bei': '13.25', 'le': '0.26', 'lle': '1.63', 'sei': '6.70'}",CHEMBL3684426,,CHEMBL3684426,6.82,False,http://www.openphacts.org/units/Nanomolar,2560631,=,37,True,=,,IC50,nM,,150.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,150.0
220862,17609861,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccc(F)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '13.88', 'le': '0.26', 'lle': '2.25', 'sei': '6.80'}",CHEMBL3684427,,CHEMBL3684427,6.92,False,http://www.openphacts.org/units/Nanomolar,2560632,=,37,True,=,,IC50,nM,,120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,120.0
220863,17609862,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)NCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.07', 'le': '0.26', 'lle': '2.12', 'sei': '6.84'}",CHEMBL3684428,,CHEMBL3684428,6.96,False,http://www.openphacts.org/units/Nanomolar,2560633,=,37,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,110.0
220864,17609863,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)c1ccc(Cl)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.93', 'le': '0.25', 'lle': '1.47', 'sei': '6.54'}",CHEMBL3684429,,CHEMBL3684429,6.66,False,http://www.openphacts.org/units/Nanomolar,2560634,=,37,True,=,,IC50,nM,,220.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,220.0
220865,17609864,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1ccc(S(=O)(=O)NCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.75', 'le': '0.24', 'lle': '2.36', 'sei': '5.24'}",CHEMBL3684430,,CHEMBL3684430,6.85,False,http://www.openphacts.org/units/Nanomolar,2560635,=,37,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,140.0
220866,17609865,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)Nc1ccccc1F,,,CHEMBL3638978,,2013.0,"{'bei': '13.63', 'le': '0.25', 'lle': '1.00', 'sei': '6.73'}",CHEMBL3684431,,CHEMBL3684431,6.51,False,http://www.openphacts.org/units/Nanomolar,2560636,=,37,True,=,,IC50,nM,,310.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,310.0
220867,17609866,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)Nc1cccc(F)c1,,,CHEMBL3638978,,2013.0,"{'bei': '12.48', 'le': '0.23', 'lle': '0.45', 'sei': '6.16'}",CHEMBL3684432,,CHEMBL3684432,5.96,False,http://www.openphacts.org/units/Nanomolar,2560637,=,37,True,=,,IC50,nM,,1100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1100.0
220868,17609867,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(NC(=O)NCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '14.07', 'le': '0.25', 'lle': '1.51', 'sei': '6.50'}",CHEMBL3684433,,CHEMBL3684433,6.89,False,http://www.openphacts.org/units/Nanomolar,2560638,=,37,True,=,,IC50,nM,,130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,130.0
220869,17609868,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)Nc1ccc(F)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.40', 'le': '0.22', 'lle': '0.41', 'sei': '6.12'}",CHEMBL3684434,,CHEMBL3684434,5.92,False,http://www.openphacts.org/units/Nanomolar,2560639,=,37,True,=,,IC50,nM,,1200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1200.0
220870,17609869,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(NC(=O)NCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '13.34', 'le': '0.24', 'lle': '0.64', 'sei': '6.53'}",CHEMBL3684435,,CHEMBL3684435,6.32,False,http://www.openphacts.org/units/Nanomolar,2560640,=,37,True,=,,IC50,nM,,480.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,480.0
220871,17609870,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CCC1,,,CHEMBL3638978,,2013.0,"{'bei': '18.41', 'le': '0.33', 'lle': '2.61', 'sei': '8.58'}",CHEMBL3684436,,CHEMBL3684436,7.00,False,http://www.openphacts.org/units/Nanomolar,2560641,=,37,True,=,,IC50,nM,,99.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,99.0
220872,17609871,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,ClCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '15.90', 'le': '0.30', 'lle': '0.93', 'sei': '10.28'}",CHEMBL3684437,,CHEMBL3684437,5.72,False,http://www.openphacts.org/units/Nanomolar,2560642,=,37,True,=,,IC50,nM,,1900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1900.0
220873,17609872,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nnc4n3-c3ccccc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.17', 'le': '0.20', 'lle': '-0.11', 'sei': '7.19'}",CHEMBL3684438,,CHEMBL3684438,6.03,False,http://www.openphacts.org/units/Nanomolar,2560643,=,37,True,=,,IC50,nM,,940.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,940.0
220874,17609873,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nnc6n5-c5ccccc5Nc5ccccc5-6)cc4)CC3)[nH]2)nc1,,,CHEMBL3638978,,2013.0,"{'bei': '11.97', 'le': '0.21', 'lle': '0.38', 'sei': '6.57'}",CHEMBL3684439,,CHEMBL3684439,6.60,False,http://www.openphacts.org/units/Nanomolar,2560644,=,37,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,250.0
220875,17609874,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]c1ccc(C(=O)NC2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '10.44', 'le': '0.19', 'lle': '-0.23', 'sei': '6.25'}",CHEMBL3684440,,CHEMBL3684440,5.77,False,http://www.openphacts.org/units/Nanomolar,2560645,=,37,True,=,,IC50,nM,,1700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1700.0
220876,17609875,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(c1)Nc1ncccc1-n1c(-c3ccc(CN4CCC(c5nnc(-c6ccncc6)[nH]5)CC4)cc3)nnc1-2,,,CHEMBL3638978,,2013.0,"{'bei': '12.25', 'le': '0.22', 'lle': '1.16', 'sei': '5.97'}",CHEMBL3684441,,CHEMBL3684441,6.77,False,http://www.openphacts.org/units/Nanomolar,2560646,=,37,True,=,,IC50,nM,,170.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,170.0
220877,17609876,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)N1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.34', 'le': '0.19', 'lle': '0.34', 'sei': '6.94'}",CHEMBL3684442,,CHEMBL3684442,5.50,False,http://www.openphacts.org/units/Nanomolar,2560647,=,37,True,=,,IC50,nM,,3200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3200.0
220878,17609877,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(C1CCCC1)N1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.82', 'le': '0.20', 'lle': '0.58', 'sei': '6.91'}",CHEMBL3684443,,CHEMBL3684443,5.47,False,http://www.openphacts.org/units/Nanomolar,2560648,=,37,True,=,,IC50,nM,,3400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3400.0
220879,17609878,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1C(=O)N1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.71', 'le': '0.21', 'lle': '1.35', 'sei': '7.20'}",CHEMBL3684444,,CHEMBL3684444,6.37,False,http://www.openphacts.org/units/Nanomolar,2560649,=,37,True,=,,IC50,nM,,430.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,430.0
220880,17609879,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCc1ccccc1)N1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.10', 'le': '0.18', 'lle': '0.14', 'sei': '6.91'}",CHEMBL3684445,,CHEMBL3684445,5.47,False,http://www.openphacts.org/units/Nanomolar,2560650,=,37,True,=,,IC50,nM,,3400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3400.0
220881,17609880,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(C(=O)N2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '11.16', 'le': '0.20', 'lle': '0.57', 'sei': '7.43'}",CHEMBL3684446,,CHEMBL3684446,5.89,False,http://www.openphacts.org/units/Nanomolar,2560651,=,37,True,=,,IC50,nM,,1300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1300.0
220882,17609881,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)N2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '10.77', 'le': '0.19', 'lle': '0.83', 'sei': '6.62'}",CHEMBL3684447,,CHEMBL3684447,5.85,False,http://www.openphacts.org/units/Nanomolar,2560652,=,37,True,=,,IC50,nM,,1400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1400.0
220883,17609882,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(C(=O)N2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '10.41', 'le': '0.19', 'lle': '0.64', 'sei': '6.40'}",CHEMBL3684448,,CHEMBL3684448,5.66,False,http://www.openphacts.org/units/Nanomolar,2560653,=,37,True,=,,IC50,nM,,2200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2200.0
220884,17609883,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]c1ccc(C(=O)N2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '11.15', 'le': '0.20', 'lle': '0.44', 'sei': '7.19'}",CHEMBL3684449,,CHEMBL3684449,6.00,False,http://www.openphacts.org/units/Nanomolar,2560654,=,37,True,=,,IC50,nM,,990.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,990.0
220885,17609884,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Cc1ccccc1)N1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '9.90', 'le': '0.18', 'lle': '0.28', 'sei': '6.59'}",CHEMBL3684450,,CHEMBL3684450,5.22,False,http://www.openphacts.org/units/Nanomolar,2560655,=,37,True,=,,IC50,nM,,6000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6000.0
220886,17609885,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccccc1F)N1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.94', 'le': '0.22', 'lle': '1.20', 'sei': '8.02'}",CHEMBL3684451,,CHEMBL3684451,6.35,False,http://www.openphacts.org/units/Nanomolar,2560656,=,37,True,=,,IC50,nM,,450.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,450.0
220887,17609886,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C(=O)N2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)no1,,,CHEMBL3638978,,2013.0,"{'bei': '10.68', 'le': '0.19', 'lle': '1.23', 'sei': '5.26'}",CHEMBL3684452,,CHEMBL3684452,5.54,False,http://www.openphacts.org/units/Nanomolar,2560657,=,37,True,=,,IC50,nM,,2900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2900.0
220888,17609887,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)c(F)c1)N1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '9.66', 'le': '0.18', 'lle': '0.02', 'sei': '6.71'}",CHEMBL3684453,,CHEMBL3684453,5.31,False,http://www.openphacts.org/units/Nanomolar,2560658,=,37,True,=,,IC50,nM,,4900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4900.0
220889,17609888,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccccc1)N1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.14', 'le': '0.20', 'lle': '0.71', 'sei': '7.23'}",CHEMBL3684454,,CHEMBL3684454,5.72,False,http://www.openphacts.org/units/Nanomolar,2560659,=,37,True,=,,IC50,nM,,1900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1900.0
220890,17609889,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1sccc1S(=O)(=O)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '9.72', 'le': '0.19', 'lle': '1.26', 'sei': '4.65'}",CHEMBL3684455,,CHEMBL3684455,6.10,False,http://www.openphacts.org/units/Nanomolar,2560660,=,37,True,=,,IC50,nM,,790.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,790.0
220891,17609890,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1noc(C)c1S(=O)(=O)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '8.87', 'le': '0.17', 'lle': '0.57', 'sei': '3.94'}",CHEMBL3684456,,CHEMBL3684456,5.17,False,http://www.openphacts.org/units/Nanomolar,2560661,=,37,True,=,,IC50,nM,,6800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6800.0
220892,17609891,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1)c1ccccc1F,,,CHEMBL3638978,,2013.0,"{'bei': '9.69', 'le': '0.18', 'lle': '0.50', 'sei': '5.37'}",CHEMBL3684457,,CHEMBL3684457,5.64,False,http://www.openphacts.org/units/Nanomolar,2560662,=,37,True,=,,IC50,nM,,2300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2300.0
220893,17609892,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(CC1CCCCC1)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '9.37', 'le': '0.18', 'lle': '-0.05', 'sei': '5.21'}",CHEMBL3639833,,CHEMBL3639833,5.47,False,http://www.openphacts.org/units/Nanomolar,2560663,=,37,True,=,,IC50,nM,,3400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3400.0
220894,17609893,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1)C1CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.00', 'le': '0.19', 'lle': '1.18', 'sei': '5.02'}",CHEMBL3684458,,CHEMBL3684458,5.28,False,http://www.openphacts.org/units/Nanomolar,2560664,=,37,True,=,,IC50,nM,,5300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5300.0
220895,17609894,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(S(=O)(=O)NC2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '9.30', 'le': '0.18', 'lle': '0.52', 'sei': '4.83'}",CHEMBL3684459,,CHEMBL3684459,5.52,False,http://www.openphacts.org/units/Nanomolar,2560665,=,37,True,=,,IC50,nM,,3000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3000.0
220896,17609895,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1ccc(S(=O)(=O)NC2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '8.54', 'le': '0.16', 'lle': '0.35', 'sei': '3.95'}",CHEMBL3684460,,CHEMBL3684460,5.30,False,http://www.openphacts.org/units/Nanomolar,2560666,=,37,True,=,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5000.0
220897,17609896,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(Cc1ccccc1)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '9.94', 'le': '0.19', 'lle': '0.60', 'sei': '5.47'}",CHEMBL3684461,,CHEMBL3684461,5.75,False,http://www.openphacts.org/units/Nanomolar,2560667,=,37,True,=,,IC50,nM,,1800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1800.0
220898,17609897,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C)c(S(=O)(=O)NC2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)s1,,,CHEMBL3638978,,2013.0,"{'bei': '8.81', 'le': '0.17', 'lle': '0.21', 'sei': '4.47'}",CHEMBL3684462,,CHEMBL3684462,5.28,False,http://www.openphacts.org/units/Nanomolar,2560668,=,37,True,=,,IC50,nM,,5300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5300.0
220899,17609898,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CS(=O)(=O)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '9.55', 'le': '0.18', 'lle': '0.60', 'sei': '4.94'}",CHEMBL3684463,,CHEMBL3684463,5.19,False,http://www.openphacts.org/units/Nanomolar,2560669,=,37,True,=,,IC50,nM,,6400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6400.0
220900,17609899,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1ccc(S(=O)(=O)NC2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '9.03', 'le': '0.17', 'lle': '0.27', 'sei': '4.48'}",CHEMBL3684464,,CHEMBL3684464,5.47,False,http://www.openphacts.org/units/Nanomolar,2560670,=,37,True,=,,IC50,nM,,3400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3400.0
220901,17609900,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1)c1ccc2c(c1)OCCO2,,,CHEMBL3638978,,2013.0,"{'bei': '9.17', 'le': '0.17', 'lle': '0.93', 'sei': '4.61'}",CHEMBL3684465,,CHEMBL3684465,5.70,False,http://www.openphacts.org/units/Nanomolar,2560671,=,37,True,=,,IC50,nM,,2000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2000.0
220902,17609901,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1)c1cccc(F)c1,,,CHEMBL3638978,,2013.0,"{'bei': '9.57', 'le': '0.18', 'lle': '0.43', 'sei': '5.30'}",CHEMBL3684466,,CHEMBL3684466,5.57,False,http://www.openphacts.org/units/Nanomolar,2560672,=,37,True,=,,IC50,nM,,2700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2700.0
220903,17609902,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc2c(c1)OCO2)N1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '9.26', 'le': '0.17', 'lle': '0.42', 'sei': '5.29'}",CHEMBL3684467,,CHEMBL3684467,5.16,False,http://www.openphacts.org/units/Nanomolar,2560673,=,37,True,=,,IC50,nM,,6900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6900.0
220904,17609903,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]c1cccc(C(=O)N2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '10.58', 'le': '0.19', 'lle': '0.14', 'sei': '6.82'}",CHEMBL3684468,,CHEMBL3684468,5.70,False,http://www.openphacts.org/units/Nanomolar,2560674,=,37,True,=,,IC50,nM,,2000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2000.0
220905,17609904,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C(=O)N2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '10.47', 'le': '0.19', 'lle': '0.20', 'sei': '6.98'}",CHEMBL3684469,,CHEMBL3684469,5.52,False,http://www.openphacts.org/units/Nanomolar,2560675,=,37,True,=,,IC50,nM,,3000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3000.0
220906,17609905,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccccn1)N1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.45', 'le': '0.19', 'lle': '0.97', 'sei': '5.84'}",CHEMBL3684470,,CHEMBL3684470,5.38,False,http://www.openphacts.org/units/Nanomolar,2560676,=,37,True,=,,IC50,nM,,4200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4200.0
220907,17609906,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCN(c2ccccc2)C12CCN(Cc1ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc1)CC2,,,CHEMBL3638978,,2013.0,"{'bei': '10.86', 'le': '0.20', 'lle': '1.04', 'sei': '6.60'}",CHEMBL3684471,,CHEMBL3684471,6.02,False,http://www.openphacts.org/units/Nanomolar,2560677,=,37,True,=,,IC50,nM,,950.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,950.0
220908,17609907,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]C1(c2ccccc2)CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.08', 'le': '0.18', 'lle': '-1.32', 'sei': '8.12'}",CHEMBL3684472,,CHEMBL3684472,5.14,False,http://www.openphacts.org/units/Nanomolar,2560678,=,37,True,=,,IC50,nM,,7300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7300.0
220909,17609908,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.83', 'le': '0.20', 'lle': '-0.55', 'sei': '7.56'}",CHEMBL3684473,,CHEMBL3684473,5.75,False,http://www.openphacts.org/units/Nanomolar,2560679,=,37,True,=,,IC50,nM,,1800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1800.0
220910,17609909,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(F)cc1)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.56', 'le': '0.21', 'lle': '0.50', 'sei': '6.48'}",CHEMBL3684474,,CHEMBL3684474,6.48,False,http://www.openphacts.org/units/Nanomolar,2560680,=,37,True,=,,IC50,nM,,330.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,330.0
220911,17609910,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C)cc1NC(=O)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.47', 'le': '0.19', 'lle': '-0.02', 'sei': '5.62'}",CHEMBL3684475,,CHEMBL3684475,6.14,False,http://www.openphacts.org/units/Nanomolar,2560681,=,37,True,=,,IC50,nM,,720.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,720.0
220912,17609911,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccccc1F)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.34', 'le': '0.21', 'lle': '0.38', 'sei': '6.36'}",CHEMBL3684476,,CHEMBL3684476,6.36,False,http://www.openphacts.org/units/Nanomolar,2560682,=,37,True,=,,IC50,nM,,440.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,440.0
220913,17609912,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(NC(=O)NC2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '11.42', 'le': '0.21', 'lle': '0.21', 'sei': '6.36'}",CHEMBL3684477,,CHEMBL3684477,6.36,False,http://www.openphacts.org/units/Nanomolar,2560683,=,37,True,=,,IC50,nM,,440.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,440.0
220914,17609913,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CCNC(=O)NC2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)cc1OC,,,CHEMBL3638978,,2013.0,"{'bei': '8.28', 'le': '0.15', 'lle': '-0.36', 'sei': '4.41'}",CHEMBL3684478,,CHEMBL3684478,5.22,False,http://www.openphacts.org/units/Nanomolar,2560684,=,37,True,=,,IC50,nM,,6000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6000.0
220915,17609914,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(NC(=O)NC2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '11.10', 'le': '0.20', 'lle': '0.03', 'sei': '6.18'}",CHEMBL3684479,,CHEMBL3684479,6.18,False,http://www.openphacts.org/units/Nanomolar,2560685,=,37,True,=,,IC50,nM,,660.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,660.0
220916,17609915,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(CNC(=O)NC2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '10.41', 'le': '0.19', 'lle': '0.58', 'sei': '5.59'}",CHEMBL3684480,,CHEMBL3684480,6.11,False,http://www.openphacts.org/units/Nanomolar,2560686,=,37,True,=,,IC50,nM,,780.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,780.0
220917,17609916,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(NC(=O)NC2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)cc1Cl,,,CHEMBL3638978,,2013.0,"{'bei': '9.75', 'le': '0.18', 'lle': '-0.58', 'sei': '5.42'}",CHEMBL3684481,,CHEMBL3684481,5.92,False,http://www.openphacts.org/units/Nanomolar,2560687,=,37,True,=,,IC50,nM,,1200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1200.0
220918,17609917,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1ccccc1Cl)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.22', 'le': '0.19', 'lle': '-0.13', 'sei': '6.04'}",CHEMBL3684482,,CHEMBL3684482,6.04,False,http://www.openphacts.org/units/Nanomolar,2560688,=,37,True,=,,IC50,nM,,910.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,910.0
220919,17609918,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc(C(F)(F)F)c1)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.15', 'le': '0.19', 'lle': '-0.66', 'sei': '6.20'}",CHEMBL3684483,,CHEMBL3684483,6.20,False,http://www.openphacts.org/units/Nanomolar,2560689,=,37,True,=,,IC50,nM,,630.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,630.0
220920,17609919,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc2c(c1)CCO2)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.73', 'le': '0.19', 'lle': '0.51', 'sei': '5.75'}",CHEMBL3684484,,CHEMBL3684484,6.28,False,http://www.openphacts.org/units/Nanomolar,2560690,=,37,True,=,,IC50,nM,,530.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,530.0
220921,17609920,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc(Cl)c1)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.26', 'le': '0.19', 'lle': '-0.57', 'sei': '5.92'}",CHEMBL3684485,,CHEMBL3684485,5.92,False,http://www.openphacts.org/units/Nanomolar,2560691,=,37,True,=,,IC50,nM,,1200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1200.0
220922,17609921,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1ccccc1NC(=O)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.46', 'le': '0.19', 'lle': '-0.68', 'sei': '6.11'}",CHEMBL3684486,,CHEMBL3684486,6.11,False,http://www.openphacts.org/units/Nanomolar,2560692,=,37,True,=,,IC50,nM,,770.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,770.0
220923,17609922,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc(F)c1)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.88', 'le': '0.20', 'lle': '0.12', 'sei': '6.10'}",CHEMBL3684487,,CHEMBL3684487,6.10,False,http://www.openphacts.org/units/Nanomolar,2560693,=,37,True,=,,IC50,nM,,790.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,790.0
220924,17609923,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1NC(=O)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.06', 'le': '0.20', 'lle': '0.00', 'sei': '6.15'}",CHEMBL3684488,,CHEMBL3684488,6.16,False,http://www.openphacts.org/units/Nanomolar,2560694,=,37,True,=,,IC50,nM,,700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,700.0
220925,17609924,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCCc1ccc(Cl)cc1)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '9.96', 'le': '0.19', 'lle': '-0.18', 'sei': '6.03'}",CHEMBL3684489,,CHEMBL3684489,6.03,False,http://www.openphacts.org/units/Nanomolar,2560695,=,37,True,=,,IC50,nM,,940.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,940.0
220926,17609925,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1CNC(=O)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.37', 'le': '0.19', 'lle': '0.09', 'sei': '5.92'}",CHEMBL3684490,,CHEMBL3684490,5.92,False,http://www.openphacts.org/units/Nanomolar,2560696,=,37,True,=,,IC50,nM,,1200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1200.0
220927,17609926,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCCc1cccs1)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.62', 'le': '0.20', 'lle': '0.50', 'sei': '6.12'}",CHEMBL3684491,,CHEMBL3684491,6.12,False,http://www.openphacts.org/units/Nanomolar,2560697,=,37,True,=,,IC50,nM,,750.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,750.0
220928,17609927,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1NC(=O)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.75', 'le': '0.20', 'lle': '0.30', 'sei': '5.63'}",CHEMBL3684492,,CHEMBL3684492,6.16,False,http://www.openphacts.org/units/Nanomolar,2560698,=,37,True,=,,IC50,nM,,700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,700.0
220929,17609928,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(NC(=O)NC2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)c(C)c1,,,CHEMBL3638978,,2013.0,"{'bei': '10.36', 'le': '0.19', 'lle': '-0.08', 'sei': '5.56'}",CHEMBL3684493,,CHEMBL3684493,6.08,False,http://www.openphacts.org/units/Nanomolar,2560699,=,37,True,=,,IC50,nM,,840.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,840.0
220930,17609929,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(COCc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)no1,,,CHEMBL3638978,,2013.0,"{'bei': '13.01', 'le': '0.23', 'lle': '0.61', 'sei': '6.25'}",CHEMBL3684494,,CHEMBL3684494,5.68,False,http://www.openphacts.org/units/Nanomolar,2560700,=,37,True,=,,IC50,nM,,2100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2100.0
220931,17609930,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-n2cc(COCc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)nn2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.66', 'le': '0.23', 'lle': '0.96', 'sei': '6.60'}",CHEMBL3684495,,CHEMBL3684495,6.31,False,http://www.openphacts.org/units/Nanomolar,2560701,=,37,True,=,,IC50,nM,,490.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,490.0
220932,17609931,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(c1)Nc1ncccc1-n1c(-c3ccc(CN4CCC(c5c[nH]c6ccccc56)CC4)cc3)nnc1-2,,,CHEMBL3638978,,2013.0,"{'bei': '12.03', 'le': '0.22', 'lle': '-0.61', 'sei': '8.44'}",CHEMBL3684496,,CHEMBL3684496,6.30,False,http://www.openphacts.org/units/Nanomolar,2560702,=,37,True,=,,IC50,nM,,500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,500.0
220933,17609932,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(OC2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.15', 'le': '0.22', 'lle': '-0.02', 'sei': '8.93'}",CHEMBL3684497,,CHEMBL3684497,6.08,False,http://www.openphacts.org/units/Nanomolar,2560703,=,37,True,=,,IC50,nM,,830.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,830.0
220934,17609933,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(OC2CCCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)C2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.06', 'le': '0.22', 'lle': '-0.06', 'sei': '8.86'}",CHEMBL3684498,,CHEMBL3684498,6.04,False,http://www.openphacts.org/units/Nanomolar,2560704,=,37,True,=,,IC50,nM,,920.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,920.0
220935,17609934,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1noc(C2CCCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)C2)n1,,,CHEMBL3638978,,2013.0,"{'bei': '13.02', 'le': '0.24', 'lle': '1.27', 'sei': '6.53'}",CHEMBL3684499,,CHEMBL3684499,6.39,False,http://www.openphacts.org/units/Nanomolar,2560705,=,37,True,=,,IC50,nM,,410.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,410.0
220936,17609935,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(-c2ccccc2)cn1C1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '12.92', 'le': '0.23', 'lle': '1.27', 'sei': '7.57'}",CHEMBL3684500,,CHEMBL3684500,7.32,False,http://www.openphacts.org/units/Nanomolar,2560706,=,37,True,=,,IC50,nM,,48.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,48.0
220937,17609936,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(N)c1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '17.56', 'le': '0.32', 'lle': '2.22', 'sei': '7.92'}",CHEMBL3684501,,CHEMBL3684501,6.47,False,http://www.openphacts.org/units/Nanomolar,2560707,=,37,True,=,,IC50,nM,,340.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,340.0
220938,17609937,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC1(c2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CCC1)c1ccccc1,,,CHEMBL3638978,,2013.0,"{'bei': '14.73', 'le': '0.26', 'lle': '1.28', 'sei': '8.42'}",CHEMBL3684502,,CHEMBL3684502,7.14,False,http://www.openphacts.org/units/Nanomolar,2560708,=,37,True,=,,IC50,nM,,73.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,73.0
220939,17609938,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccccc1)NC1(c2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CCC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.85', 'le': '0.21', 'lle': '-0.33', 'sei': '6.12'}",CHEMBL3684503,,CHEMBL3684503,5.92,False,http://www.openphacts.org/units/Nanomolar,2560709,=,37,True,=,,IC50,nM,,1200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1200.0
220940,17609939,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NC1(c2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CCC1)c1ccccc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.59', 'le': '0.24', 'lle': '1.14', 'sei': '6.44'}",CHEMBL3684504,,CHEMBL3684504,6.55,False,http://www.openphacts.org/units/Nanomolar,2560710,=,37,True,=,,IC50,nM,,280.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,280.0
220941,17609940,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(c1)Nc1ncccc1-n1c(-c3ccc(C4CCCN4)cc3)nnc1-2,,,CHEMBL3638978,,2013.0,"{'bei': '15.66', 'le': '0.28', 'lle': '1.48', 'sei': '8.81'}",CHEMBL3684505,,CHEMBL3684505,5.96,False,http://www.openphacts.org/units/Nanomolar,2560711,=,37,True,=,,IC50,nM,,1100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1100.0
220942,17609941,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NC1(c2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CCC1)c1ccc(F)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '11.58', 'le': '0.22', 'lle': '0.69', 'sei': '6.13'}",CHEMBL3684506,,CHEMBL3684506,6.24,False,http://www.openphacts.org/units/Nanomolar,2560712,=,37,True,=,,IC50,nM,,580.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,580.0
220943,17609942,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)NC2(c3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CCC2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.10', 'le': '0.23', 'lle': '0.75', 'sei': '6.35'}",CHEMBL3684507,,CHEMBL3684507,6.47,False,http://www.openphacts.org/units/Nanomolar,2560713,=,37,True,=,,IC50,nM,,340.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,340.0
220944,17609943,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(S(=O)(=O)NC2(c3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CCC2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '11.85', 'le': '0.22', 'lle': '0.62', 'sei': '6.23'}",CHEMBL3684508,,CHEMBL3684508,6.34,False,http://www.openphacts.org/units/Nanomolar,2560714,=,37,True,=,,IC50,nM,,460.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,460.0
220945,17609944,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC1(c2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CCC1)c1ccc(F)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.37', 'le': '0.22', 'lle': '0.21', 'sei': '7.33'}",CHEMBL3684509,,CHEMBL3684509,6.21,False,http://www.openphacts.org/units/Nanomolar,2560715,=,37,True,=,,IC50,nM,,610.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,610.0
220946,17609945,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)NC1CCN(Cc2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '10.93', 'le': '0.20', 'lle': '0.18', 'sei': '5.89'}",CHEMBL3684510,,CHEMBL3684510,5.72,False,http://www.openphacts.org/units/Nanomolar,2560716,=,37,True,=,,IC50,nM,,1900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1900.0
220947,17609946,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc2c(CCNCc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)c[nH]c2c1,,,CHEMBL3638978,,2013.0,"{'bei': '13.31', 'le': '0.24', 'lle': '0.67', 'sei': '8.00'}",CHEMBL3684511,,CHEMBL3684511,6.68,False,http://www.openphacts.org/units/Nanomolar,2560717,=,37,True,=,,IC50,nM,,210.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,210.0
220948,17609947,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc2nc(CCNCc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)[nH]c2c1,,,CHEMBL3638978,,2013.0,"{'bei': '13.15', 'le': '0.25', 'lle': '0.90', 'sei': '7.08'}",CHEMBL3684512,,CHEMBL3684512,6.82,False,http://www.openphacts.org/units/Nanomolar,2560718,=,37,True,=,,IC50,nM,,150.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,150.0
220949,17609948,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(NC1(c2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CCC1)c1cccc(F)c1,,,CHEMBL3638978,,2013.0,"{'bei': '11.36', 'le': '0.21', 'lle': '0.57', 'sei': '6.01'}",CHEMBL3684513,,CHEMBL3684513,6.12,False,http://www.openphacts.org/units/Nanomolar,2560719,=,37,True,=,,IC50,nM,,760.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,760.0
220950,17609949,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1ccc(S(=O)(=O)NC2(c3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CCC2)n1,,,CHEMBL3638978,,2013.0,"{'bei': '11.81', 'le': '0.22', 'lle': '2.05', 'sei': '5.18'}",CHEMBL3684514,,CHEMBL3684514,6.19,False,http://www.openphacts.org/units/Nanomolar,2560720,=,37,True,=,,IC50,nM,,640.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,640.0
220951,17609950,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C(=O)NC2(c3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CCC2)no1,,,CHEMBL3638978,,2013.0,"{'bei': '13.52', 'le': '0.24', 'lle': '1.46', 'sei': '5.98'}",CHEMBL3684515,,CHEMBL3684515,6.62,False,http://www.openphacts.org/units/Nanomolar,2560721,=,37,True,=,,IC50,nM,,240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,240.0
220952,17609951,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2nnc(C3CCN(Cc4ccc(-c5nnc6n5-c5cccnc5Nc5ccccc5-6)cc4)CC3)o2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '11.18', 'le': '0.20', 'lle': '-0.30', 'sei': '6.32'}",CHEMBL3684516,,CHEMBL3684516,6.18,False,http://www.openphacts.org/units/Nanomolar,2560722,=,37,True,=,,IC50,nM,,660.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,660.0
220953,17609952,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2c(c1)-c1nnc(-c3ccc(C4(N)CCC4)cc3)n1-c1cccnc1N2,,,CHEMBL3638978,,2013.0,"{'bei': '15.25', 'le': '0.27', 'lle': '1.32', 'sei': '7.37'}",CHEMBL3684525,,CHEMBL3684525,6.02,False,http://www.openphacts.org/units/Nanomolar,2560731,=,37,True,=,,IC50,nM,,960.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,960.0
220954,17609953,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CCCCC1,,,CHEMBL3638978,,2013.0,"{'bei': '15.42', 'le': '0.28', 'lle': '1.13', 'sei': '7.72'}",CHEMBL3684526,,CHEMBL3684526,6.30,False,http://www.openphacts.org/units/Nanomolar,2560732,=,37,True,=,,IC50,nM,,500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,500.0
220955,17609954,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2c1Nc1ncccc1-n1c(-c3ccc(C4(N)CCC4)cc3)nnc1-2,,,CHEMBL3638978,,2013.0,"{'bei': '14.84', 'le': '0.27', 'lle': '1.15', 'sei': '7.17'}",CHEMBL3684527,,CHEMBL3684527,5.85,False,http://www.openphacts.org/units/Nanomolar,2560733,=,37,True,=,,IC50,nM,,1400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1400.0
220956,17609955,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nnc4n3-c3cccnc3Nc3ccc(Br)cc3-4)cc2)CCC1,,,CHEMBL3638978,,2013.0,"{'bei': '14.99', 'le': '0.31', 'lle': '1.74', 'sei': '8.43'}",CHEMBL3684528,,CHEMBL3684528,6.89,False,http://www.openphacts.org/units/Nanomolar,2560734,=,37,True,=,,IC50,nM,,130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,130.0
220957,17609956,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nnc4n3-c3cnccc3Nc3ccccc3-4)cc2)CCC1,,,CHEMBL3638978,,2013.0,"{'bei': '13.93', 'le': '0.25', 'lle': '0.91', 'sei': '6.49'}",CHEMBL3684529,,CHEMBL3684529,5.30,False,http://www.openphacts.org/units/Nanomolar,2560735,=,37,True,=,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5000.0
220958,17609957,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)NC1(c2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '12.55', 'le': '0.23', 'lle': '0.28', 'sei': '6.23'}",CHEMBL3684530,,CHEMBL3684530,5.85,False,http://www.openphacts.org/units/Nanomolar,2560736,=,37,True,=,,IC50,nM,,1400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1400.0
220959,17609958,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '18.70', 'le': '0.33', 'lle': '2.85', 'sei': '8.39'}",CHEMBL3684531,,CHEMBL3684531,6.85,False,http://www.openphacts.org/units/Nanomolar,2560737,=,37,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,140.0
220960,17609959,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2c(c1)Nc1ncccc1-n1c(-c3ccc(C4(N)CCC4)cc3)nnc1-2,,,CHEMBL3638978,,2013.0,"{'bei': '16.00', 'le': '0.29', 'lle': '1.61', 'sei': '7.73'}",CHEMBL3684532,,CHEMBL3684532,6.31,False,http://www.openphacts.org/units/Nanomolar,2560738,=,37,True,=,,IC50,nM,,490.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,490.0
220961,17609960,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nnc4n3-c3cccnc3Nc3ccc(-c5ccccc5)cc3-4)cc2)CCC1,,,CHEMBL3638978,,2013.0,"{'bei': '12.97', 'le': '0.23', 'lle': '-0.14', 'sei': '7.25'}",CHEMBL3684533,,CHEMBL3684533,5.92,False,http://www.openphacts.org/units/Nanomolar,2560739,=,37,True,=,,IC50,nM,,1200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1200.0
220962,17609961,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,OCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccc(Br)cc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.57', 'le': '0.27', 'lle': '0.97', 'sei': '6.97'}",CHEMBL3684534,,CHEMBL3684534,5.28,False,http://www.openphacts.org/units/Nanomolar,2560740,=,37,True,=,,IC50,nM,,5200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5200.0
220963,17609962,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC1(c2ccc(-c3nnc4n3-c3ccc(Cl)nc3Nc3ccccc3-4)cc2)CCC1)C(F)(F)F,,,CHEMBL3638978,,2013.0,"{'bei': '9.85', 'le': '0.19', 'lle': '-0.73', 'sei': '5.94'}",CHEMBL3684535,,CHEMBL3684535,5.03,False,http://www.openphacts.org/units/Nanomolar,2560741,=,37,True,=,,IC50,nM,,9300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9300.0
220964,17609963,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccc(Br)cc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '12.44', 'le': '0.26', 'lle': '0.94', 'sei': '6.39'}",CHEMBL3684536,,CHEMBL3684536,5.21,False,http://www.openphacts.org/units/Nanomolar,2560742,=,37,True,=,,IC50,nM,,6100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6100.0
220965,17609964,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,Brc1ccc2c(c1)-c1nnc(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)n1-c1cccnc1N2,,,CHEMBL3638978,,2013.0,"{'bei': '11.11', 'le': '0.22', 'lle': '0.64', 'sei': '6.19'}",CHEMBL3684537,,CHEMBL3684537,7.02,False,http://www.openphacts.org/units/Nanomolar,2560743,=,37,True,=,,IC50,nM,,96.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,96.0
220966,17609965,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(CCNC2(c3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CCC2)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '11.18', 'le': '0.20', 'lle': '-0.84', 'sei': '8.01'}",CHEMBL3684538,,CHEMBL3684538,5.42,False,http://www.openphacts.org/units/Nanomolar,2560744,=,37,True,=,,IC50,nM,,3800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3800.0
220967,17609966,[],CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nnc4n3-c3cc(-c5ccccc5)cnc3Nc3ccccc3-4)cc2)CCC1,,,CHEMBL3638978,,2013.0,"{'bei': '12.23', 'le': '0.22', 'lle': '-0.47', 'sei': '6.84'}",CHEMBL3684539,,CHEMBL3684539,5.58,False,http://www.openphacts.org/units/Nanomolar,2560745,=,37,True,=,,IC50,nM,,2600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2600.0
220968,17609967,[],CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)N1CCN(C(=O)c2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '8.38', 'le': '0.15', 'lle': '-0.36', 'sei': '4.16'}",CHEMBL3684517,,CHEMBL3684517,4.39,False,http://www.openphacts.org/units/Nanomolar,2560723,=,37,True,=,,IC50,nM,,41000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,41000.0
220969,17609968,[],CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1)N1CCNCC1,,,CHEMBL3638978,,2013.0,"{'bei': '11.26', 'le': '0.20', 'lle': '1.67', 'sei': '5.42'}",CHEMBL3684518,,CHEMBL3684518,4.77,False,http://www.openphacts.org/units/Nanomolar,2560724,=,37,True,=,,IC50,nM,,17000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17000.0
220970,17609969,[],CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)NC1CCN(C(=O)c2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '7.91', 'le': '0.15', 'lle': '-0.93', 'sei': '3.72'}",CHEMBL3684519,,CHEMBL3684519,4.25,False,http://www.openphacts.org/units/Nanomolar,2560725,=,37,True,=,,IC50,nM,,56000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,56000.0
220971,17609970,[],CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCN(C(=O)c2ccc(-c3nnc4n3-c3cccnc3Nc3ccccc3-4)cc2)CC1,,,CHEMBL3638978,,2013.0,"{'bei': '9.50', 'le': '0.17', 'lle': '0.53', 'sei': '4.08'}",CHEMBL3684520,,CHEMBL3684520,4.16,False,http://www.openphacts.org/units/Nanomolar,2560726,=,37,True,=,,IC50,nM,,70000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,70000.0
220972,17609971,[],CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)NCCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '11.81', 'le': '0.22', 'lle': '0.25', 'sei': '5.71'}",CHEMBL3684521,,CHEMBL3684521,5.37,False,http://www.openphacts.org/units/Nanomolar,2560727,=,37,True,=,,IC50,nM,,4300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4300.0
220973,17609972,[],CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)NCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '11.02', 'le': '0.20', 'lle': '-0.23', 'sei': '5.17'}",CHEMBL3684522,,CHEMBL3684522,4.85,False,http://www.openphacts.org/units/Nanomolar,2560728,=,37,True,=,,IC50,nM,,14000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14000.0
220974,17609973,[],CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,,,BAO_0000190,BAO_0000357,single protein format,NCCc1ccc(-c2nnc3n2-c2cccnc2Nc2ccccc2-3)cc1,,,CHEMBL3638978,,2013.0,"{'bei': '13.70', 'le': '0.25', 'lle': '1.30', 'sei': '5.94'}",CHEMBL3684523,,CHEMBL3684523,4.85,False,http://www.openphacts.org/units/Nanomolar,2560729,=,37,True,=,,IC50,nM,,14000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14000.0
220975,17609974,[],CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(C(=O)NC2CCN(Cc3ccc(-c4nnc5n4-c4cccnc4Nc4ccccc4-5)cc3)CC2)c1,,,CHEMBL3638978,,2013.0,"{'bei': '9.18', 'le': '0.17', 'lle': '-0.34', 'sei': '5.27'}",CHEMBL3684524,,CHEMBL3684524,5.12,False,http://www.openphacts.org/units/Nanomolar,2560730,=,37,True,=,,IC50,nM,,7600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7600.0
228758,17616962,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncccc1-c1nc2ccc(-c3cccc(NC(=O)C4CC4)c3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3639320,,2013.0,"{'bei': '16.50', 'le': '0.30', 'lle': '3.09', 'sei': '6.82'}",CHEMBL3640732,,CHEMBL3640732,8.51,True,http://www.openphacts.org/units/Nanomolar,2513558,=,37,True,=,,IC50,nM,,3.09,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.09
228759,17616963,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)C(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,,,CHEMBL3639320,,2013.0,"{'bei': '16.49', 'le': '0.30', 'lle': '2.72', 'sei': '7.03'}",CHEMBL3640733,,CHEMBL3640733,8.77,True,http://www.openphacts.org/units/Nanomolar,2513559,=,37,True,=,,IC50,nM,,1.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.7
228760,17616964,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)OC(C)(C)C(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,,,CHEMBL3639320,,2013.0,"{'bei': '14.51', 'le': '0.27', 'lle': '3.00', 'sei': '5.53'}",CHEMBL3640734,,CHEMBL3640734,8.35,True,http://www.openphacts.org/units/Nanomolar,2513560,=,37,True,=,,IC50,nM,,4.46,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.46
228761,17616965,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)C(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,,,CHEMBL3639320,,2013.0,"{'bei': '16.47', 'le': '0.30', 'lle': '4.01', 'sei': '6.06'}",CHEMBL3640735,,CHEMBL3640735,8.79,True,http://www.openphacts.org/units/Nanomolar,2513561,=,37,True,=,,IC50,nM,,1.63,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.63
228762,17616966,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](O)CNC(=O)c1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,,,CHEMBL3639320,,2013.0,"{'bei': '16.14', 'le': '0.29', 'lle': '4.43', 'sei': '5.94'}",CHEMBL3640736,,CHEMBL3640736,8.61,True,http://www.openphacts.org/units/Nanomolar,2513562,=,37,True,=,,IC50,nM,,2.45,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.45
228763,17616967,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](O)CNC(=O)c1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,,,CHEMBL3639320,,2013.0,"{'bei': '16.54', 'le': '0.30', 'lle': '4.64', 'sei': '6.09'}",CHEMBL3640737,,CHEMBL3640737,8.82,True,http://www.openphacts.org/units/Nanomolar,2513563,=,37,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
228764,17616968,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)C1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,,,CHEMBL3639320,,2013.0,"{'bei': '14.66', 'le': '0.27', 'lle': '3.23', 'sei': '7.22'}",CHEMBL3640738,,CHEMBL3640738,8.60,True,http://www.openphacts.org/units/Nanomolar,2513564,=,37,True,=,,IC50,nM,,2.51,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.51
228765,17616969,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)C(=O)C1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,,,CHEMBL3639320,,2013.0,"{'bei': '13.63', 'le': '0.25', 'lle': '2.23', 'sei': '7.03'}",CHEMBL3640739,,CHEMBL3640739,8.38,True,http://www.openphacts.org/units/Nanomolar,2513565,=,37,True,=,,IC50,nM,,4.15,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.15
228766,17616970,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncccc1-c1nc2ccc(-c3cccc(N4CCC(C(=O)N5CCOCC5)CC4)c3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3639320,,2013.0,"{'bei': '13.48', 'le': '0.25', 'lle': '3.33', 'sei': '6.60'}",CHEMBL3640740,,CHEMBL3640740,8.47,True,http://www.openphacts.org/units/Nanomolar,2513566,=,37,True,=,,IC50,nM,,3.36,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.36
228767,17616971,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NC1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,,,CHEMBL3639320,,2013.0,"{'bei': '15.44', 'le': '0.28', 'lle': '3.67', 'sei': '6.91'}",CHEMBL3640741,,CHEMBL3640741,8.84,True,http://www.openphacts.org/units/Nanomolar,2513567,=,37,True,=,,IC50,nM,,1.44,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.44
228768,17616972,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(=O)N1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,,,CHEMBL3639320,,2013.0,"{'bei': '15.13', 'le': '0.28', 'lle': '3.54', 'sei': '7.27'}",CHEMBL3640742,,CHEMBL3640742,8.67,True,http://www.openphacts.org/units/Nanomolar,2513568,=,37,True,=,,IC50,nM,,2.15,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.15
228769,17616973,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncccc1-c1nc2ccc(-c3cccc(N4CCN(C(=O)C5CC5)CC4)c3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3639320,,2013.0,"{'bei': '14.94', 'le': '0.27', 'lle': '3.61', 'sei': '7.33'}",CHEMBL3640743,,CHEMBL3640743,8.73,True,http://www.openphacts.org/units/Nanomolar,2513569,=,37,True,=,,IC50,nM,,1.84,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.84
228770,17616974,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)C(=O)N1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,,,CHEMBL3639320,,2013.0,"{'bei': '14.09', 'le': '0.26', 'lle': '2.71', 'sei': '7.10'}",CHEMBL3640745,,CHEMBL3640745,8.47,True,http://www.openphacts.org/units/Nanomolar,2513571,=,37,True,=,,IC50,nM,,3.42,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.42
228771,17616975,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)C[C@@H](C)O1,,,CHEMBL3639320,,2013.0,"{'bei': '15.32', 'le': '0.28', 'lle': '2.68', 'sei': '7.73'}",CHEMBL3640746,,CHEMBL3640746,8.36,True,http://www.openphacts.org/units/Nanomolar,2513572,=,37,True,=,,IC50,nM,,4.36,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.36
228772,17616976,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncccc1-c1nc2ccc(-c3cccc(N4CCS(=O)(=O)CC4)c3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3639320,,2013.0,"{'bei': '15.46', 'le': '0.29', 'lle': '4.45', 'sei': '6.58'}",CHEMBL3640747,,CHEMBL3640747,8.75,True,http://www.openphacts.org/units/Nanomolar,2513573,=,37,True,=,,IC50,nM,,1.79,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.79
228773,17616977,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncccc1-c1nc2ccc(Nc3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3639320,,2013.0,"{'bei': '18.82', 'le': '0.34', 'lle': '3.27', 'sei': '7.82'}",CHEMBL3640748,,CHEMBL3640748,8.42,True,http://www.openphacts.org/units/Nanomolar,2513574,=,37,True,=,,IC50,nM,,3.77,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.77
228774,17616978,[],CHEMBL3705709,"Alpha Screen Assay : AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen™ (Amplified Luminescent Proximity Homogeneous Assay) technology.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncccc1-c1nc2ccc(Nc3ccc(N4CCOCC4)cc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3639320,,2013.0,"{'bei': '15.13', 'le': '0.28', 'lle': '3.08', 'sei': '6.71'}",CHEMBL3640749,,CHEMBL3640749,8.06,True,http://www.openphacts.org/units/Nanomolar,2513575,=,37,True,=,,IC50,nM,,8.72,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.72
261990,17644518,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccccc1-c1nc2ccc(-c3cccc(N4CCOCC4)c3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3638999,,2014.0,"{'bei': '14.11', 'le': '0.26', 'lle': '2.18', 'sei': '8.27'}",CHEMBL3649665,,CHEMBL3649665,7.90,False,http://www.openphacts.org/units/Nanomolar,2523292,=,37,True,=,,IC50,nM,,12.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.6
261991,17644519,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-c1nc2ccc(-c3cccc(N4CCOCC4)c3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3638999,,2014.0,"{'bei': '15.40', 'le': '0.28', 'lle': '1.70', 'sei': '11.47'}",CHEMBL3649666,,CHEMBL3649666,7.94,False,http://www.openphacts.org/units/Nanomolar,2523293,=,37,True,=,,IC50,nM,,11.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.5
261992,17644520,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(C4CCCCC4)nc4ccc(-c5cccc(N6CCOCC6)c5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '16.66', 'le': '0.30', 'lle': '2.15', 'sei': '12.22'}",CHEMBL3649667,,CHEMBL3649667,8.46,False,http://www.openphacts.org/units/Nanomolar,2523294,=,37,True,=,,IC50,nM,,3.47,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.47
261993,17644521,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(C4CC4)nc4ccc(-c5cccc(N6CCOCC6)c5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '18.69', 'le': '0.34', 'lle': '3.56', 'sei': '12.57'}",CHEMBL3649668,,CHEMBL3649668,8.70,False,http://www.openphacts.org/units/Nanomolar,2523295,=,37,True,=,,IC50,nM,,1.99,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.99
261994,17644522,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(Cl)c1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3638999,,2014.0,"{'bei': '17.40', 'le': '0.33', 'lle': '3.02', 'sei': '7.50'}",CHEMBL3649669,,CHEMBL3649669,8.14,False,http://www.openphacts.org/units/Nanomolar,2523296,=,37,True,=,,IC50,nM,,7.17,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.17
261995,17644523,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2nc3ccc(-c4ccccc4)nc3n2-c2ccc(C3(N)CCC3)cc2)c(N)n1,,,CHEMBL3638999,,2014.0,"{'bei': '18.91', 'le': '0.34', 'lle': '3.83', 'sei': '8.19'}",CHEMBL3649670,,CHEMBL3649670,8.24,False,http://www.openphacts.org/units/Nanomolar,2523297,=,37,True,=,,IC50,nM,,5.78,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.78
261996,17644524,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nccnc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3638999,,2014.0,"{'bei': '20.23', 'le': '0.36', 'lle': '4.31', 'sei': '8.08'}",CHEMBL3649671,,CHEMBL3649671,8.77,False,http://www.openphacts.org/units/Nanomolar,2523298,=,37,True,=,,IC50,nM,,1.69,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.69
261997,17644525,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4cccnc4)nc4ccc(-c5ccccc5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '20.04', 'le': '0.36', 'lle': '2.88', 'sei': '12.02'}",CHEMBL3649672,,CHEMBL3649672,8.37,False,http://www.openphacts.org/units/Nanomolar,2523299,=,37,True,=,,IC50,nM,,4.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.3
261998,17644526,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4ccccc4)nc4ccc(-c5ccccc5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '19.47', 'le': '0.35', 'lle': '2.02', 'sei': '14.30'}",CHEMBL3649673,,CHEMBL3649673,8.11,False,http://www.openphacts.org/units/Nanomolar,2523300,=,37,True,=,,IC50,nM,,7.75,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.75
261999,17644527,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4ccccc4O)nc4ccc(-c5ccccc5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '19.25', 'le': '0.34', 'lle': '2.52', 'sei': '10.82'}",CHEMBL3649674,,CHEMBL3649674,8.32,False,http://www.openphacts.org/units/Nanomolar,2523301,=,37,True,=,,IC50,nM,,4.74,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.74
262000,17644528,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4cccnc4F)nc4ccc(-c5ccccc5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '18.69', 'le': '0.34', 'lle': '2.51', 'sei': '11.69'}",CHEMBL3649675,,CHEMBL3649675,8.14,False,http://www.openphacts.org/units/Nanomolar,2523302,=,37,True,=,,IC50,nM,,7.27,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.27
262001,17644529,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3638999,,2014.0,"{'bei': '19.11', 'le': '0.34', 'lle': '2.58', 'sei': '9.97'}",CHEMBL3649676,,CHEMBL3649676,8.25,False,http://www.openphacts.org/units/Nanomolar,2523303,=,37,True,=,,IC50,nM,,5.67,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.67
262002,17644530,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4ccccn4)nc4ccc(-c5cccc(N6CCOCC6)c5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '10.50', 'le': '0.19', 'lle': '-0.04', 'sei': '6.43'}",CHEMBL3649677,,CHEMBL3649677,5.28,False,http://www.openphacts.org/units/Nanomolar,2523304,=,37,True,=,,IC50,nM,,5260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5260.0
262003,17644531,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4cc[nH]n4)nc4ccc(-c5cccc(N6CCOCC6)c5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '12.07', 'le': '0.22', 'lle': '1.29', 'sei': '6.06'}",CHEMBL3649678,,CHEMBL3649678,5.94,False,http://www.openphacts.org/units/Nanomolar,2523305,=,37,True,=,,IC50,nM,,1160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1160.0
262004,17644532,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4cccc(O)c4)nc4ccc(-c5cccc(N6CCOCC6)c5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '16.14', 'le': '0.29', 'lle': '2.72', 'sei': '9.34'}",CHEMBL3649679,,CHEMBL3649679,8.36,False,http://www.openphacts.org/units/Nanomolar,2523306,=,37,True,=,,IC50,nM,,4.42,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.42
262005,17644533,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2nc3ccc(-c4cccc(N5CCOCC5)c4)nc3n2-c2ccc(C3(N)CCC3)cc2)cc1,,,CHEMBL3638999,,2014.0,"{'bei': '15.65', 'le': '0.28', 'lle': '2.38', 'sei': '10.61'}",CHEMBL3649680,,CHEMBL3649680,8.32,False,http://www.openphacts.org/units/Nanomolar,2523307,=,37,True,=,,IC50,nM,,4.78,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.78
262006,17644534,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4cccc(F)c4)nc4ccc(-c5cccc(N6CCOCC6)c5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '14.34', 'le': '0.26', 'lle': '1.38', 'sei': '10.77'}",CHEMBL3649681,,CHEMBL3649681,7.45,False,http://www.openphacts.org/units/Nanomolar,2523308,=,37,True,=,,IC50,nM,,35.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,35.5
262007,17644535,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4cccc(Cl)c4)nc4ccc(-c5cccc(N6CCOCC6)c5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '15.35', 'le': '0.29', 'lle': '1.65', 'sei': '11.89'}",CHEMBL3649682,,CHEMBL3649682,8.23,False,http://www.openphacts.org/units/Nanomolar,2523309,=,37,True,=,,IC50,nM,,5.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.9
262008,17644536,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4ccc(Cl)cc4)nc4ccc(-c5cccc(N6CCOCC6)c5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '15.30', 'le': '0.29', 'lle': '1.62', 'sei': '11.85'}",CHEMBL3649683,,CHEMBL3649683,8.20,False,http://www.openphacts.org/units/Nanomolar,2523310,=,37,True,=,,IC50,nM,,6.27,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.27
262009,17644537,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4ncccn4)nc4ccc(-c5cccc(N6CCOCC6)c5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '16.37', 'le': '0.30', 'lle': '3.52', 'sei': '8.68'}",CHEMBL3649684,,CHEMBL3649684,8.24,False,http://www.openphacts.org/units/Nanomolar,2523311,=,37,True,=,,IC50,nM,,5.71,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.71
262010,17644538,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4ccnnc4)nc4ccc(-c5cccc(N6CCOCC6)c5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '16.49', 'le': '0.30', 'lle': '3.58', 'sei': '8.74'}",CHEMBL3649685,,CHEMBL3649685,8.30,False,http://www.openphacts.org/units/Nanomolar,2523312,=,37,True,=,,IC50,nM,,4.96,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.96
262011,17644539,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)c1cccc(-c2ccc3nc(-c4ccccc4)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,,,CHEMBL3638999,,2014.0,"{'bei': '17.16', 'le': '0.31', 'lle': '2.58', 'sei': '10.86'}",CHEMBL3649686,,CHEMBL3649686,8.37,False,http://www.openphacts.org/units/Nanomolar,2523313,=,37,True,=,,IC50,nM,,4.27,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.27
262012,17644540,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4ccccc4)nc4ccc(NCc5ccccc5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '13.60', 'le': '0.24', 'lle': '0.02', 'sei': '8.81'}",CHEMBL3649687,,CHEMBL3649687,6.06,False,http://www.openphacts.org/units/Nanomolar,2523314,=,37,True,=,,IC50,nM,,871.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,871.0
262013,17644541,[],CHEMBL3706066,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-n3c(-c4ccccc4)nc4ccc(Nc5ccccc5)nc43)cc2)CCC1,,,CHEMBL3638999,,2014.0,"{'bei': '19.43', 'le': '0.35', 'lle': '2.21', 'sei': '12.19'}",CHEMBL3649688,,CHEMBL3649688,8.38,False,http://www.openphacts.org/units/Nanomolar,2523315,=,37,True,=,,IC50,nM,,4.13,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.13
273513,17655835,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(F)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '21.61', 'le': '0.41', 'lle': '6.86', 'sei': '9.86'}",CHEMBL3112848,,CHEMBL3112848,7.75,False,http://www.openphacts.org/units/Nanomolar,2835825,=,37,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
273514,17655836,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(F)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '22.10', 'le': '0.42', 'lle': '7.04', 'sei': '10.09'}",CHEMBL3112848,,CHEMBL3112848,7.92,False,http://www.openphacts.org/units/Nanomolar,2835825,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
273515,17655837,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(C)CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21,,,CHEMBL3886154,,2015.0,"{'bei': '20.84', 'le': '0.39', 'lle': '6.21', 'sei': '9.78'}",CHEMBL3112865,,CHEMBL3112865,7.68,False,http://www.openphacts.org/units/Nanomolar,2835826,=,37,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.0
273516,17655838,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '22.00', 'le': '0.41', 'lle': '6.67', 'sei': '9.93'}",CHEMBL3112866,,CHEMBL3112866,7.80,False,http://www.openphacts.org/units/Nanomolar,2835827,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
273517,17655839,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '23.42', 'le': '0.44', 'lle': '7.17', 'sei': '10.57'}",CHEMBL3112866,,CHEMBL3112866,8.30,False,http://www.openphacts.org/units/Nanomolar,2835828,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
273518,17655840,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '21.36', 'le': '0.40', 'lle': '6.44', 'sei': '9.64'}",CHEMBL3112866,,CHEMBL3112866,7.57,False,http://www.openphacts.org/units/Nanomolar,2835827,=,37,True,=,,IC50,nM,,27.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,27.0
273519,17655841,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '22.70', 'le': '0.42', 'lle': '6.92', 'sei': '10.25'}",CHEMBL3112866,,CHEMBL3112866,8.05,False,http://www.openphacts.org/units/Nanomolar,2835828,=,37,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
273529,17655851,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N2CCN(c3cccc(C(F)(F)F)c3)CC2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '11.56', 'le': '0.22', 'lle': '1.57', 'sei': '6.16'}",CHEMBL3939475,,CHEMBL3939475,4.64,False,http://www.openphacts.org/units/Nanomolar,2835838,=,37,True,=,,IC50,nM,,23000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23000.0
282721,17665066,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cn3ccnc3nc2-c2ccc(CN3CC(c4nnc(-c5ccccn5)[nH]4)C3)cc2)cc1,,,CHEMBL3638971,,2015.0,,CHEMBL3667041,,CHEMBL3667041,,False,http://www.openphacts.org/units/Nanomolar,2542234,<,37,True,<,,IC50,nM,,50.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50.0
282722,17665067,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CC(c5nnc(-c6ccccn6)[nH]5)C4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '15.29', 'le': '0.27', 'lle': '3.09', 'sei': '7.58'}",CHEMBL3667042,,CHEMBL3667042,7.64,False,http://www.openphacts.org/units/Nanomolar,2542235,=,37,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
282723,17665068,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1cnc2nc(-c3ccc(CN4CC(c5nnc(-c6ccccn6)[nH]5)C4)cc3)c(-c3ccccc3)cn12,,,CHEMBL3638971,,2015.0,,CHEMBL3667043,,CHEMBL3667043,,False,http://www.openphacts.org/units/Nanomolar,2542236,<,37,True,<,,IC50,nM,,50.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50.0
282724,17665069,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Clc1cnc2nc(-c3ccc(CN4CC(c5nnc(-c6ccccn6)[nH]5)C4)cc3)c(-c3ccccc3)cn12,,,CHEMBL3638971,,2015.0,"{'bei': '15.84', 'le': '0.30', 'lle': '2.72', 'sei': '9.35'}",CHEMBL3667044,,CHEMBL3667044,8.22,False,http://www.openphacts.org/units/Nanomolar,2542237,=,37,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
282725,17665070,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cn3ccnc3nc2-c2ccc(CN3CCC(c4nc5ccncc5[nH]4)CC3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '14.01', 'le': '0.25', 'lle': '1.09', 'sei': '9.07'}",CHEMBL3667045,,CHEMBL3667045,6.80,False,http://www.openphacts.org/units/Nanomolar,2542238,=,37,True,=,,IC50,nM,,157.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,157.0
282726,17665071,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cn3ccnc3nc2-c2ccc(CN3CCC(c4nc5cccnc5[nH]4)CC3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '14.93', 'le': '0.27', 'lle': '1.54', 'sei': '9.67'}",CHEMBL3672010,,CHEMBL3672010,7.25,False,http://www.openphacts.org/units/Nanomolar,2547387,=,37,True,=,,IC50,nM,,56.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,56.0
282727,17665072,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc2nc(C3CCN(Cc4ccc(-c5nc6nccn6cc5-c5ccccc5)cc4)CC3)[nH]c2c1,,,CHEMBL3638971,,2015.0,"{'bei': '13.89', 'le': '0.25', 'lle': '0.89', 'sei': '8.24'}",CHEMBL3672011,,CHEMBL3672011,7.08,False,http://www.openphacts.org/units/Nanomolar,2547388,=,37,True,=,,IC50,nM,,83.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,83.0
282728,17665073,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cn3ccnc3nc2-c2ccc(CN3CCC(c4cnc5ccccc5n4)CC3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '16.91', 'le': '0.30', 'lle': '2.01', 'sei': '14.18'}",CHEMBL3672012,,CHEMBL3672012,8.40,False,http://www.openphacts.org/units/Nanomolar,2547389,=,37,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
282729,17665074,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc2nc(C3CCN(Cc4ccc(-c5nc6ccnn6cc5-c5ccccc5)cc4)CC3)[nH]c2c1,,,CHEMBL3638971,,2015.0,"{'bei': '14.54', 'le': '0.26', 'lle': '1.22', 'sei': '8.63'}",CHEMBL3672013,,CHEMBL3672013,7.41,False,http://www.openphacts.org/units/Nanomolar,2547390,=,37,True,=,,IC50,nM,,39.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,39.0
282730,17665075,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CCC(c5nc6ccc(F)cc6[nH]5)CC4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.43', 'le': '0.24', 'lle': '0.79', 'sei': '9.27'}",CHEMBL3672014,,CHEMBL3672014,6.95,False,http://www.openphacts.org/units/Nanomolar,2547391,=,37,True,=,,IC50,nM,,112.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,112.0
282731,17665076,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CCC(c5nc6ccncc6[nH]5)CC4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '11.03', 'le': '0.20', 'lle': '0.10', 'sei': '6.28'}",CHEMBL3672015,,CHEMBL3672015,5.52,False,http://www.openphacts.org/units/Nanomolar,2547392,=,37,True,=,,IC50,nM,,3000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3000.0
282732,17665077,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cn3nccc3nc2-c2ccc(CN3CCC(c4nc5cccnc5[nH]4)CC3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '15.19', 'le': '0.27', 'lle': '1.67', 'sei': '9.84'}",CHEMBL3672016,,CHEMBL3672016,7.38,False,http://www.openphacts.org/units/Nanomolar,2547393,=,37,True,=,,IC50,nM,,42.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.0
282733,17665078,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1ccc2nc(C3CCN(Cc4ccc(-c5nc6ccnn6cc5-c5ccccc5)cc4)CC3)[nH]c2c1,,,CHEMBL3638971,,2015.0,"{'bei': '11.71', 'le': '0.22', 'lle': '-0.87', 'sei': '10.42'}",CHEMBL3672017,,CHEMBL3672017,6.47,False,http://www.openphacts.org/units/Nanomolar,2547394,=,37,True,=,,IC50,nM,,338.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,338.0
282734,17665079,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc2nc(C3CCN(Cc4ccc(-c5nc6ccnn6cc5-c5ccccc5)cc4)CC3)[nH]c2c1,,,CHEMBL3638971,,2015.0,"{'bei': '14.68', 'le': '0.27', 'lle': '0.92', 'sei': '11.88'}",CHEMBL3672018,,CHEMBL3672018,7.38,False,http://www.openphacts.org/units/Nanomolar,2547395,=,37,True,=,,IC50,nM,,42.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.0
282735,17665080,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2c1cnn2C1CCN(Cc2ccc(-c3nc4ccnn4cc3-c3ccccc3)cc2)CC1,,,CHEMBL3638971,,2015.0,"{'bei': '15.16', 'le': '0.27', 'lle': '2.98', 'sei': '7.38'}",CHEMBL3672019,,CHEMBL3672019,7.60,False,http://www.openphacts.org/units/Nanomolar,2547396,=,37,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
282736,17665081,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CCC(c5nc6ccc(C#N)cc6[nH]5)CC4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '11.97', 'le': '0.21', 'lle': '0.39', 'sei': '6.36'}",CHEMBL3672020,,CHEMBL3672020,6.28,False,http://www.openphacts.org/units/Nanomolar,2547397,=,37,True,=,,IC50,nM,,525.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,525.0
282737,17665082,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CCC(c5nc6ccc(C(F)(F)F)cc6[nH]5)CC4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '10.29', 'le': '0.19', 'lle': '-1.20', 'sei': '7.78'}",CHEMBL3672021,,CHEMBL3672021,5.84,False,http://www.openphacts.org/units/Nanomolar,2547398,=,37,True,=,,IC50,nM,,1450.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1450.0
282738,17665083,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CCC(n5ncc6c(N)ncnc65)CC4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '12.66', 'le': '0.23', 'lle': '2.21', 'sei': '5.64'}",CHEMBL3672022,,CHEMBL3672022,6.54,False,http://www.openphacts.org/units/Nanomolar,2547399,=,37,True,=,,IC50,nM,,288.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,288.0
282739,17665084,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CCC(c5nc6cccnc6[nH]5)CC4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '12.99', 'le': '0.23', 'lle': '1.08', 'sei': '7.40'}",CHEMBL3672023,,CHEMBL3672023,6.50,False,http://www.openphacts.org/units/Nanomolar,2547400,=,37,True,=,,IC50,nM,,315.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,315.0
282740,17665085,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CCC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '14.32', 'le': '0.26', 'lle': '2.42', 'sei': '7.30'}",CHEMBL3672024,,CHEMBL3672024,7.36,False,http://www.openphacts.org/units/Nanomolar,2547401,=,37,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,44.0
282741,17665086,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CCC(c5cnc6ccccc6n5)CC4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '10.48', 'le': '0.19', 'lle': '-0.73', 'sei': '7.43'}",CHEMBL3672025,,CHEMBL3672025,5.36,False,http://www.openphacts.org/units/Nanomolar,2547402,=,37,True,=,,IC50,nM,,4370.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4370.0
282742,17665087,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CN(Cc4ccc(-c5nc6ncc(C)n6cc5-c5ccccc5)cc4)C3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '15.91', 'le': '0.29', 'lle': '2.69', 'sei': '9.28'}",CHEMBL3672026,,CHEMBL3672026,8.15,False,http://www.openphacts.org/units/Nanomolar,2547403,=,37,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
282743,17665088,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)c(-c3ccccc3)cn2c1Br,,,CHEMBL3638971,,2015.0,"{'bei': '14.54', 'le': '0.29', 'lle': '2.49', 'sei': '9.56'}",CHEMBL3672027,,CHEMBL3672027,8.40,False,http://www.openphacts.org/units/Nanomolar,2547404,=,37,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
282744,17665089,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cnn2cc(-c3c(F)cccc3F)c(-c3ccc(CN4CC(c5n[nH]c(-c6cccc(C)n6)n5)C4)cc3)nc12,,,CHEMBL3638971,,2015.0,"{'bei': '13.37', 'le': '0.25', 'lle': '2.70', 'sei': '6.94'}",CHEMBL3672028,,CHEMBL3672028,7.92,False,http://www.openphacts.org/units/Nanomolar,2547405,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
282745,17665090,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cnn2cc(-c3c(F)cccc3F)c(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)nc12,,,CHEMBL3638971,,2015.0,"{'bei': '13.57', 'le': '0.25', 'lle': '2.94', 'sei': '6.88'}",CHEMBL3672029,,CHEMBL3672029,7.85,False,http://www.openphacts.org/units/Nanomolar,2547406,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
282746,17665091,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1nc2nc(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.41', 'le': '0.24', 'lle': '1.72', 'sei': '7.02'}",CHEMBL3672030,,CHEMBL3672030,7.08,False,http://www.openphacts.org/units/Nanomolar,2547407,=,37,True,=,,IC50,nM,,84.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,84.0
282747,17665092,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1nc2nc(-c3ccc(CN4CCC(c5cnc6ccccc6n5)CC4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '9.59', 'le': '0.17', 'lle': '-1.73', 'sei': '7.18'}",CHEMBL3672031,,CHEMBL3672031,5.17,False,http://www.openphacts.org/units/Nanomolar,2547408,=,37,True,=,,IC50,nM,,6700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6700.0
282748,17665093,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CN(Cc4ccc(-c5nc6nc(C(C)C)nn6cc5-c5ccccc5)cc4)C3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.21', 'le': '0.24', 'lle': '1.48', 'sei': '7.10'}",CHEMBL3672032,,CHEMBL3672032,7.16,False,http://www.openphacts.org/units/Nanomolar,2547409,=,37,True,=,,IC50,nM,,70.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,70.0
282749,17665094,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cnn2cc(-c3ccc(F)cc3F)c(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)nc12,,,CHEMBL3638971,,2015.0,"{'bei': '14.09', 'le': '0.26', 'lle': '3.24', 'sei': '7.14'}",CHEMBL3672033,,CHEMBL3672033,8.15,False,http://www.openphacts.org/units/Nanomolar,2547410,=,37,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
282750,17665095,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cn3ccnc3nc2-c2ccc(CN3CC(c4n[nH]c(-c5ccccn5)n4)C3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '15.09', 'le': '0.27', 'lle': '2.61', 'sei': '8.63'}",CHEMBL3672034,,CHEMBL3672034,7.58,False,http://www.openphacts.org/units/Nanomolar,2547411,=,37,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.0
282751,17665096,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cn3ccnc3nc2-c2ccc(CN3CCC(c4cnc5ccccc5n4)CC3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '12.51', 'le': '0.23', 'lle': '-0.09', 'sei': '10.87'}",CHEMBL3672035,,CHEMBL3672035,6.44,False,http://www.openphacts.org/units/Nanomolar,2547412,=,37,True,=,,IC50,nM,,365.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,365.0
282752,17665097,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CN(Cc4ccc(-c5nc6nc(C)nn6cc5-c5ccc(F)cc5F)cc4)C3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.71', 'le': '0.25', 'lle': '2.41', 'sei': '7.48'}",CHEMBL3672036,,CHEMBL3672036,7.54,False,http://www.openphacts.org/units/Nanomolar,2547413,=,37,True,=,,IC50,nM,,29.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,29.0
282753,17665098,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cn3ccnc3nc2-c2ccc(CN3CCC(c4cnc5ccccc5n4)CC3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '14.41', 'le': '0.26', 'lle': '0.76', 'sei': '12.08'}",CHEMBL3672012,,CHEMBL3672012,7.16,False,http://www.openphacts.org/units/Nanomolar,2547389,=,37,True,=,,IC50,nM,,70.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,70.0
282754,17665099,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cn2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5cnc6ccccc6n5)CC4)cc3)nc2n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.93', 'le': '0.25', 'lle': '0.42', 'sei': '12.01'}",CHEMBL3672037,,CHEMBL3672037,7.11,False,http://www.openphacts.org/units/Nanomolar,2547414,=,37,True,=,,IC50,nM,,77.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,77.0
282755,17665100,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CN(Cc4ccc(-c5nc6nc(C)cn6cc5-c5ccccc5)cc4)C3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '15.38', 'le': '0.28', 'lle': '2.43', 'sei': '8.97'}",CHEMBL3672038,,CHEMBL3672038,7.89,False,http://www.openphacts.org/units/Nanomolar,2547415,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
282756,17665101,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CN(Cc4ccc(-c5nc6nc(C7CC7)nn6cc5-c5ccc(F)cc5)cc4)C3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.52', 'le': '0.25', 'lle': '1.98', 'sei': '7.48'}",CHEMBL3672039,,CHEMBL3672039,7.54,False,http://www.openphacts.org/units/Nanomolar,2547416,=,37,True,=,,IC50,nM,,29.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,29.0
282757,17665102,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cn3nc(C4CC4)nc3nc2-c2ccc(CN3CCC(c4cnc5ccccc5n4)CC3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '12.29', 'le': '0.22', 'lle': '-0.05', 'sei': '9.16'}",CHEMBL3672040,,CHEMBL3672040,6.61,False,http://www.openphacts.org/units/Nanomolar,2547417,=,37,True,=,,IC50,nM,,247.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,247.0
282758,17665103,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CN(Cc4ccc(-c5nc6nc(C7CC7)nn6cc5-c5ccccc5)cc4)C3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '14.82', 'le': '0.27', 'lle': '2.58', 'sei': '7.94'}",CHEMBL3672041,,CHEMBL3672041,8.00,False,http://www.openphacts.org/units/Nanomolar,2547418,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
282759,17665104,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1cnn2cc(-c3ccccc3)c(-c3ccc(CN4CC(c5n[nH]c(-c6cccc(C)n6)n5)C4)cc3)nc12,,,CHEMBL3638971,,2015.0,"{'bei': '15.76', 'le': '0.28', 'lle': '2.59', 'sei': '9.44'}",CHEMBL3672042,,CHEMBL3672042,8.30,False,http://www.openphacts.org/units/Nanomolar,2547419,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
282760,17665105,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1nc2nc(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.99', 'le': '0.25', 'lle': '2.92', 'sei': '6.38'}",CHEMBL3672043,,CHEMBL3672043,7.20,False,http://www.openphacts.org/units/Nanomolar,2547420,=,37,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,63.0
282761,17665106,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1nc2nc(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '14.11', 'le': '0.26', 'lle': '2.60', 'sei': '6.79'}",CHEMBL3672044,,CHEMBL3672044,7.66,False,http://www.openphacts.org/units/Nanomolar,2547421,=,37,True,=,,IC50,nM,,22.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22.0
282762,17665107,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)c(-c3ccccc3)c(C)n2n1,,,CHEMBL3638971,,2015.0,"{'bei': '15.88', 'le': '0.29', 'lle': '3.30', 'sei': '8.09'}",CHEMBL3672045,,CHEMBL3672045,8.15,False,http://www.openphacts.org/units/Nanomolar,2547422,=,37,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
282763,17665108,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CN(Cc4ccc(-c5nc6nc(C)nn6c(C)c5-c5ccccc5)cc4)C3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '15.16', 'le': '0.27', 'lle': '2.84', 'sei': '7.94'}",CHEMBL3672046,,CHEMBL3672046,8.00,False,http://www.openphacts.org/units/Nanomolar,2547423,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
282764,17665109,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)c(-c3ccccc3)c(NC3CCC3)n2n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.18', 'le': '0.24', 'lle': '1.98', 'sei': '6.64'}",CHEMBL3672047,,CHEMBL3672047,7.50,False,http://www.openphacts.org/units/Nanomolar,2547424,=,37,True,=,,IC50,nM,,32.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,32.0
282765,17665110,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1c(-c2ccccc2)c(-c2ccc(CN3CC(c4n[nH]c(-c5cccc(C)n5)n4)C3)cc2)nc2nc(C)nn12,,,CHEMBL3638971,,2015.0,"{'bei': '14.67', 'le': '0.27', 'lle': '3.06', 'sei': '7.05'}",CHEMBL3672048,,CHEMBL3672048,7.96,False,http://www.openphacts.org/units/Nanomolar,2547425,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
282766,17665111,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)c(-c3ccccc3)c(NC(C)C)n2n1,,,CHEMBL3638971,,2015.0,"{'bei': '14.05', 'le': '0.25', 'lle': '2.45', 'sei': '6.94'}",CHEMBL3672049,,CHEMBL3672049,7.82,False,http://www.openphacts.org/units/Nanomolar,2547426,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
282767,17665112,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)c(-c3ccccc3)c(NC(C)C)n2n1,,,CHEMBL3638971,,2015.0,"{'bei': '14.45', 'le': '0.26', 'lle': '2.68', 'sei': '7.13'}",CHEMBL3672049,,CHEMBL3672049,8.05,False,http://www.openphacts.org/units/Nanomolar,2547426,=,37,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
282768,17665113,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cnn2cc(-c3c(F)cccc3F)c(-c3ccc(CN4CCC(c5n[nH]c(-c6cccc(C)n6)n5)CC4)cc3)nc12,,,CHEMBL3638971,,2015.0,"{'bei': '13.14', 'le': '0.24', 'lle': '2.15', 'sei': '7.14'}",CHEMBL3672050,,CHEMBL3672050,8.15,False,http://www.openphacts.org/units/Nanomolar,2547427,=,37,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
282769,17665114,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cnn2cc(-c3c(F)cccc3F)c(-c3ccc(CN4CCC(c5n[nH]c(-c6ccccn6)n5)CC4)cc3)nc12,,,CHEMBL3638971,,2015.0,"{'bei': '13.68', 'le': '0.25', 'lle': '2.61', 'sei': '7.27'}",CHEMBL3672051,,CHEMBL3672051,8.30,False,http://www.openphacts.org/units/Nanomolar,2547428,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
282770,17665115,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CCN(Cc4ccc(-c5nc6nc(C)nn6cc5-c5cccc(F)c5)cc4)CC3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '14.09', 'le': '0.26', 'lle': '2.12', 'sei': '7.83'}",CHEMBL3672052,,CHEMBL3672052,7.89,False,http://www.openphacts.org/units/Nanomolar,2547429,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
282771,17665116,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CCC(c5n[nH]c(-c6ccccn6)n5)CC4)cc3)c(-c3cccc(F)c3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.84', 'le': '0.25', 'lle': '2.08', 'sei': '7.49'}",CHEMBL3672053,,CHEMBL3672053,7.55,False,http://www.openphacts.org/units/Nanomolar,2547430,=,37,True,=,,IC50,nM,,28.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,28.0
282772,17665117,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CCC(c5n[nH]c(-c6cc(Cl)ccn6)n5)CC4)cc3)c(-c3ccc(F)cc3F)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '12.80', 'le': '0.24', 'lle': '1.40', 'sei': '7.60'}",CHEMBL3672054,,CHEMBL3672054,7.66,False,http://www.openphacts.org/units/Nanomolar,2547431,=,37,True,=,,IC50,nM,,22.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22.0
282773,17665118,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CCN(Cc4ccc(-c5nc6nc(C)nn6cc5-c5ccc(F)cc5F)cc4)CC3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '12.48', 'le': '0.23', 'lle': '1.30', 'sei': '7.15'}",CHEMBL3672055,,CHEMBL3672055,7.21,False,http://www.openphacts.org/units/Nanomolar,2547432,=,37,True,=,,IC50,nM,,62.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,62.0
282774,17665119,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CCC(c5n[nH]c(-c6cnccn6)n5)CC4)cc3)c(-c3ccc(F)cc3F)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '11.42', 'le': '0.21', 'lle': '1.45', 'sei': '5.67'}",CHEMBL3672056,,CHEMBL3672056,6.45,False,http://www.openphacts.org/units/Nanomolar,2547433,=,37,True,=,,IC50,nM,,355.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,355.0
282775,17665120,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CCN(Cc4ccc(-c5nc6nc(C7CC7)nn6cc5-c5ccc(F)cc5)cc4)CC3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '12.61', 'le': '0.23', 'lle': '1.05', 'sei': '7.33'}",CHEMBL3672057,,CHEMBL3672057,7.39,False,http://www.openphacts.org/units/Nanomolar,2547434,=,37,True,=,,IC50,nM,,41.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,41.0
282776,17665121,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cn3nc(C4CC4)nc3nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '13.11', 'le': '0.24', 'lle': '1.46', 'sei': '7.44'}",CHEMBL3672058,,CHEMBL3672058,7.50,False,http://www.openphacts.org/units/Nanomolar,2547435,=,37,True,=,,IC50,nM,,32.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,32.0
282777,17665122,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cn3nc(C4CC4)nc3nc2-c2ccc(CN3CCC(c4n[nH]c(-c5cc(Cl)ccn5)n4)CC3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '11.96', 'le': '0.23', 'lle': '0.56', 'sei': '7.20'}",CHEMBL3672059,,CHEMBL3672059,7.25,False,http://www.openphacts.org/units/Nanomolar,2547436,=,37,True,=,,IC50,nM,,56.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,56.0
282778,17665123,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CCN(Cc4ccc(-c5nc6nccn6cc5-c5ccc(F)cc5)cc4)CC3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '14.77', 'le': '0.27', 'lle': '1.98', 'sei': '9.15'}",CHEMBL3672060,,CHEMBL3672060,8.05,False,http://www.openphacts.org/units/Nanomolar,2547437,=,37,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
282779,17665124,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cn3ccnc3nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '15.26', 'le': '0.28', 'lle': '2.34', 'sei': '9.21'}",CHEMBL3672061,,CHEMBL3672061,8.10,False,http://www.openphacts.org/units/Nanomolar,2547438,=,37,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
282780,17665125,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cn3ccnc3nc2-c2ccc(CN3CCC(c4n[nH]c(-c5cnccn5)n4)CC3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '12.66', 'le': '0.23', 'lle': '1.57', 'sei': '6.68'}",CHEMBL3672062,,CHEMBL3672062,6.73,False,http://www.openphacts.org/units/Nanomolar,2547439,=,37,True,=,,IC50,nM,,186.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,186.0
282781,17665126,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CCN(Cc4ccc(-c5nc6ncc(Br)n6cc5-c5ccc(F)cc5)cc4)CC3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '12.76', 'le': '0.26', 'lle': '1.13', 'sei': '9.06'}",CHEMBL3672063,,CHEMBL3672063,7.96,False,http://www.openphacts.org/units/Nanomolar,2547440,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
282782,17665127,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cn3c(Cl)cnc3nc2-c2ccc(CN3CCC(c4n[nH]c(-c5ccccn5)n4)CC3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '13.45', 'le': '0.25', 'lle': '1.18', 'sei': '8.65'}",CHEMBL3672064,,CHEMBL3672064,7.60,False,http://www.openphacts.org/units/Nanomolar,2547441,=,37,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
282783,17665128,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CCN(Cc4ccc(-c5nc6nccn6cc5-c5ccccc5F)cc4)CC3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '15.65', 'le': '0.28', 'lle': '2.45', 'sei': '9.70'}",CHEMBL3672065,,CHEMBL3672065,8.52,False,http://www.openphacts.org/units/Nanomolar,2547442,=,37,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
282784,17665129,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Brc1cnc2nc(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)c(-c3ccccc3)cn12,,,CHEMBL3638971,,2015.0,"{'bei': '14.59', 'le': '0.30', 'lle': '2.61', 'sei': '9.35'}",CHEMBL3672066,,CHEMBL3672066,8.22,False,http://www.openphacts.org/units/Nanomolar,2547443,=,37,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
282785,17665130,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cn2cc(-c3ccccc3)c(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)nc2n1,,,CHEMBL3638971,,2015.0,"{'bei': '16.05', 'le': '0.29', 'lle': '2.85', 'sei': '9.10'}",CHEMBL3672067,,CHEMBL3672067,8.00,False,http://www.openphacts.org/units/Nanomolar,2547444,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
282786,17665131,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CN(Cc4ccc(-c5nc6nc(C)c(Br)n6cc5-c5ccccc5)cc4)C3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.90', 'le': '0.28', 'lle': '2.00', 'sei': '9.35'}",CHEMBL3672068,,CHEMBL3672068,8.22,False,http://www.openphacts.org/units/Nanomolar,2547445,=,37,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
282787,17665132,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1c(-c2ccccc2)c(-c2ccc(CN3CC(c4n[nH]c(-c5ccccn5)n4)C3)cc2)nc2nccn12,,,CHEMBL3638971,,2015.0,"{'bei': '14.65', 'le': '0.26', 'lle': '2.64', 'sei': '7.53'}",CHEMBL3672069,,CHEMBL3672069,7.52,False,http://www.openphacts.org/units/Nanomolar,2547446,=,37,True,=,,IC50,nM,,30.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30.0
282788,17665133,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1c(-c2ccccc2)c(-c2ccc(CN3CC(c4n[nH]c(-c5ccccn5)n4)C3)cc2)nc2ncc(Br)n12,,,CHEMBL3638971,,2015.0,"{'bei': '12.45', 'le': '0.25', 'lle': '1.73', 'sei': '7.38'}",CHEMBL3672070,,CHEMBL3672070,7.38,False,http://www.openphacts.org/units/Nanomolar,2547447,=,37,True,=,,IC50,nM,,42.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.0
282789,17665134,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1c(-c2ccccc2)c(-c2ccc(CN3CC(c4n[nH]c(-c5ccccn5)n4)C3)cc2)nc2nc(C)cn12,,,CHEMBL3638971,,2015.0,"{'bei': '14.77', 'le': '0.27', 'lle': '2.61', 'sei': '7.80'}",CHEMBL3672071,,CHEMBL3672071,7.80,False,http://www.openphacts.org/units/Nanomolar,2547448,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
282790,17665135,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1c(-c2ccccc2)c(-c2ccc(CN3CC(c4n[nH]c(-c5cccc(C)n5)n4)C3)cc2)nc2nc(C)cn12,,,CHEMBL3638971,,2015.0,"{'bei': '14.69', 'le': '0.27', 'lle': '2.46', 'sei': '7.96'}",CHEMBL3672072,,CHEMBL3672072,7.96,False,http://www.openphacts.org/units/Nanomolar,2547449,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
282791,17665136,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,OCc1cnn2cc(-c3c(F)cccc3F)c(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)nc12,,,CHEMBL3638971,,2015.0,"{'bei': '13.19', 'le': '0.24', 'lle': '2.65', 'sei': '6.71'}",CHEMBL3672094,,CHEMBL3672094,7.26,False,http://www.openphacts.org/units/Nanomolar,2547472,=,37,True,=,,IC50,nM,,55.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,55.0
282792,17665137,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1nn2cc(-c3c(F)cccc3F)c(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)nc2c1CO,,,CHEMBL3638971,,2015.0,"{'bei': '13.53', 'le': '0.25', 'lle': '3.23', 'sei': '6.69'}",CHEMBL3672073,,CHEMBL3672073,7.85,False,http://www.openphacts.org/units/Nanomolar,2547450,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
282793,17665138,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1nn2cc(-c3c(F)cccc3F)c(-c3ccc(CN4CC(c5n[nH]c(-c6cccc(C)n6)n5)C4)cc3)nc2c1CO,,,CHEMBL3638971,,2015.0,"{'bei': '13.62', 'le': '0.25', 'lle': '3.17', 'sei': '6.90'}",CHEMBL3672074,,CHEMBL3672074,8.10,False,http://www.openphacts.org/units/Nanomolar,2547451,=,37,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
282794,17665139,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1nn2cc(-c3c(F)cccc3F)c(-c3ccc(CN4CCC(c5n[nH]c(-c6cccc(C)n6)n5)CC4)cc3)nc2c1CO,,,CHEMBL3638971,,2015.0,"{'bei': '12.44', 'le': '0.23', 'lle': '2.03', 'sei': '6.60'}",CHEMBL3672075,,CHEMBL3672075,7.75,False,http://www.openphacts.org/units/Nanomolar,2547452,=,37,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
282795,17665140,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1nn2cc(-c3c(F)cccc3F)c(-c3ccc(CN4CCC(c5n[nH]c(-c6ccccn6)n5)CC4)cc3)nc2c1CO,,,CHEMBL3638971,,2015.0,"{'bei': '13.14', 'le': '0.24', 'lle': '2.60', 'sei': '6.82'}",CHEMBL3672076,,CHEMBL3672076,8.00,False,http://www.openphacts.org/units/Nanomolar,2547453,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
282796,17665141,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cn2c(NC(C)C)c(-c3ccccc3)c(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)nc2n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.54', 'le': '0.24', 'lle': '1.55', 'sei': '7.53'}",CHEMBL3672077,,CHEMBL3672077,7.52,False,http://www.openphacts.org/units/Nanomolar,2547454,=,37,True,=,,IC50,nM,,30.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30.0
282797,17665142,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CN(Cc4ccc(-c5nc6nc(C)cn6c(NC(C)C)c5-c5ccccc5)cc4)C3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.13', 'le': '0.24', 'lle': '1.20', 'sei': '7.49'}",CHEMBL3672078,,CHEMBL3672078,7.48,False,http://www.openphacts.org/units/Nanomolar,2547455,=,37,True,=,,IC50,nM,,33.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,33.0
282798,17665143,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1c(-c2ccccc2)c(-c2ccc(CN3CC(c4n[nH]c(-c5ccccn5)n4)C3)cc2)nc2nccn12,,,CHEMBL3638971,,2015.0,"{'bei': '14.03', 'le': '0.25', 'lle': '1.94', 'sei': '7.61'}",CHEMBL3672079,,CHEMBL3672079,7.60,False,http://www.openphacts.org/units/Nanomolar,2547456,=,37,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
282799,17665144,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1c(-c2ccccc2)c(-c2ccc(CN3CC(c4n[nH]c(-c5ccccn5)n4)C3)cc2)nc2nc(-c3ccccn3)nn12,,,CHEMBL3638971,,2015.0,"{'bei': '12.74', 'le': '0.23', 'lle': '2.20', 'sei': '6.00'}",CHEMBL3672080,,CHEMBL3672080,7.54,False,http://www.openphacts.org/units/Nanomolar,2547457,=,37,True,=,,IC50,nM,,29.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,29.0
282800,17665145,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1c(-c2ccccc2)c(-c2ccc(CN3CC(c4n[nH]c(-c5ccccn5)n4)C3)cc2)nc2nc(-c3ccccn3)nn12,,,CHEMBL3638971,,2015.0,"{'bei': '12.30', 'le': '0.22', 'lle': '1.50', 'sei': '6.06'}",CHEMBL3672081,,CHEMBL3672081,7.62,False,http://www.openphacts.org/units/Nanomolar,2547458,=,37,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
282801,17665146,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(C3CN(Cc4ccc(-c5nc6nc(-c7ccccn7)nn6c(NC(C)C)c5-c5ccccc5)cc4)C3)n[nH]2)n1,,,CHEMBL3638971,,2015.0,"{'bei': '12.39', 'le': '0.22', 'lle': '1.42', 'sei': '6.25'}",CHEMBL3672082,,CHEMBL3672082,7.85,False,http://www.openphacts.org/units/Nanomolar,2547459,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
282802,17665147,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2cn3nc(C4CC4)nc3nc2-c2ccc(CN3CC(c4n[nH]c(-c5ccccn5)n4)C3)cc2)cc1,,,CHEMBL3638971,,2015.0,"{'bei': '15.51', 'le': '0.28', 'lle': '3.03', 'sei': '8.09'}",CHEMBL3639709,,CHEMBL3639709,8.15,False,http://www.openphacts.org/units/Nanomolar,2547460,=,37,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
282803,17665148,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1nc2nc(-c3ccc(CN4CC(c5n[nH]c(-c6cccc(C)n6)n5)C4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '15.21', 'le': '0.28', 'lle': '3.03', 'sei': '8.24'}",CHEMBL3672083,,CHEMBL3672083,8.30,False,http://www.openphacts.org/units/Nanomolar,2547461,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
282804,17665149,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1nc2nc(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '15.61', 'le': '0.29', 'lle': '3.34', 'sei': '8.24'}",CHEMBL3672084,,CHEMBL3672084,8.30,False,http://www.openphacts.org/units/Nanomolar,2547462,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
282805,17665150,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1nc2nc(-c3ccc(CN4CCC(c5n[nH]c(-c6ccccn6)n5)CC4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '14.57', 'le': '0.27', 'lle': '2.41', 'sei': '8.09'}",CHEMBL3672085,,CHEMBL3672085,8.15,False,http://www.openphacts.org/units/Nanomolar,2547463,=,37,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
282806,17665151,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1nc2nc(-c3ccc(CN4CCC(c5n[nH]c(-c6ncccn6)n5)CC4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '12.69', 'le': '0.24', 'lle': '1.98', 'sei': '6.26'}",CHEMBL3672086,,CHEMBL3672086,7.11,False,http://www.openphacts.org/units/Nanomolar,2547464,=,37,True,=,,IC50,nM,,77.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,77.0
282807,17665152,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1nc2nc(-c3ccc(CN4CCC(c5n[nH]c(-c6cnccn6)n5)CC4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.53', 'le': '0.25', 'lle': '2.46', 'sei': '6.67'}",CHEMBL3672087,,CHEMBL3672087,7.58,False,http://www.openphacts.org/units/Nanomolar,2547465,=,37,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.0
282808,17665153,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CSc1nc2nc(-c3ccc(CN4CCC(c5n[nH]c(-c6cccc(C)n6)n5)CC4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '14.47', 'le': '0.27', 'lle': '2.25', 'sei': '8.24'}",CHEMBL3672088,,CHEMBL3672088,8.30,False,http://www.openphacts.org/units/Nanomolar,2547466,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
282809,17665154,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)c1nc2nc(-c3ccc(CN4CCC(c5n[nH]c(-c6ccccn6)n5)CC4)cc3)c(-c3ccccc3)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '12.28', 'le': '0.23', 'lle': '2.85', 'sei': '5.39'}",CHEMBL3672089,,CHEMBL3672089,7.27,False,http://www.openphacts.org/units/Nanomolar,2547467,=,37,True,=,,IC50,nM,,54.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,54.0
282810,17665155,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cn2cc(-c3ccccc3)c(-c3ccc(CN4CC(c5n[nH]c(-c6cccc(C)n6)n5)C4)cc3)nc2n1,,,CHEMBL3638971,,2015.0,"{'bei': '14.23', 'le': '0.26', 'lle': '2.98', 'sei': '6.94'}",CHEMBL3672090,,CHEMBL3672090,7.92,False,http://www.openphacts.org/units/Nanomolar,2547468,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
282811,17665156,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cn2cc(-c3ccccc3)c(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)nc2n1,,,CHEMBL3638971,,2015.0,"{'bei': '14.74', 'le': '0.27', 'lle': '3.37', 'sei': '7.01'}",CHEMBL3672091,,CHEMBL3672091,8.00,False,http://www.openphacts.org/units/Nanomolar,2547469,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
282812,17665157,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,OCc1cn2cc(-c3ccccc3)c(-c3ccc(CN4CC(c5n[nH]c(-c6ccccn6)n5)C4)cc3)nc2n1,,,CHEMBL3638971,,2015.0,"{'bei': '13.88', 'le': '0.25', 'lle': '2.80', 'sei': '6.61'}",CHEMBL3672092,,CHEMBL3672092,7.14,False,http://www.openphacts.org/units/Nanomolar,2547470,=,37,True,=,,IC50,nM,,72.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,72.0
282813,17665158,[],CHEMBL3705788,"TR-FRET Assay: Akt1 inhibitory activity of compounds of the present invention may be quantified0 employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in am- ide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a IOOfold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2nc(-c3ccc(CN4CCC(c5n[nH]c(-c6ccccn6)n5)CC4)cc3)c(-c3cc(F)ccc3F)cn2n1,,,CHEMBL3638971,,2015.0,"{'bei': '12.81', 'le': '0.23', 'lle': '1.62', 'sei': '7.17'}",CHEMBL3672093,,CHEMBL3672093,7.22,False,http://www.openphacts.org/units/Nanomolar,2547471,=,37,True,=,,IC50,nM,,60.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,60.0
286557,17668902,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncccc1-c1nc2ccc(-c3cccc(NC(=O)C4CC4)c3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3639036,,2015.0,"{'bei': '16.50', 'le': '0.30', 'lle': '3.09', 'sei': '6.82'}",CHEMBL3640732,,CHEMBL3640732,8.51,False,http://www.openphacts.org/units/Nanomolar,2528320,=,37,True,=,,IC50,nM,,3.09,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.09
286558,17668903,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)C(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,,,CHEMBL3639036,,2015.0,"{'bei': '16.49', 'le': '0.30', 'lle': '2.72', 'sei': '7.03'}",CHEMBL3640733,,CHEMBL3640733,8.77,False,http://www.openphacts.org/units/Nanomolar,2528321,=,37,True,=,,IC50,nM,,1.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.7
286559,17668904,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)OC(C)(C)C(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,,,CHEMBL3639036,,2015.0,"{'bei': '14.51', 'le': '0.27', 'lle': '3.00', 'sei': '5.53'}",CHEMBL3640734,,CHEMBL3640734,8.35,False,http://www.openphacts.org/units/Nanomolar,2528322,=,37,True,=,,IC50,nM,,4.46,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.46
286560,17668905,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)C(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,,,CHEMBL3639036,,2015.0,"{'bei': '16.47', 'le': '0.30', 'lle': '4.01', 'sei': '6.06'}",CHEMBL3640735,,CHEMBL3640735,8.79,False,http://www.openphacts.org/units/Nanomolar,2528323,=,37,True,=,,IC50,nM,,1.63,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.63
286561,17668906,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](O)CNC(=O)c1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,,,CHEMBL3639036,,2015.0,"{'bei': '16.14', 'le': '0.29', 'lle': '4.43', 'sei': '5.94'}",CHEMBL3640736,,CHEMBL3640736,8.61,False,http://www.openphacts.org/units/Nanomolar,2528324,=,37,True,=,,IC50,nM,,2.45,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.45
286562,17668907,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](O)CNC(=O)c1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,,,CHEMBL3639036,,2015.0,"{'bei': '16.54', 'le': '0.30', 'lle': '4.64', 'sei': '6.09'}",CHEMBL3640737,,CHEMBL3640737,8.82,False,http://www.openphacts.org/units/Nanomolar,2528325,=,37,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
286563,17668908,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)C1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,,,CHEMBL3639036,,2015.0,"{'bei': '14.66', 'le': '0.27', 'lle': '3.23', 'sei': '7.22'}",CHEMBL3640738,,CHEMBL3640738,8.60,False,http://www.openphacts.org/units/Nanomolar,2528326,=,37,True,=,,IC50,nM,,2.51,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.51
286564,17668909,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)C(=O)C1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,,,CHEMBL3639036,,2015.0,"{'bei': '13.63', 'le': '0.25', 'lle': '2.23', 'sei': '7.03'}",CHEMBL3640739,,CHEMBL3640739,8.38,False,http://www.openphacts.org/units/Nanomolar,2528327,=,37,True,=,,IC50,nM,,4.15,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.15
286565,17668910,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncccc1-c1nc2ccc(-c3cccc(N4CCC(C(=O)N5CCOCC5)CC4)c3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3639036,,2015.0,"{'bei': '13.48', 'le': '0.25', 'lle': '3.33', 'sei': '6.60'}",CHEMBL3640740,,CHEMBL3640740,8.47,False,http://www.openphacts.org/units/Nanomolar,2528328,=,37,True,=,,IC50,nM,,3.36,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.36
286566,17668911,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NC1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,,,CHEMBL3639036,,2015.0,"{'bei': '15.44', 'le': '0.28', 'lle': '3.67', 'sei': '6.91'}",CHEMBL3640741,,CHEMBL3640741,8.84,False,http://www.openphacts.org/units/Nanomolar,2528329,=,37,True,=,,IC50,nM,,1.44,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.44
286567,17668912,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(=O)N1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,,,CHEMBL3639036,,2015.0,"{'bei': '15.13', 'le': '0.28', 'lle': '3.54', 'sei': '7.27'}",CHEMBL3640742,,CHEMBL3640742,8.67,False,http://www.openphacts.org/units/Nanomolar,2528330,=,37,True,=,,IC50,nM,,2.15,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.15
286568,17668913,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncccc1-c1nc2ccc(-c3cccc(N4CCN(C(=O)C5CC5)CC4)c3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3639036,,2015.0,"{'bei': '14.94', 'le': '0.27', 'lle': '3.61', 'sei': '7.33'}",CHEMBL3640743,,CHEMBL3640743,8.73,False,http://www.openphacts.org/units/Nanomolar,2528331,=,37,True,=,,IC50,nM,,1.84,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.84
286569,17668914,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)C(=O)N1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,,,CHEMBL3639036,,2015.0,"{'bei': '14.09', 'le': '0.26', 'lle': '2.71', 'sei': '7.10'}",CHEMBL3640745,,CHEMBL3640745,8.47,False,http://www.openphacts.org/units/Nanomolar,2528333,=,37,True,=,,IC50,nM,,3.42,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.42
286570,17668915,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)C[C@@H](C)O1,,,CHEMBL3639036,,2015.0,"{'bei': '15.32', 'le': '0.28', 'lle': '2.68', 'sei': '7.73'}",CHEMBL3640746,,CHEMBL3640746,8.36,False,http://www.openphacts.org/units/Nanomolar,2528334,=,37,True,=,,IC50,nM,,4.36,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.36
286571,17668916,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncccc1-c1nc2ccc(-c3cccc(N4CCS(=O)(=O)CC4)c3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3639036,,2015.0,"{'bei': '15.46', 'le': '0.29', 'lle': '4.45', 'sei': '6.58'}",CHEMBL3640747,,CHEMBL3640747,8.75,False,http://www.openphacts.org/units/Nanomolar,2528335,=,37,True,=,,IC50,nM,,1.79,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.79
286572,17668917,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncccc1-c1nc2ccc(Nc3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3639036,,2015.0,"{'bei': '18.82', 'le': '0.34', 'lle': '3.27', 'sei': '7.82'}",CHEMBL3640748,,CHEMBL3640748,8.42,False,http://www.openphacts.org/units/Nanomolar,2528336,=,37,True,=,,IC50,nM,,3.77,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.77
286573,17668918,[],CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncccc1-c1nc2ccc(Nc3ccc(N4CCOCC4)cc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL3639036,,2015.0,"{'bei': '15.13', 'le': '0.28', 'lle': '3.08', 'sei': '6.71'}",CHEMBL3640749,,CHEMBL3640749,8.06,False,http://www.openphacts.org/units/Nanomolar,2528337,=,37,True,=,,IC50,nM,,8.72,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.72
287935,17670299,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ncccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '18.97', 'le': '0.34', 'lle': '2.06', 'sei': '11.49'}",CHEMBL3699664,,CHEMBL3699664,6.46,False,http://www.openphacts.org/units/Nanomolar,2576821,=,37,True,=,,IC50,nM,,348.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,348.0
287936,17670300,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2n1,,,CHEMBL3638633,,2015.0,"{'bei': '16.75', 'le': '0.30', 'lle': '1.23', 'sei': '10.56'}",CHEMBL3699665,,CHEMBL3699665,5.94,False,http://www.openphacts.org/units/Nanomolar,2576822,=,37,True,=,,IC50,nM,,1157.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1157.0
287937,17670301,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4nc(C5CC5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '15.76', 'le': '0.28', 'lle': '0.72', 'sei': '10.67'}",CHEMBL3699666,,CHEMBL3699666,6.00,False,http://www.openphacts.org/units/Nanomolar,2576823,=,37,True,=,,IC50,nM,,1009.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1009.0
287938,17670302,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4nc(-c5ccccc5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.22', 'le': '0.29', 'lle': '0.68', 'sei': '12.02'}",CHEMBL3699667,,CHEMBL3699667,6.75,False,http://www.openphacts.org/units/Nanomolar,2576824,=,37,True,=,,IC50,nM,,176.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,176.0
287939,17670303,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-c1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2n1,,,CHEMBL3638633,,2015.0,"{'bei': '12.38', 'le': '0.22', 'lle': '-1.05', 'sei': '9.48'}",CHEMBL3699668,,CHEMBL3699668,5.33,False,http://www.openphacts.org/units/Nanomolar,2576825,=,37,True,=,,IC50,nM,,4695.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4695.0
287940,17670304,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cnc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '18.09', 'le': '0.32', 'lle': '1.70', 'sei': '11.41'}",CHEMBL3699669,,CHEMBL3699669,6.41,False,http://www.openphacts.org/units/Nanomolar,2576826,=,37,True,=,,IC50,nM,,388.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,388.0
287941,17670305,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cnc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '18.79', 'le': '0.34', 'lle': '2.55', 'sei': '10.64'}",CHEMBL3699670,,CHEMBL3699670,6.96,False,http://www.openphacts.org/units/Nanomolar,2576827,=,37,True,=,,IC50,nM,,109.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,109.0
287942,17670306,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cnc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.25', 'le': '0.31', 'lle': '1.83', 'sei': '10.14'}",CHEMBL3699671,,CHEMBL3699671,6.63,False,http://www.openphacts.org/units/Nanomolar,2576828,=,37,True,=,,IC50,nM,,233.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,233.0
287943,17670307,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ncc(-c5ccccc5)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '14.80', 'le': '0.26', 'lle': '0.09', 'sei': '10.97'}",CHEMBL3699672,,CHEMBL3699672,6.16,False,http://www.openphacts.org/units/Nanomolar,2576829,=,37,True,=,,IC50,nM,,685.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,685.0
287944,17670308,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.95', 'le': '0.32', 'lle': '1.66', 'sei': '9.75'}",CHEMBL3699673,,CHEMBL3699673,6.54,False,http://www.openphacts.org/units/Nanomolar,2576830,=,37,True,=,,IC50,nM,,287.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,287.0
287945,17670309,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(-n5cccn5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '17.24', 'le': '0.31', 'lle': '1.80', 'sei': '11.44'}",CHEMBL3699674,,CHEMBL3699674,6.99,False,http://www.openphacts.org/units/Nanomolar,2576831,=,37,True,=,,IC50,nM,,102.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,102.0
287946,17670310,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1cc(OC)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.02', 'le': '0.31', 'lle': '2.48', 'sei': '9.23'}",CHEMBL3699675,,CHEMBL3699675,7.28,False,http://www.openphacts.org/units/Nanomolar,2576832,=,37,True,=,,IC50,nM,,53.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,53.0
287947,17670311,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(N)=O)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '18.47', 'le': '0.34', 'lle': '3.51', 'sei': '7.97'}",CHEMBL3699676,,CHEMBL3699676,7.62,False,http://www.openphacts.org/units/Nanomolar,2576833,=,37,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
287948,17670312,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)Nc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.14', 'le': '0.27', 'lle': '1.47', 'sei': '7.38'}",CHEMBL3699677,,CHEMBL3699677,6.23,False,http://www.openphacts.org/units/Nanomolar,2576834,=,37,True,=,,IC50,nM,,588.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,588.0
287949,17670313,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4nc(-n5ccccc5=O)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '13.02', 'le': '0.23', 'lle': '1.09', 'sei': '7.22'}",CHEMBL3699678,,CHEMBL3699678,5.64,False,http://www.openphacts.org/units/Nanomolar,2576835,=,37,True,=,,IC50,nM,,2268.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2268.0
287950,17670314,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(-n5cccn5)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.38', 'le': '0.29', 'lle': '1.45', 'sei': '10.86'}",CHEMBL3699679,,CHEMBL3699679,6.64,False,http://www.openphacts.org/units/Nanomolar,2576836,=,37,True,=,,IC50,nM,,228.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,228.0
287951,17670315,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2n1,,,CHEMBL3638633,,2015.0,"{'bei': '18.48', 'le': '0.33', 'lle': '2.44', 'sei': '10.46'}",CHEMBL3699680,,CHEMBL3699680,6.85,False,http://www.openphacts.org/units/Nanomolar,2576837,=,37,True,=,,IC50,nM,,142.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,142.0
287952,17670316,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4nc(O)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '17.58', 'le': '0.32', 'lle': '2.15', 'sei': '8.20'}",CHEMBL3699681,,CHEMBL3699681,6.26,False,http://www.openphacts.org/units/Nanomolar,2576838,=,37,True,=,,IC50,nM,,544.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,544.0
287953,17670317,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCOc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2n1,,,CHEMBL3638633,,2015.0,"{'bei': '16.66', 'le': '0.30', 'lle': '1.45', 'sei': '10.14'}",CHEMBL3699682,,CHEMBL3699682,6.64,False,http://www.openphacts.org/units/Nanomolar,2576839,=,37,True,=,,IC50,nM,,230.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,230.0
287954,17670318,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '19.74', 'le': '0.35', 'lle': '2.31', 'sei': '10.72'}",CHEMBL3699683,,CHEMBL3699683,7.19,False,http://www.openphacts.org/units/Nanomolar,2576840,=,37,True,=,,IC50,nM,,64.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,64.0
287955,17670319,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.20', 'le': '0.31', 'lle': '0.77', 'sei': '14.04'}",CHEMBL3699684,,CHEMBL3699684,6.08,False,http://www.openphacts.org/units/Nanomolar,2576841,=,37,True,=,,IC50,nM,,829.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,829.0
287956,17670320,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '19.80', 'le': '0.35', 'lle': '1.69', 'sei': '16.16'}",CHEMBL3699685,,CHEMBL3699685,7.00,False,http://www.openphacts.org/units/Nanomolar,2576842,=,37,True,=,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100.0
287957,17670321,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '18.76', 'le': '0.33', 'lle': '1.96', 'sei': '10.19'}",CHEMBL3699686,,CHEMBL3699686,6.84,False,http://www.openphacts.org/units/Nanomolar,2576843,=,37,True,=,,IC50,nM,,145.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,145.0
287958,17670322,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '18.93', 'le': '0.34', 'lle': '1.38', 'sei': '15.45'}",CHEMBL3699687,,CHEMBL3699687,6.69,False,http://www.openphacts.org/units/Nanomolar,2576844,=,37,True,=,,IC50,nM,,203.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,203.0
287959,17670323,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '18.99', 'le': '0.34', 'lle': '2.01', 'sei': '13.35'}",CHEMBL3699688,,CHEMBL3699688,7.02,False,http://www.openphacts.org/units/Nanomolar,2576845,=,37,True,=,,IC50,nM,,96.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,96.0
287960,17670324,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.26', 'le': '0.31', 'lle': '2.47', 'sei': '9.45'}",CHEMBL3699689,,CHEMBL3699689,6.84,False,http://www.openphacts.org/units/Nanomolar,2576846,=,37,True,=,,IC50,nM,,144.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,144.0
287961,17670325,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COCc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '16.01', 'le': '0.29', 'lle': '0.99', 'sei': '11.69'}",CHEMBL3699690,,CHEMBL3699690,6.14,False,http://www.openphacts.org/units/Nanomolar,2576847,=,37,True,=,,IC50,nM,,723.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,723.0
287962,17670326,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '18.30', 'le': '0.33', 'lle': '1.75', 'sei': '12.87'}",CHEMBL3699691,,CHEMBL3699691,6.76,False,http://www.openphacts.org/units/Nanomolar,2576848,=,37,True,=,,IC50,nM,,173.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,173.0
287963,17670327,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.65', 'le': '0.32', 'lle': '1.71', 'sei': '10.65'}",CHEMBL3699692,,CHEMBL3699692,6.77,False,http://www.openphacts.org/units/Nanomolar,2576849,=,37,True,=,,IC50,nM,,171.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,171.0
287964,17670328,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(CO)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '15.57', 'le': '0.28', 'lle': '1.25', 'sei': '9.05'}",CHEMBL3699693,,CHEMBL3699693,5.75,False,http://www.openphacts.org/units/Nanomolar,2576850,=,37,True,=,,IC50,nM,,1771.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1771.0
287965,17670329,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(CO)cccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '18.34', 'le': '0.33', 'lle': '2.27', 'sei': '10.66'}",CHEMBL3699694,,CHEMBL3699694,6.78,False,http://www.openphacts.org/units/Nanomolar,2576851,=,37,True,=,,IC50,nM,,168.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,168.0
287966,17670330,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '20.15', 'le': '0.36', 'lle': '2.43', 'sei': '14.16'}",CHEMBL3699696,,CHEMBL3699696,7.44,False,http://www.openphacts.org/units/Nanomolar,2576853,=,37,True,=,,IC50,nM,,36.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,36.0
287967,17670331,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '18.76', 'le': '0.34', 'lle': '3.06', 'sei': '8.30'}",CHEMBL3699697,,CHEMBL3699697,7.17,False,http://www.openphacts.org/units/Nanomolar,2576854,=,37,True,=,,IC50,nM,,67.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,67.0
287968,17670332,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '17.96', 'le': '0.32', 'lle': '1.49', 'sei': '13.10'}",CHEMBL3699698,,CHEMBL3699698,6.89,False,http://www.openphacts.org/units/Nanomolar,2576855,=,37,True,=,,IC50,nM,,130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,130.0
287969,17670333,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.73', 'le': '0.28', 'lle': '0.21', 'sei': '13.34'}",CHEMBL3699699,,CHEMBL3699699,5.78,False,http://www.openphacts.org/units/Nanomolar,2576856,=,37,True,=,,IC50,nM,,1657.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1657.0
287970,17670334,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(-c5cn[nH]c5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.59', 'le': '0.30', 'lle': '1.33', 'sei': '9.34'}",CHEMBL3699700,,CHEMBL3699700,6.73,False,http://www.openphacts.org/units/Nanomolar,2576857,=,37,True,=,,IC50,nM,,188.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,188.0
287971,17670335,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1cccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '18.44', 'le': '0.33', 'lle': '2.54', 'sei': '10.53'}",CHEMBL3699701,,CHEMBL3699701,7.33,False,http://www.openphacts.org/units/Nanomolar,2576858,=,37,True,=,,IC50,nM,,47.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,47.0
287972,17670336,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCNCc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '12.30', 'le': '0.22', 'lle': '0.51', 'sei': '8.13'}",CHEMBL3699702,,CHEMBL3699702,5.25,False,http://www.openphacts.org/units/Nanomolar,2576859,=,37,True,=,,IC50,nM,,5643.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5643.0
287973,17670337,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(CO)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '17.04', 'le': '0.31', 'lle': '1.80', 'sei': '9.91'}",CHEMBL3699703,,CHEMBL3699703,6.30,False,http://www.openphacts.org/units/Nanomolar,2576860,=,37,True,=,,IC50,nM,,504.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,504.0
287974,17670338,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(COc2ccn3c(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc3n2)cn1,,,CHEMBL3638633,,2015.0,"{'bei': '13.94', 'le': '0.25', 'lle': '1.28', 'sei': '7.60'}",CHEMBL3639985,,CHEMBL3639985,6.66,False,http://www.openphacts.org/units/Nanomolar,2576861,=,37,True,=,,IC50,nM,,221.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,221.0
287975,17670339,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2n1,,,CHEMBL3638633,,2015.0,"{'bei': '14.30', 'le': '0.26', 'lle': '1.50', 'sei': '7.94'}",CHEMBL3699704,,CHEMBL3699704,5.93,False,http://www.openphacts.org/units/Nanomolar,2576862,=,37,True,=,,IC50,nM,,1186.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1186.0
287976,17670340,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(COc2ccn3c(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc3n2)ccn1,,,CHEMBL3638633,,2015.0,"{'bei': '14.13', 'le': '0.26', 'lle': '1.37', 'sei': '7.71'}",CHEMBL3699705,,CHEMBL3699705,6.75,False,http://www.openphacts.org/units/Nanomolar,2576863,=,37,True,=,,IC50,nM,,179.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,179.0
287977,17670341,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2n1,,,CHEMBL3638633,,2015.0,"{'bei': '17.48', 'le': '0.32', 'lle': '1.92', 'sei': '10.27'}",CHEMBL3699706,,CHEMBL3699706,6.72,False,http://www.openphacts.org/units/Nanomolar,2576864,=,37,True,=,,IC50,nM,,190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,190.0
287978,17670342,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2n1,,,CHEMBL3638633,,2015.0,"{'bei': '14.83', 'le': '0.27', 'lle': '0.72', 'sei': '9.03'}",CHEMBL3699707,,CHEMBL3699707,5.91,False,http://www.openphacts.org/units/Nanomolar,2576865,=,37,True,=,,IC50,nM,,1225.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1225.0
287979,17670343,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4nc(OC5CCCCC5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '13.41', 'le': '0.24', 'lle': '-0.23', 'sei': '8.99'}",CHEMBL3699708,,CHEMBL3699708,5.88,False,http://www.openphacts.org/units/Nanomolar,2576866,=,37,True,=,,IC50,nM,,1315.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1315.0
287980,17670344,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4nc(Oc5ccccc5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '13.54', 'le': '0.24', 'lle': '-0.33', 'sei': '8.95'}",CHEMBL3699709,,CHEMBL3699709,5.86,False,http://www.openphacts.org/units/Nanomolar,2576867,=,37,True,=,,IC50,nM,,1385.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1385.0
287981,17670345,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cnc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.43', 'le': '0.31', 'lle': '1.46', 'sei': '11.42'}",CHEMBL3699710,,CHEMBL3699710,6.42,False,http://www.openphacts.org/units/Nanomolar,2576868,=,37,True,=,,IC50,nM,,379.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,379.0
287982,17670346,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(-c5ccc(F)cc5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '13.85', 'le': '0.25', 'lle': '-0.81', 'sei': '13.86'}",CHEMBL3699711,,CHEMBL3699711,6.00,False,http://www.openphacts.org/units/Nanomolar,2576869,=,37,True,=,,IC50,nM,,989.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,989.0
287983,17670347,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '16.72', 'le': '0.30', 'lle': '1.86', 'sei': '9.55'}",CHEMBL3699712,,CHEMBL3699712,6.65,False,http://www.openphacts.org/units/Nanomolar,2576870,=,37,True,=,,IC50,nM,,226.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,226.0
287984,17670348,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '18.15', 'le': '0.33', 'lle': '2.42', 'sei': '10.36'}",CHEMBL3699713,,CHEMBL3699713,7.21,False,http://www.openphacts.org/units/Nanomolar,2576871,=,37,True,=,,IC50,nM,,61.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,61.0
287985,17670349,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(C5CC5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '15.25', 'le': '0.27', 'lle': '-0.09', 'sei': '13.36'}",CHEMBL3699714,,CHEMBL3699714,5.79,False,http://www.openphacts.org/units/Nanomolar,2576872,=,37,True,=,,IC50,nM,,1636.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1636.0
287986,17670350,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.92', 'le': '0.32', 'lle': '1.02', 'sei': '15.20'}",CHEMBL3699715,,CHEMBL3699715,6.58,False,http://www.openphacts.org/units/Nanomolar,2576873,=,37,True,=,,IC50,nM,,260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,260.0
287987,17670351,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(Br)cccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '17.88', 'le': '0.38', 'lle': '1.71', 'sei': '17.27'}",CHEMBL3699716,,CHEMBL3699716,7.48,False,http://www.openphacts.org/units/Nanomolar,2576874,=,37,True,=,,IC50,nM,,33.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,33.0
287988,17670352,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.49', 'le': '0.32', 'lle': '2.58', 'sei': '7.74'}",CHEMBL2035022,,CHEMBL2035022,6.69,False,http://www.openphacts.org/units/Nanomolar,2580576,=,37,True,=,,IC50,nM,,204.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,204.0
287989,17670353,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(C(=O)N5CCCC5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '10.79', 'le': '0.20', 'lle': '-0.53', 'sei': '7.41'}",CHEMBL3699718,,CHEMBL3699718,4.71,False,http://www.openphacts.org/units/Nanomolar,2576876,=,37,True,=,,IC50,nM,,19417.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19417.0
287990,17670354,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1cccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '17.52', 'le': '0.32', 'lle': '2.03', 'sei': '10.35'}",CHEMBL3699719,,CHEMBL3699719,7.21,False,http://www.openphacts.org/units/Nanomolar,2576877,=,37,True,=,,IC50,nM,,62.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,62.0
287991,17670355,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(F)cccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '19.16', 'le': '0.35', 'lle': '1.70', 'sei': '15.81'}",CHEMBL3699720,,CHEMBL3699720,6.85,False,http://www.openphacts.org/units/Nanomolar,2576878,=,37,True,=,,IC50,nM,,142.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,142.0
287992,17670356,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(Cl)cccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '19.70', 'le': '0.37', 'lle': '1.71', 'sei': '17.00'}",CHEMBL3699721,,CHEMBL3699721,7.37,False,http://www.openphacts.org/units/Nanomolar,2576879,=,37,True,=,,IC50,nM,,43.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,43.0
287993,17670357,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(F)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '19.57', 'le': '0.35', 'lle': '1.85', 'sei': '16.15'}",CHEMBL3699722,,CHEMBL3699722,7.00,False,http://www.openphacts.org/units/Nanomolar,2576880,=,37,True,=,,IC50,nM,,101.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,101.0
287994,17670358,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(C5CC5)cccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '18.06', 'le': '0.32', 'lle': '0.97', 'sei': '15.82'}",CHEMBL3699723,,CHEMBL3699723,6.85,False,http://www.openphacts.org/units/Nanomolar,2576881,=,37,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,140.0
287995,17670359,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.85', 'le': '0.32', 'lle': '0.87', 'sei': '15.06'}",CHEMBL3699724,,CHEMBL3699724,6.52,False,http://www.openphacts.org/units/Nanomolar,2576882,=,37,True,=,,IC50,nM,,300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,300.0
287996,17670360,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1cccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '18.45', 'le': '0.33', 'lle': '1.09', 'sei': '15.57'}",CHEMBL3699725,,CHEMBL3699725,6.75,False,http://www.openphacts.org/units/Nanomolar,2576883,=,37,True,=,,IC50,nM,,180.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,180.0
287997,17670361,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(-c5cn[nH]c5)cccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '17.27', 'le': '0.31', 'lle': '1.60', 'sei': '9.73'}",CHEMBL3699726,,CHEMBL3699726,7.00,False,http://www.openphacts.org/units/Nanomolar,2576884,=,37,True,=,,IC50,nM,,99.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,99.0
287998,17670362,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(C(=O)O)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '18.36', 'le': '0.33', 'lle': '2.34', 'sei': '8.73'}",CHEMBL3699727,,CHEMBL3699727,7.04,False,http://www.openphacts.org/units/Nanomolar,2576885,=,37,True,=,,IC50,nM,,91.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,91.0
287999,17670363,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Br)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '17.22', 'le': '0.36', 'lle': '1.94', 'sei': '14.69'}",CHEMBL3699728,,CHEMBL3699728,7.72,False,http://www.openphacts.org/units/Nanomolar,2576886,=,37,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.0
288000,17670364,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '13.59', 'le': '0.25', 'lle': '0.63', 'sei': '7.96'}",CHEMBL3699729,,CHEMBL3699729,5.77,False,http://www.openphacts.org/units/Nanomolar,2576887,=,37,True,=,,IC50,nM,,1708.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1708.0
288001,17670365,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(C(=O)NCCF)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '14.87', 'le': '0.27', 'lle': '1.66', 'sei': '8.80'}",CHEMBL3699730,,CHEMBL3699730,6.37,False,http://www.openphacts.org/units/Nanomolar,2576888,=,37,True,=,,IC50,nM,,423.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,423.0
288002,17670366,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(C(=O)NCCO)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '13.94', 'le': '0.25', 'lle': '2.21', 'sei': '6.42'}",CHEMBL3699731,,CHEMBL3699731,5.95,False,http://www.openphacts.org/units/Nanomolar,2576889,=,37,True,=,,IC50,nM,,1136.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1136.0
288003,17670367,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCNC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '14.40', 'le': '0.26', 'lle': '1.96', 'sei': '7.77'}",CHEMBL3699732,,CHEMBL3699732,6.34,False,http://www.openphacts.org/units/Nanomolar,2576890,=,37,True,=,,IC50,nM,,452.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,452.0
288004,17670368,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(C(=O)NC5CC5)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '14.93', 'le': '0.27', 'lle': '1.41', 'sei': '8.71'}",CHEMBL3699733,,CHEMBL3699733,6.31,False,http://www.openphacts.org/units/Nanomolar,2576891,=,37,True,=,,IC50,nM,,493.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,493.0
288005,17670369,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(C(=O)NCC5CC5)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '14.81', 'le': '0.27', 'lle': '1.32', 'sei': '8.93'}",CHEMBL3699734,,CHEMBL3699734,6.47,False,http://www.openphacts.org/units/Nanomolar,2576892,=,37,True,=,,IC50,nM,,342.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,342.0
288006,17670370,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(C(=O)NO)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.54', 'le': '0.30', 'lle': '2.46', 'sei': '7.11'}",CHEMBL3699735,,CHEMBL3699735,6.59,False,http://www.openphacts.org/units/Nanomolar,2576893,=,37,True,=,,IC50,nM,,257.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,257.0
288007,17670371,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1cc(Cl)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.38', 'le': '0.33', 'lle': '2.06', 'sei': '10.79'}",CHEMBL3699736,,CHEMBL3699736,7.51,False,http://www.openphacts.org/units/Nanomolar,2576894,=,37,True,=,,IC50,nM,,31.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31.0
288008,17670372,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '13.93', 'le': '0.25', 'lle': '1.01', 'sei': '8.99'}",CHEMBL3699737,,CHEMBL3699737,5.72,False,http://www.openphacts.org/units/Nanomolar,2576895,=,37,True,=,,IC50,nM,,1904.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1904.0
288009,17670373,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.65', 'le': '0.28', 'lle': '1.66', 'sei': '8.87'}",CHEMBL3699738,,CHEMBL3699738,6.42,False,http://www.openphacts.org/units/Nanomolar,2576896,=,37,True,=,,IC50,nM,,376.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,376.0
288010,17670374,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(C5CC5)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.16', 'le': '0.29', 'lle': '0.25', 'sei': '14.16'}",CHEMBL3699739,,CHEMBL3699739,6.13,False,http://www.openphacts.org/units/Nanomolar,2576897,=,37,True,=,,IC50,nM,,734.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,734.0
288011,17670375,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4nc(OCCN5CCCC5=O)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '12.36', 'le': '0.23', 'lle': '1.38', 'sei': '6.74'}",CHEMBL3699740,,CHEMBL3699740,5.78,False,http://www.openphacts.org/units/Nanomolar,2576898,=,37,True,=,,IC50,nM,,1659.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1659.0
288012,17670376,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)C1(COc2ccn3c(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc3n2)CC1,,,CHEMBL3638633,,2015.0,"{'bei': '13.17', 'le': '0.24', 'lle': '1.92', 'sei': '5.50'}",CHEMBL3699741,,CHEMBL3699741,5.97,False,http://www.openphacts.org/units/Nanomolar,2576899,=,37,True,=,,IC50,nM,,1066.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1066.0
288013,17670377,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(Cl)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '18.58', 'le': '0.35', 'lle': '1.29', 'sei': '16.04'}",CHEMBL3699742,,CHEMBL3699742,6.95,False,http://www.openphacts.org/units/Nanomolar,2576900,=,37,True,=,,IC50,nM,,113.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,113.0
288014,17670378,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(F)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '20.13', 'le': '0.36', 'lle': '2.04', 'sei': '16.61'}",CHEMBL3699743,,CHEMBL3699743,7.19,False,http://www.openphacts.org/units/Nanomolar,2576901,=,37,True,=,,IC50,nM,,64.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,64.0
288015,17670379,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(-c5ccc(F)cc5)cccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '15.02', 'le': '0.27', 'lle': '-0.30', 'sei': '15.03'}",CHEMBL3699744,,CHEMBL3699744,6.51,False,http://www.openphacts.org/units/Nanomolar,2576902,=,37,True,=,,IC50,nM,,308.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,308.0
288016,17670380,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(-c5cccc(F)c5)cccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '15.41', 'le': '0.28', 'lle': '-0.13', 'sei': '15.42'}",CHEMBL3699745,,CHEMBL3699745,6.68,False,http://www.openphacts.org/units/Nanomolar,2576903,=,37,True,=,,IC50,nM,,208.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,208.0
288017,17670381,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cncc(-c2cccn3c(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc23)c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.62', 'le': '0.28', 'lle': '0.89', 'sei': '10.66'}",CHEMBL3699746,,CHEMBL3699746,6.97,False,http://www.openphacts.org/units/Nanomolar,2576904,=,37,True,=,,IC50,nM,,106.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,106.0
288018,17670382,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(-c5ccn[nH]5)cccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '17.74', 'le': '0.32', 'lle': '1.79', 'sei': '9.99'}",CHEMBL3699747,,CHEMBL3699747,7.19,False,http://www.openphacts.org/units/Nanomolar,2576905,=,37,True,=,,IC50,nM,,64.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,64.0
288019,17670383,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(-c5ccc6cn[nH]c6c5)cccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '14.07', 'le': '0.25', 'lle': '-0.14', 'sei': '8.90'}",CHEMBL3699748,,CHEMBL3699748,6.41,False,http://www.openphacts.org/units/Nanomolar,2576906,=,37,True,=,,IC50,nM,,390.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,390.0
288020,17670384,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '19.69', 'le': '0.35', 'lle': '1.62', 'sei': '16.70'}",CHEMBL3699749,,CHEMBL3699749,7.24,False,http://www.openphacts.org/units/Nanomolar,2576907,=,37,True,=,,IC50,nM,,58.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,58.0
288021,17670385,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1Cl,,,CHEMBL3638633,,2015.0,"{'bei': '17.45', 'le': '0.33', 'lle': '0.80', 'sei': '15.63'}",CHEMBL3699750,,CHEMBL3699750,6.77,False,http://www.openphacts.org/units/Nanomolar,2576908,=,37,True,=,,IC50,nM,,170.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,170.0
288022,17670386,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(F)cc(F)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '19.40', 'le': '0.36', 'lle': '2.00', 'sei': '16.81'}",CHEMBL3699751,,CHEMBL3699751,7.28,False,http://www.openphacts.org/units/Nanomolar,2576909,=,37,True,=,,IC50,nM,,52.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,52.0
288023,17670387,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Cl)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '19.60', 'le': '0.37', 'lle': '1.63', 'sei': '17.55'}",CHEMBL3699752,,CHEMBL3699752,7.60,False,http://www.openphacts.org/units/Nanomolar,2576910,=,37,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
288024,17670388,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1cc(Br)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.84', 'le': '0.33', 'lle': '1.82', 'sei': '11.16'}",CHEMBL3699753,,CHEMBL3699753,7.77,False,http://www.openphacts.org/units/Nanomolar,2576911,=,37,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.0
288025,17670389,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(Cl)cc(Cl)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '19.97', 'le': '0.40', 'lle': '1.84', 'sei': '18.82'}",CHEMBL3699754,,CHEMBL3699754,8.15,False,http://www.openphacts.org/units/Nanomolar,2576912,=,37,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
288026,17670390,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1C#N,,,CHEMBL3638633,,2015.0,"{'bei': '16.75', 'le': '0.30', 'lle': '1.72', 'sei': '8.66'}",CHEMBL3699755,,CHEMBL3699755,6.61,False,http://www.openphacts.org/units/Nanomolar,2576913,=,37,True,=,,IC50,nM,,247.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,247.0
288027,17670391,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(Cl)c(Cl)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.71', 'le': '0.33', 'lle': '0.51', 'sei': '15.75'}",CHEMBL3699756,,CHEMBL3699756,6.82,False,http://www.openphacts.org/units/Nanomolar,2576914,=,37,True,=,,IC50,nM,,150.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,150.0
288028,17670392,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(Cl)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1Br,,,CHEMBL3638633,,2015.0,"{'bei': '16.59', 'le': '0.36', 'lle': '1.01', 'sei': '17.88'}",CHEMBL3699757,,CHEMBL3699757,7.75,False,http://www.openphacts.org/units/Nanomolar,2576915,=,37,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
288029,17670393,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Br)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.97', 'le': '0.38', 'lle': '1.69', 'sei': '17.94'}",CHEMBL3699758,,CHEMBL3699758,7.77,False,http://www.openphacts.org/units/Nanomolar,2576916,=,37,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.0
288030,17670394,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(Br)cc(Cl)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '18.33', 'le': '0.40', 'lle': '1.88', 'sei': '19.16'}",CHEMBL3699759,,CHEMBL3699759,8.30,False,http://www.openphacts.org/units/Nanomolar,2576917,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
288031,17670395,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(Cl)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1-c1ccc(F)cc1,,,CHEMBL3638633,,2015.0,"{'bei': '12.17', 'le': '0.23', 'lle': '-1.91', 'sei': '13.54'}",CHEMBL3699760,,CHEMBL3699760,5.86,False,http://www.openphacts.org/units/Nanomolar,2576918,=,37,True,=,,IC50,nM,,1368.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1368.0
288032,17670396,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(Cl)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1-c1ccn[nH]1,,,CHEMBL3638633,,2015.0,"{'bei': '14.82', 'le': '0.28', 'lle': '0.37', 'sei': '9.34'}",CHEMBL3699761,,CHEMBL3699761,6.73,False,http://www.openphacts.org/units/Nanomolar,2576919,=,37,True,=,,IC50,nM,,187.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,187.0
288033,17670397,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(-c2ccn[nH]2)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1C,,,CHEMBL3638633,,2015.0,"{'bei': '14.95', 'le': '0.27', 'lle': '0.47', 'sei': '9.00'}",CHEMBL3699762,,CHEMBL3699762,6.48,False,http://www.openphacts.org/units/Nanomolar,2576920,=,37,True,=,,IC50,nM,,330.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,330.0
288034,17670398,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cccnc2)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.85', 'le': '0.28', 'lle': '0.44', 'sei': '12.14'}",CHEMBL3699763,,CHEMBL3699763,6.82,False,http://www.openphacts.org/units/Nanomolar,2576921,=,37,True,=,,IC50,nM,,150.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,150.0
288035,17670399,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cncc(-c2cc(C)cn3c(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc23)c1,,,CHEMBL3638633,,2015.0,"{'bei': '13.96', 'le': '0.25', 'lle': '0.04', 'sei': '9.83'}",CHEMBL3699764,,CHEMBL3699764,6.43,False,http://www.openphacts.org/units/Nanomolar,2576922,=,37,True,=,,IC50,nM,,371.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,371.0
288036,17670400,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccn[nH]2)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.83', 'le': '0.28', 'lle': '0.94', 'sei': '9.22'}",CHEMBL3699765,,CHEMBL3699765,6.64,False,http://www.openphacts.org/units/Nanomolar,2576923,=,37,True,=,,IC50,nM,,229.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,229.0
288037,17670401,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn[nH]c2)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '16.90', 'le': '0.30', 'lle': '1.39', 'sei': '9.85'}",CHEMBL3699766,,CHEMBL3699766,7.09,False,http://www.openphacts.org/units/Nanomolar,2576924,=,37,True,=,,IC50,nM,,81.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,81.0
288038,17670402,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Br)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.25', 'le': '0.36', 'lle': '3.09', 'sei': '9.21'}",CHEMBL3699768,,CHEMBL3699768,7.96,False,http://www.openphacts.org/units/Nanomolar,2576926,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
288039,17670403,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C(N)=O)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.26', 'le': '0.28', 'lle': '1.64', 'sei': '7.00'}",CHEMBL3699769,,CHEMBL3699769,6.05,False,http://www.openphacts.org/units/Nanomolar,2576927,=,37,True,=,,IC50,nM,,893.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,893.0
288040,17670404,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(-c2cn[nH]c2)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '15.99', 'le': '0.29', 'lle': '2.67', 'sei': '6.23'}",CHEMBL3699770,,CHEMBL3699770,7.17,False,http://www.openphacts.org/units/Nanomolar,2576928,=,37,True,=,,IC50,nM,,67.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,67.0
288041,17670405,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(-c2ccn[nH]2)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '15.97', 'le': '0.29', 'lle': '2.66', 'sei': '6.22'}",CHEMBL3699771,,CHEMBL3699771,7.16,False,http://www.openphacts.org/units/Nanomolar,2576929,=,37,True,=,,IC50,nM,,69.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,69.0
288042,17670406,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(-c2cccnc2)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '14.69', 'le': '0.26', 'lle': '1.58', 'sei': '6.80'}",CHEMBL3699772,,CHEMBL3699772,6.75,False,http://www.openphacts.org/units/Nanomolar,2576930,=,37,True,=,,IC50,nM,,177.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,177.0
288043,17670407,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(N)=O)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1C,,,CHEMBL3638633,,2015.0,"{'bei': '16.31', 'le': '0.30', 'lle': '1.98', 'sei': '7.75'}",CHEMBL3699773,,CHEMBL3699773,6.70,False,http://www.openphacts.org/units/Nanomolar,2576931,=,37,True,=,,IC50,nM,,201.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,201.0
288044,17670408,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C(N)=O)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '19.81', 'le': '0.36', 'lle': '3.44', 'sei': '9.09'}",CHEMBL3699774,,CHEMBL3699774,7.85,False,http://www.openphacts.org/units/Nanomolar,2576932,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
288045,17670409,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn[nH]c2)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '16.63', 'le': '0.30', 'lle': '1.27', 'sei': '9.69'}",CHEMBL3699775,,CHEMBL3699775,6.97,False,http://www.openphacts.org/units/Nanomolar,2576933,=,37,True,=,,IC50,nM,,106.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,106.0
288046,17670410,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccn[nH]2)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '16.70', 'le': '0.30', 'lle': '1.30', 'sei': '9.73'}",CHEMBL3699776,,CHEMBL3699776,7.00,False,http://www.openphacts.org/units/Nanomolar,2576934,=,37,True,=,,IC50,nM,,99.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,99.0
288047,17670411,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cccnc2)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '15.69', 'le': '0.28', 'lle': '0.38', 'sei': '12.02'}",CHEMBL3699777,,CHEMBL3699777,6.76,False,http://www.openphacts.org/units/Nanomolar,2576935,=,37,True,=,,IC50,nM,,175.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,175.0
288048,17670412,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cc(C)c3nc(-c4ccc(C5(N)CCC5)cc4)c(-c4ccccc4)n3c2)[nH]n1,,,CHEMBL3638633,,2015.0,"{'bei': '15.37', 'le': '0.28', 'lle': '0.65', 'sei': '9.25'}",CHEMBL3699778,,CHEMBL3699778,6.66,False,http://www.openphacts.org/units/Nanomolar,2576936,=,37,True,=,,IC50,nM,,217.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,217.0
288049,17670413,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '20.09', 'le': '0.36', 'lle': '1.81', 'sei': '15.75'}",CHEMBL2035021,,CHEMBL2035021,6.82,False,http://www.openphacts.org/units/Nanomolar,2580577,=,37,True,=,,IC50,nM,,151.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,151.0
288050,17670414,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.45', 'le': '0.32', 'lle': '1.29', 'sei': '12.73'}",CHEMBL3703102,,CHEMBL3703102,6.69,False,http://www.openphacts.org/units/Nanomolar,2580505,=,37,True,=,,IC50,nM,,204.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,204.0
288051,17670415,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.62', 'le': '0.28', 'lle': '0.06', 'sei': '13.18'}",CHEMBL3703103,,CHEMBL3703103,5.71,False,http://www.openphacts.org/units/Nanomolar,2580506,=,37,True,=,,IC50,nM,,1951.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1951.0
288052,17670416,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(-c5ccncc5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.19', 'le': '0.29', 'lle': '0.67', 'sei': '11.99'}",CHEMBL3703104,,CHEMBL3703104,6.74,False,http://www.openphacts.org/units/Nanomolar,2580507,=,37,True,=,,IC50,nM,,181.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,181.0
288053,17670417,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(-c5cccnc5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.54', 'le': '0.29', 'lle': '0.82', 'sei': '12.26'}",CHEMBL3703105,,CHEMBL3703105,6.89,False,http://www.openphacts.org/units/Nanomolar,2580508,=,37,True,=,,IC50,nM,,129.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,129.0
288054,17670418,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(-c5ccccn5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.06', 'le': '0.29', 'lle': '0.62', 'sei': '11.90'}",CHEMBL3703106,,CHEMBL3703106,6.69,False,http://www.openphacts.org/units/Nanomolar,2580509,=,37,True,=,,IC50,nM,,204.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,204.0
288055,17670419,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(-c5cc[nH]n5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.81', 'le': '0.30', 'lle': '1.42', 'sei': '9.47'}",CHEMBL3703107,,CHEMBL3703107,6.82,False,http://www.openphacts.org/units/Nanomolar,2580510,=,37,True,=,,IC50,nM,,153.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,153.0
288056,17670420,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(-c5ncc[nH]5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '17.63', 'le': '0.31', 'lle': '1.75', 'sei': '9.93'}",CHEMBL3703108,,CHEMBL3703108,7.15,False,http://www.openphacts.org/units/Nanomolar,2580511,=,37,True,=,,IC50,nM,,71.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,71.0
288057,17670421,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(-c5cnc[nH]5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.46', 'le': '0.29', 'lle': '1.27', 'sei': '9.27'}",CHEMBL3703109,,CHEMBL3703109,6.67,False,http://www.openphacts.org/units/Nanomolar,2580512,=,37,True,=,,IC50,nM,,212.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,212.0
288058,17670422,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cncc1-c1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.80', 'le': '0.28', 'lle': '1.22', 'sei': '10.84'}",CHEMBL3703110,,CHEMBL3703110,6.63,False,http://www.openphacts.org/units/Nanomolar,2580513,=,37,True,=,,IC50,nM,,236.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,236.0
288059,17670423,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(-c5nn[nH]n5)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '18.61', 'le': '0.33', 'lle': '3.40', 'sei': '7.76'}",CHEMBL3703111,,CHEMBL3703111,7.58,False,http://www.openphacts.org/units/Nanomolar,2580514,=,37,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.0
288060,17670424,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.17', 'le': '0.31', 'lle': '1.89', 'sei': '10.15'}",CHEMBL3703112,,CHEMBL3703112,7.07,False,http://www.openphacts.org/units/Nanomolar,2580515,=,37,True,=,,IC50,nM,,86.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,86.0
288061,17670425,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(C(=O)O)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.32', 'le': '0.29', 'lle': '1.56', 'sei': '7.76'}",CHEMBL3703113,,CHEMBL3703113,6.26,False,http://www.openphacts.org/units/Nanomolar,2580516,=,37,True,=,,IC50,nM,,550.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,550.0
288062,17670426,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '16.11', 'le': '0.29', 'lle': '2.02', 'sei': '8.82'}",CHEMBL3703114,,CHEMBL3703114,6.39,False,http://www.openphacts.org/units/Nanomolar,2580517,=,37,True,=,,IC50,nM,,409.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,409.0
288063,17670427,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)/C=C/c1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.26', 'le': '0.28', 'lle': '1.27', 'sei': '9.28'}",CHEMBL3703115,,CHEMBL3703115,6.46,False,http://www.openphacts.org/units/Nanomolar,2580518,=,37,True,=,,IC50,nM,,345.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,345.0
288064,17670428,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)/C=C/c1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '16.55', 'le': '0.30', 'lle': '2.26', 'sei': '7.82'}",CHEMBL3703116,,CHEMBL3703116,6.76,False,http://www.openphacts.org/units/Nanomolar,2580519,=,37,True,=,,IC50,nM,,174.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,174.0
288065,17670429,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)CCc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '12.84', 'le': '0.23', 'lle': '0.35', 'sei': '7.85'}",CHEMBL3703117,,CHEMBL3703117,5.46,False,http://www.openphacts.org/units/Nanomolar,2580520,=,37,True,=,,IC50,nM,,3436.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3436.0
288066,17670430,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)c1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.15', 'le': '0.27', 'lle': '1.46', 'sei': '8.59'}",CHEMBL3703118,,CHEMBL3703118,6.22,False,http://www.openphacts.org/units/Nanomolar,2580521,=,37,True,=,,IC50,nM,,601.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,601.0
288067,17670431,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(C(=O)NO)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '17.26', 'le': '0.31', 'lle': '2.75', 'sei': '7.43'}",CHEMBL3703119,,CHEMBL3703119,6.88,False,http://www.openphacts.org/units/Nanomolar,2580522,=,37,True,=,,IC50,nM,,132.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,132.0
288068,17670432,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.71', 'le': '0.32', 'lle': '1.55', 'sei': '11.19'}",CHEMBL3703120,,CHEMBL3703120,6.76,False,http://www.openphacts.org/units/Nanomolar,2580523,=,37,True,=,,IC50,nM,,175.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,175.0
288069,17670433,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(-c5cnc[nH]5)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.55', 'le': '0.30', 'lle': '1.31', 'sei': '9.32'}",CHEMBL3703121,,CHEMBL3703121,6.71,False,http://www.openphacts.org/units/Nanomolar,2580524,=,37,True,=,,IC50,nM,,195.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,195.0
288070,17670434,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(-c5ncc[nH]5)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.01', 'le': '0.29', 'lle': '1.09', 'sei': '9.02'}",CHEMBL3703122,,CHEMBL3703122,6.49,False,http://www.openphacts.org/units/Nanomolar,2580525,=,37,True,=,,IC50,nM,,321.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,321.0
288071,17670435,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(-c5cc[nH]n5)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.69', 'le': '0.30', 'lle': '1.37', 'sei': '9.40'}",CHEMBL3703123,,CHEMBL3703123,6.77,False,http://www.openphacts.org/units/Nanomolar,2580526,=,37,True,=,,IC50,nM,,171.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,171.0
288072,17670436,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(-c5cn[nH]c5)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.42', 'le': '0.29', 'lle': '1.26', 'sei': '9.25'}",CHEMBL3703124,,CHEMBL3703124,6.66,False,http://www.openphacts.org/units/Nanomolar,2580527,=,37,True,=,,IC50,nM,,219.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,219.0
288073,17670437,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cncc1-c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '13.43', 'le': '0.24', 'lle': '0.22', 'sei': '9.22'}",CHEMBL3703125,,CHEMBL3703125,5.63,False,http://www.openphacts.org/units/Nanomolar,2580528,=,37,True,=,,IC50,nM,,2320.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2320.0
288074,17670438,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc3nc(-c4ccc(C5(N)CCC5)cc4)c(-c4ccccc4)n3c2)cn1,,,CHEMBL3638633,,2015.0,"{'bei': '14.68', 'le': '0.26', 'lle': '0.75', 'sei': '10.08'}",CHEMBL3703126,,CHEMBL3703126,6.16,False,http://www.openphacts.org/units/Nanomolar,2580529,=,37,True,=,,IC50,nM,,691.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,691.0
288075,17670439,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(-c5nn[nH]n5)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '17.50', 'le': '0.31', 'lle': '2.94', 'sei': '7.29'}",CHEMBL3703127,,CHEMBL3703127,7.13,False,http://www.openphacts.org/units/Nanomolar,2580530,=,37,True,=,,IC50,nM,,74.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,74.0
288076,17670440,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(-c5ccncc5)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '15.06', 'le': '0.27', 'lle': '0.20', 'sei': '11.16'}",CHEMBL3703128,,CHEMBL3703128,6.27,False,http://www.openphacts.org/units/Nanomolar,2580531,=,37,True,=,,IC50,nM,,533.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,533.0
288077,17670441,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(-c5cccnc5)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '15.05', 'le': '0.27', 'lle': '0.20', 'sei': '11.15'}",CHEMBL3703129,,CHEMBL3703129,6.27,False,http://www.openphacts.org/units/Nanomolar,2580532,=,37,True,=,,IC50,nM,,541.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,541.0
288078,17670442,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(-c5ccccn5)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '15.07', 'le': '0.27', 'lle': '0.21', 'sei': '11.16'}",CHEMBL3703130,,CHEMBL3703130,6.28,False,http://www.openphacts.org/units/Nanomolar,2580533,=,37,True,=,,IC50,nM,,530.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,530.0
288079,17670443,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(Br)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '17.59', 'le': '0.37', 'lle': '1.59', 'sei': '16.98'}",CHEMBL3699695,,CHEMBL3699695,7.36,False,http://www.openphacts.org/units/Nanomolar,2576852,=,37,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,44.0
288080,17670444,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(Cl)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '19.91', 'le': '0.38', 'lle': '1.78', 'sei': '17.18'}",CHEMBL3703131,,CHEMBL3703131,7.44,False,http://www.openphacts.org/units/Nanomolar,2580534,=,37,True,=,,IC50,nM,,36.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,36.0
288081,17670445,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)/C=C/c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.84', 'le': '0.29', 'lle': '1.52', 'sei': '9.63'}",CHEMBL3703132,,CHEMBL3703132,6.71,False,http://www.openphacts.org/units/Nanomolar,2580535,=,37,True,=,,IC50,nM,,196.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,196.0
288082,17670446,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)/C=C/c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.81', 'le': '0.28', 'lle': '1.96', 'sei': '7.48'}",CHEMBL3703133,,CHEMBL3703133,6.46,False,http://www.openphacts.org/units/Nanomolar,2580536,=,37,True,=,,IC50,nM,,347.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,347.0
288083,17670447,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.09', 'le': '0.31', 'lle': '1.85', 'sei': '10.10'}",CHEMBL3703134,,CHEMBL3703134,7.03,False,http://www.openphacts.org/units/Nanomolar,2580537,=,37,True,=,,IC50,nM,,93.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,93.0
288084,17670448,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '19.03', 'le': '0.34', 'lle': '2.05', 'sei': '12.02'}",CHEMBL3703135,,CHEMBL3703135,7.26,False,http://www.openphacts.org/units/Nanomolar,2580538,=,37,True,=,,IC50,nM,,55.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,55.0
288085,17670449,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Cl)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '18.87', 'le': '0.36', 'lle': '1.95', 'sei': '14.50'}",CHEMBL3703136,,CHEMBL3703136,7.62,False,http://www.openphacts.org/units/Nanomolar,2580539,=,37,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
288086,17670450,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(OC)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '19.12', 'le': '0.35', 'lle': '2.62', 'sei': '12.36'}",CHEMBL3703137,,CHEMBL3703137,7.64,False,http://www.openphacts.org/units/Nanomolar,2580540,=,37,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
288087,17670451,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc(OC)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.18', 'le': '0.31', 'lle': '1.25', 'sei': '13.00'}",CHEMBL3703138,,CHEMBL3703138,6.83,False,http://www.openphacts.org/units/Nanomolar,2580541,=,37,True,=,,IC50,nM,,148.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,148.0
288088,17670452,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2cnc[nH]2)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '15.74', 'le': '0.28', 'lle': '1.46', 'sei': '8.44'}",CHEMBL3703139,,CHEMBL3703139,6.86,False,http://www.openphacts.org/units/Nanomolar,2580542,=,37,True,=,,IC50,nM,,139.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,139.0
288089,17670453,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2ncc[nH]2)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '15.39', 'le': '0.28', 'lle': '1.30', 'sei': '8.25'}",CHEMBL3703140,,CHEMBL3703140,6.70,False,http://www.openphacts.org/units/Nanomolar,2580543,=,37,True,=,,IC50,nM,,198.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,198.0
288090,17670454,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccn3c(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc3c2)cn1,,,CHEMBL3638633,,2015.0,"{'bei': '14.91', 'le': '0.27', 'lle': '0.84', 'sei': '10.23'}",CHEMBL3703141,,CHEMBL3703141,6.25,False,http://www.openphacts.org/units/Nanomolar,2580544,=,37,True,=,,IC50,nM,,558.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,558.0
288091,17670455,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.74', 'le': '0.32', 'lle': '1.70', 'sei': '9.07'}",CHEMBL3703142,,CHEMBL3703142,6.29,False,http://www.openphacts.org/units/Nanomolar,2580545,=,37,True,=,,IC50,nM,,514.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,514.0
288092,17670456,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.78', 'le': '0.28', 'lle': '1.30', 'sei': '8.64'}",CHEMBL3703143,,CHEMBL3703143,6.26,False,http://www.openphacts.org/units/Nanomolar,2580546,=,37,True,=,,IC50,nM,,554.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,554.0
288093,17670457,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)Nc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.95', 'le': '0.29', 'lle': '1.84', 'sei': '6.44'}",CHEMBL3703144,,CHEMBL3703144,6.34,False,http://www.openphacts.org/units/Nanomolar,2580547,=,37,True,=,,IC50,nM,,457.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,457.0
288094,17670458,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CON(C)C(=O)c1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '13.29', 'le': '0.24', 'lle': '1.03', 'sei': '7.78'}",CHEMBL3703145,,CHEMBL3703145,5.67,False,http://www.openphacts.org/units/Nanomolar,2580548,=,37,True,=,,IC50,nM,,2145.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2145.0
288095,17670459,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.12', 'le': '0.31', 'lle': '1.48', 'sei': '8.75'}",CHEMBL3703146,,CHEMBL3703146,6.07,False,http://www.openphacts.org/units/Nanomolar,2580549,=,37,True,=,,IC50,nM,,854.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,854.0
288096,17670460,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '18.18', 'le': '0.33', 'lle': '2.25', 'sei': '9.95'}",CHEMBL3703147,,CHEMBL3703147,7.21,False,http://www.openphacts.org/units/Nanomolar,2580550,=,37,True,=,,IC50,nM,,62.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,62.0
288097,17670461,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)Nc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '16.58', 'le': '0.30', 'lle': '2.09', 'sei': '6.70'}",CHEMBL3703148,,CHEMBL3703148,6.59,False,http://www.openphacts.org/units/Nanomolar,2580551,=,37,True,=,,IC50,nM,,256.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,256.0
288098,17670462,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)Nc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.76', 'le': '0.29', 'lle': '1.73', 'sei': '7.68'}",CHEMBL3703149,,CHEMBL3703149,6.49,False,http://www.openphacts.org/units/Nanomolar,2580552,=,37,True,=,,IC50,nM,,327.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,327.0
288099,17670463,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)Nc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '12.77', 'le': '0.24', 'lle': '1.14', 'sei': '6.17'}",CHEMBL3703150,,CHEMBL3703150,5.53,False,http://www.openphacts.org/units/Nanomolar,2580553,=,37,True,=,,IC50,nM,,2988.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2988.0
288100,17670464,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1cc(OC)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '16.99', 'le': '0.31', 'lle': '1.06', 'sei': '12.79'}",CHEMBL3703151,,CHEMBL3703151,6.72,False,http://www.openphacts.org/units/Nanomolar,2580554,=,37,True,=,,IC50,nM,,191.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,191.0
288101,17670465,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@]1(c2ccc(-c3nc4nc(O)ccn4c3-c3ccccc3)cc2)C[C@H](O)C1,,,CHEMBL3638633,,2015.0,"{'bei': '17.23', 'le': '0.31', 'lle': '3.34', 'sei': '6.64'}",CHEMBL3703152,,CHEMBL3703152,6.42,False,http://www.openphacts.org/units/Nanomolar,2580555,=,37,True,=,,IC50,nM,,384.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,384.0
288102,17670466,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4nc(OCCN5C(=O)c6ccccc6C5=O)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '11.82', 'le': '0.21', 'lle': '1.18', 'sei': '6.09'}",CHEMBL3703153,,CHEMBL3703153,6.26,False,http://www.openphacts.org/units/Nanomolar,2580556,=,37,True,=,,IC50,nM,,548.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,548.0
288103,17670467,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(O)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '18.34', 'le': '0.33', 'lle': '1.81', 'sei': '10.26'}",CHEMBL3703154,,CHEMBL3703154,6.52,False,http://www.openphacts.org/units/Nanomolar,2580557,=,37,True,=,,IC50,nM,,303.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,303.0
288104,17670468,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c(O)cccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '17.53', 'le': '0.32', 'lle': '1.52', 'sei': '9.80'}",CHEMBL3703155,,CHEMBL3703155,6.23,False,http://www.openphacts.org/units/Nanomolar,2580558,=,37,True,=,,IC50,nM,,590.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,590.0
288105,17670469,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '18.92', 'le': '0.34', 'lle': '3.13', 'sei': '8.37'}",CHEMBL3703156,,CHEMBL3703156,7.24,False,http://www.openphacts.org/units/Nanomolar,2580559,=,37,True,=,,IC50,nM,,58.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,58.0
288106,17670470,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '19.00', 'le': '0.36', 'lle': '3.16', 'sei': '9.17'}",CHEMBL3703157,,CHEMBL3703157,7.92,False,http://www.openphacts.org/units/Nanomolar,2580560,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
288107,17670471,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,C#Cc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.90', 'le': '0.28', 'lle': '0.79', 'sei': '13.34'}",CHEMBL3703158,,CHEMBL3703158,5.78,False,http://www.openphacts.org/units/Nanomolar,2580561,=,37,True,=,,IC50,nM,,1658.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1658.0
288108,17670472,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)CCc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '11.93', 'le': '0.22', 'lle': '0.48', 'sei': '5.67'}",CHEMBL3703159,,CHEMBL3703159,4.90,False,http://www.openphacts.org/units/Nanomolar,2580562,=,37,True,=,,IC50,nM,,12688.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12688.0
288109,17670473,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)COc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.91', 'le': '0.29', 'lle': '2.24', 'sei': '8.63'}",CHEMBL3703161,,CHEMBL3703161,6.80,False,http://www.openphacts.org/units/Nanomolar,2580564,=,37,True,=,,IC50,nM,,158.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,158.0
288110,17670474,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)COc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.52', 'le': '0.28', 'lle': '2.53', 'sei': '6.69'}",CHEMBL3703162,,CHEMBL3703162,6.40,False,http://www.openphacts.org/units/Nanomolar,2580565,=,37,True,=,,IC50,nM,,397.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,397.0
288111,17670475,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)COc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '14.95', 'le': '0.27', 'lle': '2.12', 'sei': '9.04'}",CHEMBL3703163,,CHEMBL3703163,6.59,False,http://www.openphacts.org/units/Nanomolar,2580566,=,37,True,=,,IC50,nM,,258.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,258.0
288112,17670476,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]COc1ccn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.68', 'le': '0.28', 'lle': '0.92', 'sei': '10.87'}",CHEMBL3703164,,CHEMBL3703164,6.18,False,http://www.openphacts.org/units/Nanomolar,2580567,=,37,True,=,,IC50,nM,,655.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,655.0
288113,17670477,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)COc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '15.78', 'le': '0.29', 'lle': '2.19', 'sei': '8.56'}",CHEMBL3703165,,CHEMBL3703165,6.75,False,http://www.openphacts.org/units/Nanomolar,2580568,=,37,True,=,,IC50,nM,,179.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,179.0
288114,17670478,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]COc1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.79', 'le': '0.32', 'lle': '1.76', 'sei': '12.33'}",CHEMBL3703166,,CHEMBL3703166,7.02,False,http://www.openphacts.org/units/Nanomolar,2580569,=,37,True,=,,IC50,nM,,96.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,96.0
288115,17670479,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4cc(O)ccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '16.59', 'le': '0.30', 'lle': '1.19', 'sei': '9.28'}",CHEMBL3703167,,CHEMBL3703167,5.89,False,http://www.openphacts.org/units/Nanomolar,2580570,=,37,True,=,,IC50,nM,,1273.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1273.0
288116,17670480,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4ccc(-c5cccnc5O)cn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3638633,,2015.0,"{'bei': '13.46', 'le': '0.24', 'lle': '0.05', 'sei': '7.62'}",CHEMBL3703168,,CHEMBL3703168,5.82,False,http://www.openphacts.org/units/Nanomolar,2580571,=,37,True,=,,IC50,nM,,1510.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1510.0
288117,17670481,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc3nc(-c4ccc(C5(N)CCC5)cc4)c(-c4ccccc4)n3c2)[nH]n1,,,CHEMBL3638633,,2015.0,"{'bei': '14.69', 'le': '0.26', 'lle': '0.46', 'sei': '8.56'}",CHEMBL3640020,,CHEMBL3640020,6.16,False,http://www.openphacts.org/units/Nanomolar,2580572,=,37,True,=,,IC50,nM,,688.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,688.0
288118,17670482,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2cn[nH]c2)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3638633,,2015.0,"{'bei': '16.28', 'le': '0.29', 'lle': '1.69', 'sei': '8.73'}",CHEMBL3703169,,CHEMBL3703169,7.09,False,http://www.openphacts.org/units/Nanomolar,2580573,=,37,True,=,,IC50,nM,,81.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,81.0
288119,17670483,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n12,,,CHEMBL3638633,,2015.0,"{'bei': '16.47', 'le': '0.29', 'lle': '0.51', 'sei': '13.44'}",CHEMBL3703170,,CHEMBL3703170,5.82,False,http://www.openphacts.org/units/Nanomolar,2580574,=,37,True,=,,IC50,nM,,1505.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1505.0
288120,17670484,[],CHEMBL3705510,"TR-FRET Assay: For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cc(Cl)c2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2c1,,,CHEMBL3638633,,2015.0,"{'bei': '17.17', 'le': '0.32', 'lle': '1.32', 'sei': '10.21'}",CHEMBL3703171,,CHEMBL3703171,6.85,False,http://www.openphacts.org/units/Nanomolar,2580575,=,37,True,=,,IC50,nM,,141.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,141.0
290690,17672927,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nn4ccnc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639173,,2015.0,"{'bei': '19.41', 'le': '0.35', 'lle': '2.21', 'sei': '11.76'}",CHEMBL2035019,,CHEMBL2035019,6.61,False,http://www.openphacts.org/units/Nanomolar,2547899,=,37,True,=,,IC50,nM,,246.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,246.0
290691,17672928,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cn2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)cc2n1,,,CHEMBL3639173,,2015.0,"{'bei': '13.44', 'le': '0.24', 'lle': '0.05', 'sei': '8.47'}",CHEMBL3639713,,CHEMBL3639713,4.76,False,http://www.openphacts.org/units/Nanomolar,2547862,=,37,True,=,,IC50,nM,,17257.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17257.0
290692,17672929,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cnc2cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nn12,,,CHEMBL3639173,,2015.0,"{'bei': '17.93', 'le': '0.32', 'lle': '1.65', 'sei': '11.31'}",CHEMBL3672479,,CHEMBL3672479,6.36,False,http://www.openphacts.org/units/Nanomolar,2547863,=,37,True,=,,IC50,nM,,441.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,441.0
290693,17672930,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cccc(-c2cnc3cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nn23)c1,,,CHEMBL3639173,,2015.0,"{'bei': '18.80', 'le': '0.33', 'lle': '2.36', 'sei': '10.38'}",CHEMBL3672480,,CHEMBL3672480,8.30,False,http://www.openphacts.org/units/Nanomolar,2547864,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
290694,17672931,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)c1ccc(-c2cnc3cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nn23)cc1,,,CHEMBL3639173,,2015.0,"{'bei': '14.07', 'le': '0.26', 'lle': '1.49', 'sei': '7.70'}",CHEMBL3672481,,CHEMBL3672481,6.96,False,http://www.openphacts.org/units/Nanomolar,2547865,=,37,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,110.0
290695,17672932,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc(-c2cnc3cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nn23)cc1,,,CHEMBL3639173,,2015.0,"{'bei': '15.60', 'le': '0.28', 'lle': '0.95', 'sei': '8.61'}",CHEMBL3672482,,CHEMBL3672482,6.89,False,http://www.openphacts.org/units/Nanomolar,2547866,=,37,True,=,,IC50,nM,,129.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,129.0
290696,17672933,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cccc(-c2cnc3cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nn23)c1,,,CHEMBL3639173,,2015.0,"{'bei': '17.70', 'le': '0.32', 'lle': '2.55', 'sei': '10.18'}",CHEMBL3672483,,CHEMBL3672483,8.40,False,http://www.openphacts.org/units/Nanomolar,2547867,=,37,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
290697,17672934,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nn4c(-c5ccc(F)cc5)cnc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639173,,2015.0,"{'bei': '17.13', 'le': '0.31', 'lle': '1.23', 'sei': '13.24'}",CHEMBL3672484,,CHEMBL3672484,7.44,False,http://www.openphacts.org/units/Nanomolar,2547868,=,37,True,=,,IC50,nM,,36.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,36.0
290698,17672935,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-c2cnc3cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nn23)cc1,,,CHEMBL3639173,,2015.0,"{'bei': '17.09', 'le': '0.30', 'lle': '0.98', 'sei': '13.09'}",CHEMBL3672485,,CHEMBL3672485,7.36,False,http://www.openphacts.org/units/Nanomolar,2547869,=,37,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,44.0
290699,17672936,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nn4c(-c5cccc(CO)c5)cnc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639173,,2015.0,"{'bei': '18.41', 'le': '0.33', 'lle': '2.66', 'sei': '10.76'}",CHEMBL3672486,,CHEMBL3672486,8.22,False,http://www.openphacts.org/units/Nanomolar,2547870,=,37,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
290700,17672937,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nn4c(-c5ccc(CO)cc5)cnc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639173,,2015.0,"{'bei': '17.29', 'le': '0.31', 'lle': '2.16', 'sei': '10.10'}",CHEMBL3672487,,CHEMBL3672487,7.72,False,http://www.openphacts.org/units/Nanomolar,2547871,=,37,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.0
290701,17672938,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nn4c(-c5ccc(S(N)(=O)=O)cc5)cnc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639173,,2015.0,"{'bei': '14.79', 'le': '0.28', 'lle': '2.61', 'sei': '6.30'}",CHEMBL3672488,,CHEMBL3672488,7.33,False,http://www.openphacts.org/units/Nanomolar,2547872,=,37,True,=,,IC50,nM,,47.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,47.0
290702,17672939,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nn4c(Br)cnc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639173,,2015.0,"{'bei': '17.01', 'le': '0.36', 'lle': '1.97', 'sei': '12.69'}",CHEMBL3672489,,CHEMBL3672489,7.13,False,http://www.openphacts.org/units/Nanomolar,2547873,=,37,True,=,,IC50,nM,,74.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,74.0
290703,17672940,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nn4c(-c5ccc(F)c(CO)c5)cnc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639173,,2015.0,"{'bei': '17.32', 'le': '0.31', 'lle': '2.35', 'sei': '10.53'}",CHEMBL3672490,,CHEMBL3672490,8.05,False,http://www.openphacts.org/units/Nanomolar,2547874,=,37,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
290704,17672941,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1ccc(-c2cnc3cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nn23)cc1,,,CHEMBL3639173,,2015.0,"{'bei': '16.47', 'le': '0.30', 'lle': '2.40', 'sei': '7.62'}",CHEMBL3672491,,CHEMBL3672491,7.57,False,http://www.openphacts.org/units/Nanomolar,2547875,=,37,True,=,,IC50,nM,,27.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,27.0
290705,17672942,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc(-c2cnc3cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nn23)c1,,,CHEMBL3639173,,2015.0,"{'bei': '17.16', 'le': '0.31', 'lle': '2.72', 'sei': '7.94'}",CHEMBL3672492,,CHEMBL3672492,7.89,False,http://www.openphacts.org/units/Nanomolar,2547876,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
290706,17672943,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nn4c(-c5cn[nH]c5)cnc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639173,,2015.0,"{'bei': '19.79', 'le': '0.35', 'lle': '3.26', 'sei': '9.48'}",CHEMBL3672493,,CHEMBL3672493,8.05,False,http://www.openphacts.org/units/Nanomolar,2547877,=,37,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
290707,17672944,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nn4c(-c5ccc(O)nc5)cnc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639173,,2015.0,"{'bei': '15.77', 'le': '0.28', 'lle': '1.67', 'sei': '7.65'}",CHEMBL3672494,,CHEMBL3672494,6.84,False,http://www.openphacts.org/units/Nanomolar,2547878,=,37,True,=,,IC50,nM,,146.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,146.0
290708,17672945,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1ccc(-c2cnc3cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nn23)cn1,,,CHEMBL3639173,,2015.0,"{'bei': '16.24', 'le': '0.29', 'lle': '2.47', 'sei': '8.09'}",CHEMBL3672495,,CHEMBL3672495,7.72,False,http://www.openphacts.org/units/Nanomolar,2547879,=,37,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.0
290709,17672946,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nn4c(-c5ccn[nH]5)cnc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639173,,2015.0,"{'bei': '19.58', 'le': '0.35', 'lle': '3.17', 'sei': '9.38'}",CHEMBL3672496,,CHEMBL3672496,7.96,False,http://www.openphacts.org/units/Nanomolar,2547880,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
290710,17672947,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nn4c(-c5ccc6cn[nH]c6c5)cnc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639173,,2015.0,"{'bei': '17.43', 'le': '0.31', 'lle': '2.02', 'sei': '9.38'}",CHEMBL3672497,,CHEMBL3672497,7.96,False,http://www.openphacts.org/units/Nanomolar,2547881,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
290711,17672948,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)c1cncc(-c2cnc3cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nn23)c1,,,CHEMBL3639173,,2015.0,"{'bei': '16.66', 'le': '0.30', 'lle': '2.51', 'sei': '8.55'}",CHEMBL3672498,,CHEMBL3672498,8.15,False,http://www.openphacts.org/units/Nanomolar,2547882,=,37,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
290712,17672949,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cncc(-c2cnc3cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nn23)c1,,,CHEMBL3639173,,2015.0,"{'bei': '18.55', 'le': '0.33', 'lle': '2.83', 'sei': '10.60'}",CHEMBL3672499,,CHEMBL3672499,8.30,False,http://www.openphacts.org/units/Nanomolar,2547883,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
290713,17672950,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nn2c1-c1cccc(C(N)=O)c1,,,CHEMBL3639173,,2015.0,"{'bei': '10.18', 'le': '0.18', 'lle': '-0.66', 'sei': '4.86'}",CHEMBL3672500,,CHEMBL3672500,4.82,False,http://www.openphacts.org/units/Nanomolar,2547884,=,37,True,=,,IC50,nM,,15038.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15038.0
290714,17672951,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nn2c1-c1ccc(F)c(CO)c1,,,CHEMBL3639173,,2015.0,"{'bei': '10.44', 'le': '0.19', 'lle': '-1.01', 'sei': '6.53'}",CHEMBL3672501,,CHEMBL3672501,5.00,False,http://www.openphacts.org/units/Nanomolar,2547885,=,37,True,=,,IC50,nM,,10115.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10115.0
290715,17672952,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nn2c1-c1cn[nH]c1,,,CHEMBL3639173,,2015.0,"{'bei': '12.65', 'le': '0.23', 'lle': '0.22', 'sei': '6.27'}",CHEMBL3672502,,CHEMBL3672502,5.32,False,http://www.openphacts.org/units/Nanomolar,2547886,=,37,True,=,,IC50,nM,,4780.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4780.0
290716,17672953,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nn2c1-c1ccc(F)cc1,,,CHEMBL3639173,,2015.0,"{'bei': '11.94', 'le': '0.22', 'lle': '-1.17', 'sei': '9.52'}",CHEMBL3672503,,CHEMBL3672503,5.35,False,http://www.openphacts.org/units/Nanomolar,2547887,=,37,True,=,,IC50,nM,,4428.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4428.0
290717,17672954,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nn2c1-c1ccc(C(N)=O)cc1,,,CHEMBL3639173,,2015.0,"{'bei': '10.38', 'le': '0.19', 'lle': '-0.56', 'sei': '4.95'}",CHEMBL3672504,,CHEMBL3672504,4.92,False,http://www.openphacts.org/units/Nanomolar,2547888,=,37,True,=,,IC50,nM,,12083.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12083.0
290718,17672955,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nn2c1-c1ccn[nH]1,,,CHEMBL3639173,,2015.0,"{'bei': '13.23', 'le': '0.24', 'lle': '0.46', 'sei': '6.55'}",CHEMBL3672505,,CHEMBL3672505,5.56,False,http://www.openphacts.org/units/Nanomolar,2547889,=,37,True,=,,IC50,nM,,2732.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2732.0
290719,17672956,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(-c2c(C)nc3cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nn23)[nH]n1,,,CHEMBL3639173,,2015.0,"{'bei': '11.11', 'le': '0.20', 'lle': '-0.58', 'sei': '5.69'}",CHEMBL3672506,,CHEMBL3672506,4.83,False,http://www.openphacts.org/units/Nanomolar,2547890,=,37,True,=,,IC50,nM,,14853.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14853.0
290720,17672957,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nn4c(-c5ccc(F)cc5)c(Br)nc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639173,,2015.0,"{'bei': '13.96', 'le': '0.29', 'lle': '0.20', 'sei': '12.75'}",CHEMBL3672507,,CHEMBL3672507,7.17,False,http://www.openphacts.org/units/Nanomolar,2547891,=,37,True,=,,IC50,nM,,68.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,68.0
290721,17672958,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nn4c(-c5ccc(F)cc5)c(Cl)nc4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639173,,2015.0,"{'bei': '14.94', 'le': '0.28', 'lle': '0.14', 'sei': '12.46'}",CHEMBL3672508,,CHEMBL3672508,7.00,False,http://www.openphacts.org/units/Nanomolar,2547892,=,37,True,=,,IC50,nM,,99.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,99.0
290722,17672959,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)/C=C/c1cnc2cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nn12,,,CHEMBL3639173,,2015.0,"{'bei': '18.12', 'le': '0.33', 'lle': '3.52', 'sei': '7.47'}",CHEMBL3672509,,CHEMBL3672509,7.42,False,http://www.openphacts.org/units/Nanomolar,2547893,=,37,True,=,,IC50,nM,,38.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,38.0
290723,17672960,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,C=Cc1cnc2cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nn12,,,CHEMBL3639173,,2015.0,"{'bei': '20.07', 'le': '0.36', 'lle': '2.32', 'sei': '13.09'}",CHEMBL3672510,,CHEMBL3672510,7.36,False,http://www.openphacts.org/units/Nanomolar,2547894,=,37,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,44.0
290724,17672961,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nn2c1/C=C/C(N)=O,,,CHEMBL3639173,,2015.0,"{'bei': '11.20', 'le': '0.20', 'lle': '0.53', 'sei': '4.78'}",CHEMBL3672511,,CHEMBL3672511,4.74,False,http://www.openphacts.org/units/Nanomolar,2547895,=,37,True,=,,IC50,nM,,18031.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18031.0
290725,17672962,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)/C=C/c1c(C)nc2cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nn12,,,CHEMBL3639173,,2015.0,"{'bei': '11.91', 'le': '0.22', 'lle': '0.32', 'sei': '6.33'}",CHEMBL3672512,,CHEMBL3672512,5.22,False,http://www.openphacts.org/units/Nanomolar,2547896,=,37,True,=,,IC50,nM,,5966.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5966.0
290726,17672963,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,C=Cc1c(C)nc2cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nn12,,,CHEMBL3639173,,2015.0,"{'bei': '13.27', 'le': '0.24', 'lle': '-0.30', 'sei': '8.98'}",CHEMBL3672513,,CHEMBL3672513,5.05,False,http://www.openphacts.org/units/Nanomolar,2547897,=,37,True,=,,IC50,nM,,8937.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8937.0
290727,17672964,[],CHEMBL3706239,"TR-FRET assay: Akt1 inhibitory activity of compounds of the present invention was quantified employing the Akt1 TR-FRET assay as described in the following paragraphs. His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany).For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1c(C)nc2cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nn12,,,CHEMBL3639173,,2015.0,"{'bei': '12.28', 'le': '0.22', 'lle': '-0.57', 'sei': '8.36'}",CHEMBL3672514,,CHEMBL3672514,4.70,False,http://www.openphacts.org/units/Nanomolar,2547898,=,37,True,=,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20000.0
290765,17673002,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cc(F)ccc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '17.21', 'le': '0.31', 'lle': '1.34', 'sei': '12.51'}",CHEMBL3672515,,CHEMBL3672515,7.03,False,http://www.openphacts.org/units/Nanomolar,2547900,=,37,True,=,,IC50,nM,,93.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,93.0
290766,17673003,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cc(F)ccc5nn4c(NC4CC4)c3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '13.54', 'le': '0.24', 'lle': '0.01', 'sei': '9.20'}",CHEMBL3672516,,CHEMBL3672516,6.28,False,http://www.openphacts.org/units/Nanomolar,2547901,=,37,True,=,,IC50,nM,,528.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,528.0
290767,17673004,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1c(-c2ccccc2)c(-c2ccc(C3(N)CCC3)cc2)nc2c3cc(F)ccc3nn12,,,CHEMBL3639046,,2015.0,"{'bei': '12.75', 'le': '0.23', 'lle': '-0.16', 'sei': '8.18'}",CHEMBL3672517,,CHEMBL3672517,5.58,False,http://www.openphacts.org/units/Nanomolar,2547902,=,37,True,=,,IC50,nM,,2630.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2630.0
290768,17673005,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccc(-c2ccc3c(c2)nn2cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc32)c1,,,CHEMBL3639046,,2015.0,"{'bei': '13.94', 'le': '0.25', 'lle': '-0.24', 'sei': '8.57'}",CHEMBL3672518,,CHEMBL3672518,6.85,False,http://www.openphacts.org/units/Nanomolar,2547903,=,37,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,140.0
290769,17673006,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(-c2ccc3c(c2)nn2cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc32)cc1,,,CHEMBL3639046,,2015.0,"{'bei': '13.27', 'le': '0.25', 'lle': '0.61', 'sei': '8.00'}",CHEMBL3672519,,CHEMBL3672519,7.23,False,http://www.openphacts.org/units/Nanomolar,2547904,=,37,True,=,,IC50,nM,,59.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,59.0
290770,17673007,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5ccc(-c6ccc(F)cc6)cc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '13.70', 'le': '0.25', 'lle': '-0.72', 'sei': '11.81'}",CHEMBL3672520,,CHEMBL3672520,6.64,False,http://www.openphacts.org/units/Nanomolar,2547905,=,37,True,=,,IC50,nM,,229.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,229.0
290771,17673008,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5ccc(Br)cc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '15.04', 'le': '0.31', 'lle': '0.74', 'sei': '12.56'}",CHEMBL3672521,,CHEMBL3672521,7.06,False,http://www.openphacts.org/units/Nanomolar,2547906,=,37,True,=,,IC50,nM,,87.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,87.0
290772,17673009,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5ccc(-c6ccc(F)c(CO)c6)cc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '14.32', 'le': '0.26', 'lle': '0.52', 'sei': '9.64'}",CHEMBL3672522,,CHEMBL3672522,7.37,False,http://www.openphacts.org/units/Nanomolar,2547907,=,37,True,=,,IC50,nM,,43.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,43.0
290773,17673010,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5ccc(-c6ccc(F)c(O)c6)cc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '14.89', 'le': '0.27', 'lle': '0.39', 'sei': '9.75'}",CHEMBL3672523,,CHEMBL3672523,7.46,False,http://www.openphacts.org/units/Nanomolar,2547908,=,37,True,=,,IC50,nM,,35.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,35.0
290774,17673011,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2ccc3c(c2)nn2cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc32)ccc1F,,,CHEMBL3639046,,2015.0,"{'bei': '12.32', 'le': '0.22', 'lle': '-1.03', 'sei': '9.69'}",CHEMBL3672524,,CHEMBL3672524,6.34,False,http://www.openphacts.org/units/Nanomolar,2547909,=,37,True,=,,IC50,nM,,458.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,458.0
290775,17673012,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1cccc(-c2ccc3c(c2)nn2cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc32)c1,,,CHEMBL3639046,,2015.0,"{'bei': '13.96', 'le': '0.26', 'lle': '0.98', 'sei': '8.41'}",CHEMBL3672525,,CHEMBL3672525,7.60,False,http://www.openphacts.org/units/Nanomolar,2547910,=,37,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
290776,17673013,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccc2c(c1)nn1cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc21,,,CHEMBL3639046,,2015.0,"{'bei': '15.51', 'le': '0.28', 'lle': '1.61', 'sei': '8.43'}",CHEMBL3672526,,CHEMBL3672526,6.96,False,http://www.openphacts.org/units/Nanomolar,2547911,=,37,True,=,,IC50,nM,,111.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,111.0
290777,17673014,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc(-c2ccc3c(c2)nn2cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc32)c1,,,CHEMBL3639046,,2015.0,"{'bei': '15.30', 'le': '0.27', 'lle': '1.48', 'sei': '7.85'}",CHEMBL3672527,,CHEMBL3672527,7.80,False,http://www.openphacts.org/units/Nanomolar,2547912,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
290778,17673015,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(-c2ccc3c(c2)nn2cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc32)cc1,,,CHEMBL3639046,,2015.0,"{'bei': '15.07', 'le': '0.27', 'lle': '1.36', 'sei': '7.73'}",CHEMBL3672528,,CHEMBL3672528,7.68,False,http://www.openphacts.org/units/Nanomolar,2547913,=,37,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.0
290779,17673016,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5ccc(-c6cn[nH]c6)cc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '17.02', 'le': '0.30', 'lle': '1.83', 'sei': '9.15'}",CHEMBL3672529,,CHEMBL3672529,7.77,False,http://www.openphacts.org/units/Nanomolar,2547914,=,37,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.0
290780,17673017,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5ccc(-c6ccc(O)nc6)cc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '16.24', 'le': '0.29', 'lle': '1.53', 'sei': '8.79'}",CHEMBL3672530,,CHEMBL3672530,7.85,False,http://www.openphacts.org/units/Nanomolar,2547915,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
290781,17673018,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccc(-c2ccc3c(c2)nn2cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc32)cn1,,,CHEMBL3639046,,2015.0,"{'bei': '14.53', 'le': '0.26', 'lle': '1.24', 'sei': '8.01'}",CHEMBL3672531,,CHEMBL3672531,7.64,False,http://www.openphacts.org/units/Nanomolar,2547916,=,37,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
290782,17673019,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cc(-c6ccc(F)cc6)ccc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '14.36', 'le': '0.26', 'lle': '-0.40', 'sei': '12.38'}",CHEMBL3672532,,CHEMBL3672532,6.96,False,http://www.openphacts.org/units/Nanomolar,2547917,=,37,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,110.0
290783,17673020,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2ccc3nn4cc(-c5ccccc5)c(-c5ccc(C6(N)CCC6)cc5)nc4c3c2)cc1,,,CHEMBL3639046,,2015.0,"{'bei': '14.40', 'le': '0.26', 'lle': '-0.61', 'sei': '12.31'}",CHEMBL3672533,,CHEMBL3672533,6.92,False,http://www.openphacts.org/units/Nanomolar,2547918,=,37,True,=,,IC50,nM,,120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,120.0
290784,17673021,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1cccc(-c2ccc3nn4cc(-c5ccccc5)c(-c5ccc(C6(N)CCC6)cc5)nc4c3c2)c1,,,CHEMBL3639046,,2015.0,"{'bei': '13.13', 'le': '0.24', 'lle': '-0.12', 'sei': '8.35'}",CHEMBL3672534,,CHEMBL3672534,6.89,False,http://www.openphacts.org/units/Nanomolar,2547919,=,37,True,=,,IC50,nM,,130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,130.0
290785,17673022,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccc(-c2ccc3nn4cc(-c5ccccc5)c(-c5ccc(C6(N)CCC6)cc5)nc4c3c2)c1,,,CHEMBL3639046,,2015.0,"{'bei': '14.59', 'le': '0.26', 'lle': '0.08', 'sei': '8.97'}",CHEMBL3672535,,CHEMBL3672535,7.17,False,http://www.openphacts.org/units/Nanomolar,2547920,=,37,True,=,,IC50,nM,,67.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,67.0
290786,17673023,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cc(Br)ccc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '15.74', 'le': '0.33', 'lle': '1.07', 'sei': '13.14'}",CHEMBL3672536,,CHEMBL3672536,7.39,False,http://www.openphacts.org/units/Nanomolar,2547921,=,37,True,=,,IC50,nM,,41.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,41.0
290787,17673024,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(-c2ccc3nn4cc(-c5ccccc5)c(-c5ccc(C6(N)CCC6)cc5)nc4c3c2)cc1,,,CHEMBL3639046,,2015.0,"{'bei': '14.27', 'le': '0.25', 'lle': '-0.08', 'sei': '8.77'}",CHEMBL3672537,,CHEMBL3672537,7.01,False,http://www.openphacts.org/units/Nanomolar,2547922,=,37,True,=,,IC50,nM,,97.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,97.0
290788,17673025,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cc(-c6cccc(CO)c6)ccc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '15.70', 'le': '0.28', 'lle': '1.09', 'sei': '10.20'}",CHEMBL3672538,,CHEMBL3672538,7.80,False,http://www.openphacts.org/units/Nanomolar,2547923,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
290789,17673026,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cc(-c6ccc(CO)cc6)ccc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '15.60', 'le': '0.28', 'lle': '1.03', 'sei': '10.13'}",CHEMBL3672539,,CHEMBL3672539,7.75,False,http://www.openphacts.org/units/Nanomolar,2547924,=,37,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
290790,17673027,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cc(-c6ccc(S(N)(=O)=O)cc6)ccc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '13.76', 'le': '0.26', 'lle': '1.64', 'sei': '6.45'}",CHEMBL3672540,,CHEMBL3672540,7.51,False,http://www.openphacts.org/units/Nanomolar,2547925,=,37,True,=,,IC50,nM,,31.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31.0
290791,17673028,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cc(-c6ccc(F)c(CO)c6)ccc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '15.55', 'le': '0.28', 'lle': '1.15', 'sei': '10.47'}",CHEMBL3672541,,CHEMBL3672541,8.00,False,http://www.openphacts.org/units/Nanomolar,2547926,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
290792,17673029,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cc(-c6cn[nH]c6)ccc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '16.91', 'le': '0.30', 'lle': '1.78', 'sei': '9.10'}",CHEMBL3672542,,CHEMBL3672542,7.72,False,http://www.openphacts.org/units/Nanomolar,2547927,=,37,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.0
290793,17673030,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(-c2cccc3nn4cc(-c5ccccc5)c(-c5ccc(C6(N)CCC6)cc5)nc4c23)cc1,,,CHEMBL3639046,,2015.0,"{'bei': '13.21', 'le': '0.23', 'lle': '-0.60', 'sei': '8.12'}",CHEMBL3672543,,CHEMBL3672543,6.50,False,http://www.openphacts.org/units/Nanomolar,2547928,=,37,True,=,,IC50,nM,,320.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,320.0
290794,17673031,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccc(-c2cccc3c2nn2cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc32)c1,,,CHEMBL3639046,,2015.0,"{'bei': '10.17', 'le': '0.18', 'lle': '-2.09', 'sei': '6.25'}",CHEMBL3672544,,CHEMBL3672544,5.00,False,http://www.openphacts.org/units/Nanomolar,2547929,=,37,True,=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
290795,17673032,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cccc(Br)c5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '14.42', 'le': '0.30', 'lle': '0.45', 'sei': '12.04'}",CHEMBL3672545,,CHEMBL3672545,6.77,False,http://www.openphacts.org/units/Nanomolar,2547930,=,37,True,=,,IC50,nM,,170.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,170.0
290796,17673033,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cccc(-c6ccc(F)cc6)c5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '10.84', 'le': '0.19', 'lle': '-2.11', 'sei': '9.34'}",CHEMBL3672546,,CHEMBL3672546,5.25,False,http://www.openphacts.org/units/Nanomolar,2547931,=,37,True,=,,IC50,nM,,5600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5600.0
290797,17673034,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cccc(-c6ccc(CO)cc6)c5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '12.37', 'le': '0.22', 'lle': '-0.57', 'sei': '8.04'}",CHEMBL3672547,,CHEMBL3672547,6.14,False,http://www.openphacts.org/units/Nanomolar,2547932,=,37,True,=,,IC50,nM,,720.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,720.0
290798,17673035,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1cccc(-c2cccc3c2nn2cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc32)c1,,,CHEMBL3639046,,2015.0,"{'bei': '8.76', 'le': '0.16', 'lle': '-1.85', 'sei': '5.28'}",CHEMBL3672548,,CHEMBL3672548,4.77,False,http://www.openphacts.org/units/Nanomolar,2547933,=,37,True,=,,IC50,nM,,17000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17000.0
290799,17673036,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cccc(-c6cn[nH]c6)c5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '14.89', 'le': '0.27', 'lle': '0.86', 'sei': '8.01'}",CHEMBL3672549,,CHEMBL3672549,6.80,False,http://www.openphacts.org/units/Nanomolar,2547934,=,37,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,160.0
290800,17673037,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccc2c1nn1cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc21,,,CHEMBL3639046,,2015.0,"{'bei': '17.59', 'le': '0.31', 'lle': '1.88', 'sei': '9.14'}",CHEMBL3672550,,CHEMBL3672550,7.31,False,http://www.openphacts.org/units/Nanomolar,2547935,=,37,True,=,,IC50,nM,,49.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,49.0
290801,17673038,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1cccc2c1nn1cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc21,,,CHEMBL3639046,,2015.0,"{'bei': '13.67', 'le': '0.25', 'lle': '0.79', 'sei': '7.43'}",CHEMBL3672551,,CHEMBL3672551,6.13,False,http://www.openphacts.org/units/Nanomolar,2547936,=,37,True,=,,IC50,nM,,740.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,740.0
290802,17673039,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cccc(O)c5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '17.22', 'le': '0.31', 'lle': '1.74', 'sei': '9.16'}",CHEMBL3672552,,CHEMBL3672552,7.00,False,http://www.openphacts.org/units/Nanomolar,2547937,=,37,True,=,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100.0
290803,17673040,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)/C=C/c1cccc2c1nn1cc(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc21,,,CHEMBL3639046,,2015.0,"{'bei': '13.57', 'le': '0.24', 'lle': '1.19', 'sei': '6.28'}",CHEMBL3672553,,CHEMBL3672553,6.24,False,http://www.openphacts.org/units/Nanomolar,2547938,=,37,True,=,,IC50,nM,,580.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,580.0
290804,17673041,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5ccc(-c6ccn[nH]6)cc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '17.14', 'le': '0.31', 'lle': '1.88', 'sei': '9.22'}",CHEMBL3672554,,CHEMBL3672554,7.82,False,http://www.openphacts.org/units/Nanomolar,2547939,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
290805,17673042,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc3c(c2)nn2cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc32)[nH]n1,,,CHEMBL3639046,,2015.0,"{'bei': '17.00', 'le': '0.30', 'lle': '1.75', 'sei': '9.42'}",CHEMBL3672555,,CHEMBL3672555,8.00,False,http://www.openphacts.org/units/Nanomolar,2547940,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
290806,17673043,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1(c2ccc(-c3nc4c5cc(-c6ccn[nH]6)ccc5nn4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3639046,,2015.0,"{'bei': '17.52', 'le': '0.31', 'lle': '2.06', 'sei': '9.42'}",CHEMBL3672556,,CHEMBL3672556,8.00,False,http://www.openphacts.org/units/Nanomolar,2547941,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
290807,17673044,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc3nn4cc(-c5ccccc5)c(-c5ccc(C6(N)CCC6)cc5)nc4c3c2)[nH]n1,,,CHEMBL3639046,,2015.0,"{'bei': '17.47', 'le': '0.31', 'lle': '1.97', 'sei': '9.69'}",CHEMBL3672557,,CHEMBL3672557,8.22,False,http://www.openphacts.org/units/Nanomolar,2547942,=,37,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
290808,17673045,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)/C=C/c1ccc2nn3cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc3c2c1,,,CHEMBL3639046,,2015.0,"{'bei': '16.86', 'le': '0.30', 'lle': '2.26', 'sei': '9.70'}",CHEMBL3672558,,CHEMBL3672558,8.00,False,http://www.openphacts.org/units/Nanomolar,2547943,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
290809,17673046,[],CHEMBL3706240,"TR-FRET assay: For the assay 50 nl of a 100fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt1 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 ul => final cone, in the 5 ul assay volume is 10 ul) and substrate (1 .67 ul => final cone, in the 5 ul assay volume is 1 ul) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)/C=C/c1ccc2nn3cc(-c4ccccc4)c(-c4ccc(C5(N)CCC5)cc4)nc3c2c1,,,CHEMBL3639046,,2015.0,"{'bei': '16.37', 'le': '0.29', 'lle': '2.47', 'sei': '7.58'}",CHEMBL3672559,,CHEMBL3672559,7.52,False,http://www.openphacts.org/units/Nanomolar,2547944,=,37,True,=,,IC50,nM,,30.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30.0
292767,17675004,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '26.16', 'le': '0.50', 'lle': '7.28', 'sei': '8.27'}",CHEMBL3696234,,CHEMBL3696234,6.99,False,http://www.openphacts.org/units/Nanomolar,2573060,=,37,True,=,,IC50,nM,,102.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,102.0
292768,17675005,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)cc1,,,CHEMBL3638374,,2015.0,"{'bei': '19.54', 'le': '0.37', 'lle': '5.56', 'sei': '7.44'}",CHEMBL2151821,,CHEMBL2151821,6.49,False,http://www.openphacts.org/units/Nanomolar,2576991,=,37,True,=,,IC50,nM,,321.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,321.0
292769,17675006,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(Cl)c1,,,CHEMBL3638374,,2015.0,"{'bei': '20.07', 'le': '0.40', 'lle': '5.56', 'sei': '8.02'}",CHEMBL2151921,,CHEMBL2151921,7.00,False,http://www.openphacts.org/units/Nanomolar,2576974,=,37,True,=,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100.0
292770,17675007,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(F)c1,,,CHEMBL3638374,,2015.0,"{'bei': '21.80', 'le': '0.42', 'lle': '6.57', 'sei': '8.75'}",CHEMBL2151924,,CHEMBL2151924,7.64,False,http://www.openphacts.org/units/Nanomolar,2576977,=,37,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
292771,17675008,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)ccc1F,,,CHEMBL3638374,,2015.0,"{'bei': '17.93', 'le': '0.34', 'lle': '5.56', 'sei': '6.73'}",CHEMBL2151927,,CHEMBL2151927,6.50,False,http://www.openphacts.org/units/Nanomolar,2576980,=,37,True,=,,IC50,nM,,318.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,318.0
292772,17675009,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccccc1F,,,CHEMBL3638374,,2015.0,"{'bei': '18.47', 'le': '0.35', 'lle': '5.21', 'sei': '7.03'}",CHEMBL2151819,,CHEMBL2151819,6.14,False,http://www.openphacts.org/units/Nanomolar,2576989,=,37,True,=,,IC50,nM,,727.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,727.0
292773,17675010,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1NC(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '16.62', 'le': '0.31', 'lle': '4.36', 'sei': '6.25'}",CHEMBL2151822,,CHEMBL2151822,5.46,False,http://www.openphacts.org/units/Nanomolar,2576992,=,37,True,=,,IC50,nM,,3498.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3498.0
292774,17675011,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1NC(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '18.00', 'le': '0.34', 'lle': '5.40', 'sei': '6.42'}",CHEMBL3696238,,CHEMBL3696238,6.20,False,http://www.openphacts.org/units/Nanomolar,2573064,=,37,True,=,,IC50,nM,,632.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,632.0
292775,17675012,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(F)c1F,,,CHEMBL3638374,,2015.0,"{'bei': '17.51', 'le': '0.34', 'lle': '5.06', 'sei': '7.02'}",CHEMBL3639951,,CHEMBL3639951,6.13,False,http://www.openphacts.org/units/Nanomolar,2573065,=,37,True,=,,IC50,nM,,737.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,737.0
292776,17675013,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(F)c1,,,CHEMBL3638374,,2015.0,"{'bei': '18.79', 'le': '0.36', 'lle': '5.31', 'sei': '7.15'}",CHEMBL2151820,,CHEMBL2151820,6.24,False,http://www.openphacts.org/units/Nanomolar,2576990,=,37,True,=,,IC50,nM,,570.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,570.0
292777,17675014,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(Cl)cc1,,,CHEMBL3638374,,2015.0,"{'bei': '16.77', 'le': '0.33', 'lle': '4.41', 'sei': '6.70'}",CHEMBL2151920,,CHEMBL2151920,5.85,False,http://www.openphacts.org/units/Nanomolar,2576973,=,37,True,=,,IC50,nM,,1420.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1420.0
292778,17675015,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '17.63', 'le': '0.33', 'lle': '5.27', 'sei': '6.29'}",CHEMBL2151922,,CHEMBL2151922,6.07,False,http://www.openphacts.org/units/Nanomolar,2576975,=,37,True,=,,IC50,nM,,850.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,850.0
292779,17675016,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(C(F)(F)F)c1,,,CHEMBL3638374,,2015.0,"{'bei': '15.25', 'le': '0.29', 'lle': '4.02', 'sei': '6.68'}",CHEMBL3696240,,CHEMBL3696240,5.83,False,http://www.openphacts.org/units/Nanomolar,2573067,=,37,True,=,,IC50,nM,,1481.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1481.0
292780,17675017,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(Br)c1,,,CHEMBL3638374,,2015.0,"{'bei': '19.42', 'le': '0.43', 'lle': '6.09', 'sei': '8.75'}",CHEMBL2151923,,CHEMBL2151923,7.64,False,http://www.openphacts.org/units/Nanomolar,2576976,=,37,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
292781,17675018,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '15.79', 'le': '0.30', 'lle': '5.31', 'sei': '5.18'}",CHEMBL3696242,,CHEMBL3696242,5.88,False,http://www.openphacts.org/units/Nanomolar,2573069,=,37,True,=,,IC50,nM,,1314.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1314.0
292782,17675019,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(C(=O)O)c1,,,CHEMBL3638374,,2015.0,"{'bei': '13.95', 'le': '0.26', 'lle': '4.51', 'sei': '4.01'}",CHEMBL3696243,,CHEMBL3696243,5.00,False,http://www.openphacts.org/units/Nanomolar,2573070,=,37,True,=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
292783,17675020,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '18.11', 'le': '0.34', 'lle': '4.55', 'sei': '7.39'}",CHEMBL3696244,,CHEMBL3696244,6.46,False,http://www.openphacts.org/units/Nanomolar,2573071,=,37,True,=,,IC50,nM,,350.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,350.0
292784,17675021,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '22.56', 'le': '0.42', 'lle': '6.31', 'sei': '8.48'}",CHEMBL2151919,,CHEMBL2151919,7.41,False,http://www.openphacts.org/units/Nanomolar,2576972,=,37,True,=,,IC50,nM,,39.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,39.0
292785,17675022,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '16.62', 'le': '0.31', 'lle': '4.98', 'sei': '5.08'}",CHEMBL3696246,,CHEMBL3696246,5.64,False,http://www.openphacts.org/units/Nanomolar,2573073,=,37,True,=,,IC50,nM,,2287.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2287.0
292786,17675023,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)ccc1F,,,CHEMBL3638374,,2015.0,"{'bei': '19.54', 'le': '0.37', 'lle': '5.53', 'sei': '7.75'}",CHEMBL2151925,,CHEMBL2151925,6.77,False,http://www.openphacts.org/units/Nanomolar,2576978,=,37,True,=,,IC50,nM,,171.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,171.0
292787,17675024,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(Cl)c1,,,CHEMBL3638374,,2015.0,"{'bei': '18.91', 'le': '0.38', 'lle': '5.36', 'sei': '7.94'}",CHEMBL2151926,,CHEMBL2151926,6.94,False,http://www.openphacts.org/units/Nanomolar,2576979,=,37,True,=,,IC50,nM,,116.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,116.0
292788,17675025,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(O)c1,,,CHEMBL3638374,,2015.0,"{'bei': '16.47', 'le': '0.31', 'lle': '4.95', 'sei': '5.06'}",CHEMBL3696250,,CHEMBL3696250,5.44,False,http://www.openphacts.org/units/Nanomolar,2573077,=,37,True,=,,IC50,nM,,3635.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3635.0
292789,17675026,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(Br)c1,,,CHEMBL3638374,,2015.0,"{'bei': '17.10', 'le': '0.38', 'lle': '5.34', 'sei': '8.05'}",CHEMBL2151048,,CHEMBL2151048,7.03,False,http://www.openphacts.org/units/Nanomolar,2576981,=,37,True,=,,IC50,nM,,93.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,93.0
292790,17675027,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cc(F)c(F)c(F)c1,,,CHEMBL3638374,,2015.0,"{'bei': '16.87', 'le': '0.33', 'lle': '5.01', 'sei': '7.12'}",CHEMBL3696251,,CHEMBL3696251,6.21,False,http://www.openphacts.org/units/Nanomolar,2573078,=,37,True,=,,IC50,nM,,609.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,609.0
292791,17675028,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(CO)c1,,,CHEMBL3638374,,2015.0,"{'bei': '13.80', 'le': '0.26', 'lle': '4.58', 'sei': '4.65'}",CHEMBL3696252,,CHEMBL3696252,5.00,False,http://www.openphacts.org/units/Nanomolar,2573079,=,37,True,=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
292792,17675029,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(C2CC2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '18.90', 'le': '0.35', 'lle': '5.03', 'sei': '7.67'}",CHEMBL3696253,,CHEMBL3696253,6.70,False,http://www.openphacts.org/units/Nanomolar,2573080,=,37,True,=,,IC50,nM,,200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,200.0
292793,17675030,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccccc1O,,,CHEMBL3638374,,2015.0,"{'bei': '15.14', 'le': '0.28', 'lle': '4.51', 'sei': '4.65'}",CHEMBL3696254,,CHEMBL3696254,5.00,False,http://www.openphacts.org/units/Nanomolar,2573081,=,37,True,=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
292794,17675031,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(OC(F)F)c1,,,CHEMBL3638374,,2015.0,"{'bei': '16.61', 'le': '0.32', 'lle': '4.93', 'sei': '6.54'}",CHEMBL3696255,,CHEMBL3696255,6.32,False,http://www.openphacts.org/units/Nanomolar,2573082,=,37,True,=,,IC50,nM,,480.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,480.0
292795,17675032,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(NC(=O)C(C)c2nc(N3CCOCC3)cc(=O)[nH]2)ccc1F,,,CHEMBL3638374,,2015.0,"{'bei': '15.29', 'le': '0.29', 'lle': '4.25', 'sei': '5.96'}",CHEMBL3696256,,CHEMBL3696256,5.75,False,http://www.openphacts.org/units/Nanomolar,2573083,=,37,True,=,,IC50,nM,,1763.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1763.0
292796,17675033,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1C,,,CHEMBL3638374,,2015.0,"{'bei': '17.01', 'le': '0.32', 'lle': '4.43', 'sei': '6.67'}",CHEMBL3696257,,CHEMBL3696257,5.83,False,http://www.openphacts.org/units/Nanomolar,2573084,=,37,True,=,,IC50,nM,,1494.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1494.0
292797,17675034,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1F,,,CHEMBL3638374,,2015.0,"{'bei': '18.88', 'le': '0.36', 'lle': '5.30', 'sei': '7.49'}",CHEMBL3696258,,CHEMBL3696258,6.54,False,http://www.openphacts.org/units/Nanomolar,2573085,=,37,True,=,,IC50,nM,,290.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,290.0
292798,17675035,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc2ocnc12,,,CHEMBL3638374,,2015.0,"{'bei': '18.00', 'le': '0.34', 'lle': '5.47', 'sei': '5.64'}",CHEMBL3696259,,CHEMBL3696259,6.40,False,http://www.openphacts.org/units/Nanomolar,2573086,=,37,True,=,,IC50,nM,,400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,400.0
292799,17675036,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(OC(F)(F)F)c1,,,CHEMBL3638374,,2015.0,"{'bei': '15.72', 'le': '0.31', 'lle': '4.57', 'sei': '6.48'}",CHEMBL3696260,,CHEMBL3696260,6.26,False,http://www.openphacts.org/units/Nanomolar,2573087,=,37,True,=,,IC50,nM,,549.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,549.0
292800,17675037,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Oc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '17.48', 'le': '0.33', 'lle': '4.94', 'sei': '6.74'}",CHEMBL3696261,,CHEMBL3696261,6.51,False,http://www.openphacts.org/units/Nanomolar,2573088,=,37,True,=,,IC50,nM,,308.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,308.0
292801,17675038,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(F)ccc1NC(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '18.17', 'le': '0.35', 'lle': '5.64', 'sei': '6.82'}",CHEMBL3696262,,CHEMBL3696262,6.58,False,http://www.openphacts.org/units/Nanomolar,2573089,=,37,True,=,,IC50,nM,,261.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,261.0
292802,17675039,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)OC(=O)NCCc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '12.24', 'le': '0.23', 'lle': '3.75', 'sei': '4.46'}",CHEMBL3696263,,CHEMBL3696263,5.60,False,http://www.openphacts.org/units/Nanomolar,2573090,=,37,True,=,,IC50,nM,,2498.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2498.0
292803,17675040,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(C(F)(F)F)c1,,,CHEMBL3638374,,2015.0,"{'bei': '16.14', 'le': '0.32', 'lle': '4.51', 'sei': '7.40'}",CHEMBL3696264,,CHEMBL3696264,6.46,False,http://www.openphacts.org/units/Nanomolar,2573091,=,37,True,=,,IC50,nM,,346.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,346.0
292804,17675041,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,C#Cc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '19.90', 'le': '0.37', 'lle': '5.97', 'sei': '7.71'}",CHEMBL3696265,,CHEMBL3696265,6.74,False,http://www.openphacts.org/units/Nanomolar,2573092,=,37,True,=,,IC50,nM,,184.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,184.0
292805,17675042,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)cc1O,,,CHEMBL3638374,,2015.0,"{'bei': '14.85', 'le': '0.28', 'lle': '4.54', 'sei': '4.81'}",CHEMBL3696267,,CHEMBL3696267,5.17,False,http://www.openphacts.org/units/Nanomolar,2573094,=,37,True,=,,IC50,nM,,6721.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6721.0
292806,17675043,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2ccccc21,,,CHEMBL3638374,,2015.0,"{'bei': '20.20', 'le': '0.38', 'lle': '6.14', 'sei': '8.76'}",CHEMBL3112690,,CHEMBL3112690,6.88,False,http://www.openphacts.org/units/Nanomolar,2577001,=,37,True,=,,IC50,nM,,133.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,133.0
292807,17675044,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(C2CC2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '17.84', 'le': '0.34', 'lle': '4.84', 'sei': '7.61'}",CHEMBL3696268,,CHEMBL3696268,6.64,False,http://www.openphacts.org/units/Nanomolar,2573095,=,37,True,=,,IC50,nM,,227.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,227.0
292808,17675045,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(OC(F)(F)F)c1,,,CHEMBL3638374,,2015.0,"{'bei': '14.64', 'le': '0.29', 'lle': '4.26', 'sei': '6.31'}",CHEMBL3696270,,CHEMBL3696270,6.09,False,http://www.openphacts.org/units/Nanomolar,2573097,=,37,True,=,,IC50,nM,,807.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,807.0
292809,17675046,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(OCCO)c1,,,CHEMBL3638374,,2015.0,"{'bei': '13.35', 'le': '0.25', 'lle': '4.84', 'sei': '4.28'}",CHEMBL3696271,,CHEMBL3696271,5.00,False,http://www.openphacts.org/units/Nanomolar,2573098,=,37,True,=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
292810,17675047,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(I)c1,,,CHEMBL3638374,,2015.0,"{'bei': '15.59', 'le': '0.39', 'lle': '5.47', 'sei': '7.86'}",CHEMBL3696272,,CHEMBL3696272,6.86,False,http://www.openphacts.org/units/Nanomolar,2573099,=,37,True,=,,IC50,nM,,137.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,137.0
292811,17675048,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)ccc1F,,,CHEMBL3638374,,2015.0,"{'bei': '13.40', 'le': '0.26', 'lle': '4.52', 'sei': '4.60'}",CHEMBL2151928,,CHEMBL2151928,5.23,False,http://www.openphacts.org/units/Nanomolar,2576982,=,37,True,=,,IC50,nM,,5865.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5865.0
292812,17675049,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,CCOc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '17.07', 'le': '0.32', 'lle': '4.93', 'sei': '6.34'}",CHEMBL3696273,,CHEMBL3696273,6.12,False,http://www.openphacts.org/units/Nanomolar,2573100,=,37,True,=,,IC50,nM,,760.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,760.0
292813,17675050,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(F)ccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1F,,,CHEMBL3638374,,2015.0,"{'bei': '16.77', 'le': '0.32', 'lle': '5.31', 'sei': '6.61'}",CHEMBL3696274,,CHEMBL3696274,6.38,False,http://www.openphacts.org/units/Nanomolar,2573101,=,37,True,=,,IC50,nM,,417.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,417.0
292814,17675051,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCOc2ccccc21,,,CHEMBL3638374,,2015.0,"{'bei': '17.61', 'le': '0.33', 'lle': '5.71', 'sei': '7.15'}",CHEMBL3696277,,CHEMBL3696277,6.28,False,http://www.openphacts.org/units/Nanomolar,2573104,=,37,True,=,,IC50,nM,,530.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,530.0
292815,17675052,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c([N+](=O)[O-])c1,,,CHEMBL3638374,,2015.0,"{'bei': '13.81', 'le': '0.26', 'lle': '4.38', 'sei': '3.99'}",CHEMBL2151929,,CHEMBL2151929,5.21,False,http://www.openphacts.org/units/Nanomolar,2576983,=,37,True,=,,IC50,nM,,6155.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6155.0
292816,17675053,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cc(F)ccc1O,,,CHEMBL3638374,,2015.0,"{'bei': '14.90', 'le': '0.28', 'lle': '4.56', 'sei': '4.83'}",CHEMBL3696279,,CHEMBL3696279,5.19,False,http://www.openphacts.org/units/Nanomolar,2573106,=,37,True,=,,IC50,nM,,6460.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6460.0
292817,17675054,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3638374,,2015.0,"{'bei': '20.11', 'le': '0.39', 'lle': '5.94', 'sei': '7.68'}",CHEMBL3696281,,CHEMBL3696281,5.66,False,http://www.openphacts.org/units/Nanomolar,2573108,=,37,True,=,,IC50,nM,,2207.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2207.0
292818,17675055,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2ccc(F)c(Cl)c2)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '17.58', 'le': '0.35', 'lle': '5.10', 'sei': '8.76'}",CHEMBL2151935,,CHEMBL2151935,6.70,False,http://www.openphacts.org/units/Nanomolar,2576988,=,37,True,=,,IC50,nM,,202.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,202.0
292819,17675056,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2cccc(Br)c2)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '16.21', 'le': '0.36', 'lle': '5.04', 'sei': '8.63'}",CHEMBL3696282,,CHEMBL3696282,6.60,False,http://www.openphacts.org/units/Nanomolar,2573109,=,37,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,250.0
292820,17675057,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)OC(=O)n1ccc2c(NC(=O)Cc3nc(N4CCOCC4)cc(=O)[nH]3)cccc21,,,CHEMBL3638374,,2015.0,"{'bei': '11.62', 'le': '0.22', 'lle': '2.74', 'sei': '4.45'}",CHEMBL3696284,,CHEMBL3696284,5.27,False,http://www.openphacts.org/units/Nanomolar,2573111,=,37,True,=,,IC50,nM,,5375.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5375.0
292821,17675058,[],CHEMBL3706188,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473. The phosphorylation of AKT (pAKT) is measured by western blotting in the PC3 human prostate carcinoma line (ATCC CRL-1435), using an antibody that specifically recognises pAKT-S473.On day 1, the PC3 cells are seeded into 6-well plates (TPP, #92006) at the concentration of 0.8x106 cells/well in 1800 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (SVF Gibco, #10500-056) and 1% glutamine (L-Glu Gibco #25030-024), and incubated at 37 C., 5% CO2, overnight.On day 2, the cells are incubated in the presence or absence of the test products for 1 to 2 hours at 37 C. in the presence of 5% CO2. The molecules, diluted in dimethyl sulphoxide (DMSO Sigma #D2650), are added from a 10-times concentrated stock solution, the final percentage of DMSO being 0.1%. The molecules are tested either at a single concentration of less than or equal to 10 uM, or ....",B,,,BAO_0000190,BAO_0000219,cell-based format,COCc1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)ccc1F,,,CHEMBL3638374,,2015.0,"{'bei': '16.44', 'le': '0.31', 'lle': '5.12', 'sei': '6.41'}",CHEMBL3696286,,CHEMBL3696286,6.19,False,http://www.openphacts.org/units/Nanomolar,2573113,=,37,True,=,,IC50,nM,,650.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,650.0
292822,17675059,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)c1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '19.13', 'le': '0.36', 'lle': '5.99', 'sei': '7.55'}",CHEMBL3696235,,CHEMBL3696235,6.84,False,http://www.openphacts.org/units/Nanomolar,2573061,=,37,True,=,,IC50,nM,,145.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,145.0
292823,17675060,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)cc1F,,,CHEMBL3638374,,2015.0,"{'bei': '20.82', 'le': '0.40', 'lle': '6.22', 'sei': '8.35'}",CHEMBL3696236,,CHEMBL3696236,7.29,False,http://www.openphacts.org/units/Nanomolar,2573062,=,37,True,=,,IC50,nM,,51.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,51.0
292824,17675061,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccsc1,,,CHEMBL3638374,,2015.0,"{'bei': '23.84', 'le': '0.47', 'lle': '6.79', 'sei': '8.75'}",CHEMBL3696237,,CHEMBL3696237,7.64,False,http://www.openphacts.org/units/Nanomolar,2573063,=,37,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
292825,17675062,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cc(F)cc(F)c1,,,CHEMBL3638374,,2015.0,"{'bei': '20.41', 'le': '0.39', 'lle': '6.08', 'sei': '8.19'}",CHEMBL3696239,,CHEMBL3696239,7.15,False,http://www.openphacts.org/units/Nanomolar,2573066,=,37,True,=,,IC50,nM,,71.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,71.0
292826,17675063,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(F)c1,,,CHEMBL3638374,,2015.0,"{'bei': '21.46', 'le': '0.41', 'lle': '6.20', 'sei': '8.17'}",CHEMBL2151820,,CHEMBL2151820,7.13,False,http://www.openphacts.org/units/Nanomolar,2576990,=,37,True,=,,IC50,nM,,74.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,74.0
292827,17675064,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '19.91', 'le': '0.37', 'lle': '5.29', 'sei': '8.45'}",CHEMBL3696241,,CHEMBL3696241,7.38,False,http://www.openphacts.org/units/Nanomolar,2573068,=,37,True,=,,IC50,nM,,42.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.0
292828,17675065,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)ccc1F,,,CHEMBL3638374,,2015.0,"{'bei': '18.49', 'le': '0.35', 'lle': '5.81', 'sei': '5.95'}",CHEMBL3696245,,CHEMBL3696245,6.61,False,http://www.openphacts.org/units/Nanomolar,2573072,=,37,True,=,,IC50,nM,,247.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,247.0
292829,17675066,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)cn1,,,CHEMBL3638374,,2015.0,"{'bei': '21.45', 'le': '0.41', 'lle': '6.83', 'sei': '7.13'}",CHEMBL3696247,,CHEMBL3696247,7.15,False,http://www.openphacts.org/units/Nanomolar,2573074,=,37,True,=,,IC50,nM,,71.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,71.0
292830,17675067,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccnc1,,,CHEMBL3638374,,2015.0,"{'bei': '18.99', 'le': '0.36', 'lle': '5.81', 'sei': '5.97'}",CHEMBL3696248,,CHEMBL3696248,5.99,False,http://www.openphacts.org/units/Nanomolar,2573075,=,37,True,=,,IC50,nM,,1030.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1030.0
292831,17675068,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(F)ccc1NC(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '20.89', 'le': '0.40', 'lle': '6.00', 'sei': '8.29'}",CHEMBL3696249,,CHEMBL3696249,7.24,False,http://www.openphacts.org/units/Nanomolar,2573076,=,37,True,=,,IC50,nM,,58.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,58.0
292832,17675069,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1F,,,CHEMBL3638374,,2015.0,"{'bei': '20.85', 'le': '0.39', 'lle': '5.98', 'sei': '8.27'}",CHEMBL3696258,,CHEMBL3696258,7.22,False,http://www.openphacts.org/units/Nanomolar,2573085,=,37,True,=,,IC50,nM,,60.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,60.0
292833,17675070,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc2ocnc12,,,CHEMBL3638374,,2015.0,"{'bei': '19.22', 'le': '0.36', 'lle': '5.90', 'sei': '6.03'}",CHEMBL3696259,,CHEMBL3696259,6.83,False,http://www.openphacts.org/units/Nanomolar,2573086,=,37,True,=,,IC50,nM,,148.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,148.0
292834,17675071,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(OC2CCCC2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '17.16', 'le': '0.32', 'lle': '4.73', 'sei': '7.08'}",CHEMBL3696266,,CHEMBL3696266,6.84,False,http://www.openphacts.org/units/Nanomolar,2573093,=,37,True,=,,IC50,nM,,146.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,146.0
292835,17675072,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(F)c1F,,,CHEMBL3638374,,2015.0,"{'bei': '19.50', 'le': '0.38', 'lle': '5.97', 'sei': '8.22'}",CHEMBL3696269,,CHEMBL3696269,7.18,False,http://www.openphacts.org/units/Nanomolar,2573096,=,37,True,=,,IC50,nM,,66.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,66.0
292836,17675073,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(OC(F)(F)F)c1,,,CHEMBL3638374,,2015.0,"{'bei': '17.23', 'le': '0.34', 'lle': '5.34', 'sei': '7.43'}",CHEMBL3696270,,CHEMBL3696270,7.17,False,http://www.openphacts.org/units/Nanomolar,2573097,=,37,True,=,,IC50,nM,,67.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,67.0
292837,17675074,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CCOc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1,,,CHEMBL3638374,,2015.0,"{'bei': '19.95', 'le': '0.38', 'lle': '5.96', 'sei': '7.40'}",CHEMBL3696273,,CHEMBL3696273,7.15,False,http://www.openphacts.org/units/Nanomolar,2573100,=,37,True,=,,IC50,nM,,71.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,71.0
292838,17675075,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(F)ccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1F,,,CHEMBL3638374,,2015.0,"{'bei': '19.20', 'le': '0.37', 'lle': '6.23', 'sei': '7.56'}",CHEMBL3696274,,CHEMBL3696274,7.30,False,http://www.openphacts.org/units/Nanomolar,2573101,=,37,True,=,,IC50,nM,,50.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50.0
292839,17675076,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cc(F)c(F)cc1F,,,CHEMBL3638374,,2015.0,"{'bei': '17.75', 'le': '0.34', 'lle': '5.34', 'sei': '7.49'}",CHEMBL3696275,,CHEMBL3696275,6.54,False,http://www.openphacts.org/units/Nanomolar,2573102,=,37,True,=,,IC50,nM,,290.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,290.0
292840,17675077,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cc(Cl)c(F)c(Cl)c1,,,CHEMBL3638374,,2015.0,"{'bei': '17.73', 'le': '0.37', 'lle': '4.88', 'sei': '8.15'}",CHEMBL3696276,,CHEMBL3696276,7.11,False,http://www.openphacts.org/units/Nanomolar,2573103,=,37,True,=,,IC50,nM,,77.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,77.0
292841,17675078,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(C(=O)O)c1,,,CHEMBL3638374,,2015.0,"{'bei': '13.29', 'le': '0.25', 'lle': '4.38', 'sei': '4.01'}",CHEMBL3696278,,CHEMBL3696278,5.00,False,http://www.openphacts.org/units/Nanomolar,2573105,=,37,True,=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
292842,17675079,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)cc1Br,,,CHEMBL3638374,,2015.0,"{'bei': '16.74', 'le': '0.38', 'lle': '5.19', 'sei': '7.88'}",CHEMBL3696280,,CHEMBL3696280,6.88,False,http://www.openphacts.org/units/Nanomolar,2573107,=,37,True,=,,IC50,nM,,131.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,131.0
292843,17675080,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2ccc(F)c(Cl)c2)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '18.65', 'le': '0.37', 'lle': '5.51', 'sei': '9.29'}",CHEMBL2151935,,CHEMBL2151935,7.10,False,http://www.openphacts.org/units/Nanomolar,2576988,=,37,True,=,,IC50,nM,,79.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,79.0
292844,17675081,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(CC(=O)Nc2ccc(F)cc2)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '18.62', 'le': '0.35', 'lle': '5.29', 'sei': '8.78'}",CHEMBL3696283,,CHEMBL3696283,6.71,False,http://www.openphacts.org/units/Nanomolar,2573110,=,37,True,=,,IC50,nM,,195.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,195.0
292845,17675082,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)OC(=O)n1ccc2c(NC(=O)Cc3nc(N4CCOCC4)cc(=O)[nH]3)cccc21,,,CHEMBL3638374,,2015.0,"{'bei': '15.26', 'le': '0.29', 'lle': '4.39', 'sei': '5.84'}",CHEMBL3696284,,CHEMBL3696284,6.92,False,http://www.openphacts.org/units/Nanomolar,2573111,=,37,True,=,,IC50,nM,,120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,120.0
292846,17675083,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)C(C(=O)Nc1ccc(F)cc1)c1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '18.83', 'le': '0.36', 'lle': '4.93', 'sei': '8.07'}",CHEMBL3696285,,CHEMBL3696285,7.05,False,http://www.openphacts.org/units/Nanomolar,2573112,=,37,True,=,,IC50,nM,,89.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,89.0
292847,17675084,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(I)c1,,,CHEMBL3638374,,2015.0,"{'bei': '17.46', 'le': '0.44', 'lle': '6.47', 'sei': '9.16'}",CHEMBL3696287,,CHEMBL3696287,8.00,False,http://www.openphacts.org/units/Nanomolar,2573114,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
292848,17675085,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(OC(F)(F)C(F)F)c1,,,CHEMBL3638374,,2015.0,"{'bei': '16.64', 'le': '0.33', 'lle': '5.14', 'sei': '7.42'}",CHEMBL3696288,,CHEMBL3696288,7.16,False,http://www.openphacts.org/units/Nanomolar,2573115,=,37,True,=,,IC50,nM,,69.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,69.0
292849,17675086,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(C(F)F)c1,,,CHEMBL3638374,,2015.0,"{'bei': '18.61', 'le': '0.36', 'lle': '5.25', 'sei': '8.15'}",CHEMBL3696289,,CHEMBL3696289,7.11,False,http://www.openphacts.org/units/Nanomolar,2573116,=,37,True,=,,IC50,nM,,77.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,77.0
292850,17675087,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccc(F)cc1)C(F)(F)c1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '16.71', 'le': '0.32', 'lle': '4.68', 'sei': '7.05'}",CHEMBL3696290,,CHEMBL3696290,6.16,False,http://www.openphacts.org/units/Nanomolar,2573117,=,37,True,=,,IC50,nM,,698.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,698.0
292851,17675088,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2ccc(F)c(F)c2)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '18.91', 'le': '0.36', 'lle': '5.81', 'sei': '9.01'}",CHEMBL2151932,,CHEMBL2151932,6.89,False,http://www.openphacts.org/units/Nanomolar,2576985,=,37,True,=,,IC50,nM,,129.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,129.0
292852,17675089,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CCc3ccccc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '21.72', 'le': '0.40', 'lle': '6.95', 'sei': '11.38'}",CHEMBL3112861,,CHEMBL3112861,7.70,False,http://www.openphacts.org/units/Nanomolar,2576993,=,37,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
292853,17675090,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2ccc(F)c(Br)c2)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '16.52', 'le': '0.37', 'lle': '5.33', 'sei': '9.19'}",CHEMBL2151933,,CHEMBL2151933,7.03,False,http://www.openphacts.org/units/Nanomolar,2576986,=,37,True,=,,IC50,nM,,94.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,94.0
292854,17675091,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2ccc(F)c(CO)c2)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '15.18', 'le': '0.29', 'lle': '5.28', 'sei': '5.91'}",CHEMBL3696291,,CHEMBL3696291,5.71,False,http://www.openphacts.org/units/Nanomolar,2573118,=,37,True,=,,IC50,nM,,1940.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1940.0
292855,17675092,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2cccc(C3CC3)c2)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '18.66', 'le': '0.35', 'lle': '5.20', 'sei': '8.99'}",CHEMBL3696292,,CHEMBL3696292,6.88,False,http://www.openphacts.org/units/Nanomolar,2573119,=,37,True,=,,IC50,nM,,133.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,133.0
292856,17675093,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)n2C)ccc1F,,,CHEMBL3638374,,2015.0,"{'bei': '18.44', 'le': '0.35', 'lle': '5.99', 'sei': '8.10'}",CHEMBL2151934,,CHEMBL2151934,6.94,False,http://www.openphacts.org/units/Nanomolar,2576987,=,37,True,=,,IC50,nM,,115.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,115.0
292857,17675094,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc2occc12,,,CHEMBL3638374,,2015.0,"{'bei': '21.92', 'le': '0.41', 'lle': '6.24', 'sei': '7.73'}",CHEMBL3696293,,CHEMBL3696293,7.77,False,http://www.openphacts.org/units/Nanomolar,2573120,=,37,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.0
292858,17675095,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2ccccc2)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '19.70', 'le': '0.37', 'lle': '5.67', 'sei': '8.46'}",CHEMBL2151930,,CHEMBL2151930,6.47,False,http://www.openphacts.org/units/Nanomolar,2576984,=,37,True,=,,IC50,nM,,340.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,340.0
292859,17675096,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2ccc(F)c(C3CC3)c2)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '19.63', 'le': '0.37', 'lle': '5.78', 'sei': '9.92'}",CHEMBL3696294,,CHEMBL3696294,7.58,False,http://www.openphacts.org/units/Nanomolar,2573121,=,37,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.0
292860,17675097,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(F)c1O,,,CHEMBL3638374,,2015.0,"{'bei': '20.45', 'le': '0.39', 'lle': '6.49', 'sei': '6.62'}",CHEMBL3696295,,CHEMBL3696295,7.12,False,http://www.openphacts.org/units/Nanomolar,2573122,=,37,True,=,,IC50,nM,,75.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,75.0
292861,17675098,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(F)cccc21,,,CHEMBL3638374,,2015.0,"{'bei': '23.16', 'le': '0.44', 'lle': '7.42', 'sei': '10.57'}",CHEMBL3112848,,CHEMBL3112848,8.30,False,http://www.openphacts.org/units/Nanomolar,2835974,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
292862,17675099,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(Cl)cccc21,,,CHEMBL3638374,,2015.0,"{'bei': '22.74', 'le': '0.45', 'lle': '7.13', 'sei': '10.85'}",CHEMBL3112849,,CHEMBL3112849,8.52,False,http://www.openphacts.org/units/Nanomolar,2576997,=,37,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
292863,17675100,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,C#Cc1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)ccc1F,,,CHEMBL3638374,,2015.0,"{'bei': '22.04', 'le': '0.41', 'lle': '6.94', 'sei': '8.99'}",CHEMBL3696296,,CHEMBL3696296,7.85,False,http://www.openphacts.org/units/Nanomolar,2573123,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
292864,17675101,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(O)cccc21,,,CHEMBL3638374,,2015.0,"{'bei': '20.06', 'le': '0.38', 'lle': '6.71', 'sei': '7.24'}",CHEMBL3696297,,CHEMBL3696297,7.15,False,http://www.openphacts.org/units/Nanomolar,2573124,=,37,True,=,,IC50,nM,,71.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,71.0
292865,17675102,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(F)cc(F)cc21,,,CHEMBL3638374,,2015.0,"{'bei': '19.25', 'le': '0.37', 'lle': '6.22', 'sei': '9.22'}",CHEMBL3696298,,CHEMBL3696298,7.24,False,http://www.openphacts.org/units/Nanomolar,2573125,=,37,True,=,,IC50,nM,,57.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,57.0
292866,17675103,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2ccc(F)c(I)c2)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '15.25', 'le': '0.38', 'lle': '5.66', 'sei': '9.42'}",CHEMBL3696299,,CHEMBL3696299,7.20,False,http://www.openphacts.org/units/Nanomolar,2573126,=,37,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,63.0
292867,17675104,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c1ccc(F)c2F,,,CHEMBL3638374,,2015.0,"{'bei': '21.15', 'le': '0.40', 'lle': '6.94', 'sei': '10.13'}",CHEMBL3696300,,CHEMBL3696300,7.96,False,http://www.openphacts.org/units/Nanomolar,2573127,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
292868,17675105,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2ccc(F)cc21,,,CHEMBL3638374,,2015.0,"{'bei': '20.81', 'le': '0.39', 'lle': '6.58', 'sei': '9.49'}",CHEMBL3696301,,CHEMBL3696301,7.46,False,http://www.openphacts.org/units/Nanomolar,2573128,=,37,True,=,,IC50,nM,,35.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,35.0
292869,17675106,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '23.20', 'le': '0.43', 'lle': '7.09', 'sei': '10.47'}",CHEMBL3112862,,CHEMBL3112862,8.22,False,http://www.openphacts.org/units/Nanomolar,2577006,=,37,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
292870,17675107,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2ccc(F)c(C(F)F)c2)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '16.61', 'le': '0.32', 'lle': '4.72', 'sei': '8.61'}",CHEMBL3696302,,CHEMBL3696302,6.58,False,http://www.openphacts.org/units/Nanomolar,2573129,=,37,True,=,,IC50,nM,,260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,260.0
292871,17675108,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2cc(F)c(F)c(F)c2)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '17.42', 'le': '0.34', 'lle': '5.44', 'sei': '8.71'}",CHEMBL3696303,,CHEMBL3696303,6.66,False,http://www.openphacts.org/units/Nanomolar,2573130,=,37,True,=,,IC50,nM,,219.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,219.0
292872,17675109,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ccc2c(NC(=O)Cc3nc(N4CCOCC4)cc(=O)[nH]3)cccc21,,,CHEMBL3638374,,2015.0,"{'bei': '16.81', 'le': '0.31', 'lle': '4.90', 'sei': '6.70'}",CHEMBL3696304,,CHEMBL3696304,6.18,False,http://www.openphacts.org/units/Nanomolar,2573131,=,37,True,=,,IC50,nM,,666.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,666.0
292873,17675110,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '24.05', 'le': '0.45', 'lle': '7.47', 'sei': '10.85'}",CHEMBL3112851,,CHEMBL3112851,8.52,False,http://www.openphacts.org/units/Nanomolar,2576995,=,37,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
292874,17675111,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21,,,CHEMBL3638374,,2015.0,"{'bei': '22.25', 'le': '0.41', 'lle': '6.59', 'sei': '10.04'}",CHEMBL3112864,,CHEMBL3112864,7.89,False,http://www.openphacts.org/units/Nanomolar,2577005,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
292875,17675112,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CCc3c(F)cccc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '19.78', 'le': '0.37', 'lle': '6.48', 'sei': '10.89'}",CHEMBL3696305,,CHEMBL3696305,7.37,False,http://www.openphacts.org/units/Nanomolar,2573132,=,37,True,=,,IC50,nM,,43.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,43.0
292876,17675113,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2cc(F)ccc21,,,CHEMBL3638374,,2015.0,"{'bei': '22.76', 'le': '0.43', 'lle': '7.27', 'sei': '10.38'}",CHEMBL3112847,,CHEMBL3112847,8.15,False,http://www.openphacts.org/units/Nanomolar,2577000,=,37,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
292877,17675114,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CCc3c(Cl)cccc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '18.97', 'le': '0.37', 'lle': '5.98', 'sei': '10.90'}",CHEMBL3696306,,CHEMBL3696306,7.38,False,http://www.openphacts.org/units/Nanomolar,2573133,=,37,True,=,,IC50,nM,,42.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.0
292878,17675115,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc2sccc12,,,CHEMBL3638374,,2015.0,"{'bei': '21.12', 'le': '0.41', 'lle': '5.82', 'sei': '8.96'}",CHEMBL3696307,,CHEMBL3696307,7.82,False,http://www.openphacts.org/units/Nanomolar,2573134,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
292879,17675116,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1c2ccccc2CC1CO,,,CHEMBL3638374,,2015.0,"{'bei': '20.43', 'le': '0.38', 'lle': '7.47', 'sei': '7.66'}",CHEMBL3696308,,CHEMBL3696308,7.57,False,http://www.openphacts.org/units/Nanomolar,2573135,=,37,True,=,,IC50,nM,,27.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,27.0
292880,17675117,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccccc1OCCN1CCCCC1,,,CHEMBL3638374,,2015.0,"{'bei': '17.26', 'le': '0.33', 'lle': '5.97', 'sei': '7.64'}",CHEMBL3696309,,CHEMBL3696309,7.62,False,http://www.openphacts.org/units/Nanomolar,2573136,=,37,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
292881,17675118,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,COCCOc1ccccc1NC(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '18.67', 'le': '0.35', 'lle': '6.44', 'sei': '6.86'}",CHEMBL3696310,,CHEMBL3696310,7.25,False,http://www.openphacts.org/units/Nanomolar,2573137,=,37,True,=,,IC50,nM,,56.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,56.0
292882,17675119,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CCc3c(O)cccc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '19.89', 'le': '0.37', 'lle': '6.92', 'sei': '8.38'}",CHEMBL3696311,,CHEMBL3696311,7.37,False,http://www.openphacts.org/units/Nanomolar,2573138,=,37,True,=,,IC50,nM,,43.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,43.0
292883,17675120,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3638374,,2015.0,"{'bei': '17.05', 'le': '0.32', 'lle': '5.80', 'sei': '8.53'}",CHEMBL3696312,,CHEMBL3696312,6.56,False,http://www.openphacts.org/units/Nanomolar,2573139,=,37,True,=,,IC50,nM,,278.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,278.0
292884,17675121,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2ccccc2C1,,,CHEMBL3638374,,2015.0,"{'bei': '18.40', 'le': '0.34', 'lle': '5.79', 'sei': '8.30'}",CHEMBL3696313,,CHEMBL3696313,6.52,False,http://www.openphacts.org/units/Nanomolar,2573140,=,37,True,=,,IC50,nM,,301.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,301.0
292885,17675122,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccccc1OCCN1CCCC1,,,CHEMBL3638374,,2015.0,"{'bei': '17.87', 'le': '0.34', 'lle': '6.38', 'sei': '7.65'}",CHEMBL3696314,,CHEMBL3696314,7.64,False,http://www.openphacts.org/units/Nanomolar,2573141,=,37,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
292886,17675123,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccccc1OCc1cccnc1,,,CHEMBL3638374,,2015.0,"{'bei': '14.66', 'le': '0.27', 'lle': '4.42', 'sei': '5.64'}",CHEMBL3696315,,CHEMBL3696315,6.18,False,http://www.openphacts.org/units/Nanomolar,2573142,=,37,True,=,,IC50,nM,,664.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,664.0
292887,17675124,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3638374,,2015.0,"{'bei': '20.59', 'le': '0.38', 'lle': '6.53', 'sei': '11.21'}",CHEMBL3699779,,CHEMBL3699779,7.58,False,http://www.openphacts.org/units/Nanomolar,2576937,=,37,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.0
292888,17675125,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CC1CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21,,,CHEMBL3638374,,2015.0,"{'bei': '20.13', 'le': '0.38', 'lle': '7.16', 'sei': '9.78'}",CHEMBL3699780,,CHEMBL3699780,8.00,False,http://www.openphacts.org/units/Nanomolar,2576938,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
292889,17675126,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CCc3c(Br)cccc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '16.83', 'le': '0.37', 'lle': '5.78', 'sei': '10.78'}",CHEMBL3699781,,CHEMBL3699781,7.29,False,http://www.openphacts.org/units/Nanomolar,2576939,=,37,True,=,,IC50,nM,,51.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,51.0
292890,17675127,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '21.79', 'le': '0.41', 'lle': '6.59', 'sei': '9.83'}",CHEMBL3112866,,CHEMBL3112866,7.72,False,http://www.openphacts.org/units/Nanomolar,2835975,=,37,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.0
292891,17675128,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '22.35', 'le': '0.42', 'lle': '6.79', 'sei': '10.09'}",CHEMBL3112867,,CHEMBL3112867,7.92,False,http://www.openphacts.org/units/Nanomolar,2835976,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
292892,17675129,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)n2C)c2ccccc21,,,CHEMBL3638374,,2015.0,"{'bei': '18.22', 'le': '0.34', 'lle': '5.40', 'sei': '9.92'}",CHEMBL3699782,,CHEMBL3699782,6.71,False,http://www.openphacts.org/units/Nanomolar,2576940,=,37,True,=,,IC50,nM,,194.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,194.0
292893,17675130,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,COCC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '20.70', 'le': '0.39', 'lle': '7.21', 'sei': '9.07'}",CHEMBL3699783,,CHEMBL3699783,7.96,False,http://www.openphacts.org/units/Nanomolar,2576941,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
292894,17675131,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CCOc1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '19.14', 'le': '0.36', 'lle': '6.22', 'sei': '8.38'}",CHEMBL3699784,,CHEMBL3699784,7.36,False,http://www.openphacts.org/units/Nanomolar,2576942,=,37,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,44.0
292895,17675132,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)C1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '16.43', 'le': '0.31', 'lle': '6.71', 'sei': '5.18'}",CHEMBL3699785,,CHEMBL3699785,6.30,False,http://www.openphacts.org/units/Nanomolar,2576943,=,37,True,=,,IC50,nM,,503.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,503.0
292896,17675133,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3638374,,2015.0,"{'bei': '19.31', 'le': '0.36', 'lle': '5.97', 'sei': '10.51'}",CHEMBL3699786,,CHEMBL3699786,7.11,False,http://www.openphacts.org/units/Nanomolar,2576944,=,37,True,=,,IC50,nM,,77.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,77.0
292897,17675134,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CCc3ccc(F)cc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '18.55', 'le': '0.35', 'lle': '6.02', 'sei': '10.21'}",CHEMBL3699787,,CHEMBL3699787,6.91,False,http://www.openphacts.org/units/Nanomolar,2576945,=,37,True,=,,IC50,nM,,124.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,124.0
292898,17675135,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21,,,CHEMBL3638374,,2015.0,"{'bei': '22.00', 'le': '0.41', 'lle': '6.50', 'sei': '9.93'}",CHEMBL3699788,,CHEMBL3699788,7.80,False,http://www.openphacts.org/units/Nanomolar,2576946,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
292899,17675136,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21,,,CHEMBL3638374,,2015.0,"{'bei': '20.44', 'le': '0.38', 'lle': '5.94', 'sei': '9.22'}",CHEMBL3699811,,CHEMBL3699811,7.24,False,http://www.openphacts.org/units/Nanomolar,2576970,=,37,True,=,,IC50,nM,,57.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,57.0
292900,17675137,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CCc3cc(F)c(F)cc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '18.48', 'le': '0.35', 'lle': '6.18', 'sei': '10.66'}",CHEMBL3699789,,CHEMBL3699789,7.21,False,http://www.openphacts.org/units/Nanomolar,2576947,=,37,True,=,,IC50,nM,,61.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,61.0
292901,17675138,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CCc3c2ccc(F)c3F)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '18.34', 'le': '0.35', 'lle': '6.13', 'sei': '10.58'}",CHEMBL3699790,,CHEMBL3699790,7.16,False,http://www.openphacts.org/units/Nanomolar,2576948,=,37,True,=,,IC50,nM,,69.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,69.0
292902,17675139,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1Cc2ccccc2C1,,,CHEMBL3638374,,2015.0,"{'bei': '17.63', 'le': '0.33', 'lle': '5.31', 'sei': '7.64'}",CHEMBL3699791,,CHEMBL3699791,6.00,False,http://www.openphacts.org/units/Nanomolar,2576949,=,37,True,=,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
292903,17675140,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2cccc3sccc23)nc(N2CCOCC2)cc1=O,,,CHEMBL3638374,,2015.0,"{'bei': '18.61', 'le': '0.36', 'lle': '5.14', 'sei': '9.36'}",CHEMBL3699792,,CHEMBL3699792,7.16,False,http://www.openphacts.org/units/Nanomolar,2576950,=,37,True,=,,IC50,nM,,70.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,70.0
292904,17675141,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCCc2c(Cl)cccc21,,,CHEMBL3638374,,2015.0,"{'bei': '19.00', 'le': '0.37', 'lle': '5.61', 'sei': '9.41'}",CHEMBL3699793,,CHEMBL3699793,7.39,False,http://www.openphacts.org/units/Nanomolar,2576951,=,37,True,=,,IC50,nM,,41.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,41.0
292905,17675142,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(CO)cccc21,,,CHEMBL3638374,,2015.0,"{'bei': '16.94', 'le': '0.32', 'lle': '6.04', 'sei': '6.35'}",CHEMBL3699794,,CHEMBL3699794,6.27,False,http://www.openphacts.org/units/Nanomolar,2576952,=,37,True,=,,IC50,nM,,533.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,533.0
292906,17675143,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)cc1OCC1CCNCC1,,,CHEMBL3638374,,2015.0,"{'bei': '15.17', 'le': '0.29', 'lle': '5.45', 'sei': '6.23'}",CHEMBL3699795,,CHEMBL3699795,6.76,False,http://www.openphacts.org/units/Nanomolar,2576953,=,37,True,=,,IC50,nM,,174.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,174.0
292907,17675144,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2cc(Cl)ccc21,,,CHEMBL3638374,,2015.0,"{'bei': '18.43', 'le': '0.36', 'lle': '5.52', 'sei': '8.79'}",CHEMBL3112592,,CHEMBL3112592,6.91,False,http://www.openphacts.org/units/Nanomolar,2576999,=,37,True,=,,IC50,nM,,124.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,124.0
292908,17675145,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(Br)cccc21,,,CHEMBL3638374,,2015.0,"{'bei': '21.47', 'le': '0.47', 'lle': '7.50', 'sei': '11.46'}",CHEMBL3112850,,CHEMBL3112850,9.00,False,http://www.openphacts.org/units/Nanomolar,2576996,=,37,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
292909,17675146,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C[C@H]1CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21,,,CHEMBL3638374,,2015.0,"{'bei': '19.08', 'le': '0.36', 'lle': '6.75', 'sei': '9.28'}",CHEMBL3699796,,CHEMBL3699796,7.58,False,http://www.openphacts.org/units/Nanomolar,2576954,=,37,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.0
292910,17675147,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C[C@@H]1CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21,,,CHEMBL3638374,,2015.0,"{'bei': '18.03', 'le': '0.34', 'lle': '6.33', 'sei': '8.77'}",CHEMBL3699812,,CHEMBL3699812,7.17,False,http://www.openphacts.org/units/Nanomolar,2576971,=,37,True,=,,IC50,nM,,68.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,68.0
292911,17675148,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,COCCOc1cc(F)ccc1NC(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '18.35', 'le': '0.35', 'lle': '6.51', 'sei': '7.05'}",CHEMBL3699797,,CHEMBL3699797,7.46,False,http://www.openphacts.org/units/Nanomolar,2576955,=,37,True,=,,IC50,nM,,35.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,35.0
292912,17675149,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc2[nH]cnc12,,,CHEMBL3638374,,2015.0,"{'bei': '15.59', 'le': '0.29', 'lle': '4.86', 'sei': '4.76'}",CHEMBL3699798,,CHEMBL3699798,5.52,False,http://www.openphacts.org/units/Nanomolar,2576956,=,37,True,=,,IC50,nM,,3000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3000.0
292913,17675150,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1O,,,CHEMBL3638374,,2015.0,"{'bei': '16.79', 'le': '0.32', 'lle': '6.24', 'sei': '4.87'}",CHEMBL3699799,,CHEMBL3699799,6.52,False,http://www.openphacts.org/units/Nanomolar,2576957,=,37,True,=,,IC50,nM,,302.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,302.0
292914,17675151,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '19.50', 'le': '0.37', 'lle': '6.47', 'sei': '8.23'}",CHEMBL3112852,,CHEMBL3112852,7.22,False,http://www.openphacts.org/units/Nanomolar,2576994,=,37,True,=,,IC50,nM,,60.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,60.0
292915,17675152,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(Br)c1O,,,CHEMBL3638374,,2015.0,"{'bei': '18.71', 'le': '0.42', 'lle': '6.40', 'sei': '7.12'}",CHEMBL3699800,,CHEMBL3699800,7.66,False,http://www.openphacts.org/units/Nanomolar,2576958,=,37,True,=,,IC50,nM,,22.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22.0
292916,17675153,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc2c1OCCN2,,,CHEMBL3638374,,2015.0,"{'bei': '17.03', 'le': '0.32', 'lle': '5.74', 'sei': '5.83'}",CHEMBL3699801,,CHEMBL3699801,6.33,False,http://www.openphacts.org/units/Nanomolar,2576959,=,37,True,=,,IC50,nM,,473.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,473.0
292917,17675154,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cc(F)ccc1NC(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3638374,,2015.0,"{'bei': '16.30', 'le': '0.31', 'lle': '5.65', 'sei': '5.60'}",CHEMBL3699802,,CHEMBL3699802,6.37,False,http://www.openphacts.org/units/Nanomolar,2576960,=,37,True,=,,IC50,nM,,432.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,432.0
292918,17675155,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CC1CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21,,,CHEMBL3638374,,2015.0,"{'bei': '17.44', 'le': '0.33', 'lle': '5.80', 'sei': '9.07'}",CHEMBL3639986,,CHEMBL3639986,7.42,False,http://www.openphacts.org/units/Nanomolar,2576961,=,37,True,=,,IC50,nM,,38.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,38.0
292919,17675156,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2ncccc21,,,CHEMBL3638374,,2015.0,"{'bei': '19.76', 'le': '0.37', 'lle': '6.61', 'sei': '7.38'}",CHEMBL3699803,,CHEMBL3699803,6.75,False,http://www.openphacts.org/units/Nanomolar,2576962,=,37,True,=,,IC50,nM,,180.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,180.0
292920,17675157,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2cc(F)c(F)cc21,,,CHEMBL3638374,,2015.0,"{'bei': '22.31', 'le': '0.42', 'lle': '7.38', 'sei': '10.69'}",CHEMBL3699804,,CHEMBL3699804,8.40,False,http://www.openphacts.org/units/Nanomolar,2576963,=,37,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
292921,17675158,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc2c1NCCC2,,,CHEMBL3638374,,2015.0,"{'bei': '17.95', 'le': '0.34', 'lle': '5.48', 'sei': '6.67'}",CHEMBL3699805,,CHEMBL3699805,6.63,False,http://www.openphacts.org/units/Nanomolar,2576964,=,37,True,=,,IC50,nM,,234.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,234.0
292922,17675159,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCOc2c(Cl)cccc21,,,CHEMBL3638374,,2015.0,"{'bei': '18.85', 'le': '0.37', 'lle': '6.14', 'sei': '8.39'}",CHEMBL3699806,,CHEMBL3699806,7.37,False,http://www.openphacts.org/units/Nanomolar,2576965,=,37,True,=,,IC50,nM,,43.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,43.0
292923,17675160,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1O,,,CHEMBL3638374,,2015.0,"{'bei': '19.52', 'le': '0.37', 'lle': '5.92', 'sei': '6.25'}",CHEMBL3699807,,CHEMBL3699807,6.72,False,http://www.openphacts.org/units/Nanomolar,2576966,=,37,True,=,,IC50,nM,,189.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,189.0
292924,17675161,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc([N+](=O)[O-])c1O,,,CHEMBL3638374,,2015.0,"{'bei': '20.08', 'le': '0.38', 'lle': '7.14', 'sei': '5.00'}",CHEMBL3699808,,CHEMBL3699808,7.54,False,http://www.openphacts.org/units/Nanomolar,2576967,=,37,True,=,,IC50,nM,,29.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,29.0
292925,17675162,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1O,,,CHEMBL3638374,,2015.0,"{'bei': '16.96', 'le': '0.32', 'lle': '5.67', 'sei': '4.59'}",CHEMBL3699809,,CHEMBL3699809,6.03,False,http://www.openphacts.org/units/Nanomolar,2576968,=,37,True,=,,IC50,nM,,938.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,938.0
292926,17675163,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(C(F)(F)F)c1O,,,CHEMBL3638374,,2015.0,"{'bei': '18.35', 'le': '0.36', 'lle': '5.80', 'sei': '6.80'}",CHEMBL3699810,,CHEMBL3699810,7.31,False,http://www.openphacts.org/units/Nanomolar,2576969,=,37,True,=,,IC50,nM,,49.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,49.0
292927,17675164,[],CHEMBL3706189,"Inhibitory Assay: This test is based on measuring the expression of the AKT protein phosphorylated on serine 473 (P-AKT-S473), in the PC3 human prostate carcinoma line, by means of the technique based on a sandwich immunoassay using the MSD Multi-spot Biomarker Detection kit from Meso Scale Discovery: phospho-Akt (Ser473) whole cell lysate kit (#K151CAD) or phospho-Akt (Ser473)/Total Akt whole cell lysate kit (#K15100D). The primary antibody specific for P-AKT-S473 (Kit #K151CAD) is coated on to an electrode in each well of the 96-well plates of the MSD, kit: after the addition of a protein lysate to each well, the signal is visualised by adding a secondary detection antibody labelled with an electrochemoluminescent compound. The procedure followed is that described in the kit.On day 1, the PC3 cells are seeded into 96-well plates (TPP, #92096) at the concentration of 35 000 cells/well in 200 ul of DMEM medium (DMEM Gibco #11960-044) containing 10% of foetal calf serum (FCS Gibco, #10500-056).",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(C)CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21,,,CHEMBL3638374,,2015.0,"{'bei': '20.50', 'le': '0.38', 'lle': '6.08', 'sei': '9.62'}",CHEMBL3112865,,CHEMBL3112865,7.55,False,http://www.openphacts.org/units/Nanomolar,2835977,=,37,True,=,,IC50,nM,,28.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,28.0
320038,17699959,[],CHEMBL3705654,"In Vitro Assay: This assay determines the ability of test compounds to inhibit phosphorylation of Serine 473 in Akt as assessed using Acumen Explorer technology (Acumen Bioscience Limited), a plate reader that can be used to rapidly quantitate features of images generated by laser-scanning.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(-c3ccc4c(c3)C(=O)NCCN4)nc2n1,,,CHEMBL3638644,,2015.0,"{'bei': '13.11', 'le': '0.24', 'lle': '4.12', 'sei': '6.13'}",CHEMBL3693591,,CHEMBL3693591,6.42,False,http://www.openphacts.org/units/Nanomolar,2570231,=,37,True,=,,IC50,nM,,381.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,381.3
320039,17699960,[],CHEMBL3705654,"In Vitro Assay: This assay determines the ability of test compounds to inhibit phosphorylation of Serine 473 in Akt as assessed using Acumen Explorer technology (Acumen Bioscience Limited), a plate reader that can be used to rapidly quantitate features of images generated by laser-scanning.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(-c3cccc(N)c3)nc2n1,,,CHEMBL3638644,,2015.0,"{'bei': '18.67', 'le': '0.35', 'lle': '5.13', 'sei': '8.76'}",CHEMBL3688934,,CHEMBL3688934,7.85,False,http://www.openphacts.org/units/Nanomolar,2565349,=,37,True,=,,IC50,nM,,14.15,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.15
320040,17699961,[],CHEMBL3705654,"In Vitro Assay: This assay determines the ability of test compounds to inhibit phosphorylation of Serine 473 in Akt as assessed using Acumen Explorer technology (Acumen Bioscience Limited), a plate reader that can be used to rapidly quantitate features of images generated by laser-scanning.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COCCN1c1nc(N2CCOC[C@@H]2C)c2ccc(-c3ccc4[nH]nc(N)c4c3)nc2n1,,,CHEMBL3638644,,2015.0,"{'bei': '15.67', 'le': '0.29', 'lle': '4.62', 'sei': '6.10'}",CHEMBL3688935,,CHEMBL3688935,7.22,False,http://www.openphacts.org/units/Nanomolar,2565350,=,37,True,=,,IC50,nM,,60.66,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,60.66
320041,17699962,[],CHEMBL3705654,"In Vitro Assay: This assay determines the ability of test compounds to inhibit phosphorylation of Serine 473 in Akt as assessed using Acumen Explorer technology (Acumen Bioscience Limited), a plate reader that can be used to rapidly quantitate features of images generated by laser-scanning.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)S(=O)(=O)Nc1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1,,,CHEMBL3638644,,2015.0,"{'bei': '11.96', 'le': '0.23', 'lle': '3.01', 'sei': '5.74'}",CHEMBL3693446,,CHEMBL3693446,6.30,False,http://www.openphacts.org/units/Nanomolar,2570084,=,37,True,=,,IC50,nM,,505.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,505.1
320042,17699963,[],CHEMBL3705654,"In Vitro Assay: This assay determines the ability of test compounds to inhibit phosphorylation of Serine 473 in Akt as assessed using Acumen Explorer technology (Acumen Bioscience Limited), a plate reader that can be used to rapidly quantitate features of images generated by laser-scanning.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)C1CCN(c2nc(N3CCOC[C@@H]3C)c3ccc(-c4ccc(N)nc4)nc3n2)CC1,,,CHEMBL3638644,,2015.0,"{'bei': '13.33', 'le': '0.25', 'lle': '4.31', 'sei': '5.04'}",CHEMBL3693558,,CHEMBL3693558,6.17,False,http://www.openphacts.org/units/Nanomolar,2570197,=,37,True,=,,IC50,nM,,682.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,682.1
320043,17699964,[],CHEMBL3705654,"In Vitro Assay: This assay determines the ability of test compounds to inhibit phosphorylation of Serine 473 in Akt as assessed using Acumen Explorer technology (Acumen Bioscience Limited), a plate reader that can be used to rapidly quantitate features of images generated by laser-scanning.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COCCN1c1nc(N2CCOCC2)nc2nc(-c3ccc(N)nc3)ccc12,,,CHEMBL3638644,,2015.0,"{'bei': '16.03', 'le': '0.30', 'lle': '4.80', 'sei': '6.37'}",CHEMBL3693559,,CHEMBL3693559,6.53,False,http://www.openphacts.org/units/Nanomolar,2570198,=,37,True,=,,IC50,nM,,295.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,295.1
326863,17705590,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1)N1CCc2c(F)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '20.35', 'le': '0.39', 'lle': '6.64', 'sei': '9.75'}",CHEMBL3961677,,CHEMBL3961677,7.66,False,http://www.openphacts.org/units/Nanomolar,2838708,=,37,True,=,,IC50,nM,,22.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22.0
326864,17705591,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C(=O)N1CCc2c(F)cccc21)c1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '14.90', 'le': '0.28', 'lle': '4.44', 'sei': '8.91'}",CHEMBL3896167,,CHEMBL3896167,6.03,False,http://www.openphacts.org/units/Nanomolar,2838709,=,37,True,=,,IC50,nM,,938.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,938.0
326865,17705592,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CCc3c(F)cccc32)nc(N2CCOCC2)c(F)c1=O,,,CHEMBL3886154,,2015.0,"{'bei': '17.42', 'le': '0.33', 'lle': '5.77', 'sei': '10.05'}",CHEMBL3956312,,CHEMBL3956312,6.80,False,http://www.openphacts.org/units/Nanomolar,2838710,=,37,True,=,,IC50,nM,,158.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,158.0
326866,17705593,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '16.91', 'le': '0.32', 'lle': '5.03', 'sei': '8.02'}",CHEMBL3974788,,CHEMBL3974788,6.30,False,http://www.openphacts.org/units/Nanomolar,2838711,=,37,True,=,,IC50,nM,,503.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,503.0
326867,17705594,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '21.01', 'le': '0.40', 'lle': '6.55', 'sei': '9.96'}",CHEMBL3893935,,CHEMBL3893935,7.82,False,http://www.openphacts.org/units/Nanomolar,2838712,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
326868,17705595,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '20.49', 'le': '0.39', 'lle': '6.60', 'sei': '10.19'}",CHEMBL3918391,,CHEMBL3918391,8.00,False,http://www.openphacts.org/units/Nanomolar,2838713,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
326869,17705596,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '21.83', 'le': '0.42', 'lle': '7.12', 'sei': '10.85'}",CHEMBL3918391,,CHEMBL3918391,8.52,False,http://www.openphacts.org/units/Nanomolar,2838713,=,37,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
326870,17705597,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '18.04', 'le': '0.34', 'lle': '5.69', 'sei': '10.30'}",CHEMBL3905243,,CHEMBL3905243,6.97,False,http://www.openphacts.org/units/Nanomolar,2838714,=,37,True,=,,IC50,nM,,107.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,107.0
326871,17705598,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '17.91', 'le': '0.34', 'lle': '5.64', 'sei': '10.23'}",CHEMBL3942235,,CHEMBL3942235,6.92,False,http://www.openphacts.org/units/Nanomolar,2838715,=,37,True,=,,IC50,nM,,120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,120.0
326872,17705599,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(F)cccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '17.77', 'le': '0.34', 'lle': '5.54', 'sei': '8.83'}",CHEMBL3917798,,CHEMBL3917798,6.94,False,http://www.openphacts.org/units/Nanomolar,2838716,=,37,True,=,,IC50,nM,,116.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,116.0
326873,17705600,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(F)cccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '19.52', 'le': '0.37', 'lle': '6.22', 'sei': '9.70'}",CHEMBL3917798,,CHEMBL3917798,7.62,False,http://www.openphacts.org/units/Nanomolar,2838716,=,37,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
326874,17705601,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)c(F)cc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '19.09', 'le': '0.37', 'lle': '6.26', 'sei': '9.93'}",CHEMBL3890826,,CHEMBL3890826,7.80,False,http://www.openphacts.org/units/Nanomolar,2838717,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
326875,17705602,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)c(F)cc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '16.63', 'le': '0.32', 'lle': '5.25', 'sei': '8.65'}",CHEMBL3890826,,CHEMBL3890826,6.79,False,http://www.openphacts.org/units/Nanomolar,2838717,=,37,True,=,,IC50,nM,,162.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,162.0
326876,17705603,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '17.95', 'le': '0.34', 'lle': '5.84', 'sei': '10.73'}",CHEMBL3896311,,CHEMBL3896311,7.26,False,http://www.openphacts.org/units/Nanomolar,2838718,=,37,True,=,,IC50,nM,,55.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,55.0
326877,17705604,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '17.77', 'le': '0.34', 'lle': '5.77', 'sei': '10.62'}",CHEMBL3896311,,CHEMBL3896311,7.19,False,http://www.openphacts.org/units/Nanomolar,2838718,=,37,True,=,,IC50,nM,,65.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,65.0
326878,17705605,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '14.00', 'le': '0.31', 'lle': '4.29', 'sei': '8.04'}",CHEMBL3913066,,CHEMBL3913066,6.32,False,http://www.openphacts.org/units/Nanomolar,2838719,=,37,True,=,,IC50,nM,,483.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,483.0
326879,17705606,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '16.28', 'le': '0.36', 'lle': '5.32', 'sei': '9.36'}",CHEMBL3913066,,CHEMBL3913066,7.35,False,http://www.openphacts.org/units/Nanomolar,2838719,=,37,True,=,,IC50,nM,,45.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,45.0
326880,17705607,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '18.24', 'le': '0.36', 'lle': '5.50', 'sei': '9.45'}",CHEMBL3916280,,CHEMBL3916280,7.42,False,http://www.openphacts.org/units/Nanomolar,2838720,=,37,True,=,,IC50,nM,,38.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,38.0
326881,17705608,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '18.98', 'le': '0.38', 'lle': '5.80', 'sei': '9.83'}",CHEMBL3916280,,CHEMBL3916280,7.72,False,http://www.openphacts.org/units/Nanomolar,2838720,=,37,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.0
326882,17705609,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(ccc(F)c2F)N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '21.30', 'le': '0.41', 'lle': '7.16', 'sei': '11.08'}",CHEMBL3931890,,CHEMBL3931890,8.70,False,http://www.openphacts.org/units/Nanomolar,2838721,=,37,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
326883,17705610,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(ccc(F)c2F)N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '19.16', 'le': '0.37', 'lle': '6.28', 'sei': '9.96'}",CHEMBL3931890,,CHEMBL3931890,7.82,False,http://www.openphacts.org/units/Nanomolar,2838721,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
326884,17705611,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(F)cccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '17.33', 'le': '0.33', 'lle': '5.59', 'sei': '10.36'}",CHEMBL3922944,,CHEMBL3922944,7.01,False,http://www.openphacts.org/units/Nanomolar,2838722,=,37,True,=,,IC50,nM,,98.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,98.0
326885,17705612,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(F)cccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '16.55', 'le': '0.32', 'lle': '5.27', 'sei': '9.89'}",CHEMBL3922944,,CHEMBL3922944,6.69,False,http://www.openphacts.org/units/Nanomolar,2838722,=,37,True,=,,IC50,nM,,203.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,203.0
326886,17705613,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(ccc(F)c2F)N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '15.41', 'le': '0.30', 'lle': '4.96', 'sei': '9.62'}",CHEMBL3917496,,CHEMBL3917496,6.51,False,http://www.openphacts.org/units/Nanomolar,2838723,=,37,True,=,,IC50,nM,,310.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,310.0
326887,17705614,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(ccc(F)c2F)N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '16.59', 'le': '0.32', 'lle': '5.46', 'sei': '10.36'}",CHEMBL3917496,,CHEMBL3917496,7.01,False,http://www.openphacts.org/units/Nanomolar,2838723,=,37,True,=,,IC50,nM,,98.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,98.0
326888,17705615,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)c(F)cc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '15.80', 'le': '0.30', 'lle': '5.13', 'sei': '9.87'}",CHEMBL3951881,,CHEMBL3951881,6.68,False,http://www.openphacts.org/units/Nanomolar,2838724,=,37,True,=,,IC50,nM,,211.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,211.0
326889,17705616,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)c(F)cc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '15.55', 'le': '0.30', 'lle': '5.02', 'sei': '9.71'}",CHEMBL3951881,,CHEMBL3951881,6.57,False,http://www.openphacts.org/units/Nanomolar,2838724,=,37,True,=,,IC50,nM,,270.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,270.0
326890,17705617,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '15.02', 'le': '0.30', 'lle': '4.39', 'sei': '9.34'}",CHEMBL3974610,,CHEMBL3974610,6.32,False,http://www.openphacts.org/units/Nanomolar,2838725,=,37,True,=,,IC50,nM,,476.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,476.0
326891,17705618,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '18.29', 'le': '0.36', 'lle': '5.77', 'sei': '11.38'}",CHEMBL3974610,,CHEMBL3974610,7.70,False,http://www.openphacts.org/units/Nanomolar,2838725,=,37,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
326892,17705619,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '16.75', 'le': '0.37', 'lle': '5.76', 'sei': '11.52'}",CHEMBL3982597,,CHEMBL3982597,7.80,False,http://www.openphacts.org/units/Nanomolar,2838726,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
326893,17705620,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '16.81', 'le': '0.37', 'lle': '5.78', 'sei': '11.56'}",CHEMBL3982597,,CHEMBL3982597,7.82,False,http://www.openphacts.org/units/Nanomolar,2838726,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
326894,17705621,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2ccc(F)cc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '18.95', 'le': '0.36', 'lle': '6.00', 'sei': '9.42'}",CHEMBL3890103,,CHEMBL3890103,7.40,False,http://www.openphacts.org/units/Nanomolar,2838727,=,37,True,=,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,40.0
326895,17705622,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2ccc(F)cc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '18.22', 'le': '0.35', 'lle': '5.71', 'sei': '9.06'}",CHEMBL3890103,,CHEMBL3890103,7.11,False,http://www.openphacts.org/units/Nanomolar,2838727,=,37,True,=,,IC50,nM,,77.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,77.0
326896,17705623,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(ccc(F)c2Cl)N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '20.48', 'le': '0.41', 'lle': '6.64', 'sei': '11.08'}",CHEMBL3970127,,CHEMBL3970127,8.70,False,http://www.openphacts.org/units/Nanomolar,2838728,=,37,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
326897,17705624,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)c(Cl)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '17.63', 'le': '0.35', 'lle': '5.07', 'sei': '8.73'}",CHEMBL3952768,,CHEMBL3952768,6.85,False,http://www.openphacts.org/units/Nanomolar,2838729,=,37,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,140.0
326898,17705625,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)c(Cl)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '18.67', 'le': '0.37', 'lle': '5.48', 'sei': '9.24'}",CHEMBL3981502,,CHEMBL3981502,7.26,False,http://www.openphacts.org/units/Nanomolar,2838730,=,37,True,=,,IC50,nM,,55.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,55.0
326899,17705626,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)c(Br)c(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '16.74', 'le': '0.37', 'lle': '5.36', 'sei': '9.23'}",CHEMBL3950856,,CHEMBL3950856,7.25,False,http://www.openphacts.org/units/Nanomolar,2838731,=,37,True,=,,IC50,nM,,56.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,56.0
326900,17705627,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1)N1c2ccccc2CC1CO,,,CHEMBL3886154,,2015.0,"{'bei': '15.30', 'le': '0.29', 'lle': '5.70', 'sei': '6.02'}",CHEMBL3923121,,CHEMBL3923121,5.94,False,http://www.openphacts.org/units/Nanomolar,2838732,=,37,True,=,,IC50,nM,,1138.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1138.0
326901,17705628,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)c(F)c(=O)[nH]1)N1c2ccccc2CC1CO,,,CHEMBL3886154,,2015.0,"{'bei': '16.08', 'le': '0.30', 'lle': '6.01', 'sei': '6.32'}",CHEMBL3923121,,CHEMBL3923121,6.25,False,http://www.openphacts.org/units/Nanomolar,2838732,=,37,True,=,,IC50,nM,,568.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,568.0
326902,17705629,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CN(c2cc(=O)[nH]c(CC(=O)Nc3ccc(F)cc3)n2)CCO1,,,CHEMBL3886154,,2015.0,"{'bei': '21.90', 'le': '0.41', 'lle': '6.27', 'sei': '8.69'}",CHEMBL3935564,,CHEMBL3935564,7.58,False,http://www.openphacts.org/units/Nanomolar,2838733,=,37,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.0
326903,17705630,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CN(c2cc(=O)[nH]c(CC(=O)Nc3ccc(F)cc3)n2)CCO1,,,CHEMBL3886154,,2015.0,"{'bei': '23.74', 'le': '0.45', 'lle': '6.90', 'sei': '9.42'}",CHEMBL3935564,,CHEMBL3935564,8.22,False,http://www.openphacts.org/units/Nanomolar,2838733,=,37,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.0
326904,17705631,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOC(CF)C2)cc(=O)[nH]1)Nc1ccc(F)cc1,,,CHEMBL3886154,,2015.0,"{'bei': '18.02', 'le': '0.34', 'lle': '5.31', 'sei': '7.52'}",CHEMBL3978959,,CHEMBL3978959,6.57,False,http://www.openphacts.org/units/Nanomolar,2838734,=,37,True,=,,IC50,nM,,271.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,271.0
326905,17705632,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOC(CF)C2)cc(=O)[nH]1)Nc1ccc(F)cc1,,,CHEMBL3886154,,2015.0,"{'bei': '19.02', 'le': '0.36', 'lle': '5.67', 'sei': '7.93'}",CHEMBL3978959,,CHEMBL3978959,6.93,False,http://www.openphacts.org/units/Nanomolar,2838734,=,37,True,=,,IC50,nM,,118.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,118.0
326906,17705633,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)Nc2ccc(F)c(Cl)c2)nc(N2CCOC(CF)C2)cc1=O,,,CHEMBL3886154,,2015.0,"{'bei': '16.71', 'le': '0.34', 'lle': '4.97', 'sei': '9.02'}",CHEMBL3983824,,CHEMBL3983824,6.90,False,http://www.openphacts.org/units/Nanomolar,2838735,=,37,True,=,,IC50,nM,,127.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,127.0
326907,17705634,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOC(CF)C2)cc(=O)[nH]1)N1CCc2c(F)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '18.54', 'le': '0.35', 'lle': '6.02', 'sei': '9.22'}",CHEMBL3984868,,CHEMBL3984868,7.24,False,http://www.openphacts.org/units/Nanomolar,2838736,=,37,True,=,,IC50,nM,,58.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,58.0
326908,17705635,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOC(CF)C2)cc(=O)[nH]1)N1CCc2c(F)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '19.67', 'le': '0.37', 'lle': '6.46', 'sei': '9.78'}",CHEMBL3984868,,CHEMBL3984868,7.68,False,http://www.openphacts.org/units/Nanomolar,2838736,=,37,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.0
326909,17705636,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CN(c2cc(=O)[nH]c(CC(=O)N3CCc4c(F)cccc43)n2)CCO1,,,CHEMBL3886154,,2015.0,"{'bei': '20.80', 'le': '0.39', 'lle': '6.47', 'sei': '9.86'}",CHEMBL3928308,,CHEMBL3928308,7.75,False,http://www.openphacts.org/units/Nanomolar,2838737,=,37,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
326910,17705637,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CN(c2cc(=O)[nH]c(CC(=O)N3CCc4c(F)cccc43)n2)CCO1,,,CHEMBL3886154,,2015.0,"{'bei': '18.28', 'le': '0.34', 'lle': '5.54', 'sei': '8.67'}",CHEMBL3928308,,CHEMBL3928308,6.81,False,http://www.openphacts.org/units/Nanomolar,2838737,=,37,True,=,,IC50,nM,,156.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,156.0
326911,17705638,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CN(c2cc(=O)[nH]c(CC(=O)N3CCc4c(F)cccc43)n2)CCO1,,,CHEMBL3886154,,2015.0,"{'bei': '21.74', 'le': '0.41', 'lle': '6.83', 'sei': '10.31'}",CHEMBL3928308,,CHEMBL3928308,8.10,False,http://www.openphacts.org/units/Nanomolar,2838737,=,37,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
326912,17705639,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOC3CCCC32)cc(=O)[nH]1)N1CCc2c(F)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '19.88', 'le': '0.37', 'lle': '6.12', 'sei': '10.09'}",CHEMBL3943810,,CHEMBL3943810,7.92,False,http://www.openphacts.org/units/Nanomolar,2838738,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
326913,17705640,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(-c2ccncc2)cc(=O)[nH]1)N1CCc2c(F)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '18.36', 'le': '0.34', 'lle': '4.33', 'sei': '8.15'}",CHEMBL3977387,,CHEMBL3977387,6.43,False,http://www.openphacts.org/units/Nanomolar,2838739,=,37,True,=,,IC50,nM,,370.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,370.0
326914,17705641,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(-c2cc(=O)[nH]c(CC(=O)N3CCc4c(F)cccc43)n2)ccn1,,,CHEMBL3886154,,2015.0,"{'bei': '14.52', 'le': '0.27', 'lle': '3.41', 'sei': '6.26'}",CHEMBL3938410,,CHEMBL3938410,5.52,False,http://www.openphacts.org/units/Nanomolar,2838740,=,37,True,=,,IC50,nM,,3000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3000.0
326915,17705642,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCC1CN(c2cc(=O)[nH]c(CC(=O)Nc3ccc(F)cc3)n2)CCO1,,,CHEMBL3886154,,2015.0,"{'bei': '18.18', 'le': '0.34', 'lle': '4.84', 'sei': '7.50'}",CHEMBL3972428,,CHEMBL3972428,6.55,False,http://www.openphacts.org/units/Nanomolar,2838741,=,37,True,=,,IC50,nM,,280.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,280.0
326916,17705643,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCC1CN(c2cc(=O)[nH]c(CC(=O)Nc3ccc(F)cc3)n2)CCO1,,,CHEMBL3886154,,2015.0,"{'bei': '19.36', 'le': '0.37', 'lle': '5.27', 'sei': '7.99'}",CHEMBL3972428,,CHEMBL3972428,6.98,False,http://www.openphacts.org/units/Nanomolar,2838741,=,37,True,=,,IC50,nM,,105.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,105.0
326917,17705644,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(-c2cc(=O)[nH]c(CC(=O)N3CCc4c(F)cccc43)n2)ccn1,,,CHEMBL3886154,,2015.0,"{'bei': '18.15', 'le': '0.33', 'lle': '4.20', 'sei': '8.38'}",CHEMBL3961321,,CHEMBL3961321,6.61,False,http://www.openphacts.org/units/Nanomolar,2838742,=,37,True,=,,IC50,nM,,244.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,244.0
326918,17705645,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(-c2ccnc(F)c2)cc(=O)[nH]1)N1CCc2c(F)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '15.05', 'le': '0.28', 'lle': '3.30', 'sei': '7.02'}",CHEMBL3986565,,CHEMBL3986565,5.54,False,http://www.openphacts.org/units/Nanomolar,2838743,=,37,True,=,,IC50,nM,,2855.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2855.0
326919,17705646,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOC(CO)C2)cc(=O)[nH]1)N1CCc2c(Cl)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '18.69', 'le': '0.37', 'lle': '6.82', 'sei': '7.66'}",CHEMBL3893924,,CHEMBL3893924,7.57,False,http://www.openphacts.org/units/Nanomolar,2838744,=,37,True,=,,IC50,nM,,27.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,27.0
326920,17705647,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOC(CO)C2)cc(=O)[nH]1)N1CCc2c(Cl)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '16.35', 'le': '0.32', 'lle': '5.87', 'sei': '6.70'}",CHEMBL3893924,,CHEMBL3893924,6.62,False,http://www.openphacts.org/units/Nanomolar,2838744,=,37,True,=,,IC50,nM,,240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,240.0
326921,17705648,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOC(CO)C2)cc(=O)[nH]1)N1CCc2c(F)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '15.13', 'le': '0.29', 'lle': '5.64', 'sei': '5.95'}",CHEMBL3954012,,CHEMBL3954012,5.88,False,http://www.openphacts.org/units/Nanomolar,2838745,=,37,True,=,,IC50,nM,,1332.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1332.0
326922,17705649,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CN(c2cc(=O)[nH]c(CC(=O)N3CCc4c(Cl)cccc43)n2)CCO1,,,CHEMBL3886154,,2015.0,"{'bei': '20.37', 'le': '0.40', 'lle': '6.14', 'sei': '10.09'}",CHEMBL3926375,,CHEMBL3926375,7.92,False,http://www.openphacts.org/units/Nanomolar,2838746,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
326923,17705650,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CN(c2cc(=O)[nH]c(CC(=O)N3c4ccccc4C[C@@H]3C)n2)CCO1,,,CHEMBL3886154,,2015.0,"{'bei': '20.68', 'le': '0.39', 'lle': '6.10', 'sei': '9.70'}",CHEMBL3908338,,CHEMBL3908338,7.62,False,http://www.openphacts.org/units/Nanomolar,2838747,=,37,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
326924,17705651,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOC(CF)C2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '19.04', 'le': '0.36', 'lle': '5.90', 'sei': '9.37'}",CHEMBL3981833,,CHEMBL3981833,7.36,False,http://www.openphacts.org/units/Nanomolar,2838748,=,37,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,44.0
326925,17705652,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOC(CO)C2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '17.71', 'le': '0.33', 'lle': '6.32', 'sei': '6.89'}",CHEMBL3899292,,CHEMBL3899292,6.81,False,http://www.openphacts.org/units/Nanomolar,2838749,=,37,True,=,,IC50,nM,,156.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,156.0
326926,17705653,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '21.35', 'le': '0.42', 'lle': '6.52', 'sei': '10.57'}",CHEMBL3970476,,CHEMBL3970476,8.30,False,http://www.openphacts.org/units/Nanomolar,2838750,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
326927,17705654,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '21.35', 'le': '0.42', 'lle': '6.52', 'sei': '10.57'}",CHEMBL3970476,,CHEMBL3970476,8.30,False,http://www.openphacts.org/units/Nanomolar,2838750,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
326928,17705655,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '23.14', 'le': '0.46', 'lle': '7.22', 'sei': '11.46'}",CHEMBL3970476,,CHEMBL3970476,9.00,False,http://www.openphacts.org/units/Nanomolar,2838750,=,37,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
326929,17705656,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CC(C)(C)c3c(Cl)cccc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3886154,,2015.0,"{'bei': '17.88', 'le': '0.35', 'lle': '5.32', 'sei': '11.02'}",CHEMBL3897578,,CHEMBL3897578,7.46,False,http://www.openphacts.org/units/Nanomolar,2838751,=,37,True,=,,IC50,nM,,35.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,35.0
326930,17705657,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(C)CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2cccc(Cl)c21,,,CHEMBL3886154,,2015.0,"{'bei': '19.49', 'le': '0.38', 'lle': '5.72', 'sei': '10.00'}",CHEMBL3911266,,CHEMBL3911266,7.85,False,http://www.openphacts.org/units/Nanomolar,2838752,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
326931,17705658,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(O)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '20.57', 'le': '0.39', 'lle': '6.79', 'sei': '7.72'}",CHEMBL3910203,,CHEMBL3910203,7.62,False,http://www.openphacts.org/units/Nanomolar,2838753,=,37,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
326932,17705659,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CC(C)(C)c3c(F)cccc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3886154,,2015.0,"{'bei': '18.35', 'le': '0.35', 'lle': '5.73', 'sei': '10.86'}",CHEMBL3934544,,CHEMBL3934544,7.35,False,http://www.openphacts.org/units/Nanomolar,2838754,=,37,True,=,,IC50,nM,,45.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,45.0
326933,17705660,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(C)CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2cccc(F)c21,,,CHEMBL3886154,,2015.0,"{'bei': '18.85', 'le': '0.36', 'lle': '5.67', 'sei': '9.28'}",CHEMBL3981254,,CHEMBL3981254,7.28,False,http://www.openphacts.org/units/Nanomolar,2838755,=,37,True,=,,IC50,nM,,52.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,52.0
326934,17705661,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(O)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '18.73', 'le': '0.35', 'lle': '6.11', 'sei': '7.03'}",CHEMBL3910203,,CHEMBL3910203,6.94,False,http://www.openphacts.org/units/Nanomolar,2838753,=,37,True,=,,IC50,nM,,115.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,115.0
326935,17705662,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(O)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '20.67', 'le': '0.39', 'lle': '6.83', 'sei': '7.75'}",CHEMBL3910203,,CHEMBL3910203,7.66,False,http://www.openphacts.org/units/Nanomolar,2838753,=,37,True,=,,IC50,nM,,22.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22.0
326936,17705663,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2cccc(O)c21,,,CHEMBL3886154,,2015.0,"{'bei': '19.56', 'le': '0.37', 'lle': '6.24', 'sei': '7.34'}",CHEMBL3970508,,CHEMBL3970508,7.24,False,http://www.openphacts.org/units/Nanomolar,2838756,=,37,True,=,,IC50,nM,,57.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,57.0
326937,17705664,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '22.29', 'le': '0.42', 'lle': '7.03', 'sei': '10.57'}",CHEMBL3932198,,CHEMBL3932198,8.30,False,http://www.openphacts.org/units/Nanomolar,2838757,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
326938,17705665,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '23.36', 'le': '0.44', 'lle': '7.43', 'sei': '11.08'}",CHEMBL3932198,,CHEMBL3932198,8.70,False,http://www.openphacts.org/units/Nanomolar,2838757,=,37,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
326939,17705666,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '19.55', 'le': '0.37', 'lle': '6.27', 'sei': '11.16'}",CHEMBL3901730,,CHEMBL3901730,7.55,False,http://www.openphacts.org/units/Nanomolar,2838758,=,37,True,=,,IC50,nM,,28.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,28.0
326940,17705667,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '20.41', 'le': '0.38', 'lle': '6.61', 'sei': '11.65'}",CHEMBL3901730,,CHEMBL3901730,7.89,False,http://www.openphacts.org/units/Nanomolar,2838758,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
326941,17705668,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(ccc(F)c2F)N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '21.51', 'le': '0.41', 'lle': '7.00', 'sei': '10.69'}",CHEMBL3910755,,CHEMBL3910755,8.40,False,http://www.openphacts.org/units/Nanomolar,2838759,=,37,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
326942,17705669,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(ccc(F)c2F)N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '23.05', 'le': '0.44', 'lle': '7.60', 'sei': '11.46'}",CHEMBL3910755,,CHEMBL3910755,9.00,False,http://www.openphacts.org/units/Nanomolar,2838759,=,37,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
326943,17705670,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(ccc(F)c2F)N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '19.09', 'le': '0.36', 'lle': '6.30', 'sei': '11.41'}",CHEMBL3916147,,CHEMBL3916147,7.72,False,http://www.openphacts.org/units/Nanomolar,2838760,=,37,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.0
326944,17705671,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(ccc(F)c2F)N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '19.50', 'le': '0.37', 'lle': '6.47', 'sei': '11.65'}",CHEMBL3916147,,CHEMBL3916147,7.89,False,http://www.openphacts.org/units/Nanomolar,2838760,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
326945,17705672,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)c(F)cc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '19.90', 'le': '0.38', 'lle': '6.37', 'sei': '9.89'}",CHEMBL3925163,,CHEMBL3925163,7.77,False,http://www.openphacts.org/units/Nanomolar,2838761,=,37,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.0
326946,17705673,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)c(F)cc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '22.28', 'le': '0.42', 'lle': '7.30', 'sei': '11.08'}",CHEMBL3925163,,CHEMBL3925163,8.70,False,http://www.openphacts.org/units/Nanomolar,2838761,=,37,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
326947,17705674,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)c(F)cc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '18.53', 'le': '0.35', 'lle': '6.07', 'sei': '11.08'}",CHEMBL3937641,,CHEMBL3937641,7.50,False,http://www.openphacts.org/units/Nanomolar,2838762,=,37,True,=,,IC50,nM,,32.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,32.0
326948,17705675,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2cc(F)c(F)cc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '17.17', 'le': '0.33', 'lle': '5.52', 'sei': '10.26'}",CHEMBL3937641,,CHEMBL3937641,6.94,False,http://www.openphacts.org/units/Nanomolar,2838762,=,37,True,=,,IC50,nM,,114.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,114.0
326949,17705676,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '17.10', 'le': '0.37', 'lle': '5.52', 'sei': '9.43'}",CHEMBL3971065,,CHEMBL3971065,7.41,False,http://www.openphacts.org/units/Nanomolar,2838763,=,37,True,=,,IC50,nM,,39.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,39.0
326950,17705677,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '19.67', 'le': '0.43', 'lle': '6.63', 'sei': '10.85'}",CHEMBL3971065,,CHEMBL3971065,8.52,False,http://www.openphacts.org/units/Nanomolar,2838763,=,37,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
326951,17705678,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(F)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '22.55', 'le': '0.42', 'lle': '7.13', 'sei': '10.69'}",CHEMBL3965878,,CHEMBL3965878,8.40,False,http://www.openphacts.org/units/Nanomolar,2838764,=,37,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
326952,17705679,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(F)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '18.82', 'le': '0.35', 'lle': '5.74', 'sei': '8.92'}",CHEMBL3965878,,CHEMBL3965878,7.01,False,http://www.openphacts.org/units/Nanomolar,2838764,=,37,True,=,,IC50,nM,,98.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,98.0
326953,17705680,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(F)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '18.83', 'le': '0.35', 'lle': '6.00', 'sei': '10.75'}",CHEMBL3893392,,CHEMBL3893392,7.28,False,http://www.openphacts.org/units/Nanomolar,2838765,=,37,True,=,,IC50,nM,,53.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,53.0
326954,17705681,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(F)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '18.47', 'le': '0.35', 'lle': '5.86', 'sei': '10.55'}",CHEMBL3893392,,CHEMBL3893392,7.14,False,http://www.openphacts.org/units/Nanomolar,2838765,=,37,True,=,,IC50,nM,,73.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,73.0
326955,17705682,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '16.64', 'le': '0.36', 'lle': '5.54', 'sei': '11.00'}",CHEMBL3917877,,CHEMBL3917877,7.44,False,http://www.openphacts.org/units/Nanomolar,2838766,=,37,True,=,,IC50,nM,,36.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,36.0
326956,17705683,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '17.56', 'le': '0.38', 'lle': '5.95', 'sei': '11.61'}",CHEMBL3917877,,CHEMBL3917877,7.85,False,http://www.openphacts.org/units/Nanomolar,2838766,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
326957,17705684,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '18.02', 'le': '0.35', 'lle': '5.47', 'sei': '10.73'}",CHEMBL3908482,,CHEMBL3908482,7.26,False,http://www.openphacts.org/units/Nanomolar,2838767,=,37,True,=,,IC50,nM,,55.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,55.0
326958,17705685,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '16.42', 'le': '0.32', 'lle': '4.83', 'sei': '9.78'}",CHEMBL3908482,,CHEMBL3908482,6.62,False,http://www.openphacts.org/units/Nanomolar,2838767,=,37,True,=,,IC50,nM,,242.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,242.0
326959,17705686,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2ccc(F)cc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '20.32', 'le': '0.38', 'lle': '6.30', 'sei': '9.64'}",CHEMBL3896158,,CHEMBL3896158,7.57,False,http://www.openphacts.org/units/Nanomolar,2838768,=,37,True,=,,IC50,nM,,27.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,27.0
326960,17705687,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2ccc(F)cc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '21.61', 'le': '0.41', 'lle': '6.78', 'sei': '10.25'}",CHEMBL3896158,,CHEMBL3896158,8.05,False,http://www.openphacts.org/units/Nanomolar,2838768,=,37,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
326961,17705688,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(ccc(F)c2Cl)N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '20.04', 'le': '0.40', 'lle': '6.23', 'sei': '10.38'}",CHEMBL3930708,,CHEMBL3930708,8.15,False,http://www.openphacts.org/units/Nanomolar,2838769,=,37,True,=,,IC50,nM,,7.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.0
326962,17705689,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(ccc(F)c2Cl)N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '22.12', 'le': '0.44', 'lle': '7.08', 'sei': '11.46'}",CHEMBL3930708,,CHEMBL3930708,9.00,False,http://www.openphacts.org/units/Nanomolar,2838769,=,37,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
326963,17705690,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)C1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '21.96', 'le': '0.41', 'lle': '6.64', 'sei': '10.69'}",CHEMBL3918242,,CHEMBL3918242,8.40,False,http://www.openphacts.org/units/Nanomolar,2838770,=,37,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
326964,17705691,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)C1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '17.29', 'le': '0.32', 'lle': '4.85', 'sei': '8.42'}",CHEMBL3918242,,CHEMBL3918242,6.61,False,http://www.openphacts.org/units/Nanomolar,2838770,=,37,True,=,,IC50,nM,,243.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,243.0
326965,17705692,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C(=O)N1CCc2c(F)cccc21)c1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '20.24', 'le': '0.38', 'lle': '6.10', 'sei': '9.60'}",CHEMBL3937375,,CHEMBL3937375,7.54,False,http://www.openphacts.org/units/Nanomolar,2838771,=,37,True,=,,IC50,nM,,29.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,29.0
326966,17705693,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '17.43', 'le': '0.32', 'lle': '4.90', 'sei': '8.18'}",CHEMBL3959404,,CHEMBL3959404,6.42,False,http://www.openphacts.org/units/Nanomolar,2838772,=,37,True,=,,IC50,nM,,380.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,380.0
326967,17705694,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '21.32', 'le': '0.40', 'lle': '6.33', 'sei': '10.00'}",CHEMBL3959404,,CHEMBL3959404,7.85,False,http://www.openphacts.org/units/Nanomolar,2838772,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
326968,17705695,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(F)(C(=O)N1CCc2c(F)cccc21)c1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '17.56', 'le': '0.33', 'lle': '5.33', 'sei': '8.73'}",CHEMBL3947247,,CHEMBL3947247,6.85,False,http://www.openphacts.org/units/Nanomolar,2838773,=,37,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,140.0
326969,17705696,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(F)(C(=O)N1CCc2c(F)cccc21)c1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '16.87', 'le': '0.32', 'lle': '5.07', 'sei': '8.39'}",CHEMBL3947247,,CHEMBL3947247,6.58,False,http://www.openphacts.org/units/Nanomolar,2838773,=,37,True,=,,IC50,nM,,260.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,260.0
326970,17705697,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '19.15', 'le': '0.35', 'lle': '6.39', 'sei': '6.84'}",CHEMBL3922497,,CHEMBL3922497,7.00,False,http://www.openphacts.org/units/Nanomolar,2838774,=,37,True,=,,IC50,nM,,101.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,101.0
326971,17705698,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CC2(CC2)c2ccccc21,,,CHEMBL3886154,,2015.0,"{'bei': '20.70', 'le': '0.38', 'lle': '6.36', 'sei': '9.66'}",CHEMBL3950222,,CHEMBL3950222,7.58,False,http://www.openphacts.org/units/Nanomolar,2838775,=,37,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.0
326972,17705699,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccccc3)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '18.30', 'le': '0.34', 'lle': '5.21', 'sei': '9.70'}",CHEMBL3112855,,CHEMBL3112855,7.62,False,http://www.openphacts.org/units/Nanomolar,2838776,=,37,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
326973,17705700,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(OC(F)(F)F)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '17.13', 'le': '0.33', 'lle': '5.63', 'sei': '8.28'}",CHEMBL3112854,,CHEMBL3112854,7.27,False,http://www.openphacts.org/units/Nanomolar,2838777,=,37,True,=,,IC50,nM,,54.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,54.0
326974,17705701,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CCc3c2cccc3C(F)(F)F)nc(N2CCOCC2)cc1=O,,,CHEMBL3886154,,2015.0,"{'bei': '17.05', 'le': '0.33', 'lle': '5.43', 'sei': '10.64'}",CHEMBL3927896,,CHEMBL3927896,7.20,False,http://www.openphacts.org/units/Nanomolar,2838778,=,37,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,63.0
326975,17705702,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c1cccc2C(F)(F)F,,,CHEMBL3886154,,2015.0,"{'bei': '19.70', 'le': '0.38', 'lle': '6.29', 'sei': '10.25'}",CHEMBL3112853,,CHEMBL3112853,8.05,False,http://www.openphacts.org/units/Nanomolar,2838779,=,37,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
326976,17705703,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1-c1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '16.79', 'le': '0.31', 'lle': '5.08', 'sei': '8.54'}",CHEMBL3931282,,CHEMBL3931282,7.50,False,http://www.openphacts.org/units/Nanomolar,2838780,=,37,True,=,,IC50,nM,,32.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,32.0
326977,17705704,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1CCCCC1c1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '15.02', 'le': '0.28', 'lle': '4.31', 'sei': '8.55'}",CHEMBL3908806,,CHEMBL3908806,6.99,False,http://www.openphacts.org/units/Nanomolar,2838781,=,37,True,=,,IC50,nM,,102.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,102.0
326978,17705705,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CCc3c(OC(F)F)cccc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3886154,,2015.0,"{'bei': '17.18', 'le': '0.33', 'lle': '5.87', 'sei': '9.39'}",CHEMBL3936766,,CHEMBL3936766,7.22,False,http://www.openphacts.org/units/Nanomolar,2838782,=,37,True,=,,IC50,nM,,60.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,60.0
326979,17705706,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(OC(F)F)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '18.10', 'le': '0.35', 'lle': '6.02', 'sei': '8.38'}",CHEMBL3921269,,CHEMBL3921269,7.36,False,http://www.openphacts.org/units/Nanomolar,2838783,=,37,True,=,,IC50,nM,,44.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,44.0
326980,17705707,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccncc3)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '16.83', 'le': '0.31', 'lle': '5.23', 'sei': '7.69'}",CHEMBL3112858,,CHEMBL3112858,7.03,False,http://www.openphacts.org/units/Nanomolar,2838784,=,37,True,=,,IC50,nM,,94.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,94.0
326981,17705708,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCC2(CC1)CN(C(=O)Cc1nc(N3CCOCC3)cc(=O)[nH]1)c1ccccc12,,,CHEMBL3886154,,2015.0,"{'bei': '17.91', 'le': '0.33', 'lle': '6.43', 'sei': '9.28'}",CHEMBL3945651,,CHEMBL3945651,7.58,False,http://www.openphacts.org/units/Nanomolar,2838785,=,37,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.0
326982,17705709,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccccn3)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '17.20', 'le': '0.32', 'lle': '5.38', 'sei': '7.85'}",CHEMBL3112856,,CHEMBL3112856,7.18,False,http://www.openphacts.org/units/Nanomolar,2838786,=,37,True,=,,IC50,nM,,66.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,66.0
326983,17705710,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3cccnc3)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '17.43', 'le': '0.32', 'lle': '5.48', 'sei': '7.96'}",CHEMBL3112857,,CHEMBL3112857,7.28,False,http://www.openphacts.org/units/Nanomolar,2838787,=,37,True,=,,IC50,nM,,53.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,53.0
326984,17705711,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccccc3Cl)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '16.36', 'le': '0.31', 'lle': '4.32', 'sei': '9.39'}",CHEMBL3971261,,CHEMBL3971261,7.38,False,http://www.openphacts.org/units/Nanomolar,2838788,=,37,True,=,,IC50,nM,,42.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.0
326985,17705712,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)n1C1CC1)N1CCc2c(Cl)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '17.91', 'le': '0.35', 'lle': '5.23', 'sei': '10.98'}",CHEMBL3914529,,CHEMBL3914529,7.43,False,http://www.openphacts.org/units/Nanomolar,2838789,=,37,True,=,,IC50,nM,,37.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,37.0
326986,17705713,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1c2ccccc2C2CCCC21,,,CHEMBL3886154,,2015.0,"{'bei': '19.77', 'le': '0.37', 'lle': '5.69', 'sei': '9.58'}",CHEMBL3893813,,CHEMBL3893813,7.52,False,http://www.openphacts.org/units/Nanomolar,2838790,=,37,True,=,,IC50,nM,,30.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30.0
326987,17705714,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCN(Cc2cccc3c2CCN3C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)CC1,,,CHEMBL3886154,,2015.0,"{'bei': '12.75', 'le': '0.25', 'lle': '6.77', 'sei': '5.53'}",CHEMBL3985936,,CHEMBL3985936,6.59,False,http://www.openphacts.org/units/Nanomolar,2838791,=,37,True,=,,IC50,nM,,259.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,259.0
326988,17705715,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(Cc2cccc3c2CCN3C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)CC1,,,CHEMBL3886154,,2015.0,"{'bei': '14.51', 'le': '0.27', 'lle': '6.08', 'sei': '7.72'}",CHEMBL3112860,,CHEMBL3112860,6.57,False,http://www.openphacts.org/units/Nanomolar,2838792,=,37,True,=,,IC50,nM,,272.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,272.0
326989,17705716,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccccc3F)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '17.58', 'le': '0.33', 'lle': '5.10', 'sei': '9.73'}",CHEMBL3953697,,CHEMBL3953697,7.64,False,http://www.openphacts.org/units/Nanomolar,2838793,=,37,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
326990,17705717,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(Cc2cccc3c2CCN3C(=O)Cc2nc(N3CCOCC3)cc(=O)n2C)CC1,,,CHEMBL3886154,,2015.0,"{'bei': '13.47', 'le': '0.25', 'lle': '5.78', 'sei': '8.47'}",CHEMBL3930747,,CHEMBL3930747,6.28,False,http://www.openphacts.org/units/Nanomolar,2838794,=,37,True,=,,IC50,nM,,520.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,520.0
326991,17705718,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CC2(CCOCC2)c2ccccc21,,,CHEMBL3886154,,2015.0,"{'bei': '16.59', 'le': '0.31', 'lle': '5.57', 'sei': '7.76'}",CHEMBL3904288,,CHEMBL3904288,6.81,False,http://www.openphacts.org/units/Nanomolar,2838795,=,37,True,=,,IC50,nM,,155.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,155.0
326992,17705719,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CC3(CCOCC3)c3ccccc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3886154,,2015.0,"{'bei': '16.43', 'le': '0.31', 'lle': '5.72', 'sei': '9.07'}",CHEMBL3936162,,CHEMBL3936162,6.97,False,http://www.openphacts.org/units/Nanomolar,2838796,=,37,True,=,,IC50,nM,,106.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,106.0
326993,17705720,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CC3(CCNCC3)c3ccccc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3886154,,2015.0,"{'bei': '15.84', 'le': '0.30', 'lle': '5.88', 'sei': '8.42'}",CHEMBL3893381,,CHEMBL3893381,6.71,False,http://www.openphacts.org/units/Nanomolar,2838797,=,37,True,=,,IC50,nM,,196.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,196.0
326994,17705721,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1c2ccccc2CC1c1ccccc1,,,CHEMBL3886154,,2015.0,"{'bei': '16.06', 'le': '0.29', 'lle': '4.21', 'sei': '8.52'}",CHEMBL3945090,,CHEMBL3945090,6.69,False,http://www.openphacts.org/units/Nanomolar,2838798,=,37,True,=,,IC50,nM,,205.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,205.0
326995,17705722,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1c2ccccc2CC1c1ccccc1,,,CHEMBL3886154,,2015.0,"{'bei': '19.93', 'le': '0.37', 'lle': '5.82', 'sei': '10.57'}",CHEMBL3945090,,CHEMBL3945090,8.30,False,http://www.openphacts.org/units/Nanomolar,2838798,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
326996,17705723,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(c2cccc3c2CCN3C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)CC1,,,CHEMBL3886154,,2015.0,"{'bei': '15.45', 'le': '0.29', 'lle': '6.29', 'sei': '7.97'}",CHEMBL3112859,,CHEMBL3112859,6.78,False,http://www.openphacts.org/units/Nanomolar,2838799,=,37,True,=,,IC50,nM,,167.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,167.0
326997,17705724,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1c2ccccc2CC1c1ccc(F)cc1,,,CHEMBL3886154,,2015.0,"{'bei': '14.64', 'le': '0.27', 'lle': '3.74', 'sei': '8.10'}",CHEMBL3914007,,CHEMBL3914007,6.36,False,http://www.openphacts.org/units/Nanomolar,2838800,=,37,True,=,,IC50,nM,,435.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,435.0
326998,17705725,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1c2ccccc2CC1c1ccc(F)cc1,,,CHEMBL3886154,,2015.0,"{'bei': '20.02', 'le': '0.37', 'lle': '6.08', 'sei': '11.08'}",CHEMBL3914007,,CHEMBL3914007,8.70,False,http://www.openphacts.org/units/Nanomolar,2838800,=,37,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
326999,17705726,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(OC(F)F)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '17.80', 'le': '0.34', 'lle': '5.75', 'sei': '8.52'}",CHEMBL3964324,,CHEMBL3964324,7.48,False,http://www.openphacts.org/units/Nanomolar,2838801,=,37,True,=,,IC50,nM,,33.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,33.0
327000,17705727,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(OC(F)F)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '19.26', 'le': '0.37', 'lle': '6.37', 'sei': '9.23'}",CHEMBL3964324,,CHEMBL3964324,8.10,False,http://www.openphacts.org/units/Nanomolar,2838801,=,37,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
327001,17705728,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(OC(F)F)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '15.60', 'le': '0.30', 'lle': '5.04', 'sei': '8.81'}",CHEMBL3939903,,CHEMBL3939903,6.78,False,http://www.openphacts.org/units/Nanomolar,2838802,=,37,True,=,,IC50,nM,,167.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,167.0
327002,17705729,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(OC(F)F)cccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '16.62', 'le': '0.32', 'lle': '5.48', 'sei': '9.39'}",CHEMBL3939903,,CHEMBL3939903,7.22,False,http://www.openphacts.org/units/Nanomolar,2838802,=,37,True,=,,IC50,nM,,60.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,60.0
327003,17705730,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(N3CCOCC3)cccc21,,,CHEMBL3886154,,2015.0,"{'bei': '16.35', 'le': '0.31', 'lle': '6.38', 'sei': '7.64'}",CHEMBL3930892,,CHEMBL3930892,6.96,False,http://www.openphacts.org/units/Nanomolar,2838803,=,37,True,=,,IC50,nM,,111.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,111.0
327004,17705731,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1c2ccccc2CC1C1CC1,,,CHEMBL3886154,,2015.0,"{'bei': '19.24', 'le': '0.36', 'lle': '5.80', 'sei': '9.32'}",CHEMBL3964685,,CHEMBL3964685,7.32,False,http://www.openphacts.org/units/Nanomolar,2838804,=,37,True,=,,IC50,nM,,48.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,48.0
327005,17705732,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1c2ccccc2CC1C1CC1,,,CHEMBL3886154,,2015.0,"{'bei': '21.82', 'le': '0.40', 'lle': '6.78', 'sei': '10.57'}",CHEMBL3964685,,CHEMBL3964685,8.30,False,http://www.openphacts.org/units/Nanomolar,2838804,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
327006,17705733,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(cccc2C(F)(F)F)N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '19.65', 'le': '0.38', 'lle': '6.15', 'sei': '10.57'}",CHEMBL3940961,,CHEMBL3940961,8.30,False,http://www.openphacts.org/units/Nanomolar,2838805,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
327007,17705734,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(cccc2C(F)(F)F)N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '20.59', 'le': '0.40', 'lle': '6.55', 'sei': '11.08'}",CHEMBL3940961,,CHEMBL3940961,8.70,False,http://www.openphacts.org/units/Nanomolar,2838805,=,37,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
327008,17705735,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1c2ccccc2CC1CF,,,CHEMBL3886154,,2015.0,"{'bei': '21.01', 'le': '0.40', 'lle': '6.74', 'sei': '9.96'}",CHEMBL3968336,,CHEMBL3968336,7.82,False,http://www.openphacts.org/units/Nanomolar,2838806,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
327009,17705736,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)n1-c1ccccc1)N1CCc2ccccc21,,,CHEMBL3886154,,2015.0,"{'bei': '17.51', 'le': '0.32', 'lle': '5.09', 'sei': '10.78'}",CHEMBL3943531,,CHEMBL3943531,7.29,False,http://www.openphacts.org/units/Nanomolar,2838807,=,37,True,=,,IC50,nM,,51.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,51.0
327010,17705737,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1c2ccccc2CC1CF,,,CHEMBL3886154,,2015.0,"{'bei': '21.18', 'le': '0.40', 'lle': '6.81', 'sei': '10.04'}",CHEMBL3968336,,CHEMBL3968336,7.89,False,http://www.openphacts.org/units/Nanomolar,2838806,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
327011,17705738,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,Nn1c(CC(=O)N2CCc3ccccc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3886154,,2015.0,"{'bei': '19.37', 'le': '0.36', 'lle': '6.95', 'sei': '7.35'}",CHEMBL3932244,,CHEMBL3932244,6.88,False,http://www.openphacts.org/units/Nanomolar,2838808,=,37,True,=,,IC50,nM,,131.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,131.0
327012,17705739,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cn1c(CC(=O)N2CCc3ccccc32)nc(N2CCOCC2)cc1=O,,,CHEMBL3886154,,2015.0,"{'bei': '20.85', 'le': '0.39', 'lle': '7.08', 'sei': '8.33'}",CHEMBL3974771,,CHEMBL3974771,7.62,False,http://www.openphacts.org/units/Nanomolar,2838809,=,37,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
327013,17705740,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=S)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '20.67', 'le': '0.40', 'lle': '5.16', 'sei': '12.46'}",CHEMBL3907424,,CHEMBL3907424,7.66,False,http://www.openphacts.org/units/Nanomolar,2838810,=,37,True,=,,IC50,nM,,22.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22.0
327014,17705741,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=S)Cc1nc(N2CCOCC2)cc(=S)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '21.73', 'le': '0.44', 'lle': '5.10', 'sei': '18.92'}",CHEMBL3971967,,CHEMBL3971967,8.40,False,http://www.openphacts.org/units/Nanomolar,2838811,=,37,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
327015,17705742,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=S)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '21.86', 'le': '0.43', 'lle': '5.60', 'sei': '13.17'}",CHEMBL3898401,,CHEMBL3898401,8.10,False,http://www.openphacts.org/units/Nanomolar,2838812,=,37,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
327016,17705743,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=S)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '19.21', 'le': '0.37', 'lle': '4.88', 'sei': '14.60'}",CHEMBL3964814,,CHEMBL3964814,7.39,False,http://www.openphacts.org/units/Nanomolar,2838813,=,37,True,=,,IC50,nM,,41.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,41.0
327017,17705744,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=S)n1C,,,CHEMBL3886154,,2015.0,"{'bei': '18.59', 'le': '0.36', 'lle': '4.64', 'sei': '14.13'}",CHEMBL3929547,,CHEMBL3929547,7.15,False,http://www.openphacts.org/units/Nanomolar,2838814,=,37,True,=,,IC50,nM,,71.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,71.0
327018,17705745,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CCc3c(F)cccc32)nc(N2CCOCC2)cc1=S,,,CHEMBL3886154,,2015.0,"{'bei': '19.33', 'le': '0.38', 'lle': '5.25', 'sei': '14.84'}",CHEMBL3944470,,CHEMBL3944470,7.51,False,http://www.openphacts.org/units/Nanomolar,2838815,=,37,True,=,,IC50,nM,,31.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31.0
327019,17705746,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CC(=O)N2CCc3c(Cl)cccc32)nc(N2CCOCC2)cc1=S,,,CHEMBL3886154,,2015.0,"{'bei': '18.48', 'le': '0.38', 'lle': '4.71', 'sei': '14.79'}",CHEMBL3916531,,CHEMBL3916531,7.48,False,http://www.openphacts.org/units/Nanomolar,2838816,=,37,True,=,,IC50,nM,,33.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,33.0
327020,17705747,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(ccc(F)c2F)N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=S)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '18.75', 'le': '0.37', 'lle': '5.05', 'sei': '12.95'}",CHEMBL3925391,,CHEMBL3925391,7.96,False,http://www.openphacts.org/units/Nanomolar,2838817,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
327021,17705748,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1Cc2c(ccc(F)c2F)N1C(=S)Cc1nc(N2CCOCC2)c(F)c(=S)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '20.43', 'le': '0.42', 'lle': '5.29', 'sei': '20.27'}",CHEMBL3900870,,CHEMBL3900870,9.00,False,http://www.openphacts.org/units/Nanomolar,2838818,=,37,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
327022,17705749,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=S)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '17.13', 'le': '0.34', 'lle': '4.02', 'sei': '10.83'}",CHEMBL3930072,,CHEMBL3930072,6.66,False,http://www.openphacts.org/units/Nanomolar,2838819,=,37,True,=,,IC50,nM,,221.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,221.0
327023,17705750,[],CHEMBL3887079,"Sandwich Immunoassay: This test is based on measurement of the expression of AKT protein phosphorylated on serine 473 (P-AKT-S473) in the PC3 human prostate carcinoma line, by the technique based on a sandwich immunoassay using the Kit MSD Multi-spot Biomarker Detection of Meso Scale Discovery: phospho-Akt kits (Ser473) whole cell lysate (# K151 CAD) or phospho-Akt (Ser473) / Akt whole cell lysate Total (# K15100D). The primary antibody specific for P-AKT-S473 (Kit # K151 CAD) is coated onto an electrode in each well of 96-well plates of the MSD kit: after adding a protein lysate in each well, the revelation of the signal done by the addition of a secondary antibody labeled with an electrochemiluminescent detection compound. The procedure is described in the kit.On day 1, the PC3 cells are inoculated in 96-well plates (TPP # 92096) at a concentration of 35000 cells / well in 200 uL DMEM medium (DMEM Gibco # 1 1960-044) containing 10% fetal calf serum (FBS Gibco, # 10500-056) and 1% glutamine.",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)c(F)c(=S)[nH]1,,,CHEMBL3886154,,2015.0,"{'bei': '18.57', 'le': '0.36', 'lle': '4.57', 'sei': '11.74'}",CHEMBL3902097,,CHEMBL3902097,7.21,False,http://www.openphacts.org/units/Nanomolar,2838820,=,37,True,=,,IC50,nM,,61.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,61.0
328326,17706916,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCCN(c2ccc(C(N)=O)c3ncncc23)C1,,,CHEMBL3886157,,2015.0,,CHEMBL3947957,,CHEMBL3947957,,False,http://www.openphacts.org/units/Nanomolar,2839606,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328327,17706917,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(N2CCC(Nc3ccc(C(N)=O)c4ncncc34)CC2)c1,,,CHEMBL3886157,,2015.0,,CHEMBL3921030,,CHEMBL3921030,,False,http://www.openphacts.org/units/Nanomolar,2839607,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328328,17706918,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(Nc2ccc(C(N)=O)c3ncncc23)C1,,,CHEMBL3886157,,2015.0,,CHEMBL3948835,,CHEMBL3948835,,False,http://www.openphacts.org/units/Nanomolar,2839608,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328329,17706919,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CNCC1CCCN(c2ccc(C(N)=O)c3ncncc23)C1,,,CHEMBL3886157,,2015.0,"{'bei': '15.85', 'le': '0.29', 'lle': '3.58', 'sei': '5.64'}",CHEMBL3933454,,CHEMBL3933454,4.75,False,http://www.openphacts.org/units/Nanomolar,2839609,=,37,True,=,,IC50,nM,,18000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18000.0
328330,17706920,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NC[C@@H]2CCNC2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL4110740,,CHEMBL4110740,,False,http://www.openphacts.org/units/Nanomolar,2839610,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328331,17706921,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NC[C@H]2CCNC2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL3942427,,CHEMBL3942427,,False,http://www.openphacts.org/units/Nanomolar,2839611,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328332,17706922,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NCc2cccnc2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '14.88', 'le': '0.27', 'lle': '2.41', 'sei': '4.43'}",CHEMBL3972029,,CHEMBL3972029,4.16,False,http://www.openphacts.org/units/Nanomolar,2839612,=,37,True,=,,IC50,nM,,70000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,70000.0
328333,17706923,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NCc2cccc(Cl)c2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '15.73', 'le': '0.31', 'lle': '1.93', 'sei': '6.08'}",CHEMBL3954224,,CHEMBL3954224,4.92,False,http://www.openphacts.org/units/Nanomolar,2839613,=,37,True,=,,IC50,nM,,12000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12000.0
328334,17706924,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N2CCC(CCc3ccccc3)C2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '15.90', 'le': '0.29', 'lle': '2.32', 'sei': '7.64'}",CHEMBL3930070,,CHEMBL3930070,5.51,False,http://www.openphacts.org/units/Nanomolar,2839614,=,37,True,=,,IC50,nM,,3100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3100.0
328335,17706925,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N2CCC(OCc3ccccc3)C2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL3945508,,CHEMBL3945508,,False,http://www.openphacts.org/units/Nanomolar,2839615,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328336,17706926,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N2CCC(O)(c3ccccc3)C2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL3890779,,CHEMBL3890779,,False,http://www.openphacts.org/units/Nanomolar,2839616,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328337,17706927,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc([C@@H]2CN(c3ccc(C(N)=O)c4ncncc34)C[C@H]2CO)c1,,,CHEMBL3886157,,2015.0,"{'bei': '14.03', 'le': '0.26', 'lle': '2.84', 'sei': '5.51'}",CHEMBL3940185,,CHEMBL3940185,5.09,False,http://www.openphacts.org/units/Nanomolar,2839617,=,37,True,=,,IC50,nM,,8200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8200.0
328338,17706928,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(CNc1ccc(C(N)=O)c2ncncc12)c1cccc(Cl)c1,,,CHEMBL3886157,,2015.0,,CHEMBL3908671,,CHEMBL3908671,,False,http://www.openphacts.org/units/Nanomolar,2839618,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328339,17706929,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NCC(c2ccccc2)N2CCNCC2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL3931144,,CHEMBL3931144,,False,http://www.openphacts.org/units/Nanomolar,2839619,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328340,17706930,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NC2CCNCC2c2ccc(F)cc2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '15.33', 'le': '0.28', 'lle': '3.17', 'sei': '6.03'}",CHEMBL3903158,,CHEMBL3903158,5.60,False,http://www.openphacts.org/units/Nanomolar,2839620,=,37,True,=,,IC50,nM,,2500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2500.0
328341,17706931,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NC2CNCC2c2cccc(C(F)(F)F)c2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '13.32', 'le': '0.25', 'lle': '2.43', 'sei': '5.75'}",CHEMBL3921054,,CHEMBL3921054,5.35,False,http://www.openphacts.org/units/Nanomolar,2839621,=,37,True,=,,IC50,nM,,4500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4500.0
328342,17706932,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NC2CNCC2c2cccc(OC(F)(F)F)c2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL3896544,,CHEMBL3896544,,False,http://www.openphacts.org/units/Nanomolar,2839622,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328343,17706933,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(C2CCNCC2Nc2ccc(C(N)=O)c3ncncc23)c1,,,CHEMBL3886157,,2015.0,"{'bei': '13.96', 'le': '0.26', 'lle': '2.46', 'sei': '5.43'}",CHEMBL3909073,,CHEMBL3909073,5.05,False,http://www.openphacts.org/units/Nanomolar,2839623,=,37,True,=,,IC50,nM,,9000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9000.0
328344,17706934,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NC2CNCCC2c2cccc(C(F)(F)F)c2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '13.67', 'le': '0.26', 'lle': '2.37', 'sei': '6.11'}",CHEMBL3933453,,CHEMBL3933453,5.68,False,http://www.openphacts.org/units/Nanomolar,2839624,=,37,True,=,,IC50,nM,,2100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2100.0
328345,17706935,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NC2CNCCC2c2ccc(Cl)c(F)c2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '17.22', 'le': '0.34', 'lle': '3.81', 'sei': '7.41'}",CHEMBL3896518,,CHEMBL3896518,6.89,False,http://www.openphacts.org/units/Nanomolar,2839625,=,37,True,=,,IC50,nM,,130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,130.0
328346,17706936,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NC2CNCCC2c2ccc(F)c(Cl)c2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '15.62', 'le': '0.30', 'lle': '3.16', 'sei': '6.72'}",CHEMBL3924538,,CHEMBL3924538,6.24,False,http://www.openphacts.org/units/Nanomolar,2839626,=,37,True,=,,IC50,nM,,570.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,570.0
328347,17706937,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N[C@H]2CNCC[C@@H]2c2ccc(F)c(Cl)c2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '15.18', 'le': '0.30', 'lle': '2.99', 'sei': '6.53'}",CHEMBL4109551,,CHEMBL4109551,6.07,False,http://www.openphacts.org/units/Nanomolar,2839627,=,37,True,=,,IC50,nM,,850.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,850.0
328348,17706938,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N[C@@H]2CNCC[C@H]2c2ccc(F)c(Cl)c2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '13.11', 'le': '0.26', 'lle': '2.16', 'sei': '5.64'}",CHEMBL3919102,,CHEMBL3919102,5.24,False,http://www.openphacts.org/units/Nanomolar,2839628,=,37,True,=,,IC50,nM,,5700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5700.0
328349,17706939,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NC2CNCCC2c2ccc(F)cc2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '15.60', 'le': '0.29', 'lle': '3.27', 'sei': '6.13'}",CHEMBL3980317,,CHEMBL3980317,5.70,False,http://www.openphacts.org/units/Nanomolar,2839629,=,37,True,=,,IC50,nM,,2000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2000.0
328350,17706940,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N[C@H]2CNCC[C@@H]2c2ccc(F)cc2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '15.48', 'le': '0.29', 'lle': '3.23', 'sei': '6.09'}",CHEMBL4106661,,CHEMBL4106661,5.66,False,http://www.openphacts.org/units/Nanomolar,2839630,=,37,True,=,,IC50,nM,,2200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2200.0
328351,17706941,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N[C@@H]2CNCC[C@H]2c2ccc(F)cc2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '16.55', 'le': '0.31', 'lle': '3.62', 'sei': '6.51'}",CHEMBL3910187,,CHEMBL3910187,6.05,False,http://www.openphacts.org/units/Nanomolar,2839631,=,37,True,=,,IC50,nM,,900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,900.0
328352,17706942,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL3919249,,CHEMBL3919249,,False,http://www.openphacts.org/units/Nanomolar,2839640,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328353,17706943,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N2CCN(c3ccccc3)CC2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '14.47', 'le': '0.26', 'lle': '2.76', 'sei': '6.40'}",CHEMBL3905526,,CHEMBL3905526,4.82,False,http://www.openphacts.org/units/Nanomolar,2839641,=,37,True,=,,IC50,nM,,15000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15000.0
328354,17706944,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N2CCN(c3ccc(F)c(F)c3)CC2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL3932697,,CHEMBL3932697,,False,http://www.openphacts.org/units/Nanomolar,2839642,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328355,17706945,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N2CCN(c3ccc(F)c(Cl)c3)CC2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL3906249,,CHEMBL3906249,,False,http://www.openphacts.org/units/Nanomolar,2839644,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328356,17706946,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N2CCN(c3cccc(F)c3)CC2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '14.78', 'le': '0.27', 'lle': '3.00', 'sei': '6.89'}",CHEMBL3918934,,CHEMBL3918934,5.19,False,http://www.openphacts.org/units/Nanomolar,2839645,=,37,True,=,,IC50,nM,,6400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6400.0
328357,17706947,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N2CCN(c3cccc(Cl)c3)CC2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL3943330,,CHEMBL3943330,,False,http://www.openphacts.org/units/Nanomolar,2839646,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328358,17706948,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NCc2ccccc2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '15.25', 'le': '0.28', 'lle': '1.90', 'sei': '5.25'}",CHEMBL3960835,,CHEMBL3960835,4.24,False,http://www.openphacts.org/units/Nanomolar,2839647,=,37,True,=,,IC50,nM,,57000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,57000.0
328359,17706949,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NCCc2ccccc2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '17.96', 'le': '0.33', 'lle': '2.87', 'sei': '6.49'}",CHEMBL3891824,,CHEMBL3891824,5.25,False,http://www.openphacts.org/units/Nanomolar,2839648,=,37,True,=,,IC50,nM,,5600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5600.0
328360,17706950,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NCCc2cccc(F)c2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '18.11', 'le': '0.33', 'lle': '3.10', 'sei': '6.95'}",CHEMBL3968412,,CHEMBL3968412,5.62,False,http://www.openphacts.org/units/Nanomolar,2839649,=,37,True,=,,IC50,nM,,2400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2400.0
328361,17706951,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NCCc2ccc(F)cc2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '17.14', 'le': '0.32', 'lle': '2.80', 'sei': '6.57'}",CHEMBL3949722,,CHEMBL3949722,5.32,False,http://www.openphacts.org/units/Nanomolar,2839650,=,37,True,=,,IC50,nM,,4800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4800.0
328362,17706952,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NCCc2ccc(F)c(F)c2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '13.36', 'le': '0.25', 'lle': '1.73', 'sei': '5.42'}",CHEMBL3942274,,CHEMBL3942274,4.39,False,http://www.openphacts.org/units/Nanomolar,2839651,=,37,True,=,,IC50,nM,,41000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,41000.0
328363,17706953,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NCCCCc2ccccc2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL3932743,,CHEMBL3932743,,False,http://www.openphacts.org/units/Nanomolar,2839652,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328364,17706954,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCc1ccccc1)c1ccc(C(N)=O)c2ncncc12,,,CHEMBL3886157,,2015.0,"{'bei': '15.84', 'le': '0.29', 'lle': '2.44', 'sei': '6.73'}",CHEMBL3933947,,CHEMBL3933947,4.85,False,http://www.openphacts.org/units/Nanomolar,2839653,=,37,True,=,,IC50,nM,,14000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14000.0
328365,17706955,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(NCCc2ccc(Cl)c(Cl)c2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL3902499,,CHEMBL3902499,,False,http://www.openphacts.org/units/Nanomolar,2839654,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328366,17706956,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N(CCc2ccccc2)[C@@H]2CCCNC2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL4108594,,CHEMBL4108594,,False,http://www.openphacts.org/units/Nanomolar,2839655,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328367,17706957,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N2CCC(c3cccc(C(F)(F)F)c3)C(N)C2)c2cncnc12,,,CHEMBL3886157,,2015.0,"{'bei': '12.26', 'le': '0.23', 'lle': '2.02', 'sei': '5.19'}",CHEMBL3948252,,CHEMBL3948252,5.09,False,http://www.openphacts.org/units/Nanomolar,2839657,=,37,True,=,,IC50,nM,,8100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8100.0
328368,17706958,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N2CCN(c3ccc(F)cc3)CC2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL3923951,,CHEMBL3923951,,False,http://www.openphacts.org/units/Nanomolar,2839658,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328369,17706959,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(N2CCN(c3ccc(Cl)c(Cl)c3)CC2)c2cncnc12,,,CHEMBL3886157,,2015.0,,CHEMBL3911505,,CHEMBL3911505,,False,http://www.openphacts.org/units/Nanomolar,2839659,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
328370,17706960,[],CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25° C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Cl)cc1N1CCN(c2ccc(C(N)=O)c3ncncc23)CC1,,,CHEMBL3886157,,2015.0,,CHEMBL3969122,,CHEMBL3969122,,False,http://www.openphacts.org/units/Nanomolar,2839660,>,37,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
329769,17708359,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2Br)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.38', 'le': '0.32', 'lle': '2.42', 'sei': '9.86'}",CHEMBL3917944,,CHEMBL3917944,7.18,False,http://www.openphacts.org/units/Nanomolar,2840600,=,37,True,=,,IC50,nM,,66.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,66.0
329770,17708360,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4cccc(C(F)(F)F)c4)c[nH]3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '12.35', 'le': '0.27', 'lle': '1.16', 'sei': '6.89'}",CHEMBL3926903,,CHEMBL3926903,5.77,False,http://www.openphacts.org/units/Nanomolar,2840602,=,37,True,=,,IC50,nM,,1700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1700.0
329771,17708361,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)c1cccc(-c2c[nH]c(C3CCN(c4ncncc4Br)CC3)n2)c1,,,CHEMBL3886265,,2015.0,"{'bei': '11.53', 'le': '0.25', 'lle': '0.18', 'sei': '9.04'}",CHEMBL3895400,,CHEMBL3895400,5.21,False,http://www.openphacts.org/units/Nanomolar,2840603,=,37,True,=,,IC50,nM,,6100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6100.0
329772,17708362,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.16', 'le': '0.29', 'lle': '2.99', 'sei': '7.56'}",CHEMBL3904322,,CHEMBL3904322,6.80,False,http://www.openphacts.org/units/Nanomolar,2840605,=,37,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,160.0
329773,17708363,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.62', 'le': '0.30', 'lle': '3.09', 'sei': '7.20'}",CHEMBL3941307,,CHEMBL3941307,6.96,False,http://www.openphacts.org/units/Nanomolar,2840606,=,37,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,110.0
329774,17708364,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.00', 'le': '0.31', 'lle': '4.14', 'sei': '8.05'}",CHEMBL3916864,,CHEMBL3916864,8.04,False,http://www.openphacts.org/units/Nanomolar,2840607,=,37,True,=,,IC50,nM,,9.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.1
329775,17708365,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.11', 'le': '0.27', 'lle': '2.35', 'sei': '7.74'}",CHEMBL3964789,,CHEMBL3964789,6.36,False,http://www.openphacts.org/units/Nanomolar,2840608,=,37,True,=,,IC50,nM,,440.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,440.0
329776,17708366,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2ccc(F)cc2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.00', 'le': '0.21', 'lle': '-0.15', 'sei': '7.76'}",CHEMBL3925871,,CHEMBL3925871,5.66,False,http://www.openphacts.org/units/Nanomolar,2840609,=,37,True,=,,IC50,nM,,2200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2200.0
329777,17708367,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2c(N)ncnc2N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3C)CC2)cc1,,,CHEMBL3886265,,2015.0,"{'bei': '11.93', 'le': '0.23', 'lle': '0.60', 'sei': '7.66'}",CHEMBL3985874,,CHEMBL3985874,6.28,False,http://www.openphacts.org/units/Nanomolar,2840610,=,37,True,=,,IC50,nM,,520.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,520.0
329778,17708368,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2c(N)ncnc2N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3C)CC2)cc1,,,CHEMBL3886265,,2015.0,"{'bei': '9.95', 'le': '0.19', 'lle': '-0.90', 'sei': '6.97'}",CHEMBL3980785,,CHEMBL3980785,5.08,False,http://www.openphacts.org/units/Nanomolar,2840612,=,37,True,=,,IC50,nM,,8300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8300.0
329779,17708369,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2ccc(CO)cc2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.54', 'le': '0.24', 'lle': '1.44', 'sei': '7.09'}",CHEMBL3910716,,CHEMBL3910716,6.60,False,http://www.openphacts.org/units/Nanomolar,2840613,=,37,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,250.0
329780,17708370,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2cccc(C#N)c2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.08', 'le': '0.25', 'lle': '1.28', 'sei': '7.06'}",CHEMBL3909655,,CHEMBL3909655,6.82,False,http://www.openphacts.org/units/Nanomolar,2840614,=,37,True,=,,IC50,nM,,150.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,150.0
329781,17708371,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2ccc(C#N)cc2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.43', 'le': '0.31', 'lle': '3.03', 'sei': '8.87'}",CHEMBL3897066,,CHEMBL3897066,8.57,False,http://www.openphacts.org/units/Nanomolar,2840616,=,37,True,=,,IC50,nM,,2.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.7
329782,17708372,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2c(N)ncnc2N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3C)CC2)cn1,,,CHEMBL3886265,,2015.0,"{'bei': '11.28', 'le': '0.21', 'lle': '0.40', 'sei': '6.73'}",CHEMBL3901580,,CHEMBL3901580,5.77,False,http://www.openphacts.org/units/Nanomolar,2840618,=,37,True,=,,IC50,nM,,1700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1700.0
329783,17708373,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2c(N)ncnc2N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3C)CC2)s1,,,CHEMBL3886265,,2015.0,"{'bei': '10.78', 'le': '0.21', 'lle': '-0.47', 'sei': '7.64'}",CHEMBL3940535,,CHEMBL3940535,5.57,False,http://www.openphacts.org/units/Nanomolar,2840619,=,37,True,=,,IC50,nM,,2700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2700.0
329784,17708374,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2CO)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.23', 'le': '0.25', 'lle': '2.47', 'sei': '6.40'}",CHEMBL3927385,,CHEMBL3927385,5.96,False,http://www.openphacts.org/units/Nanomolar,2840635,=,37,True,=,,IC50,nM,,1100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1100.0
329785,17708375,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.51', 'le': '0.24', 'lle': '2.70', 'sei': '5.00'}",CHEMBL3964726,,CHEMBL3964726,5.80,False,http://www.openphacts.org/units/Nanomolar,2840636,=,37,True,=,,IC50,nM,,1600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1600.0
329786,17708376,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.59', 'le': '0.26', 'lle': '3.96', 'sei': '5.94'}",CHEMBL3936329,,CHEMBL3936329,7.08,False,http://www.openphacts.org/units/Nanomolar,2840637,=,37,True,=,,IC50,nM,,84.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,84.0
329787,17708377,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2ccncc2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.19', 'le': '0.23', 'lle': '1.01', 'sei': '7.07'}",CHEMBL3978717,,CHEMBL3978717,6.07,False,http://www.openphacts.org/units/Nanomolar,2840638,=,37,True,=,,IC50,nM,,860.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,860.0
329788,17708378,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2ccc(N)nc2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '10.87', 'le': '0.21', 'lle': '0.92', 'sei': '4.98'}",CHEMBL3904694,,CHEMBL3904694,5.57,False,http://www.openphacts.org/units/Nanomolar,2840639,=,37,True,=,,IC50,nM,,2700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2700.0
329789,17708379,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncncc2Br)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.09', 'le': '0.27', 'lle': '0.67', 'sei': '12.50'}",CHEMBL3892829,,CHEMBL3892829,5.85,False,http://www.openphacts.org/units/Nanomolar,2840640,=,37,True,=,,IC50,nM,,1400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1400.0
329790,17708380,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)c[nH]3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '12.82', 'le': '0.28', 'lle': '1.47', 'sei': '7.43'}",CHEMBL3906130,,CHEMBL3906130,6.22,False,http://www.openphacts.org/units/Nanomolar,2840642,=,37,True,=,,IC50,nM,,600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,600.0
329791,17708381,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)c[nH]3)CC2)c1-c1ccc(F)cc1,,,CHEMBL3886265,,2015.0,"{'bei': '10.03', 'le': '0.19', 'lle': '-0.78', 'sei': '6.00'}",CHEMBL3979925,,CHEMBL3979925,5.02,False,http://www.openphacts.org/units/Nanomolar,2840643,=,37,True,=,,IC50,nM,,9500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9500.0
329792,17708382,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2cncnc2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.75', 'le': '0.24', 'lle': '1.90', 'sei': '6.44'}",CHEMBL3929608,,CHEMBL3929608,6.36,False,http://www.openphacts.org/units/Nanomolar,2840647,=,37,True,=,,IC50,nM,,440.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,440.0
329793,17708383,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2cccnc2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.17', 'le': '0.23', 'lle': '1.00', 'sei': '7.06'}",CHEMBL3958964,,CHEMBL3958964,6.06,False,http://www.openphacts.org/units/Nanomolar,2840652,=,37,True,=,,IC50,nM,,880.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,880.0
329794,17708384,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COC/C=C/c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.50', 'le': '0.24', 'lle': '1.47', 'sei': '7.47'}",CHEMBL3889930,,CHEMBL3889930,6.13,False,http://www.openphacts.org/units/Nanomolar,2840653,=,37,True,=,,IC50,nM,,740.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,740.0
329795,17708385,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ncc(-c2c(N)ncnc2N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3C)CC2)s1,,,CHEMBL3886265,,2015.0,"{'bei': '11.73', 'le': '0.23', 'lle': '0.64', 'sei': '7.08'}",CHEMBL3922417,,CHEMBL3922417,6.07,False,http://www.openphacts.org/units/Nanomolar,2840654,=,37,True,=,,IC50,nM,,850.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,850.0
329796,17708386,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '13.48', 'le': '0.29', 'lle': '2.53', 'sei': '10.32'}",CHEMBL3982415,,CHEMBL3982415,7.85,False,http://www.openphacts.org/units/Nanomolar,2840655,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
329797,17708387,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)c1-c1ccc(F)cc1,,,CHEMBL3886265,,2015.0,"{'bei': '11.47', 'le': '0.22', 'lle': '0.48', 'sei': '9.01'}",CHEMBL3916957,,CHEMBL3916957,6.85,False,http://www.openphacts.org/units/Nanomolar,2840656,=,37,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,140.0
329798,17708388,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)c1-c1ccccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '11.92', 'le': '0.23', 'lle': '0.75', 'sei': '9.36'}",CHEMBL3944868,,CHEMBL3944868,7.12,False,http://www.openphacts.org/units/Nanomolar,2840657,=,37,True,=,,IC50,nM,,75.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,75.0
329799,17708389,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)c1-c1ccc(F)c(F)c1,,,CHEMBL3886265,,2015.0,"{'bei': '11.30', 'le': '0.22', 'lle': '0.45', 'sei': '9.14'}",CHEMBL3907965,,CHEMBL3907965,6.96,False,http://www.openphacts.org/units/Nanomolar,2840658,=,37,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,110.0
329800,17708390,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.42', 'le': '0.29', 'lle': '2.97', 'sei': '10.73'}",CHEMBL3932421,,CHEMBL3932421,8.17,False,http://www.openphacts.org/units/Nanomolar,2840659,=,37,True,=,,IC50,nM,,6.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.8
329801,17708391,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCCC3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '13.49', 'le': '0.29', 'lle': '2.34', 'sei': '10.57'}",CHEMBL3956468,,CHEMBL3956468,8.05,False,http://www.openphacts.org/units/Nanomolar,2840660,=,37,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
329802,17708392,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCCC3)CC2)c1-c1ccc(F)cc1,,,CHEMBL3886265,,2015.0,"{'bei': '10.55', 'le': '0.20', 'lle': '-0.30', 'sei': '8.48'}",CHEMBL3932445,,CHEMBL3932445,6.46,False,http://www.openphacts.org/units/Nanomolar,2840661,=,37,True,=,,IC50,nM,,350.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,350.0
329803,17708393,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCCC3)CC2)c1-c1ccccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '11.26', 'le': '0.21', 'lle': '0.13', 'sei': '9.05'}",CHEMBL3977191,,CHEMBL3977191,6.89,False,http://www.openphacts.org/units/Nanomolar,2840662,=,37,True,=,,IC50,nM,,130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,130.0
329804,17708394,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCCC3)CC2)c1-c1cccc(F)c1,,,CHEMBL3886265,,2015.0,"{'bei': '11.56', 'le': '0.22', 'lle': '0.31', 'sei': '9.29'}",CHEMBL3947929,,CHEMBL3947929,7.07,False,http://www.openphacts.org/units/Nanomolar,2840663,=,37,True,=,,IC50,nM,,85.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,85.0
329805,17708395,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.57', 'le': '0.28', 'lle': '2.33', 'sei': '10.41'}",CHEMBL3972216,,CHEMBL3972216,7.92,False,http://www.openphacts.org/units/Nanomolar,2840664,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
329806,17708396,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCCC3)CC2)ncn1,,,CHEMBL3886265,,2015.0,"{'bei': '12.34', 'le': '0.24', 'lle': '1.44', 'sei': '8.39'}",CHEMBL3939144,,CHEMBL3939144,6.39,False,http://www.openphacts.org/units/Nanomolar,2840665,=,37,True,=,,IC50,nM,,410.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,410.0
329807,17708397,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2Br)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.43', 'le': '0.31', 'lle': '3.24', 'sei': '10.55'}",CHEMBL3961106,,CHEMBL3961106,8.03,False,http://www.openphacts.org/units/Nanomolar,2840666,=,37,True,=,,IC50,nM,,9.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.3
329808,17708398,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2ccc(F)cc2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.61', 'le': '0.22', 'lle': '0.81', 'sei': '8.72'}",CHEMBL3933645,,CHEMBL3933645,6.64,False,http://www.openphacts.org/units/Nanomolar,2840667,=,37,True,=,,IC50,nM,,230.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,230.0
329809,17708399,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2ccncc2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.28', 'le': '0.25', 'lle': '2.28', 'sei': '8.28'}",CHEMBL3895298,,CHEMBL3895298,7.37,False,http://www.openphacts.org/units/Nanomolar,2840668,=,37,True,=,,IC50,nM,,43.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,43.0
329810,17708400,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2ccc(N)nc2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.84', 'le': '0.22', 'lle': '2.07', 'sei': '5.86'}",CHEMBL3973946,,CHEMBL3973946,6.75,False,http://www.openphacts.org/units/Nanomolar,2840669,=,37,True,=,,IC50,nM,,180.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,180.0
329811,17708401,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2cnc(N)nc2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.12', 'le': '0.21', 'lle': '2.28', 'sei': '4.96'}",CHEMBL3922652,,CHEMBL3922652,6.35,False,http://www.openphacts.org/units/Nanomolar,2840670,=,37,True,=,,IC50,nM,,450.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,450.0
329812,17708402,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=C(C)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.12', 'le': '0.29', 'lle': '2.76', 'sei': '10.28'}",CHEMBL3954073,,CHEMBL3954073,7.82,False,http://www.openphacts.org/units/Nanomolar,2840671,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
329813,17708403,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.09', 'le': '0.31', 'lle': '3.43', 'sei': '10.65'}",CHEMBL3931848,,CHEMBL3931848,8.10,False,http://www.openphacts.org/units/Nanomolar,2840672,=,37,True,=,,IC50,nM,,7.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.9
329814,17708404,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.69', 'le': '0.32', 'lle': '4.55', 'sei': '8.59'}",CHEMBL3962807,,CHEMBL3962807,8.59,False,http://www.openphacts.org/units/Nanomolar,2840673,=,37,True,=,,IC50,nM,,2.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.6
329815,17708405,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(Cl)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '18.13', 'le': '0.35', 'lle': '5.04', 'sei': '8.73'}",CHEMBL3940867,,CHEMBL3940867,8.72,False,http://www.openphacts.org/units/Nanomolar,2840674,=,37,True,=,,IC50,nM,,1.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.9
329816,17708406,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(OC(F)F)cc3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.78', 'le': '0.24', 'lle': '2.83', 'sei': '5.79'}",CHEMBL3970397,,CHEMBL3970397,6.32,False,http://www.openphacts.org/units/Nanomolar,2840675,=,37,True,=,,IC50,nM,,479.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,479.0
329817,17708407,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(C3CCCCC3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.38', 'le': '0.30', 'lle': '3.86', 'sei': '7.13'}",CHEMBL3925234,,CHEMBL3925234,7.12,False,http://www.openphacts.org/units/Nanomolar,2840676,=,37,True,=,,IC50,nM,,76.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,76.0
329818,17708408,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.75', 'le': '0.28', 'lle': '4.58', 'sei': '6.59'}",CHEMBL3949501,,CHEMBL3949501,7.85,False,http://www.openphacts.org/units/Nanomolar,2840677,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
329819,17708409,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(Cl)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.28', 'le': '0.32', 'lle': '5.22', 'sei': '6.82'}",CHEMBL3962020,,CHEMBL3962020,8.12,False,http://www.openphacts.org/units/Nanomolar,2840678,=,37,True,=,,IC50,nM,,7.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.5
329820,17708410,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(C3CCCCC3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.93', 'le': '0.24', 'lle': '3.36', 'sei': '4.91'}",CHEMBL3961623,,CHEMBL3961623,5.85,False,http://www.openphacts.org/units/Nanomolar,2840679,=,37,True,=,,IC50,nM,,1400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1400.0
329821,17708411,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(OC(F)F)cc3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '9.41', 'le': '0.18', 'lle': '2.11', 'sei': '3.76'}",CHEMBL3972226,,CHEMBL3972226,4.82,False,http://www.openphacts.org/units/Nanomolar,2840680,=,37,True,=,,IC50,nM,,15000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15000.0
329822,17708412,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.67', 'le': '0.30', 'lle': '3.33', 'sei': '10.41'}",CHEMBL3911401,,CHEMBL3911401,7.92,False,http://www.openphacts.org/units/Nanomolar,2840681,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
329823,17708413,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2CCC2CC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.32', 'le': '0.24', 'lle': '1.35', 'sei': '8.83'}",CHEMBL3897534,,CHEMBL3897534,6.72,False,http://www.openphacts.org/units/Nanomolar,2840682,=,37,True,=,,IC50,nM,,190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,190.0
329824,17708414,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.77', 'le': '0.23', 'lle': '1.87', 'sei': '7.58'}",CHEMBL3901997,,CHEMBL3901997,6.47,False,http://www.openphacts.org/units/Nanomolar,2840683,=,37,True,=,,IC50,nM,,340.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,340.0
329825,17708415,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2/C=C/C2CC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.55', 'le': '0.26', 'lle': '1.92', 'sei': '9.68'}",CHEMBL3903026,,CHEMBL3903026,7.37,False,http://www.openphacts.org/units/Nanomolar,2840684,=,37,True,=,,IC50,nM,,43.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,43.0
329826,17708416,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCO/C=C/c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.34', 'le': '0.29', 'lle': '3.37', 'sei': '9.84'}",CHEMBL3973987,,CHEMBL3973987,8.40,False,http://www.openphacts.org/units/Nanomolar,2840685,=,37,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
329827,17708417,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2ccc(C(C)(C)O)cc2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '10.99', 'le': '0.21', 'lle': '0.80', 'sei': '6.98'}",CHEMBL3904383,,CHEMBL3904383,6.72,False,http://www.openphacts.org/units/Nanomolar,2840686,=,37,True,=,,IC50,nM,,190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,190.0
329828,17708418,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccc(-c2c(N)ncnc2N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN(C)C)CC2)cc1,,,CHEMBL3886265,,2015.0,"{'bei': '11.48', 'le': '0.22', 'lle': '1.54', 'sei': '6.86'}",CHEMBL3937511,,CHEMBL3937511,7.02,False,http://www.openphacts.org/units/Nanomolar,2840687,=,37,True,=,,IC50,nM,,95.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,95.0
329829,17708419,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2-c2ccc(C(=O)O)cc2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.52', 'le': '0.24', 'lle': '2.09', 'sei': '6.60'}",CHEMBL3979190,,CHEMBL3979190,7.48,False,http://www.openphacts.org/units/Nanomolar,2840688,=,37,True,=,,IC50,nM,,33.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,33.0
329830,17708420,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C2=CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.81', 'le': '0.26', 'lle': '1.92', 'sei': '9.87'}",CHEMBL3950150,,CHEMBL3950150,7.51,False,http://www.openphacts.org/units/Nanomolar,2840689,=,37,True,=,,IC50,nM,,31.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31.0
329831,17708421,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C2CC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.07', 'le': '0.31', 'lle': '3.42', 'sei': '10.93'}",CHEMBL3900512,,CHEMBL3900512,8.32,False,http://www.openphacts.org/units/Nanomolar,2840690,=,37,True,=,,IC50,nM,,4.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.8
329832,17708422,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CC(F)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.35', 'le': '0.26', 'lle': '2.47', 'sei': '9.39'}",CHEMBL3890270,,CHEMBL3890270,7.15,False,http://www.openphacts.org/units/Nanomolar,2840691,=,37,True,=,,IC50,nM,,71.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,71.0
329833,17708423,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CC(C)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.26', 'le': '0.29', 'lle': '3.13', 'sei': '10.66'}",CHEMBL3963881,,CHEMBL3963881,8.11,False,http://www.openphacts.org/units/Nanomolar,2840692,=,37,True,=,,IC50,nM,,7.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.7
329834,17708424,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CC(F)(F)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '10.47', 'le': '0.20', 'lle': '0.82', 'sei': '7.62'}",CHEMBL3934633,,CHEMBL3934633,5.80,False,http://www.openphacts.org/units/Nanomolar,2840693,=,37,True,=,,IC50,nM,,1600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1600.0
329835,17708425,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(C)Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.45', 'le': '0.22', 'lle': '1.80', 'sei': '7.92'}",CHEMBL3931709,,CHEMBL3931709,6.28,False,http://www.openphacts.org/units/Nanomolar,2840694,=,37,True,=,,IC50,nM,,520.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,520.0
329836,17708426,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.80', 'le': '0.28', 'lle': '3.14', 'sei': '9.50'}",CHEMBL3904712,,CHEMBL3904712,8.10,False,http://www.openphacts.org/units/Nanomolar,2840695,=,37,True,=,,IC50,nM,,7.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.9
329837,17708427,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.81', 'le': '0.30', 'lle': '4.03', 'sei': '9.63'}",CHEMBL3954017,,CHEMBL3954017,8.21,False,http://www.openphacts.org/units/Nanomolar,2840696,=,37,True,=,,IC50,nM,,6.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.1
329838,17708428,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1-c1cn[nH]c1,,,CHEMBL3886265,,2015.0,"{'bei': '14.69', 'le': '0.28', 'lle': '3.60', 'sei': '7.79'}",CHEMBL3927188,,CHEMBL3927188,8.16,False,http://www.openphacts.org/units/Nanomolar,2840697,=,37,True,=,,IC50,nM,,6.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.9
329839,17708429,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3cncc(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.47', 'le': '0.29', 'lle': '3.75', 'sei': '8.70'}",CHEMBL3951221,,CHEMBL3951221,7.75,False,http://www.openphacts.org/units/Nanomolar,2840698,=,37,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
329840,17708430,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3cccc(OC(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.12', 'le': '0.29', 'lle': '3.33', 'sei': '9.14'}",CHEMBL3980688,,CHEMBL3980688,7.80,False,http://www.openphacts.org/units/Nanomolar,2840699,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
329841,17708431,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3cncc(Cl)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.08', 'le': '0.31', 'lle': '3.89', 'sei': '8.44'}",CHEMBL3907940,,CHEMBL3907940,7.51,False,http://www.openphacts.org/units/Nanomolar,2840700,=,37,True,=,,IC50,nM,,31.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31.0
329842,17708432,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.72', 'le': '0.30', 'lle': '3.82', 'sei': '9.83'}",CHEMBL3932390,,CHEMBL3932390,8.39,False,http://www.openphacts.org/units/Nanomolar,2840701,=,37,True,=,,IC50,nM,,4.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.1
329843,17708433,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1OCC(F)(F)F,,,CHEMBL3886265,,2015.0,"{'bei': '13.92', 'le': '0.27', 'lle': '3.07', 'sei': '9.59'}",CHEMBL3895450,,CHEMBL3895450,8.18,False,http://www.openphacts.org/units/Nanomolar,2840702,=,37,True,=,,IC50,nM,,6.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.6
329844,17708434,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccnc(Cl)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.66', 'le': '0.32', 'lle': '4.16', 'sei': '8.75'}",CHEMBL3923440,,CHEMBL3923440,7.78,False,http://www.openphacts.org/units/Nanomolar,2840703,=,37,True,=,,IC50,nM,,16.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.5
329845,17708435,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccnc(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.75', 'le': '0.30', 'lle': '3.90', 'sei': '8.86'}",CHEMBL3920419,,CHEMBL3920419,7.89,False,http://www.openphacts.org/units/Nanomolar,2840704,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
329846,17708436,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(N)=O)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.84', 'le': '0.28', 'lle': '4.50', 'sei': '6.13'}",CHEMBL3962465,,CHEMBL3962465,7.31,False,http://www.openphacts.org/units/Nanomolar,2840705,=,37,True,=,,IC50,nM,,49.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,49.0
329847,17708437,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(OC)c(C(N)=O)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.47', 'le': '0.25', 'lle': '4.12', 'sei': '5.29'}",CHEMBL3950201,,CHEMBL3950201,6.80,False,http://www.openphacts.org/units/Nanomolar,2840706,=,37,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,160.0
329848,17708438,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(OC)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.35', 'le': '0.32', 'lle': '4.60', 'sei': '9.75'}",CHEMBL3935483,,CHEMBL3935483,8.32,False,http://www.openphacts.org/units/Nanomolar,2840707,=,37,True,=,,IC50,nM,,4.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.8
329849,17708439,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1-c1cnoc1,,,CHEMBL3886265,,2015.0,"{'bei': '15.80', 'le': '0.30', 'lle': '3.98', 'sei': '8.61'}",CHEMBL3941451,,CHEMBL3941451,8.80,False,http://www.openphacts.org/units/Nanomolar,2840708,=,37,True,=,,IC50,nM,,1.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.6
329850,17708440,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1-c1cc[nH]c1,,,CHEMBL3886265,,2015.0,"{'bei': '15.73', 'le': '0.30', 'lle': '3.55', 'sei': '9.49'}",CHEMBL3965271,,CHEMBL3965271,8.72,False,http://www.openphacts.org/units/Nanomolar,2840709,=,37,True,=,,IC50,nM,,1.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.9
329851,17708441,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccnc(C)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.62', 'le': '0.29', 'lle': '3.69', 'sei': '7.84'}",CHEMBL3965063,,CHEMBL3965063,6.97,False,http://www.openphacts.org/units/Nanomolar,2840710,=,37,True,=,,IC50,nM,,106.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,106.0
329852,17708442,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccnc(OC)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.03', 'le': '0.24', 'lle': '3.05', 'sei': '6.14'}",CHEMBL3904876,,CHEMBL3904876,6.03,False,http://www.openphacts.org/units/Nanomolar,2840711,=,37,True,=,,IC50,nM,,940.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,940.0
329853,17708443,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3cncc(C)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.18', 'le': '0.26', 'lle': '3.05', 'sei': '7.12'}",CHEMBL3941855,,CHEMBL3941855,6.33,False,http://www.openphacts.org/units/Nanomolar,2840712,=,37,True,=,,IC50,nM,,465.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,465.0
329854,17708444,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.39', 'le': '0.29', 'lle': '2.89', 'sei': '10.75'}",CHEMBL3917410,,CHEMBL3917410,8.18,False,http://www.openphacts.org/units/Nanomolar,2840713,=,37,True,=,,IC50,nM,,6.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.6
329855,17708445,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N)ncnc1N1CCC(c2nc(-c3ccnc(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.28', 'le': '0.29', 'lle': '4.25', 'sei': '7.82'}",CHEMBL3890310,,CHEMBL3890310,7.68,False,http://www.openphacts.org/units/Nanomolar,2840714,=,37,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.0
329856,17708446,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1c(N)ncnc1N1CCC(c2nc(-c3ccnc(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.65', 'le': '0.30', 'lle': '4.27', 'sei': '8.23'}",CHEMBL3959379,,CHEMBL3959379,8.09,False,http://www.openphacts.org/units/Nanomolar,2840715,=,37,True,=,,IC50,nM,,8.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.2
329857,17708447,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1c(N)ncnc1N1CCC(c2nc(-c3ccnc(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.15', 'le': '0.29', 'lle': '3.83', 'sei': '8.19'}",CHEMBL3927446,,CHEMBL3927446,8.04,False,http://www.openphacts.org/units/Nanomolar,2840716,=,37,True,=,,IC50,nM,,9.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.1
329858,17708448,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccnc(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1OCC(F)(F)F,,,CHEMBL3886265,,2015.0,"{'bei': '13.46', 'le': '0.26', 'lle': '3.31', 'sei': '7.82'}",CHEMBL3965033,,CHEMBL3965033,7.68,False,http://www.openphacts.org/units/Nanomolar,2840717,=,37,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.0
329859,17708449,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3cccc(C(F)(F)F)n3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.74', 'le': '0.24', 'lle': '2.39', 'sei': '7.17'}",CHEMBL3968002,,CHEMBL3968002,6.38,False,http://www.openphacts.org/units/Nanomolar,2840718,=,37,True,=,,IC50,nM,,420.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,420.0
329860,17708450,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '18.09', 'le': '0.34', 'lle': '5.59', 'sei': '7.90'}",CHEMBL3938454,,CHEMBL3938454,8.62,False,http://www.openphacts.org/units/Nanomolar,2840719,=,37,True,=,,IC50,nM,,2.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.4
329861,17708451,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '17.43', 'le': '0.33', 'lle': '6.36', 'sei': '6.71'}",CHEMBL3933597,,CHEMBL3933597,8.62,False,http://www.openphacts.org/units/Nanomolar,2840720,=,37,True,=,,IC50,nM,,2.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.4
329862,17708452,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '18.89', 'le': '0.35', 'lle': '5.37', 'sei': '8.71'}",CHEMBL3961056,,CHEMBL3961056,8.70,False,http://www.openphacts.org/units/Nanomolar,2840721,=,37,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
329863,17708453,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3cccc(Cl)n3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.08', 'le': '0.25', 'lle': '2.49', 'sei': '6.86'}",CHEMBL3905865,,CHEMBL3905865,6.11,False,http://www.openphacts.org/units/Nanomolar,2840722,=,37,True,=,,IC50,nM,,780.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,780.0
329864,17708454,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '16.41', 'le': '0.31', 'lle': '5.29', 'sei': '6.59'}",CHEMBL3972162,,CHEMBL3972162,7.85,False,http://www.openphacts.org/units/Nanomolar,2840723,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
329865,17708455,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccnc(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.11', 'le': '0.30', 'lle': '4.71', 'sei': '7.11'}",CHEMBL3947888,,CHEMBL3947888,8.01,False,http://www.openphacts.org/units/Nanomolar,2840724,=,37,True,=,,IC50,nM,,9.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.7
329866,17708456,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccnc(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '15.70', 'le': '0.34', 'lle': '4.47', 'sei': '9.73'}",CHEMBL3977147,,CHEMBL3977147,8.66,False,http://www.openphacts.org/units/Nanomolar,2840725,=,37,True,=,,IC50,nM,,2.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.2
329867,17708457,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccnc(C(F)(F)F)c4)cn3CCNCCCCl)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '14.55', 'le': '0.32', 'lle': '3.85', 'sei': '8.75'}",CHEMBL3951747,,CHEMBL3951747,8.55,False,http://www.openphacts.org/units/Nanomolar,2840726,=,37,True,=,,IC50,nM,,2.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.8
329868,17708458,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccnc(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.67', 'le': '0.26', 'lle': '4.53', 'sei': '5.33'}",CHEMBL3956421,,CHEMBL3956421,7.05,False,http://www.openphacts.org/units/Nanomolar,2840727,=,37,True,=,,IC50,nM,,90.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,90.0
329869,17708459,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccoc3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.78', 'le': '0.29', 'lle': '4.12', 'sei': '5.84'}",CHEMBL3908333,,CHEMBL3908333,6.60,False,http://www.openphacts.org/units/Nanomolar,2840728,=,37,True,=,,IC50,nM,,250.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,250.0
329870,17708460,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccsc3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.20', 'le': '0.31', 'lle': '4.09', 'sei': '7.05'}",CHEMBL3970947,,CHEMBL3970947,7.04,False,http://www.openphacts.org/units/Nanomolar,2840729,=,37,True,=,,IC50,nM,,91.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,91.0
329871,17708461,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccccc3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.83', 'le': '0.29', 'lle': '3.90', 'sei': '6.79'}",CHEMBL3931262,,CHEMBL3931262,6.78,False,http://www.openphacts.org/units/Nanomolar,2840730,=,37,True,=,,IC50,nM,,165.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,165.0
329872,17708462,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3cnoc3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.87', 'le': '0.29', 'lle': '4.79', 'sei': '5.29'}",CHEMBL3906804,,CHEMBL3906804,6.66,False,http://www.openphacts.org/units/Nanomolar,2840731,=,37,True,=,,IC50,nM,,220.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,220.0
329873,17708463,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccoc3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.47', 'le': '0.23', 'lle': '3.74', 'sei': '4.11'}",CHEMBL3962137,,CHEMBL3962137,5.44,False,http://www.openphacts.org/units/Nanomolar,2840732,=,37,True,=,,IC50,nM,,3600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3600.0
329874,17708464,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccsc3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.64', 'le': '0.24', 'lle': '3.55', 'sei': '4.80'}",CHEMBL3922482,,CHEMBL3922482,5.72,False,http://www.openphacts.org/units/Nanomolar,2840733,=,37,True,=,,IC50,nM,,1900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1900.0
329875,17708465,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3cnoc3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.99', 'le': '0.26', 'lle': '5.02', 'sei': '4.21'}",CHEMBL3929885,,CHEMBL3929885,6.12,False,http://www.openphacts.org/units/Nanomolar,2840734,=,37,True,=,,IC50,nM,,760.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,760.0
329876,17708466,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccccc3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.81', 'le': '0.24', 'lle': '3.61', 'sei': '4.80'}",CHEMBL3913487,,CHEMBL3913487,5.72,False,http://www.openphacts.org/units/Nanomolar,2840735,=,37,True,=,,IC50,nM,,1900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1900.0
329877,17708467,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2C2CCNC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.90', 'le': '0.30', 'lle': '4.09', 'sei': '7.32'}",CHEMBL3935986,,CHEMBL3935986,7.96,False,http://www.openphacts.org/units/Nanomolar,2840736,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
329878,17708468,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2C2CCNC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.50', 'le': '0.26', 'lle': '3.90', 'sei': '5.47'}",CHEMBL3908032,,CHEMBL3908032,7.00,False,http://www.openphacts.org/units/Nanomolar,2840737,=,37,True,=,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100.0
329879,17708469,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.13', 'le': '0.33', 'lle': '4.19', 'sei': '8.27'}",CHEMBL3968744,,CHEMBL3968744,8.18,False,http://www.openphacts.org/units/Nanomolar,2840738,=,37,True,=,,IC50,nM,,6.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.6
329880,17708470,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CC2CNC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.60', 'le': '0.28', 'lle': '4.79', 'sei': '5.91'}",CHEMBL3942663,,CHEMBL3942663,7.57,False,http://www.openphacts.org/units/Nanomolar,2840739,=,37,True,=,,IC50,nM,,27.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,27.0
329881,17708471,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CC2CNC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.37', 'le': '0.27', 'lle': '3.63', 'sei': '6.62'}",CHEMBL3957354,,CHEMBL3957354,7.19,False,http://www.openphacts.org/units/Nanomolar,2840740,=,37,True,=,,IC50,nM,,64.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,64.5
329882,17708472,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2C2CNC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.61', 'le': '0.26', 'lle': '3.14', 'sei': '6.09'}",CHEMBL3891763,,CHEMBL3891763,6.62,False,http://www.openphacts.org/units/Nanomolar,2840741,=,37,True,=,,IC50,nM,,240.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,240.0
329883,17708473,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2C2CNC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.24', 'le': '0.23', 'lle': '3.46', 'sei': '4.82'}",CHEMBL3952076,,CHEMBL3952076,6.17,False,http://www.openphacts.org/units/Nanomolar,2840742,=,37,True,=,,IC50,nM,,670.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,670.0
329884,17708474,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccnc(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '16.97', 'le': '0.34', 'lle': '4.52', 'sei': '9.67'}",CHEMBL3980922,,CHEMBL3980922,8.60,False,http://www.openphacts.org/units/Nanomolar,2840743,=,37,True,=,,IC50,nM,,2.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.5
329885,17708475,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3cn[nH]c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.96', 'le': '0.24', 'lle': '4.83', 'sei': '3.83'}",CHEMBL3963232,,CHEMBL3963232,5.66,False,http://www.openphacts.org/units/Nanomolar,2840744,=,37,True,=,,IC50,nM,,2200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2200.0
329886,17708476,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CC2CCN2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.00', 'le': '0.28', 'lle': '3.81', 'sei': '6.91'}",CHEMBL3906193,,CHEMBL3906193,7.51,False,http://www.openphacts.org/units/Nanomolar,2840745,=,37,True,=,,IC50,nM,,31.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31.0
329887,17708477,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CC2CCCN2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.59', 'le': '0.32', 'lle': '4.45', 'sei': '7.86'}",CHEMBL3968352,,CHEMBL3968352,8.54,False,http://www.openphacts.org/units/Nanomolar,2840746,=,37,True,=,,IC50,nM,,2.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.9
329888,17708478,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CC3CNC3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '15.26', 'le': '0.30', 'lle': '3.44', 'sei': '9.17'}",CHEMBL3897233,,CHEMBL3897233,7.78,False,http://www.openphacts.org/units/Nanomolar,2840747,=,37,True,=,,IC50,nM,,16.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.5
329889,17708479,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CC3CCN3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '14.55', 'le': '0.29', 'lle': '2.94', 'sei': '8.74'}",CHEMBL3896152,,CHEMBL3896152,7.42,False,http://www.openphacts.org/units/Nanomolar,2840748,=,37,True,=,,IC50,nM,,38.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,38.0
329890,17708480,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CC2CCN2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.84', 'le': '0.25', 'lle': '3.73', 'sei': '5.20'}",CHEMBL3955405,,CHEMBL3955405,6.66,False,http://www.openphacts.org/units/Nanomolar,2840749,=,37,True,=,,IC50,nM,,220.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,220.0
329891,17708481,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CC2CNC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.33', 'le': '0.29', 'lle': '3.47', 'sei': '9.10'}",CHEMBL3892286,,CHEMBL3892286,7.72,False,http://www.openphacts.org/units/Nanomolar,2840750,=,37,True,=,,IC50,nM,,19.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,19.0
329892,17708482,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CC2CCN2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.01', 'le': '0.25', 'lle': '2.16', 'sei': '7.72'}",CHEMBL3961268,,CHEMBL3961268,6.55,False,http://www.openphacts.org/units/Nanomolar,2840751,=,37,True,=,,IC50,nM,,280.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,280.0
329893,17708483,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CC2CCCN2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.50', 'le': '0.24', 'lle': '3.34', 'sei': '5.20'}",CHEMBL3901251,,CHEMBL3901251,6.66,False,http://www.openphacts.org/units/Nanomolar,2840752,=,37,True,=,,IC50,nM,,220.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,220.0
329894,17708484,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2C2CCNCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.87', 'le': '0.23', 'lle': '2.83', 'sei': '4.94'}",CHEMBL3968856,,CHEMBL3968856,6.32,False,http://www.openphacts.org/units/Nanomolar,2840753,=,37,True,=,,IC50,nM,,480.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,480.0
329895,17708485,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2C2CCNCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.21', 'le': '0.25', 'lle': '2.54', 'sei': '6.25'}",CHEMBL3906695,,CHEMBL3906695,6.80,False,http://www.openphacts.org/units/Nanomolar,2840754,=,37,True,=,,IC50,nM,,160.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,160.0
329896,17708486,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CC(Cn2cc(-c3ccc(F)c(C(F)(F)F)c3)nc2C2CCN(c3ncnc(N)c3C(N)=O)CC2)C1,,,CHEMBL3886265,,2015.0,"{'bei': '13.32', 'le': '0.25', 'lle': '3.97', 'sei': '5.95'}",CHEMBL3977344,,CHEMBL3977344,7.09,False,http://www.openphacts.org/units/Nanomolar,2840755,=,37,True,=,,IC50,nM,,81.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,81.0
329897,17708487,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2C2CCNCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.99', 'le': '0.25', 'lle': '1.77', 'sei': '7.92'}",CHEMBL3915684,,CHEMBL3915684,6.72,False,http://www.openphacts.org/units/Nanomolar,2840756,=,37,True,=,,IC50,nM,,190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,190.0
329898,17708488,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.80', 'le': '0.34', 'lle': '5.15', 'sei': '6.88'}",CHEMBL3899777,,CHEMBL3899777,8.44,False,http://www.openphacts.org/units/Nanomolar,2840757,=,37,True,=,,IC50,nM,,3.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.6
329899,17708489,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.89', 'le': '0.31', 'lle': '5.30', 'sei': '5.51'}",CHEMBL3926535,,CHEMBL3926535,7.82,False,http://www.openphacts.org/units/Nanomolar,2840758,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
329900,17708490,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCO)c(C3CCN(c4ncnc(N)c4-c4cn[nH]c4)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '13.35', 'le': '0.25', 'lle': '3.03', 'sei': '5.07'}",CHEMBL3900157,,CHEMBL3900157,6.17,False,http://www.openphacts.org/units/Nanomolar,2840759,=,37,True,=,,IC50,nM,,670.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,670.0
329901,17708491,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCNC3CC3)c(C3CCN(c4ncnc(N)c4-c4cn[nH]c4)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '13.60', 'le': '0.25', 'lle': '2.92', 'sei': '6.01'}",CHEMBL3983786,,CHEMBL3983786,6.82,False,http://www.openphacts.org/units/Nanomolar,2840760,=,37,True,=,,IC50,nM,,150.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,150.0
329902,17708492,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CNCCn1cc(-c2ccc(F)c(C)c2)nc1C1CCN(c2ncnc(N)c2-c2cn[nH]c2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.14', 'le': '0.30', 'lle': '4.32', 'sei': '6.76'}",CHEMBL3913969,,CHEMBL3913969,7.68,False,http://www.openphacts.org/units/Nanomolar,2840761,=,37,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.0
329903,17708493,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN(C)C)c(C3CCN(c4ncnc(N)c4-c4cn[nH]c4)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '16.99', 'le': '0.32', 'lle': '4.61', 'sei': '7.94'}",CHEMBL3957657,,CHEMBL3957657,8.32,False,http://www.openphacts.org/units/Nanomolar,2840762,=,37,True,=,,IC50,nM,,4.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.8
329904,17708494,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4-c4cn[nH]c4)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '16.47', 'le': '0.30', 'lle': '4.41', 'sei': '7.88'}",CHEMBL3922949,,CHEMBL3922949,8.26,False,http://www.openphacts.org/units/Nanomolar,2840763,=,37,True,=,,IC50,nM,,5.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.5
329905,17708495,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCNC(C)(C)C)c(C3CCN(c4ncnc(N)c4-c4cn[nH]c4)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '15.96', 'le': '0.30', 'lle': '3.73', 'sei': '7.27'}",CHEMBL3970663,,CHEMBL3970663,8.26,False,http://www.openphacts.org/units/Nanomolar,2840764,=,37,True,=,,IC50,nM,,5.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.5
329906,17708496,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CNCCn1cc(-c2ccnc(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2Br)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.80', 'le': '0.37', 'lle': '5.12', 'sei': '9.02'}",CHEMBL3899490,,CHEMBL3899490,8.82,False,http://www.openphacts.org/units/Nanomolar,2840765,=,37,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
329907,17708497,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CNCCn1cc(-c2ccnc(C(F)(F)F)c2)nc1C1CCN(c2cc(N)ncn2)CC1,,,CHEMBL3886265,,2015.0,,CHEMBL3912226,,CHEMBL3912226,,False,http://www.openphacts.org/units/Nanomolar,2840766,>,37,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
329908,17708498,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccnc(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1-c1cnoc1,,,CHEMBL3886265,,2015.0,"{'bei': '15.88', 'le': '0.30', 'lle': '4.49', 'sei': '7.45'}",CHEMBL3908552,,CHEMBL3908552,8.57,False,http://www.openphacts.org/units/Nanomolar,2840767,=,37,True,=,,IC50,nM,,2.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.7
329909,17708499,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CNCCn1cc(-c2ccnc(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '18.60', 'le': '0.35', 'lle': '5.96', 'sei': '7.21'}",CHEMBL3949795,,CHEMBL3949795,8.77,False,http://www.openphacts.org/units/Nanomolar,2840768,=,37,True,=,,IC50,nM,,1.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.7
329910,17708500,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CNCCn1cc(-c2ccnc(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C2C=NOC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.42', 'le': '0.26', 'lle': '3.88', 'sei': '5.80'}",CHEMBL3978853,,CHEMBL3978853,6.92,False,http://www.openphacts.org/units/Nanomolar,2840769,=,37,True,=,,IC50,nM,,120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,120.0
329911,17708501,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccnc(C(F)(F)F)c3)cn2CCNC)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '18.29', 'le': '0.35', 'lle': '5.18', 'sei': '8.87'}",CHEMBL3910789,,CHEMBL3910789,8.68,False,http://www.openphacts.org/units/Nanomolar,2840770,=,37,True,=,,IC50,nM,,2.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.1
329912,17708502,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CNCCn1cc(-c2ccnc(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2Cl)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '18.41', 'le': '0.37', 'lle': '5.26', 'sei': '9.05'}",CHEMBL3948454,,CHEMBL3948454,8.85,False,http://www.openphacts.org/units/Nanomolar,2840771,=,37,True,=,,IC50,nM,,1.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.4
329913,17708503,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccnc(C(F)(F)F)c4)cn3CCNC3CC3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '16.66', 'le': '0.33', 'lle': '4.31', 'sei': '8.64'}",CHEMBL3931731,,CHEMBL3931731,8.44,False,http://www.openphacts.org/units/Nanomolar,2840772,=,37,True,=,,IC50,nM,,3.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.6
329914,17708504,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2OC(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.33', 'le': '0.33', 'lle': '4.42', 'sei': '9.86'}",CHEMBL3943127,,CHEMBL3943127,9.28,False,http://www.openphacts.org/units/Nanomolar,2840773,=,37,True,=,,IC50,nM,,0.52,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.52
329915,17708505,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CC2CNC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.64', 'le': '0.30', 'lle': '3.88', 'sei': '8.87'}",CHEMBL3925183,,CHEMBL3925183,8.35,False,http://www.openphacts.org/units/Nanomolar,2840774,=,37,True,=,,IC50,nM,,4.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.5
329916,17708506,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CC2CNC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.98', 'le': '0.31', 'lle': '4.22', 'sei': '8.82'}",CHEMBL3900660,,CHEMBL3900660,8.30,False,http://www.openphacts.org/units/Nanomolar,2840775,=,37,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.0
329917,17708507,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '18.09', 'le': '0.34', 'lle': '4.82', 'sei': '10.17'}",CHEMBL3916178,,CHEMBL3916178,8.68,False,http://www.openphacts.org/units/Nanomolar,2840776,=,37,True,=,,IC50,nM,,2.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.1
329918,17708508,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4OC(C)C)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '17.36', 'le': '0.33', 'lle': '4.32', 'sei': '10.04'}",CHEMBL3985943,,CHEMBL3985943,8.57,False,http://www.openphacts.org/units/Nanomolar,2840777,=,37,True,=,,IC50,nM,,2.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.7
329919,17708509,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccnc(C(C)C)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.65', 'le': '0.33', 'lle': '4.29', 'sei': '9.41'}",CHEMBL3944209,,CHEMBL3944209,8.38,False,http://www.openphacts.org/units/Nanomolar,2840778,=,37,True,=,,IC50,nM,,4.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.2
329920,17708510,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4Cl)CC3)n2)ccn1,,,CHEMBL3886265,,2015.0,"{'bei': '17.92', 'le': '0.35', 'lle': '4.44', 'sei': '9.69'}",CHEMBL3912769,,CHEMBL3912769,8.62,False,http://www.openphacts.org/units/Nanomolar,2840779,=,37,True,=,,IC50,nM,,2.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.4
329921,17708511,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4Br)CC3)n2)ccn1,,,CHEMBL3886265,,2015.0,"{'bei': '18.69', 'le': '0.39', 'lle': '5.53', 'sei': '11.04'}",CHEMBL3966806,,CHEMBL3966806,9.82,False,http://www.openphacts.org/units/Nanomolar,2840780,=,37,True,=,,IC50,nM,,0.15,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.15
329922,17708512,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1c(N)ncnc1N1CCC(c2nc(-c3ccnc(C(C)C)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '18.32', 'le': '0.34', 'lle': '4.49', 'sei': '9.73'}",CHEMBL3891980,,CHEMBL3891980,8.66,False,http://www.openphacts.org/units/Nanomolar,2840781,=,37,True,=,,IC50,nM,,2.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.2
329923,17708513,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CC2CNC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.22', 'le': '0.27', 'lle': '2.80', 'sei': '8.40'}",CHEMBL3952282,,CHEMBL3952282,7.13,False,http://www.openphacts.org/units/Nanomolar,2840782,=,37,True,=,,IC50,nM,,74.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,74.0
329924,17708514,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C)c3)cn2CC2CNC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '19.13', 'le': '0.36', 'lle': '5.66', 'sei': '9.18'}",CHEMBL3981085,,CHEMBL3981085,8.64,False,http://www.openphacts.org/units/Nanomolar,2840783,=,37,True,=,,IC50,nM,,2.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.3
329925,17708515,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C)c3)cn2CC2CNC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.57', 'le': '0.33', 'lle': '4.81', 'sei': '8.69'}",CHEMBL3943569,,CHEMBL3943569,8.18,False,http://www.openphacts.org/units/Nanomolar,2840784,=,37,True,=,,IC50,nM,,6.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.6
329926,17708516,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CC3CNC3)c(C3CCN(c4ncnc(N)c4OCC(F)(F)F)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '15.68', 'le': '0.30', 'lle': '4.24', 'sei': '8.66'}",CHEMBL3976254,,CHEMBL3976254,8.15,False,http://www.openphacts.org/units/Nanomolar,2840785,=,37,True,=,,IC50,nM,,7.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.1
329927,17708517,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CC3CNC3)c(C3CCN(c4ncnc(N)c4OC(C)C)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '17.08', 'le': '0.32', 'lle': '4.43', 'sei': '8.71'}",CHEMBL3987123,,CHEMBL3987123,8.19,False,http://www.openphacts.org/units/Nanomolar,2840786,=,37,True,=,,IC50,nM,,6.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.4
329928,17708518,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C)c3)cn2CC2CNC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '19.21', 'le': '0.36', 'lle': '5.10', 'sei': '10.18'}",CHEMBL3967750,,CHEMBL3967750,8.64,False,http://www.openphacts.org/units/Nanomolar,2840787,=,37,True,=,,IC50,nM,,2.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.3
329929,17708519,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CC3CNC3)c(C3CCN(c4ncnc(N)c4C(C)C)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '18.00', 'le': '0.34', 'lle': '4.25', 'sei': '9.83'}",CHEMBL3974201,,CHEMBL3974201,8.35,False,http://www.openphacts.org/units/Nanomolar,2840788,=,37,True,=,,IC50,nM,,4.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.5
329930,17708520,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4Br)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '19.44', 'le': '0.41', 'lle': '5.78', 'sei': '13.14'}",CHEMBL3899716,,CHEMBL3899716,10.00,False,http://www.openphacts.org/units/Nanomolar,2840789,=,37,True,=,,IC50,nM,,0.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.1
329931,17708521,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CC3CNC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '17.52', 'le': '0.32', 'lle': '4.98', 'sei': '7.20'}",CHEMBL3943038,,CHEMBL3943038,7.82,False,http://www.openphacts.org/units/Nanomolar,2840790,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
329932,17708522,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncnc(N2CCC(c3nc(-c4ccnc(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '9.87', 'le': '0.20', 'lle': '0.60', 'sei': '6.86'}",CHEMBL3984446,,CHEMBL3984446,5.14,False,http://www.openphacts.org/units/Nanomolar,2840791,=,37,True,=,,IC50,nM,,7200.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7200.0
329933,17708523,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C)c4)cn3CC3CNC3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '11.16', 'le': '0.22', 'lle': '1.15', 'sei': '7.40'}",CHEMBL3923651,,CHEMBL3923651,5.24,False,http://www.openphacts.org/units/Nanomolar,2840792,=,37,True,=,,IC50,nM,,5700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5700.0
329934,17708524,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CC3CNC3)c(C3CCC(c4ncnc(N)c4C(C)C)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '16.85', 'le': '0.31', 'lle': '2.65', 'sei': '9.55'}",CHEMBL3899097,,CHEMBL3899097,7.80,False,http://www.openphacts.org/units/Nanomolar,2840793,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
329935,17708525,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)cc3)cn2CCN2CCOCC2)CC1,,,CHEMBL3886265,,2015.0,,CHEMBL3953761,,CHEMBL3953761,,False,http://www.openphacts.org/units/Nanomolar,2840794,>,37,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
329936,17708526,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(F)c3)cn2CCN2CCOCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.93', 'le': '0.24', 'lle': '2.95', 'sei': '7.54'}",CHEMBL3971381,,CHEMBL3971381,6.43,False,http://www.openphacts.org/units/Nanomolar,2840795,=,37,True,=,,IC50,nM,,370.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,370.0
329937,17708527,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)cc3)cn2CCN2CC3(COC3)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.01', 'le': '0.26', 'lle': '3.55', 'sei': '8.07'}",CHEMBL3909262,,CHEMBL3909262,6.89,False,http://www.openphacts.org/units/Nanomolar,2840796,=,37,True,=,,IC50,nM,,130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,130.0
329938,17708528,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(F)c3)cn2CCN2CC3(COC3)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.94', 'le': '0.24', 'lle': '3.11', 'sei': '7.73'}",CHEMBL3976391,,CHEMBL3976391,6.59,False,http://www.openphacts.org/units/Nanomolar,2840797,=,37,True,=,,IC50,nM,,255.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,255.0
329939,17708529,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(F)c3)cn2CCN2CC(F)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.21', 'le': '0.25', 'lle': '2.61', 'sei': '8.43'}",CHEMBL3922457,,CHEMBL3922457,6.42,False,http://www.openphacts.org/units/Nanomolar,2840798,=,37,True,=,,IC50,nM,,385.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,385.0
329940,17708530,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)cc3)cn2CCN2CC(F)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.25', 'le': '0.25', 'lle': '2.53', 'sei': '8.14'}",CHEMBL3894443,,CHEMBL3894443,6.19,False,http://www.openphacts.org/units/Nanomolar,2840799,=,37,True,=,,IC50,nM,,640.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,640.0
329941,17708531,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)cc3)cn2CCN2CCC3(COC3)C2)CC1,,,CHEMBL3886265,,2015.0,,CHEMBL3943713,,CHEMBL3943713,,False,http://www.openphacts.org/units/Nanomolar,2840800,>,37,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
329942,17708532,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(F)c3)cn2CCN2CCC3(COC3)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.46', 'le': '0.25', 'lle': '3.18', 'sei': '8.26'}",CHEMBL3926249,,CHEMBL3926249,7.05,False,http://www.openphacts.org/units/Nanomolar,2840801,=,37,True,=,,IC50,nM,,89.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,89.0
329943,17708533,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(F)c3)cn2CCN2CCC23COC3)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '10.99', 'le': '0.21', 'lle': '1.98', 'sei': '6.57'}",CHEMBL3971435,,CHEMBL3971435,5.60,False,http://www.openphacts.org/units/Nanomolar,2840802,=,37,True,=,,IC50,nM,,2500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2500.0
329944,17708534,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)cc3)cn2CCN2CCC23COC3)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.07', 'le': '0.21', 'lle': '1.96', 'sei': '6.38'}",CHEMBL3941846,,CHEMBL3941846,5.44,False,http://www.openphacts.org/units/Nanomolar,2840803,=,37,True,=,,IC50,nM,,3600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3600.0
329945,17708535,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3cnc(F)c(Cl)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '18.44', 'le': '0.36', 'lle': '5.82', 'sei': '7.88'}",CHEMBL3966203,,CHEMBL3966203,8.89,False,http://www.openphacts.org/units/Nanomolar,2840804,=,37,True,=,,IC50,nM,,1.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.3
329946,17708536,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccnc(F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.62', 'le': '0.33', 'lle': '5.47', 'sei': '6.99'}",CHEMBL3932866,,CHEMBL3932866,7.89,False,http://www.openphacts.org/units/Nanomolar,2840805,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
329947,17708537,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc4[nH]ncc4c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.89', 'le': '0.27', 'lle': '4.22', 'sei': '5.43'}",CHEMBL3955055,,CHEMBL3955055,6.98,False,http://www.openphacts.org/units/Nanomolar,2840806,=,37,True,=,,IC50,nM,,105.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,105.0
329948,17708538,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.27', 'le': '0.29', 'lle': '3.00', 'sei': '10.67'}",CHEMBL3927440,,CHEMBL3927440,8.12,False,http://www.openphacts.org/units/Nanomolar,2840807,=,37,True,=,,IC50,nM,,7.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.6
329949,17708539,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '16.09', 'le': '0.32', 'lle': '3.45', 'sei': '11.38'}",CHEMBL3986793,,CHEMBL3986793,8.66,False,http://www.openphacts.org/units/Nanomolar,2840808,=,37,True,=,,IC50,nM,,2.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.2
329950,17708540,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(O)c(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '15.90', 'le': '0.31', 'lle': '3.74', 'sei': '8.85'}",CHEMBL3961556,,CHEMBL3961556,8.52,False,http://www.openphacts.org/units/Nanomolar,2840809,=,37,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
329951,17708541,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)c1F,,,CHEMBL3886265,,2015.0,"{'bei': '14.65', 'le': '0.28', 'lle': '2.94', 'sei': '10.04'}",CHEMBL3895789,,CHEMBL3895789,7.64,False,http://www.openphacts.org/units/Nanomolar,2840810,=,37,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
329952,17708542,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=C(C)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.98', 'le': '0.27', 'lle': '1.82', 'sei': '10.24'}",CHEMBL3923786,,CHEMBL3923786,7.80,False,http://www.openphacts.org/units/Nanomolar,2840811,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
329953,17708543,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=C(C)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.16', 'le': '0.27', 'lle': '2.11', 'sei': '10.12'}",CHEMBL3901242,,CHEMBL3901242,7.70,False,http://www.openphacts.org/units/Nanomolar,2840812,=,37,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
329954,17708544,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)ncn1,,,CHEMBL3886265,,2015.0,"{'bei': '13.39', 'le': '0.26', 'lle': '2.18', 'sei': '8.86'}",CHEMBL3932730,,CHEMBL3932730,6.75,False,http://www.openphacts.org/units/Nanomolar,2840813,=,37,True,=,,IC50,nM,,180.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,180.0
329955,17708545,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.46', 'le': '0.30', 'lle': '3.13', 'sei': '10.51'}",CHEMBL3910308,,CHEMBL3910308,8.00,False,http://www.openphacts.org/units/Nanomolar,2840814,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
329956,17708546,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCCC3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '14.58', 'le': '0.29', 'lle': '2.45', 'sei': '10.57'}",CHEMBL3938237,,CHEMBL3938237,8.05,False,http://www.openphacts.org/units/Nanomolar,2840815,=,37,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
329957,17708547,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '15.20', 'le': '0.33', 'lle': '3.71', 'sei': '11.35'}",CHEMBL3894578,,CHEMBL3894578,8.64,False,http://www.openphacts.org/units/Nanomolar,2840816,=,37,True,=,,IC50,nM,,2.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.3
329958,17708548,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '17.18', 'le': '0.34', 'lle': '4.18', 'sei': '11.83'}",CHEMBL3919089,,CHEMBL3919089,9.00,False,http://www.openphacts.org/units/Nanomolar,2840817,=,37,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
329959,17708549,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1-c1ccc(F)cc1,,,CHEMBL3886265,,2015.0,"{'bei': '14.80', 'le': '0.28', 'lle': '2.66', 'sei': '11.35'}",CHEMBL3903522,,CHEMBL3903522,8.64,False,http://www.openphacts.org/units/Nanomolar,2840818,=,37,True,=,,IC50,nM,,2.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.3
329960,17708550,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.25', 'le': '0.31', 'lle': '3.57', 'sei': '11.01'}",CHEMBL3931504,,CHEMBL3931504,8.38,False,http://www.openphacts.org/units/Nanomolar,2840819,=,37,True,=,,IC50,nM,,4.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.2
329961,17708551,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCC3)CC2)ncn1,,,CHEMBL3886265,,2015.0,"{'bei': '14.60', 'le': '0.28', 'lle': '2.98', 'sei': '9.39'}",CHEMBL3917257,,CHEMBL3917257,7.15,False,http://www.openphacts.org/units/Nanomolar,2840820,=,37,True,=,,IC50,nM,,71.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,71.0
329962,17708552,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccc(-c2c(N)ncnc2N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCC3)CC2)cc1,,,CHEMBL3886265,,2015.0,"{'bei': '11.81', 'le': '0.22', 'lle': '1.75', 'sei': '7.19'}",CHEMBL3987000,,CHEMBL3987000,7.37,False,http://www.openphacts.org/units/Nanomolar,2840821,=,37,True,=,,IC50,nM,,43.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,43.0
329963,17708553,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccc(-c2c(N)ncnc2N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)cc1,,,CHEMBL3886265,,2015.0,"{'bei': '11.15', 'le': '0.21', 'lle': '1.10', 'sei': '6.94'}",CHEMBL3926246,,CHEMBL3926246,7.11,False,http://www.openphacts.org/units/Nanomolar,2840822,=,37,True,=,,IC50,nM,,78.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,78.0
329964,17708554,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1-c1ccc(C(=O)O)cc1,,,CHEMBL3886265,,2015.0,"{'bei': '12.99', 'le': '0.25', 'lle': '2.38', 'sei': '6.98'}",CHEMBL3901741,,CHEMBL3901741,7.92,False,http://www.openphacts.org/units/Nanomolar,2840823,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
329965,17708555,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)c1-c1ccc(C(=O)O)cc1,,,CHEMBL3886265,,2015.0,"{'bei': '12.70', 'le': '0.24', 'lle': '1.99', 'sei': '6.98'}",CHEMBL3960331,,CHEMBL3960331,7.92,False,http://www.openphacts.org/units/Nanomolar,2840824,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
329966,17708556,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(F)c4)cn3CCN3CCCC3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '16.47', 'le': '0.35', 'lle': '4.33', 'sei': '11.52'}",CHEMBL3944201,,CHEMBL3944201,8.77,False,http://www.openphacts.org/units/Nanomolar,2840825,=,37,True,=,,IC50,nM,,1.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.7
329967,17708557,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)cc4)cn3CCN3CCCC3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '16.60', 'le': '0.35', 'lle': '4.24', 'sei': '11.22'}",CHEMBL3911853,,CHEMBL3911853,8.54,False,http://www.openphacts.org/units/Nanomolar,2840826,=,37,True,=,,IC50,nM,,2.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.9
329968,17708558,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4cccc(F)c4)cn3CCN3CCCC3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '16.00', 'le': '0.34', 'lle': '3.93', 'sei': '10.81'}",CHEMBL3949523,,CHEMBL3949523,8.23,False,http://www.openphacts.org/units/Nanomolar,2840827,=,37,True,=,,IC50,nM,,5.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.9
329969,17708559,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(C(F)(F)F)c(F)c4)cn3CCN3CCCC3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '12.27', 'le': '0.26', 'lle': '1.83', 'sei': '9.39'}",CHEMBL3950518,,CHEMBL3950518,7.15,False,http://www.openphacts.org/units/Nanomolar,2840828,=,37,True,=,,IC50,nM,,71.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,71.0
329970,17708560,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.20', 'le': '0.31', 'lle': '3.66', 'sei': '11.02'}",CHEMBL3922798,,CHEMBL3922798,8.39,False,http://www.openphacts.org/units/Nanomolar,2840829,=,37,True,=,,IC50,nM,,4.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.1
329971,17708561,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3cccc(F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.83', 'le': '0.29', 'lle': '3.24', 'sei': '9.64'}",CHEMBL3969229,,CHEMBL3969229,7.34,False,http://www.openphacts.org/units/Nanomolar,2840830,=,37,True,=,,IC50,nM,,46.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,46.0
329972,17708562,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)cc3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.61', 'le': '0.31', 'lle': '3.60', 'sei': '10.12'}",CHEMBL3894577,,CHEMBL3894577,7.70,False,http://www.openphacts.org/units/Nanomolar,2840831,=,37,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
329973,17708563,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.79', 'le': '0.32', 'lle': '3.85', 'sei': '10.63'}",CHEMBL3954781,,CHEMBL3954781,8.09,False,http://www.openphacts.org/units/Nanomolar,2840832,=,37,True,=,,IC50,nM,,8.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.2
329974,17708564,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(C(F)(F)F)c(F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.90', 'le': '0.23', 'lle': '1.21', 'sei': '8.32'}",CHEMBL3983416,,CHEMBL3983416,6.33,False,http://www.openphacts.org/units/Nanomolar,2840833,=,37,True,=,,IC50,nM,,470.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,470.0
329975,17708565,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(C(F)(F)F)c(F)c4)cn3CCN3CCCC3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '11.15', 'le': '0.22', 'lle': '0.79', 'sei': '7.88'}",CHEMBL3929830,,CHEMBL3929830,6.00,False,http://www.openphacts.org/units/Nanomolar,2840834,=,37,True,=,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
329976,17708566,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4cccc(F)c4)cn3CCN3CCCC3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '17.22', 'le': '0.33', 'lle': '3.90', 'sei': '10.63'}",CHEMBL3978595,,CHEMBL3978595,8.09,False,http://www.openphacts.org/units/Nanomolar,2840835,=,37,True,=,,IC50,nM,,8.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.1
329977,17708567,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)cc4)cn3CCN3CCCC3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '18.05', 'le': '0.35', 'lle': '4.29', 'sei': '11.15'}",CHEMBL3912632,,CHEMBL3912632,8.48,False,http://www.openphacts.org/units/Nanomolar,2840836,=,37,True,=,,IC50,nM,,3.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.3
329978,17708568,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(F)c4)cn3CCN3CCCC3)CC2)c1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '17.41', 'le': '0.34', 'lle': '4.16', 'sei': '11.16'}",CHEMBL3940627,,CHEMBL3940627,8.49,False,http://www.openphacts.org/units/Nanomolar,2840837,=,37,True,=,,IC50,nM,,3.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.2
329979,17708569,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(C(F)(F)F)c(F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.61', 'le': '0.24', 'lle': '1.48', 'sei': '8.78'}",CHEMBL3964344,,CHEMBL3964344,6.68,False,http://www.openphacts.org/units/Nanomolar,2840838,=,37,True,=,,IC50,nM,,210.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,210.0
329980,17708570,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1c(N)ncnc1N1CCC(c2nc(-c3cccc(F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.63', 'le': '0.31', 'lle': '3.50', 'sei': '10.09'}",CHEMBL3928074,,CHEMBL3928074,7.68,False,http://www.openphacts.org/units/Nanomolar,2840839,=,37,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.0
329981,17708571,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)cc3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.89', 'le': '0.31', 'lle': '3.62', 'sei': '10.24'}",CHEMBL3974191,,CHEMBL3974191,7.80,False,http://www.openphacts.org/units/Nanomolar,2840840,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
329982,17708572,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.71', 'le': '0.31', 'lle': '3.69', 'sei': '10.53'}",CHEMBL3913177,,CHEMBL3913177,8.01,False,http://www.openphacts.org/units/Nanomolar,2840841,=,37,True,=,,IC50,nM,,9.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.7
329983,17708573,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(N2CCC(c3nc(-c4ccc(F)c(F)c4)cn3CCN3CCCC3)CC2)ncn1,,,CHEMBL3886265,,2015.0,"{'bei': '15.88', 'le': '0.30', 'lle': '3.52', 'sei': '9.46'}",CHEMBL3973291,,CHEMBL3973291,7.20,False,http://www.openphacts.org/units/Nanomolar,2840842,=,37,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,63.0
329984,17708574,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(N2CCC(c3nc(-c4cccc(F)c4)cn3CCN3CCCC3)CC2)ncn1,,,CHEMBL3886265,,2015.0,"{'bei': '15.33', 'le': '0.29', 'lle': '3.14', 'sei': '8.78'}",CHEMBL3907714,,CHEMBL3907714,6.68,False,http://www.openphacts.org/units/Nanomolar,2840843,=,37,True,=,,IC50,nM,,210.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,210.0
329985,17708575,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(C(F)(F)F)c(F)c3)cn2CCN2CC[C@H](F)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.09', 'le': '0.25', 'lle': '2.12', 'sei': '9.45'}",CHEMBL3889695,,CHEMBL3889695,7.19,False,http://www.openphacts.org/units/Nanomolar,2840844,=,37,True,=,,IC50,nM,,64.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,64.0
329986,17708576,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(C(F)(F)F)c(F)c3)cn2CCN2CC[C@@H](F)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.83', 'le': '0.27', 'lle': '2.53', 'sei': '9.99'}",CHEMBL4108380,,CHEMBL4108380,7.60,False,http://www.openphacts.org/units/Nanomolar,2840845,=,37,True,=,,IC50,nM,,25.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.0
329987,17708577,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(C(F)(F)F)c(F)c3)cn2CCN2CCC(F)(F)CC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '10.80', 'le': '0.21', 'lle': '0.52', 'sei': '8.26'}",CHEMBL3913067,,CHEMBL3913067,6.28,False,http://www.openphacts.org/units/Nanomolar,2840846,=,37,True,=,,IC50,nM,,520.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,520.0
329988,17708578,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(C(F)(F)F)c(F)c3)cn2CCN2CCCC(F)(F)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '10.32', 'le': '0.20', 'lle': '0.24', 'sei': '7.88'}",CHEMBL3950042,,CHEMBL3950042,6.00,False,http://www.openphacts.org/units/Nanomolar,2840847,=,37,True,=,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
329989,17708579,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(C(F)(F)F)c(F)c3)cn2CCN2CCC(F)CC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.54', 'le': '0.24', 'lle': '1.61', 'sei': '9.28'}",CHEMBL3908831,,CHEMBL3908831,7.07,False,http://www.openphacts.org/units/Nanomolar,2840848,=,37,True,=,,IC50,nM,,86.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,86.0
329990,17708580,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(C(F)(F)F)c(F)c3)cn2CCN2CCCC(F)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.85', 'le': '0.23', 'lle': '1.22', 'sei': '8.78'}",CHEMBL3976022,,CHEMBL3976022,6.68,False,http://www.openphacts.org/units/Nanomolar,2840849,=,37,True,=,,IC50,nM,,210.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,210.0
329991,17708581,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(Cl)c(F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.29', 'le': '0.28', 'lle': '2.36', 'sei': '9.36'}",CHEMBL3977596,,CHEMBL3977596,7.12,False,http://www.openphacts.org/units/Nanomolar,2840850,=,37,True,=,,IC50,nM,,76.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,76.0
329992,17708582,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(Cl)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '18.87', 'le': '0.37', 'lle': '4.64', 'sei': '12.35'}",CHEMBL3906990,,CHEMBL3906990,9.40,False,http://www.openphacts.org/units/Nanomolar,2840851,=,37,True,=,,IC50,nM,,0.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.4
329993,17708583,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(C(F)(F)F)c(F)c4)cn3CCN3CCCCC3)CC2)c1C1CCC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.21', 'le': '0.25', 'lle': '1.33', 'sei': '9.92'}",CHEMBL3891427,,CHEMBL3891427,7.55,False,http://www.openphacts.org/units/Nanomolar,2840852,=,37,True,=,,IC50,nM,,28.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,28.0
329994,17708584,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(C(F)(F)F)c(F)c4)cn3CCN3CCCC3)CC2)c1C1CCC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.42', 'le': '0.27', 'lle': '2.21', 'sei': '10.57'}",CHEMBL3915954,,CHEMBL3915954,8.04,False,http://www.openphacts.org/units/Nanomolar,2840853,=,37,True,=,,IC50,nM,,9.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.1
329995,17708585,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(F)c4)cn3CCN3CCCC3)CC2)c1C1CCC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.81', 'le': '0.30', 'lle': '3.08', 'sei': '10.55'}",CHEMBL3961562,,CHEMBL3961562,8.03,False,http://www.openphacts.org/units/Nanomolar,2840854,=,37,True,=,,IC50,nM,,9.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.4
329996,17708586,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)cc4)cn3CCN3CCCC3)CC2)c1C1CCC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.25', 'le': '0.30', 'lle': '3.15', 'sei': '10.46'}",CHEMBL3892575,,CHEMBL3892575,7.96,False,http://www.openphacts.org/units/Nanomolar,2840855,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
329997,17708587,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4cccc(F)c4)cn3CCN3CCCC3)CC2)c1C1CCC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.72', 'le': '0.29', 'lle': '2.89', 'sei': '10.12'}",CHEMBL3969159,,CHEMBL3969159,7.70,False,http://www.openphacts.org/units/Nanomolar,2840856,=,37,True,=,,IC50,nM,,20.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.0
329998,17708588,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(C(F)(F)F)c(F)c4)cn3CCN3CCCC3)CC2)c1C1CCC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.51', 'le': '0.22', 'lle': '0.59', 'sei': '8.44'}",CHEMBL3915954,,CHEMBL3915954,6.42,False,http://www.openphacts.org/units/Nanomolar,2840853,=,37,True,=,,IC50,nM,,380.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,380.0
329999,17708589,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(C(F)(F)F)cc4)cn3CCN3CCCC3)CC2)c1C1CCC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.80', 'le': '0.22', 'lle': '0.68', 'sei': '8.37'}",CHEMBL3942949,,CHEMBL3942949,6.37,False,http://www.openphacts.org/units/Nanomolar,2840857,=,37,True,=,,IC50,nM,,430.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,430.0
330000,17708590,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(Cl)c(F)c4)cn3CCN3CCCC3)CC2)c1C1CCC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.69', 'le': '0.26', 'lle': '1.71', 'sei': '9.43'}",CHEMBL3972543,,CHEMBL3972543,7.17,False,http://www.openphacts.org/units/Nanomolar,2840858,=,37,True,=,,IC50,nM,,67.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,67.0
330001,17708591,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4cccc(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)c1C1CCC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.99', 'le': '0.28', 'lle': '2.40', 'sei': '10.63'}",CHEMBL3981168,,CHEMBL3981168,8.09,False,http://www.openphacts.org/units/Nanomolar,2840859,=,37,True,=,,IC50,nM,,8.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.1
330002,17708592,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(Cl)c4)cn3CCN3CCCC3)CC2)c1C1CCC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.86', 'le': '0.31', 'lle': '2.85', 'sei': '10.92'}",CHEMBL3952378,,CHEMBL3952378,8.31,False,http://www.openphacts.org/units/Nanomolar,2840860,=,37,True,=,,IC50,nM,,4.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.9
330003,17708593,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(Cl)cc4)cn3CCN3CCCC3)CC2)c1C1CCC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.03', 'le': '0.27', 'lle': '1.78', 'sei': '9.33'}",CHEMBL3892087,,CHEMBL3892087,7.10,False,http://www.openphacts.org/units/Nanomolar,2840861,=,37,True,=,,IC50,nM,,79.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,79.0
330004,17708594,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4cccc(Cl)c4)cn3CCN3CCCC3)CC2)c1C1CCC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.22', 'le': '0.31', 'lle': '2.89', 'sei': '10.79'}",CHEMBL3957616,,CHEMBL3957616,8.21,False,http://www.openphacts.org/units/Nanomolar,2840862,=,37,True,=,,IC50,nM,,6.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.2
330005,17708595,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(C(F)(F)F)cc4)cn3CCN3CCCC3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '12.33', 'le': '0.26', 'lle': '1.78', 'sei': '9.14'}",CHEMBL3897494,,CHEMBL3897494,6.96,False,http://www.openphacts.org/units/Nanomolar,2840863,=,37,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,110.0
330006,17708596,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(Cl)c(F)c4)cn3CCN3CCCC3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '14.20', 'le': '0.31', 'lle': '2.84', 'sei': '10.24'}",CHEMBL3968655,,CHEMBL3968655,7.80,False,http://www.openphacts.org/units/Nanomolar,2840864,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
330007,17708597,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4cccc(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '14.84', 'le': '0.32', 'lle': '3.20', 'sei': '11.01'}",CHEMBL3906488,,CHEMBL3906488,8.38,False,http://www.openphacts.org/units/Nanomolar,2840865,=,37,True,=,,IC50,nM,,4.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.2
330008,17708598,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(Cl)c4)cn3CCN3CCCC3)CC2)c1Br,,,CHEMBL3886265,,2015.0,"{'bei': '15.93', 'le': '0.35', 'lle': '3.78', 'sei': '11.49'}",CHEMBL3980219,,CHEMBL3980219,8.74,False,http://www.openphacts.org/units/Nanomolar,2840866,=,37,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
330009,17708599,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(C(F)(F)F)cc3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.14', 'le': '0.25', 'lle': '1.66', 'sei': '8.83'}",CHEMBL3919026,,CHEMBL3919026,6.72,False,http://www.openphacts.org/units/Nanomolar,2840867,=,37,True,=,,IC50,nM,,190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,190.0
330010,17708600,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(N2CCC(c3nc(-c4ccc(C(F)(F)F)cc4)cn3CCN3CCCC3)CC2)ncn1,,,CHEMBL3886265,,2015.0,"{'bei': '12.36', 'le': '0.23', 'lle': '1.58', 'sei': '7.88'}",CHEMBL3890965,,CHEMBL3890965,6.00,False,http://www.openphacts.org/units/Nanomolar,2840868,=,37,True,=,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
330011,17708601,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(C(F)(F)F)cc3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.13', 'le': '0.25', 'lle': '1.76', 'sei': '8.86'}",CHEMBL3950595,,CHEMBL3950595,6.75,False,http://www.openphacts.org/units/Nanomolar,2840869,=,37,True,=,,IC50,nM,,180.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,180.0
330012,17708602,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3cccc(C(F)(F)F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.61', 'le': '0.30', 'lle': '3.04', 'sei': '10.54'}",CHEMBL3982706,,CHEMBL3982706,8.02,False,http://www.openphacts.org/units/Nanomolar,2840870,=,37,True,=,,IC50,nM,,9.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.6
330013,17708603,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(Cl)cc3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.00', 'le': '0.27', 'lle': '2.10', 'sei': '8.83'}",CHEMBL3945304,,CHEMBL3945304,6.72,False,http://www.openphacts.org/units/Nanomolar,2840871,=,37,True,=,,IC50,nM,,190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,190.0
330014,17708604,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3cccc(Cl)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.50', 'le': '0.32', 'lle': '3.30', 'sei': '10.41'}",CHEMBL3905187,,CHEMBL3905187,7.92,False,http://www.openphacts.org/units/Nanomolar,2840872,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
330015,17708605,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCC(F)(F)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.22', 'le': '0.22', 'lle': '1.00', 'sei': '8.37'}",CHEMBL3973744,,CHEMBL3973744,6.37,False,http://www.openphacts.org/units/Nanomolar,2840873,=,37,True,=,,IC50,nM,,430.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,430.0
330016,17708606,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.72', 'le': '0.28', 'lle': '2.52', 'sei': '10.55'}",CHEMBL3899177,,CHEMBL3899177,8.03,False,http://www.openphacts.org/units/Nanomolar,2840874,=,37,True,=,,IC50,nM,,9.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.3
330017,17708607,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3cccc(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.50', 'le': '0.29', 'lle': '3.15', 'sei': '10.18'}",CHEMBL3921412,,CHEMBL3921412,7.75,False,http://www.openphacts.org/units/Nanomolar,2840875,=,37,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
330018,17708608,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3cccc(F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.79', 'le': '0.29', 'lle': '3.39', 'sei': '9.33'}",CHEMBL3894252,,CHEMBL3894252,7.10,False,http://www.openphacts.org/units/Nanomolar,2840876,=,37,True,=,,IC50,nM,,79.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,79.5
330019,17708609,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3cccc(Cl)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.73', 'le': '0.32', 'lle': '3.57', 'sei': '10.24'}",CHEMBL3939097,,CHEMBL3939097,7.80,False,http://www.openphacts.org/units/Nanomolar,2840877,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
330020,17708610,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(C(F)(F)F)c(F)c4)cn3CCN3CCC3)CC2)c1C1CCC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.97', 'le': '0.28', 'lle': '2.70', 'sei': '10.69'}",CHEMBL3948660,,CHEMBL3948660,8.14,False,http://www.openphacts.org/units/Nanomolar,2840878,=,37,True,=,,IC50,nM,,7.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.3
330021,17708611,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(Cl)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.60', 'le': '0.32', 'lle': '3.67', 'sei': '10.56'}",CHEMBL3985540,,CHEMBL3985540,8.04,False,http://www.openphacts.org/units/Nanomolar,2840879,=,37,True,=,,IC50,nM,,9.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.2
330022,17708612,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.30', 'le': '0.31', 'lle': '3.77', 'sei': '10.01'}",CHEMBL3912123,,CHEMBL3912123,7.62,False,http://www.openphacts.org/units/Nanomolar,2840880,=,37,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
330023,17708613,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1[N+](=O)[O-],,,CHEMBL3886265,,2015.0,"{'bei': '16.03', 'le': '0.31', 'lle': '4.49', 'sei': '7.19'}",CHEMBL3927590,,CHEMBL3927590,8.57,False,http://www.openphacts.org/units/Nanomolar,2840881,=,37,True,=,,IC50,nM,,2.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.7
330024,17708614,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1N,,,CHEMBL3886265,,2015.0,"{'bei': '14.45', 'le': '0.28', 'lle': '3.54', 'sei': '7.14'}",CHEMBL3899565,,CHEMBL3899565,7.29,False,http://www.openphacts.org/units/Nanomolar,2840882,=,37,True,=,,IC50,nM,,51.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,51.5
330025,17708615,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCC3)CC2)c1C=O,,,CHEMBL3886265,,2015.0,"{'bei': '17.11', 'le': '0.33', 'lle': '4.87', 'sei': '9.50'}",CHEMBL3890352,,CHEMBL3890352,8.85,False,http://www.openphacts.org/units/Nanomolar,2840883,=,37,True,=,,IC50,nM,,1.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.4
330026,17708616,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)c1C(=O)O,,,CHEMBL3886265,,2015.0,"{'bei': '11.21', 'le': '0.21', 'lle': '1.88', 'sei': '5.41'}",CHEMBL3918796,,CHEMBL3918796,6.14,False,http://www.openphacts.org/units/Nanomolar,2840884,=,37,True,=,,IC50,nM,,730.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,730.0
330027,17708617,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnc(N2CCC(c3nc(-c4ccc(F)c(C(F)(F)F)c4)cn3CCN3CCCC3)CC2)c1C=O,,,CHEMBL3886265,,2015.0,"{'bei': '16.93', 'le': '0.32', 'lle': '4.63', 'sei': '9.66'}",CHEMBL3941283,,CHEMBL3941283,9.00,False,http://www.openphacts.org/units/Nanomolar,2840885,=,37,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
330028,17708618,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.30', 'le': '0.24', 'lle': '2.59', 'sei': '6.39'}",CHEMBL3913301,,CHEMBL3913301,6.72,False,http://www.openphacts.org/units/Nanomolar,2840886,=,37,True,=,,IC50,nM,,190.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,190.0
330029,17708619,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(Cl)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.88', 'le': '0.33', 'lle': '4.09', 'sei': '10.17'}",CHEMBL3928772,,CHEMBL3928772,8.68,False,http://www.openphacts.org/units/Nanomolar,2840887,=,37,True,=,,IC50,nM,,2.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.1
330030,17708620,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(Cl)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.47', 'le': '0.32', 'lle': '3.72', 'sei': '10.19'}",CHEMBL3904291,,CHEMBL3904291,8.70,False,http://www.openphacts.org/units/Nanomolar,2840888,=,37,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
330031,17708621,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.52', 'le': '0.30', 'lle': '3.68', 'sei': '9.49'}",CHEMBL3976247,,CHEMBL3976247,8.10,False,http://www.openphacts.org/units/Nanomolar,2840889,=,37,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
330032,17708622,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.16', 'le': '0.29', 'lle': '3.31', 'sei': '9.52'}",CHEMBL3905494,,CHEMBL3905494,8.12,False,http://www.openphacts.org/units/Nanomolar,2840890,=,37,True,=,,IC50,nM,,7.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.6
330033,17708623,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C)c3)cn2CCN(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '18.75', 'le': '0.35', 'lle': '5.06', 'sei': '10.28'}",CHEMBL3948085,,CHEMBL3948085,8.77,False,http://www.openphacts.org/units/Nanomolar,2840891,=,37,True,=,,IC50,nM,,1.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.7
330034,17708624,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN(C)C)c(C3CCN(c4ncnc(N)c4OC(C)C)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '18.11', 'le': '0.34', 'lle': '4.62', 'sei': '10.22'}",CHEMBL3984164,,CHEMBL3984164,8.72,False,http://www.openphacts.org/units/Nanomolar,2840892,=,37,True,=,,IC50,nM,,1.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.9
330035,17708625,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C)c3)cn2CCN(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.91', 'le': '0.32', 'lle': '3.76', 'sei': '10.04'}",CHEMBL3960833,,CHEMBL3960833,7.64,False,http://www.openphacts.org/units/Nanomolar,2840893,=,37,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
330036,17708626,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C)c3)cn2CCN(CC)CC)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.90', 'le': '0.33', 'lle': '3.93', 'sei': '11.28'}",CHEMBL3891820,,CHEMBL3891820,8.59,False,http://www.openphacts.org/units/Nanomolar,2840894,=,37,True,=,,IC50,nM,,2.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.6
330037,17708627,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.13', 'le': '0.32', 'lle': '3.77', 'sei': '10.75'}",CHEMBL3975180,,CHEMBL3975180,8.18,False,http://www.openphacts.org/units/Nanomolar,2840895,=,37,True,=,,IC50,nM,,6.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.6
330038,17708628,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.57', 'le': '0.31', 'lle': '3.93', 'sei': '9.59'}",CHEMBL3900809,,CHEMBL3900809,8.18,False,http://www.openphacts.org/units/Nanomolar,2840896,=,37,True,=,,IC50,nM,,6.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.6
330039,17708629,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN3CCCC3)c(C3CCN(c4ncnc(N)c4OC(C)C)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '15.86', 'le': '0.30', 'lle': '3.41', 'sei': '9.43'}",CHEMBL3939239,,CHEMBL3939239,8.05,False,http://www.openphacts.org/units/Nanomolar,2840897,=,37,True,=,,IC50,nM,,8.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.9
330040,17708630,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C)c3)cn2CCN(CC)C(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.31', 'le': '0.31', 'lle': '3.00', 'sei': '10.58'}",CHEMBL3968774,,CHEMBL3968774,8.05,False,http://www.openphacts.org/units/Nanomolar,2840898,=,37,True,=,,IC50,nM,,8.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.9
330041,17708631,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC1CN(c2cc(N)ncn2)CCC1c1nc(-c2ccc(F)c(C)c2)cn1CCN(CC)C(C)C,,,CHEMBL3886265,,2015.0,"{'bei': '15.96', 'le': '0.30', 'lle': '3.64', 'sei': '9.54'}",CHEMBL3975500,,CHEMBL3975500,8.14,False,http://www.openphacts.org/units/Nanomolar,2840899,=,37,True,=,,IC50,nM,,7.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.3
330042,17708632,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CCn1cc(-c2ccc(F)c(C)c2)nc1C1CCN(c2ncnc(N)c2OC(C)C)CC1)C(C)C,,,CHEMBL3886265,,2015.0,"{'bei': '15.66', 'le': '0.29', 'lle': '2.93', 'sei': '9.61'}",CHEMBL3904672,,CHEMBL3904672,8.20,False,http://www.openphacts.org/units/Nanomolar,2840900,=,37,True,=,,IC50,nM,,6.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.3
330043,17708633,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C)c3)cn2CCN(CC)CC)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '18.35', 'le': '0.35', 'lle': '4.61', 'sei': '10.66'}",CHEMBL3986943,,CHEMBL3986943,9.10,False,http://www.openphacts.org/units/Nanomolar,2840901,=,37,True,=,,IC50,nM,,0.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.8
330044,17708634,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCn1cc(-c2ccc(F)c(C)c2)nc1C1CCN(c2ncnc(N)c2OC(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.84', 'le': '0.32', 'lle': '3.71', 'sei': '10.06'}",CHEMBL3913659,,CHEMBL3913659,8.59,False,http://www.openphacts.org/units/Nanomolar,2840902,=,37,True,=,,IC50,nM,,2.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.6
330045,17708635,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.07', 'le': '0.31', 'lle': '4.06', 'sei': '8.50'}",CHEMBL3959291,,CHEMBL3959291,8.49,False,http://www.openphacts.org/units/Nanomolar,2840903,=,37,True,=,,IC50,nM,,3.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.2
330046,17708636,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.97', 'le': '0.32', 'lle': '4.57', 'sei': '8.13'}",CHEMBL3890225,,CHEMBL3890225,8.12,False,http://www.openphacts.org/units/Nanomolar,2840904,=,37,True,=,,IC50,nM,,7.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.6
330047,17708637,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(Cl)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.83', 'le': '0.34', 'lle': '4.75', 'sei': '8.83'}",CHEMBL3967010,,CHEMBL3967010,8.82,False,http://www.openphacts.org/units/Nanomolar,2840905,=,37,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
330048,17708638,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)cc3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.12', 'le': '0.32', 'lle': '4.48', 'sei': '7.89'}",CHEMBL3899172,,CHEMBL3899172,7.89,False,http://www.openphacts.org/units/Nanomolar,2840906,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
330049,17708639,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3cccc(F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.67', 'le': '0.31', 'lle': '4.27', 'sei': '7.69'}",CHEMBL3968052,,CHEMBL3968052,7.68,False,http://www.openphacts.org/units/Nanomolar,2840907,=,37,True,=,,IC50,nM,,21.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.0
330050,17708640,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3cccc(C(F)(F)F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.90', 'le': '0.30', 'lle': '3.83', 'sei': '8.13'}",CHEMBL3896892,,CHEMBL3896892,8.12,False,http://www.openphacts.org/units/Nanomolar,2840908,=,37,True,=,,IC50,nM,,7.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.6
330051,17708641,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3cccc(Cl)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.93', 'le': '0.32', 'lle': '4.15', 'sei': '8.08'}",CHEMBL3918965,,CHEMBL3918965,8.08,False,http://www.openphacts.org/units/Nanomolar,2840909,=,37,True,=,,IC50,nM,,8.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.4
330052,17708642,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.92', 'le': '0.30', 'lle': '3.82', 'sei': '8.65'}",CHEMBL3927877,,CHEMBL3927877,8.64,False,http://www.openphacts.org/units/Nanomolar,2840910,=,37,True,=,,IC50,nM,,2.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.3
330053,17708643,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.29', 'le': '0.32', 'lle': '4.87', 'sei': '8.04'}",CHEMBL3950203,,CHEMBL3950203,8.03,False,http://www.openphacts.org/units/Nanomolar,2840911,=,37,True,=,,IC50,nM,,9.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.3
330054,17708644,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(OC(F)F)c(F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.36', 'le': '0.31', 'lle': '4.77', 'sei': '7.69'}",CHEMBL3972741,,CHEMBL3972741,8.39,False,http://www.openphacts.org/units/Nanomolar,2840912,=,37,True,=,,IC50,nM,,4.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.1
330055,17708645,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3cc[nH]c(=O)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.14', 'le': '0.26', 'lle': '4.73', 'sei': '4.75'}",CHEMBL3975126,,CHEMBL3975126,6.30,False,http://www.openphacts.org/units/Nanomolar,2840913,=,37,True,=,,IC50,nM,,500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,500.0
330056,17708646,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)cc1C(F)(F)F,,,CHEMBL3886265,,2015.0,"{'bei': '14.92', 'le': '0.28', 'lle': '3.41', 'sei': '7.63'}",CHEMBL3949201,,CHEMBL3949201,7.62,False,http://www.openphacts.org/units/Nanomolar,2840914,=,37,True,=,,IC50,nM,,24.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.0
330057,17708647,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)ccn1,,,CHEMBL3886265,,2015.0,"{'bei': '16.88', 'le': '0.31', 'lle': '4.56', 'sei': '7.06'}",CHEMBL3966620,,CHEMBL3966620,7.96,False,http://www.openphacts.org/units/Nanomolar,2840915,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
330058,17708648,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)ccn1,,,CHEMBL3886265,,2015.0,"{'bei': '17.10', 'le': '0.31', 'lle': '4.98', 'sei': '6.94'}",CHEMBL3936879,,CHEMBL3936879,7.82,False,http://www.openphacts.org/units/Nanomolar,2840916,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
330059,17708649,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccnc(C4CC4)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.27', 'le': '0.30', 'lle': '4.48', 'sei': '6.77'}",CHEMBL3968742,,CHEMBL3968742,7.64,False,http://www.openphacts.org/units/Nanomolar,2840917,=,37,True,=,,IC50,nM,,23.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,23.0
330060,17708650,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)cc1F,,,CHEMBL3886265,,2015.0,"{'bei': '15.89', 'le': '0.29', 'lle': '3.99', 'sei': '7.33'}",CHEMBL3965676,,CHEMBL3965676,7.32,False,http://www.openphacts.org/units/Nanomolar,2840918,=,37,True,=,,IC50,nM,,48.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,48.0
330061,17708651,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)cc1F,,,CHEMBL3886265,,2015.0,"{'bei': '15.17', 'le': '0.28', 'lle': '4.20', 'sei': '6.62'}",CHEMBL3948379,,CHEMBL3948379,7.23,False,http://www.openphacts.org/units/Nanomolar,2840919,=,37,True,=,,IC50,nM,,59.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,59.0
330062,17708652,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)cc1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '16.53', 'le': '0.32', 'lle': '4.04', 'sei': '7.89'}",CHEMBL3980667,,CHEMBL3980667,7.89,False,http://www.openphacts.org/units/Nanomolar,2840920,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
330063,17708653,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)cc1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '15.23', 'le': '0.29', 'lle': '3.96', 'sei': '6.88'}",CHEMBL3943041,,CHEMBL3943041,7.51,False,http://www.openphacts.org/units/Nanomolar,2840921,=,37,True,=,,IC50,nM,,31.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31.0
330064,17708654,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN3CCCC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '17.82', 'le': '0.33', 'lle': '4.74', 'sei': '8.47'}",CHEMBL3972635,,CHEMBL3972635,8.46,False,http://www.openphacts.org/units/Nanomolar,2840922,=,37,True,=,,IC50,nM,,3.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.5
330065,17708655,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN(C)C)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '20.17', 'le': '0.37', 'lle': '5.86', 'sei': '9.06'}",CHEMBL3971598,,CHEMBL3971598,9.05,False,http://www.openphacts.org/units/Nanomolar,2840923,=,37,True,=,,IC50,nM,,0.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.9
330066,17708656,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCn1cc(-c2ccc(F)c(C)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '18.05', 'le': '0.34', 'lle': '4.63', 'sei': '8.61'}",CHEMBL3896910,,CHEMBL3896910,8.60,False,http://www.openphacts.org/units/Nanomolar,2840924,=,37,True,=,,IC50,nM,,2.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.5
330067,17708657,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CCn1cc(-c2ccc(F)c(C)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1)C(C)C,,,CHEMBL3886265,,2015.0,"{'bei': '17.43', 'le': '0.32', 'lle': '4.19', 'sei': '8.56'}",CHEMBL3957053,,CHEMBL3957053,8.55,False,http://www.openphacts.org/units/Nanomolar,2840925,=,37,True,=,,IC50,nM,,2.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.8
330068,17708658,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.20', 'le': '0.27', 'lle': '4.46', 'sei': '5.75'}",CHEMBL3985709,,CHEMBL3985709,6.85,False,http://www.openphacts.org/units/Nanomolar,2840926,=,37,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,140.0
330069,17708659,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.94', 'le': '0.26', 'lle': '4.14', 'sei': '5.81'}",CHEMBL3940823,,CHEMBL3940823,6.92,False,http://www.openphacts.org/units/Nanomolar,2840927,=,37,True,=,,IC50,nM,,120.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,120.0
330070,17708660,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(Cl)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.31', 'le': '0.30', 'lle': '4.56', 'sei': '6.59'}",CHEMBL3973734,,CHEMBL3973734,7.85,False,http://www.openphacts.org/units/Nanomolar,2840928,=,37,True,=,,IC50,nM,,14.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.0
330071,17708661,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.31', 'le': '0.27', 'lle': '4.16', 'sei': '6.56'}",CHEMBL3955767,,CHEMBL3955767,7.82,False,http://www.openphacts.org/units/Nanomolar,2840929,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
330072,17708662,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)ccn1,,,CHEMBL3886265,,2015.0,"{'bei': '15.18', 'le': '0.28', 'lle': '4.80', 'sei': '5.63'}",CHEMBL3928144,,CHEMBL3928144,7.43,False,http://www.openphacts.org/units/Nanomolar,2840930,=,37,True,=,,IC50,nM,,37.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,37.0
330073,17708663,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)cc3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.42', 'le': '0.25', 'lle': '3.78', 'sei': '5.39'}",CHEMBL3966878,,CHEMBL3966878,6.42,False,http://www.openphacts.org/units/Nanomolar,2840931,=,37,True,=,,IC50,nM,,380.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,380.0
330074,17708664,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3cccc(F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.97', 'le': '0.24', 'lle': '3.57', 'sei': '5.21'}",CHEMBL3933596,,CHEMBL3933596,6.21,False,http://www.openphacts.org/units/Nanomolar,2840932,=,37,True,=,,IC50,nM,,620.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,620.0
330075,17708665,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3cccc(C(F)(F)F)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.31', 'le': '0.25', 'lle': '3.52', 'sei': '5.90'}",CHEMBL3972161,,CHEMBL3972161,7.04,False,http://www.openphacts.org/units/Nanomolar,2840933,=,37,True,=,,IC50,nM,,92.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,92.0
330076,17708666,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3cccc(Cl)c3)cn2CCN2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.38', 'le': '0.28', 'lle': '3.97', 'sei': '5.97'}",CHEMBL3942559,,CHEMBL3942559,7.12,False,http://www.openphacts.org/units/Nanomolar,2840934,=,37,True,=,,IC50,nM,,76.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,76.0
330077,17708667,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCN2CCCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.20', 'le': '0.27', 'lle': '3.91', 'sei': '6.68'}",CHEMBL3980207,,CHEMBL3980207,7.96,False,http://www.openphacts.org/units/Nanomolar,2840935,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
330078,17708668,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(OC(F)F)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.21', 'le': '0.27', 'lle': '4.69', 'sei': '5.87'}",CHEMBL3954717,,CHEMBL3954717,7.54,False,http://www.openphacts.org/units/Nanomolar,2840936,=,37,True,=,,IC50,nM,,29.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,29.0
330079,17708669,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3cc[nH]c(=O)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.30', 'le': '0.21', 'lle': '4.44', 'sei': '3.44'}",CHEMBL3948232,,CHEMBL3948232,5.24,False,http://www.openphacts.org/units/Nanomolar,2840937,=,37,True,=,,IC50,nM,,5800.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5800.0
330080,17708670,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)cc1C(F)(F)F,,,CHEMBL3886265,,2015.0,"{'bei': '12.06', 'le': '0.23', 'lle': '2.94', 'sei': '5.35'}",CHEMBL3920410,,CHEMBL3920410,6.38,False,http://www.openphacts.org/units/Nanomolar,2840938,=,37,True,=,,IC50,nM,,420.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,420.0
330081,17708671,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)ccn1,,,CHEMBL3886265,,2015.0,"{'bei': '13.34', 'le': '0.25', 'lle': '4.28', 'sei': '4.81'}",CHEMBL3913252,,CHEMBL3913252,6.35,False,http://www.openphacts.org/units/Nanomolar,2840939,=,37,True,=,,IC50,nM,,450.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,450.0
330082,17708672,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccnc(C4CC4)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.80', 'le': '0.27', 'lle': '4.83', 'sei': '5.46'}",CHEMBL3941240,,CHEMBL3941240,7.21,False,http://www.openphacts.org/units/Nanomolar,2840940,=,37,True,=,,IC50,nM,,61.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,61.0
330083,17708673,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1cc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)ccn1,,,CHEMBL3886265,,2015.0,"{'bei': '13.44', 'le': '0.25', 'lle': '3.97', 'sei': '5.13'}",CHEMBL3918747,,CHEMBL3918747,6.77,False,http://www.openphacts.org/units/Nanomolar,2840941,=,37,True,=,,IC50,nM,,170.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,170.0
330084,17708674,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)cc1F,,,CHEMBL3886265,,2015.0,"{'bei': '11.74', 'le': '0.22', 'lle': '3.06', 'sei': '4.71'}",CHEMBL3922125,,CHEMBL3922125,5.62,False,http://www.openphacts.org/units/Nanomolar,2840942,=,37,True,=,,IC50,nM,,2400.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2400.0
330085,17708675,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)cc1F,,,CHEMBL3886265,,2015.0,"{'bei': '9.88', 'le': '0.19', 'lle': '2.63', 'sei': '3.80'}",CHEMBL3899515,,CHEMBL3899515,4.89,False,http://www.openphacts.org/units/Nanomolar,2840943,=,37,True,=,,IC50,nM,,13000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13000.0
330086,17708676,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)cc1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '13.45', 'le': '0.26', 'lle': '3.59', 'sei': '5.59'}",CHEMBL3927542,,CHEMBL3927542,6.66,False,http://www.openphacts.org/units/Nanomolar,2840944,=,37,True,=,,IC50,nM,,220.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,220.0
330087,17708677,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)cc1Cl,,,CHEMBL3886265,,2015.0,"{'bei': '11.75', 'le': '0.23', 'lle': '3.23', 'sei': '4.68'}",CHEMBL3912088,,CHEMBL3912088,6.00,False,http://www.openphacts.org/units/Nanomolar,2840945,=,37,True,=,,IC50,nM,,990.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,990.0
330088,17708678,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN(C)C)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '16.06', 'le': '0.30', 'lle': '5.08', 'sei': '6.29'}",CHEMBL3977710,,CHEMBL3977710,7.50,False,http://www.openphacts.org/units/Nanomolar,2840946,=,37,True,=,,IC50,nM,,32.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,32.0
330089,17708679,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCn1cc(-c2ccc(F)c(C)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.68', 'le': '0.28', 'lle': '4.07', 'sei': '6.09'}",CHEMBL3976090,,CHEMBL3976090,7.26,False,http://www.openphacts.org/units/Nanomolar,2840947,=,37,True,=,,IC50,nM,,55.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,55.0
330090,17708680,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN3CCCC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '16.24', 'le': '0.30', 'lle': '5.05', 'sei': '6.71'}",CHEMBL3905309,,CHEMBL3905309,8.00,False,http://www.openphacts.org/units/Nanomolar,2840948,=,37,True,=,,IC50,nM,,10.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.0
330091,17708681,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CCn1cc(-c2ccc(F)c(C)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1)C(C)C,,,CHEMBL3886265,,2015.0,"{'bei': '14.39', 'le': '0.27', 'lle': '3.74', 'sei': '6.14'}",CHEMBL3908761,,CHEMBL3908761,7.32,False,http://www.openphacts.org/units/Nanomolar,2840949,=,37,True,=,,IC50,nM,,48.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,48.0
330092,17708682,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3cnc(N(C)C)nc3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.00', 'le': '0.20', 'lle': '2.81', 'sei': '4.99'}",CHEMBL3982217,,CHEMBL3982217,5.24,False,http://www.openphacts.org/units/Nanomolar,2840950,=,37,True,=,,IC50,nM,,5700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5700.0
330093,17708683,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccccc3F)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.35', 'le': '0.28', 'lle': '3.83', 'sei': '6.86'}",CHEMBL3905622,,CHEMBL3905622,6.85,False,http://www.openphacts.org/units/Nanomolar,2840951,=,37,True,=,,IC50,nM,,140.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,140.0
330094,17708684,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3cccc(S(N)(=O)=O)c3)cn2CCN2CCC2)CC1,,,CHEMBL3886265,,2015.0,,CHEMBL3979122,,CHEMBL3979122,,False,http://www.openphacts.org/units/Nanomolar,2840952,>,37,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
330095,17708685,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1cccc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)c1,,,CHEMBL3886265,,2015.0,"{'bei': '14.01', 'le': '0.27', 'lle': '4.81', 'sei': '5.30'}",CHEMBL3894291,,CHEMBL3894291,7.10,False,http://www.openphacts.org/units/Nanomolar,2840953,=,37,True,=,,IC50,nM,,80.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,80.0
330096,17708686,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1cccc(-c2cn(CCN3CCC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)c1,,,CHEMBL3886265,,2015.0,"{'bei': '11.92', 'le': '0.23', 'lle': '4.74', 'sei': '4.08'}",CHEMBL3890873,,CHEMBL3890873,6.25,False,http://www.openphacts.org/units/Nanomolar,2840954,=,37,True,=,,IC50,nM,,560.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,560.0
330097,17708687,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCO)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.48', 'le': '0.28', 'lle': '3.56', 'sei': '5.89'}",CHEMBL3913464,,CHEMBL3913464,6.89,False,http://www.openphacts.org/units/Nanomolar,2840955,=,37,True,=,,IC50,nM,,130.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,130.0
330098,17708688,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCNCC2CC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.64', 'le': '0.32', 'lle': '4.46', 'sei': '8.09'}",CHEMBL3983282,,CHEMBL3983282,8.80,False,http://www.openphacts.org/units/Nanomolar,2840956,=,37,True,=,,IC50,nM,,1.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.6
330099,17708689,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCNCC2CC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.49', 'le': '0.28', 'lle': '4.36', 'sei': '6.19'}",CHEMBL3900963,,CHEMBL3900963,7.92,False,http://www.openphacts.org/units/Nanomolar,2840957,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
330100,17708690,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.15', 'le': '0.31', 'lle': '3.89', 'sei': '8.58'}",CHEMBL3909180,,CHEMBL3909180,8.57,False,http://www.openphacts.org/units/Nanomolar,2840958,=,37,True,=,,IC50,nM,,2.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.7
330101,17708691,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.51', 'le': '0.28', 'lle': '4.06', 'sei': '6.68'}",CHEMBL3976678,,CHEMBL3976678,7.96,False,http://www.openphacts.org/units/Nanomolar,2840959,=,37,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,11.0
330102,17708692,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.72', 'le': '0.24', 'lle': '3.29', 'sei': '6.90'}",CHEMBL3912087,,CHEMBL3912087,7.12,False,http://www.openphacts.org/units/Nanomolar,2840960,=,37,True,=,,IC50,nM,,76.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,76.0
330103,17708693,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.88', 'le': '0.27', 'lle': '3.68', 'sei': '6.95'}",CHEMBL3974022,,CHEMBL3974022,7.58,False,http://www.openphacts.org/units/Nanomolar,2840961,=,37,True,=,,IC50,nM,,26.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.0
330104,17708694,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCNCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.15', 'le': '0.31', 'lle': '5.03', 'sei': '7.30'}",CHEMBL3903066,,CHEMBL3903066,8.60,False,http://www.openphacts.org/units/Nanomolar,2840962,=,37,True,=,,IC50,nM,,2.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.5
330105,17708695,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '10.62', 'le': '0.20', 'lle': '3.08', 'sei': '5.01'}",CHEMBL3963052,,CHEMBL3963052,6.14,False,http://www.openphacts.org/units/Nanomolar,2840963,=,37,True,=,,IC50,nM,,730.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,730.0
330106,17708696,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '11.26', 'le': '0.22', 'lle': '3.22', 'sei': '4.95'}",CHEMBL3897576,,CHEMBL3897576,6.36,False,http://www.openphacts.org/units/Nanomolar,2840964,=,37,True,=,,IC50,nM,,440.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,440.0
330107,17708697,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCNCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.03', 'le': '0.25', 'lle': '4.37', 'sei': '5.23'}",CHEMBL3957688,,CHEMBL3957688,7.17,False,http://www.openphacts.org/units/Nanomolar,2840965,=,37,True,=,,IC50,nM,,67.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,67.0
330108,17708698,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1)Cc1ccccc1,,,CHEMBL3886265,,2015.0,"{'bei': '10.26', 'le': '0.19', 'lle': '1.42', 'sei': '5.13'}",CHEMBL3986416,,CHEMBL3986416,6.12,False,http://www.openphacts.org/units/Nanomolar,2840966,=,37,True,=,,IC50,nM,,760.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,760.0
330109,17708699,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.01', 'le': '0.31', 'lle': '3.94', 'sei': '7.61'}",CHEMBL3924599,,CHEMBL3924599,8.27,False,http://www.openphacts.org/units/Nanomolar,2840967,=,37,True,=,,IC50,nM,,5.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.4
330110,17708700,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.09', 'le': '0.31', 'lle': '5.04', 'sei': '6.72'}",CHEMBL3919834,,CHEMBL3919834,8.60,False,http://www.openphacts.org/units/Nanomolar,2840968,=,37,True,=,,IC50,nM,,2.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.5
330111,17708701,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,COCC(C)NCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '12.52', 'le': '0.24', 'lle': '3.88', 'sei': '5.15'}",CHEMBL3917106,,CHEMBL3917106,7.07,False,http://www.openphacts.org/units/Nanomolar,2840969,=,37,True,=,,IC50,nM,,85.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,85.0
330112,17708702,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CNCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.25', 'le': '0.33', 'lle': '4.57', 'sei': '8.42'}",CHEMBL3980521,,CHEMBL3980521,9.15,False,http://www.openphacts.org/units/Nanomolar,2840970,=,37,True,=,,IC50,nM,,0.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.7
330113,17708703,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CNCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.44', 'le': '0.28', 'lle': '4.11', 'sei': '6.19'}",CHEMBL3919344,,CHEMBL3919344,7.92,False,http://www.openphacts.org/units/Nanomolar,2840971,=,37,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
330114,17708704,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CNCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '18.06', 'le': '0.34', 'lle': '5.26', 'sei': '8.12'}",CHEMBL3894849,,CHEMBL3894849,8.82,False,http://www.openphacts.org/units/Nanomolar,2840972,=,37,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
330115,17708705,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)NCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.44', 'le': '0.31', 'lle': '4.00', 'sei': '8.02'}",CHEMBL3895898,,CHEMBL3895898,8.72,False,http://www.openphacts.org/units/Nanomolar,2840973,=,37,True,=,,IC50,nM,,1.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.9
330116,17708706,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CNCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.77', 'le': '0.28', 'lle': '4.70', 'sei': '5.85'}",CHEMBL3967166,,CHEMBL3967166,7.48,False,http://www.openphacts.org/units/Nanomolar,2840974,=,37,True,=,,IC50,nM,,33.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,33.0
330117,17708707,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)NCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.61', 'le': '0.28', 'lle': '4.06', 'sei': '6.26'}",CHEMBL3904852,,CHEMBL3904852,8.01,False,http://www.openphacts.org/units/Nanomolar,2840975,=,37,True,=,,IC50,nM,,9.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.7
330118,17708708,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCNCC3CC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '18.20', 'le': '0.34', 'lle': '5.01', 'sei': '7.95'}",CHEMBL3972479,,CHEMBL3972479,8.64,False,http://www.openphacts.org/units/Nanomolar,2840976,=,37,True,=,,IC50,nM,,2.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.3
330119,17708709,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN(C)C(C)C)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '17.98', 'le': '0.33', 'lle': '4.60', 'sei': '8.58'}",CHEMBL3963056,,CHEMBL3963056,8.57,False,http://www.openphacts.org/units/Nanomolar,2840977,=,37,True,=,,IC50,nM,,2.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.7
330120,17708710,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCNC(C)C)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '18.46', 'le': '0.34', 'lle': '4.92', 'sei': '7.86'}",CHEMBL3890076,,CHEMBL3890076,8.54,False,http://www.openphacts.org/units/Nanomolar,2840978,=,37,True,=,,IC50,nM,,2.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.9
330121,17708711,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCNC2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.77', 'le': '0.32', 'lle': '4.23', 'sei': '8.37'}",CHEMBL3960355,,CHEMBL3960355,9.10,False,http://www.openphacts.org/units/Nanomolar,2840979,=,37,True,=,,IC50,nM,,0.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.8
330122,17708712,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(C)(C)NCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '15.36', 'le': '0.29', 'lle': '3.26', 'sei': '7.70'}",CHEMBL3891300,,CHEMBL3891300,8.37,False,http://www.openphacts.org/units/Nanomolar,2840980,=,37,True,=,,IC50,nM,,4.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.3
330123,17708713,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCNCC3CC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '16.39', 'le': '0.31', 'lle': '5.23', 'sei': '6.31'}",CHEMBL3974713,,CHEMBL3974713,8.08,False,http://www.openphacts.org/units/Nanomolar,2840981,=,37,True,=,,IC50,nM,,8.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.4
330124,17708714,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCO)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '15.08', 'le': '0.28', 'lle': '3.74', 'sei': '5.44'}",CHEMBL3900331,,CHEMBL3900331,6.36,False,http://www.openphacts.org/units/Nanomolar,2840982,=,37,True,=,,IC50,nM,,440.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,440.0
330125,17708715,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCN(C)C(C)C)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '14.91', 'le': '0.28', 'lle': '4.19', 'sei': '6.19'}",CHEMBL3946371,,CHEMBL3946371,7.38,False,http://www.openphacts.org/units/Nanomolar,2840983,=,37,True,=,,IC50,nM,,42.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,42.0
330126,17708716,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCNC(C)C)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '16.28', 'le': '0.31', 'lle': '4.97', 'sei': '6.11'}",CHEMBL3975681,,CHEMBL3975681,7.82,False,http://www.openphacts.org/units/Nanomolar,2840984,=,37,True,=,,IC50,nM,,15.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15.0
330127,17708717,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCNC2CCCC2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.41', 'le': '0.28', 'lle': '3.98', 'sei': '6.31'}",CHEMBL3951639,,CHEMBL3951639,8.08,False,http://www.openphacts.org/units/Nanomolar,2840985,=,37,True,=,,IC50,nM,,8.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.4
330128,17708718,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(C)(C)NCCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.02', 'le': '0.27', 'lle': '3.55', 'sei': '6.16'}",CHEMBL3983708,,CHEMBL3983708,7.89,False,http://www.openphacts.org/units/Nanomolar,2840986,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
330129,17708719,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCNC3CCCC3)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '18.74', 'le': '0.35', 'lle': '4.99', 'sei': '8.42'}",CHEMBL3927358,,CHEMBL3927358,9.15,False,http://www.openphacts.org/units/Nanomolar,2840987,=,37,True,=,,IC50,nM,,0.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.7
330130,17708720,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCNCC(C)C)c(C3CCN(c4ncnc(N)c4C#N)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '18.58', 'le': '0.35', 'lle': '4.98', 'sei': '8.15'}",CHEMBL3954981,,CHEMBL3954981,8.85,False,http://www.openphacts.org/units/Nanomolar,2840988,=,37,True,=,,IC50,nM,,1.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.4
330131,17708721,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCNC3CCCC3)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '16.29', 'le': '0.30', 'lle': '4.87', 'sei': '6.45'}",CHEMBL3934916,,CHEMBL3934916,8.25,False,http://www.openphacts.org/units/Nanomolar,2840989,=,37,True,=,,IC50,nM,,5.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.6
330132,17708722,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCNCC(C)C)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '15.94', 'le': '0.30', 'lle': '4.79', 'sei': '6.16'}",CHEMBL3974261,,CHEMBL3974261,7.89,False,http://www.openphacts.org/units/Nanomolar,2840990,=,37,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.0
330133,17708723,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CCO)c(C3CCN(c4ncnc(N)c4C(N)=O)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '16.67', 'le': '0.31', 'lle': '5.48', 'sei': '5.38'}",CHEMBL3897830,,CHEMBL3897830,7.33,False,http://www.openphacts.org/units/Nanomolar,2840991,=,37,True,=,,IC50,nM,,47.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,47.0
330134,17708724,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CNCCn1cc(-c2ccc(F)c(C)c2)nc1C1CCN(c2ncnc(N)c2C#N)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '20.18', 'le': '0.37', 'lle': '5.93', 'sei': '8.07'}",CHEMBL3969016,,CHEMBL3969016,8.77,False,http://www.openphacts.org/units/Nanomolar,2840992,=,37,True,=,,IC50,nM,,1.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.7
330135,17708725,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCO)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '13.67', 'le': '0.26', 'lle': '4.18', 'sei': '4.95'}",CHEMBL3949232,,CHEMBL3949232,6.75,False,http://www.openphacts.org/units/Nanomolar,2840993,=,37,True,=,,IC50,nM,,180.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,180.0
330136,17708726,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C)c3)cn2CCO)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '14.68', 'le': '0.28', 'lle': '3.33', 'sei': '6.32'}",CHEMBL3924930,,CHEMBL3924930,6.47,False,http://www.openphacts.org/units/Nanomolar,2840994,=,37,True,=,,IC50,nM,,340.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,340.0
330137,17708727,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CNCCn1cc(-c2ccc(F)c(C)c2)nc1C1CCN(c2ncnc(N)c2C(N)=O)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '17.23', 'le': '0.32', 'lle': '5.73', 'sei': '6.09'}",CHEMBL3940462,,CHEMBL3940462,7.80,False,http://www.openphacts.org/units/Nanomolar,2840995,=,37,True,=,,IC50,nM,,16.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.0
330138,17708728,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C(F)(F)F)c3)cn2CCNC(C)C)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '16.48', 'le': '0.32', 'lle': '3.96', 'sei': '9.38'}",CHEMBL3912471,,CHEMBL3912471,8.82,False,http://www.openphacts.org/units/Nanomolar,2840996,=,37,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
330139,17708729,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cn(CC3CN(CO)C3)c(C3CCN(c4ncnc(N)c4C(C)C)CC3)n2)ccc1F,,,CHEMBL3886265,,2015.0,"{'bei': '14.69', 'le': '0.28', 'lle': '3.49', 'sei': '7.53'}",CHEMBL3974777,,CHEMBL3974777,7.25,False,http://www.openphacts.org/units/Nanomolar,2840997,=,37,True,=,,IC50,nM,,56.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,56.0
330140,17708730,[],CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1c(N)ncnc1N1CCC(c2nc(-c3ccc(F)c(C)c3)cn2CC2CN(C)C2)CC1,,,CHEMBL3886265,,2015.0,"{'bei': '20.54', 'le': '0.38', 'lle': '5.64', 'sei': '12.51'}",CHEMBL3936990,,CHEMBL3936990,9.52,False,http://www.openphacts.org/units/Nanomolar,2840998,=,37,True,=,,IC50,nM,,0.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.3
337091,17714921,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CC(C(F)F)C2)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '16.54', 'le': '0.32', 'lle': '4.51', 'sei': '8.12'}",CHEMBL3908126,,CHEMBL3908126,8.66,False,http://www.openphacts.org/units/Nanomolar,2845149,=,37,True,=,,IC50,nM,,2.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.2
337092,17714922,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,N#CC1CN(c2cnc(C(=O)Nc3csc(-c4nncn4C4CC4)n3)cc2-n2cnc(C3CC3)c2)C1,,,CHEMBL3886314,,2015.0,"{'bei': '18.14', 'le': '0.34', 'lle': '5.64', 'sei': '6.93'}",CHEMBL3975211,,CHEMBL3975211,9.05,False,http://www.openphacts.org/units/Nanomolar,2845150,=,37,True,=,,IC50,nM,,0.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.9
337093,17714923,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C#N)CN(c2cnc(C(=O)Nc3csc(-c4nncn4C4CC4)n3)cc2-n2cnc(C3CC3)c2)C1,,,CHEMBL3886314,,2015.0,"{'bei': '17.01', 'le': '0.32', 'lle': '4.92', 'sei': '6.69'}",CHEMBL3935565,,CHEMBL3935565,8.72,False,http://www.openphacts.org/units/Nanomolar,2845151,=,37,True,=,,IC50,nM,,1.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.9
337094,17714924,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1(C)CN(c2cnc(C(=O)Nc3csc(-c4nncn4C4CC4)n3)cc2-n2cnc(C3CC3)c2)C1,,,CHEMBL3886314,,2015.0,"{'bei': '16.89', 'le': '0.32', 'lle': '5.07', 'sei': '7.55'}",CHEMBL3905950,,CHEMBL3905950,8.74,False,http://www.openphacts.org/units/Nanomolar,2845152,=,37,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
337095,17714925,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CC(F)(F)C2)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '16.79', 'le': '0.32', 'lle': '4.65', 'sei': '8.02'}",CHEMBL3957940,,CHEMBL3957940,8.55,False,http://www.openphacts.org/units/Nanomolar,2845153,=,37,True,=,,IC50,nM,,2.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.8
337096,17714926,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCN(c2cnc(C(=O)Nc3csc(-c4nncn4C4CC4)n3)cc2-n2cnc(C3CC3)c2)C1,,,CHEMBL3886314,,2015.0,"{'bei': '16.52', 'le': '0.32', 'lle': '4.88', 'sei': '7.38'}",CHEMBL3895494,,CHEMBL3895494,8.55,False,http://www.openphacts.org/units/Nanomolar,2845154,=,37,True,=,,IC50,nM,,2.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.8
337097,17714927,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCC(C(F)(F)F)CC2)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '14.91', 'le': '0.29', 'lle': '3.26', 'sei': '7.97'}",CHEMBL3924518,,CHEMBL3924518,8.49,False,http://www.openphacts.org/units/Nanomolar,2845155,=,37,True,=,,IC50,nM,,3.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.2
337098,17714928,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCC(F)CC2)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '16.55', 'le': '0.32', 'lle': '4.21', 'sei': '8.07'}",CHEMBL3920406,,CHEMBL3920406,8.60,False,http://www.openphacts.org/units/Nanomolar,2845156,=,37,True,=,,IC50,nM,,2.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.5
337099,17714929,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,N#CC1CCN(c2cnc(C(=O)Nc3csc(-c4nncn4C4CC4)n3)cc2-n2cnc(C3CC3)c2)CC1,,,CHEMBL3886314,,2015.0,"{'bei': '16.44', 'le': '0.31', 'lle': '4.47', 'sei': '6.64'}",CHEMBL3898363,,CHEMBL3898363,8.66,False,http://www.openphacts.org/units/Nanomolar,2845157,=,37,True,=,,IC50,nM,,2.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.2
337100,17714930,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCN(c2cnc(C(=O)Nc3csc(-c4nncn4C4CC4)n3)cc2-n2cnc(C3CC3)c2)CC1,,,CHEMBL3886314,,2015.0,"{'bei': '15.98', 'le': '0.31', 'lle': '4.43', 'sei': '7.33'}",CHEMBL3943452,,CHEMBL3943452,8.49,False,http://www.openphacts.org/units/Nanomolar,2845158,=,37,True,=,,IC50,nM,,3.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.2
337101,17714931,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)C1CCN(c2cnc(C(=O)Nc3csc(-c4nncn4C4CC4)n3)cc2-n2cnc(C3CC3)c2)CC1,,,CHEMBL3886314,,2015.0,"{'bei': '16.82', 'le': '0.32', 'lle': '5.99', 'sei': '6.92'}",CHEMBL3969572,,CHEMBL3969572,9.40,False,http://www.openphacts.org/units/Nanomolar,2845159,=,37,True,=,,IC50,nM,,0.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.4
337102,17714932,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1(C)CCN(c2cnc(C(=O)Nc3csc(-c4nncn4C4CC4)n3)cc2-n2cnc(C3CC3)c2)CC1,,,CHEMBL3886314,,2015.0,"{'bei': '14.38', 'le': '0.27', 'lle': '3.40', 'sei': '6.77'}",CHEMBL3981380,,CHEMBL3981380,7.85,False,http://www.openphacts.org/units/Nanomolar,2845160,=,37,True,=,,IC50,nM,,14.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.2
337103,17714933,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCN(CC(F)(F)F)CC2)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '14.60', 'le': '0.28', 'lle': '4.41', 'sei': '7.77'}",CHEMBL3953443,,CHEMBL3953443,8.54,False,http://www.openphacts.org/units/Nanomolar,2845161,=,37,True,=,,IC50,nM,,2.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.9
337104,17714934,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCCOCC2)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '16.27', 'le': '0.31', 'lle': '4.75', 'sei': '7.27'}",CHEMBL3893943,,CHEMBL3893943,8.42,False,http://www.openphacts.org/units/Nanomolar,2845162,=,37,True,=,,IC50,nM,,3.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.8
337105,17714935,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCN3CCCC3C2)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '15.79', 'le': '0.30', 'lle': '4.84', 'sei': '7.80'}",CHEMBL3964706,,CHEMBL3964706,8.57,False,http://www.openphacts.org/units/Nanomolar,2845163,=,37,True,=,,IC50,nM,,2.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.7
337106,17714936,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCN3C(=O)OCC3C2)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '15.34', 'le': '0.29', 'lle': '5.48', 'sei': '6.29'}",CHEMBL3963748,,CHEMBL3963748,8.57,False,http://www.openphacts.org/units/Nanomolar,2845164,=,37,True,=,,IC50,nM,,2.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.7
337107,17714937,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CC3CC3C2)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '17.93', 'le': '0.34', 'lle': '5.06', 'sei': '8.40'}",CHEMBL3922577,,CHEMBL3922577,8.96,False,http://www.openphacts.org/units/Nanomolar,2845165,=,37,True,=,,IC50,nM,,1.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.1
337108,17714938,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CC(N3CCOCC3)C2)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '15.46', 'le': '0.29', 'lle': '5.67', 'sei': '7.25'}",CHEMBL3986247,,CHEMBL3986247,8.64,False,http://www.openphacts.org/units/Nanomolar,2845166,=,37,True,=,,IC50,nM,,2.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.3
337109,17714939,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCN(C3CC3)CC2)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '15.76', 'le': '0.30', 'lle': '4.82', 'sei': '7.78'}",CHEMBL3954180,,CHEMBL3954180,8.55,False,http://www.openphacts.org/units/Nanomolar,2845167,=,37,True,=,,IC50,nM,,2.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.8
337110,17714940,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCN(CC3CC3)CC2)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '15.45', 'le': '0.29', 'lle': '4.62', 'sei': '7.83'}",CHEMBL3978053,,CHEMBL3978053,8.60,False,http://www.openphacts.org/units/Nanomolar,2845168,=,37,True,=,,IC50,nM,,2.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.5
337111,17714941,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCC3(CC2)COC3)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '16.04', 'le': '0.31', 'lle': '4.66', 'sei': '7.53'}",CHEMBL3948895,,CHEMBL3948895,8.72,False,http://www.openphacts.org/units/Nanomolar,2845169,=,37,True,=,,IC50,nM,,1.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.9
337112,17714942,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CC3(CCOCC3)C2)cn1,,,CHEMBL3886314,,2015.0,"{'bei': '15.35', 'le': '0.29', 'lle': '4.29', 'sei': '7.20'}",CHEMBL3973753,,CHEMBL3973753,8.35,False,http://www.openphacts.org/units/Nanomolar,2845170,=,37,True,=,,IC50,nM,,4.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.5
337113,17714943,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,COCC1CN(c2cnc(C(=O)Nc3csc(-c4nncn4[C@@H](C)C(F)(F)F)n3)cc2-n2cnc(C3CC3)c2)C1,,,CHEMBL3886314,,2015.0,"{'bei': '15.17', 'le': '0.30', 'lle': '4.38', 'sei': '7.51'}",CHEMBL3946920,,CHEMBL3946920,8.70,False,http://www.openphacts.org/units/Nanomolar,2845171,=,37,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
337114,17714944,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CC(C)(C#N)C3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '15.57', 'le': '0.30', 'lle': '4.26', 'sei': '6.79'}",CHEMBL3893968,,CHEMBL3893968,8.85,False,http://www.openphacts.org/units/Nanomolar,2845172,=,37,True,=,,IC50,nM,,1.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.4
337115,17714945,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1(C)CN(c2cnc(C(=O)Nc3csc(-c4nncn4[C@@H](C)C(F)(F)F)n3)cc2-n2cnc(C3CC3)c2)C1,,,CHEMBL3886314,,2015.0,"{'bei': '15.17', 'le': '0.30', 'lle': '4.24', 'sei': '7.51'}",CHEMBL3953748,,CHEMBL3953748,8.70,False,http://www.openphacts.org/units/Nanomolar,2845173,=,37,True,=,,IC50,nM,,2.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.0
337116,17714946,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CC(C(F)F)C3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '15.13', 'le': '0.30', 'lle': '3.83', 'sei': '8.22'}",CHEMBL3930015,,CHEMBL3930015,8.77,False,http://www.openphacts.org/units/Nanomolar,2845174,=,37,True,=,,IC50,nM,,1.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.7
337117,17714947,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCC(F)(F)C3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '14.97', 'le': '0.30', 'lle': '3.60', 'sei': '8.14'}",CHEMBL3961734,,CHEMBL3961734,8.68,False,http://www.openphacts.org/units/Nanomolar,2845175,=,37,True,=,,IC50,nM,,2.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.1
337118,17714948,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCN(c2cnc(C(=O)Nc3csc(-c4nncn4[C@@H](C)C(F)(F)F)n3)cc2-n2cnc(C3CC3)c2)C1,,,CHEMBL3886314,,2015.0,"{'bei': '15.20', 'le': '0.30', 'lle': '4.26', 'sei': '7.53'}",CHEMBL3909615,,CHEMBL3909615,8.72,False,http://www.openphacts.org/units/Nanomolar,2845176,=,37,True,=,,IC50,nM,,1.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.9
337119,17714949,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCC(C#N)CC3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '15.05', 'le': '0.29', 'lle': '3.79', 'sei': '6.72'}",CHEMBL3917308,,CHEMBL3917308,8.77,False,http://www.openphacts.org/units/Nanomolar,2845177,=,37,True,=,,IC50,nM,,1.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.7
337120,17714950,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCN(c2cnc(C(=O)Nc3csc(-c4nncn4[C@@H](C)C(F)(F)F)n3)cc2-n2cnc(C3CC3)c2)CC1,,,CHEMBL3886314,,2015.0,"{'bei': '14.70', 'le': '0.29', 'lle': '3.79', 'sei': '7.45'}",CHEMBL3904498,,CHEMBL3904498,8.64,False,http://www.openphacts.org/units/Nanomolar,2845178,=,37,True,=,,IC50,nM,,2.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.3
337121,17714951,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)C1CCN(c2cnc(C(=O)Nc3csc(-c4nncn4[C@@H](C)C(F)(F)F)n3)cc2-n2cnc(C3CC3)c2)CC1,,,CHEMBL3886314,,2015.0,"{'bei': '14.05', 'le': '0.27', 'lle': '4.44', 'sei': '6.36'}",CHEMBL3908356,,CHEMBL3908356,8.64,False,http://www.openphacts.org/units/Nanomolar,2845179,=,37,True,=,,IC50,nM,,2.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.3
337122,17714952,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCC(C(F)(F)F)CC3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '14.10', 'le': '0.28', 'lle': '2.81', 'sei': '8.27'}",CHEMBL3976987,,CHEMBL3976987,8.82,False,http://www.openphacts.org/units/Nanomolar,2845180,=,37,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
337123,17714953,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCN(CC(F)(F)F)CC3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '13.93', 'le': '0.28', 'lle': '4.00', 'sei': '8.12'}",CHEMBL3902880,,CHEMBL3902880,8.92,False,http://www.openphacts.org/units/Nanomolar,2845181,=,37,True,=,,IC50,nM,,1.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.2
337124,17714954,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCC(F)CC3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '15.24', 'le': '0.30', 'lle': '3.60', 'sei': '8.22'}",CHEMBL3962884,,CHEMBL3962884,8.77,False,http://www.openphacts.org/units/Nanomolar,2845182,=,37,True,=,,IC50,nM,,1.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.7
337125,17714955,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1(C)CCN(c2cnc(C(=O)Nc3csc(-c4nncn4[C@@H](C)C(F)(F)F)n3)cc2-n2cnc(C3CC3)c2)CC1,,,CHEMBL3886314,,2015.0,"{'bei': '14.39', 'le': '0.28', 'lle': '3.42', 'sei': '7.47'}",CHEMBL3893936,,CHEMBL3893936,8.66,False,http://www.openphacts.org/units/Nanomolar,2845183,=,37,True,=,,IC50,nM,,2.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.2
337126,17714956,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCCOCC3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '15.20', 'le': '0.30', 'lle': '4.26', 'sei': '7.53'}",CHEMBL3954144,,CHEMBL3954144,8.72,False,http://www.openphacts.org/units/Nanomolar,2845184,=,37,True,=,,IC50,nM,,1.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.9
337127,17714957,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCN4CCCC4C3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '14.61', 'le': '0.28', 'lle': '4.22', 'sei': '7.96'}",CHEMBL3979677,,CHEMBL3979677,8.74,False,http://www.openphacts.org/units/Nanomolar,2845185,=,37,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
337128,17714958,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CC4CN(C)CC4C3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '14.40', 'le': '0.28', 'lle': '4.39', 'sei': '7.84'}",CHEMBL3899813,,CHEMBL3899813,8.62,False,http://www.openphacts.org/units/Nanomolar,2845186,=,37,True,=,,IC50,nM,,2.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.4
337129,17714959,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCN4C(=O)OCC4C3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '14.05', 'le': '0.27', 'lle': '4.76', 'sei': '6.34'}",CHEMBL3926976,,CHEMBL3926976,8.64,False,http://www.openphacts.org/units/Nanomolar,2845187,=,37,True,=,,IC50,nM,,2.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.3
337130,17714960,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CC4CC4C3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '15.58', 'le': '0.30', 'lle': '3.97', 'sei': '8.12'}",CHEMBL3953359,,CHEMBL3953359,8.66,False,http://www.openphacts.org/units/Nanomolar,2845188,=,37,True,=,,IC50,nM,,2.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.2
337131,17714961,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CC(N4CCOCC4)C3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '14.19', 'le': '0.28', 'lle': '4.96', 'sei': '7.32'}",CHEMBL3924482,,CHEMBL3924482,8.72,False,http://www.openphacts.org/units/Nanomolar,2845189,=,37,True,=,,IC50,nM,,1.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.9
337132,17714962,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCN(C4CC4)CC3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '14.61', 'le': '0.28', 'lle': '4.22', 'sei': '7.96'}",CHEMBL3925596,,CHEMBL3925596,8.74,False,http://www.openphacts.org/units/Nanomolar,2845190,=,37,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
337133,17714963,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCN(CC4CC4)CC3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '14.27', 'le': '0.28', 'lle': '3.97', 'sei': '7.96'}",CHEMBL3897512,,CHEMBL3897512,8.74,False,http://www.openphacts.org/units/Nanomolar,2845191,=,37,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
337134,17714964,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCC4(CC3)COC4)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '14.47', 'le': '0.28', 'lle': '3.83', 'sei': '7.49'}",CHEMBL3961404,,CHEMBL3961404,8.68,False,http://www.openphacts.org/units/Nanomolar,2845192,=,37,True,=,,IC50,nM,,2.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.1
337135,17714965,[],CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CC4(CCOCC4)C3)cn2)cs1)C(F)(F)F,,,CHEMBL3886314,,2015.0,"{'bei': '14.32', 'le': '0.28', 'lle': '3.74', 'sei': '7.41'}",CHEMBL3903012,,CHEMBL3903012,8.59,False,http://www.openphacts.org/units/Nanomolar,2845193,=,37,True,=,,IC50,nM,,2.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.6
381886,17755432,[],CHEMBL3888207,"Akt1 TR-FRET assay: His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany). For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 μl of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 °C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 μl of a solution of adenosine-tri-phosphate (ATP, 16.7 μM=>final conc. in the 5 μl assay volume is 10 μM) and substrate (1.67 μM=>final conc. in the 5 μl assay volume is 1 μM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 °C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot and was chosen appropriate to have the assay in the linear range, typical enzyme concentrations were in the range of about 0.05 ng/μl (final conc. in the 5 μl assay volume). The reaction was stopped by the addition of 5 μl of a solution of HTRF detection reagents (200 nM streptavidine-XL665 [Cisbio] and 1.5 nM anti-phosho-Serine antibody [Millipore, cat. #35-001] and 0.75 nM LANCE Eu-W 1024 labeled anti-mouse IgG antibody [Perkin Elmer]) in an aqueous EDTA-solution (100 mM EDTA, 0.1% (w/v) bovine serum albumin in 50 mM HEPES/NaOH pH 7.5). The resulting mixture was incubated 1 h at 22 °C. to allow the binding of the biotinylated phosphorylated peptide to the streptavidine-XL665 and the antibodies. Subsequently the amount of phosphorylated substrate was evaluated by measurement of the resonance energy transfer from the anti-mouse-IgG-Eu-Chelate to the streptavidine-XL665. Therefore, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm was measured in a HTRF reader, e.g. a Rubystar (BMG Labtechnologies, Offenburg, Germany) or a Viewlux (Perkin-Elmer). The ratio of the emissions at 665 nm and at 622 nm was taken as the measure for the amount of phosphorylated substrate. The data were normalised (enzyme reaction without inhibitor=0% inhibition, all other assay components but no enzyme=100% inhibition). Normally test compound were tested on the same microtiter plate at 10 different concentrations in the range of 20 μM to 1 nM (20 μM, 6.7 μM, 2.2 μM, 0.74 μM, 0.25 μM, 82 nM, 27 nM, 9.2 nM, 3.1 nM and 1 nM, dilution series prepared before the assay at the level of the 100 fold conc. stock solutions by serial 1:3 dilutions) in duplicate values for each concentration and IC50 values were calculated by a 4 parameter fit using an in-house software.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC1(c2ccc(-c3nc4c(O)nccn4c3-c3ccccc3)cc2)CCC1,,,CHEMBL3886620,,2016.0,"{'bei': '16.26', 'le': '0.29', 'lle': '1.69', 'sei': '7.58'}",CHEMBL3982161,,CHEMBL3982161,5.80,False,http://www.openphacts.org/units/Nanomolar,2872264,=,37,True,=,,IC50,nM,,1600.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1600.0
381887,17755433,[],CHEMBL3888207,"Akt1 TR-FRET assay: His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany). For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 μl of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 °C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 μl of a solution of adenosine-tri-phosphate (ATP, 16.7 μM=>final conc. in the 5 μl assay volume is 10 μM) and substrate (1.67 μM=>final conc. in the 5 μl assay volume is 1 μM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 °C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot and was chosen appropriate to have the assay in the linear range, typical enzyme concentrations were in the range of about 0.05 ng/μl (final conc. in the 5 μl assay volume). The reaction was stopped by the addition of 5 μl of a solution of HTRF detection reagents (200 nM streptavidine-XL665 [Cisbio] and 1.5 nM anti-phosho-Serine antibody [Millipore, cat. #35-001] and 0.75 nM LANCE Eu-W 1024 labeled anti-mouse IgG antibody [Perkin Elmer]) in an aqueous EDTA-solution (100 mM EDTA, 0.1% (w/v) bovine serum albumin in 50 mM HEPES/NaOH pH 7.5). The resulting mixture was incubated 1 h at 22 °C. to allow the binding of the biotinylated phosphorylated peptide to the streptavidine-XL665 and the antibodies. Subsequently the amount of phosphorylated substrate was evaluated by measurement of the resonance energy transfer from the anti-mouse-IgG-Eu-Chelate to the streptavidine-XL665. Therefore, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm was measured in a HTRF reader, e.g. a Rubystar (BMG Labtechnologies, Offenburg, Germany) or a Viewlux (Perkin-Elmer). The ratio of the emissions at 665 nm and at 622 nm was taken as the measure for the amount of phosphorylated substrate. The data were normalised (enzyme reaction without inhibitor=0% inhibition, all other assay components but no enzyme=100% inhibition). Normally test compound were tested on the same microtiter plate at 10 different concentrations in the range of 20 μM to 1 nM (20 μM, 6.7 μM, 2.2 μM, 0.74 μM, 0.25 μM, 82 nM, 27 nM, 9.2 nM, 3.1 nM and 1 nM, dilution series prepared before the assay at the level of the 100 fold conc. stock solutions by serial 1:3 dilutions) in duplicate values for each concentration and IC50 values were calculated by a 4 parameter fit using an in-house software.",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c(C)n1,,,CHEMBL3886620,,2016.0,"{'bei': '19.58', 'le': '0.35', 'lle': '2.19', 'sei': '12.84'}",CHEMBL3944710,,CHEMBL3944710,7.21,False,http://www.openphacts.org/units/Nanomolar,2872265,=,37,True,=,,IC50,nM,,61.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,61.0
381888,17755434,[],CHEMBL3888207,"Akt1 TR-FRET assay: His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany). For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 μl of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 °C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 μl of a solution of adenosine-tri-phosphate (ATP, 16.7 μM=>final conc. in the 5 μl assay volume is 10 μM) and substrate (1.67 μM=>final conc. in the 5 μl assay volume is 1 μM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 °C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot and was chosen appropriate to have the assay in the linear range, typical enzyme concentrations were in the range of about 0.05 ng/μl (final conc. in the 5 μl assay volume). The reaction was stopped by the addition of 5 μl of a solution of HTRF detection reagents (200 nM streptavidine-XL665 [Cisbio] and 1.5 nM anti-phosho-Serine antibody [Millipore, cat. #35-001] and 0.75 nM LANCE Eu-W 1024 labeled anti-mouse IgG antibody [Perkin Elmer]) in an aqueous EDTA-solution (100 mM EDTA, 0.1% (w/v) bovine serum albumin in 50 mM HEPES/NaOH pH 7.5). The resulting mixture was incubated 1 h at 22 °C. to allow the binding of the biotinylated phosphorylated peptide to the streptavidine-XL665 and the antibodies. Subsequently the amount of phosphorylated substrate was evaluated by measurement of the resonance energy transfer from the anti-mouse-IgG-Eu-Chelate to the streptavidine-XL665. Therefore, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm was measured in a HTRF reader, e.g. a Rubystar (BMG Labtechnologies, Offenburg, Germany) or a Viewlux (Perkin-Elmer). The ratio of the emissions at 665 nm and at 622 nm was taken as the measure for the amount of phosphorylated substrate. The data were normalised (enzyme reaction without inhibitor=0% inhibition, all other assay components but no enzyme=100% inhibition). Normally test compound were tested on the same microtiter plate at 10 different concentrations in the range of 20 μM to 1 nM (20 μM, 6.7 μM, 2.2 μM, 0.74 μM, 0.25 μM, 82 nM, 27 nM, 9.2 nM, 3.1 nM and 1 nM, dilution series prepared before the assay at the level of the 100 fold conc. stock solutions by serial 1:3 dilutions) in duplicate values for each concentration and IC50 values were calculated by a 4 parameter fit using an in-house software.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1nc(Br)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3886620,,2016.0,"{'bei': '17.04', 'le': '0.36', 'lle': '2.49', 'sei': '11.70'}",CHEMBL3977365,,CHEMBL3977365,7.66,False,http://www.openphacts.org/units/Nanomolar,2872266,=,37,True,=,,IC50,nM,,22.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,22.0
381889,17755435,[],CHEMBL3888207,"Akt1 TR-FRET assay: His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany). For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 μl of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 °C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 μl of a solution of adenosine-tri-phosphate (ATP, 16.7 μM=>final conc. in the 5 μl assay volume is 10 μM) and substrate (1.67 μM=>final conc. in the 5 μl assay volume is 1 μM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 °C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot and was chosen appropriate to have the assay in the linear range, typical enzyme concentrations were in the range of about 0.05 ng/μl (final conc. in the 5 μl assay volume). The reaction was stopped by the addition of 5 μl of a solution of HTRF detection reagents (200 nM streptavidine-XL665 [Cisbio] and 1.5 nM anti-phosho-Serine antibody [Millipore, cat. #35-001] and 0.75 nM LANCE Eu-W 1024 labeled anti-mouse IgG antibody [Perkin Elmer]) in an aqueous EDTA-solution (100 mM EDTA, 0.1% (w/v) bovine serum albumin in 50 mM HEPES/NaOH pH 7.5). The resulting mixture was incubated 1 h at 22 °C. to allow the binding of the biotinylated phosphorylated peptide to the streptavidine-XL665 and the antibodies. Subsequently the amount of phosphorylated substrate was evaluated by measurement of the resonance energy transfer from the anti-mouse-IgG-Eu-Chelate to the streptavidine-XL665. Therefore, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm was measured in a HTRF reader, e.g. a Rubystar (BMG Labtechnologies, Offenburg, Germany) or a Viewlux (Perkin-Elmer). The ratio of the emissions at 665 nm and at 622 nm was taken as the measure for the amount of phosphorylated substrate. The data were normalised (enzyme reaction without inhibitor=0% inhibition, all other assay components but no enzyme=100% inhibition). Normally test compound were tested on the same microtiter plate at 10 different concentrations in the range of 20 μM to 1 nM (20 μM, 6.7 μM, 2.2 μM, 0.74 μM, 0.25 μM, 82 nM, 27 nM, 9.2 nM, 3.1 nM and 1 nM, dilution series prepared before the assay at the level of the 100 fold conc. stock solutions by serial 1:3 dilutions) in duplicate values for each concentration and IC50 values were calculated by a 4 parameter fit using an in-house software.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c(OC)n1,,,CHEMBL3886620,,2016.0,"{'bei': '17.46', 'le': '0.32', 'lle': '1.99', 'sei': '10.63'}",CHEMBL3895917,,CHEMBL3895917,6.96,False,http://www.openphacts.org/units/Nanomolar,2872267,=,37,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,110.0
381890,17755436,[],CHEMBL3888207,"Akt1 TR-FRET assay: His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany). For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 μl of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 °C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 μl of a solution of adenosine-tri-phosphate (ATP, 16.7 μM=>final conc. in the 5 μl assay volume is 10 μM) and substrate (1.67 μM=>final conc. in the 5 μl assay volume is 1 μM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 °C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot and was chosen appropriate to have the assay in the linear range, typical enzyme concentrations were in the range of about 0.05 ng/μl (final conc. in the 5 μl assay volume). The reaction was stopped by the addition of 5 μl of a solution of HTRF detection reagents (200 nM streptavidine-XL665 [Cisbio] and 1.5 nM anti-phosho-Serine antibody [Millipore, cat. #35-001] and 0.75 nM LANCE Eu-W 1024 labeled anti-mouse IgG antibody [Perkin Elmer]) in an aqueous EDTA-solution (100 mM EDTA, 0.1% (w/v) bovine serum albumin in 50 mM HEPES/NaOH pH 7.5). The resulting mixture was incubated 1 h at 22 °C. to allow the binding of the biotinylated phosphorylated peptide to the streptavidine-XL665 and the antibodies. Subsequently the amount of phosphorylated substrate was evaluated by measurement of the resonance energy transfer from the anti-mouse-IgG-Eu-Chelate to the streptavidine-XL665. Therefore, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm was measured in a HTRF reader, e.g. a Rubystar (BMG Labtechnologies, Offenburg, Germany) or a Viewlux (Perkin-Elmer). The ratio of the emissions at 665 nm and at 622 nm was taken as the measure for the amount of phosphorylated substrate. The data were normalised (enzyme reaction without inhibitor=0% inhibition, all other assay components but no enzyme=100% inhibition). Normally test compound were tested on the same microtiter plate at 10 different concentrations in the range of 20 μM to 1 nM (20 μM, 6.7 μM, 2.2 μM, 0.74 μM, 0.25 μM, 82 nM, 27 nM, 9.2 nM, 3.1 nM and 1 nM, dilution series prepared before the assay at the level of the 100 fold conc. stock solutions by serial 1:3 dilutions) in duplicate values for each concentration and IC50 values were calculated by a 4 parameter fit using an in-house software.",B,,,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)c1cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2cn1,,,CHEMBL3886620,,2016.0,"{'bei': '16.97', 'le': '0.31', 'lle': '2.42', 'sei': '8.48'}",CHEMBL3968885,,CHEMBL3968885,7.00,False,http://www.openphacts.org/units/Nanomolar,2872268,=,37,True,=,,IC50,nM,,100.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100.0
381891,17755437,[],CHEMBL3888207,"Akt1 TR-FRET assay: His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany). For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 μl of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 °C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 μl of a solution of adenosine-tri-phosphate (ATP, 16.7 μM=>final conc. in the 5 μl assay volume is 10 μM) and substrate (1.67 μM=>final conc. in the 5 μl assay volume is 1 μM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 °C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot and was chosen appropriate to have the assay in the linear range, typical enzyme concentrations were in the range of about 0.05 ng/μl (final conc. in the 5 μl assay volume). The reaction was stopped by the addition of 5 μl of a solution of HTRF detection reagents (200 nM streptavidine-XL665 [Cisbio] and 1.5 nM anti-phosho-Serine antibody [Millipore, cat. #35-001] and 0.75 nM LANCE Eu-W 1024 labeled anti-mouse IgG antibody [Perkin Elmer]) in an aqueous EDTA-solution (100 mM EDTA, 0.1% (w/v) bovine serum albumin in 50 mM HEPES/NaOH pH 7.5). The resulting mixture was incubated 1 h at 22 °C. to allow the binding of the biotinylated phosphorylated peptide to the streptavidine-XL665 and the antibodies. Subsequently the amount of phosphorylated substrate was evaluated by measurement of the resonance energy transfer from the anti-mouse-IgG-Eu-Chelate to the streptavidine-XL665. Therefore, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm was measured in a HTRF reader, e.g. a Rubystar (BMG Labtechnologies, Offenburg, Germany) or a Viewlux (Perkin-Elmer). The ratio of the emissions at 665 nm and at 622 nm was taken as the measure for the amount of phosphorylated substrate. The data were normalised (enzyme reaction without inhibitor=0% inhibition, all other assay components but no enzyme=100% inhibition). Normally test compound were tested on the same microtiter plate at 10 different concentrations in the range of 20 μM to 1 nM (20 μM, 6.7 μM, 2.2 μM, 0.74 μM, 0.25 μM, 82 nM, 27 nM, 9.2 nM, 3.1 nM and 1 nM, dilution series prepared before the assay at the level of the 100 fold conc. stock solutions by serial 1:3 dilutions) in duplicate values for each concentration and IC50 values were calculated by a 4 parameter fit using an in-house software.",B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2cn1,,,CHEMBL3886620,,2016.0,"{'bei': '18.15', 'le': '0.33', 'lle': '3.46', 'sei': '7.01'}",CHEMBL3932688,,CHEMBL3932688,6.96,False,http://www.openphacts.org/units/Nanomolar,2872269,=,37,True,=,,IC50,nM,,110.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,110.0
381892,17755438,[],CHEMBL3888207,"Akt1 TR-FRET assay: His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany). For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 μl of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 °C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 μl of a solution of adenosine-tri-phosphate (ATP, 16.7 μM=>final conc. in the 5 μl assay volume is 10 μM) and substrate (1.67 μM=>final conc. in the 5 μl assay volume is 1 μM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 °C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot and was chosen appropriate to have the assay in the linear range, typical enzyme concentrations were in the range of about 0.05 ng/μl (final conc. in the 5 μl assay volume). The reaction was stopped by the addition of 5 μl of a solution of HTRF detection reagents (200 nM streptavidine-XL665 [Cisbio] and 1.5 nM anti-phosho-Serine antibody [Millipore, cat. #35-001] and 0.75 nM LANCE Eu-W 1024 labeled anti-mouse IgG antibody [Perkin Elmer]) in an aqueous EDTA-solution (100 mM EDTA, 0.1% (w/v) bovine serum albumin in 50 mM HEPES/NaOH pH 7.5). The resulting mixture was incubated 1 h at 22 °C. to allow the binding of the biotinylated phosphorylated peptide to the streptavidine-XL665 and the antibodies. Subsequently the amount of phosphorylated substrate was evaluated by measurement of the resonance energy transfer from the anti-mouse-IgG-Eu-Chelate to the streptavidine-XL665. Therefore, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm was measured in a HTRF reader, e.g. a Rubystar (BMG Labtechnologies, Offenburg, Germany) or a Viewlux (Perkin-Elmer). The ratio of the emissions at 665 nm and at 622 nm was taken as the measure for the amount of phosphorylated substrate. The data were normalised (enzyme reaction without inhibitor=0% inhibition, all other assay components but no enzyme=100% inhibition). Normally test compound were tested on the same microtiter plate at 10 different concentrations in the range of 20 μM to 1 nM (20 μM, 6.7 μM, 2.2 μM, 0.74 μM, 0.25 μM, 82 nM, 27 nM, 9.2 nM, 3.1 nM and 1 nM, dilution series prepared before the assay at the level of the 100 fold conc. stock solutions by serial 1:3 dilutions) in duplicate values for each concentration and IC50 values were calculated by a 4 parameter fit using an in-house software.",B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2c(OC)n1,,,CHEMBL3886620,,2016.0,"{'bei': '16.79', 'le': '0.31', 'lle': '2.99', 'sei': '7.84'}",CHEMBL3956697,,CHEMBL3956697,7.19,False,http://www.openphacts.org/units/Nanomolar,2872270,=,37,True,=,,IC50,nM,,64.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,64.0
381893,17755439,[],CHEMBL3888207,"Akt1 TR-FRET assay: His-tagged human recombinant kinase full-length Akt1 expressed in insect cells was purchased form Invitrogen (part number PV 3599). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx-KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlin-Buch, Germany). For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 μl of a solution of Akt1 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 °C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 μl of a solution of adenosine-tri-phosphate (ATP, 16.7 μM=>final conc. in the 5 μl assay volume is 10 μM) and substrate (1.67 μM=>final conc. in the 5 μl assay volume is 1 μM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 °C. The concentration of Akt1 in the assay was adjusted depending of the activity of the enzyme lot and was chosen appropriate to have the assay in the linear range, typical enzyme concentrations were in the range of about 0.05 ng/μl (final conc. in the 5 μl assay volume). The reaction was stopped by the addition of 5 μl of a solution of HTRF detection reagents (200 nM streptavidine-XL665 [Cisbio] and 1.5 nM anti-phosho-Serine antibody [Millipore, cat. #35-001] and 0.75 nM LANCE Eu-W 1024 labeled anti-mouse IgG antibody [Perkin Elmer]) in an aqueous EDTA-solution (100 mM EDTA, 0.1% (w/v) bovine serum albumin in 50 mM HEPES/NaOH pH 7.5). The resulting mixture was incubated 1 h at 22 °C. to allow the binding of the biotinylated phosphorylated peptide to the streptavidine-XL665 and the antibodies. Subsequently the amount of phosphorylated substrate was evaluated by measurement of the resonance energy transfer from the anti-mouse-IgG-Eu-Chelate to the streptavidine-XL665. Therefore, the fluorescence emissions at 620 nm and 665 nm after excitation at 350 nm was measured in a HTRF reader, e.g. a Rubystar (BMG Labtechnologies, Offenburg, Germany) or a Viewlux (Perkin-Elmer). The ratio of the emissions at 665 nm and at 622 nm was taken as the measure for the amount of phosphorylated substrate. The data were normalised (enzyme reaction without inhibitor=0% inhibition, all other assay components but no enzyme=100% inhibition). Normally test compound were tested on the same microtiter plate at 10 different concentrations in the range of 20 μM to 1 nM (20 μM, 6.7 μM, 2.2 μM, 0.74 μM, 0.25 μM, 82 nM, 27 nM, 9.2 nM, 3.1 nM and 1 nM, dilution series prepared before the assay at the level of the 100 fold conc. stock solutions by serial 1:3 dilutions) in duplicate values for each concentration and IC50 values were calculated by a 4 parameter fit using an in-house software.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1nc(C(N)=O)cn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc12,,,CHEMBL3886620,,2016.0,"{'bei': '18.23', 'le': '0.33', 'lle': '4.03', 'sei': '6.95'}",CHEMBL3931748,,CHEMBL3931748,7.54,False,http://www.openphacts.org/units/Nanomolar,2872271,=,37,True,=,,IC50,nM,,29.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,29.0
390591,17762701,[],CHEMBL3888334,"Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1=NN(C(=O)c2ccc(Cl)cc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2ncccn2)cc1,,,CHEMBL3886664,,2016.0,"{'bei': '9.28', 'le': '0.19', 'lle': '1.18', 'sei': '3.16'}",CHEMBL603852,,CHEMBL603852,4.62,False,http://www.openphacts.org/units/Nanomolar,2876684,=,37,True,=,,IC50,nM,,24000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24000.0
390592,17762702,[],CHEMBL3888334,"Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1nnc(NS(=O)(=O)c2cccc3cccnc23)s1,,,CHEMBL3886664,,2016.0,"{'bei': '11.58', 'le': '0.26', 'lle': '3.77', 'sei': '2.97'}",CHEMBL1994702,,CHEMBL1994702,4.30,False,http://www.openphacts.org/units/Nanomolar,2876685,=,37,True,=,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
390593,17762703,[],CHEMBL3888334,"Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,CC1=NN(C(=O)c2ccc(Cl)cc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2nnc(C)s2)cc1,,,CHEMBL3886664,,2016.0,"{'bei': '10.23', 'le': '0.21', 'lle': '1.49', 'sei': '3.62'}",CHEMBL3931875,,CHEMBL3931875,5.30,False,http://www.openphacts.org/units/Nanomolar,2876686,=,37,True,=,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5000.0
390594,17762704,[],CHEMBL3888334,"Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(NS(=O)(=O)c2ccc(NS(=O)(=O)c3c(C)noc3C)cc2)nc(OC)n1,,,CHEMBL3886664,,2016.0,"{'bei': '12.78', 'le': '0.26', 'lle': '4.30', 'sei': '3.69'}",CHEMBL3912759,,CHEMBL3912759,6.00,False,http://www.openphacts.org/units/Nanomolar,2876687,=,37,True,=,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
390595,17762705,[],CHEMBL3888335,"Cellular Assay: Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL3886664,,2016.0,"{'bei': '18.33', 'le': '0.40', 'lle': '3.78', 'sei': '4.80'}",CHEMBL286737,,CHEMBL286737,4.70,False,http://www.openphacts.org/units/Nanomolar,2876688,=,37,True,=,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20000.0
390596,17762706,[],CHEMBL3888335,"Cellular Assay: Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccccc1)c1ccccc1NC(=O)c1ccccc1C(=O)O,,,CHEMBL3886664,,2016.0,"{'bei': '11.94', 'le': '0.22', 'lle': '0.41', 'sei': '4.50'}",CHEMBL1733315,,CHEMBL1733315,4.30,False,http://www.openphacts.org/units/Nanomolar,2876689,=,37,True,=,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
390597,17762707,[],CHEMBL3888335,"Cellular Assay: Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,CCOc1ccccc1C(=O)Nc1ccccc1C(=O)O,,,CHEMBL3886664,,2016.0,"{'bei': '16.13', 'le': '0.30', 'lle': '1.56', 'sei': '6.08'}",CHEMBL3985551,,CHEMBL3985551,4.60,False,http://www.openphacts.org/units/Nanomolar,2876690,=,37,True,=,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25000.0
390598,17762708,[],CHEMBL3888335,"Cellular Assay: Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(NS(=O)(=O)c2ccc(Nc3ccco3)cc2)nc(OC)n1,,,CHEMBL3886664,,2016.0,"{'bei': '11.43', 'le': '0.23', 'lle': '1.67', 'sei': '3.72'}",CHEMBL3987198,,CHEMBL3987198,4.30,False,http://www.openphacts.org/units/Nanomolar,2876691,=,37,True,=,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
390599,17762709,[],CHEMBL3888335,"Cellular Assay: Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(NS(=O)(=O)c2ccc(NC(=O)c3ccco3)cc2)nc(OC)n1,,,CHEMBL3886664,,2016.0,"{'bei': '10.64', 'le': '0.21', 'lle': '2.16', 'sei': '3.24'}",CHEMBL1533790,,CHEMBL1533790,4.30,False,http://www.openphacts.org/units/Nanomolar,2876692,=,37,True,=,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
390600,17762710,[],CHEMBL3888335,"Cellular Assay: Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(NS(=O)(=O)c2ccc(NC(C)=O)cc2)nc(OC)n1,,,CHEMBL3886664,,2016.0,"{'bei': '12.21', 'le': '0.24', 'lle': '3.05', 'sei': '3.60'}",CHEMBL1349361,,CHEMBL1349361,4.30,False,http://www.openphacts.org/units/Nanomolar,2876693,=,37,True,=,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
390601,17762711,[],CHEMBL3888335,"Cellular Assay: Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nnc(NS(=O)(=O)c2ccc(NS(=O)(=O)c3ccc4ccccc4c3)cc2)s1,,,CHEMBL3886664,,2016.0,"{'bei': '9.99', 'le': '0.21', 'lle': '1.00', 'sei': '3.90'}",CHEMBL595786,,CHEMBL595786,4.60,False,http://www.openphacts.org/units/Nanomolar,2876694,=,37,True,=,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25000.0
390602,17762712,[],CHEMBL3888335,"Cellular Assay: Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(S(=O)(=O)Nc2ccc(S(=O)(=O)Nc3nnc(S(N)(=O)=O)s3)cc2)cc1,,,CHEMBL3886664,,2016.0,"{'bei': '8.77', 'le': '0.20', 'lle': '3.93', 'sei': '2.11'}",CHEMBL3910424,,CHEMBL3910424,4.30,False,http://www.openphacts.org/units/Nanomolar,2876695,=,37,True,=,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
390616,17762726,[],CHEMBL3888334,"Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL3886664,,2016.0,"{'bei': '18.33', 'le': '0.40', 'lle': '3.78', 'sei': '4.80'}",CHEMBL286737,,CHEMBL286737,4.70,False,http://www.openphacts.org/units/Nanomolar,2876688,=,37,True,=,,IC50,nM,,20000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20000.0
390617,17762727,[],CHEMBL3888334,"Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL3886664,,2016.0,"{'bei': '17.96', 'le': '0.39', 'lle': '3.68', 'sei': '4.70'}",CHEMBL286737,,CHEMBL286737,4.60,False,http://www.openphacts.org/units/Nanomolar,2876688,=,37,True,=,,IC50,nM,,25000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25000.0
390618,17762728,[],CHEMBL3888334,"Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL3886664,,2016.0,"{'bei': '12.18', 'le': '0.25', 'lle': '0.58', 'sei': '4.95'}",CHEMBL595582,,CHEMBL595582,5.00,False,http://www.openphacts.org/units/Nanomolar,2876696,=,37,True,=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
390619,17762729,[],CHEMBL3888334,"Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL3886664,,2016.0,"{'bei': '11.75', 'le': '0.24', 'lle': '0.40', 'sei': '4.77'}",CHEMBL595582,,CHEMBL595582,4.82,False,http://www.openphacts.org/units/Nanomolar,2876696,=,37,True,=,,IC50,nM,,15000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,15000.0
390620,17762730,[],CHEMBL3888334,"Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL3886664,,2016.0,,CHEMBL593946,,CHEMBL593946,,False,http://www.openphacts.org/units/Nanomolar,2876697,>,37,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
390621,17762731,[],CHEMBL3888334,"Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,COCCOCCOCC(=O)Nc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL3886664,,2016.0,,CHEMBL611216,,CHEMBL611216,,False,http://www.openphacts.org/units/Nanomolar,2876698,>,37,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50000.0
390622,17762732,[],CHEMBL3888334,"Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL3886664,,2016.0,"{'bei': '12.70', 'le': '0.26', 'lle': '-0.60', 'sei': '7.23'}",CHEMBL595583,,CHEMBL595583,5.20,False,http://www.openphacts.org/units/Nanomolar,2876699,=,37,True,=,,IC50,nM,,6300.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6300.0
390623,17762733,[],CHEMBL3888334,"Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008).",B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCCCCc1ccc(S(=O)(=O)Nc2nncs2)cc1,,,CHEMBL3886664,,2016.0,"{'bei': '12.21', 'le': '0.25', 'lle': '-0.80', 'sei': '6.95'}",CHEMBL595583,,CHEMBL595583,5.00,False,http://www.openphacts.org/units/Nanomolar,2876699,=,37,True,=,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
412002,17776717,[],CHEMBL3888646,"Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1,,,CHEMBL3886794,,2016.0,,CHEMBL3903725,,CHEMBL3903725,,False,http://www.openphacts.org/units/Nanomolar,2886096,>,37,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,18008347,[],CHEMBL4003700,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1cc(-c2ccn3c(-c4ccc(C(N)=O)c(OCc5cccc(F)c5)c4)cnc3c2)cn1,,,CHEMBL4002599,Eur J Med Chem,2017.0,"{'bei': '12.47', 'le': '0.23', 'lle': '1.98', 'sei': '6.85'}",CHEMBL4062453,,CHEMBL4062453,6.22,False,http://www.openphacts.org/units/Nanomolar,2984227,=,1,True,=,,IC50,nM,,608.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,608.0
,18012407,[],CHEMBL4004227,Inhibition of recombinant human N-terminal GST-tagged AKT1 catalytic domain (104 to 480 residues) expressed in baculovirus expression system,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12,,,CHEMBL4002626,Bioorg Med Chem Lett,2017.0,,CHEMBL3822972,,CHEMBL3822972,,False,http://www.openphacts.org/units/Nanomolar,2984809,>,1,True,>,,IC50,nM,,50000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,50.0
,18031599,[],CHEMBL4007682,Inhibition of AKT (unknown origin) after 60 mins by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21,,,CHEMBL4007384,Bioorg Med Chem Lett,2016.0,,CHEMBL4069365,,CHEMBL4069365,,False,http://www.openphacts.org/units/Nanomolar,2987739,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
Not Determined,18066753,[],CHEMBL4014550,Inhibition of human AKT1,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cnc3scc(NC(=O)C4CCCCC4)c3c2)cc1OC,,,CHEMBL4014275,Eur J Med Chem,2017.0,,CHEMBL3334979,,CHEMBL3334979,,False,,2994492,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,18102177,[],CHEMBL4022195,Inhibition of recombinant full length human His-tagged AKT1 expressed in baculovirus expression system using ser/thr 6 as substrate after 1 hr by FRET-based Z'-Lyte assay,B,,,BAO_0000190,BAO_0000019,assay format,NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1,,,CHEMBL4020778,Bioorg Med Chem Lett,2017.0,"{'bei': '23.65', 'le': '0.46', 'lle': '4.50', 'sei': '9.90'}",CHEMBL3544960,AT-13148,CHEMBL3544960,7.42,False,http://www.openphacts.org/units/Nanomolar,3002034,=,1,True,=,,IC50,nM,,38.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,38.0
,18105907,[],CHEMBL4022690,Inhibition of human AKT1/PKB using phospho-AKT peptide substrate after 1 hr by scintillation counting method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nc(NCCNc2ncc(-n3ccnc3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-],,,CHEMBL4020814,J Med Chem,2017.0,,CHEMBL3185148,,CHEMBL3185148,,False,http://www.openphacts.org/units/Nanomolar,3002593,>,1,True,>,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.0
,18105908,[],CHEMBL4022690,Inhibition of human AKT1/PKB using phospho-AKT peptide substrate after 1 hr by scintillation counting method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-],,,CHEMBL4020814,J Med Chem,2017.0,,CHEMBL1080901,,CHEMBL1080901,,False,http://www.openphacts.org/units/Nanomolar,3002632,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18105909,[],CHEMBL4022690,Inhibition of human AKT1/PKB using phospho-AKT peptide substrate after 1 hr by scintillation counting method,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1,,,CHEMBL4020814,J Med Chem,2017.0,,CHEMBL412142,CHIR-99021,CHEMBL412142,,False,http://www.openphacts.org/units/Nanomolar,3002659,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18231693,[],CHEMBL4050183,Inhibition of human AKT1 using KGSGSGRPRTSSFAEG as substrate in presence of [gamma-32P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL4049399,Bioorg Med Chem,2017.0,"{'bei': '17.63', 'le': '0.32', 'lle': '3.88', 'sei': '11.84'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.23,False,http://www.openphacts.org/units/Nanomolar,3025474,=,1,True,=,,IC50,nM,,5.94,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-9M,UO_0000065,,5.94
Not Determined,18231723,[],CHEMBL4050183,Inhibition of human AKT1 using KGSGSGRPRTSSFAEG as substrate in presence of [gamma-32P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,,,CHEMBL4049399,Bioorg Med Chem,2017.0,,CHEMBL573339,PI-103,CHEMBL573339,,False,,3025475,,1,False,,,IC50,,,,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,,,,
,18288050,[],CHEMBL4121773,Inhibition of human recombinant AKT1 expressed in insect cells incubated for 60 mins measured at apparent ATP Km level by kinase ADP-FP assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CC(=O)Nc2ncnc(N3CCC(c4nc(-c5ccc(F)c(C(F)(F)F)c5)cn4CCN4CCCC4)CC3)c21,,,CHEMBL4118128,Bioorg Med Chem Lett,2018.0,"{'bei': '14.91', 'le': '0.28', 'lle': '3.10', 'sei': '10.76'}",CHEMBL4128457,,CHEMBL4128457,8.52,False,http://www.openphacts.org/units/Nanomolar,3035496,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.003
,18288051,[],CHEMBL4121773,Inhibition of human recombinant AKT1 expressed in insect cells incubated for 60 mins measured at apparent ATP Km level by kinase ADP-FP assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CC(=O)Nc2ncnc(N3CCC(c4nc(C(F)(F)F)cn4CCN4CCCC4)CC3)c21,,,CHEMBL4118128,Bioorg Med Chem Lett,2018.0,"{'bei': '16.67', 'le': '0.32', 'lle': '4.34', 'sei': '10.05'}",CHEMBL4129817,,CHEMBL4129817,7.96,False,http://www.openphacts.org/units/Nanomolar,3035497,=,1,True,=,,IC50,nM,,11.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.011
,18288052,[],CHEMBL4121773,Inhibition of human recombinant AKT1 expressed in insect cells incubated for 60 mins measured at apparent ATP Km level by kinase ADP-FP assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CC(=O)Nc2ncnc(N3CCC(c4nc(C5CCOCC5)cn4CCN4CCCC4)CC3)c21,,,CHEMBL4118128,Bioorg Med Chem Lett,2018.0,"{'bei': '17.01', 'le': '0.32', 'lle': '4.91', 'sei': '9.50'}",CHEMBL4126067,,CHEMBL4126067,8.40,False,http://www.openphacts.org/units/Nanomolar,3035498,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.004
,18288053,[],CHEMBL4121773,Inhibition of human recombinant AKT1 expressed in insect cells incubated for 60 mins measured at apparent ATP Km level by kinase ADP-FP assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CC(=O)Nc2ncnc(N3CCC(c4nc(CCC(F)(F)F)cn4CCN4CCCC4)CC3)c21,,,CHEMBL4118128,Bioorg Med Chem Lett,2018.0,"{'bei': '16.42', 'le': '0.31', 'lle': '4.21', 'sei': '10.48'}",CHEMBL4129379,,CHEMBL4129379,8.30,False,http://www.openphacts.org/units/Nanomolar,3035499,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.005
,18288075,[],CHEMBL4121779,Inhibition of AKT1 in human U87MG cells assessed as reduction in GSK3beta Ser9 phosphorylation incubated for 1 hr by alpha screen Surefire assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CC(=O)Nc2ncnc(N3CCC(c4nc(-c5ccc(F)c(C(F)(F)F)c5)cn4CCN4CCCC4)CC3)c21,,,CHEMBL4118128,Bioorg Med Chem Lett,2018.0,"{'bei': '12.96', 'le': '0.25', 'lle': '1.99', 'sei': '9.36'}",CHEMBL4128457,,CHEMBL4128457,7.41,False,http://www.openphacts.org/units/Nanomolar,3035496,=,1,True,=,,IC50,nM,,39.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.039
,18288076,[],CHEMBL4121779,Inhibition of AKT1 in human U87MG cells assessed as reduction in GSK3beta Ser9 phosphorylation incubated for 1 hr by alpha screen Surefire assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CC(=O)Nc2ncnc(N3CCC(c4nc(C(F)(F)F)cn4CCN4CCCC4)CC3)c21,,,CHEMBL4118128,Bioorg Med Chem Lett,2018.0,"{'bei': '11.75', 'le': '0.23', 'lle': '1.99', 'sei': '7.08'}",CHEMBL4129817,,CHEMBL4129817,5.61,False,http://www.openphacts.org/units/Nanomolar,3035497,=,1,True,=,,IC50,nM,,2460.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,2.46
,18288077,[],CHEMBL4121779,Inhibition of AKT1 in human U87MG cells assessed as reduction in GSK3beta Ser9 phosphorylation incubated for 1 hr by alpha screen Surefire assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CC(=O)Nc2ncnc(N3CCC(c4nc(C5CCOCC5)cn4CCN4CCCC4)CC3)c21,,,CHEMBL4118128,Bioorg Med Chem Lett,2018.0,"{'bei': '13.45', 'le': '0.25', 'lle': '3.15', 'sei': '7.51'}",CHEMBL4126067,,CHEMBL4126067,6.64,False,http://www.openphacts.org/units/Nanomolar,3035498,=,1,True,=,,IC50,nM,,230.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.23
,18288078,[],CHEMBL4121779,Inhibition of AKT1 in human U87MG cells assessed as reduction in GSK3beta Ser9 phosphorylation incubated for 1 hr by alpha screen Surefire assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CC(=O)Nc2ncnc(N3CCC(c4nc(CCC(F)(F)F)cn4CCN4CCCC4)CC3)c21,,,CHEMBL4118128,Bioorg Med Chem Lett,2018.0,"{'bei': '13.92', 'le': '0.27', 'lle': '2.95', 'sei': '8.89'}",CHEMBL4129379,,CHEMBL4129379,7.04,False,http://www.openphacts.org/units/Nanomolar,3035499,=,1,True,=,,IC50,nM,,92.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.092
,18318408,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1ccccc1,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '16.87', 'le': '0.31', 'lle': '3.95', 'sei': '6.61'}",CHEMBL4163627,,CHEMBL4163627,8.33,False,http://www.openphacts.org/units/Nanomolar,3041328,=,1,True,=,,IC50,nM,,4.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.7
,18318409,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1ccccc1F,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '15.81', 'le': '0.29', 'lle': '3.57', 'sei': '6.41'}",CHEMBL4160193,,CHEMBL4160193,8.09,False,http://www.openphacts.org/units/Nanomolar,3041329,=,1,True,=,,IC50,nM,,8.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.2
,18318410,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1ccc(F)cc1,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '13.20', 'le': '0.24', 'lle': '2.23', 'sei': '5.36'}",CHEMBL4159491,,CHEMBL4159491,6.75,False,http://www.openphacts.org/units/Nanomolar,3041330,=,1,True,=,,IC50,nM,,176.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,176.0
,18318411,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1ccc(OC)cc1,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '16.74', 'le': '0.31', 'lle': '4.37', 'sei': '6.48'}",CHEMBL4169791,,CHEMBL4169791,8.76,False,http://www.openphacts.org/units/Nanomolar,3041331,=,1,True,=,,IC50,nM,,1.72,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.72
,18318412,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1cccc(OC)c1,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '12.61', 'le': '0.23', 'lle': '2.21', 'sei': '4.88'}",CHEMBL4163164,,CHEMBL4163164,6.60,False,http://www.openphacts.org/units/Nanomolar,3041332,=,1,True,=,,IC50,nM,,251.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,251.0
,18318413,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1ccc(OC)c(OC)c1,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '12.54', 'le': '0.23', 'lle': '2.54', 'sei': '4.80'}",CHEMBL4171390,,CHEMBL4171390,6.94,False,http://www.openphacts.org/units/Nanomolar,3041333,=,1,True,=,,IC50,nM,,115.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,115.0
,18318414,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1ccc(C)cc1,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '11.84', 'le': '0.22', 'lle': '1.32', 'sei': '4.77'}",CHEMBL4161273,,CHEMBL4161273,6.01,False,http://www.openphacts.org/units/Nanomolar,3041334,=,1,True,=,,IC50,nM,,980.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,980.0
,18318415,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1CC(C)C,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '16.73', 'le': '0.31', 'lle': '4.01', 'sei': '6.28'}",CHEMBL4173126,,CHEMBL4173126,7.92,False,http://www.openphacts.org/units/Nanomolar,3041335,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,18318416,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1ccccc1,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '15.12', 'le': '0.28', 'lle': '3.26', 'sei': '5.75'}",CHEMBL4172716,,CHEMBL4172716,7.25,False,http://www.openphacts.org/units/Nanomolar,3041336,=,1,True,=,,IC50,nM,,56.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,56.0
,18318417,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1ccccc1F,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '12.79', 'le': '0.23', 'lle': '2.23', 'sei': '5.05'}",CHEMBL4164809,,CHEMBL4164809,6.37,False,http://www.openphacts.org/units/Nanomolar,3041337,=,1,True,=,,IC50,nM,,432.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,432.0
,18318418,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1ccc(F)cc1,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '13.07', 'le': '0.24', 'lle': '2.37', 'sei': '5.16'}",CHEMBL4169321,,CHEMBL4169321,6.50,False,http://www.openphacts.org/units/Nanomolar,3041338,=,1,True,=,,IC50,nM,,313.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,313.0
,18318419,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1ccc(OC)cc1,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '12.16', 'le': '0.22', 'lle': '2.19', 'sei': '4.58'}",CHEMBL4161394,,CHEMBL4161394,6.19,False,http://www.openphacts.org/units/Nanomolar,3041339,=,1,True,=,,IC50,nM,,640.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,640.0
,18318420,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1cccc(OC)c1,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '12.40', 'le': '0.23', 'lle': '2.32', 'sei': '4.67'}",CHEMBL4170874,,CHEMBL4170874,6.32,False,http://www.openphacts.org/units/Nanomolar,3041340,=,1,True,=,,IC50,nM,,482.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,482.0
,18318421,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1ccc(OC)c(OC)c1,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '12.06', 'le': '0.22', 'lle': '2.50', 'sei': '4.50'}",CHEMBL4160580,,CHEMBL4160580,6.51,False,http://www.openphacts.org/units/Nanomolar,3041341,=,1,True,=,,IC50,nM,,311.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,311.0
,18318422,[],CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1c(C)nc(NNC(=O)c2cccc3c(=O)c4ccccc4[nH]c23)nc1-c1ccc(C)cc1,,,CHEMBL4130433,Eur J Med Chem,2017.0,"{'bei': '12.42', 'le': '0.23', 'lle': '1.83', 'sei': '4.86'}",CHEMBL4176130,,CHEMBL4176130,6.13,False,http://www.openphacts.org/units/Nanomolar,3041342,=,1,True,=,,IC50,nM,,738.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,738.0
,18379950,[],CHEMBL4145851,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL4145442,Eur J Med Chem,2017.0,"{'bei': '18.05', 'le': '0.33', 'lle': '4.07', 'sei': '12.12'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.42,False,http://www.openphacts.org/units/Nanomolar,3050784,=,1,True,=,,IC50,nM,,3.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.8
,18402519,[],CHEMBL4150391,Inhibition of AKT1 (unknown origin) using FAM-labeled peptide as substrate by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ncc(-c2cc(OC3CCOCC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,,,CHEMBL4145625,J Med Chem,2018.0,,CHEMBL4166144,,CHEMBL4166144,,False,http://www.openphacts.org/units/Nanomolar,3054408,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,18402608,[],CHEMBL4150391,Inhibition of AKT1 (unknown origin) using FAM-labeled peptide as substrate by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ncc(-c2cc(O[C@@H]3CCOC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,,,CHEMBL4145625,J Med Chem,2018.0,,CHEMBL4176771,,CHEMBL4176771,,False,http://www.openphacts.org/units/Nanomolar,3054409,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,18402701,[],CHEMBL4150391,Inhibition of AKT1 (unknown origin) using FAM-labeled peptide as substrate by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(OC3CCOCC3)c2n1,,,CHEMBL4145625,J Med Chem,2018.0,,CHEMBL4166594,,CHEMBL4166594,,False,http://www.openphacts.org/units/Nanomolar,3054426,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,18402782,[],CHEMBL4150391,Inhibition of AKT1 (unknown origin) using FAM-labeled peptide as substrate by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(O[C@@H]3CCOC3)c2n1,,,CHEMBL4145625,J Med Chem,2018.0,,CHEMBL4174909,,CHEMBL4174909,,False,http://www.openphacts.org/units/Nanomolar,3054432,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,18436521,[],CHEMBL4156333,Inhibition of Akt in human A549 cells after 24 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CSc1nnc(COc2ccc3c(c2)CCCC3)o1)Nc1nc2ccc(F)cc2s1,,,CHEMBL4152328,Eur J Med Chem,2018.0,"{'bei': '8.52', 'le': '0.17', 'lle': '-1.00', 'sei': '4.45'}",CHEMBL4170467,,CHEMBL4170467,4.01,False,http://www.openphacts.org/units/Nanomolar,3059817,=,1,True,=,,IC50,nM,,98330.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,98.33
,18436522,[],CHEMBL4156333,Inhibition of Akt in human A549 cells after 24 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2nc(NC(=O)CSc3nnc(COc4ccc5c(c4)CCCC5)o3)sc2c1,,,CHEMBL4152328,Eur J Med Chem,2018.0,"{'bei': '9.45', 'le': '0.19', 'lle': '-0.32', 'sei': '4.59'}",CHEMBL4163608,,CHEMBL4163608,4.56,False,http://www.openphacts.org/units/Nanomolar,3059821,=,1,True,=,,IC50,nM,,27500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,27.5
,18436523,[],CHEMBL4156333,Inhibition of Akt in human A549 cells after 24 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CSc1nnc(COc2ccc3c(c2)CCCC3)o1)Nc1ncc([N+](=O)[O-])s1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4152328,Eur J Med Chem,2018.0,,CHEMBL4168160,,CHEMBL4168160,,False,http://www.openphacts.org/units/Nanomolar,3059824,=,1,True,=,,IC50,nM,,138330.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,138.33
,18436524,[],CHEMBL4156333,Inhibition of Akt in human A549 cells after 24 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,,,CHEMBL4152328,Eur J Med Chem,2018.0,"{'bei': '11.19', 'le': '0.21', 'lle': '3.18', 'sei': '3.47'}",CHEMBL494089,GSK-690693,CHEMBL494089,4.76,False,http://www.openphacts.org/units/Nanomolar,3059825,=,1,True,=,,IC50,nM,,17330.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,17.33
,18499534,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(CC3CCCC3)c2n1,,,CHEMBL4184298,J Med Chem,2018.0,,CHEMBL4204515,,CHEMBL4204515,,False,http://www.openphacts.org/units/Nanomolar,3070958,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18499535,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCN(c2ccc(-c3nn(CC4CCCC4)c4nc(NC)ncc34)cn2)CC1,,,CHEMBL4184298,J Med Chem,2018.0,,CHEMBL4213775,,CHEMBL4213775,,False,http://www.openphacts.org/units/Nanomolar,3070957,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18499536,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(CC3CCCC3)c2n1,,,CHEMBL4184298,J Med Chem,2018.0,,CHEMBL4208852,,CHEMBL4208852,,False,http://www.openphacts.org/units/Nanomolar,3070956,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18499537,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1,,,CHEMBL4184298,J Med Chem,2018.0,,CHEMBL4218175,,CHEMBL4218175,,False,http://www.openphacts.org/units/Nanomolar,3070955,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18499538,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2,,,CHEMBL4184298,J Med Chem,2018.0,,CHEMBL3809489,BEMCENTINIB,CHEMBL3809489,,False,http://www.openphacts.org/units/Nanomolar,3070954,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18499539,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1,,,CHEMBL4184298,J Med Chem,2018.0,,CHEMBL4207004,,CHEMBL4207004,,False,http://www.openphacts.org/units/Nanomolar,3070953,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18499540,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCN(c2ccc(-c3nn(Cc4cn(Cc5ccccc5)nn4)c4nc(NC)ncc34)cn2)CC1,,,CHEMBL4184298,J Med Chem,2018.0,"{'bei': '11.23', 'le': '0.21', 'lle': '2.96', 'sei': '5.41'}",CHEMBL4217649,,CHEMBL4217649,5.72,False,http://www.openphacts.org/units/Nanomolar,3070952,=,1,True,=,,IC50,nM,,1900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.9
,18499541,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1,,,CHEMBL4184298,J Med Chem,2018.0,,CHEMBL4218369,,CHEMBL4218369,,False,http://www.openphacts.org/units/Nanomolar,3070951,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18499542,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1,,,CHEMBL4184298,J Med Chem,2018.0,,CHEMBL4211308,,CHEMBL4211308,,False,http://www.openphacts.org/units/Nanomolar,3070950,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18499543,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(-c4ccsc4C(=O)OC)nn3)c2n1,,,CHEMBL4184298,J Med Chem,2018.0,,CHEMBL4205191,,CHEMBL4205191,,False,http://www.openphacts.org/units/Nanomolar,3070949,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18499544,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1,,,CHEMBL4184298,J Med Chem,2018.0,,CHEMBL4210084,,CHEMBL4210084,,False,http://www.openphacts.org/units/Nanomolar,3070948,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18499545,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2c(-c3ccc(OC)cc3)nn(CC3OCCO3)c2n1,,,CHEMBL4184298,J Med Chem,2018.0,,CHEMBL4209569,,CHEMBL4209569,,False,http://www.openphacts.org/units/Nanomolar,3070947,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18499546,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3OCCO3)c2n1,,,CHEMBL4184298,J Med Chem,2018.0,,CHEMBL4214476,,CHEMBL4214476,,False,http://www.openphacts.org/units/Nanomolar,3070946,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18499547,[],CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3CCCC3)c2n1,,,CHEMBL4184298,J Med Chem,2018.0,,CHEMBL4213003,,CHEMBL4213003,,False,http://www.openphacts.org/units/Nanomolar,3070945,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,18514149,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Cc1ccc(Cl)cc1)N1CCN(c2ncnc3[nH]cc(Br)c23)CC1,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '17.82', 'le': '0.41', 'lle': '4.47', 'sei': '11.89'}",CHEMBL4214539,,CHEMBL4214539,7.75,False,http://www.openphacts.org/units/Nanomolar,3073929,=,1,True,=,,IC50,nM,,18.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,18.0
,18514150,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1ccc(C2(C(=O)N3CCN(c4ncnc5[nH]ccc45)CC3)CCNCC2)cc1,,,CHEMBL4190265,Eur J Med Chem,2017.0,,CHEMBL4208194,,CHEMBL4208194,,False,http://www.openphacts.org/units/Nanomolar,3073921,>,1,True,>,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,40.0
,18514151,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C2(C(=O)N3CCN(c4ncnc5[nH]ccc45)CC3)CCNCC2)cc1,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '17.71', 'le': '0.33', 'lle': '5.51', 'sei': '8.62'}",CHEMBL4217489,,CHEMBL4217489,7.45,False,http://www.openphacts.org/units/Nanomolar,3073922,=,1,True,=,,IC50,nM,,35.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,35.6
,18514152,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]ccc23)CC1)C1(c2ccc(Cl)cc2)CCNCC1,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '17.83', 'le': '0.34', 'lle': '5.00', 'sei': '9.82'}",CHEMBL4212569,,CHEMBL4212569,7.58,False,http://www.openphacts.org/units/Nanomolar,3073923,=,1,True,=,,IC50,nM,,26.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.5
,18514153,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]ccc23)CC1)C1(c2ccc(Br)cc2)CCNCC1,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '16.12', 'le': '0.34', 'lle': '4.88', 'sei': '9.81'}",CHEMBL4211584,,CHEMBL4211584,7.57,False,http://www.openphacts.org/units/Nanomolar,3073924,=,1,True,=,,IC50,nM,,27.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,27.1
,18514154,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]ccc23)CC1)C1(c2ccc(Cl)c(Cl)c2)CCNCC1,,,CHEMBL4190265,Eur J Med Chem,2017.0,,CHEMBL4206698,,CHEMBL4206698,,False,http://www.openphacts.org/units/Nanomolar,3073925,>,1,True,>,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,40.0
,18514155,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]cc(Cl)c23)CC1)C1(c2cccc(Br)c2)CCNCC1,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '16.38', 'le': '0.36', 'lle': '4.91', 'sei': '10.70'}",CHEMBL4217723,,CHEMBL4217723,8.25,False,http://www.openphacts.org/units/Nanomolar,3073926,=,1,True,=,,IC50,nM,,5.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.6
,18514156,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]cc(Cl)c23)CC1)C1(c2ccc(Cl)cc2)CCNCC1,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '18.98', 'le': '0.38', 'lle': '5.49', 'sei': '11.30'}",CHEMBL4204854,,CHEMBL4204854,8.72,False,http://www.openphacts.org/units/Nanomolar,3073927,=,1,True,=,,IC50,nM,,1.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.9
,18514157,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]cc(Cl)c23)CC1)C1(c2ccc(Br)cc2)CCNCC1,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '17.36', 'le': '0.39', 'lle': '5.40', 'sei': '11.33'}",CHEMBL4202879,,CHEMBL4202879,8.74,False,http://www.openphacts.org/units/Nanomolar,3073928,=,1,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
,18514158,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]cc(Cl)c23)CC1)C1(c2ccc(Cl)c(Cl)c2)CCNCC1,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '17.29', 'le': '0.36', 'lle': '4.65', 'sei': '11.07'}",CHEMBL4213657,,CHEMBL4213657,8.54,False,http://www.openphacts.org/units/Nanomolar,3073932,=,1,True,=,,IC50,nM,,2.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.9
,18514159,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]cc(Br)c23)CC1)C1(c2ccccc2)CCNCC1,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '16.39', 'le': '0.35', 'lle': '5.00', 'sei': '9.97'}",CHEMBL4217841,,CHEMBL4217841,7.69,False,http://www.openphacts.org/units/Nanomolar,3073933,=,1,True,=,,IC50,nM,,20.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,20.3
,18514160,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]cc(Br)c23)CC1)C1(c2cccc(Br)c2)CCNCC1,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '14.81', 'le': '0.36', 'lle': '4.67', 'sei': '10.52'}",CHEMBL4212000,,CHEMBL4212000,8.12,False,http://www.openphacts.org/units/Nanomolar,3073934,=,1,True,=,,IC50,nM,,7.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.6
,18514161,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C2(C(=O)N3CCN(c4ncnc5[nH]cc(Br)c45)CC3)CCNCC2)cc1,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '15.72', 'le': '0.34', 'lle': '5.15', 'sei': '9.09'}",CHEMBL4216977,,CHEMBL4216977,7.85,False,http://www.openphacts.org/units/Nanomolar,3073935,=,1,True,=,,IC50,nM,,14.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,14.1
,18514162,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]cc(Br)c23)CC1)C1(c2ccc(Cl)cc2)CCNCC1,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '17.51', 'le': '0.39', 'lle': '5.48', 'sei': '11.44'}",CHEMBL4207231,,CHEMBL4207231,8.82,False,http://www.openphacts.org/units/Nanomolar,3073930,=,1,True,=,,IC50,nM,,1.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.5
,18514163,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]cc(Br)c23)CC1)C1(c2ccc(Cl)c(Cl)c2)CCNCC1,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '15.54', 'le': '0.36', 'lle': '4.37', 'sei': '10.84'}",CHEMBL4207643,,CHEMBL4207643,8.37,False,http://www.openphacts.org/units/Nanomolar,3073936,=,1,True,=,,IC50,nM,,4.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.3
,18514164,[],CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,,,CHEMBL4190265,Eur J Med Chem,2017.0,"{'bei': '20.61', 'le': '0.39', 'lle': '7.19', 'sei': '6.39'}",CHEMBL494089,GSK-690693,CHEMBL494089,8.77,False,http://www.openphacts.org/units/Nanomolar,3073931,=,1,True,=,,IC50,nM,,1.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.7
,18578782,[],CHEMBL4222453,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CCO)Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1,,,CHEMBL4219148,Bioorg Med Chem Lett,2018.0,,CHEMBL4228240,,CHEMBL4228240,,False,http://www.openphacts.org/units/Nanomolar,3085039,>,1,True,>,,IC50,nM,,500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,500.0
,18578783,[],CHEMBL4222453,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccccn3)ns2)n1,,,CHEMBL4219148,Bioorg Med Chem Lett,2018.0,,CHEMBL4227082,,CHEMBL4227082,,False,http://www.openphacts.org/units/Nanomolar,3085046,>,1,True,>,,IC50,nM,,500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,500.0
,18578784,[],CHEMBL4222453,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1,,,CHEMBL4219148,Bioorg Med Chem Lett,2018.0,,CHEMBL4225923,,CHEMBL4225923,,False,http://www.openphacts.org/units/Nanomolar,3085066,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.0
,18656498,[],CHEMBL4231206,Inhibition of recombinant human AKT1 expressed in insect cells using CREBtide as substrate after 60 mins by LANCE method,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL4229349,Eur J Med Chem,2018.0,"{'bei': '15.54', 'le': '0.28', 'lle': '2.90', 'sei': '10.44'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,7.25,False,http://www.openphacts.org/units/Nanomolar,3098546,=,1,True,=,,IC50,nM,,56.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-8M,UO_0000065,,5.6
,18665496,[],CHEMBL4233284,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1,,,CHEMBL4229420,Bioorg Med Chem Lett,2018.0,,CHEMBL4251324,,CHEMBL4251324,,False,http://www.openphacts.org/units/Nanomolar,3100085,>,1,True,>,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5000.0
,18665568,[],CHEMBL4233284,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1,,,CHEMBL4229420,Bioorg Med Chem Lett,2018.0,,CHEMBL4245507,,CHEMBL4245507,,False,http://www.openphacts.org/units/Nanomolar,3100083,>,1,True,>,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10000.0
,18706779,[],CHEMBL4256136,Inhibition of AKT1 (unknown origin) by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL4251714,J Nat Prod,2018.0,"{'bei': '16.98', 'le': '0.31', 'lle': '3.57', 'sei': '11.41'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,7.92,False,http://www.openphacts.org/units/Nanomolar,3106870,=,1,True,=,,IC50,nM,,12.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.0
,18728807,[],CHEMBL4259693,Inhibition of AKT1 (unknown origin) using biotin-labelled STK as substrate measured after 45 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]nc(Cl)c23)CC1)C1(c2ccc(Cl)cc2)CCNCC1,,,CHEMBL4257535,MedChemComm,2018.0,"{'bei': '15.59', 'le': '0.32', 'lle': '4.55', 'sei': '7.97'}",CHEMBL4284420,,CHEMBL4284420,7.18,False,http://www.openphacts.org/units/Nanomolar,3111475,=,1,True,=,,IC50,nM,,66.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,66.6
,18728808,[],CHEMBL4259693,Inhibition of AKT1 (unknown origin) using biotin-labelled STK as substrate measured after 45 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]nc(Cl)c23)CC1)C1(c2ccc(Br)cc2)CCNCC1,,,CHEMBL4257535,MedChemComm,2018.0,"{'bei': '14.82', 'le': '0.33', 'lle': '4.74', 'sei': '8.31'}",CHEMBL4282775,,CHEMBL4282775,7.48,False,http://www.openphacts.org/units/Nanomolar,3111476,=,1,True,=,,IC50,nM,,32.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,32.9
,18728809,[],CHEMBL4259693,Inhibition of AKT1 (unknown origin) using biotin-labelled STK as substrate measured after 45 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]nc(Cl)c23)CC1)C1(c2ccc(Cl)c(Cl)c2)CCNCC1,,,CHEMBL4257535,MedChemComm,2018.0,"{'bei': '15.39', 'le': '0.32', 'lle': '4.33', 'sei': '8.46'}",CHEMBL4285143,,CHEMBL4285143,7.61,False,http://www.openphacts.org/units/Nanomolar,3111477,=,1,True,=,,IC50,nM,,24.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24.3
,18728810,[],CHEMBL4259693,Inhibition of AKT1 (unknown origin) using biotin-labelled STK as substrate measured after 45 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]nc(Br)c23)CC1)C1(c2ccc(Cl)cc2)CCNCC1,,,CHEMBL4257535,MedChemComm,2018.0,"{'bei': '15.00', 'le': '0.33', 'lle': '4.83', 'sei': '8.41'}",CHEMBL4281435,,CHEMBL4281435,7.57,False,http://www.openphacts.org/units/Nanomolar,3111479,=,1,True,=,,IC50,nM,,26.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,26.9
,18728811,[],CHEMBL4259693,Inhibition of AKT1 (unknown origin) using biotin-labelled STK as substrate measured after 45 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]nc(Br)c23)CC1)C1(c2ccc(Br)cc2)CCNCC1,,,CHEMBL4257535,MedChemComm,2018.0,"{'bei': '13.26', 'le': '0.32', 'lle': '4.43', 'sei': '8.09'}",CHEMBL4292059,,CHEMBL4292059,7.29,False,http://www.openphacts.org/units/Nanomolar,3111480,=,1,True,=,,IC50,nM,,51.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,51.9
,18728812,[],CHEMBL4259693,Inhibition of AKT1 (unknown origin) using biotin-labelled STK as substrate measured after 45 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N1CCN(c2ncnc3[nH]nc(Br)c23)CC1)C1(c2ccc(Cl)c(Cl)c2)CCNCC1,,,CHEMBL4257535,MedChemComm,2018.0,"{'bei': '13.94', 'le': '0.32', 'lle': '4.13', 'sei': '8.35'}",CHEMBL4284849,,CHEMBL4284849,7.52,False,http://www.openphacts.org/units/Nanomolar,3111481,=,1,True,=,,IC50,nM,,30.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30.5
,18728813,[],CHEMBL4259693,Inhibition of AKT1 (unknown origin) using biotin-labelled STK as substrate measured after 45 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,,,CHEMBL4257535,MedChemComm,2018.0,"{'bei': '18.03', 'le': '0.34', 'lle': '6.09', 'sei': '5.59'}",CHEMBL494089,GSK-690693,CHEMBL494089,7.67,False,http://www.openphacts.org/units/Nanomolar,3111490,=,1,True,=,,IC50,nM,,21.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.3
,18851342,[],CHEMBL4305834,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C,,,CHEMBL4304763,Eur J Med Chem,2019.0,,CHEMBL4448494,,CHEMBL4448494,,False,http://www.openphacts.org/units/Nanomolar,3146778,>,1,True,>,,IC50,nM,,30000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,30000.0
,18854034,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)s1,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '19.93', 'le': '0.40', 'lle': '4.31', 'sei': '13.56'}",CHEMBL4438248,,CHEMBL4597086,7.99,False,http://www.openphacts.org/units/Nanomolar,3147157,=,1,True,=,,IC50,nM,,10.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.2
,18854035,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Cn1ncc(Cl)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)s1,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '20.09', 'le': '0.43', 'lle': '4.41', 'sei': '14.83'}",CHEMBL4454791,,CHEMBL4597931,8.74,False,http://www.openphacts.org/units/Nanomolar,3147156,=,1,True,=,,IC50,nM,,1.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.8
,18854036,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)s1,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '20.74', 'le': '0.40', 'lle': '4.81', 'sei': '13.53'}",CHEMBL4445702,,CHEMBL4597199,7.97,False,http://www.openphacts.org/units/Nanomolar,3147158,=,1,True,=,,IC50,nM,,10.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.6
,18854037,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Cn1ncc(Cl)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)s1,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '21.48', 'le': '0.44', 'lle': '5.18', 'sei': '15.27'}",CHEMBL4435124,,CHEMBL4597087,9.00,False,http://www.openphacts.org/units/Nanomolar,3147159,=,1,True,=,,IC50,nM,,1.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.0
,18854038,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Cn1ncc(Br)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)s1,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '17.83', 'le': '0.40', 'lle': '4.33', 'sei': '14.02'}",CHEMBL4444441,,CHEMBL4595315,8.26,False,http://www.openphacts.org/units/Nanomolar,3147160,=,1,True,=,,IC50,nM,,5.46,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.46
,18854039,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Cn1ncc(Cl)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)c(C(F)(F)F)c2)s1,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '14.28', 'le': '0.31', 'lle': '1.84', 'sei': '12.19'}",CHEMBL4460688,,CHEMBL4597797,7.19,False,http://www.openphacts.org/units/Nanomolar,3147161,=,1,True,=,,IC50,nM,,65.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,65.2
,18854040,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnn(C)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)s1.Cl,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '20.19', 'le': '0.39', 'lle': '4.58', 'sei': '13.65'}",CHEMBL4579551,,CHEMBL4598166,8.05,False,http://www.openphacts.org/units/Nanomolar,3147162,=,1,True,=,,IC50,nM,,9.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.0
,18854041,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,C=Cc1cnn(C)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)s1.Cl,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '17.85', 'le': '0.35', 'lle': '3.52', 'sei': '12.43'}",CHEMBL4467970,,CHEMBL4598057,7.33,False,http://www.openphacts.org/units/Nanomolar,3147163,=,1,True,=,,IC50,nM,,46.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,46.9
,18854042,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CCc1cnn(C)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)s1.Cl,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '17.72', 'le': '0.34', 'lle': '3.58', 'sei': '12.40'}",CHEMBL4554198,,CHEMBL4596617,7.31,False,http://www.openphacts.org/units/Nanomolar,3147164,=,1,True,=,,IC50,nM,,48.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,48.9
,18854043,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Cn1ncc(C(=O)O)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)s1,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '16.33', 'le': '0.32', 'lle': '4.14', 'sei': '7.27'}",CHEMBL4461200,,CHEMBL4597802,7.00,False,http://www.openphacts.org/units/Nanomolar,3147165,=,1,True,=,,IC50,nM,,101.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,101.0
,18854044,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Cn1ncc(CO)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)s1,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '17.38', 'le': '0.34', 'lle': '4.55', 'sei': '9.10'}",CHEMBL4455194,,CHEMBL4595316,7.21,False,http://www.openphacts.org/units/Nanomolar,3147166,=,1,True,=,,IC50,nM,,62.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,62.2
,18854045,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Cn1ncc(-c2ccccc2)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)s1,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '15.53', 'le': '0.30', 'lle': '2.32', 'sei': '12.13'}",CHEMBL4526242,,CHEMBL4595780,7.15,False,http://www.openphacts.org/units/Nanomolar,3147167,=,1,True,=,,IC50,nM,,70.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,70.4
,18854046,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Cn1ncc(-c2ccncc2)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)s1,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '15.17', 'le': '0.29', 'lle': '2.77', 'sei': '9.74'}",CHEMBL4577134,,CHEMBL4595204,7.00,False,http://www.openphacts.org/units/Nanomolar,3147168,=,1,True,=,,IC50,nM,,99.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,99.9
,18854047,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '18.68', 'le': '0.39', 'lle': '4.46', 'sei': '9.31'}",CHEMBL3137336,UPROSERTIB,CHEMBL3137336,8.02,False,http://www.openphacts.org/units/Nanomolar,3147169,=,1,True,=,,IC50,nM,,9.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.6
,18854048,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '18.19', 'le': '0.39', 'lle': '3.88', 'sei': '10.66'}",CHEMBL2219422,AFURESERTIB,CHEMBL2219422,7.77,False,http://www.openphacts.org/units/Nanomolar,3147170,=,1,True,=,,IC50,nM,,16.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,16.9
,18854049,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1csc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)c1,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '18.06', 'le': '0.38', 'lle': '3.53', 'sei': '13.34'}",CHEMBL4442226,,CHEMBL4442226,7.86,False,http://www.openphacts.org/units/Nanomolar,3147171,=,1,True,=,,IC50,nM,,13.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.7
,18854050,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Cn1ncc(Cl)c1-c1csc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)c1,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '21.24', 'le': '0.43', 'lle': '5.08', 'sei': '15.10'}",CHEMBL4451854,,CHEMBL4596143,8.90,False,http://www.openphacts.org/units/Nanomolar,3147172,=,1,True,=,,IC50,nM,,1.26,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.26
,18854051,[],CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Cn1ncc(Cl)c1-c1csc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)c(C(F)(F)F)c2)c1,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '14.80', 'le': '0.32', 'lle': '2.10', 'sei': '12.64'}",CHEMBL4545734,,CHEMBL4595309,7.45,False,http://www.openphacts.org/units/Nanomolar,3147173,=,1,True,=,,IC50,nM,,35.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,35.3
,18854053,[],CHEMBL4307006,Inhibition of Akt1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)sc1Cl,,,CHEMBL4304777,Eur J Med Chem,2019.0,"{'bei': '15.42', 'le': '0.33', 'lle': '2.52', 'sei': '11.86'}",CHEMBL4515689,,CHEMBL4515689,6.99,True,http://www.openphacts.org/units/Nanomolar,3147174,=,1,True,=,,IC50,nM,,102.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,102.0
,18938781,[],CHEMBL4328300,Inhibition of human AKT1 using KGSGSGRPRTSSFAEG as substrate by [gamma-33P]-ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL4325871,Eur J Med Chem,2019.0,"{'bei': '17.47', 'le': '0.32', 'lle': '3.80', 'sei': '11.74'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.15,False,http://www.openphacts.org/units/Nanomolar,3159540,=,1,True,=,,IC50,nM,,7.04,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,10'-9M,UO_0000065,,7.04
,19067254,[],CHEMBL4360635,Inhibition of AKT (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,,,CHEMBL4359824,Eur J Med Chem,2019.0,"{'bei': '18.82', 'le': '0.34', 'lle': '2.86', 'sei': '8.78'}",CHEMBL379218,,CHEMBL379218,6.75,False,http://www.openphacts.org/units/Nanomolar,3181156,=,1,True,=,,IC50,nM,,180.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nmol/L,UO_0000065,,180.0
,19137939,[],CHEMBL4375942,Inhibition of AKT phosphorylation in human K562 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(Cc2ccc(NC(=O)Nc3ccc(Br)cc3)nc2)c(=O)oc2cc(O)c(C(C)(C)C)cc12,,,CHEMBL4373717,Eur J Med Chem,2019.0,,CHEMBL4464965,,CHEMBL4464965,,False,http://www.openphacts.org/units/Nanomolar,3193953,<,1,True,<,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,19137944,[],CHEMBL4375942,Inhibition of AKT phosphorylation in human K562 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(Cc2ccc(NC(=O)Nc3ccccc3Cl)nc2)c(=O)oc2cc(O)c(C(C)(C)C)cc12,,,CHEMBL4373717,Eur J Med Chem,2019.0,,CHEMBL4516895,,CHEMBL4516895,,False,http://www.openphacts.org/units/Nanomolar,3193954,<,1,True,<,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,19137949,[],CHEMBL4375942,Inhibition of AKT phosphorylation in human K562 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(NC(=O)Nc2ccc(Cc3c(C)c4cc(C(C)(C)C)c(O)cc4oc3=O)cn2)cc1,,,CHEMBL4373717,Eur J Med Chem,2019.0,,CHEMBL4551568,,CHEMBL4551568,,False,http://www.openphacts.org/units/Nanomolar,3193955,<,1,True,<,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,19137954,[],CHEMBL4375942,Inhibition of AKT phosphorylation in human K562 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(NC(=O)Nc2ccc(Cc3c(C)c4cc(C(C)(C)C)c(O)cc4oc3=O)cn2)cc1,,,CHEMBL4373717,Eur J Med Chem,2019.0,,CHEMBL4463428,,CHEMBL4463428,,False,http://www.openphacts.org/units/Nanomolar,3193956,<,1,True,<,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,19137959,[],CHEMBL4375942,Inhibition of AKT phosphorylation in human K562 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(Cc2ccc(NC(=O)Nc3cccc(Cl)c3)nc2)c(=O)oc2cc(O)c(C(C)(C)C)cc12,,,CHEMBL4373717,Eur J Med Chem,2019.0,,CHEMBL4551206,,CHEMBL4551206,,False,http://www.openphacts.org/units/Nanomolar,3193957,<,1,True,<,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,19137964,[],CHEMBL4375942,Inhibition of AKT phosphorylation in human K562 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(Cc2ccc(NC(=O)Nc3ccc(F)cc3)nc2)c(=O)oc2cc(O)c(C(C)(C)C)cc12,,,CHEMBL4373717,Eur J Med Chem,2019.0,,CHEMBL4570215,,CHEMBL4570215,,False,http://www.openphacts.org/units/Nanomolar,3193958,<,1,True,<,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,19137969,[],CHEMBL4375942,Inhibition of AKT phosphorylation in human K562 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(Cc2ccc(NC(=O)Nc3ccc(F)c(F)c3)nc2)c(=O)oc2cc(O)c(C(C)(C)C)cc12,,,CHEMBL4373717,Eur J Med Chem,2019.0,,CHEMBL4439821,,CHEMBL4439821,,False,http://www.openphacts.org/units/Nanomolar,3193959,<,1,True,<,,IC50,nM,,10000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,10.0
,19167540,[],CHEMBL4384269,Inhibition of PKBalpha (unknown origin) expressed in Sf9 insect cells using Biotin-SGRARTSSFAEPG as substrate after 30 mins by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(O)c(C(=O)c2ccc(C(=O)N[C@@H]3CCCNC[C@H]3NC(=O)c3ccncc3)cc2)c1F.Cl.Cl,,,CHEMBL4382239,Eur J Med Chem,2019.0,"{'bei': '16.58', 'le': '0.31', 'lle': '5.95', 'sei': '6.48'}",CHEMBL4468352,,CHEMBL1233481,8.40,False,http://www.openphacts.org/units/Nanomolar,3198931,=,1,True,=,,IC50,nM,,4.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.0
,19273724,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.78', 'le': '0.33', 'lle': '1.91', 'sei': '10.01'}",CHEMBL3805228,,CHEMBL3805228,7.21,False,http://www.openphacts.org/units/Nanomolar,3218617,=,1,True,=,,IC50,nM,,61.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,61.0
,19273725,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@@H]2c2ccc(F)c(F)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '18.89', 'le': '0.39', 'lle': '4.46', 'sei': '11.93'}",CHEMBL4552655,,CHEMBL4552655,8.60,False,http://www.openphacts.org/units/Nanomolar,3218616,=,1,True,=,,IC50,nM,,2.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.5
,19274123,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '17.71', 'le': '0.35', 'lle': '5.44', 'sei': '6.32'}",CHEMBL2325741,CAPIVASERTIB,CHEMBL2325741,7.59,False,http://www.openphacts.org/units/Nanomolar,3218615,=,1,True,=,,IC50,nM,,25.43,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,25.43
,19274124,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)OCC[C@@H]1C[C@@H](c2ccc(F)c(F)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.64', 'le': '0.32', 'lle': '4.01', 'sei': '8.61'}",CHEMBL4531735,,CHEMBL4531735,8.47,False,http://www.openphacts.org/units/Nanomolar,3218614,=,1,True,=,,IC50,nM,,3.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.4
,19274125,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)NCC[C@@H]1C[C@@H](c2ccc(F)c(F)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.92', 'le': '0.33', 'lle': '4.56', 'sei': '8.50'}",CHEMBL4460525,,CHEMBL4460525,8.60,False,http://www.openphacts.org/units/Nanomolar,3218613,=,1,True,=,,IC50,nM,,2.49,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.49
,19274126,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCNS(C)(=O)=O)C[C@H]2c2ccc(F)c(F)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.72', 'le': '0.31', 'lle': '5.03', 'sei': '7.17'}",CHEMBL4441416,,CHEMBL4441416,8.48,False,http://www.openphacts.org/units/Nanomolar,3218612,=,1,True,=,,IC50,nM,,3.29,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.29
,19274127,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)C[C@@H]1C[C@@H](c2ccc(F)c(F)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '16.84', 'le': '0.35', 'lle': '5.21', 'sei': '8.76'}",CHEMBL4440965,,CHEMBL4440965,8.86,False,http://www.openphacts.org/units/Nanomolar,3218611,=,1,True,=,,IC50,nM,,1.37,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.37
,19274128,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(O)CO)C[C@H]2c2ccc(F)c(F)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '16.02', 'le': '0.33', 'lle': '5.23', 'sei': '7.53'}",CHEMBL4567295,,CHEMBL4567295,8.48,False,http://www.openphacts.org/units/Nanomolar,3218610,=,1,True,=,,IC50,nM,,3.31,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.31
,19274129,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCO)C[C@H]2c2ccc(F)c(F)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '18.04', 'le': '0.37', 'lle': '5.12', 'sei': '9.76'}",CHEMBL4441825,,CHEMBL4441825,9.01,False,http://www.openphacts.org/units/Nanomolar,3218609,=,1,True,=,,IC50,nM,,0.98,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,0.98
,19274130,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(=O)NCC(O)CO)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '13.73', 'le': '0.30', 'lle': '5.10', 'sei': '6.00'}",CHEMBL4593086,,CHEMBL4593086,8.50,False,http://www.openphacts.org/units/Nanomolar,3218608,=,1,True,=,,IC50,nM,,3.13,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.13
,19274131,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(=O)NCCO)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.02', 'le': '0.33', 'lle': '4.81', 'sei': '7.29'}",CHEMBL4554668,,CHEMBL4554668,8.85,False,http://www.openphacts.org/units/Nanomolar,3218607,=,1,True,=,,IC50,nM,,1.41,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.41
,19274132,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(=O)NC3CCC3)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '13.51', 'le': '0.29', 'lle': '2.50', 'sei': '8.00'}",CHEMBL4447158,,CHEMBL4447158,8.10,False,http://www.openphacts.org/units/Nanomolar,3218606,=,1,True,=,,IC50,nM,,7.98,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.98
,19274133,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(=O)NC3CC3)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.36', 'le': '0.31', 'lle': '3.19', 'sei': '8.30'}",CHEMBL4589576,,CHEMBL4589576,8.40,False,http://www.openphacts.org/units/Nanomolar,3218605,=,1,True,=,,IC50,nM,,3.95,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.95
,19274134,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)C[C@@H]1C[C@@H](c2ccc(Cl)c(Cl)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.34', 'le': '0.33', 'lle': '3.91', 'sei': '8.48'}",CHEMBL4475923,,CHEMBL4475923,8.58,False,http://www.openphacts.org/units/Nanomolar,3218604,=,1,True,=,,IC50,nM,,2.64,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.64
,19274135,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(N)=O)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.57', 'le': '0.34', 'lle': '4.08', 'sei': '7.37'}",CHEMBL4438877,,CHEMBL4438877,8.49,False,http://www.openphacts.org/units/Nanomolar,3218603,=,1,True,=,,IC50,nM,,3.24,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.24
,19274136,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(=O)O)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.95', 'le': '0.35', 'lle': '3.70', 'sei': '7.96'}",CHEMBL4447967,,CHEMBL4447967,8.71,False,http://www.openphacts.org/units/Nanomolar,3218602,=,1,True,=,,IC50,nM,,1.94,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1.94
,19274137,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCn3cncn3)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.31', 'le': '0.31', 'lle': '3.13', 'sei': '8.12'}",CHEMBL4519793,,CHEMBL4519793,8.35,False,http://www.openphacts.org/units/Nanomolar,3218601,=,1,True,=,,IC50,nM,,4.47,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,4.47
,19274138,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCN3CCC(O)CC3)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '13.36', 'le': '0.29', 'lle': '2.84', 'sei': '8.60'}",CHEMBL4518523,,CHEMBL4518523,8.22,False,http://www.openphacts.org/units/Nanomolar,3218600,=,1,True,=,,IC50,nM,,5.99,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.99
,19274139,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCN3CCOCC3)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '13.40', 'le': '0.29', 'lle': '2.80', 'sei': '9.53'}",CHEMBL4450403,,CHEMBL4450403,8.06,False,http://www.openphacts.org/units/Nanomolar,3218599,=,1,True,=,,IC50,nM,,8.78,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.78
,19274140,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCN3CCCCC3)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '13.76', 'le': '0.30', 'lle': '1.84', 'sei': '10.95'}",CHEMBL4524940,,CHEMBL4524940,8.25,False,http://www.openphacts.org/units/Nanomolar,3218598,=,1,True,=,,IC50,nM,,5.65,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.65
,19274141,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCN3CCCC3)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.00', 'le': '0.30', 'lle': '2.17', 'sei': '10.88'}",CHEMBL4546392,,CHEMBL4546392,8.19,False,http://www.openphacts.org/units/Nanomolar,3218597,=,1,True,=,,IC50,nM,,6.41,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.41
,19274142,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)CC[C@@H]1C[C@@H](c2ccc(Cl)c(Cl)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.14', 'le': '0.33', 'lle': '2.98', 'sei': '11.24'}",CHEMBL4590906,,CHEMBL4590906,8.47,False,http://www.openphacts.org/units/Nanomolar,3218596,=,1,True,=,,IC50,nM,,3.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.4
,19274143,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,COCC[C@@H]1C[C@@H](c2ccc(Cl)c(Cl)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.93', 'le': '0.33', 'lle': '2.58', 'sei': '10.03'}",CHEMBL4568343,,CHEMBL4568343,8.15,False,http://www.openphacts.org/units/Nanomolar,3218595,=,1,True,=,,IC50,nM,,7.01,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.01
,19274144,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CC(O)CO)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.98', 'le': '0.33', 'lle': '4.14', 'sei': '7.48'}",CHEMBL4470606,,CHEMBL4470606,8.42,False,http://www.openphacts.org/units/Nanomolar,3218594,=,1,True,=,,IC50,nM,,3.79,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.79
,19274145,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCO)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '16.09', 'le': '0.35', 'lle': '3.64', 'sei': '9.27'}",CHEMBL4517950,,CHEMBL4517950,8.56,False,http://www.openphacts.org/units/Nanomolar,3218593,=,1,True,=,,IC50,nM,,2.74,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.74
,19274146,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCCO)C[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.73', 'le': '0.35', 'lle': '3.28', 'sei': '9.31'}",CHEMBL4451765,,CHEMBL4451765,8.59,False,http://www.openphacts.org/units/Nanomolar,3218592,=,1,True,=,,IC50,nM,,2.56,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.56
,19274147,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,C=CC[C@@H]1C[C@@H](c2ccc(Cl)c(Cl)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.97', 'le': '0.33', 'lle': '1.80', 'sei': '10.97'}",CHEMBL4449509,,CHEMBL4449509,7.91,False,http://www.openphacts.org/units/Nanomolar,3218591,=,1,True,=,,IC50,nM,,12.41,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,12.41
,19274148,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](c2ccc(Cl)c(Cl)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.05', 'le': '0.33', 'lle': '1.64', 'sei': '11.07'}",CHEMBL4467439,,CHEMBL4467439,7.98,False,http://www.openphacts.org/units/Nanomolar,3218590,=,1,True,=,,IC50,nM,,10.44,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,10.44
,19274149,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Br)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)nc1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.71', 'le': '0.32', 'lle': '3.48', 'sei': '9.38'}",CHEMBL4544069,,CHEMBL4544069,6.74,False,http://www.openphacts.org/units/Nanomolar,3218589,=,1,True,=,,IC50,nM,,181.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,181.8
,19274150,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)nc1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '16.87', 'le': '0.33', 'lle': '3.83', 'sei': '9.72'}",CHEMBL4470602,,CHEMBL4470602,6.98,False,http://www.openphacts.org/units/Nanomolar,3218588,=,1,True,=,,IC50,nM,,104.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,104.1
,19274151,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)nc1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '18.75', 'le': '0.35', 'lle': '4.62', 'sei': '9.91'}",CHEMBL4522719,,CHEMBL4522719,7.12,False,http://www.openphacts.org/units/Nanomolar,3218587,=,1,True,=,,IC50,nM,,76.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,76.6
,19274152,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Br)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)cn1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '13.79', 'le': '0.30', 'lle': '3.17', 'sei': '9.14'}",CHEMBL4587088,,CHEMBL4587088,6.57,False,http://www.openphacts.org/units/Nanomolar,3218586,=,1,True,=,,IC50,nM,,269.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,269.8
,19274153,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)cn1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.44', 'le': '0.30', 'lle': '3.38', 'sei': '9.28'}",CHEMBL4451405,,CHEMBL4451405,6.67,False,http://www.openphacts.org/units/Nanomolar,3218585,=,1,True,=,,IC50,nM,,215.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,215.0
,19274154,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)cn1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '18.21', 'le': '0.34', 'lle': '4.60', 'sei': '10.08'}",CHEMBL4528834,,CHEMBL4528834,7.24,False,http://www.openphacts.org/units/Nanomolar,3218584,=,1,True,=,,IC50,nM,,57.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,57.7
,19274155,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)cc1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '17.29', 'le': '0.34', 'lle': '3.38', 'sei': '12.11'}",CHEMBL4593509,,CHEMBL4593509,7.14,False,http://www.openphacts.org/units/Nanomolar,3218583,=,1,True,=,,IC50,nM,,72.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,72.3
,19274156,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Br)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)cc1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.01', 'le': '0.32', 'lle': '3.13', 'sei': '12.10'}",CHEMBL4445690,,CHEMBL4445690,7.13,False,http://www.openphacts.org/units/Nanomolar,3218582,=,1,True,=,,IC50,nM,,73.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,73.5
,19274157,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)cc1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '17.55', 'le': '0.34', 'lle': '3.67', 'sei': '12.83'}",CHEMBL4574492,,CHEMBL4574492,7.56,False,http://www.openphacts.org/units/Nanomolar,3218581,=,1,True,=,,IC50,nM,,27.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,27.3
,19274158,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)cc1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '19.34', 'le': '0.36', 'lle': '4.43', 'sei': '13.00'}",CHEMBL4460756,,CHEMBL4460756,7.67,False,http://www.openphacts.org/units/Nanomolar,3218580,=,1,True,=,,IC50,nM,,21.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,21.6
,19274159,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Br)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)n(C)c1Br,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '12.06', 'le': '0.31', 'lle': '2.22', 'sei': '10.49'}",CHEMBL4560290,,CHEMBL4560290,6.70,False,http://www.openphacts.org/units/Nanomolar,3218579,=,1,True,=,,IC50,nM,,199.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,199.1
,19274160,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)n(C)c1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.62', 'le': '0.31', 'lle': '2.57', 'sei': '10.69'}",CHEMBL4446884,,CHEMBL4446884,6.83,False,http://www.openphacts.org/units/Nanomolar,3218578,=,1,True,=,,IC50,nM,,149.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,149.3
,19274161,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(Br)cnn2C)cc1C(=O)N[C@@H]1CNCC[C@H]1c1ccc(Cl)cc1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '13.83', 'le': '0.31', 'lle': '2.87', 'sei': '10.32'}",CHEMBL4588742,,CHEMBL4588742,6.59,False,http://www.openphacts.org/units/Nanomolar,3218577,=,1,True,=,,IC50,nM,,255.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,255.3
,19274162,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2c(Cl)cnn2C)cc1C(=O)N[C@@H]1CNCC[C@H]1c1ccc(Cl)cc1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.44', 'le': '0.31', 'lle': '3.06', 'sei': '10.45'}",CHEMBL4457188,,CHEMBL4457188,6.67,False,http://www.openphacts.org/units/Nanomolar,3218576,=,1,True,=,,IC50,nM,,211.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,211.9
,19274163,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)c(C(F)(F)F)c2)sc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '12.07', 'le': '0.27', 'lle': '0.49', 'sei': '11.01'}",CHEMBL4453662,,CHEMBL4453662,6.49,False,http://www.openphacts.org/units/Nanomolar,3218575,=,1,True,=,,IC50,nM,,321.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,321.6
,19274164,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)sc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.12', 'le': '0.30', 'lle': '2.04', 'sei': '11.29'}",CHEMBL4582476,,CHEMBL4582476,6.65,False,http://www.openphacts.org/units/Nanomolar,3218574,=,1,True,=,,IC50,nM,,222.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,222.2
,19274165,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(F)c2)sc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.42', 'le': '0.33', 'lle': '2.52', 'sei': '11.86'}",CHEMBL4515689,,CHEMBL4515689,6.99,False,http://www.openphacts.org/units/Nanomolar,3218573,=,1,True,=,,IC50,nM,,101.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,101.6
,19274166,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)sc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '13.51', 'le': '0.30', 'lle': '1.37', 'sei': '10.77'}",CHEMBL4543839,,CHEMBL4543839,6.35,False,http://www.openphacts.org/units/Nanomolar,3218572,=,1,True,=,,IC50,nM,,448.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,448.9
,19274167,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1nccc1-c1csc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)c1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '16.78', 'le': '0.34', 'lle': '3.05', 'sei': '11.41'}",CHEMBL4530506,,CHEMBL4530506,6.73,False,http://www.openphacts.org/units/Nanomolar,3218571,=,1,True,=,,IC50,nM,,187.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,187.9
,19274168,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Br)c1-c1oc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)cc1Br,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '13.87', 'le': '0.35', 'lle': '2.80', 'sei': '10.44'}",CHEMBL4439720,,CHEMBL4439720,7.53,False,http://www.openphacts.org/units/Nanomolar,3218570,=,1,True,=,,IC50,nM,,29.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,29.8
,19274169,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1oc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)cc1Br,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.85', 'le': '0.35', 'lle': '2.78', 'sei': '10.26'}",CHEMBL4583911,,CHEMBL4583911,7.40,False,http://www.openphacts.org/units/Nanomolar,3218569,=,1,True,=,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,40.0
,19274170,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1nccc1-c1oc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)cc1Br,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.64', 'le': '0.33', 'lle': '2.82', 'sei': '9.42'}",CHEMBL4544411,,CHEMBL4544411,6.79,False,http://www.openphacts.org/units/Nanomolar,3218568,=,1,True,=,,IC50,nM,,162.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,162.5
,19274171,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Br)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)o1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '16.18', 'le': '0.37', 'lle': '3.54', 'sei': '10.41'}",CHEMBL4578995,,CHEMBL4578995,7.51,False,http://www.openphacts.org/units/Nanomolar,3218567,=,1,True,=,,IC50,nM,,31.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,31.2
,19274172,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)o1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '18.75', 'le': '0.38', 'lle': '4.00', 'sei': '10.91'}",CHEMBL4450141,,CHEMBL4450141,7.86,False,http://www.openphacts.org/units/Nanomolar,3218566,=,1,True,=,,IC50,nM,,13.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,13.7
,19274173,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)o1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '17.25', 'le': '0.34', 'lle': '3.43', 'sei': '9.21'}",CHEMBL4522820,,CHEMBL4522820,6.64,False,http://www.openphacts.org/units/Nanomolar,3218565,=,1,True,=,,IC50,nM,,230.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,230.2
,19274174,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Br)c1-c1coc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)c1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '16.06', 'le': '0.36', 'lle': '3.48', 'sei': '10.33'}",CHEMBL4465905,,CHEMBL4465905,7.45,False,http://www.openphacts.org/units/Nanomolar,3218564,=,1,True,=,,IC50,nM,,35.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,35.6
,19274175,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1coc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '19.70', 'le': '0.39', 'lle': '4.80', 'sei': '11.50'}",CHEMBL4529738,,CHEMBL4529738,8.29,False,http://www.openphacts.org/units/Nanomolar,3218563,=,1,True,=,,IC50,nM,,5.1,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,5.1
,19274176,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1nccc1-c1coc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)c1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '19.57', 'le': '0.38', 'lle': '4.32', 'sei': '10.45'}",CHEMBL4518386,,CHEMBL4518386,7.53,False,http://www.openphacts.org/units/Nanomolar,3218562,=,1,True,=,,IC50,nM,,29.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,29.4
,19274177,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(N[C@@H]1CNCC[C@H]1c1ccc(Cl)cc1)c1ccc(-c2ncnc3c2CCC3O)s1,,,CHEMBL4406807,J Med Chem,2019.0,,CHEMBL4454985,,CHEMBL4454985,,False,http://www.openphacts.org/units/Nanomolar,3218561,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
,19274178,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CNc1cc(-c2ccc(C(=O)N[C@@H]3CNCC[C@H]3c3ccc(Cl)cc3)o2)ncn1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '15.24', 'le': '0.30', 'lle': '2.97', 'sei': '6.82'}",CHEMBL4435265,,CHEMBL4435265,6.28,False,http://www.openphacts.org/units/Nanomolar,3218560,=,1,True,=,,IC50,nM,,529.5,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,529.5
,19274179,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2coc(C(=O)N[C@@H]3CNCC[C@H]3c3ccc(Cl)cc3)c2)cn1,,,CHEMBL4406807,J Med Chem,2019.0,,CHEMBL4585334,,CHEMBL4585334,,False,http://www.openphacts.org/units/Nanomolar,3218559,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
,19274180,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(N[C@@H]1CNCC[C@H]1c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)o1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '19.68', 'le': '0.38', 'lle': '4.10', 'sei': '8.80'}",CHEMBL4540052,,CHEMBL4540052,7.30,False,http://www.openphacts.org/units/Nanomolar,3218558,=,1,True,=,,IC50,nM,,50.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,50.3
,19274181,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2ccc(C(=O)N[C@@H]3CNCC[C@H]3c3ccc(Cl)cc3)o2)cn1,,,CHEMBL4406807,J Med Chem,2019.0,,CHEMBL4531682,,CHEMBL4531682,,False,http://www.openphacts.org/units/Nanomolar,3218557,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
,19274182,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)cc2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '17.11', 'le': '0.37', 'lle': '3.24', 'sei': '10.77'}",CHEMBL4554683,,CHEMBL4554683,7.76,False,http://www.openphacts.org/units/Nanomolar,3218556,=,1,True,=,,IC50,nM,,17.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.3
,19274183,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2cccc(C(F)(F)F)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '16.62', 'le': '0.35', 'lle': '3.22', 'sei': '11.23'}",CHEMBL4585120,,CHEMBL4585120,8.10,False,http://www.openphacts.org/units/Nanomolar,3218555,=,1,True,=,,IC50,nM,,8.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,8.0
,19274184,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(Cl)c(Cl)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '17.49', 'le': '0.39', 'lle': '3.37', 'sei': '11.84'}",CHEMBL4445510,,CHEMBL4445510,8.54,False,http://www.openphacts.org/units/Nanomolar,3218554,=,1,True,=,,IC50,nM,,2.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,2.9
,19274185,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H]2CNCC[C@@H]2c2ccc(F)c(F)c2)oc1Cl.O=C(O)[C@H](O)[C@@H](O)C(=O)O,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '16.01', 'le': '0.33', 'lle': '3.15', 'sei': '10.11'}",CHEMBL4533641,,CHEMBL4594793,7.29,False,http://www.openphacts.org/units/Nanomolar,3218553,=,1,True,=,,IC50,nM,,51.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,51.2
,19274186,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)oc1Cl.O=C(O)[C@H](O)[C@@H](O)C(=O)O,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '18.72', 'le': '0.39', 'lle': '4.38', 'sei': '11.82'}",CHEMBL4457064,,CHEMBL4597153,8.52,False,http://www.openphacts.org/units/Nanomolar,3218552,=,1,True,=,,IC50,nM,,3.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3.0
,19274187,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H]2CNCC[C@@H]2c2ccc(C(F)(F)F)cc2)oc1Cl.O=C(O)[C@H](O)[C@@H](O)C(=O)O,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.15', 'le': '0.29', 'lle': '2.01', 'sei': '9.56'}",CHEMBL4435138,,CHEMBL4594637,6.89,False,http://www.openphacts.org/units/Nanomolar,3218551,=,1,True,=,,IC50,nM,,127.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,127.4
,19274188,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(C(F)(F)F)cc2)oc1Cl.O=C(O)[C@H](O)[C@@H](O)C(=O)O,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '16.48', 'le': '0.34', 'lle': '3.15', 'sei': '11.14'}",CHEMBL4591854,,CHEMBL4595846,8.03,False,http://www.openphacts.org/units/Nanomolar,3218550,=,1,True,=,,IC50,nM,,9.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,9.3
,19274189,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '19.40', 'le': '0.41', 'lle': '4.77', 'sei': '9.67'}",CHEMBL3137336,UPROSERTIB,CHEMBL3137336,8.33,False,http://www.openphacts.org/units/Nanomolar,3218549,=,1,True,=,,IC50,nM,,4.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,9.6,4.7
,19274190,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)NC2CNCC2c2ccc(C(F)(F)F)cc2)oc1Cl,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '13.25', 'le': '0.28', 'lle': '1.78', 'sei': '8.70'}",CHEMBL4461188,,CHEMBL4461188,6.27,False,http://www.openphacts.org/units/Nanomolar,3218548,=,1,True,=,,IC50,nM,,538.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,538.0
,19274191,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Br)c1-c1coc(C(=O)NC2CNCC2c2ccc(F)c(F)c2)c1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '12.05', 'le': '0.27', 'lle': '2.23', 'sei': '7.54'}",CHEMBL4449288,,CHEMBL4449288,5.44,False,http://www.openphacts.org/units/Nanomolar,3218547,=,1,True,=,,IC50,nM,,3646.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,3646.0
,19274192,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1coc(C(=O)NC2CNCC2c2ccc(F)c(F)c2)c1,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '14.27', 'le': '0.28', 'lle': '2.71', 'sei': '8.05'}",CHEMBL4473634,,CHEMBL4473634,5.80,False,http://www.openphacts.org/units/Nanomolar,3218546,=,1,True,=,,IC50,nM,,1566.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1566.0
,19274193,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)NC2CNCCC2c2ccc(F)c(F)c2)oc1Cl.O=C(O)[C@H](O)[C@@H](O)C(=O)O,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '18.00', 'le': '0.37', 'lle': '4.05', 'sei': '11.37'}",CHEMBL4465572,,CHEMBL4597527,8.19,False,http://www.openphacts.org/units/Nanomolar,3218545,=,1,True,=,,IC50,nM,,6.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,6.4
,19274194,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)NC2CNCCC2c2ccc(C(F)(F)F)cc2)oc1Cl.O=C(O)[C@H](O)[C@@H](O)C(=O)O,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '16.71', 'le': '0.35', 'lle': '3.26', 'sei': '11.30'}",CHEMBL4536780,,CHEMBL4598293,8.14,False,http://www.openphacts.org/units/Nanomolar,3218544,=,1,True,=,,IC50,nM,,7.2,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,7.2
,19274195,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)NC2CNCCC2c2ccc(Cl)cc2)oc1Cl.O=C(O)[C@H](O)[C@@H](O)C(=O)O,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '17.11', 'le': '0.37', 'lle': '3.24', 'sei': '10.77'}",CHEMBL4443488,,CHEMBL4595262,7.76,False,http://www.openphacts.org/units/Nanomolar,3218543,=,1,True,=,,IC50,nM,,17.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.3
,19274196,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncc(Cl)c1-c1cc(C(=O)NC2CNCCC2c2ccccc2)oc1Cl.O=C(O)[C@H](O)[C@@H](O)C(=O)O,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '18.49', 'le': '0.38', 'lle': '3.89', 'sei': '10.76'}",CHEMBL4471578,,CHEMBL4598384,7.75,False,http://www.openphacts.org/units/Nanomolar,3218542,=,1,True,=,,IC50,nM,,17.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,17.6
,19274197,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1nccc1-c1coc(C(=O)NC2CNCCC2c2ccc(F)c(F)c2)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '17.39', 'le': '0.33', 'lle': '3.89', 'sei': '9.32'}",CHEMBL4570911,,CHEMBL4597750,6.72,False,http://www.openphacts.org/units/Nanomolar,3218541,=,1,True,=,,IC50,nM,,191.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,191.0
,19274198,[],CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1nccc1-c1coc(C(=O)NC2CNCCC2c2ccccc2)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O,,,CHEMBL4406807,J Med Chem,2019.0,"{'bei': '17.55', 'le': '0.32', 'lle': '3.59', 'sei': '8.53'}",CHEMBL4446375,,CHEMBL4596926,6.15,False,http://www.openphacts.org/units/Nanomolar,3218540,=,1,True,=,,IC50,nM,,709.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,709.6
,19371150,[],CHEMBL4424902,Inhibition of human full-length N-terminal His6-tagged PKBalpha expressed in baculovirus infected Sf21 insect cells using Crosstide as substrate,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1,,,CHEMBL4422686,Bioorg Med Chem Lett,2019.0,,CHEMBL4474690,,CHEMBL4474690,,False,http://www.openphacts.org/units/Nanomolar,3242204,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,1000.0
,19411486,[],CHEMBL4427679,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21,,,CHEMBL4425174,Bioorg Med Chem Lett,2016.0,,CHEMBL4564126,,CHEMBL4564126,,False,http://www.openphacts.org/units/Nanomolar,3244489,>=,1,True,>=,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.0
,19424626,[],CHEMBL4427679,Inhibition of AKT1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21,,,CHEMBL4425174,Bioorg Med Chem Lett,2016.0,,CHEMBL4564126,,CHEMBL4564126,,False,http://www.openphacts.org/units/Nanomolar,3244489,>=,1,True,>=,,IC50,nM,,5000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.0
,19471305,[],CHEMBL4478653,"Inhibition of full length active AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate/PDK1/MAPKAPK2/DOPS/DOPC/PtdIns(3,4,5)P3 addition measured after 30 mins by Alphascreen assay",B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '19.19', 'le': '0.34', 'lle': '3.23', 'sei': '8.68'}",CHEMBL4523032,,CHEMBL4297188,8.30,False,http://www.openphacts.org/units/Nanomolar,3255920,=,1,True,=,,IC50,nM,,5.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.005
,19471306,[],CHEMBL4478653,"Inhibition of full length active AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate/PDK1/MAPKAPK2/DOPS/DOPC/PtdIns(3,4,5)P3 addition measured after 30 mins by Alphascreen assay",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1.Cl,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '17.64', 'le': '0.32', 'lle': '3.61', 'sei': '6.93'}",CHEMBL4519558,,CHEMBL4595504,8.64,False,http://www.openphacts.org/units/Nanomolar,3255924,=,1,True,=,,IC50,nM,,2.3,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.0023
,19471307,[],CHEMBL4478653,"Inhibition of full length active AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate/PDK1/MAPKAPK2/DOPS/DOPC/PtdIns(3,4,5)P3 addition measured after 30 mins by Alphascreen assay",B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '19.18', 'le': '0.34', 'lle': '3.94', 'sei': '7.06'}",CHEMBL4574111,,CHEMBL4595158,8.59,False,http://www.openphacts.org/units/Nanomolar,3255925,=,1,True,=,,IC50,nM,,2.6,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.0026
,19471308,[],CHEMBL4478653,"Inhibition of full length active AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate/PDK1/MAPKAPK2/DOPS/DOPC/PtdIns(3,4,5)P3 addition measured after 30 mins by Alphascreen assay",B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '17.23', 'le': '0.31', 'lle': '3.01', 'sei': '6.88'}",CHEMBL4544109,,CHEMBL4596346,7.47,False,http://www.openphacts.org/units/Nanomolar,3255926,=,1,True,=,,IC50,nM,,34.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.034
,19471317,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2c(-c3cccnc3N)nc3cccnc32)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '20.38', 'le': '0.36', 'lle': '2.77', 'sei': '8.82'}",CHEMBL4535365,,CHEMBL4535365,6.14,False,http://www.openphacts.org/units/Nanomolar,3255906,=,1,True,=,,IC50,nM,,720.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.72
,19471318,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccc(-n2c(-c3cccnc3N)nc3cccnc32)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '15.23', 'le': '0.27', 'lle': '0.87', 'sei': '7.51'}",CHEMBL2177840,,CHEMBL2177840,5.23,False,http://www.openphacts.org/units/Nanomolar,3255907,=,1,True,=,,IC50,nM,,5900.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,5.9
,19471319,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.NCc1ccc(-n2c(-c3cccnc3N)nc3cccnc32)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '18.24', 'le': '0.33', 'lle': '3.25', 'sei': '6.03'}",CHEMBL4517839,,CHEMBL2177847,5.77,False,http://www.openphacts.org/units/Nanomolar,3255908,=,1,True,=,,IC50,nM,,1700.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.7
,19471320,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccnc2c1nc(-c1cccnc1N)n2-c1ccc(CN)cc1.Cl,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '19.07', 'le': '0.34', 'lle': '3.47', 'sei': '6.59'}",CHEMBL4568743,,CHEMBL4597164,6.30,False,http://www.openphacts.org/units/Nanomolar,3255909,=,1,True,=,,IC50,nM,,500.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.5
,19471321,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cnc2c(c1)nc(-c1cccnc1N)n2-c1ccc(CN)cc1.Cl,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '19.88', 'le': '0.36', 'lle': '3.74', 'sei': '6.87'}",CHEMBL4565210,,CHEMBL4595609,6.57,False,http://www.openphacts.org/units/Nanomolar,3255910,=,1,True,=,,IC50,nM,,270.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.27
,19471322,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc2nc(-c3cccnc3N)n(-c3ccc(CN)cc3)c2nc1C.Cl,,,CHEMBL4477217,J Med Chem,2016.0,,CHEMBL4543768,,CHEMBL4594703,,False,http://www.openphacts.org/units/Nanomolar,3255911,>,1,True,>,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,1.0
,19471323,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.NCc1ccc(-n2c(-c3cccnc3N)nc3ccc(Cl)nc32)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '18.72', 'le': '0.36', 'lle': '3.39', 'sei': '6.87'}",CHEMBL4545250,,CHEMBL4595610,6.57,False,http://www.openphacts.org/units/Nanomolar,3255912,=,1,True,=,,IC50,nM,,270.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.27
,19471324,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.NCc1ccc(-n2c(-c3cccnc3N)nc3cc(Br)cnc32)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '16.43', 'le': '0.35', 'lle': '3.20', 'sei': '6.79'}",CHEMBL4558319,,CHEMBL4596345,6.50,False,http://www.openphacts.org/units/Nanomolar,3255913,=,1,True,=,,IC50,nM,,320.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.32
,19471325,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.NCc1ccc(-n2c(-c3cccnc3N)nc3ccc(-c4ccccc4)nc32)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '21.48', 'le': '0.38', 'lle': '4.24', 'sei': '8.82'}",CHEMBL4513257,,CHEMBL4597416,8.43,False,http://www.openphacts.org/units/Nanomolar,3255914,=,1,True,=,,IC50,nM,,3.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.0037
,19471326,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CN)cc4)c3n2)c1.Cl,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '17.54', 'le': '0.32', 'lle': '3.74', 'sei': '6.32'}",CHEMBL4546484,,CHEMBL4597417,7.89,False,http://www.openphacts.org/units/Nanomolar,3255915,=,1,True,=,,IC50,nM,,13.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.013
,19471327,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1ccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CN)cc4)c3n2)cc1.Cl,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '15.89', 'le': '0.29', 'lle': '2.99', 'sei': '5.73'}",CHEMBL4586184,,CHEMBL4595502,7.14,False,http://www.openphacts.org/units/Nanomolar,3255916,=,1,True,=,,IC50,nM,,72.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.072
,19471328,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.NCc1ccc(-n2c(-c3cccnc3N)nc3ccc(-c4cn[nH]c4)nc32)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '20.32', 'le': '0.37', 'lle': '4.86', 'sei': '6.25'}",CHEMBL4576518,,CHEMBL4597165,7.77,False,http://www.openphacts.org/units/Nanomolar,3255917,=,1,True,=,,IC50,nM,,17.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.017
,19471329,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.NCc1ccc(-n2c(-c3cccnc3N)nc3cc(-c4cccnc4)cnc32)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '18.92', 'le': '0.34', 'lle': '3.85', 'sei': '6.86'}",CHEMBL4550916,,CHEMBL4595503,7.44,False,http://www.openphacts.org/units/Nanomolar,3255918,=,1,True,=,,IC50,nM,,36.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.036
,19471330,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(N)c1ccc(-n2c(-c3cccnc3N)nc3ccc(-c4ccccc4)nc32)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '19.66', 'le': '0.35', 'lle': '3.34', 'sei': '8.64'}",CHEMBL4528363,,CHEMBL4528363,8.27,False,http://www.openphacts.org/units/Nanomolar,3255919,=,1,True,=,,IC50,nM,,5.4,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.0054
,19471331,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '19.81', 'le': '0.35', 'lle': '3.50', 'sei': '8.96'}",CHEMBL4523032,,CHEMBL4297188,8.57,False,http://www.openphacts.org/units/Nanomolar,3255920,=,1,True,=,,IC50,nM,,2.7,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.0027
,19471332,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)NC1(c2ccc(-n3c(-c4cccnc4N)nc4ccc(-c5ccccc5)nc43)cc2)CCC1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '15.71', 'le': '0.28', 'lle': '2.21', 'sei': '7.55'}",CHEMBL4553900,,CHEMBL4553900,7.46,False,http://www.openphacts.org/units/Nanomolar,3255921,=,1,True,=,,IC50,nM,,35.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.035
,19471333,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)C1(c2ccc(-n3c(-c4cccnc4N)nc4ccc(-c5ccccc5)nc43)cc2)CCC1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '13.18', 'le': '0.24', 'lle': '0.94', 'sei': '6.53'}",CHEMBL4526693,,CHEMBL4526693,6.27,False,http://www.openphacts.org/units/Nanomolar,3255922,=,1,True,=,,IC50,nM,,540.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.54
,19471334,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)C1(c2ccc(-n3c(-c4cccnc4N)nc4ccc(-c5ccccc5)nc43)cc2)CCC1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '16.19', 'le': '0.29', 'lle': '2.82', 'sei': '6.62'}",CHEMBL4517319,,CHEMBL4517319,7.46,False,http://www.openphacts.org/units/Nanomolar,3255923,=,1,True,=,,IC50,nM,,35.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.035
,19471335,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1.Cl,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '17.47', 'le': '0.32', 'lle': '3.52', 'sei': '6.86'}",CHEMBL4519558,,CHEMBL4595504,8.55,False,http://www.openphacts.org/units/Nanomolar,3255924,=,1,True,=,,IC50,nM,,2.8,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.0028
,19471336,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '19.49', 'le': '0.35', 'lle': '4.07', 'sei': '7.17'}",CHEMBL4574111,,CHEMBL4595158,8.72,False,http://www.openphacts.org/units/Nanomolar,3255925,=,1,True,=,,IC50,nM,,1.9,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.0019
,19471337,[],CHEMBL4478656,Inhibition of full length unphosphorylated AKT1 (1 to 480 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '18.97', 'le': '0.34', 'lle': '3.76', 'sei': '7.58'}",CHEMBL4544109,,CHEMBL4596346,8.22,False,http://www.openphacts.org/units/Nanomolar,3255926,=,1,True,=,,IC50,nM,,6.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.006
,19471400,[],CHEMBL4478663,Inhibition of AKT1 phosphorylation at Ser473 in EGF/insulin-stimulated human AN3CA cells incubated for 1 hr followed by stimulation for 15 mins by Western blot analysis,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '17.10', 'le': '0.31', 'lle': '2.33', 'sei': '7.74'}",CHEMBL4523032,,CHEMBL4297188,7.40,False,http://www.openphacts.org/units/Nanomolar,3255920,=,1,True,=,,IC50,nM,,40.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.04
,19471401,[],CHEMBL4478663,Inhibition of AKT1 phosphorylation at Ser473 in EGF/insulin-stimulated human AN3CA cells incubated for 1 hr followed by stimulation for 15 mins by Western blot analysis,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '16.73', 'le': '0.30', 'lle': '2.79', 'sei': '6.68'}",CHEMBL4544109,,CHEMBL4596346,7.25,False,http://www.openphacts.org/units/Nanomolar,3255926,=,1,True,=,,IC50,nM,,56.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.056
,19471402,[],CHEMBL4478664,Inhibition of AKT1 phosphorylation at Ser473 in EGF/insulin-stimulated human A2780 cells incubated for 1 hr followed by stimulation for 15 mins by Western blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1.Cl,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '15.09', 'le': '0.27', 'lle': '2.36', 'sei': '5.92'}",CHEMBL4519558,,CHEMBL4595504,7.39,False,http://www.openphacts.org/units/Nanomolar,3255924,=,1,True,=,,IC50,nM,,41.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.041
,19471403,[],CHEMBL4478665,Inhibition of AKT1 phosphorylation at Thr308 in EGF/insulin-stimulated human AN3CA cells incubated for 1 hr followed by stimulation for 15 mins by Western blot analysis,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '16.68', 'le': '0.30', 'lle': '2.14', 'sei': '7.54'}",CHEMBL4523032,,CHEMBL4297188,7.21,False,http://www.openphacts.org/units/Nanomolar,3255920,=,1,True,=,,IC50,nM,,61.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.061
,19471404,[],CHEMBL4478665,Inhibition of AKT1 phosphorylation at Thr308 in EGF/insulin-stimulated human AN3CA cells incubated for 1 hr followed by stimulation for 15 mins by Western blot analysis,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '16.61', 'le': '0.30', 'lle': '2.74', 'sei': '6.63'}",CHEMBL4544109,,CHEMBL4596346,7.20,False,http://www.openphacts.org/units/Nanomolar,3255926,=,1,True,=,,IC50,nM,,63.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.063
,19471405,[],CHEMBL4478666,Inhibition of AKT1 phosphorylation at Thr308 in EGF/insulin-stimulated human A2780 cells incubated for 1 hr followed by stimulation for 15 mins by Western blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1.Cl,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '15.18', 'le': '0.27', 'lle': '2.40', 'sei': '5.96'}",CHEMBL4519558,,CHEMBL4595504,7.43,False,http://www.openphacts.org/units/Nanomolar,3255924,=,1,True,=,,IC50,nM,,37.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.037
,19471406,[],CHEMBL4478667,Inhibition of AKT1 in EGF/insulin-stimulated human AN3CA cells assessed as reduction in phosphorylation at Thr246 incubated for 1 hr followed by stimulation for 15 mins by Western blot analysis,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '15.05', 'le': '0.27', 'lle': '1.44', 'sei': '6.81'}",CHEMBL4523032,,CHEMBL4297188,6.51,False,http://www.openphacts.org/units/Nanomolar,3255920,=,1,True,=,,IC50,nM,,310.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.31
,19471407,[],CHEMBL4478667,Inhibition of AKT1 in EGF/insulin-stimulated human AN3CA cells assessed as reduction in phosphorylation at Thr246 incubated for 1 hr followed by stimulation for 15 mins by Western blot analysis,B,,,BAO_0000190,BAO_0000019,assay format,Cl.Nc1ncccc1-c1nc2ccc(-c3cccnc3)nc2n1-c1ccc(C2(N)CCC2)cc1,,,CHEMBL4477217,J Med Chem,2016.0,"{'bei': '14.29', 'le': '0.26', 'lle': '1.73', 'sei': '5.71'}",CHEMBL4544109,,CHEMBL4596346,6.19,False,http://www.openphacts.org/units/Nanomolar,3255926,=,1,True,=,,IC50,nM,,640.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,0.64
,19471408,[],CHEMBL4478668,Inhibition of AKT1 in EGF/insulin-stimulated human A2780 cells assessed as reduction in phosphorylation at Thr246 incubated for 1 hr followed by stimulation for 15 mins by Western blot analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(C5(N)CCC5)cc4)c3n2)c1.Cl,,,CHEMBL4477217,J Med Chem,2016.0,,CHEMBL4519558,,CHEMBL4595504,,False,http://www.openphacts.org/units/Nanomolar,3255924,>,1,True,>,,IC50,nM,,3000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,uM,UO_0000065,,3.0
,19476543,[],CHEMBL4479691,Inhibition of full-length recombinant human His-tagged AKT1-alpha expressed in baculovirus expression system by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1,,,CHEMBL4477252,Bioorg Med Chem Lett,2016.0,"{'bei': '8.72', 'le': '0.17', 'lle': '-0.66', 'sei': '6.44'}",CHEMBL4569508,,CHEMBL4569508,4.62,False,http://www.openphacts.org/units/Nanomolar,3256955,=,1,True,=,,IC50,nM,,24000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,24000.0
,19476643,[],CHEMBL4479691,Inhibition of full-length recombinant human His-tagged AKT1-alpha expressed in baculovirus expression system by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1,,,CHEMBL4477252,Bioorg Med Chem Lett,2016.0,,CHEMBL4550702,,CHEMBL4550702,,False,http://www.openphacts.org/units/Nanomolar,3256963,>,1,True,>,,IC50,nM,,100000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,100000.0
,19476743,[],CHEMBL4479691,Inhibition of full-length recombinant human His-tagged AKT1-alpha expressed in baculovirus expression system by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1,,,CHEMBL4477252,Bioorg Med Chem Lett,2016.0,"{'bei': '16.84', 'le': '0.32', 'lle': '4.24', 'sei': '6.88'}",CHEMBL4568087,,CHEMBL4568087,7.10,False,http://www.openphacts.org/units/Nanomolar,3256973,=,1,True,=,,IC50,nM,,80.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,80.0
,19476843,[],CHEMBL4479691,Inhibition of full-length recombinant human His-tagged AKT1-alpha expressed in baculovirus expression system by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12,,,CHEMBL4477252,Bioorg Med Chem Lett,2016.0,"{'bei': '14.23', 'le': '0.30', 'lle': '2.40', 'sei': '7.10'}",CHEMBL4552628,,CHEMBL4552628,6.06,False,http://www.openphacts.org/units/Nanomolar,3256981,=,1,True,=,,IC50,nM,,870.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,IC50,nM,UO_0000065,,870.0
,20144322,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'uM', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'uM', 'value': '1.0'}]",CHEMBL4512995,Akt1 [PKBalpha(AKT1PHFB)] Takeda global kinase panel,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21,,,CHEMBL4507326,,,"{'bei': '13.09', 'le': '0.26', 'lle': '4.87', 'sei': '5.89'}",CHEMBL4097778,,CHEMBL4097778,6.00,False,http://www.openphacts.org/units/Nanomolar,3359781,=,54,True,=,,IC50,nM,,1000.0,CHEMBL4282,Homo sapiens,Serine/threonine-protein kinase AKT,9606,,,pIC50,,UO_0000065,,6.0
